GO,Function,Proteins,Gene Name,Ontology group,Count of protein,Number of proteins detected within the genome,GO frequency within the dataset (%),GO frequency within the genome (%),P-Value,P-Values_BH
GO:0005737,cytoplasm,A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)G3X793(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q2YDJ9(Evidence code:ISS/Database source:UniProtKB:Q9Y5P6)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR005937)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9N287(Evidence code:ISS/Database source:UniProtKB:Q9UKB3)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)P62194(Evidence code:IEA/Database source:InterPro:IPR005937)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433338)A4FUC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR005937)P48034(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q1JPG7(Evidence code:IBA/Database source:PANTHER:PTN000212670)O46414(Evidence code:IBA/Database source:PANTHER:PTN000153092)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPM0(Evidence code:IBA/Database source:PANTHER:PTN000022879)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q92543|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MNF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F2Z4C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR004493)Q17QB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)Q3MHR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9Z2J0)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)E1B719(Evidence code:IBA/Database source:PANTHER:PTN001506277)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1B937(Evidence code:IEA/Database source:InterPro:IPR003732)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6H7B5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)O62768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E9D5(Evidence code:ISS/Database source:UniProtKB:Q9R0P5)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)E1BMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:Q8BGX0|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)O97764(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P26696)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MKE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q3ZBJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1B953(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)F1MXQ5(Evidence code:IBA/Database source:PANTHER:PTN000021568)F1MX60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)A1A4P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0IIA3(Evidence code:IBA/Database source:PANTHER:PTN000021568)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN000192346)P61356(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BNB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32KW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P84798(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR005937)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q504T8|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q2TBQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32L99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BLB5(Evidence code:IEA/Database source:UniProtKB:Q15735|ens)E1B9H1(Evidence code:IEA/Database source:UniProtKB:Q99JR5|ens)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR009976)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)Q32PA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)A6QLG1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)Q0VCN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q4JIJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q5E9A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0P568(Evidence code:IEA/Database source:UniProtKB:P70362|ens)P00376(Evidence code:ISS/Database source:UniProtKB:Q920D2)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MM21(Evidence code:IBA/Database source:PANTHER:PTN000090250)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)Q2KI18(Evidence code:IBA/Database source:PANTHER:PTN000274414)F1MCX4(Evidence code:IEA/Database source:UniProtKB:P29597|ens)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)G3MZP6(Evidence code:IEA/Database source:UniProtKB:Q8IYT2|ens)G5E567(Evidence code:IEA/Database source:UniProtKB:Q96P70|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q3T0P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MQD1(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q32L41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)A5PJL3(Evidence code:IBA/Database source:PANTHER:PTN000622075)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011407)G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q3T0M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SYU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)A5D7P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q9XTA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KIT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2TBX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)A6QP57(Evidence code:ISS/Database source:UniProtKB:Q08188)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)Q58DC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q3ZC42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)E1BP38(Evidence code:IEA/Database source:UniProtKB:Q6GYP7|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)Q2NKZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)F1N3K4(Evidence code:IBA/Database source:PANTHER:PTN000584061)F1N1X8(Evidence code:IBA/Database source:PANTHER:PTN000629506)A3KMV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6H7D7(Evidence code:IEA/Database source:UniProtKB:Q9Y6E2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695)Q0III2(Evidence code:ISS/Database source:UniProtKB:O43462)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)E1BFJ4(Evidence code:IEA/Database source:UniProtKB:Q99MV7|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)G3X6L5(Evidence code:IEA/Database source:UniProtKB:Q96BM9|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268)A2VDS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T099(Evidence code:IEA/Database source:InterPro:IPR002306)A7Z045(Evidence code:IEA/Database source:UniProtKB:Q96KN1|ens)A6QLD1(Evidence code:IEA/Database source:UniProtKB:Q96A65|ens)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6)F1MBM5(Evidence code:IEA/Database source:UniProtKB:Q9ER41|ens)A7YSY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)Q8SPX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2YDE9(Evidence code:ISS/Database source:UniProtKB:P47226)Q0VCP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PJV3(Evidence code:IEA/Database source:InterPro:IPR005920)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)F1MJI3(Evidence code:IBA/Database source:PANTHER:PTN001021265)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6H769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7Z052(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)F1MTH3(Evidence code:IEA/Database source:UniProtKB:Q6ZPF3|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P61211)P48644(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q3T178(Evidence code:ISS/Database source:UniProtKB:Q9UK41)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9QXG4|ens)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P61283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZBF0(Evidence code:IBA/Database source:PANTHER:PTN000557970)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)A6QQ21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B8X4(Evidence code:IBA/Database source:PANTHER:PTN000102039)Q9TTK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MB16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)A5D980(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)A8E4N3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)O02811(Evidence code:ISS/Database source:UniProtKB:P42356)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q0VC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)Q0IIM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BLZ8(Evidence code:IEA/Database source:InterPro:IPR027531)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BQ04(Evidence code:IBA/Database source:PANTHER:PTN000344873)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)Q0VCX5(Evidence code:IEA/Database source:InterPro:IPR004403)Q58DA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3MHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KHX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BL29(Evidence code:IBA/Database source:PANTHER:PTN001621808)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004522)Q29460(Evidence code:ISS/Database source:UniProtKB:Q61205)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q6VNB8|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BMN0(Evidence code:IBA/Database source:PANTHER:PTN000066595)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR015212)Q3ZC12(Evidence code:IEA/Database source:InterPro:IPR017334)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BEE6(Evidence code:IBA/Database source:PANTHER:PTN000344873)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)A4IFE3(Evidence code:ISS/Database source:UniProtKB:P42025)Q2HJ86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VD53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR009374)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q32LB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N1C5(Evidence code:IEA/Database source:UniProtKB:P62932|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005673)Q95106(Evidence code:ISS/Database source:UniProtKB:P21237)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O43182|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)Q17QK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P16116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)E1BN72(Evidence code:IBA/Database source:PANTHER:PTN000678822)Q32L40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)Q5E953(Evidence code:IBA/Database source:PANTHER:PTN000308898)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q3T148(Evidence code:IEA/Database source:InterPro:IPR027528)E1BB00(Evidence code:IEA/Database source:UniProtKB:Q8WXI3|ens)F1MJP2(Evidence code:IBA/Database source:PANTHER:PTN000341955)Q3MI00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR027529)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q32LM0(Evidence code:IEA/Database source:InterPro:IPR004148)Q3T0E0(Evidence code:IBA/Database source:PANTHER:PTN000517250)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N6C1(Evidence code:IBA/Database source:PANTHER:PTN001147562)P11064(Evidence code:IEA/Database source:InterPro:IPR002115)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q28007(Evidence code:IEA/Database source:InterPro:IPR005720)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P61763(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001482048)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR012234)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MX23(Evidence code:IEA/Database source:InterPro:IPR004148)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR002318|I)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q5E966(Evidence code:IEA/Database source:InterPro:IPR027525)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4IFC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BER6(Evidence code:IEA/Database source:InterPro:IPR011778)A6QLE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR030703)F1MTK2(Evidence code:IEA/Database source:UniProtKB:Q6P9B6|ens)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P20456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32LM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLY4(Evidence code:IBA/Database source:PANTHER:PTN001797383)F1ML89(Evidence code:IBA/Database source:PANTHER:PTN000150222)F1MV85(Evidence code:IBA/Database source:PANTHER:PTN001002363)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)Q5E9L2(Evidence code:ISS/Database source:UniProtKB:O60477)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)P80227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A8E641(Evidence code:IEA/Database source:InterPro:IPR011778|I)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)A2VDK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR009161)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)F1MZM7(Evidence code:IBA/Database source:PANTHER:PTN000571279)P02510(Evidence code:ISS/Database source:UniProtKB:P02511)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJP2(Evidence code:IBA/Database source:PANTHER:PTN000571279)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)G3X736(Evidence code:IEA/Database source:UniProtKB:P61201|ens)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7Q7(Evidence code:IBA/Database source:PANTHER:PTN000134256)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q58DC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0Z7(Evidence code:IEA/Database source:UniProtKB:P09417|ens)F6PW02(Evidence code:IEA/Database source:GO:0006888)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q14145|ens)Q2HJ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000015249)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)A6H767(Evidence code:ISS/Database source:UniProtKB:P28656)G5E5Q8(Evidence code:IEA/Database source:UniProtKB:O95248|ens)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)A7YY70(Evidence code:IBA/Database source:PANTHER:PTN000000493)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VCF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)A0JN39(Evidence code:IEA/Database source:InterPro:IPR016460)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MKY9(Evidence code:IBA/Database source:PANTHER:PTN000366978)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-1)Q3MHL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)P83437(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)Q56JX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BE13(Evidence code:IBA/Database source:PANTHER:PTN000005165)A7YY57(Evidence code:IEA/Database source:UniProtKB:Q52LW3|ens)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BG38(Evidence code:IEA/Database source:InterPro:IPR015212)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)P81948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q09139(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q32S26(Evidence code:IEA/Database source:UniProtKB:Q7JJ13|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)Q17QL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SX07(Evidence code:IBA/Database source:PANTHER:PTN000124846)F6RP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q9NQI0)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q0P5L0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)Q3T0N5(Evidence code:IBA/Database source:PANTHER:PTN000622075)E1BIX3(Evidence code:IBA/Database source:PANT, FOXO4 MCTS1 NSFL1C MAPK11 DHX9 NCOA3 GMPPB FKBP4 TNFAIP8L3 CHMP1B PPP1CB COPA ACTR5 USP20 PSMC6 PCMT1 G6PD RAB3B SEC23A DNAJC12 COPB2 MALT1 SYNJ1 FMNL3 PSMC5 SNX27 DHX8 RHPN2 PSMC3 AOX1 PPP2CB UBQLN1 PKLR FTH1 MX2 RASAL1 DYNLL2 SNX19 CDC5L VPS25 SEPT7 BRAF AGTPBP1 HINT3 QARS APC2 SRC FAM213B LOC100141266 PSMA4 TUBA1A ATP1A2 LARS RAB30 LAMP1 LYPLA1 NDC1 SLC23A1 TRIM68 ANKHD1 RASAL2 DTD2 DCTN3 CSNK1G1 NAPRT COPS3 TXNRD1 DSTN SPOPL HPS6 CLTA DDX1 AP2A1 TRIM23 PAK2 ACTR1A TDRD1 CRYZ PSEN1 MAPK1 DGCR8 TAF8 SPTB EIF4A2 BEX5 PSMB8 PSMB10 DLG1 LOC533307 HIPK4 NUAK1 CUBN RPAP2 CAPN11 CYFIP2 FLNC PFDN2 SRI ZMYM5 RPL27 PABPC1L DYNLL1 ALOX15 UBXN1 POLD3 PSMC1 ARPC5L PIGT MAP3K4 MIDN AXIN1 PGLS PTGR2 INPP5J TINAGL1 PDXP EXOC5 MYO9B LIN7C PHPT1 WEE1 LOC515358 CPSF3L NMRAL1 MTRR MKL1 ABHD12 NPAT NIF3L1 HCFC1 PCBP1 UFD1L DHFR ARFGEF1 HCFC2 COPE RGS6 DNM1 XPO1 CPNE6 PPP3CC ANKRD17 PNPLA2 TYK2 HEPACAM SVIL LTA4H SH3PXD2A PPP2R5A CMTR2 IPO9 SETX CASP6 CAPN5 GCHFR COPS5 ABL1 KLHL26 MAPK12 SLK ALDH1L2 RTN4R SMG1 EPRS ARL4A TNPO1 EGLN3 TUBGCP2 PTPRM CHMP3 PUM1 TAOK2 PREP PSMB3 DNPH1 CTNNA1 DNAJB4 IER5 UBE2V1 CORO7 PDCD10 CHMP2B VBP1 GOLGA4 TGM3 CDK3 BCL9 GTPBP1 PSMD12 TAF10 KATNAL2 PTPN23 ADH5 USP36 PRMT5 CDC27 SGSM2 TMC6 RALGAPA1 PAK1 RPS15A RPS6KA5 CCT7 COPZ1 RPS6KA2 MAP3K9 UBE2Z RANBP10 BZW2 GLI1 PARP1 MBTPS2 STK36 RNF17 GPSM2 BRSK2 DNMT3A ARL8A MYLK2 ARCN1 E2F1 IMPDH2 SCLY PKHD1 TMEM184A WARS2 FAM84B EXOC4 PPP3CA CAND1 TOR1B SPATA5L1 EIF2B5 SMTNL1 GRB2 CRYL1 NF2 PKNOX1 PANK4 TES SEPT8 BCL3 NLRP5 AMDHD1 ALDH1A3 SRGAP3 MASTL PRKACB MAPKAPK3 SWAP70 KHDRBS1 CLINT1 RPS7 DNPEP WDR6 ASB14 FAM129B TIAM2 SPTBN4 TUBB1 EIF6 ARL1 ALDH1A1 RPL11 TNPO3 LOC101905447 SOX4 ATP2B2 TRAPPC2L TAOK3 CHMP4A VPS28 MAP2K4 ACSS2 PRKAR2A BANF1 ALDOB NADSYN1 DDX58 COPS6 NAE1 LYST ZFYVE26 EIF3B TTI1 CDC42SE2 PACSIN3 PTPN6 CPNE1 BRCA1 RSPH3 MOB1B PI4KA SP7 MAPK10 CTU1 ANKIB1 HSPH1 EIF3F KPNB1 SEPT11 BLM PKP4 TDRD5 GRHPR ETF1 GLRX3 RAP2C RGS14 UTRN WNK1 MAP3K8 S100A14 CRYM BLMH GALK1 NARS PAFAH1B3 CHMP4B WDFY3 BRCA2 ARL2 TUBB4A NEU4 ARHGEF12 EIF3G MAP3K14 WRN NUDT16 ACTR1B TUBA1D VPS26A EIF3K SNRPE LEF1 CXXC5 FBXO40 IKBKAP DOCK10 NEDD4 PIK3CD BDNF ARL8B ARHGAP6 OTUD7B SPR SEC23B AKR1B1 CTNND1 RPS19 NIM1K TCP1 HYAL1 MAP3K10 UFC1 TPR STAT5A EIF3M ASB10 RNF165 DNAJB1 RPGRIP1L AGO3 PTGES3 ADSS GIPC1 STAT5B SH3GLB1 ATOX1 DYNC1I2 LRRK1 ACP1 CTTN ARAP3 MPP5 DICER1 CLUH DPYD ACTN2 RAN STXBP1 CASP3 EIF4E1B MYO1A RANBP2 VPS29 PREX1 TOR1A CCAR2 ZAP70 ARHGAP35 SH3GL3 BRCC3 METAP2 AARS EEF1E1 MROH2B AGO4 CUL3 EIF3I SIRT2 VPS36 PABPC4 SLIT2 CRMP1 TDRD7 CLIC4 HDAC5 TLDC1 COPG2 IMPA1 SGTA PSMB4 ISOC1 CPS1 PBDC1 SHMT2 BRINP1 TNKS1BP1 APEH DPYSL5 DDX20 WASF2 RNF112 DNAJC7 ACAT2 BTBD11 PIWIL2 PFKP SDCBP2 SYDE2 CRYAB UBE2K RAD23B RACGAP1 STRAP COPS2 CSNK1A1 PAK6 TRIP12 COL2A1 PEF1 TUBB3 PALM MAGI1 DHX34 CPPED1 QDPR TFG PKN1 RNF220 CAMK2D PDCD6 LRRK2 KEAP1 PITPNA BFSP1 POLQ PCM1 ARVCF NAP1L1 SBF1 SNRPN SLC34A1 FERMT2 SRSF1 SIKE1 UBE4B SSH2 SNX3 PTTG1IP STK3 COPB1 PAK3 EIF4A3 GLI2 ALPK2 SH3BP4 STRN3 TSC22D1 STK26 MMS19 XPO7 COG5 RYR1 RPS28 CSNK1G2 BIRC6 ARHGAP29 NFKB1 SEPT6 ARHGEF1 CAMK2A PCBD1 NXF3 GNAI1 SDCCAG8 TUBA4A PAN2 FABP7 ZMYM4 BRD2 ARF6 TET3 IQGAP2 SMG6 AXIN2 GNPDA2 PUS3 LOC100295712 TSC2 FGF1 PACSIN2 GK PHACTR4 PTPN14 COMT PABPC1 VTA1 XPNPEP1 PIN1 DDX4 DAB2IP UBXN6 CDK6 RBM42 MAP3K1 STK25 MRI1 SRF PRKACA MAPK13 CAPN7 OXT ITPR1 ARPC1A PPP1R1C NDRG2 TSN SH3GLB2 LOC101902172 MB21D1 PTPA ALDH9A1 PLK3 PRKCB BAIAP2 DYNLRB1 ALDH1L1 EMILIN3 RNF128 KCNMA1 MTAP ABCE1 AP5Z1 MT3 RAB11FIP1 EPM2AIP1 DNM2 ROCK2 IPO4 CDK1 RPS6KA4 ATP6V1B1 PTP4A1 MIB2 RDX PFKM DYNLT1 MYH14 SULT1A1 IARS CHML SH3GL1 PASK DSTYK SHC1 MPI PPP2R5E PINK1 PMM2 UBE2L3 XPOT IDE BICD2 PPP2CA ACLY TDRD9 GARS SSUH2 FHIT KLC4 TACC1 MYO1C DGKQ OSBP MYLK3 MPDZ SPAG1 EIF1 SNAP25 TAX1BP3 CAPN2 PRKCI PDCD4 UBTD2 DNAJB11 NDRG1 MARK3 SEC24A PURA CSNK1G3 EIF4G1 MARS ZFHX3 UBE2M CCT3 PNPT1 ARL6 GART GPN1 ZFYVE27 ERCC2 RPS18 DHX37 KIF2A TSTD1 PEX1 MTHFD1 CAD DIP2B IRF1 CDK5RAP2 COLEC10 MCM3AP AHCYL2 UBE2G2 UXS1 AIFM2 GPHN LIPE PABPN1 TRAF6 USP9X KIF13B MYO6 POU4F2 CLIC6 PSMA7 PDZD2 TOM1 SEPT2 TUBA3E PKIB PLK4 CELF3 FKBP2 RPS9 PPP1CC CCT6B SNF8 RFFL CDH11 DYRK2 AHCTF1 ISPD BDH2 JAK2 VAV2 CCT8 PSMB9 NRBF2 AFAP1L2 S100B RAB23 SPG20 CYFIP1 MVB12A AIFM1 RAB4A AARS2 NAP1L4 SSB ECT2 TWF1 SAP18 AP3B2 WWC1 STRIP2 SPRY4 IKBKG UBR2 AASS MAPK9 LZTFL1 RARS2 MAPK4 VPS4B UFM1 NPEPPS PSMA3 EIF4H HUWE1 PCBP2 UBE2V2 PIP4K2C FRS2 MAPK8IP3 EXOC8 IPO5 DZIP3 TBC1D2 DCTN2 RARS RBP1 TJP1 CDK17 ANXA11 SH3BGRL2 FKBP9 PSMC2 COPS4 EXD3 COPS8 WWTR1 TEKT4 VPS35 SPAST FIGNL1 STAT3 ELMO2 TUBA8 PRUNE1 LRPPRC CAMK2B SH2B2 GAPDHS PAK4 INTS3 MICAL3 RAPGEF2 PPID MRVI1 TSG101 MTMR1 GNAT3 CNP NFE2L2 SYNGAP1,CC,749,749 of 1304,32.85,57.44,0,0
GO:0005634,nucleus,Q32L48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MT17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)G3N3L9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)G3N068(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004826|I)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MXR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0II50(Evidence code:ISS/Database source:UniProtKB:Q9BQ65)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR017357|I)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)E1B8E2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:A0A140VK27)F1MRK2(Evidence code:IBA/Database source:PANTHER:PTN000573351)E1BKC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BAN2(Evidence code:IBA/Database source:PANTHER:PTN000553509)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)F1MBK6(Evidence code:IEA/Database source:UniProtKB:A2A884|ens)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR014978)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217)Q3MHL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N413(Evidence code:IEA/Database source:InterPro:IPR007728)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR000747)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KIW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0P5L0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MLE1(Evidence code:IEA/Database source:UniProtKB:Q9P265|ens)Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80)Q2KHT7(Evidence code:IEA/Database source:UniProtKB:P42677|ens)Q1MW18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P02638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BCY1(Evidence code:IEA/Database source:UniProtKB:A6ND36|ens)F1N2I0(Evidence code:IEA/Database source:UniProtKB:P26374|ens)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6)E1BPM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)Q08E07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BC24(Evidence code:IEA/Database source:InterPro:IPR012099)Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN000383724)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)M5FK72(Evidence code:IEA/Database source:InterPro:IPR026936)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628|I)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N226(Evidence code:IEA/Database source:UniProtKB:Q06481|ens)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:Q8BGX0|ens)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BET5(Evidence code:IEA/Database source:UniProtKB:P28290|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000015268)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR030703)G3X793(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BL97(Evidence code:IEA/Database source:InterPro:IPR029547)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1BF32(Evidence code:IBA/Database source:PANTHER:PTN000035347)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MN42(Evidence code:IBA/Database source:PANTHER:PTN000623091)A1A4R2(Evidence code:IEA/Database source:InterPro:IPR026306)E1BE98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MNR5(Evidence code:IBA/Database source:PANTHER:PTN000682064)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O43439|ens)A1A4I8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E9F8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)F1MIL2(Evidence code:IEA/Database source:InterPro:IPR009146)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q3MHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7Z061(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5D7C4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR008013)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)G5E526(Evidence code:IBA/Database source:PANTHER:PTN000596947)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:Q9R1C7|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)E1BGN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P37359(Evidence code:ISS/Database source:UniProtKB:Q61221)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q3TPJ7|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62269|ens)P02510(Evidence code:ISS/Database source:UniProtKB:P02511)E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)E1BN72(Evidence code:IBA/Database source:PANTHER:PTN000678822)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR003888|I)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:B0LPF3|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A6QR44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR006560)F1MBH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)Q2KII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BDG9(Evidence code:IEA/Database source:UniProtKB:Q3SY69|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:A0A024R6A3)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BKQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G8JL00(Evidence code:IEA/Database source:InterPro:IPR002119)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)A5D7F6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3MZY8(Evidence code:IEA/Database source:UniProtKB:P08775|ens)F1N281(Evidence code:ISS/Database source:UniProtKB:Q7Z4V0)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F2Z4E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:A0A024R1Y6)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939)Q0VCK2(Evidence code:IBA/Database source:PANTHER:PTN000395870)Q17QL4(Evidence code:IEA/Database source:UniProtKB:A0A024R9Y7)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040|I)Q32L41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MYE0(Evidence code:IEA/Database source:UniProtKB:A0A024R499)Q3SYX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)G3N053(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462267)P06526(Evidence code:IEA/Database source:InterPro:IPR018944)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QP24(Evidence code:ISS/Database source:UniProtKB:Q9NTI7)E1BDV5(Evidence code:IEA/Database source:UniProtKB:C9JFV4|ens)P84798(Evidence code:IEA/Database source:InterPro:IPR019038)E1BNQ9(Evidence code:IEA/Database source:UniProtKB:Q00PI9|ens)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR001699|I)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)E1BJE7(Evidence code:IEA/Database source:UniProtKB:O60318|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)E1BBH8(Evidence code:IEA/Database source:InterPro:IPR001739)Q28165(Evidence code:ISS/Database source:UniProtKB:Q86U42)F1MCX4(Evidence code:IEA/Database source:UniProtKB:P29597|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q5E9A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)P10881(Evidence code:IEA/Database source:InterPro:IPR002344)E1BDZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1BD77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:F8VVT9|ens)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR001951|I)E1BNH7(Evidence code:IEA/Database source:InterPro:IPR006560)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)F1ML85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)E1B8Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR004582|I)A4IFC8(Evidence code:IBA/Database source:PANTHER:PTN000048763)A7YW98(Evidence code:IEA/Database source:UniProtKB:P54136|ens)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)A5PJW1(Evidence code:IEA/Database source:InterPro:IPR003923)A5PKI6(Evidence code:IBA/Database source:PANTHER:PTN000317389)E1BJP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2HJ84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MHR3(Evidence code:IEA/Database source:UniProtKB:A0A024RC95)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217)F1MBP8(Evidence code:IEA/Database source:UniProtKB:A0A024R7W9)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR026607)Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q15819|ens)E1BF96(Evidence code:IEA/Database source:InterPro:IPR003617|I)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q32KX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9R078|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)F1N0D7(Evidence code:IEA/Database source:UniProtKB:A0A024RDY6)P61283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245)F1MVZ2(Evidence code:IBA/Database source:PANTHER:PTN000678822)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)F1MHP1(Evidence code:IEA/Database source:UniProtKB:O15042|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR003893)E1B793(Evidence code:IEA/Database source:UniProtKB:Q9NRP7|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)F1N734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004826|I)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MU53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR030449)E1BEB7(Evidence code:IEA/Database source:UniProtKB:Q8WWH5|ens)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q1RMU0(Evidence code:IEA/Database source:InterPro:IPR006988|I)E1BNY9(Evidence code:IBA/Database source:PANTHER:PTN000745052)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E938(Evidence code:IEA/Database source:UniProtKB:P41567|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O88286|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)A6QP29(Evidence code:IEA/Database source:UniProtKB:Q9BYX2|ens)G3MYD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR033486)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q8CFT2|ens)A6H7B5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q08DY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MLP0(Evidence code:IEA/Database source:InterPro:IPR029833)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)Q32PF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MUU2(Evidence code:IEA/Database source:UniProtKB:Q8TDR2|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)Q3MI00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)F1MPR9(Evidence code:IEA/Database source:UniProtKB:Q6P4R8|ens)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR002119)A5PJL3(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)E1BC18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BH22(Evidence code:IEA/Database source:InterPro:IPR002119)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)A5PJT2(Evidence code:IEA/Database source:UniProtKB:Q9NVR2|ens)Q9BE45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q8CHW4|ens)F1N1T6(Evidence code:IEA/Database source:UniProtKB:A0A024R419)Q2TBX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3X8E7(Evidence code:IEA/Database source:UniProtKB:Q8CFE5|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P58108(Evidence code:ISS/Database source:UniProtKB:O54950)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BM22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)Q3T0N5(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q0VCN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SX07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:Q14517|ens)Q3SZ52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q05B83(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PJQ1(Evidence code:IEA/Database source:UniProtKB:P35659|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)P61635(Evidence code:IEA/Database source:InterPro:IPR001217)A5PJT8(Evidence code:IBA/Database source:PANTHER:PTN000889801)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9HB09|ens)A6QNN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR002119)A5PK61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)M5FMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MRP8(Evidence code:IEA/Database source:UniProtKB:Q5JYA6|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314)Q17QN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T087(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BK57(Evidence code:IEA/Database source:InterPro:IPR001699|I)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628|I)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR002119)E1B7Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)A6QNT4(Evidence code:IEA/Database source:InterPro:IPR026784)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818)G3X7J6(Evidence code:IBA/Database source:PANTHER:PTN000341338)E1BB00(Evidence code:IEA/Database source:UniProtKB:Q8WXI3|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR003888|I)E1BAI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)F1MYZ3(Evidence code:IEA/Database source:InterPro:IPR003888|I)E1BPV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E9F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q2QDE9(Evidence code:IBA/Database source:PANTHER:PTN000889801)E1BPI3(Evidence code:IEA/Database source:UniProtKB:P42685|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR017995)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q6NS86|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR016362)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)G3MZP6(Evidence code:IEA/Database source:UniProtKB:Q8IYT2|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)Q1LZE9(Evidence code:IEA/Database source:UniProtKB:O95084|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BA57(Evidence code:IEA/Database source:UniProtKB:Q5TB30|ens)Q3MHY4(Evidence code:IEA/Database source:InterPro:IPR004367)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR002119)E1BHB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR006536)A4FUE0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BC56(Evidence code:IEA/Database source:InterPro:IPR000079)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)A3KMV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3MYE7(Evidence code:IEA/Database source:InterPro:IPR001739|I)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR008013)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4J6)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR028363)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q96GX5)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N397(Evidence code:IEA/Database source:UniProtKB:A0A140VJD0)P35071(Evidence code:ISS/Database source:UniProtKB:P34158)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR004806)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q8VBV7|ens)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR002119)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1B8G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR021169)O02754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7E3A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5D7J3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622075)F1MUD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)A1A4P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q32LB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)E1BL49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)Q3T0W4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MV26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR009110|I)P61085(Evidence code:IEA/Database source:UniProtKB:P61087|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BP38(Evidence code:IEA/Database source:InterPro:IPR027107)E1B925(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens)P35509(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628|I)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P17612)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR017357)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)A6H767(Evidence code:IEA/Database source:InterPro:IPR002164)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)O19137(Evidence code:IEA/Database source:UniProtKB-KW:, HIST1H2BN ASXL1 FOXO4 CUX2 PPID LOC613363 ANKRD17 LOC614378 SMARCAL1 EIF6 PIN1 NFE2L2 CLIC6 PSMB10 ONECUT2 PCBP2 VPS25 VPS4B NSFL1C USB1 ASB14 TSHZ1 TERF2 MARCH7 ATF6B COPS4 SP7 CIC PRKCB PTPA LTA4H SPEN NIPBL CAPN2 CCNY RUVBL2 KATNAL2 PTPN14 BCL9 HIVEP3 SMARCA2 STAT5B TSC22D1 CLCC1 EHMT2 DYNLL1 EN1 CDK13 PSMC6 RBM42 DIP2B NIF3L1 RPS27 LHX4 S100B FAM83G CHML CAND1 CHD7 TOP2B OTUB1 RNF112 CELF3 MDN1 DICER1 MVB12A COPS2 UBN1 EPM2AIP1 PAXIP1 LRRK2 NR2F6 PPP2CB CPNE1 APLP2 TRIM23 PSMA7 SSFA2 WDFY3 POLQ PSMD2 HBP1 ESRP1 RAN DGKQ HDAC5 MAPK11 MX2 SOX13 ARL2 KIAA2022 PABPC4 PTPN23 MYO1C CDK17 RSBN1L XPO1 RPS6KA2 EGLN3 CBFA2T2 XPO7 H3F3B AGTPBP1 RGS14 PSMA3 TRIM68 ADARB1 OSBP TLE6 DNAJB2 CSRP1 ZBTB18 ANXA11 LOC615183 PPP1CB ALKBH2 CDC27 TNPO3 gata4 SIRT2 PTP4A1 FIGNL1 ZNF516 ABL1 MEGF8 PRPF40A SMG1 HIST2H3D MT3 DHX9 MAPK4 DLX2 PTTG1IP MIDN PYGO2 KIF23 RPS18 CRYAB OTUD7B SHOX2 RPL30 BAG5 HIPK4 NIM1K KMT2A GRB2 SOX4 DGCR8 ASH1L FOXF1 BCL3 MMS19 DUSP3 HIST1H2BI ALDH1L2 PSEN1 SOX1 ARID1B LOC104975684 ZBTB17 SMG6 LMO2 PPWD1 DHX8 MAML2 POLR2A ZNF438 SALL4 HIST1H2BB HEYL PALM CPSF3L MICAL2 PKIB MAGED2 E2F7 ZNF148 SNRPE RUNX1 GCHFR IRS1 ZNF394 GCFC2 HIST1H2BA TEKT4 DNTT AGO4 TSN FAM212B PELP1 POLD3 HNRNPUL2 PRUNE1 TOR1A AEBP2 MGA PPP1R13B PRMT5 MCM3AP TAX1BP3 MBD6 PABPN1 TYK2 IDE PCBP1 APPL1 ZNF462 SSB CHD9 VPS36 ZMYND8 SRC PTPN6 ZFHX2 PSMA4 LOC526488 PSMB3 UFM1 CSNK1A1 ZHX3 RACGAP1 INSM1 GPKOW AGAP2 TCF20 PPM1D LOC619094 WHSC1L1 PSMC5 AHR SHMT2 IPO8 MYCBP2 PSMD1 RAD17 LIG1 RARS ZBTB8A SETX ATM LANCL2 TAF10 CC2D1A SRF PKNOX1 ALDH1A3 GPN1 MAPKAPK3 MAPK10 PSMB9 TRAF6 STAT5A COPS5 PRKDC CAD DMRTC2 UBE2V2 PPP1R10 RIF1 IKBKAP BCL11A PINK1 TDG BRCA2 MKL1 ROCK2 TFDP2 PRKAB1 PLK3 UBE2Z ZIC2 BANF1 ZBTB4 NXF3 BRSK2 PPIE U2SURP CHMP4A IRX1 STK36 SMTNL1 CHD6 MAF RUVBL1 ZNF446 WWC1 UBE4B DOCK10 SP1 TRUB1 MRI1 PPP3CA NAB2 HUWE1 CTBP1 SWAP70 EIF1 WIZ AHCTF1 TBC1D2 LOC100297725 RFX5 SETD1B COPS3 MIER1 ZBTB22 GLO1 CLIC4 BCOR PCNP HIST1H2BJ STK35 BCL11B CDK6 CCAR2 MAGI1 STRAP PABPC1 BRCC3 DNAJB1 EGR4 HINT3 TNRC18 NFRKB H2AFZ MAPK12 UBE2L3 LOC617043 HIST2H2AB PTPRN DDX1 ACAT2 ASH2L HCFC1 TRA2A WWTR1 INTS10 NFKBIZ EIF2B5 FASTKD2 VBP1 BTBD7 SUZ12 DYRK2 CD3EAP SNF8 PRKACB PRKAG1 NDRG1 LOC100300167 PSMB8 INTS3 GLI2 PDCD6 EIF3G IGFBP3 MAPK13 NMRAL1 CDC5L POLA1 PUS3 PHF14 WRN POLE4 GCK FAT1 UBE2V1 SNRNP70 PURA TET3 RAD18 RFC2 NUP214 SRSF1 DEK CHMP4B STAT3 DNASE1L2 BCL2L12 LOC515042 PCBD1 HIST1H2AJ H3F3C RAI1 SGTA ARFGEF1 SOX8 PLEKHG1 NUMA1 IRF1 SNRPN RANBP2 GLI1 CIDEC RPL11 HIST2H2BE TBX3 ATRX ESRRG IER5 HIST3H2A TRIP12 AIFM1 PFKM BRD1 PUM1 DNPH1 PPP1CC CTNND1 FAM120B FERMT2 PSMD13 DNM1 MAP3K14 DNAJB11 H1FX EXD3 ASB10 AXIN2 ECT2 KMT2B ANHX HIST1H1A JAK2 KMT2C ZFHX3 PSMC2 RNF165 PKN1 MYO6 DNASE1L1 FRK MYLK2 CHD8 HOXA7 ERCC2 SIM2 SAP18 ZNF366 AXIN1 POU3F1 PRDM13 HSPH1 CMTR2 PDCD4 PRSS23 PRKCI LEF1 DEPDC1 CCNL2 H2AFJ RAX HNRNPL MEIS1 LOC785479 BRCA1 RANBP10 MECP2 PAN2 PSMB4 ZNF750 GATA6 CDK1 ACTR5 KHDRBS1 PMM2 POLR2F PIWIL2 ARID3A GOLGA3 MASTL ZMYM5 LRWD1 CFTR RAD23B COPS8 LOC614881 HCFC2 RPS6KA4 HIST3H2BB KDM3B DOT1L CEBPA NCOR1 KNOP1 MAPK9 HIST2H2BF PRPF8 ETV2 KANSL3 BLM BCL9L ZNF367 TDRD9 NUDT16 RPAP2 PFDN2 LSM4 CXXC5 PURB SAPCD2 LOC614206 FAM129B PPP1R7 LOC525433 NCOA3 UBE2K NPAT NF2 LIPE EIF4A3 RALGAPA1 ARID1A DLG1 PIAS1 CSNK1G3 CTDSP1 NR1I2 POU4F2 CDK12 SHISA5 MOB1B NACC1 MALT1 PRKACA PLK4 RREB1 UHRF1 TERF1 TNKS1BP1 NAP1L1 MICAL3 CPSF4 SPAST UHMK1 PARP1 CRYM FOXI3 TACSTD2 LOC613345 ZNF638 HIST1H2AC BRD2 CCNL1 NUAK1 COPS6 NFKB1 SOX17 IKBKG LRPPRC SSUH2 PPP2CA EFTUD2 SYF2 DNMT3A CNP TSC2 SIRT6 TAOK2 TAF8 AP5Z1 UBXN6 ARL4A TCF7L2 IPO5 SNRNP200 INO80 ARVCF HIST1H1D ETAA1 TJP1 HSPA9 MNX1 SPOPL KDM6B IPO7 FGF1 MAPK1 FKBP4 HIST1H1E TIGD5 WEE1 USP31 EEF1E1 DXO EIF4G1 SFPQ CSNK1G2 GON4L IMPDH2 LOC523702 APPL2 XPOT BTBD3 CDK3 RPL23A TNPO2 GNAI1 HIVEP1 RAD21L1 NAP1L4 TPR CUL3 RAX2 SEC13 PASK NLRP5 SH3BGRL2 TNPO1 MTAP E2F1 EIF3K RPS6KA5 MYF5 LPIN2 CSNK1G1,CC,616,616 of 1172,27.02,52.56,8.273E-242,2.165E-238
GO:0005829,cytosol,P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q3MHH4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BQ15(Evidence code:IEA/Database source:UniProtKB:J3KR49|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)Q32PF2(Evidence code:IEA/Database source:UniProtKB:A0A024R1T9)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q3T054(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:A0A140VK27)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q9UKS6|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)Q8SPX7(Evidence code:ISS/Database source:UniProtKB:P14755)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A4FV68(Evidence code:IEA/Database source:UniProtKB:Q16537|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:A0A140VJR0)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:P31644|ens)A1A4P5(Evidence code:TAS/Database source:)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)E1BIU0(Evidence code:IEA/Database source:UniProtKB:P53992|ens)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:A0A024RC95)G5E6P3(Evidence code:IEA/Database source:UniProtKB:A0A024R8M0)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256598)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:Q9DB34|ens)Q0VCK0(Evidence code:IEA/Database source:UniProtKB:P31939|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)E1BCH6(Evidence code:ISS/Database source:UniProtKB:A4D126)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:A0A024RDV9)Q08DK5(Evidence code:IEA/Database source:UniProtKB:Q9NR46|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:A3RJH1|ens)E1BG38(Evidence code:IEA/Database source:UniProtKB:Q92888|ens)Q32PA4(Evidence code:IEA/Database source:InterPro:IPR028441)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BM86(Evidence code:IEA/Database source:UniProtKB:Q6ZN04|ens)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens)F1MNM7(Evidence code:IEA/Database source:UniProtKB:Q96Q06|ens)A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNG6(Evidence code:IBA/Database source:PANTHER:PTN000297583)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)F1MM21(Evidence code:IEA/Database source:UniProtKB:P49758|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BCY1(Evidence code:IEA/Database source:UniProtKB:A6ND36|ens)A4FUD1(Evidence code:IEA/Database source:UniProtKB:Q9HCN4|ens)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)F1MW03(Evidence code:IEA/Database source:UniProtKB:Q8NFU3|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)E1BK77(Evidence code:IEA/Database source:UniProtKB:Q96HP0|ens)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)A7MBC5(Evidence code:IEA/Database source:UniProtKB:P41252|ens)P80227(Evidence code:IEA/Database source:UniProtKB:A0A024R2U9)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)P48452(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4C6)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BPM0(Evidence code:IEA/Database source:UniProtKB:O95294|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB:P25789|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q3SZA0(Evidence code:IBA/Database source:PANTHER:PTN000091645)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BKQ2(Evidence code:IEA/Database source:UniProtKB:Q6WKZ4|ens)E1BCW3(Evidence code:IEA/Database source:UniProtKB:Q9WUA3|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q3SZC2(Evidence code:IEA/Database source:UniProtKB:P28065|ens)A6H7B5(Evidence code:IEA/Database source:UniProtKB:Q9UNS2|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)P35605(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens)A6QP29(Evidence code:IEA/Database source:UniProtKB:Q9BYX2|ens)F1N1V1(Evidence code:IEA/Database source:UniProtKB:A0A024R0G2)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:Q80ZJ1|ens)Q2KII5(Evidence code:IEA/Database source:UniProtKB:A0A024QZZ7)F1MS56(Evidence code:IBA/Database source:PANTHER:PTN000501326)E1BIU7(Evidence code:IEA/Database source:GO:0045022)Q2YDM1(Evidence code:IEA/Database source:GO:0042147)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)Q4TVR5(Evidence code:IBA/Database source:PANTHER:PTN000357044)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q75WB5(Evidence code:IBA/Database source:PANTHER:PTN000146326)A6QLP2(Evidence code:IEA/Database source:UniProtKB:Q68FL4|ens)O62768(Evidence code:TAS/Database source:)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)Q32LB3(Evidence code:IEA/Database source:UniProtKB:Q7LFL8|ens)P61283(Evidence code:IEA/Database source:UniProtKB:A0A024R5H0)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62191|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)Q28021(Evidence code:TAS/Database source:)E1BB73(Evidence code:IEA/Database source:UniProtKB:P32019|ens)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:Q9WTX5)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:A0A024R9W5)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q8TCU6|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:A0A024R4D1)F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)Q2YDE9(Evidence code:IEA/Database source:UniProtKB:A4D0U5|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107947)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)G3N3N1(Evidence code:IDA/Database source:)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)F1MYE0(Evidence code:IEA/Database source:UniProtKB:A0A024R499)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61457|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)E1B8H4(Evidence code:IEA/Database source:GO:0042147)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q3T0M0(Evidence code:IEA/Database source:GO:0042147)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)A4IFE6(Evidence code:IEA/Database source:UniProtKB:P61221|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q5GJ75|ens)Q05204(Evidence code:IEA/Database source:GO:0090160)E1B793(Evidence code:IEA/Database source:UniProtKB:A0A140VJW1)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)E1BGT8(Evidence code:IEA/Database source:UniProtKB:Q08AE8|ens)F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)P61356(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q647I9(Evidence code:IDA/Database source:)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)E1BPI3(Evidence code:IEA/Database source:UniProtKB:P42685|ens)A6QQ47(Evidence code:IEA/Database source:GO:0042147)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)P26882(Evidence code:IEA/Database source:UniProtKB:E5KN55|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)P16386(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BFI8(Evidence code:IEA/Database source:UniProtKB:Q07617|ens)A2VDS1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)A6QNT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36551|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)A7YW98(Evidence code:ISS/Database source:UniProtKB:P54136)Q3T0V3(Evidence code:IEA/Database source:UniProtKB:Q9UBQ5|ens)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)F1N281(Evidence code:IEA/Database source:UniProtKB:Q7Z4V0|ens)Q5E994(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)Q5NUA6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)F1MRI6(Evidence code:IEA/Database source:GO:0045022)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)E1BJE7(Evidence code:IEA/Database source:UniProtKB:O60318|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)Q2TBX2(Evidence code:TAS/Database source:)A2VE21(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58CY6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8G9(Evidence code:IEA/Database source:UniProtKB:Q8N257|ens)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)A4FUD6(Evidence code:ISS/Database source:UniProtKB:Q96JJ3)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)A7Z052(Evidence code:IEA/Database source:UniProtKB:A0A087X295)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB:A0A024RA85)E1BB16(Evidence code:IEA/Database source:GO:0042147)F1MNS8(Evidence code:IEA/Database source:UniProtKB:Q13442|ens)E1BJF4(Evidence code:IEA/Database source:UniProtKB:A6NMQ1|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens)P48644(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLT9(Evidence code:IEA/Database source:UniProtKB:P49588|ens)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)E1BDC9(Evidence code:IEA/Database source:GO:0042147)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BEB7(Evidence code:IEA/Database source:UniProtKB:Q8WWH5|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q6P1N0|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:Q6PFX9|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q58CS7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)F1N2D3(Evidence code:IEA/Database source:UniProtKB:G3V1L9|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:W0Z7M9|ens)Q3ZBU7(Evidence code:TAS/Database source:)E1B8E3(Evidence code:IEA/Database source:UniProtKB:Q86SG2|ens)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)Q17R14(Evidence code:IEA/Database source:GO:0061502)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q0VD53(Evidence code:IEA/Database source:GO:0042147)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)O97764(Evidence code:ISS/Database source:UniProtKB:Q08257)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN001229949)F1MHL2(Evidence code:IEA/Database source:UniProtKB:Q92625|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)A5PK51(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBF0(Evidence code:IEA/Database source:UniProtKB:Q6IA69|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1MN90(Evidence code:ISS/Database source:UniProtKB:Q96AQ7)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)Q32P83(Evidence code:IBA/Database source:PANTHER:PTN000328285)Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P02694(Evidence code:IEA/Database source:InterPro:IPR031264)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q1RMX7(Evidence code:IEA/Database source:UniProtKB:Q99J77|ens)G5E567(Evidence code:IBA/Database source:PANTHER:PTN000108134)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4J6)E1BC24(Evidence code:IEA/Database source:UniProtKB:Q9NU22|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:A0A140VK54)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q5EAC2(Evidence code:IBA/Database source:PANTHER:PTN000122964)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q9H3U1|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)Q2KHV6(Evidence code:IEA/Database source:GO:0034498)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens)Q5I598(Evidence code:IBA/Database source:PANTHER:PTN000472667)E1BFI2(Evidence code:IBA/Database source:PANTHER:PTN000568260)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q3TPJ7|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)A5PK86(Evidence code:IEA/Database source:UniProtKB:P41279|ens)Q2HJH1(Evidence code:IEA/Database source:UniProtKB:E7ETB3|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:A0A024R0F8)E1BG23(Evidence code:IEA/Database source:UniProtKB:Q96LD4|ens)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)E1BBT9(Evidence code:IEA/Database source:UniProtKB:O95757|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)A7E3X2(Evidence code:IEA/Database source:UniProtKB:A0A024R5W3)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F6RRD7(Evidence code:IEA/Database source:UniProtKB:Q8IXW5|ens)G3MWR8(Evidence code:IEA/Database source:UniProtKB:Q7RTP6|ens)E1BI31(Evidence code:IEA/Database source:UniProtKB:Q86TI2|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)P46195(Evidence code:IBA/Database source:PANTHER:PTN000563396)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q12792|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)E1BM45(Evidence code:IEA/Database source:UniProtKB:A0A024R2C3)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens)Q58DA7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q56JX6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens)Q2KJD2(Evidence code:IEA/Database source:GO:0042147)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB:Q9NQW7|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)A2VDZ4(Evidence code:IEA/Database source:UniProtKB:O00444|ens)E1BAF6(Evidence code:IEA/Database source:UniProtKB:P48634|ens)E1BGE5(Evidence code:IEA/Database source:UniProtKB:O95373|ens)E1BHZ4(Evidence code:IEA/Database source:UniProtKB:Q9UPT8|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q92598|ens)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:A0A024R7C0)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q8R1F1|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)E1BET5(Evidence code:IEA/Database source:UniProtKB:P28290|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)A3KMV8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MD79(Evidence code:IEA/Database source:GO:0042147)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)Q5E9F9(Evidence code:IEA/Database source:UniProtKB:A0A140VK70)Q17QL4(Evidence code:IEA/Database source:UniProtKB:A0A024R9Y7)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)Q5BIM5(Evidence code:IEA/Database source:UniProtKB:Q5T4F4|ens)Q9TRY0(Evidence code:ISS/Database source:UniProtKB:Q9QVC8)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens)A6QLR2(Evidence code:IBA/Database source:PANTHER:PTN000236067)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)Q2KIT4(Evidence code:IEA/Database source:UniProtKB:Q9UDY4|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)P35071(Evidence code:IBA/Database source:PANTHER:PTN000658664)Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)G3N337(Evidence code:IBA/Database source:PANTHER:PTN000237128)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BP91(Evidence code:IEA/Database source:UniProtKB:P55786|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:A0A024R1J8)Q2HJ94(Evidence code:IEA/Database source:UniProtKB:O60884|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)E1BQ01(Evidence code:IEA/Database source:UniProtKB:Q8N1G0|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q6FGM0|ens)Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061)Q08DW1(Evidence code:IEA/Database source:GO:0042147)Q3SWY3(Evidence code:IEA/Database source:UniProtKB:P12268|ens)F1MQA8(Evidence code:IEA/Database source:UniProtKB:Q8NDI1|ens)F1N2I0(Evidence code:IEA/Database source:UniProtKB:P26374|ens)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)Q3T0M9(Evidence code:IEA/Database source:UniProtKB:A0A024R9Z2)F1MB84(Evidence code:IBA/Database source:PANTHER:PTN000107947)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)P83437(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDN5(Evidence code:IEA/Database source:UniProtKB:E5KRP5|ens)Q1JQ98(Evidence code:IEA/Database source:GO:0042147)A7YY62(Evidence code:IEA/Database source:GO:0045022)P11019(Evidence code:ISS/Database source:UniProtKB:P50518)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:A0A087WYT3)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)P48034(Evidence code:ISS/Database source:UniProtKB:Q06278)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q8BU31|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)A6QL80(Evidence code:IEA/Database source:UniProtKB:Q922H1|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)G3N0Y7(Evidence code:IEA/Database source:UniProtKB:Q9NTX9|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)F2Z4E8(Evidence code:IEA/Database source:UniProtKB:A0A024RCJ9)F1MGX4(Evidence code:IEA/Database source:UniProtKB:O95466|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)F1N746(Evidence code:IEA/Database source:UniProtKB:Q9Y3P9|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)A7MBG0(Evidence code:IEA/Database source:UniProtKB:A0A024R5Q7)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62269|ens)P61763(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BMN4(Evidence code:IEA/Database source:UniProtKB:P28336|ens)Q0VC66(Evidence code:ISS/Database source:UniProtKB:P53088)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens), PRKACB AFAP1L2 EPRS QARS CLASP2 PAK1 DAAM1 ACLY STK26 FLNC SAPCD2 ZBTB4 RAN LTA4H PACSIN3 PABPC4 UBE2Z CRYL1 PDCD6IP PPP2R5E GLI1 PDE4D CAD GABRA5 PFDN2 BAIAP2 SEC24C GOLGA3 ALDH1A3 GNA13 LPIN2 KIF14 CHMP2A ATIC SNX3 RAPGEF4 ISPD CRMP1 SPG20 SH3GLB2 DDX1 ARHGEF1 PHPT1 ZAP70 PCM1 MEX3B AKAP12 PLIN4 COPB1 CDK6 GCHFR PPIP5K2 UBXN1 SEC23B HIC1 TSG101 RGS6 AGTPBP1 FAM83G GPN1 ACAT2 TSTD1 ANO6 DOCK6 IPO8 IARS APEH PPP2CA SNF8 AIFM2 PNPT1 PPP3CA LITAF RASAL1 PEX1 PSMA4 CLIC4 COPS4 CNP TSC2 RAB11FIP1 PFKP BICD2 EIF4G1 APPL1 PSMB9 COPS3 ARID3A COPB2 PRUNE1 EXOC8 BTBD3 TBC1D2 DENND2D SPHK2 RAP2A HIST1H2BI PGM3 PTPN23 ARL1 BAG5 GCK DENND1A DSTYK PDGFC SMG6 OPLAH AHCYL2 TXNRD1 MOB1B ARL6 CXXC5 BANF1 CTNND1 DCTN3 PSMC1 SNX27 GOLPH3 ACSS2 MALT1 ROCK2 INPP5B SKP1 PPP2R5A EGLN3 HUWE1 PREX1 COPS8 STARD10 TES S100A14 BCL3 CAND1 CTBP1 PRMT5 ARF6 PFKM MB21D1 IRS1 AKR1A1 SRI CRYAB DNAJB2 PCBD1 CDK1 DENND2A BCR VPS29 RAB23 ABCE1 RASEF TNFAIP8L3 LAMP1 STK36 GARS SPIRE1 IRS4 RPL27 NLRP5 PUM1 MRI1 FRK VPS51 CTTN PPID HCFC2 LIPE SPAG1 SCLY GOLGA4 ALOX15 SEC24A CPOX CCT3 RARS EIF3K TXLNG WWC1 RBX1 ZNF438 CHMP1B VPS4B NFKB1 ZC3HAV1 MTHFD1 ARL2 NFE2L2 AIFM1 LMTK2 NCOA3 MCM3AP YES1 VBP1 COPG2 FAM213B HIST3H2BB EPS8L1 ELMO2 TOP2B CORO7 TNRC18 WDR6 LRRK2 CDK13 GCC2 PDAP1 POLA1 PLEKHA5 G6PD DDX20 ALDH1A1 AARS STRIP2 VPS52 PCNT KPNB1 MAPK9 TRUB1 SNX33 CC2D1A PDCD10 TNKS RAPGEF2 ADARB1 MYO9B CHMP3 WDFY3 TJP1 BRCA2 MAP3K14 PINK1 CD3EAP MKL1 TUBB4A ANKRD23 DNAJC7 MYO1D MARS COPS5 VPS26A DNAH7 RAD23B SNRPE CRYZ BTBD6 ANKS1A USP9X VPS35 IDE NAPRT NADSYN1 UBXN6 TAOK2 CIDEC BAIAP3 NBEA PAK2 PPP2R2A RABIF FHIT RUVBL1 NDRG1 RBP1 PCBP2 NANS IPO9 PMM2 MDN1 GLO1 GIPC1 STAMBP SETD1B DNAJC13 GSS UNC45A TRIM68 GCFC2 SNX8 IKBKAP TXNDC17 MTHFR DHTKD1 MIDN FNDC3A MARCH7 MAPK1 PSMD13 KNTC1 MAP3K8 DNPEP CHMP2B HK2 PASK GPSM2 TRIM47 TOM1 HSPA4L FGF1 CSNK1G1 PRPF40A PACSIN2 RPAP2 MICAL3 DPP9 BLM SIRT2 GUK1 AGO4 TRAF6 TWF1 CAPN2 CRYM PIGN LSM4 GLRX3 RPS28 DDX58 PPM1D VAMP3 XPNPEP1 CHMP4B ABL1 FOXO4 GTPBP1 EIF2B5 LANCL2 PLK4 PRRC2A IPO7 ZC3H4 SGTA HSPH1 PPP1R13B KEAP1 DYRK2 WWTR1 FAM129B UBQLN1 XPO1 SSFA2 ARFGEF1 CRKL OSBP RANBP10 ANKFY1 DGKQ PSMC2 MAGED2 DOCK10 APC2 BAIAP2L1 ZFYVE27 FKBP4 ASNS LARS PRKCI MCTS1 RUNX1 DNAJB4 NSFL1C RPS6KA4 CFTR VPS25 UAP1L1 CPSF3L NUMA1 NPEPPS NF2 DNAJA2 PDCD4 FMNL3 EPS15 UNC13B STRAP ZNF687 SH3GL1 EIF6 RAB9A IMPDH2 EHBP1 CHML PDXP SEC23A ARL4A GRHPR ALOX15B COG5 SPAST AP1S1 FAM160A2 ATP6V1E1 PTGES3 PCBP1 AOX1 RAP2C CTNNA1 PRMT3 MVB12A FAM217B DUSP3 HIST1H2BB FMNL1 IKBKG LRRK1 SRC WNK1 XPOT RABGAP1 RPS19 PRNP ADSS ZCCHC6 RPS18 STXBP1 NMBR CTU1 DCTN2 KMT2A,CC,418,418 of 769,18.33,54.36,2.46E-173,4.292E-170
GO:0016020,membrane,Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P53712(Evidence code:ISS/Database source:UniProtKB:P09055)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BFP0(Evidence code:IBA/Database source:PANTHER:PTN000548303)Q2KIT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJZ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MF38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MKY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001190|I)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q148L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SYV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001320|I)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)E1BMN0(Evidence code:IBA/Database source:PANTHER:PTN000066595)E1BAI4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VCP0(Evidence code:IEA/Database source:InterPro:IPR004752)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q32L41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens)E1BMQ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR002438)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR006011|I)Q0VC64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR020849)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJ59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32KW9(Evidence code:IEA/Database source:InterPro:IPR007743)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR017104)E1BHK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BI45(Evidence code:IEA/Database source:InterPro:IPR006043|I)F1N226(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJA3(Evidence code:IEA/Database source:InterPro:IPR002659)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MC27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BC61(Evidence code:IEA/Database source:InterPro:IPR003915)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q2KI29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P10279(Evidence code:IEA/Database source:InterPro:IPR000817|I)O18875(Evidence code:IEA/Database source:InterPro:IPR002984)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIP5(Evidence code:IEA/Database source:InterPro:IPR026628)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001320|I)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MI35(Evidence code:IEA/Database source:InterPro:IPR001190|I)Q0P559(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR000699|I)E1BIL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIS6(Evidence code:IEA/Database source:UniProtKB:Q70IV5|ens)F1ME12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR020849)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58CW5(Evidence code:IEA/Database source:InterPro:IPR005016)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)Q17QB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MBJ3(Evidence code:IEA/Database source:InterPro:IPR001382|I)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F6R7C3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MW09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MFY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VD53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MNY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MS08(Evidence code:IEA/Database source:InterPro:IPR002443|I)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FUW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QR09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QE7(Evidence code:IEA/Database source:InterPro:IPR005076)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)Q2TA46(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BL94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T110(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MY32(Evidence code:IEA/Database source:InterPro:IPR003342)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MLR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MD25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR001717|I)F1N3I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P23389(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B8X1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR001879|I)F1MD64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001320|I)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VE11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5B1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)F1MMH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0W2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BGL9(Evidence code:IEA/Database source:InterPro:IPR001565)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BM45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR002126|I)A4IFN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q00KA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9XS26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7H3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)E1BF53(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q3SZJ7(Evidence code:IEA/Database source:InterPro:IPR002000)F1MG76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P81127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BK86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BFD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)E1BMA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MEX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7H2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4IFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O18784(Evidence code:IEA/Database source:InterPro:IPR002153|I)F1N758(Evidence code:IEA/Database source:InterPro:IPR006211)A6QQ87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR003020|I)G5E618(Evidence code:IEA/Database source:UniProtKB:Q9Y566|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q3ULJ0|ens)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)A7MB15(Evidence code:IEA/Database source:InterPro:IPR000539)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)Q1JQC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000699|I)F1N740(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006042|I)G5E6J0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BLE8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689)A6QQK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC83(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR000699|I)Q2KJ41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9E7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MNP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TA30(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58CZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28204(Evidence code:IEA/Database source:InterPro:IPR003929|I)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001320|I)E1BM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FUD6(Evidence code:ISS/Database source:UniProtKB:Q96JJ3)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1RMV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR000699|I)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7H9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MW11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YWN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000699|I)Q17QQ3(Evidence code:ISS/Database source:UniProtKB:P60879)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR002153|I)E1BF06(Evidence code:IEA/Database source:InterPro:IPR006052|I)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MS75(Evidence code:IEA/Database source:InterPro:IPR002443|I)G3MW12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32PI9(Evidence code:IEA/Database source:InterPro:IPR000920)A8DC37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N2I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08D78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3X812(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MZZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MG24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3X6G8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QR68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P67810(Evidence code:IEA/Database source:InterPro:IPR001733)Q28053(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4IFM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q09YM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BJ99(Evidence code:IEA/Database source:InterPro:IPR005052)E1BJU6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N3Q4(Evidence code:IEA/Database source:InterPro:IPR004965)Q0III2(Evidence code:IEA/Database source:InterPro:IPR001193)A6QP06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A7YY44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BM97(Evidence code:IEA/Database source:InterPro:IPR003938|I)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)D7GLD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR016251|I)E1BA07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MK52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O62826(Evidence code:IEA/Database source:InterPro:IPR002153|I)E1BKQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A8KC68(Evidence code:IEA/Database source:InterPro:IPR000460)P63217(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)G3N2S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q32LK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)V6F7Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQ36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QL5(Evidence code:IEA/Database source:InterPro:IPR005045)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR020849)F1MX24(Evidence code:IEA/Database source:InterPro:IPR003492|I)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MB64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MGS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2YDG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P61420(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MXQ8(Evidence code:IEA/Database source:InterPro:IPR001382|I)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZCB8(Evidence code:IEA/Database source:InterPro:IPR002809|I)E1BI49(Evidence code:IEA/Database source:InterPro:IPR001382|I)E1BFN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q01107(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P31836(Evidence code:IEA/Database source:InterPro:IPR009138)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q4ZJV8(Evidence code:IEA/Database source:InterPro:IPR013525)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR020849)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MSN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BGU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MY84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR007875)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR017104)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR020849)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29455(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MGE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MBT5(Evidence code:IBA/Database source:PANTHER:PTN001142599)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)B6ULZ4(Evidence code:IEA/Database source:InterPro:IPR001190|I)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N5Z0(Evidence code:IEA/Database source:InterPro:IPR000425)Q3SZ20(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YWN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR003378)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VE53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR001879|I)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58DS4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)Q2TBI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031)E1BCG1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MIU3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MT41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MWK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QNP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MKI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N5P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V7N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)F1MPT8(Evidence code:IEA/Database source:InterPro:IPR005045)Q08E50(Evidence code:IEA/Database source:InterPro:IPR001390)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FUZ5(Evidence code:IEA/Database source:InterPro:IPR005016)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)P35071(Evidence code:IEA/Database source:InterPro:IPR009147)A3KN28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VCP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O46631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)B0JYK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BJW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)G3X7E9(Evidence code:IEA/Database source:InterPro:IPR003532)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B9W1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B749(Evidence code:IEA/Database source:InterPro:IPR001734)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001320|I)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q95JC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B757(Evidence code:IEA/Database source:InterPro:IPR000920)G3N2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MTF9(Evidence code:IEA/Database source:InterPro:IPR003531)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens)Q08E55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B7G0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BB73(Evidence code:IEA/Database source:UniProtKB:P32019|ens)F1MUC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR020849)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC26(Evidence code:IEA/Database source:InterPro:IPR001734)F1MFH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B9D3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q1JQB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)C3V9V7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)E1BB93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BQ05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N3Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VCR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32P83(Evidence code:IBA/Database source:PANTHER:PTN000328285)Q1JQ95(Evidence code:IEA/Database source:InterPro:IPR008253)A7MBI9(Evidence code:IEA/Database source:InterPro:IPR001046)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR016251|I)G5E5T3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BN79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O46405(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q95J79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MP51(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)E1BB56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VD06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N271(Evidence code:IEA/Database source:InterPro:IPR006042|I)E1BBU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P06623(Evidence code:IEA/Database source:InterPro:IPR008431)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR000072)F1N0J3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BLU2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q95JH2(Evidence code:IEA/Database source:InterPro:IPR004552)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8HYW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7N8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P30671(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)E1BP63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4M2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N5R0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BAK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MTK2(Evidence code:IEA/Database source:UniProtKB:Q6P9B6|ens)F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I)F1N4S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YY65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000998)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)P12820(Evidence code:IEA/Database source:InterPro:IPR001548)Q17QB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BAI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VE81(Evidence code:IEA/Database source:InterPro:IPR008253)E1BPZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P02722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR016251)E1BMA2(Ev, TMEM184A ITGB1 LIN7B NHSL1 DNAJB4 KCNG4 TSPAN9 EMB PANX3 SUSD5 TMPRSS2 COPE ITGAL ATP13A1 TMEM263 LAPTM5 DCTN2 ATP2C2 GRIA1 TOR1A NEU4 CLIC6 BEST3 SLC33A1 RAB25 KCNC3 ALOX15 GCHFR SCARA3 SGTA OTOF SLC6A20 STX7 MANSC1 SEC23B ST8SIA3 CHMP3 DIRAS2 SORD HEPACAM TMEM125 IRGC PRKCB AP2A2 SNX33 PCDH1 SLC23A1 APLP2 GNAS B3GALT4 fgfr3 SDK1 LMTK3 PCDH20 PKDREJ GK2 KCNF1 DCHS2 TMEM256 MYO1C FLOT2 PRNP SLC6A8 SEPT2 CDH11 GALNT7 CD44 PDZK1IP1 DHRS3 GRIA3 RNF128 HHIPL1 IFITM1 RYR1 CNNM2 ZFYVE27 SYNM DSEL RAP2C EPHB4 SERINC2 SLC25A29 ABHD17C KCNC4 RAB30 EDEM2 LRP6 TRPM4 EPHA6 RNF112 LGR4 PEX2 LOC509854 DPP4 TLR4 VPS35 TSC2 VPS28 CORO7 UTRN ANO6 VPS26A TMEM2 KHDRBS1 CHMP1B SLC12A2 OR5M11 TXNDC11 HAS2 SLC25A26 GBGT1 CD97 GRB2 UBL3 VSIG2 TM4SF18 TMTC2 SCAP ASTN1 KIAA1549L CTNNA1 SLC4A2 MYOF CHGB FNDC3A PTH1R PIEZO1 GRIK4 MRVI1 IGSF8 PEX13 ATP2B4 RIMS1 ITGA9 DNM2 PKN1 MGC126945 SYT6 LOC788634 PIGN MAPK1 FAT2 SNX18 LRP4 HAS3 SLC44A2 CACNA1E CDH7 LAMP2 GPR75 CAPN2 GNAI1 DBH NAPG PKHD1 VAMP2 ANKLE2 TRPM7 PRTG UNC13B VPS4B TENM2 CPNE1 CYP2R1 BACE1 STRN3 LRRC24 TRPC1 ERBB4 ULBP3 SLC4A7 SHANK1 GPD1L KCNG2 FZD1 PAK1 TENM3 TFRC BoLA G0S2 ADAM7 SPCS3 LIN7A STARD10 SLC22A23 ITPR2 FRAS1 LIN7C CYP7A1 LOC100298868 TMEM200B GRM7 VAMP1 SLC39A6 TEX2 SLC29A1 RYR2 TSPAN14 KIT RHOT2 GLT8D1 GRIA4 RAB39B NINJ1 TSPAN2 ITGAV ABHD2 ENTPD6 UGT2B10 VPS29 FAM205A KCNMA1 MAGI1 CLDN3 VPS25 PDXP GRIN3B NDC1 HERC4 ATP13A5 PPP2R5A EFHD1 FNDC3B ELMO2 TMEM106B ENG RYR3 TMPRSS6 SLC6A14 LOC523126 COPB2 SNX19 ITGB7 SEC24A MFSD6L ITPR1 SNAP25 DPEP3 TRPC3 TNFSF15 BFSP1 SLC12A1 LOC100337053 MPZL1 FCGR2A KLRF2 LOC512672 CLDN4 RAB3C NOTCH4 SPAG4 ABCA1 CACNA1C PPP1R3F LGR6 CAMK2D SLC31A1 SEC11A APP CLDN8 PRKAR2A ULBP15 OR51Q1 LMAN1L SYNE3 LOC531090 NDRG1 RANBP2 PALM MBTPS2 SYTL2 GLI2 F2R HCN1 CACNA1A SPAST MFN2 JAK2 SLC17A8 PROM1 SCO1 ITGB6 TRPC2 ARID1B TMEM59 PHKB NLGN2 GNG5 ANKFY1 LRRC26 ITM2B PCDH8 CYSTM1 SCN3A DSCAML1 LOC100295883 LOC100850276 TPST2 TMEM30A ARL1 AP2B1 RRAS CLN3 FAT1 ROCK2 NMBR SOX1 ITPRIP NAALAD2 SWAP70 ABHD12 GPRC5C ATP6V0D1 MAN1B1 RRH SORL1 NOA1 OR13C3 CLCC1 EMC3 MAN1A2 NRXN2 DSC1 SRI RAB3B NCAM1 JSRP1 ABCG8 DAD1 RAP2A SPHK2 FLT3 TACSTD2 SOGA3 CSPG4 SPRY4 LOC100125916 AP2A1 C1QTNF5 ATP2B2 HRAS PCDH12 MGAT1 PRKACA DNAJC5 PPP3CA FRMD5 BCR CHGA IMMT SNX8 LIPE PIGK WC1 SPTBN4 PTPRN AQP5 SHMT2 COPA CDHR1 BIRC6 BAIAP2 ENTPD2 OSBP SVIL LFNG SAR1B VPS52 SCN8A KCNA4 TMC3 SIRPB1 RAB3A SNX27 PIP4K2C SH3GL1 IKBIP RAB26 PTH2R GALNT2 TMEM171 SPTA1 CACNA1H TRAP1 IDE PSEN1 ABCA7 VAMP3 CAMK2B VTA1 TMC5 PTGFRN NRXN1 PTK7 FLOT1 RGR BTNL2 NDUFS3 ATP7B PRKACB DNER SHISA5 IGSF5 AP2S1 SUSD2 RC3H2 TMEM30B GABRA5 CPT1B MPV17 COMT ITGA2 SERINC3 FIS1 GNAT1 SCN5A CACNA1F CFTR ST7L CCDC149 SIRPA NPC1 STEAP4 COPB1 ALOX15B IL13RA1 CCNYL1 SEZ6L2 TMEM114 SLC5A9 GRIA2 MVB12A SLC1A5 SCN2B SMIM1 HPS6 LMTK2 SLC44A1 IL9R CLDN7 LSM4 MBTPS1 IFNLR1 INPP5B LOC515333 RIT1 PTPRZ1 SDK2 ARFGEF1 CHMP4A SLC5A11 FREM2 GPR179 SYNGAP1 GPR4 EXT1 TMED2 CACNA1B BOC XKR7 ABCC3 TMEM68 RABIF CMTM7 SLC11A2 RAPGEF2 JAK1 LOC100299180 COPG2 LOC614090 CES5A CD80 TYROBP AP2M1 KCNH5 MARCH5 RAB4A PTTG1IP ATP1A2 SEC13 CHMP4B DCST2 LEMD3 NPTN DYSF LOC100337457 ADAM15 CNP PDGFC ATP11A ARL8B SH3GLB1 ATP8B1 SLC19A2 AGPAT1 CDC42SE2 RHOT1 MARCH8 DSTYK atp1A3 PTPRA TMPO AP1S1 GNG7 GK CLTA CACNA1D RNF139 EMC10 SLC6A5 SYVN1 TLDC1 LOC100848815 ULBP11 GIPC1 MTG1 RDX MTCH1 MEGF8 PTPRM TOM1 ACE PLA2G16 KL ARL6 ADORA2A OCLN PIGO AP2B1 SLC25A4 TYK2 KCNH6 CDON AAK1 COPZ1 CDH22 PCDHGC3 PLLP STK26 ATP2B3 SEC23A LRRC32 UBXN6 ADCY7 FKBP2 LAMP1 MAOB MAL2 ATP6V0C GNG10 POMGNT1 CHMP2B SNX9 SLC45A4 CACNA1S PI4KA MARCO TIMM17B SDC3 SCN11A ECE1 LOC786512 MGAT2 DPM3 CPOX TPCN2 CPNE6 CLINT1 PNPLA2 COG5 SLC35B1 LOC788626 DNAJA2 SLC34A1 F11R VPS36 CLIC4 ARCN1 ATP6V1B1 CYB561 NRCAM DPAGT1 KCNT2 RXFP3 VAMP5 WRB SCN10A STXBP1 SYT4 AIFM2 TJP1 ZAP70 ALCAM GRAMD3 ARL4A PCDHA13 SERINC5 PROM2 CD63 ITGAD AP3B2 TMC6 CNGB3 QSOX2 LY6H CYP2J2 SNF8 FCER1G PCDHB8 RNF130 FAM174B TMPRSS9 PINK1 CHRNE TIAM2 SLC7A2 GPM6B LOC786796,CC,618,618 of 1837,27.11,33.64,3.095E-166,4.05E-163
GO:0005524,ATP binding,Q32PF2(Evidence code:IEA/Database source:InterPro:IPR013815)F1MKU1(Evidence code:IEA/Database source:InterPro:IPR011545)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BHE5(Evidence code:IEA/Database source:InterPro:IPR004536|I)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR012724)E1BN72(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QNN6(Evidence code:IEA/Database source:InterPro:IPR003959|I)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MG18(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR011704|I)Q08E52(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q75WB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BDZ3(Evidence code:IEA/Database source:InterPro:IPR000330)F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408)F1MLB1(Evidence code:IEA/Database source:InterPro:IPR000330)F1MNE5(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6H768(Evidence code:IEA/Database source:InterPro:IPR000705|I)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q2HJB1(Evidence code:IEA/Database source:InterPro:IPR003959)P46196(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR011545|I)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR012947|I)E1B793(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I)G5E631(Evidence code:IEA/Database source:InterPro:IPR011545)G3MW11(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5W5U4(Evidence code:IEA/Database source:InterPro:IPR011545)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR009161)Q0IIM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR001609)P35071(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q05B83(Evidence code:IEA/Database source:InterPro:IPR003959)Q17QG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1ML89(Evidence code:IEA/Database source:InterPro:IPR005479|I)F1MM57(Evidence code:IEA/Database source:InterPro:IPR001609|I)A1A4M8(Evidence code:IEA/Database source:InterPro:IPR001270|I)F1MUU2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR000719|I)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR003439|I)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0VC88(Evidence code:IEA/Database source:InterPro:IPR002891)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q12792|ens)P58108(Evidence code:ISS/Database source:UniProtKB:P80385)P35509(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR001609|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BL08(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR001609|I)P05131(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MI74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00517(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)G3X696(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MEM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)A5PK75(Evidence code:IEA/Database source:InterPro:IPR001270|I)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR000738|I)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR003959|I)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens)P43481(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR001609)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BA03(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BAN2(Evidence code:IEA/Database source:InterPro:IPR003959)E1BMP3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN42(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHZ1(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR000330)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MG13(Evidence code:IEA/Database source:InterPro:IPR001609)A8QID1(Evidence code:IEA/Database source:InterPro:IPR000719)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR003959|I)Q3T084(Evidence code:IEA/Database source:InterPro:IPR002194|I)P10568(Evidence code:IEA/Database source:InterPro:IPR001609)Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404)E1BPM4(Evidence code:IEA/Database source:InterPro:IPR000330)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q1RMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q3ZCH0(Evidence code:IEA/Database source:InterPro:IPR012725)A4FV00(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR001208|I)A6QLW1(Evidence code:IEA/Database source:InterPro:IPR000719)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR030334)Q2HJ82(Evidence code:IEA/Database source:InterPro:IPR015726)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q32L40(Evidence code:IEA/Database source:InterPro:IPR002194|I)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N159(Evidence code:IEA/Database source:InterPro:IPR013815)F1MX93(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR000330)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MMC7(Evidence code:IEA/Database source:InterPro:IPR001609)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q27966(Evidence code:IEA/Database source:InterPro:IPR001609)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)Q3ZCI9(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q0IIK5(Evidence code:IEA/Database source:InterPro:IPR011545)G3MW12(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1N758(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BBT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QPF2(Evidence code:IEA/Database source:InterPro:IPR006935)E1BB49(Evidence code:IEA/Database source:InterPro:IPR000719|I)P67827(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q4ZJV8(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q3SWY6(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7YSY2(Evidence code:IEA/Database source:InterPro:IPR003959|I)A4IFE6(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q2NKZ1(Evidence code:IEA/Database source:InterPro:IPR002194|I)F1MBM5(Evidence code:IEA/Database source:InterPro:IPR010448|I)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR035699)Q4TVR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MY45(Evidence code:IEA/Database source:InterPro:IPR011761)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)P17599(Evidence code:IEA/Database source:InterPro:IPR013815)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MM88(Evidence code:IEA/Database source:InterPro:IPR000719)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR011704|I)F1MBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MQ85(Evidence code:IEA/Database source:InterPro:IPR000330)Q0V8H0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q28141(Evidence code:IEA/Database source:InterPro:IPR011545)G3MW09(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1N734(Evidence code:IEA/Database source:InterPro:IPR000330)A4IFM7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR011545)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR000719|I)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q17R14(Evidence code:IEA/Database source:InterPro:IPR001609)F1N6C1(Evidence code:IEA/Database source:InterPro:IPR000719)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BH78(Evidence code:IEA/Database source:InterPro:IPR011545)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR000719|I)V6F977(Evidence code:IEA/Database source:InterPro:IPR000719|I)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408|I)E1BB50(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B9B6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BJM5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BKM6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BA80(Evidence code:IEA/Database source:InterPro:IPR001609)A6QP44(Evidence code:IEA/Database source:InterPro:IPR006204)G3N326(Evidence code:IEA/Database source:InterPro:IPR000330)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR005479|I)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MUF5(Evidence code:IEA/Database source:InterPro:IPR000850)E1BN63(Evidence code:IEA/Database source:InterPro:IPR000719|I)P62194(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MLB2(Evidence code:IEA/Database source:InterPro:IPR000330)F1N724(Evidence code:IEA/Database source:InterPro:IPR011704|I)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312|I)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I)F1N3T0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X793(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0VD48(Evidence code:IEA/Database source:InterPro:IPR003959|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)G3N1E4(Evidence code:IEA/Database source:InterPro:IPR001752)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001278|I)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MU48(Evidence code:IEA/Database source:InterPro:IPR001154|I)Q59A32(Evidence code:IEA/Database source:InterPro:IPR011761|I)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000719)F1MH24(Evidence code:IEA/Database source:InterPro:IPR000719)E1BP55(Evidence code:IEA/Database source:InterPro:IPR003959)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR011545)Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR009161)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR011704|I)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q58D16(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB57(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN96(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539|I)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1N5W5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVZ2(Evidence code:IEA/Database source:InterPro:IPR000719)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR004166)Q3SYZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR014930)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNA1(Evidence code:IEA/Database source:InterPro:IPR011545)A4IFE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB52(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000719)G3N2C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BC36(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000559|I)F2Z4F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)Q2NL22(Evidence code:IEA/Database source:InterPro:IPR011545)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MIM5(Evidence code:IEA/Database source:InterPro:IPR011704)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR000719)E1BDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MRN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)G3X7J5(Evidence code:IEA/Database source:InterPro:IPR010448|I)D3IVZ2(Evidence code:IEA/Database source:InterPro:IPR011545)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR011545)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)A2VDN5(Evidence code:IEA/Database source:InterPro:IPR003959|I)A6QLB8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR012947|I)E1BJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BNQ2(Evidence code:IEA/Database source:InterPro:IPR011545)Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003694|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRI6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MKY9(Evidence code:IEA/Database source:InterPro:IPR004166)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752)Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MB90(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A3KN22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)P31407(Evidence code:IEA/Database source:InterPro:IPR000194|I)A5PK86(Evidence code:IEA/Database source:InterPro:IPR000719)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR011545)F1MC27(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VE07(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T0K2(Evidence code:IEA/Database source:InterPro:IPR002194|I)A4IFF6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR035699)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BC24(Evidence code:IEA/Database source:InterPro:IPR011704)Q95M13(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E58(Evidence code:IEA/Database source:InterPro:IPR013815)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001278|I)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q08E45(Evidence code:IEA/Database source:InterPro:IPR000719|I)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1B8H0(Evidence code:IEA/Database source:InterPro:IPR000719)E1BG90(Evidence code:IEA/Database source:InterPro:IPR000719|I)P48734(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FUH1(Evidence code:IEA/Database source:InterPro:IPR001270|I)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR010339)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MRW7(Evidence code:IEA/Database source:InterPro:IPR011545)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR000330|I)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR000719|I)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)A5PJP8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR000719)Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR004887|I)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR010339)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F1MG24(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR000738|I)A4FV09(Evidence code:IEA/Database source:InterPro:IPR004567)P05126(Evidence code:IEA/Database source:InterPro:IPR000719|I), ACLY DDX58 NME1 SEPHS2 ATP1A2 DNAJA2 NIM1K NVL JAK1 DCLK2 IARS PSMC3 MYLK4 ADCY7 DNAH10 PAK1 OPLAH CHD9 ATP2B3 EP400 FIGNL1 HCK GALK1 KIF5A VPS4A MAPK1 BLM RUNX1 AARS2 STK36 LIG1 DDX3X LOC523126 KIF5C RPS6KA4 DDX4 PFKP HSPH1 MYO9A CFTR RFC2 UBE2G2 CPS1 MYH14 TOR3A STK35 WEE1 UBE2K LOC515333 PLK4 PAPSS2 UBE2L3 EPHA6 TWF1 PRKAG1 CSNK1G3 MYO7B OBSCN MAP3K14 MYO6 PRKACB NLRP12 CDC42BPB PRKACA NLRP5 SLK DHX8 TOR1A MARS PEX1 CHORDC1 KIT PIP4K2C MYO9B LCK PAK6 KATNAL2 MYLK3 CDK17 NEK10 SMARCAL1 MYH11 MYO15A ULK3 PSMC6 CCT6B MYO1A TRAP1 CHD7 MYO5B UBE2D2 HSPA9 MAPK10 KIF1B MCM4 PIK3R4 PAK3 ATP2B2 ATP2C2 SPEG ABCC3 TCP1 MAP3K10 SYN2 MYO5C INO80 PSMC2 MYO1F MAPK4 MYO1C LOC100299180 ACTR3B CCT8 DDX1 LOC100337053 ERBB4 FRK KIF2A HSPA4L JAK2 LRRK2 FANCM HIPK4 CSNK1A1 TAOK3 EPRS ABCG8 STK25 KIFC1 TYK2 SPATA5L1 ABCE1 CCT7 TOR1B PRKDC DNHD1 DSTYK CARNS1 ATP7B CAMK2B SYN1 ATM MAPK13 NEK9 DNAH5 SMG1 ATRX DHX57 DHX9 LOC509854 CHD6 MYLK2 PRKCI MASTL EIF4A2 FLT3 PTPA LARS ZAP70 MAP3K1 PI4KA MYO1D LRRK1 SRC SNRNP200 PIK3CD CAMK2D SIK3 ATP2B4 CDK12 NUAK1 PASK TAOK2 MYO18A MYO18B FUK SRCAP TRPM4 ABCC5 CAD DGKQ MARK3 NME3 AK9 WNK1 PSMC5 CHD8 DNAH11 HK2 ERCC2 MAP3K4 PINK1 CDK3 MAPK11 VPS4B MAST4 GCK KIF26A WARS2 RARS KIF13B TOP2B GART UHMK1 AAK1 NAV3 BRAF POLQ PFKM DYNC1H1 MAPK9 ROCK2 QARS MATK YES1 STK3 RPS6KA5 ATP8B1 MB21D1 STK26 BRSK2 GK ABCA7 PLK3 TRPM7 MAPKAPK3 NARS CDC42BPA MAP3K9 TDRD9 ACTR1B KIF26B EPHB4 CDK13 TRIO NLRP7 CDK6 KIF13A TEC MTHFD1 ACTR1A TDG EIF4A3 KIFC3 VWA8 PTK7 NLRP14 ATP13A5 PGK2 TOR4A DDX3Y WRN UBE4B ATP11A SPAST GSK3A AARS DHX34 DHX37 NADSYN1 OXSR1 LMTK2 ALPK2 KIF15 IDE KIF5B CSNK1G2 PAK2 UBE2M ATP6V1B1 MAP3K8 DICER1 LMTK3 STK24 MAPK12 CCT3 NEK3 DNAH7 CNNM2 KIF23 MDN1 fgfr3 TTLL12 RARS2 MYO5A CAMK2A KIF14 PEAK1 DYRK2 CDK1 TOR2A RPS6KA2 ASNS CSNK1G1 RUVBL1 PKN1 PSMC1 DDX20 SMARCA2 PAK4 GUK1 MAP2K4 CAMK2G GSS RUVBL2 EIF4G1 ABCA1 ABL1 GARS PANK4 PRKCB,MF,311,311 of 403,13.64,77.17,2.499E-162,2.616E-159
GO:0005886,plasma membrane,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q9UKS6|ens)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MNS8(Evidence code:IEA/Database source:UniProtKB:Q13442|ens)P38408(Evidence code:TAS/Database source:)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:A0A024RDV9)P63217(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MF97(Evidence code:IEA/Database source:UniProtKB:Q14112|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63086)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)F1MJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q0VCK0(Evidence code:IEA/Database source:UniProtKB:P31939|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)F1MNM7(Evidence code:IEA/Database source:UniProtKB:O88492|ens)F1N611(Evidence code:IEA/Database source:UniProtKB:Q9H4G0|ens)E1BPM0(Evidence code:IEA/Database source:UniProtKB:O95294|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)Q3T099(Evidence code:IEA/Database source:UniProtKB:Q9UGM6|ens)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:P63024)F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)A2VE13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)E1BF53(Evidence code:IEA/Database source:InterPro:IPR020894)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001283)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)Q2KIT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005674)A2VDU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)P30671(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)E1BF03(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A2VE81(Evidence code:IEA/Database source:UniRule:UR000001395)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:A0A024R1Y6)Q2YDG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)F1N5R0(Evidence code:IEA/Database source:UniProtKB:Q9Y345|ens)F1MP22(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MML3(Evidence code:IEA/Database source:UniProtKB:Q5H9F3|ens)A6QLR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)E1BDI1(Evidence code:IEA/Database source:UniProtKB:Q9DA79|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN000634601)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8NFT8|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BMN4(Evidence code:IEA/Database source:UniProtKB:P28336|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P21282(Evidence code:ISS/Database source:UniProtKB:Q9Z1G3)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)F1N3I2(Evidence code:IBA/Database source:PANTHER:PTN000422281)A0JNB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BLK3(Evidence code:IEA/Database source:UniProtKB:Q9JJA9|ens)E1B7G0(Evidence code:IBA/Database source:PANTHER:PTN000466212)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B7T1(Evidence code:IEA/Database source:UniProtKB:Q7Z7B0|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)Q3T0M9(Evidence code:ISS/Database source:UniProtKB:P40617)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BLE8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3MYM1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)F1MQA8(Evidence code:IEA/Database source:UniProtKB:Q8NDI1|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:A0A024R499)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR020894)F1N4S4(Evidence code:IBA/Database source:PANTHER:PTN000422281)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)Q01107(Evidence code:IEA/Database source:InterPro:IPR020894)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR020894)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B9D3(Evidence code:IBA/Database source:PANTHER:PTN002091395)Q1JQB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3X7P3(Evidence code:IBA/Database source:PANTHER:PTN000090250)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3MWR8(Evidence code:IEA/Database source:UniProtKB:Q7RTP6|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR020894)Q1KZG4(Evidence code:IEA/Database source:UniProtKB:A0A024R366)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:A0A140VJR0)Q29455(Evidence code:ISS/Database source:UniProtKB:Q9H3Z4)Q32PF2(Evidence code:IEA/Database source:UniProtKB:A0A024R1T9)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)A6QQ36(Evidence code:IBA/Database source:PANTHER:PTN000422281)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR020894)A6QQP7(Evidence code:ISS/Database source:UniProtKB:O75923)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)E1BHM6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)A7Z052(Evidence code:IEA/Database source:UniProtKB:A0A087X295)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)P31836(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MJZ6(Evidence code:IEA/Database source:UniProtKB:O75954|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)O02811(Evidence code:ISS/Database source:UniProtKB:P42356)Q08DD1(Evidence code:IEA/Database source:UniProtKB:P50428|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR020894)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)F1MHP0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A2VDV7(Evidence code:IEA/Database source:UniProtKB:O15393|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1B9S9(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)A6QP06(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)Q17QR2(Evidence code:IEA/Database source:UniProtKB:A0A140VK54)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)E1BGE2(Evidence code:IEA/Database source:UniProtKB:O75691|ens)E1BHR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)A7MB64(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323194)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)Q2TA46(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7YY70(Evidence code:IEA/Database source:InterPro:IPR029848)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BLU2(Evidence code:IEA/Database source:UniProtKB:O60779|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q1LZF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BBK9(Evidence code:IEA/Database source:UniProtKB:Q8IYJ3|ens)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BN05(Evidence code:IEA/Database source:UniProtKB:Q8BMF8|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)F1MDE1(Evidence code:IEA/Database source:UniRule:UR000484796)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR020894)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7YWH4(Evidence code:IBA/Database source:PANTHER:PTN000422281)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000818658)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR020894)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR020894)F1MWI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001107229)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A4IFM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287)E1BAF6(Evidence code:IEA/Database source:UniProtKB:P48634|ens)F1N0J3(Evidence code:IBA/Database source:PANTHER:PTN000642368)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)E1BFE6(Evidence code:ISS/Database source:UniProtKB:Q9Z2C4)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:A0A024R1J8)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)Q95JC7(Evidence code:ISS/Database source:UniProtKB:Q15758)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BC13(Evidence code:IEA/Database source:UniProtKB:Q14003|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR020894)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MM21(Evidence code:IBA/Database source:PANTHER:PTN000090250)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:G3V1L9|ens)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BM45(Evidence code:IEA/Database source:UniProtKB:A0A024R2C3)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR020894)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MT41(Evidence code:IBA/Database source:PANTHER:PTN000258543)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9TU34(Evidence code:IBA/Database source:PANTHER:PTN001416417)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3X6L9(Evidence code:IEA/Database source:UniProtKB:Q8CGC7|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR020894)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)E1BIB9(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1BET5(Evidence code:IEA/Database source:InterPro:IPR026648)F1MHR3(Evidence code:IEA/Database source:UniProtKB:A0A024RC95)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N416(Evidence code:IEA/Database source:InterPro:IPR020894)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q6P1N0|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)F1MMU9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2YDE9(Evidence code:IEA/Database source:UniProtKB:A4D0U5|ens)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1ML52(Evidence code:IEA/Database source:UniProtKB:Q8TDN1|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q3UUY6|ens)Q8WN96(Evidence code:IBA/Database source:PANTHER:PTN001416417)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090250)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q29450(Evidence code:IEA/Database source:InterPro:IPR009398|I)Q3SZ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q765N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635134)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q9NZM1|ens)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN001124099)G3N152(Evidence code:IEA/Database source:InterPro:IPR020894)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)A7MBG0(Evidence code:IEA/Database source:UniProtKB:A0A024R5Q7)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)E1B968(Evidence code:IEA/Database source:UniProtKB:P52569|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR020894)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)F1N2Q9(Evidence code:IEA/Database source:UniProtKB:Q96HU8|ens)A7Z045(Evidence code:IEA/Database source:UniProtKB:Q96KN1|ens)E1BG38(Evidence code:IEA/Database source:UniProtKB:Q92888|ens), ARF6 PACSIN3 OR5M11 PDAP1 GNA14 COPB1 DAB2IP TRPM4 SPG20 GNG5 NID2 MAPK1 RGS14 CRYAB PHKB ATIC WDFY3 PLIN4 EPB41L1 RASAL1 UBQLN1 LRRK2 RAB39B ECE1 RAP2A VAV2 LIPE PACSIN2 HFE2 TDG WARS2 VAMP3 ATP2B3 GRB2 MAL2 ABCA1 OR13C3 FAM129B CDH7 SYT6 LAMP1 PRTG GNAI1 DNAJB4 PIK3CD SPRY4 ABHD17C STX7 PKN1 CLIC4 PPP1R13B GNG7 BFSP1 VPS28 KNTC1 PANX3 CD63 F11R OCLN GPD1L AP2B1 PALM GPRC5C AQP5 SLC6A5 CACNA1E BCORL1 FLOT2 NPC1 LOC531090 ALOX15 BEST3 TEC DPEP3 PDXP CHRNE RAB17 MARCH7 BRAF MTSS1L DNER CPNE1 NMBR LANCL2 C1QTNF5 ATP6V1C1 SEPT2 NRXN1 RFFL RYR1 LOC788634 LY6H GRASP IFNLR1 LIN7C CD97 RAB3A FILIP1 CPNE6 TSPAN14 NDC1 RAB3B NBEA ARL4A LGR4 GRM7 SCN10A BCR AFAP1L2 EHBP1 GLO1 IRS1 TMEM30A PCDH1 ULBP11 CTTN DSC1 CDH11 ZFYVE27 GPR179 GPR4 AXIN2 ATP6V1B1 PPP3CA MICAL3 PAK1 ABHD2 LOC614090 DCHS2 FHIT MCTS1 BCL3 PDE4D DNAJC5 ACLY BAIAP2L1 LOC100850276 PCDH12 DYSF SH2B2 TSG101 ARVCF SCN11A TLR4 PSEN1 WDR6 PTPRN FMNL1 NCAM1 CAMK2D PRKACB DPP4 TSPAN9 HCFC2 SNAP25 CLDN7 PI4KA ARSA MICALL2 PCDH8 ARRDC1 CHMP4A GABRA5 GRIA2 SYN2 YES1 SCN5A SRC AP2M1 SNF8 SIRT2 ATP2B4 STRN3 FRS2 MYO1C TMPRSS2 BAIAP3 CACNA1F STEAP4 SYTL2 CD44 STAMBP F2R SDCBP2 UTP20 SCN3A AKAP12 RAB23 ITPRIP PIEZO1 LIN7A VAMP2 SERINC5 UBL3 SLC34A1 TRAF6 SLC19A2 PDGFC ADORA2A SHANK2 SCRIB PTH1R CKAP5 ARHGAP21 RNPEP NEDD4 ALOX15B RIF1 SYTL1 RAB3C GLDN FLOT1 TMEM59 HCN1 JAK2 LRP6 FAT2 RDX BoLA SHC1 CDHR1 PCDHA13 GRIN3B DLG1 CHMP2B CLDN4 STAT3 PREX1 MPP5 TACSTD2 AP2S1 KIF14 SERINC3 CLDN8 ITM2B PRRC2A ATP11A PTK7 SVIL CCNY TNFSF15 GNAS TSPAN2 SRI MAPK8IP3 CCT3 CFTR CACNA1B DGKQ CCNYL1 MTMR1 AMER3 PKP4 NDRG1 FMNL3 COMT NSFL1C NF2 TRPM7 SLC1A5 BRCA1 KIT LITAF KCNC3 SHANK1 PPP2CA CSPG4 PCDHGC3 S100A14 FLNC CTNND1 RAB26 RNF112 RGS6 CNNM2 PRKACA SYT4 TJP1 PRNP LIN7B PIGN RTN4R PNPLA2 LOC786512 CACNA1D AAK1 ALCAM PTGFRN TMEM184A ITPR1 PROM1 GRIA3 SEZ6L2 ITGAL EPRS IDE PCDH20 RAPGEF2 TPCN2 SSFA2 ALDH1A3 TNFAIP8L3 INPP5J DSTYK OR51Q1 FCER1G TMPRSS6 GRIA1 DNM2 AP2A2 ATP1A2 MARK3 KCNMA1 CDH22 ZAP70 RAP2C CC2D1A ANO6 VAMP5 ATP8B1 SCN8A TES PRKAR2A KCNG4 PROM2 ITPR2 CTNNA1 ROCK2 AXIN1 ARL6 LCK SWAP70 ADCY7 GNG10 PTPRM TFRC UTRN SMPDL3B ITGB1 CLDN3 EPS15 ABCA7 RAB25 CDC42SE2 CAPN2 LOC788626 RAB37 MYOF CBLC PCDHB8 SLC23A1 ADSS BICD2 SLC7A2 DAAM1 INO80 KCNA4 IRS4 FAT1 BACE1 DIRAS2 FAM84B ARHGEF1,CC,363,363 of 630,15.92,57.62,5.39E-158,4.702E-155
GO:0005654,nucleoplasm,A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN000192346)A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)A7YW98(Evidence code:IEA/Database source:UniProtKB:P54136|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O95785|ens)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:A0A140VK27)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)G3MWR8(Evidence code:IEA/Database source:UniProtKB:Q7RTP6|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens)F1MHP1(Evidence code:IEA/Database source:UniProtKB:O15042|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A6H7B5(Evidence code:IEA/Database source:UniProtKB:Q9UNS2|ens)F1MLT6(Evidence code:IEA/Database source:UniProtKB:A2RRH5|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:A0A024R7W9)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033)Q2NL22(Evidence code:IEA/Database source:UniProtKB:A0A024R8W0)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BHZ4(Evidence code:IEA/Database source:UniProtKB:Q9UPT8|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1N2I0(Evidence code:IEA/Database source:UniProtKB:P26374|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1BBS6(Evidence code:IEA/Database source:UniProtKB:Q6ZRP7|ens)Q32LB3(Evidence code:IEA/Database source:UniProtKB:Q7LFL8|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)P27214(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:W0Z7M9|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)O19137(Evidence code:IEA/Database source:UniProtKB:O95639|ens)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)Q9TTA5(Evidence code:IEA/Database source:UniProtKB:Q9NZC9|ens)Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q9UJQ4|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB:P30047|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)F1N281(Evidence code:IEA/Database source:UniProtKB:Q7Z4V0|ens)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)E1BAW2(Evidence code:IEA/Database source:UniProtKB:A0A024R5J7)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q5GJ75|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:A0A024R9W5)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)Q2KII5(Evidence code:IEA/Database source:UniProtKB:A0A024QZZ7)A6QQX8(Evidence code:IEA/Database source:UniProtKB:Q53GS9|ens)F1MWT0(Evidence code:IEA/Database source:UniProtKB:Q9NTJ4|ens)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q2L6I0|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)E1BDE3(Evidence code:IEA/Database source:UniProtKB:A0A024R461)G3MZ78(Evidence code:IEA/Database source:UniProtKB:Q9H0L4|ens)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)Q9TU47(Evidence code:IEA/Database source:UniProtKB:P56537|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q92598|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:A0A024R7E0)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1BDU9(Evidence code:IEA/Database source:UniProtKB:Q8WXI9|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:A0A024R7L6)Q3T0M9(Evidence code:IEA/Database source:UniProtKB:A0A024R9Z2)Q2TBI4(Evidence code:IEA/Database source:UniProtKB:A0A140VJY2)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62191|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)Q17QN3(Evidence code:IEA/Database source:UniProtKB:X5DP00|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB:A0A024R2W7)A4FV74(Evidence code:IEA/Database source:UniProtKB:A0A024R4D1)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:B0LPF3|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q14190|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)P61283(Evidence code:IEA/Database source:UniProtKB:A0A024R5H0)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:Q03052|ens)F1MRP8(Evidence code:IEA/Database source:UniProtKB:Q5JYA6|ens)A4IFC8(Evidence code:IEA/Database source:UniProtKB:P18858|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:A0A024R7C0)E1BE97(Evidence code:IEA/Database source:UniProtKB:Q7LBC6|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BJV5(Evidence code:IEA/Database source:UniProtKB:Q14966|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)G3N0Y7(Evidence code:IEA/Database source:UniProtKB:Q9NTX9|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)Q28104(Evidence code:IEA/Database source:UniProtKB:M0QXB4|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P13349|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:A4LAA3|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)E1BJF4(Evidence code:IEA/Database source:UniProtKB:A6NMQ1|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)F1MML3(Evidence code:IEA/Database source:UniProtKB:Q5H9F3|ens)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5BIM5(Evidence code:IEA/Database source:UniProtKB:Q5T4F4|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)F1MVT7(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q08DB4(Evidence code:IEA/Database source:UniProtKB:B0QZ18|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BH30(Evidence code:IEA/Database source:UniProtKB:Q96BY7|ens)E1BGK7(Evidence code:IEA/Database source:UniProtKB:J3KTH2|ens)E1BL97(Evidence code:IEA/Database source:UniProtKB:Q9UN79|ens)F1MQH2(Evidence code:IEA/Database source:UniProtKB:A0A0B4J1T8)P48452(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4C6)Q32PD5(Evidence code:IEA/Database source:UniProtKB:B0ZBD0|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB:Q96L92|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)E1BGE5(Evidence code:IEA/Database source:UniProtKB:O95373|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB:E5KRP5|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z5H3)A4FUD1(Evidence code:IEA/Database source:UniProtKB:Q9HCN4|ens)Q3SZ43(Evidence code:IEA/Database source:UniProtKB:A0M8W4|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:F1D8P9|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:A0A087WYT3)E1BAF6(Evidence code:IEA/Database source:UniProtKB:P48634|ens)Q08DK5(Evidence code:IEA/Database source:UniProtKB:Q9NR46|ens)P26882(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:A0A024R136)F1N1V1(Evidence code:IEA/Database source:UniProtKB:A0A024R0G2)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)E1BIP2(Evidence code:IEA/Database source:UniProtKB:A0A024R151)E1BGT8(Evidence code:IEA/Database source:UniProtKB:Q08AE8|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:Q8IVL1|ens)E1B8T3(Evidence code:IEA/Database source:UniProtKB:Q9UGU0|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)E1BQ01(Evidence code:IEA/Database source:UniProtKB:Q8N1G0|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q9NR48|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BB93(Evidence code:IEA/Database source:UniProtKB:Q9BWV1|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)Q0VCY7(Evidence code:ISS/Database source:UniProtKB:Q07955)Q2KIT4(Evidence code:IEA/Database source:UniProtKB:Q9UDY4|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)E1BM86(Evidence code:IEA/Database source:UniProtKB:Q6ZN04|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:P18564|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:P31644|ens)Q32S26(Evidence code:IEA/Database source:UniProtKB:P25440|ens)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q13617|ens)E1BBH8(Evidence code:IEA/Database source:UniProtKB:A0A024RBA3)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)F2Z4E8(Evidence code:IEA/Database source:UniProtKB:A0A024RCJ9)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61457|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)F1MHL2(Evidence code:IEA/Database source:UniProtKB:Q92625|ens)F1N2G1(Evidence code:IEA/Database source:UniProtKB:Q8NFC6|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:A2ABF8|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens)E1B8G9(Evidence code:IEA/Database source:UniProtKB:Q8N257|ens)Q3T087(Evidence code:ISS/Database source:UniProtKB:P62913)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P02694(Evidence code:IEA/Database source:UniProtKB:A0A0A0MQT0)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q32PF2(Evidence code:IEA/Database source:UniProtKB:A0A024R1T9)Q17QR2(Evidence code:IEA/Database source:UniProtKB:A0A140VK54)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:Q9HAU0|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)A5D7P5(Evidence code:IEA/Database source:UniProtKB:Q9BSJ2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)E1B8E3(Evidence code:IEA/Database source:UniProtKB:Q86SG2|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:A3RJH1|ens), ZMYM5 SIRT6 CDC27 PCBP1 RARS DUSP3 WIZ LTA4H AP5Z1 OSBP MICAL3 CRKL TNRC18 NFKB1 ACSS2 U2SURP TAF8 NPAT DHX9 COPS3 WDR27 COPS5 SRI STRN3 EIF4A3 AGO4 PTPN23 WWTR1 SCRIB ZC3H4 PLCB3 KHDRBS1 TDG DNAJC7 NUDT16 TOP2B CHML SP1 UBQLN1 QSOX2 CXXC5 PTPN14 STRAP RUVBL1 CPSF3L ANXA11 FERMT2 DYRK2 RPS6KA5 PCBP2 DENND1A MKL1 CTBP1 ZHX3 SPEN CHD7 INO80 CPSF4 SNRNP70 MRI1 SMARCAL1 MIER1 CNP SALL4 CAD GCHFR SYVN1 KANSL3 SNRNP200 ZNF438 ZMYM4 TRIP12 LRRC32 ZNF367 TNFAIP8L3 RAD23B HUWE1 ESRP1 HIST1H2BI USP39 MAN2C1 PPP1R13B INA PPP1R10 HCFC2 CTDSP1 CSTF2T DOCK10 EIF6 HSPH1 MYO6 LITAF NACC1 KIF23 GATAD2B TAF10 MVB12A ARL4A TRAP1 PSMC1 RUNX1 SNRPN HIVEP1 DOT1L MAPKAPK3 COPS8 GRB2 ARID1A UTRN DHX8 RPS6KA4 E2F1 SIM2 DNM1 BANF1 BAIAP2L1 NSFL1C POU3F1 PLEKHG1 LIG1 ONECUT2 WRN RPP25 KEAP1 KDM3B HOXA7 ZNF638 GCFC2 FAM217B TNKS GOLGA3 COPE MYF5 ATRX PTPA BCL3 POLA1 NUMA1 NCOA3 BCORL1 HIC1 SETX CDK6 GTF3C6 PPP1CC ZFYVE27 BRCA2 RAD18 EPM2AIP1 CPNE1 KMT2A PPP1CB ADARB1 GCC2 ATG2B TAF4B SOX13 EPHA6 PPP3CA RPS19 SNX27 ARID3A SFPQ KPNB1 IPO7 JAK2 SPAST CCAR2 CLINT1 GPN1 UBE2V2 MAGI1 NR1I2 FAM129B PTGES3 PRRC2A SH3GLB2 PPID SEC13 RACGAP1 DENND2D SETD1B SLC44A1 SPIRE1 CAND1 NAV2 TCF20 BCL9L ZNF687 PUM1 ASH1L UBE2Z PIN1 BOC RNF112 UHMK1 SRSF1 DNAJB4 CDC5L MEX3B XPOT ITGB6 GABRA5 BRD2 CUL2 MBD6 PRKDC HIST1H2BB PCBD1 SNF8 RAI1 ANKS1A BOD1L1 PTTG1IP EHMT2 SMG1 EAF2 HIST3H2BB RPL11 ZBTB4 CHD6 MYO1C RBP1 ABL1 ACLY STAMBP GPKOW PLEKHA5 TRPM4 TUBGCP2 GLI1 ZCCHC6 SMARCA2 ANKRD23 DDX1,CC,235,235 of 315,10.31,74.6,4.229E-122,2.459E-119
GO:0016021,integral component of membrane,Q08E50(Evidence code:IEA/Database source:InterPro:IPR005435|I)F1MSU3(Evidence code:IEA/Database source:InterPro:IPR000276|I)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B749(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR000832|I)Q58CW5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MLR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQP7(Evidence code:IEA/Database source:InterPro:IPR006614|I)G3X812(Evidence code:IEA/Database source:InterPro:IPR008297|I)Q1JQC7(Evidence code:IEA/Database source:InterPro:IPR005828)F1N740(Evidence code:IEA/Database source:InterPro:IPR003644)Q2YDG0(Evidence code:IEA/Database source:InterPro:IPR017978)E1BKL9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q17QL5(Evidence code:IEA/Database source:InterPro:IPR030351)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MPT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR001757|I)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR011527|I)A5D7N8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7YWN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMQ1(Evidence code:IEA/Database source:InterPro:IPR012561|I)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BGU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A3KMX1(Evidence code:IEA/Database source:InterPro:IPR005331|I)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR009460)Q0VC64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P47803(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR001757|I)Q05037(Evidence code:IEA/Database source:InterPro:IPR012897|I)Q0P5B1(Evidence code:IEA/Database source:InterPro:IPR007223|I)Q9XSK2(Evidence code:IEA/Database source:InterPro:IPR000301|I)Q0VCP0(Evidence code:IEA/Database source:InterPro:IPR024371)P10897(Evidence code:IEA/Database source:InterPro:IPR028837)F1MWK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q32LK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QR09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TA30(Evidence code:IEA/Database source:InterPro:IPR007007)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR029601)Q2KJA5(Evidence code:IEA/Database source:InterPro:IPR004687|I)Q0VCP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X6G8(Evidence code:IEA/Database source:InterPro:IPR002131)A6QQM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08D78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8WN91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR001757|I)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM92(Evidence code:IEA/Database source:InterPro:IPR008795)E1B7G0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P63026(Evidence code:IEA/Database source:InterPro:IPR001388)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BKU0(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q95J79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BKQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A8DC37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3SZJ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A3KN28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VDN5(Evidence code:IEA/Database source:UniRule:UR000107246)E1BP63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N4T0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MTF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5R0(Evidence code:IEA/Database source:InterPro:IPR000175)F1MK52(Evidence code:IEA/Database source:InterPro:IPR008795)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR011527|I)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P31836(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJ99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1ME12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BAW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q00KA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR000175)E1BL94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MLX5(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BC61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BBU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VE13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0V7N0(Evidence code:IEA/Database source:InterPro:IPR001388)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MW11(Evidence code:IEA/Database source:InterPro:IPR011527|I)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR009460)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4IFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BBS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B757(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X7E9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EA65(Evidence code:IEA/Database source:InterPro:IPR000715)G3MY32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N416(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MQP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BEB2(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005405)F1MFY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1RMK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8WN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A8KC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QR68(Evidence code:IEA/Database source:InterPro:IPR007274)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KI48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0P559(Evidence code:IEA/Database source:InterPro:IPR007593)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR013769)E1BIP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1JQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MJ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR001108|I)A7YWN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q01107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MNY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884|I)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BB93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MP76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MS08(Evidence code:IEA/Database source:InterPro:IPR004842)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7H3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MSN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3MU93(Evidence code:IEA/Database source:InterPro:IPR010660)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ47(Evidence code:IBA/Database source:PANTHER:PTN000409559)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)Q765N9(Evidence code:IEA/Database source:InterPro:IPR004031)E1BMA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR001757|I)Q5E9C2(Evidence code:IEA/Database source:InterPro:IPR003038)A2VE53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7MBI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MKY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B968(Evidence code:IEA/Database source:InterPro:IPR004755)E1BM45(Evidence code:IEA/Database source:InterPro:IPR037671)Q3T110(Evidence code:IEA/Database source:InterPro:IPR008661)E1BPQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMX7(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O18784(Evidence code:IEA/Database source:InterPro:IPR004729|I)F1MMG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJD2(Evidence code:IEA/Database source:InterPro:IPR001388)Q32PI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q58CZ7(Evidence code:IEA/Database source:InterPro:IPR000301|I)B0JYK2(Evidence code:IEA/Database source:InterPro:IPR003392|I)G3N2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XS26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MIU7(Evidence code:IEA/Database source:InterPro:IPR030307)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MWI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZCB8(Evidence code:ISS/Database source:UniProtKB:Q9P0I2)Q1RMV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)C3V9V7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N2I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR005292|I)F1MCW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)Q2KJ41(Evidence code:IEA/Database source:InterPro:IPR000301|I)Q09YM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MY84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR000832|I)Q2KIN6(Evidence code:IEA/Database source:InterPro:IPR007248)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1JQB3(Evidence code:IEA/Database source:InterPro:IPR000276|I)A7YY65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N226(Evidence code:IEA/Database source:InterPro:IPR008155)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MYG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5Z0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BFN9(Evidence code:IEA/Database source:InterPro:IPR037440)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MS75(Evidence code:IEA/Database source:InterPro:IPR004842)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR001426)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MW12(Evidence code:IEA/Database source:InterPro:IPR011527|I)F1N7K7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4IFM4(Evidence code:IEA/Database source:InterPro:IPR004031)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR001757|I)E1BK86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MD25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q28146(Evidence code:IEA/Database source:InterPro:IPR037440)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR011531|I)G3N127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MG76(Evidence code:IEA/Database source:InterPro:IPR000276|I)A5PJQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MF38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR009460)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005459)F1MX24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMN4(Evidence code:IEA/Database source:InterPro:IPR000276|I)A7YY70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X8A9(Evidence code:IEA/Database source:InterPro:IPR000276|I)A2VDQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5T9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BF06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005404)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T0W2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)M5FK87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FUW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MNP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N2S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MGS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR001426)F1MPF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MG24(Evidence code:IEA/Database source:InterPro:IPR026082)F1MPN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR012315)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MR98(Evidence code:IEA/Database source:InterPro:IPR000276|I)O46405(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0V7N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MZZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJ40(Evidence code:IEA/Database source:InterPro:IPR009119|I)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FV32(Evidence code:IBA/Database source:PANTHER:PTN001023612)Q05B70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPZ1(Evidence code:IEA/Database source:InterPro:IPR006581)Q08DB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)V6F7Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9TU34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BA07(Evidence code:IEA/Database source:InterPro:IPR011701)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BQ05(Evidence code:IEA/Database source:InterPro:IPR018629)F1MMH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MXA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O46631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q29423(Evidence code:IEA/Database source:InterPro:IPR001231)Q2KI29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KIP5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MN60(Evidence code:IEA/Database source:InterPro:IPR001757)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9E7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BF53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BAK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B9W1(Evidence code:IEA/Database source:InterPro:IPR004031)F1MEC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q4ZJV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q95M13(Evidence code:IEA/Database source:InterPro:IPR016248)P35071(Evidence code:IEA/Database source:InterPro:IPR011527|I)E1BKW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR026082)G3N0Y0(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1N758(Evidence code:IEA/Database source:InterPro:IPR016245)F1MT41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MPT8(Evidence code:IEA/Database source:InterPro:IPR030352)E1BGL9(Evidence code:IEA/Database source:InterPro:IPR028701)E1BMY3(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BN79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B813(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B8X1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q148L2(Evidence code:IEA/Database source:InterPro:IPR001757)A6QQK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7F4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7MB15(Evidence code:IEA/Database source:InterPro:IPR017981)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X6Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC83(Evidence code:IEA/Database source:InterPro:IPR002259|I)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR001757|I)A2VE81(Evidence code:IEA/Database source:InterPro:IPR002958)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4IFK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q28053(Evidence code:IEA/Database source:InterPro:IPR008155|I)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7F2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N271(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N3I4(Evidence code:IEA/Database source:InterPro:IPR006614|I)F1MMU8(Evidence code:IEA/Database source:InterPro:IPR012496)G3MW09(Evidence code:IEA/Database source:InterPro:IPR011527|I)Q8HYW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BB36(Evidence code:IEA/Database source:InterPro:IPR007754)P67810(Evidence code:IEA/Database source:InterPro:IPR019756|I)A6H7B0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q6Q146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VCR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)B6ULZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BGZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A8E4P5(Evidence code:IEA/Database source:InterPro:IPR001614)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR000832|I)F1MC27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BDL0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MGE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X828(Evidence code:IEA/Database source:InterPro:IPR000276|I)F6R7C3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR015338|I)E1BFD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VCU9(Evidence code:IEA/Database source:InterPro:IPR012496)Q6BBL6(Evidence code:IEA/Database source:InterPro:IPR004031)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)A5D7V2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F6Q9J4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BLE8(Evidence code:IEA/Database source:InterPro:IPR000162|I)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N4S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BLU2(Evidence code:IEA/Database source:InterPro:IPR002666|I)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MIU3(Evidence code:IEA/Database source:InterPro:IPR012496)Q3B7N4(Evidence code:IEA/Database source:InterPro:IPR004031)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)Q08DW9(Evidence code:ISS/Database source:UniProtKB:Q99LR1)E1BHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR009471)P02722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QNP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR017978)Q08DD1(Evidence code:IEA/Database source:UniProtKB:P50428|ens)Q0VD06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G5E6J0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q95JC7(Evidence code:IEA/Database source:InterPro:IPR001991|I)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR030172)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08E55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJ59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q17QB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P02715(Evidence code:IEA/Database source:InterPro:IPR002394|I)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MD64(Evidence code:IEA/Database source:InterPro:IPR027272)E1BIE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3SYV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q58DS4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFH3(Evidence code:IEA/Database source:InterPro:IPR003644)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MJZ6(Evidence code:IEA/Database source:InterPro:IPR000301|I)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O18875(Evidence code:IEA/Database source:InterPro:IPR000175)O62826(Evidence code:IEA/Database source:InterPro:IPR005458)E1BM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q09YL9(Evidence code:IEA/Database source:InterPro:IPR001388)Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)E1BJW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BB56(Evidence code:IEA/Database source:InterPro:IPR012858)A5D7H9(Evidence code:IEA/Database source:InterPro:IPR000175)F1MS16(Evidence code:IEA/Database source:InterPro:IPR001757)E1BI45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BN52(Evidence code:IEA/Database source:InterPro:IPR003644)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR001757|I)Q2KHY2(Evidence code:IEA/Database source:InterPro:IPR001388)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VE11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812), GABRA5 RXFP3 DPP4 SLC5A9 CD97 SERINC2 SLC35B1 ASTN1 DYSF NOTCH4 SLC22A23 FRAS1 GPRC5C FAT1 TMEM30A CPT1B SDK2 ATP11A LOC100299180 TMPO ENTPD2 GALNT7 OTOF KCNG2 SOGA3 CHST14 ITGAV RYR1 MANSC1 FLT3 RGR ATP13A5 KCNA4 PEX13 CD63 SLC33A1 CYB561 PTK7 CYSTM1 SLC25A26 PTPRM CACNA1B MARCH8 DPEP3 NINJ1 TRPM7 LAPTM5 CCDC149 LGR6 MFSD6L LOC512672 CDHR1 CYP2J2 ATP7B ITM2B PROM2 IFNLR1 VAMP2 DHRS3 LEMD3 ADORA2A TYROBP ARID1B FCGR2A LAMP2 ST7L SLC5A11 SPAST RNF139 EMC10 BoLA KCNT2 IL9R RHOT1 KCNG4 KCNF1 SLC6A5 PROM1 LOC515333 SCN3A NCAM1 LMAN1L LOC100295883 DSEL LRRC32 LRP4 SLC6A20 VSIG2 LGR4 PKDREJ GRIA3 ADAM15 LFNG WRB MAL2 VAMP1 KCNH5 LOC523126 RYR3 CYP2R1 LRRC24 TMPRSS9 ADCY7 POMGNT1 AGPAT1 QSOX2 DNER SCN2B MRVI1 IL13RA1 DPAGT1 TMTC2 CACNA1D CDH22 DCHS2 CYP7A1 HEPACAM LOC531090 ABHD2 KCNC4 ANO6 SEZ6L2 FAM174B ITPR2 NLGN2 SLC31A1 FIS1 PTTG1IP IFITM1 SLC4A7 SLC44A1 CMTM7 LRP6 PCDHA13 PTPRN TPCN2 PSEN1 ITGB7 DSC1 SIRPB1 TMEM2 CDON MFN2 BEST3 BOC ITGAD SDC3 F11R SLC12A2 RHOT2 SLC44A2 TACSTD2 Notch1 TMPRSS6 VPS51 ZFYVE27 INPP5B CLDN3 PRTG ATP2C2 DAD1 IKBIP SLC11A2 SUSD5 LOC100850276 SLC7A2 PIGN TM4SF18 IGSF5 SCN5A OR51Q1 CLCC1 TRPC1 SCARA3 VAMP3 MPZL1 PNPLA2 LMTK2 TSPAN2 NPC1 SMIM1 HAS3 SLC27A3 HAS2 GRIN3B PANX3 PIGO EMC3 ENG TMED2 KLRF2 TMEM106B ABCC3 GRIK4 ABCC5 TSPAN14 ULBP15 CSPG4 PTH1R MPV17 ITGAL GPR4 MTCH1 APLP2 PIGK SLC39A6 ITGB1 AQP5 MAN1A2 ADAM7 NRXN2 CACNA1F SLC12A1 EPHA6 SHISA5 LOC100337053 MARCO CLDN8 ATP1A2 PKHD1 KIAA1549L GRIA2 NRXN1 LOC100125916 IMMT SLC4A2 G0S2 GPR75 RNF130 EMB RYR2 TRPC3 CLN3 NMBR SLC34A1 OR5M11 CDH11 ITGB6 SERINC5 TNFSF15 KCNC3 TMEM184A MGC126945 LAMP1 RNF112 DPM3 CACNA1H TXNDC11 GAL3ST2 TRPM4 SCN8A MEGF8 SOX1 TPST2 TIMM17B GRIA4 FAM205A LRRC26 NAALAD2 HCN1 EPHB4 FAT2 ABCA1 FNDC3B ULBP3 SYNE3 SCN11A RRH CD80 GRIA1 SUSD2 TFRC SPAG4 BACE1 CACNA1S PLEKHB2 GRAMD3 SORL1 HERC4 SDK1 DSCAML1 ITPR1 CNNM2 SLC17A8 B3GALT4 XKR7 ITGA9 CNGB3 SIRPA CD44 TMEM256 PDZK1IP1 ATP2B2 COMT MBTPS2 GLT8D1 CDH7 SYVN1 TMEM114 PCDH8 ABCG8 CLIC4 MAOB fgfr3 CFTR SNX19 ABCA7 LOC788626 ERBB4 PTGFRN TMEM30B SYT6 LOC614090 CES5A LOC786796 FNDC3A ATP13A1 TEX2 PCDHGC3 FCER1G FZD1 SCO1 AIFM2 GALNT2 PCDH20 PTPRA SLC29A1 ATP2B4 OCLN GK2 PCDH1 APP STX7 SYT4 LOC100337457 KIT SERINC3 MYOF TMC3 LOC509854 atp1A3 MGAT2 SEC11A PLLP NRCAM TMEM68 WC1 SLC45A4 GPM6B PTH2R LMTK3 LOC786512 MARCH5 ITGA2 FRMD5 OR13C3 PEX2 EXT1 ANKLE2 TMC6 CLDN4 KL PCDH12 LOC100848815 GRM7 ST8SIA3 ULBP11 SLC19A2 RNF128 TMC5 CLDN7 F2R TLR4 ABHD12 PPP1R3F ENTPD6 TENM3 SLC25A4 SCAP BTNL2 ATP6V0C GPR179 ARSA NPTN TMEM200B MAN1B1 SCN10A SLC1A5 KCNH6 KCNMA1 MBTPS1 TMEM125 PCDHB8 PLA2G16 TMPRSS2 CHRNE UGT2B10 ALCAM CACNA1E PIEZO1 LOC100298868 TMEM59 DBH ECE1 TMEM263 CACNA1C TMEM171 FREM2 MGAT1 TSPAN9 PTPRZ1 SLC6A8 TRPC2 NDC1 STXBP5 SPCS3 STEAP4 SLC25A29 DCST2 SLC6A14 ATP2B3 SLC23A1 FREM1 ATP8B1 VAMP5 LOC788634 IGSF8,CC,427,427 of 1299,18.73,32.87,1.788E-116,8.507E-114
GO:0009987,cellular process,F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens),FMNL1,BP,1,1 of 3971,0.04,0.03,2.578E-109,1.124E-106
GO:0000166,nucleotide binding,A4IFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BFA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7MBA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E5S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZBF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17QG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32KW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)D3IVZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR010997)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0V8H0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5D7N6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q75WB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BGB0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001412|I)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1JP95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5D7A4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MW12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F6RP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3X6L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q28007(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MB90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N3Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P62194(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJ86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR023299)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BCG1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A3KN22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MMQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BC41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1ML89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BNQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17R14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BN72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002314|I)Q3MHM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR010997)F1MLR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VCP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08E45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR023299)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR002318|I)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3N2C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2YDJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MW09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7E3C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NKZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR023299)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P10568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1RMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MZH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32L40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58DV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q05B83(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MG13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MN60(Evidence code:IEA/Database source:InterPro:IPR023299)Q0II58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MS16(Evidence code:IEA/Database source:InterPro:IPR023299)Q2TBH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBB1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BA80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P81948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5EAC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KIW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E5T3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MXH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BBT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MUU2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MX93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MXH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4H6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MUC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR002318|I)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR023299)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17QB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2T9S0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BIL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P38408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B870(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BC36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E6P3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3N3N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MXV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MU48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BNV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BPK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PJJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000924|I)G3MW11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N1I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MY45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BKQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3N1E4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MMC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MM57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR023299)E1BJK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7YSY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9TTA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MG24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BNQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MEM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P0C7Q4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58DC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006134|I)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PJP8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QPN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q4ZJV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MG18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0P5I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR023299)F1N2Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N758(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MI74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR023299)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MVC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B953(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5E9F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZC28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BBN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547), NEK3 ZAP70 KIFC3 RARS KIFC1 NLRP14 KIF14 DHX34 ARL2 ARL4A GNAT1 ACTR1B NADSYN1 UBE2G2 KATNAL2 IRGC GNAS DDX3Y WRN DGKQ PFKM ADCY7 DHX57 KIF23 SPAST GPN1 OPLAH PAK1 QARS SEPT11 KIF13B RARS2 TEC GART PSMC3 UBE2L3 RIT1 LOC100337053 LOC100295712 MATK CSNK1G3 PIP4K2C GNAT2 DICER1 FRK TRAP1 FLT3 CDK13 VPS4B RNF112 ARL8A PAK2 EIF4A3 PKN1 DPYD STK25 CSNK1G2 ABCC3 PSMC5 TUBA1D PRKACA PRKCB ATP8B1 RAB26 ABCA7 UBE2M NLRP5 PSMC1 SEPT7 GUK1 PRKACB MYO5B CCT3 KIF15 CPS1 PRKAG1 LCK DHX37 TYK2 MB21D1 JAK1 MYO1D SEPT2 IARS MYLK2 NIM1K MTG1 GARS KIF5B CAMK2D TOR2A BLM MYO7B SEPT8 TUBB4A DDX4 NUDT16 PANK4 JAK2 EFTUD2 DDX3X RHOT2 SRC RAP2C CAMK2A RAN EIF4A2 ATP2C2 AARS RUVBL2 PAK4 DXO GUCY1A3 NLRP7 MASTL GMPPB WARS2 UBE2K CCT6B LOC509854 KIF5A TUBA8 MAPK11 KIF26B CCT7 ATP1A2 MAPK9 MYO1A PLK4 UBE2D2 PIK3CD MYO5A TDRD9 PAK6 RUVBL1 TCP1 FHIT RP2 RFC2 ADSS ARL1 IDE ASNS ACTR1A MYO15A RAB25 PLK3 ATP2B2 KIF5C ATP2B3 RRAS HSPH1 LOC783604 MYO18B DDX1 BRAF CSNK1A1 TUBA4A GSS CSNK1G1 PSMC6 LOC100299180 NME1 HRAS LIG1 ARL6 MAST4 HSPA4L GCK DNM1 CAMK2B STK35 NOA1 MYO5C ARL8B MYO9A CHD8 TRIM23 LOC515333 AARS2 AAK1 CFTR ATP7B PRKDC IMPDH2 ABL1 RPS6KA4 HCK RAB30 TUBB3 WEE1 EPHB4 DNM2 CDC42BPB ERCC2 PI4KA GNA12 GNA14 ARL16 LOC100141266 MAPK1 KIF2A PRKAR2A PTPA CDK6 PFKP GNA13 ARF6 KIF13A MDN1 MAPK10 TOP2B MX2 MYO9B RAB4A MAPKAPK3 MYO6 CDK3 CDK12 NME3 EPRS LOC523126 GK SMG1 SEPT6 LOC100336669 CARNS1 MYO18A MARK3 MARS YES1 HINT3 PRKCI GALK1 RAB39B PAK3 KIF26A MAP3K10 MYO1F CCT8 MYH14 DHX9 DSTYK HK2 RAB3B ACLY NARS ATP11A TUBB1 MAPK13 SPATA5L1 SMARCAL1 ABCA1 ROCK2 RPS6KA5 GNAI1 RAP2A SAR1B DHX8 GNAT3 GTPBP1 POLA1 ATM MAP2K4 MYH11 GNAL RAB3C RPS6KA2 LARS ABCG8 MAP3K9 MYLK4 MCM4 ATP2B4 DIRAS2 ERBB4 NLRP12 TUBA3E ATP13A5 CDK1 ABCE1 fgfr3 FIGNL1 CAD MYO1C RHOT1 MAPK12 TUBA1A LOC533307 PSMC2 ARL13B KIT RAB3A KIF1B EPHA6 GSK3A HSPA9,MF,297,297 of 677,13.03,43.87,1.231E-107,4.956E-105
GO:0005622,intracellular,G3N3N1(Evidence code:IEA/Database source:InterPro:IPR024156)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)Q3SX45(Evidence code:IEA/Database source:GO:0035556)Q3B7N3(Evidence code:IEA/Database source:GO:0006886)F1MKU3(Evidence code:IEA/Database source:InterPro:IPR000315)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q3T087(Evidence code:IEA/Database source:InterPro:IPR020929)Q5BIP4(Evidence code:IEA/Database source:InterPro:IPR004152)E1BKJ6(Evidence code:IEA/Database source:GO:0014065)G3MZ78(Evidence code:IEA/Database source:UniProtKB:Q9H0L4|ens)Q5E9S7(Evidence code:IEA/Database source:GO:0007264)F1MQ96(Evidence code:IBA/Database source:PANTHER:PTN000683254)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR002108)F1MCY2(Evidence code:IEA/Database source:UniProtKB:Q501J7|ens)F1MK99(Evidence code:IEA/Database source:GO:0035556)G3N065(Evidence code:IEA/Database source:GO:0072332)F1MS53(Evidence code:IEA/Database source:GO:0007264)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)E1BG23(Evidence code:IEA/Database source:InterPro:IPR000315)Q2KI07(Evidence code:IEA/Database source:InterPro:IPR024156)A5PKC1(Evidence code:IEA/Database source:GO:0035556)G3N2N6(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MQD1(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MU53(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1MY84(Evidence code:IEA/Database source:GO:0035556)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)E1B7G6(Evidence code:IEA/Database source:GO:1990126)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR002121)E1BQ22(Evidence code:IEA/Database source:InterPro:IPR000315)F1N6C0(Evidence code:IEA/Database source:GO:0019722)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN000584058)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)Q1JQD5(Evidence code:IEA/Database source:GO:0035556)Q27971(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MCK0(Evidence code:IEA/Database source:UniProtKB:Q8N3A8|ens)Q1LZF7(Evidence code:IEA/Database source:GO:0007189)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BF06(Evidence code:IEA/Database source:GO:0007250)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)A1A4I4(Evidence code:IBA/Database source:PANTHER:PTN000683254)F6QPI1(Evidence code:IEA/Database source:GO:0007263)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)E1B870(Evidence code:IEA/Database source:InterPro:IPR024156)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)F1MLZ5(Evidence code:IEA/Database source:GO:0008333)F1MN90(Evidence code:IEA/Database source:InterPro:IPR003508)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)E1BIX3(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MP51(Evidence code:IEA/Database source:UniProtKB:Q8NCM2|ens)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592)A7YVE7(Evidence code:IEA/Database source:GO:0035556)E1BNM4(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q2YDM1(Evidence code:IEA/Database source:InterPro:IPR024156)E1BN32(Evidence code:IEA/Database source:GO:0035556)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A8WFQ1(Evidence code:IEA/Database source:InterPro:IPR000315|I)A5PK70(Evidence code:IBA/Database source:PANTHER:PTN000887110)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MHB9(Evidence code:IEA/Database source:GO:0048016)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592)Q17QT7(Evidence code:IEA/Database source:UniProtKB:Q9H0Q0|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MQ43(Evidence code:IEA/Database source:GO:0007264)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR001912|I)Q0IIM2(Evidence code:IEA/Database source:InterPro:IPR024156)Q2HJ54(Evidence code:IEA/Database source:InterPro:IPR001666)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR000315)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR018277)C3VEX2(Evidence code:IEA/Database source:InterPro:IPR001666)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q3ZC28(Evidence code:IEA/Database source:InterPro:IPR024156)A6H7F7(Evidence code:IEA/Database source:InterPro:IPR006722)E1BBX9(Evidence code:IEA/Database source:GO:0035556)E1BM69(Evidence code:IEA/Database source:InterPro:IPR000315)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR000315|I)E1BKU0(Evidence code:IEA/Database source:GO:0007189)P63097(Evidence code:IEA/Database source:UniProtKB:B2RSH2|ens)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR002359)Q3T0M9(Evidence code:IEA/Database source:InterPro:IPR024156)Q58DL5(Evidence code:IEA/Database source:GO:0007264)G3MXV5(Evidence code:IEA/Database source:GO:0072383)E1BD05(Evidence code:IEA/Database source:GO:0006405)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)P05126(Evidence code:IBA/Database source:PANTHER:PTN000683254)Q3T0T7(Evidence code:IEA/Database source:InterPro:IPR006687)F1N657(Evidence code:IEA/Database source:GO:0035556)Q56JV6(Evidence code:IEA/Database source:InterPro:IPR002108)Q32LM6(Evidence code:IEA/Database source:GO:0048489)Q2TA37(Evidence code:IEA/Database source:InterPro:IPR024156)E1BGQ4(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)G3X6L5(Evidence code:IEA/Database source:InterPro:IPR024156)A5PK10(Evidence code:IEA/Database source:InterPro:IPR004152)F1MMN0(Evidence code:IEA/Database source:InterPro:IPR000315)P43481(Evidence code:IEA/Database source:GO:0035556)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q27995(Evidence code:IEA/Database source:GO:0007263)F1N7V2(Evidence code:IEA/Database source:UniProtKB:Q9H0T7|ens)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002121)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)F1MY16(Evidence code:IEA/Database source:GO:0035556)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR001909|I), ARF6 RPL30 ASB2 RANBP6 BSPRY MYLK3 RPL11 TOM1 NYAP1 CSTF2T RASGEF1A PRKCI DSTN PHACTR4 UNC13A ZNF385C RAPGEF6 RPL35A TRIM47 ARL8B CDC42BPA ZFP37 RPS18 SGSM2 CAPN5 ZNF446 CSPG4 MYLK4 RPL27 ANKRD50 BLM TRIM68 CALM1 BRAF MRPL3 SRI RPS17 OXSR1 CAPN2 PARP8 PTH1R TUBB3 TBC1D22B TNFSF15 RPL28 PKN1 NDNF RPL38 ARL16 ATF6B DENND3 CIDEC RPS7 CAPN7 KCNH5 RPS27L CIT ZNF282 ARL1 RP1L1 RPL22 LRRK2 TRIM37 NME3 TBC1D2 INPP5A ALOX15B RPS27 FAM49A ABI1 MT3 DOCK9 IKBKG RPS9 ARL6 PITPNA CLIC4 RPS4Y1 RNF31 RPS19 PITPNM2 CHMP2B CAPN11 ARL13B TRAPPC2L UNC13C LOC516599 TRIM23 ADORA2A GNAI1 RPL9 ARL4A BCAR3 KIF13A POM121L2 RABGAP1 PRKCB SAR1B SPATA13 TWF1 LIN7A ARL2 ZNF316 RPS28 LOC511302 RPS4X ANO6 BCL11B WASF2 ARL8A TOM1L2 TRIM14 KIT PSEN1 NOS2 RAB17 WRN RPL23A AKAP13 ZNF394,CC,120,120 of 95,5.26,126.32,2.792E-81,1.044E-78
GO:0006468,protein phosphorylation,E1BA03(Evidence code:IEA/Database source:InterPro:IPR000719)Q3SZK4(Evidence code:IEA/Database source:GO:0004672)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR000719|I)P46196(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BL08(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR000719|I)P58108(Evidence code:IEA/Database source:GO:0004679)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR014930)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)A7MB90(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MG18(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLJ0(Evidence code:IEA/Database source:GO:0004672)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFM7(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MC27(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N1T6(Evidence code:IEA/Database source:GO:0004672)G3X793(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB50(Evidence code:IEA/Database source:InterPro:IPR000719|I)P35509(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9Y478|ens)P48734(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BKM6(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SYZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MY16(Evidence code:IEA/Database source:GO:0004691)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFF6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHZ1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BC36(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B8H0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B9B6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00517(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN63(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MJ90(Evidence code:IEA/Database source:GO:0004689)Q4TVR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N758(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VE07(Evidence code:IEA/Database source:InterPro:IPR000719)A5PJP8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MM88(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BJM5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLB8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A8QID1(Evidence code:IEA/Database source:InterPro:IPR000719)A0JN96(Evidence code:IEA/Database source:InterPro:IPR000719)Q08E45(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR000719)Q58DV4(Evidence code:IEA/Database source:GO:0004672)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MKY9(Evidence code:IEA/Database source:InterPro:IPR004166)P05126(Evidence code:IEA/Database source:InterPro:IPR000719|I)V6F977(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X736(Evidence code:IEA/Database source:UniProtKB:P61201|ens)A4FV00(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR004166)E1BB52(Evidence code:IEA/Database source:InterPro:IPR000719|I)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR000719)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18052|ens)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PK86(Evidence code:IEA/Database source:InterPro:IPR000719|I)P67827(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB57(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN42(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000719)F1N3T0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN72(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MH24(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58D16(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB49(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2HJ82(Evidence code:IEA/Database source:InterPro:IPR015726)G3X696(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E52(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000719|I)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N5W5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B793(Evidence code:IEA/Database source:InterPro:IPR000719|I)P43481(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N6C1(Evidence code:IEA/Database source:InterPro:IPR000719)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BHE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRI6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MUU2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BG90(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SWY6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q95M13(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLW1(Evidence code:IEA/Database source:InterPro:IPR000719|I)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05131(Evidence code:IEA/Database source:InterPro:IPR000719|I), PAK6 TBRG4 EPHB4 MAPK1 MAST4 CAMK2G MAP3K14 PLK3 MAPK4 PRKAG1 CDC42BPA COPS8 CSNK1G2 FRK MYLK4 ERCC2 MAPK12 OBSCN MYLK2 MAPK9 LMTK3 ZAP70 FASTKD2 MAPK11 CDK3 BRSK2 CDK12 CSNK1G3 FLT3 PRKAB1 CDK1 TAOK2 MAPKAPK3 AKAP13 CSNK1G1 PLK4 PIK3CD CAMK2D NEK3 NEK10 PAK3 ATM HCK CDK6 PEAK1 ABL1 SRC NUAK1 RPS6KA4 PRKACA WNK1 MAP3K9 PHKB DSTYK ERBB4 MASTL STK24 MAP2K4 NEK9 LRRK2 MYLK3 MAP3K1 PASK JAK2 PINK1 GSK3A ULK3 STK3 CAMK2A OXSR1 FASTK LCK ALPK2 PRKCB SIK3 COPS2 MAPK10 TEC TRPM7 CDK13 PAK4 RPS6KA5 PTPRA EPHA6 PAK2 PRKCI MAP3K8 CSNK1A1 TRIO YES1 MAPK13 CDK17 TYK2 PTK7 UHMK1 MAP3K4 NIM1K WEE1 AAK1 MATK HIPK4 SPEG SLK PAK1 ROCK2 JAK1 STK26 STK36 KIT MARK3 BRAF LRRK1 CDC42BPB CAMK2B PRKDC TAOK3 RPS6KA2 LMTK2 MAP3K10 STK35 DYRK2 STK25 DCLK2 fgfr3 PIK3R4 IGFBP3 PKN1 PRKACB,BP,128,128 of 125,5.61,102.4,1.815E-79,6.335E-77
GO:0004672,protein kinase activity,Q2KI72(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN63(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X696(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRI6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B9B6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000719)E1BJM5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N1T6(Evidence code:IEA/Database source:InterPro:IPR010622)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB50(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR000719)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR000719|I)V6F977(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000719)A2VE07(Evidence code:IEA/Database source:InterPro:IPR000719)F1N758(Evidence code:IEA/Database source:InterPro:IPR000719|I)P35509(Evidence code:IEA/Database source:InterPro:IPR000719|I)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR000719)A5PK86(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR000719)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHZ1(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BC36(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SZK4(Evidence code:IEA/Database source:InterPro:IPR010622)A4FV00(Evidence code:IEA/Database source:InterPro:IPR000719|I)A8QID1(Evidence code:IEA/Database source:InterPro:IPR000719)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05126(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB52(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)F1MM88(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BG90(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN72(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B793(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9Y478|ens)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN42(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N3T0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MC27(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR000719)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SYZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB49(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E45(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X793(Evidence code:IEA/Database source:InterPro:IPR000719)Q08E52(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B8H0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)A5PJJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N5W5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB57(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000719|I)P48734(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFF6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BL08(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MH24(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BA03(Evidence code:IEA/Database source:InterPro:IPR000719)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q95M13(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MUU2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58D16(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLB8(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58DV4(Evidence code:IEA/Database source:InterPro:IPR010622)F1N6C1(Evidence code:IEA/Database source:InterPro:IPR000719)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MG18(Evidence code:IEA/Database source:InterPro:IPR000719|I)P46196(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN96(Evidence code:IEA/Database source:InterPro:IPR000719)P43481(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q4TVR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR000719|I)P67827(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05131(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB90(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFM7(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLW1(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00517(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BKM6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SWY6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR000719|I), MAPK9 RPS6KA5 WNK1 SRC SLK MAP3K1 PINK1 MAP3K9 LMTK2 NUAK1 UHMK1 PASK MASTL FASTKD2 HCK CDK12 MAP2K4 MAPK12 ABL1 SIK3 MYLK3 CDC42BPB STK24 ERBB4 CSNK1G3 PAK4 MAP3K8 OXSR1 RPS6KA2 NEK10 WEE1 CDK6 TBRG4 MAPK10 ULK3 JAK1 OBSCN PRKCB CDK13 ERCC2 NEK9 JAK2 BRAF DCLK2 DYRK2 CAMK2B FRK NIM1K STK36 PRKAB1 RPS6KA4 MAPK4 LRRK2 CDK17 MAP3K4 MARK3 LMTK3 CSNK1G1 MAPK13 PKN1 MAPKAPK3 HIPK4 CAMK2A MAST4 MAPK11 PAK1 CAMK2G PEAK1 PRKDC CDK3 TRIO STK26 TAOK3 YES1 ROCK2 CDK1 TEC NEK3 MAP3K14 BRSK2 EPHB4 AAK1 PAK6 TYK2 EPHA6 fgfr3 STK35 MATK GSK3A FASTK LRRK1 PRKCI MYLK4 MAPK1 STK3 KIT ZAP70 FLT3 DSTYK LCK MAP3K10 CSNK1A1 PLK3 PLK4 PAK2 PRKACB CSNK1G2 MYLK2 PIK3R4 PRKACA TAOK2 PTK7 CAMK2D STK25 PAK3,MF,115,115 of 116,5.04,99.14,1.1E-70,3.598E-68
GO:0043227,membrane-bounded organelle,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,CC,1,1 of 2520,0.04,0.04,3.675E-70,1.132E-67
GO:0043229,intracellular organelle,E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7),SLC23A1,CC,1,1 of 2510,0.04,0.04,5.427E-70,1.578E-67
GO:0071704,organic substance metabolic process,F1MS56(Evidence code:IEA/Database source:InterPro:IPR005843|I),PGM3,BP,1,1 of 2421,0.04,0.04,1.516E-67,4.176E-65
GO:0050794,regulation of cellular process,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens),WNK1,BP,1,1 of 2267,0.04,0.04,3.153E-63,8.251E-61
GO:0044237,cellular metabolic process,E1BQ04(Evidence code:IEA/Database source:InterPro:IPR010997)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR010997)Q2NL31(Evidence code:IEA/Database source:InterPro:IPR000649), BLM WRN MRI1,BP,3,3 of 2375,0.13,0.13,1.357E-62,3.383E-60
GO:0003677,DNA binding,E1BHB8(Evidence code:IEA/Database source:InterPro:IPR001356|I)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001723)E1BL97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN000192346)G3N2P2(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BGW2(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MBK6(Evidence code:IEA/Database source:UniProtKB:A2A884|ens)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR012308|I)Q2NL18(Evidence code:IEA/Database source:InterPro:IPR003650)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)E1B925(Evidence code:IEA/Database source:InterPro:IPR001606|I)E1BDI3(Evidence code:IEA/Database source:InterPro:IPR001098|I)P61283(Evidence code:IEA/Database source:InterPro:IPR004122|I)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q32LH8(Evidence code:IEA/Database source:InterPro:IPR006642)A5D9H9(Evidence code:IEA/Database source:InterPro:IPR011722|I)Q5E9F8(Evidence code:IEA/Database source:InterPro:IPR000164|I)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BK57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q5E9A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR001208|I)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MC99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I)Q32L48(Evidence code:IEA/Database source:InterPro:IPR000558|I)P61635(Evidence code:IEA/Database source:InterPro:IPR013801)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BM22(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040|I)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)G3MY13(Evidence code:IEA/Database source:InterPro:IPR001356)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)E1BH22(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004826|I)Q2KJC1(Evidence code:IEA/Database source:InterPro:IPR009057)E1BKB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q32LB3(Evidence code:IEA/Database source:InterPro:IPR002857)A6QLP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1N4U8(Evidence code:IEA/Database source:InterPro:IPR026905)F1MBH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)O97764(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR020838)M5FMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q32KX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)E1BGN3(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1B8G9(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1ML85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR002119|I)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F2Z4E8(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR001951|I)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR002119|I)F1MUD2(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR002100|I)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR008013)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR002119|I)A6QPF2(Evidence code:IEA/Database source:InterPro:IPR006935)P06526(Evidence code:IEA/Database source:InterPro:IPR002054|I)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR011539|I)G3N053(Evidence code:IEA/Database source:InterPro:IPR000558|I)A5PK61(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)F1N453(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BL49(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q0VCF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MU48(Evidence code:IEA/Database source:InterPro:IPR001154|I)A5D7N8(Evidence code:IEA/Database source:InterPro:IPR013146)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1N1F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BJ93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR009057)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR002119|I)E1BLB9(Evidence code:IEA/Database source:InterPro:IPR000047|I)Q1MW18(Evidence code:IEA/Database source:InterPro:IPR001356|I)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1N5F3(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1MXR2(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8C6L5)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR001356|I)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818|I)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)P18493(Evidence code:IEA/Database source:InterPro:IPR001510|I)F1MU40(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR001356|I)G3N2D1(Evidence code:IEA/Database source:InterPro:IPR026905)E1B8E2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1B9S7(Evidence code:IEA/Database source:InterPro:IPR002653)E1BFM5(Evidence code:IEA/Database source:InterPro:IPR002857)G3MYE7(Evidence code:IEA/Database source:InterPro:IPR001739|I)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006134)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q7YRX0(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR003150|I)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BD77(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q05B83(Evidence code:IEA/Database source:InterPro:IPR008921)A4FUE0(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q95115(Evidence code:IEA/Database source:InterPro:IPR013801)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR002857)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR001356|I)G3MZR4(Evidence code:IEA/Database source:InterPro:IPR000558|I)O02754(Evidence code:ISS/Database source:UniProtKB:P05554-2)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR009057)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)G3N3L9(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR013801)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR017956)Q0V8G1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0371)Q2HJ84(Evidence code:IEA/Database source:InterPro:IPR001356|I)F1MVT7(Evidence code:IBA/Database source:PANTHER:PTN000192346)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)E1BC18(Evidence code:IEA/Database source:InterPro:IPR000558|I)P17667(Evidence code:IEA/Database source:InterPro:IPR002546)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004826|I)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR009057)E1BGZ3(Evidence code:IEA/Database source:InterPro:IPR001606|I)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)E1BBH8(Evidence code:IEA/Database source:InterPro:IPR001739|I)F1MT17(Evidence code:IEA/Database source:InterPro:IPR001356|I)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818|I)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR008013)G3MY92(Evidence code:IEA/Database source:InterPro:IPR015660)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR001606|I)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR002857)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR006110|I)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR020587)F1MLP0(Evidence code:IEA/Database source:InterPro:IPR029833)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A7E3A6(Evidence code:IEA/Database source:InterPro:IPR009057)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)F1MV26(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001723|I)E1BGF9(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)G3MYD7(Evidence code:IEA/Database source:InterPro:IPR000164|I)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR009057)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BCF7(Evidence code:IEA/Database source:InterPro:IPR000047|I)E1BAI9(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001723|I)E1BG94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)Q2KII5(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3MY25(Evidence code:IEA/Database source:InterPro:IPR007889|I)G3N068(Evidence code:IEA/Database source:InterPro:IPR000558|I)G5E655(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1B7I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000684|I)G8JL00(Evidence code:IEA/Database source:InterPro:IPR002119|I)E1BCK9(Evidence code:IEA/Database source:InterPro:IPR009057)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR001098)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR000747|I), RAX NR1I2 SOX13 ZMYM5 LOC613345 HIST1H2BJ HBP1 HIVEP3 GTF3C6 LIG1 HEYL BCL3 ARID1A POLG BANF1 GLI2 RAD18 POLDIP2 H3F3B AIFM2 TBX3 PCBP1 MCM4 DDX1 SIM2 SP1 AEBP2 DMRTC2 FOXI3 ERCC2 HIST1H2BN STAT3 TCF7L2 POU4F2 LOC100300167 RUNX1 HIST1H2AJ EGR4 TSHZ1 BLM SP7 HIST2H2AB NFE2L2 CDC5L MGA CXXC5 FOXO4 ASXL1 FOXF1 ZBTB8A CRYZ INO80 SOX8 TFDP2 H2AFZ BRCA1 HIST2H3D ZBTB17 ZBTB18 HIST3H2BB AHR LOC614881 SOX1 HIST1H2BB LOC619094 HIST3H2A HIST2H2BF SRF AIFM1 gata4 H2AFJ FANCM DNTT NFKB1 HIST1H2BA H3F3C WRN HIST2H2BE LOC614206 SOX4 TOP2B TMPO INSM1 SOX17 E2F7 PURA SWAP70 LEF1 DHX9 GON4L HIST1H2AC SHOX2 LHX4 POLE4 LOC615183 ONECUT2 MB21D1 POU3F1 HIST1H1D TDG PARP1 MNX1 ZFHX3 ASXL3 CIC OTUD7B TET1 MECP2 POLA1 SFPQ ZMYM4 RAX2 RFX5 H1FX ZFHX2 RFC2 MEIS1 ZNF148 STAT5A KMT2A IRX1 LOC523702 CEBPA MIER1 PURB LOC613363 STAT5B HOXA7 ASH1L ZFHX4 PKNOX1 EPM2AIP1 TAF10 LOC617043 MYF5 MAF TERF1 ARID3A GCFC2 MBD6 CUX2 HIST1H1A GATA6 ASCL4 ARID1B PRKDC KMT2B POLR2F MYO18A ZBTB22 TSN NCOR1 RC3H2 LOC525433 NR2F6 ZHX3 DNMT3A LOC100297725 TERF2 UHRF1 TAF4B IRF1 IMPDH2 DLX2 ANHX ESRRG E2F1 GLI1 HIST1H2BI TIGD5 LOC614378 LOC526488 HIST1H1E ETV2 POLR2A LOC104975684 SNAPC4 CHD8 POLQ EN1,MF,180,180 of 481,7.89,37.42,5.525E-59,1.315E-56
GO:0045944,positive regulation of transcription by RNA polymerase II,F1ML85(Evidence code:IBA/Database source:PANTHER:PTN000837813)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:O43151|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q91X20|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9HB09|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR033897)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)Q7YRX0(Evidence code:IEA/Database source:UniProtKB:Q96IS3|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:Q9Y2V3|ens)E1BGG6(Evidence code:IEA/Database source:UniProtKB:P48382|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)E1BGF3(Evidence code:IEA/Database source:GO:0001205)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1B9X1(Evidence code:IBA/Database source:PANTHER:PTN000383895), AHR PLAC8 MYDGF RUNX1 TMPRSS6 TET3 DOT1L NIPBL ZNF750 ZNF462 STRN3 SOX1 GSK3A FOXO4 SETX BCL3 NCOA3 MLLT6 E2F1 CCNL1 ERCC2 GLI1 DAB2IP ASH2L WWTR1 AGAP2 KDM6B RPS6KA4 DDX58 SOX4 SMARCA2 E2F7 CDON IER5 TFDP2 NR1I2 BCL2L12 DHX9 PIN1 CHD7 STAT5B DLX2 BCL9 STAT5A ASXL1 SRF SIRT2 TNKS RPS6KA5 SFPQ MEIS1 MKL1 HOXA7 COPS5 NFKB1 MAML2 TRAF6 INO80 TCF20 PKNOX1 PPP3CA CDK13 TAF2 ASH1L GLI2 EAF2 TAF4B RREB1 ATRX SOX17 PFKM IKBKG SP1 ATF6B SHOX2 KMT2A SALL4 FGF1 RAX2 TCF7L2 BCL11B BCL9L BRCA1 LRP6 SBNO2 NFE2L2 EN1 GATA6 CDK12 LITAF ETV2 HSPH1 CDC5L FOXF1 MYO6 ONECUT2 ZBTB17 PRKDC LPIN2 HFE2 LEF1 RAX RFX5 ESRRG ARID3A PTPRN LMO2 POU4F2 MYF5 SP7 YES1 HCFC1 AHI1 RAI1,BP,114,114 of 177,5,64.41,2.369E-56,5.39E-54
GO:0005794,Golgi apparatus,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q08DS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9CRA5|ens)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q0V8F1(Evidence code:IEA/Database source:InterPro:IPR027331)P02668(Evidence code:IDA/Database source:)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q2KHV3(Evidence code:ISS/Database source:UniProtKB:Q99732)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q687X5|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)A3KMX1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A7MBC2(Evidence code:IEA/Database source:UniProtKB:Q6P996|ens)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q5E9E7(Evidence code:IBA/Database source:PANTHER:PTN001012071)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q8BHC1)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)E1BLW3(Evidence code:IEA/Database source:UniProtKB:Q8N653|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)E1BI49(Evidence code:IEA/Database source:UniProtKB:O60476|ens)E1BMM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q9Y2H6|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q8BHJ6|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BB52(Evidence code:IEA/Database source:UniProtKB:A0A024RA85)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q32LF7(Evidence code:IEA/Database source:UniProtKB:B2RAZ5|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MKI1(Evidence code:IEA/Database source:UniProtKB:A0A024RDX3)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BBS6(Evidence code:IEA/Database source:UniProtKB:Q6ZRP7|ens)A7Z035(Evidence code:IEA/Database source:InterPro:IPR030544)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q9H3U1|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:A0A024R7L6)P35605(Evidence code:ISS/Database source:UniProtKB:O55029)E1B9D0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56817)F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)F1MX39(Evidence code:IBA/Database source:PANTHER:PTN001179054)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BQ15(Evidence code:IEA/Database source:UniProtKB:J3KR49|ens)G3X7D3(Evidence code:IBA/Database source:PANTHER:PTN001179054)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)P83437(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)Q17QB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q9NR48|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1N0M7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BB36(Evidence code:IEA/Database source:UniProtKB:Q10469|ens), DLG1 SAR1B AP2B1 GOLPH3 SYN1 CORO7 CSN3 APC2 LITAF GOLGA4 ABCA1 CUBN STEAP4 CTTN MYO6 CHST14 LFNG PDXDC1 B3GALT4 UNC13B AP1S1 VPS51 FMNL3 YES1 VPS41 PRMT5 COPE ITM2B GLT8D1 FAM20A PDCD10 RAB39B GOLGA3 LZTR1 SORL1 ATP8B1 MAN1A2 CHPF VAMP5 ST8SIA3 ARCN1 ARFGEF1 KIFC3 CUL3 FNDC3A LMTK2 BCL9 SH3GLB1 STK25 SERINC5 CAPN2 POMGNT1 CDK13 TRIM68 COPB1 STRN3 ATP2B3 SERINC3 SYT4 COPZ1 TMEM30A RAB3B B4GALT4 OSBP NPC1 EXT1 ATP7B TMC6 CDK5RAP2 CLCC1 TMEM59 QSOX2 CLINT1 TRPM4 ARL2 NSFL1C UNC45A PSEN1 ARL1 RAB33B NEDD4 TRAPPC2L COPG2 LRRK2 TSC2 ARHGAP21 PRNP GALNT2 MVB12A COPB2 CHPF2 BACE1 GAL3ST2 PTPRN RAB42 TPST2 CLASP2 RAB39A SCAP LRP6 BICD2 CAND1 COPA TNKS COG5 UHMK1 RAB30 STK26 ASH1L MAPK1 ABCA7 VPS52 TRAPPC4 GALNT7 DYNLT1 B4GALNT3 GCC2 MGAT2,CC,118,118 of 202,5.18,58.42,6.454E-55,1.408E-52
GO:0006807,nitrogen compound metabolic process,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR005483|I)F1ML89(Evidence code:IEA/Database source:InterPro:IPR005483|I)Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003010), CAD CPS1 NADSYN1,BP,3,3 of 2021,0.13,0.15,4.632E-53,9.698E-51
GO:0046872,metal ion binding,C3VEX2(Evidence code:IEA/Database source:InterPro:IPR004177)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N346(Evidence code:IEA/Database source:InterPro:IPR029518)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2T9P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP22(Evidence code:IEA/Database source:InterPro:IPR000571|I)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32L93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BIQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR006121|I)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBF5(Evidence code:IEA/Database source:InterPro:IPR037217)Q58DC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N1M2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P0C7Q4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32LB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BHZ4(Evidence code:IEA/Database source:InterPro:IPR000571|I)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MDC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5BIM5(Evidence code:IEA/Database source:InterPro:IPR000306)P13608(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1L568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P20456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR010606|I)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BL62(Evidence code:IEA/Database source:InterPro:IPR002888|I)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q59A32(Evidence code:IEA/Database source:InterPro:IPR011761)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0V8A7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SYX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3X812(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58DA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A4FUZ1(Evidence code:IEA/Database source:InterPro:IPR004361|I)E1BPS3(Evidence code:IEA/Database source:InterPro:IPR000306)E1BDU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MF35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P38408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MRN7(Evidence code:IEA/Database source:UniRule:UR000169786)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BA23(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MY77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02459(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q01107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7E305(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QQX8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P27479(Evidence code:IEA/Database source:InterPro:IPR000907|I)A7E348(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MEU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5D7L9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KJC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P37359(Evidence code:IEA/Database source:InterPro:IPR000006|I)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1B7S1(Evidence code:IEA/Database source:InterPro:IPR000571)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6R7C3(Evidence code:IEA/Database source:InterPro:IPR018957)Q32S24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0E0(Evidence code:IEA/Database source:InterPro:IPR006121|I)F1MD79(Evidence code:IEA/Database source:InterPro:IPR000306)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MS56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58CS5(Evidence code:IEA/Database source:InterPro:IPR000306)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7YY57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BNV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MY16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DF2(Evidence code:IEA/Database source:InterPro:IPR018957)E1BQ22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BG23(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QR47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6QHJ6(Evidence code:IEA/Database source:InterPro:IPR000571|I)E1BBX9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q864U1(Evidence code:IEA/Database source:InterPro:IPR018957)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BGQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A8WFQ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MII9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MZE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02510(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QR44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N0D9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BD77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR000306)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0III9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MJ18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P06526(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3X7G7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VFX8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G5E5M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5PJV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q95KV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MF74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0P571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BM69(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q27995(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1B9X1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N5J5(Evidence code:IEA/Database source:InterPro:IPR018957)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q1LZ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QNU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1ML89(Evidence code:IEA/Database source:InterPro:IPR011761)Q32LH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q24K02(Evidence code:IEA/Database source:InterPro:IPR011249)E1BF96(Evidence code:IEA/Database source:InterPro:IPR000571|I)A5PJM0(Evidence code:IEA/Database source:InterPro:IPR000571)E1BPV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR011761)F1MP30(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KHT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZI0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MI25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MY45(Evidence code:IEA/Database source:InterPro:IPR011761)F1MHX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MQ85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P51176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N6T8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR008899)G3N065(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QQN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N1C5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29RL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MGL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O46414(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MLY5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5EAC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O19137(Evidence code:IEA/Database source:InterPro:IPR000571|I)E1BC39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BNM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR000907|I)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2YDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MJP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BD03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N2S5(Evidence code:IEA/Database source:InterPro:IPR018957)P02465(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BCF8(Evidence code:IEA/Database source:InterPro:IPR000571)F1MU53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BL04(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N3S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5PKC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N2N6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6QK60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q6TNF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MS27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SYY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3MX12(Evidence code:IEA/Database source:InterPro:IPR010606|I)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1B8T3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28007(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P48034(Evidence code:IEA/Database source:InterPro:IPR002888|I)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3MHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6REL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BC37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P23206(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BEL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BKP2(Evidence code:IEA/Database source:InterPro:IPR000571)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MK99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F2Z4H6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479), PITPNM2 PARP1 TRMT1L KDM6B ASH1L RHOT1 DPEP3 EFCAB3 PFKP DMRTC2 DXO RC3H2 KMT2C GMPR2 ASAP2 AGAP2 ATP7B DHX9 IDO1 CPPED1 GATA6 GNAT3 CXXC5 ZC3H4 USP5 MICAL3 INSM1 DDX58 PPP1CC IMPDH2 ANKIB1 ZFYVE27 ACAN ZNF638 KMT2B RNF220 PEPD LTA4H IMPA1 MIB2 RAN SEC23B AOX4 PRUNE1 ZNF148 GNAS ALKBH2 GART SEC24A ARFGAP1 ZNF394 NOTCH4 UTRN GLRX3 CYB561 MARCH5 GLO1 WDFY3 GATAD2B TLL2 GNA14 ATP13A5 LFNG AMPD3 NRXN1 DBH ZMYND8 WEE1 BRCC3 NUDT16 COL2A1 AARS2 DSC1 ADH5 POLA1 ZSWIM8 USP39 RPAP2 ALOX15 PYGO2 LOC540627 PRKCB NRAP FKBP9 MT3 CAPN2 PARP12 ZBTB8A DNPEP DNAJA2 PEX2 COL11A2 ATOX1 ANKFY1 ITGB1 PGM3 FGD3 AEBP2 ARL1 ARHGAP29 MYO9B AKAP13 RNF112 TRIM68 PPP2CA KCNMA1 TRIM47 MARCH7 ZNF750 KIT UNK UNC13C XPNPEP1 STK25 BRCA1 SORD ZNF316 RACGAP1 PRNP LOC100295883 TRIM37 RFFL TDRD1 CRYAB DGCR8 BRD1 ZFHX2 RNF139 ARSA POMGNT1 ZFYVE26 HDAC5 ACTN3 MB21D1 CBFA2T2 DNTT KMT2A PLEKHM1 CRIP2 TGM3 PHF3 NR1I2 PPP3CA AMDHD1 gata4 MICAL2 MBTPS2 MYLPF ZBTB18 LOC516599 METAP2 NOS2 PDXP ADAMTS4 RPS27L RAI1 ITGAL RNF187 EFHD1 PAN2 GNAI1 LMO2 RNF31 CPS1 CYB5R4 CDC42BPB IDE PPP1R10 MBNL1 ZFHX3 CAD UNC13B RPS27 COMT SAR1B S100B BRAF MPI ADSS HIVEP1 CYP7A1 AGO3 ATP2B4 DICER1 CARNS1 PHF14 ATRX AARS GNAT2 TGM2 MMP19 VAV2 PFKM BSN ZNF385C ADCY7 SMPDL3B VPS29 FBXO40 CHORDC1 EXT1 ADAMTS5 AGAP1 ERCC2 TRAF6 FTH1 MLLT6 ACLY GSS CPSF4 ESRRG EGR4 ZNF282 DYSF ALOX15B PRKCI ECE1 IKBKG PAH TES RNF165 PPM1D SH3RF3 COL1A2 ZC3HAV1 ZNF446 XIRP2 ITGAV NR2F6 CDC42BPA ATP1A2 ITGA2 EGLN3 MARCH8 PPP1CB ZFP37 SIRT2 TGM1 NPEPPS PDE4D SCO1 P4HA2 HERC2 UHRF1 CYP2J2 SEC23A TCF20 PLCG1 DPYD AOX1 ZMYM5 CSRP1 MICALL2 WHSC1L1 GPATCH8 PPP2CB USP13 COL10A1 ACTN2 RNF128 USP20 ROCK2 HBE1 LENG9 CYP2R1 UNC13A RHOT2 TRIM23,MF,268,268 of 1125,11.75,23.82,9.819E-53,1.977E-50
GO:0004674,protein serine/threonine kinase activity,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)P05131(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR033700)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)V6F977(Evidence code:IEA/Database source:InterPro:IPR034672)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BN72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR028570)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR034372)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR039071)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR039071)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)G3X696(Evidence code:IEA/Database source:InterPro:IPR022165)P46196(Evidence code:ISS/Database source:UniProtKB:P28482)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)A5PJP8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000961|I)P05126(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR004166|I)E1BA03(Evidence code:IEA/Database source:InterPro:IPR033923)P00517(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR020658)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR039071)A4IFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A7MB90(Evidence code:IEA/Database source:InterPro:IPR022247)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q08E45(Evidence code:IEA/Database source:InterPro:IPR039071)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A6QLB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR014930)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680267)A0JN96(Evidence code:IEA/Database source:InterPro:IPR024205)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR031559|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR033923|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR024678|I)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519|I)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BC36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A5PJJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR022247)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR015726)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MG18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR033923)F1MUU2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q08E52(Evidence code:IEA/Database source:InterPro:IPR033923)Q2HJ82(Evidence code:IEA/Database source:InterPro:IPR015726)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q16644)F1MKY9(Evidence code:IEA/Database source:InterPro:IPR004166)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR033923|I)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N6C1(Evidence code:IBA/Database source:PANTHER:PTN001147562)E1BN63(Evidence code:IEA/Database source:InterPro:IPR024678)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR033624|I)P67827(Evidence code:ISS/Database source:UniProtKB:P48729), PASK PRKACB PRKCI MAPK13 MAP3K9 PLK4 CDK1 SIK3 LMTK2 MAP3K8 NIM1K TRIO UHMK1 PIK3R4 CAMK2D CAMK2B MAST4 RPS6KA2 PRKDC TAOK2 LRRK2 TAOK3 SLK MAPK1 AAK1 MAP2K4 CDK13 MASTL PRKCB TRPM7 PAK6 PRKACA PLK3 CDK12 CAMK2G NEK3 DSTYK CSNK1G2 MAP3K10 MAPK11 CAMK2A MAPK9 MYLK2 STK25 GSK3A CDC42BPA DYRK2 CSNK1G3 DCLK2 STK3 MAPK12 CDC42BPB ROCK2 RPS6KA4 SMG1 PAK3 OXSR1 PKN1 NUAK1 ATM MAP3K14 CDK6 CDK3 CSNK1G1 MAP3K4 OBSCN BRAF MYLK4 PAK4 STK35 PAK1 SPEG MAPK10 MAPKAPK3 ALPK2 PAK2 MAP3K1 LRRK1 WNK1 PINK1 BRSK2 RPS6KA5 MARK3 CSNK1A1,MF,84,84 of 90,3.68,93.33,6.526E-51,1.265E-48
GO:0016310,phosphorylation,A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MUF5(Evidence code:IEA/Database source:GO:0019205)Q2NKZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2YDP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1RMR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MNG6(Evidence code:IEA/Database source:GO:0033857)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN82(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1JPG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58DV4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BJM1(Evidence code:IEA/Database source:GO:0003951)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VE07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR031559)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VC86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SZD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P02638(Evidence code:NAS/Database source:)E1BHE5(Evidence code:IEA/Database source:GO:0004756)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VC88(Evidence code:IEA/Database source:GO:0004020)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q17R18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)B3IVN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A0JN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), MAPK12 GUK1 GK2 AK9 LOC538702 ROCK2 TSKS CDC42BPB PACSIN2 PPIP5K2 EPHB4 MAP3K10 PRKDC CSNK1G3 MAST4 CAMK2D MAP3K9 MAPK8IP3 JAK2 CSNK1G1 PAK6 FRK AAK1 HCK CDK13 DGKQ BRAF MYLK2 PKLR ITPKA KIT RPS6KA5 MASTL PRKACA CDK1 FASTK SPHK2 CAMK2B PAK3 STK24 PIP4K2C SMG1 STK25 PFKM PRKCB GK PTK2 MAPK10 NADK GCK PKN1 PRKCI TYK2 HK2 fgfr3 MAPK1 STAT3 ZAP70 PANK4 S100B SEPHS2 NME3 PFKP MAPKAPK3 PIK3CD NME1 PAPSS2 LRRK2 ADK DSTYK SRC YES1 MAPK13 PLK3 ABL1 CSNK1A1 CAMK2A GALK1 PI4KA CDK12 PAK2 EPHA6 PKM MARK3 ATM RPS6KA4 PAK4 LCK MAPK11 PRKACB MATK WEE1 MAPK9 PLK4 TEC FLT3 STK3 JAK1 PAK1 RPS6KA2 PGK2,BP,101,101 of 164,4.43,61.59,6.484E-49,1.212E-46
GO:0005856,cytoskeleton,Q0VC86(Evidence code:IEA/Database source:InterPro:IPR000299)F1MNF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2HJB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F2Z4C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1B7G7(Evidence code:IEA/Database source:InterPro:IPR000299|I)Q1JP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F2Z4K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2HJ86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1N611(Evidence code:IEA/Database source:InterPro:IPR000299|I)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VDK6(Evidence code:IEA/Database source:InterPro:IPR028288)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000299)Q0VBX2(Evidence code:IEA/Database source:InterPro:IPR000299)E1B953(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q56JV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F6RP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q32LP2(Evidence code:IEA/Database source:InterPro:IPR000299)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BIG2(Evidence code:IEA/Database source:InterPro:IPR000299)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000299)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P81948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0VCP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A7YY37(Evidence code:IEA/Database source:InterPro:IPR000299)F1MKE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BJK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q32L40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2HJJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A4IFE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MGE1(Evidence code:IEA/Database source:InterPro:IPR000299)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60880|ens)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A8E4N3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MG13(Evidence code:IEA/Database source:InterPro:IPR000299|I)E1BLT3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR000299|I)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000299)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2T9S0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A5D7P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6H769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000299)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), PTK2 LOC100141266 CDC42SE2 RNF128 MAPK1 TUBB4A TUBA8 TUBA1A PLEKHH3 ARPC1A TUBA3E NDRG1 ARL6 GNAI1 DNM1 TUBA1D PDXP USP20 DYNLRB1 TEC DYNLL2 CAMK2B EPB41L1 ALDOB SEPT7 BRCC3 TEKT4 CDK1 WASF2 TYK2 TLN2 LOC533307 TWF1 UBXN6 ARL2 LOC100295712 BAIAP2 RDX CSNK1A1 DCTN2 NF2 DYNC1I2 PTPN14 SEPT11 MICAL3 ERCC2 TUBA4A SEPT8 EPB41L4A SPTB PPP2CA PPP2CB TUBB1 TCP1 KATNAL2 ARL8B NSFL1C PINK1 DYNLL1 KLC4 ACTR1B PKP4 ROCK2 MASTL BFSP1 DNM2 LRPPRC UTRN FRMD5 SNAP25 CTNNA1 SPAST ANXA11 DCTN3 RSPH3 MMS19 DHX9 KIF2A MYO15A SPTBN4 MYO7B ALOX15B JAK1 SVIL MVB12A CCT8 SEPT2 TUBB3 LOC101905447 ARPC5L FKBP4 SEPT6 LOC101902172 TUBGCP2 PLK4 ZFYVE26 DYNLT1 RPS7 JAK2 CLTA DGKQ,CC,101,101 of 165,4.43,61.21,9.747E-49,1.759E-46
GO:0016740,transferase activity,A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2NKZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MSM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MZY8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B8R5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q7YRV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PJZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G8JKZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5E9E7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SZ20(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A2VE03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BM45(Evidence code:IEA/Database source:InterPro:IPR017852)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PK45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A2VDS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QL80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32PG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B7Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q17QE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P06526(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q17QG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32LF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P29702(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BMM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B9D0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P51176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BNY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MJ10(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q17QI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MZP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4FV33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P10950(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BM12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2YDJ9(Evidence code:IEA/Database source:InterPro:IPR018357)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B729(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q1JPG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZBM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N0M7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P11181(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0P582(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MX12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BCH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q1RMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A3KMX1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)B3IVN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MDC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q58CZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EA65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A3KN22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808), PANK4 DGKQ LOC538702 ROCK2 MAPK11 KMT2B GCK EPHA6 GYG2 EXT1 MAPK1 MAP3K9 FLT3 AAK1 CDK12 POLR2A TNKS CDC42BPB PLK3 PAK6 ABL1 BRCA1 PI4KA HK2 DNMT3A MB21D1 SMG1 CDK1 MASTL PRMT5 MYLK2 HECTD3 PRIM1 PIK3CD GALK1 MARCH8 NSUN2 COMT KIT SULT1C4 PKN1 PFKM POMGNT1 AGPAT1 KMT2A NME3 RNF112 MTAP PIP4K2C TYK2 GLT8D1 NME1 ZAP70 MAST4 TRAF6 SHMT2 ATIC ASH1L WEE1 GK ITCH RPS6KA5 PRKCB RNF220 MAP3K10 PIGN UBE2K PRKACA UHRF1 JAK1 UBE2L3 PRKCI CSNK1G3 COLGALT1 MATK SCLY RPS6KA2 MAPKAPK3 PRMT3 PRKDC NEDD4L ATM SRC TRIP12 GBGT1 MAPK12 ST8SIA3 DNTT MAPK9 UBE2G2 CSNK1G1 MAPK13 CPT1B GFPT2 KMT2C B4GALT4 ACLY FNTA MGAT1 CAMK2B STK25 DPH2 TGM3 MARCH5 TRMT1L EPHB4 CHPF CHPF2 POLE4 TGM2 B3GALT4 HUWE1 PAK1 CDK13 NEDD4 PLK4 RPS6KA4 fgfr3 ACAT2 GUK1 GK2 CMTR2 ITPKA TAOK3 SULT1A1 BRAF DOT1L ASMT SRM GMPPB PAK4 RANBP2 CSNK1A1 RNF128 GALNT7 pofut2 HS3ST6 CAMK2D UGT2B10 PRKACB PARP8 LCK PKLR PGK2 PAK2 TRPT1 HCK B4GALNT3 TPST2 DBT PARP14 HERC2 PAK3 WHSC1L1 NAPRT LFNG FRK MARK3 POLA1 PFKP ISPD UBE2D2 HAS2 CHST14 GART MAPK10 JAK2 CTU1 PKM YES1 ANKIB1 TAT TEC GALNT2 DPAGT1 UBE2M UMPS PARP1 DSTYK PCMT1,MF,180,180 of 633,7.89,28.44,3.711E-45,6.474E-43
GO:0016301,kinase activity,A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV33(Evidence code:IEA/Database source:InterPro:IPR005522)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR018936|I)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58DV4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1JPG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VC86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1RMR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN82(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)O02811(Evidence code:IEA/Database source:InterPro:IPR018936|I)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR001206)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2NKZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VE07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2YDP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR018936|I)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q17R18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)B3IVN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BE66(Evidence code:IEA/Database source:InterPro:IPR018936|I)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SZD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR018936|I)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BJM1(Evidence code:IEA/Database source:InterPro:IPR001206)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A0JN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), NME3 ITPKA MAP3K10 CAMK2B SMG1 MAPK11 HCK RPS6KA2 MAP3K9 STK25 FASTK PKLR PRKACA GK2 DSTYK PTK2 CAMK2D TRPM7 PLK3 AAK1 PACSIN2 ABL1 RPS6KA4 BRAF ZAP70 RPS6KA5 MAPK8IP3 PI4KA CSNK1A1 PAK1 DGKQ SRC PFKP PFKM GALK1 PANK4 MAPK1 MASTL LOC538702 STK24 CDK13 TSKS CDK12 PRKDC MYLK2 LRRK2 PIP4K2C CSNK1G1 FRK ADK FLT3 WEE1 PKM PIK3CD TYK2 MAST4 CDK1 MAPK10 MAPK9 PAK3 GCK TEC EPHA6 ROCK2 NADK MAPKAPK3 CAMK2A GK JAK2 PRKACB GUK1 PAK6 CSNK1G3 MAPK12 MATK CDC42BPB NME1 MARK3 ATM JAK1 SPHK2 PLK4 PAK4 KIT MAPK13 PAK2 CDK6 PRKCI EPHB4 HK2 fgfr3 PINK1 PGK2 STK3 LCK PKN1 YES1 PRKCB,MF,98,98 of 174,4.3,56.32,5.3E-45,8.948E-43
GO:0000122,negative regulation of transcription by RNA polymerase II,F1MI25(Evidence code:IEA/Database source:UniProtKB:F8VPM9|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)G3MY13(Evidence code:IEA/Database source:GO:0001078)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)F1MZQ1(Evidence code:IEA/Database source:UniProtKB:Q9H0E3|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1BGG6(Evidence code:IEA/Database source:UniProtKB:Q9JL61|ens)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q17QV0(Evidence code:IEA/Database source:UniProtKB:P57722|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:Q05925|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579358)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q9WUK6)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:O14529|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q32LB3(Evidence code:ISS/Database source:UniProtKB:Q7LFL8)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Z1Z2|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)F1N312(Evidence code:IEA/Database source:UniProtKB:Q56A10|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)F1ML16(Evidence code:IEA/Database source:InterPro:IPR028424)A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)G3MYE7(Evidence code:IEA/Database source:InterPro:IPR017353)E1BGF9(Evidence code:IBA/Database source:PANTHER:PTN001435424)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q3UH06|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)E1BJK0(Evidence code:IEA/Database source:UniProtKB:P78414|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q8K1A6|ens)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)E1BPI3(Evidence code:IEA/Database source:UniProtKB:P42685|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens), HIVEP1 TRAF6 UHRF1 DAB2IP TSHZ1 SFPQ CTBP1 SAP130 TDG GCFC2 PEX2 SHOX2 PURB RFX5 NR2F6 DLG1 DLX2 CRYM GLI2 CUL3 PCBP3 AEBP2 ARHGAP35 EN1 BCL11A PPID ZBTB18 TBX3 POU4F2 BCOR FOXF1 SOX17 CUX2 ARID1A PSEN1 CXXC5 HFE2 WWTR1 SUZ12 STRAP ZFHX3 E2F1 ZNF608 SPEN HOXA7 CBFA2T2 DDX20 HIC1 HIST1H1D EHMT2 RIF1 PLK3 NFKB1 MECP2 ZHX3 GATA6 ZNF366 E2F7 TPR RREB1 TCF7L2 STRN3 IRX1 INSM1 ZBTB4 CC2D1A PHF14 WWC1 LEF1 PIAS1 SALL4 SIM2 NIPBL PRDM13 FRK OTUD7B TMPRSS6 SIRT2 CDK6,BP,79,79 of 115,3.46,68.7,3.118E-41,5.1E-39
GO:0043547,positive regulation of GTPase activity,F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)P48820(Evidence code:IEA/Database source:GO:0005096)F1N2I0(Evidence code:IEA/Database source:GO:0005096)F1MD62(Evidence code:IEA/Database source:GO:0005096)E1B714(Evidence code:IEA/Database source:GO:0005096)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q58DV1(Evidence code:IEA/Database source:UniRule:UR000136804)A5D793(Evidence code:IEA/Database source:GO:0005096)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)A7YY57(Evidence code:IEA/Database source:GO:0005096)F1MTH3(Evidence code:IEA/Database source:GO:0005096)A0JN64(Evidence code:IEA/Database source:GO:0005096)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)E1BIQ2(Evidence code:IEA/Database source:GO:0005096)E1BP38(Evidence code:IEA/Database source:InterPro:IPR027107)G3MYM2(Evidence code:IEA/Database source:GO:0005096)F1MKZ2(Evidence code:IEA/Database source:GO:0005096)E1BNB7(Evidence code:IEA/Database source:GO:0005096)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028443)F1MM21(Evidence code:IEA/Database source:UniProtKB:P49758|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BPU0(Evidence code:IEA/Database source:GO:0005096)F1MZA2(Evidence code:IEA/Database source:GO:0005096)F1MM72(Evidence code:IEA/Database source:GO:0005096)E1B801(Evidence code:IEA/Database source:GO:0005096)E1B800(Evidence code:IEA/Database source:GO:0005096)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR037858)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR003913|I)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)G3X7P3(Evidence code:IEA/Database source:GO:0005096)E1BPM0(Evidence code:IEA/Database source:GO:0005096)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)A6QNV8(Evidence code:IEA/Database source:GO:0005096)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR037769)Q0V8A7(Evidence code:IEA/Database source:GO:0005096)E1BB77(Evidence code:IEA/Database source:GO:0005096)A7MB27(Evidence code:IEA/Database source:GO:0005096)F1MXV4(Evidence code:IEA/Database source:GO:0005096)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)F1N746(Evidence code:IEA/Database source:InterPro:IPR033185)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR028557)F1MJI3(Evidence code:IEA/Database source:GO:0005096)P04896(Evidence code:ISS/Database source:UniProtKB:P63092)F1MGL2(Evidence code:IEA/Database source:GO:0005096)F1MHG5(Evidence code:IBA/Database source:PANTHER:PTN001141612)E1BJP2(Evidence code:IEA/Database source:GO:0005096)F1MBI8(Evidence code:IEA/Database source:GO:0005096)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O54834|ens)Q29RJ2(Evidence code:IEA/Database source:GO:0005096)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR028558)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens), PREX1 RANBP2 CHML ARHGAP20 AXIN1 S100A10 RP2 ECT2 RGS14 ARHGAP29 TIAM2 GARNL3 TBC1D2 LARS AGAP2 RALGAPA1 TBC1D4 ASAP2 ARHGAP26 PKP4 RGS6 DENND1A LRRK2 ARHGEF12 ARHGAP22 ARHGAP35 RASAL2 PIN1 ARAP3 TSC2 RTN4R AXIN2 RASAL1 F11R RGS1 BCR ARFGAP1 DAB2IP ARHGAP36 SIPA1L1 SGSM2 RABGAP1 MYO9B SRGAP3 GNAS AGAP1 ARHGAP21 RACGAP1 SYNGAP1 RAPGEF2 ARHGAP6 TBC1D24 MYO9A SNX18,BP,54,54 of 36,2.37,150,4.527E-40,7.181E-38
GO:0005525,GTP binding,E1BIQ2(Evidence code:IEA/Database source:InterPro:IPR001806)Q4PS77(Evidence code:IEA/Database source:InterPro:IPR006073|I)F1N7V2(Evidence code:IEA/Database source:InterPro:IPR001806)F1MGL2(Evidence code:IEA/Database source:InterPro:IPR001806)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR001114|I)P38408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR002453|I)Q0IIM2(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR002453|I)Q0II28(Evidence code:IEA/Database source:InterPro:IPR001806|I)P04896(Evidence code:IEA/Database source:InterPro:IPR000367)P11023(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q17QB7(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q3T0T7(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q2KI07(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q08DF2(Evidence code:IEA/Database source:InterPro:IPR015894|I)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR001806|I)P10949(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q17QU4(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2YDJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q58DC5(Evidence code:IEA/Database source:InterPro:IPR000795)Q3SZN0(Evidence code:IEA/Database source:InterPro:IPR016491|I)G5E6P3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)A4FUD3(Evidence code:IEA/Database source:InterPro:IPR000795|I)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR002452|I)Q29RR0(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1B801(Evidence code:IEA/Database source:InterPro:IPR001806)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR001806|I)A2VE99(Evidence code:IEA/Database source:InterPro:IPR016491|I)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR002452|I)P63097(Evidence code:IEA/Database source:InterPro:IPR001408)E1B953(Evidence code:IEA/Database source:InterPro:IPR002453)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR001806|I)P04696(Evidence code:IEA/Database source:InterPro:IPR001408)Q2YDM1(Evidence code:IEA/Database source:InterPro:IPR005225|I)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q32LB9(Evidence code:IEA/Database source:InterPro:IPR006073|I)F1MX39(Evidence code:IEA/Database source:InterPro:IPR001806|I)G3X7D3(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR002452|I)P81948(Evidence code:IEA/Database source:InterPro:IPR002452|I)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR005225|I)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2NKY7(Evidence code:IEA/Database source:InterPro:IPR008113|I)E1BLD5(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q58DV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q08DW1(Evidence code:IEA/Database source:InterPro:IPR001806|I)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR000375|I)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR002452|I)Q6Q137(Evidence code:IEA/Database source:InterPro:IPR008115|I)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR002453|I)Q3ZC28(Evidence code:IEA/Database source:InterPro:IPR005225|I)A5PJP3(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q08DF4(Evidence code:IEA/Database source:InterPro:IPR000375|I)Q9BDI7(Evidence code:IEA/Database source:InterPro:IPR000375|I)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR005225)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR001806|I)F1N1I1(Evidence code:IEA/Database source:InterPro:IPR003191|I)Q58DW6(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1B870(Evidence code:IEA/Database source:InterPro:IPR006689|I)G3X6L5(Evidence code:IEA/Database source:InterPro:IPR005225|I)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q3T0M9(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q08DC2(Evidence code:IEA/Database source:InterPro:IPR001806|I)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR030381)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR001806|I)A7Z031(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1BIL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q3T107(Evidence code:IEA/Database source:InterPro:IPR001806|I)A6QPX8(Evidence code:IEA/Database source:InterPro:IPR001806|I)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR002452|I)Q3T054(Evidence code:IEA/Database source:InterPro:IPR001806|I)F6RP72(Evidence code:IEA/Database source:InterPro:IPR002452|I)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001408)G3N3N1(Evidence code:IEA/Database source:InterPro:IPR005225|I)A7MBB1(Evidence code:IEA/Database source:InterPro:IPR015894|I)E1BAI0(Evidence code:IEA/Database source:InterPro:IPR001806|I)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2TBH7(Evidence code:IEA/Database source:InterPro:IPR001806|I)P10948(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q32KW9(Evidence code:IEA/Database source:InterPro:IPR007743|I)A4FUD7(Evidence code:IEA/Database source:InterPro:IPR001806|I)P04695(Evidence code:IEA/Database source:InterPro:IPR001408)Q2TA37(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q0VCP4(Evidence code:IEA/Database source:InterPro:IPR016491|I), AGAP2 MTG1 RAB17 AGAP1 ADSS GNA14 RAP2C TUBB3 ARL6 TUBB4A RAB4B GNAS RAB3A RAB30 SAR1B ARL8B RNF112 RHOT1 RAB3C RAB39B GMPPB GTPBP1 SEPT6 GNA13 EFTUD2 GNAL TUBA3E RAB26 ARHGAP35 DIRAS2 SEPT11 TUBA1A GNAI1 LOC533307 RHOT2 GNAT2 ARL1 NUDT16 MB21D1 NOA1 RAB42 RAB39A TUBA1D TUBA4A TRIM23 RAP2A SEPT2 RAB37 RP2 RAB9A DNM2 TUBA8 SEPT7 TUBB1 ARL13B RAB22A DNM1 MX2 LRRK2 HRAS LOC100336669 RAB25 ARL16 ARL8A GPN1 ARL4A RAB31 MFN2 RRAS RASEF GNA12 RAB24 RAB12 LOC100141266 RAN LOC100295712 GNAT3 ARF6 LOC783604 RAB23 RIT1 RAB4A RAB3B IRGC RAB33B GNAT1 ARL2 SEPT8,MF,88,88 of 165,3.86,53.33,2.979E-39,4.586E-37
GO:0008270,zinc ion binding,E1BCW1(Evidence code:IEA/Database source:InterPro:IPR003126)G3X743(Evidence code:IEA/Database source:InterPro:IPR014782|I)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)Q2HJI9(Evidence code:IEA/Database source:InterPro:IPR024766)F1MRT9(Evidence code:IEA/Database source:InterPro:IPR000433)E1BD77(Evidence code:IEA/Database source:InterPro:IPR003604)G3N0A8(Evidence code:IEA/Database source:InterPro:IPR003126)Q24JZ9(Evidence code:IEA/Database source:InterPro:IPR004181)F1MF35(Evidence code:IEA/Database source:InterPro:IPR006026)G3MX12(Evidence code:IEA/Database source:InterPro:IPR000433)F1MLX9(Evidence code:IEA/Database source:InterPro:IPR014311)Q3ZC24(Evidence code:IEA/Database source:InterPro:IPR011016)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BM69(Evidence code:IEA/Database source:InterPro:IPR000315)F1MJP2(Evidence code:IEA/Database source:InterPro:IPR011016)F1MHR5(Evidence code:IEA/Database source:InterPro:IPR010507)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR003604)Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q58D31(Evidence code:IEA/Database source:InterPro:IPR002328)F1MKS6(Evidence code:IEA/Database source:InterPro:IPR000834)E1BQ22(Evidence code:IEA/Database source:InterPro:IPR000315)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)A8WFQ1(Evidence code:IEA/Database source:InterPro:IPR000315)Q32L99(Evidence code:ISS/Database source:UniProtKB:Q8N8N7)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR000679|I)Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR001250)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR002857|I)A6QP33(Evidence code:IEA/Database source:InterPro:IPR010507)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR000690|I)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1N413(Evidence code:IEA/Database source:InterPro:IPR007728)E1BER3(Evidence code:IEA/Database source:InterPro:IPR000834)E1BDU9(Evidence code:IEA/Database source:InterPro:IPR000679|I)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q2HJH1(Evidence code:IEA/Database source:InterPro:IPR001948)A7E305(Evidence code:IEA/Database source:InterPro:IPR007527)E1BP63(Evidence code:IEA/Database source:InterPro:IPR011016)E1BG23(Evidence code:IEA/Database source:InterPro:IPR000315)E1BL52(Evidence code:IEA/Database source:InterPro:IPR024766)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)E1B847(Evidence code:IEA/Database source:InterPro:IPR007527)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR001293|I)Q32LB3(Evidence code:IEA/Database source:InterPro:IPR002857)A6QR47(Evidence code:IEA/Database source:InterPro:IPR011016)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR001607)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens)P05126(Evidence code:IEA/Database source:InterPro:IPR014375)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895)F1MKA6(Evidence code:IEA/Database source:UniRule:UR000375824)Q2YDE9(Evidence code:IEA/Database source:InterPro:IPR010442)P02638(Evidence code:IEA/Database source:InterPro:IPR028481)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)F6QK60(Evidence code:IEA/Database source:InterPro:IPR017328)O19137(Evidence code:IEA/Database source:InterPro:IPR001878|I)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628|I)E1B9S7(Evidence code:IEA/Database source:InterPro:IPR002653)P18493(Evidence code:IEA/Database source:InterPro:IPR001510|I)E1BP91(Evidence code:IEA/Database source:InterPro:IPR014782)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)A6QLT9(Evidence code:IEA/Database source:UniRule:UR000375824)Q0VD59(Evidence code:IEA/Database source:InterPro:IPR011016)Q32P83(Evidence code:IEA/Database source:UniProtKB:P47224|ens)A6QPH9(Evidence code:IEA/Database source:InterPro:IPR010507)Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)O97764(Evidence code:IEA/Database source:InterPro:IPR002364)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR001607)A7Z056(Evidence code:IEA/Database source:InterPro:IPR001607)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR000679|I)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR000433)E1BFM5(Evidence code:IEA/Database source:InterPro:IPR002857)G3N065(Evidence code:IEA/Database source:InterPro:IPR003604)Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR002328|I)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628|I)F1N1C5(Evidence code:IEA/Database source:InterPro:IPR001293)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BAR2(Evidence code:IEA/Database source:InterPro:IPR001878|I)F1MMN0(Evidence code:IEA/Database source:InterPro:IPR000315)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR000315)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR002857|I)A1L548(Evidence code:IEA/Database source:InterPro:IPR001607)F1MI25(Evidence code:IEA/Database source:InterPro:IPR003604)F1MKU3(Evidence code:IEA/Database source:InterPro:IPR000315)F1N0J8(Evidence code:IEA/Database source:InterPro:IPR007527)Q3SZH7(Evidence code:IEA/Database source:InterPro:IPR012777|I)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628|I)F1MKU1(Evidence code:IEA/Database source:UniRule:UR000401119)Q3T0M0(Evidence code:IBA/Database source:PANTHER:PTN000122545)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR000315), UBR2 RNPEP MMP19 RBX1 UTRN ZFHX2 UBR4 PIAS1 TLL2 HERC2 GDA MARCH5 SEC23A LOC516599 RNF165 ZMYM4 ZFHX3 PEX10 BLM SORD AGTPBP1 TRIM68 SEC24C TRIM37 PTGR2 gata4 MPI KMT2A ZMYM6 ZNF638 TNKS EHMT2 CPXM2 GATAD2B MYCBP2 MT3 DNPEP ZSWIM8 RNF139 TRIM47 LOC780968 CAD MAP3K1 TRAF6 CXXC5 MARCH7 UHRF1 USP13 CHORDC1 PRKCB SEC24D AARS2 TES S100B EPRS SIRT2 CPSF4 SEC23B NR1I2 OTUD7B PARP1 NPEPPS GLO1 GLI2 AARS MARCH8 RABIF ZMYM5 IDE CRYZ USP39 USP20 GATA6 MIB2 TET1 ZNF385C ADH5 SEC24A NR2F6 FBXO40 BRCA1 LITAF ZCCHC6 TRIM14 RNF31 KMT2B USP5 HIVEP1 BSPRY ZSWIM6 LTA4H ESRRG DDX58 VPS29 TRIM23,MF,95,95 of 207,4.17,45.89,4.828E-38,7.22E-36
GO:0042802,identical protein binding,Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens)Q0VCN1(Evidence code:IEA/Database source:UniProtKB:Q9HBL8|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)Q2KHV6(Evidence code:IEA/Database source:UniProtKB:Q9Y5X2|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)F1N226(Evidence code:IEA/Database source:UniProtKB:Q06481|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q7L775|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)Q08DK5(Evidence code:IEA/Database source:UniProtKB:Q9NR46|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)Q08DM8(Evidence code:IEA/Database source:UniProtKB:Q15631|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q8IY63|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)E1BM28(Evidence code:IEA/Database source:UniProtKB:O43598|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q13867|ens)E1BM12(Evidence code:IEA/Database source:UniProtKB:P19623|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)Q05B89(Evidence code:IEA/Database source:UniProtKB:Q9GZT8|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)F1MZI1(Evidence code:IEA/Database source:UniProtKB:O43586|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61457|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)A5D7C4(Evidence code:IEA/Database source:UniProtKB:Q9Y5L0|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q2KIT8(Evidence code:IEA/Database source:UniProtKB:Q13630|ens)E1BI31(Evidence code:IEA/Database source:UniProtKB:Q86TI2|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MP76(Evidence code:IEA/Database source:UniProtKB:O75056|ens)A6QR68(Evidence code:IEA/Database source:UniProtKB:O15431|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)P02668(Evidence code:IPI/Database source:UniProtKB:P02668)Q0VD00(Evidence code:IEA/Database source:UniProtKB:Q96SI1|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q99961|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)Q6BBL6(Evidence code:ISS/Database source:UniProtKB:Q9Z0G9)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:Q9R0M6|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)F6PW02(Evidence code:IEA/Database source:InterPro:IPR033512)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q15742|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)Q29460(Evidence code:IEA/Database source:UniProtKB:Q15102|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F6PR93(Evidence code:IEA/Database source:InterPro:IPR011717)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)A2VDZ4(Evidence code:IEA/Database source:UniProtKB:O00444|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)Q05B70(Evidence code:IEA/Database source:UniProtKB:Q96HH9|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB:Q13554|ens)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB:O14818|ens)P80227(Evidence code:IEA/Database source:UniProtKB:P13798|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q5GFL6|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q1KZG4(Evidence code:IEA/Database source:UniProtKB:P49789|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A5PKI0(Evidence code:IEA/Database source:InterPro:IPR037929)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)E1B7H2(Evidence code:IEA/Database source:UniProtKB:Q63870|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)Q3T105(Evidence code:IEA/Database source:UniProtKB:Q14376|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)Q08DW2(Evidence code:IEA/Database source:UniProtKB:Q14558|ens)G3MY14(Evidence code:IEA/Database source:UniProtKB:P11908|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)E1BFN3(Evidence code:IEA/Database source:UniProtKB:Q8N157|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)F1MX23(Evidence code:IEA/Database source:UniProtKB:Q99963|ens), CLDN3 NMRAL1 PACSIN2 KHDRBS1 IMPA1 SNX8 DNM1 MRI1 APLP2 TFRC SORD EPM2AIP1 DHX8 ARRDC1 CRKL SH3GLB2 GCC2 TSN AMOTL1 SLIT2 DDX58 UHRF1 COL1A2 GPSM2 DNPH1 KEAP1 RAD18 SEC13 S100B DCTN2 BLMH SRM PEAK1 VPS4B LRP6 CAD NIF3L1 RASEF PSTPIP1 SNRNP200 PCBD1 SETX STK26 TCL1A TRIM23 PFKM TNPO3 PDCD6 TSTA3 DPP9 HCFC1 SDC3 SLC31A1 CRYAB CHMP1A EPS15 SYT6 MALT1 CSN3 KCTD15 SH3GL1 DAB2IP UBQLN1 CAMK2A CLDN4 EPRS RAB9A ADORA2A ST8SIA3 IER5 TFG SGTA NAB2 EIF4G1 FOXO4 SH3BP4 PAFAH1B3 C1QTNF5 NFKB1 TTC21B CHMP4A GARS PLK4 PRNP IKBKG E2F7 PTPRM JAK2 LRRK2 KMT2A GRAMD3 DGCR8 STK3 VPS41 AQP5 TRAF6 G6PD CAMK2B PSMA7 APEH SNX33 VWA2 HCN1 AXIN1 PAK2 FHIT LRRK1 CHMP4B APPL1 LCK GRB2 EMILIN1 COL7A1 BRCA2 TPCN2 GALE SDCBP2 PRPSAP1 PRPS2 SLK COL2A1 DAAM1 AHI1 MYBPC3 BANF1 SH3GL3,MF,126,126 of 379,5.53,33.25,5.743E-38,8.349E-36
GO:0005509,calcium ion binding,A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR000233|I)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR002048)E1B9K4(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q8WN96(Evidence code:IBA/Database source:PANTHER:PTN001416417)F1MK99(Evidence code:IEA/Database source:InterPro:IPR037302)E1BPS6(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q01107(Evidence code:IEA/Database source:InterPro:IPR000233|I)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1BMQ1(Evidence code:IEA/Database source:InterPro:IPR029996)Q0P571(Evidence code:IEA/Database source:InterPro:IPR002048)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR002048)F1MF35(Evidence code:IEA/Database source:InterPro:IPR001881|I)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR002048|I)P05059(Evidence code:IDA/Database source:)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR014815|I)P02638(Evidence code:IEA/Database source:InterPro:IPR001751|I)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR002126|I)A6QQP7(Evidence code:ISS/Database source:UniProtKB:O75923)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MZD0(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002048)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR037302)Q0IIA3(Evidence code:IEA/Database source:InterPro:IPR002048)Q3MHP3(Evidence code:IEA/Database source:InterPro:IPR028493)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001283)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001972)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001283)E1BF53(Evidence code:IEA/Database source:InterPro:IPR000233|I)A5D7S6(Evidence code:IEA/Database source:InterPro:IPR002048)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:P04350|ens)Q0III9(Evidence code:IEA/Database source:InterPro:IPR002048)P27214(Evidence code:IEA/Database source:InterPro:IPR001464|I)Q17QM6(Evidence code:IEA/Database source:InterPro:IPR002048)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BH09(Evidence code:IEA/Database source:InterPro:IPR001881)Q1LZ81(Evidence code:IEA/Database source:InterPro:IPR002048)Q08DD1(Evidence code:ISS/Database source:UniProtKB:P15289)F1MNH3(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR002048|I)A7Z031(Evidence code:IEA/Database source:InterPro:IPR002048)A5D7I1(Evidence code:IEA/Database source:InterPro:IPR002048)Q00KA9(Evidence code:IEA/Database source:InterPro:IPR001881|I)A7MBJ3(Evidence code:IEA/Database source:InterPro:IPR001382|I)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)Q3ZC55(Evidence code:IEA/Database source:InterPro:IPR002048)Q2KJC8(Evidence code:IEA/Database source:InterPro:IPR002048)P60902(Evidence code:IEA/Database source:InterPro:IPR001751)F1MMQ8(Evidence code:IEA/Database source:InterPro:IPR002048)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR002126|I)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR002126|I)G3MXQ8(Evidence code:IEA/Database source:InterPro:IPR001382|I)F1MF97(Evidence code:IEA/Database source:InterPro:IPR001881|I)A0JNJ5(Evidence code:IEA/Database source:InterPro:IPR002048)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002048)F1MP30(Evidence code:IEA/Database source:InterPro:IPR037302)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR002048)A6QP57(Evidence code:ISS/Database source:UniProtKB:Q08188)F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens)F1N5P0(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q0II63(Evidence code:IEA/Database source:InterPro:IPR002048)Q27971(Evidence code:IEA/Database source:InterPro:IPR002048|I)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR002048)E1BI49(Evidence code:IEA/Database source:InterPro:IPR001382|I)Q5E9Z2(Evidence code:IEA/Database source:InterPro:IPR001881)P85100(Evidence code:IEA/Database source:InterPro:IPR002048)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR002048)F1MLJ7(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1BE11(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001283)A7MBG5(Evidence code:IEA/Database source:InterPro:IPR002048)F1MD94(Evidence code:IEA/Database source:InterPro:IPR001881)G3X812(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1N416(Evidence code:IEA/Database source:InterPro:IPR000233|I)E1BC61(Evidence code:IEA/Database source:InterPro:IPR003915)P81282(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q2T9P0(Evidence code:IEA/Database source:InterPro:IPR002048)P0CG25(Evidence code:IEA/Database source:InterPro:IPR002048)P08487(Evidence code:IEA/Database source:InterPro:IPR002048)P13608(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MKV7(Evidence code:IEA/Database source:InterPro:IPR001881|I)G3N152(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1N6C0(Evidence code:IEA/Database source:InterPro:IPR002048|I)P07507(Evidence code:IEA/Database source:InterPro:IPR000294|I)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR014741)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q9TU34(Evidence code:IBA/Database source:PANTHER:PTN001416417)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR002048)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR001881|I), CDH11 DNAH7 HMCN2 PCDH8 ITPR2 UNC13A MEGF8 DSC1 CD97 OTOF MYLPF USP32 TLL2 PCDH12 LOC786512 RHOT2 CHGA PLCB3 S100B PCDHGC3 DYSF FAT2 FBN3 CACNA1E UNC13C SRI S100A14 SYTL2 SYT4 SYT6 CDH7 PEF1 TUBB4A ACTN3 ANXA11 EFHD1 CDHR1 VWA2 PDCD6 ARSA SVEP1 RHOT1 RASEF EPS15 LRP4 EDEM2 PCDH20 TRPM4 ACTN2 FKBP9 S100A10 SPTA1 PCDHA13 PCDH1 MAN1B1 NID2 MYL1 CACNA1B UNC13B RYR2 TGM3 TMEM2 DNER ALOX15B EFHB CAPN2 DCHS2 RYR1 MAN1A2 HABP2 MYL3 RYR3 SLIT2 HMCN1 SYTL1 TBC1D9B MATN3 NOTCH4 CDH22 PKDREJ VCAN EFCAB3 EFCC1 PLCG1 ACAN CUBN PCDHB8 CALM1 MGP CBLC BAIAP3 ITPR1 CAPN11 FAT1,MF,94,94 of 203,4.12,46.31,6.545E-38,9.258E-36
GO:0019222,regulation of metabolic process,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens),SH2B2,BP,1,1 of 1349,0.04,0.07,1.108E-37,1.526E-35
GO:0003924,GTPase activity,P10948(Evidence code:IEA/Database source:InterPro:IPR001806|I)G3X7D3(Evidence code:IEA/Database source:InterPro:IPR001806)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469|I)Q0II28(Evidence code:IEA/Database source:InterPro:IPR001806)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019|I)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR001806)A4FUD7(Evidence code:IEA/Database source:InterPro:IPR001806)Q08DC2(Evidence code:IEA/Database source:InterPro:IPR001806)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR001806)E1BIQ2(Evidence code:IEA/Database source:InterPro:IPR001806)Q29RR0(Evidence code:IEA/Database source:InterPro:IPR001806)Q3T107(Evidence code:IEA/Database source:InterPro:IPR001806)P04695(Evidence code:IEA/Database source:InterPro:IPR001019|I)P04696(Evidence code:IEA/Database source:InterPro:IPR001019|I)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR003008)P30671(Evidence code:IEA/Database source:InterPro:IPR001770)E1BAI0(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR003008)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR003008)P04896(Evidence code:IEA/Database source:InterPro:IPR000367|I)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2TBH7(Evidence code:IEA/Database source:InterPro:IPR001806)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR003008)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884|I)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR003008)A5PJP3(Evidence code:IEA/Database source:InterPro:IPR001806)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR001401|I)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR001806)P63097(Evidence code:IEA/Database source:InterPro:IPR001019|I)Q32KW9(Evidence code:IBA/Database source:PANTHER:PTN001595864)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR003008)F1N7V2(Evidence code:IEA/Database source:InterPro:IPR001806)P10949(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q9BDI7(Evidence code:IEA/Database source:InterPro:IPR001401|I)A7Z031(Evidence code:IEA/Database source:InterPro:IPR001806)Q58DC5(Evidence code:IEA/Database source:InterPro:IPR000795)A4FUD3(Evidence code:IEA/Database source:InterPro:IPR000795)F1MGL2(Evidence code:IEA/Database source:InterPro:IPR001806)Q3SZ98(Evidence code:IEA/Database source:InterPro:IPR001770)Q08DF2(Evidence code:IEA/Database source:InterPro:IPR015894)F1MX39(Evidence code:IEA/Database source:InterPro:IPR001806)Q17QU4(Evidence code:IEA/Database source:InterPro:IPR001806)F1N1I1(Evidence code:IEA/Database source:InterPro:IPR003191|I)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367|I)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17)A6QPX8(Evidence code:IEA/Database source:InterPro:IPR001806)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR003008)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR001806)P81948(Evidence code:IEA/Database source:InterPro:IPR003008)F6RP72(Evidence code:IEA/Database source:InterPro:IPR003008)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR003008)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1BLD5(Evidence code:IEA/Database source:InterPro:IPR001806)P11023(Evidence code:IEA/Database source:InterPro:IPR001806|I)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR001806)P63217(Evidence code:IEA/Database source:InterPro:IPR001770)P38408(Evidence code:IEA/Database source:InterPro:IPR000654|I)E1B801(Evidence code:IEA/Database source:InterPro:IPR001806)Q32LB9(Evidence code:IBA/Database source:PANTHER:PTN000119716)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469|I)Q58DW6(Evidence code:IEA/Database source:InterPro:IPR001806)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR001806)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A7MBB1(Evidence code:IEA/Database source:InterPro:IPR015894)E1B953(Evidence code:IEA/Database source:InterPro:IPR003008)A4FUD1(Evidence code:IEA/Database source:InterPro:IPR030230)Q08DW1(Evidence code:IEA/Database source:InterPro:IPR001806)Q08DF4(Evidence code:IEA/Database source:InterPro:IPR001401|I)Q17QB7(Evidence code:IEA/Database source:InterPro:IPR001806)Q3T054(Evidence code:IEA/Database source:InterPro:IPR001806|I), RAB3B RAB39A GNA13 RAB4B GNAT3 HRAS RAB33B RAB31 TRIM23 RAP2A AGAP2 RAB26 RAB24 GNAT1 GNAT2 TUBA8 GNG7 RAB23 TUBB1 LOC100141266 GNAS RHOT1 RAB4A TUBA1A MFN2 TUBA3E RAB22A DNM2 RAP2C GNAI1 IRGC TUBB4A RAB17 RAB3C MX2 RASEF GTPBP1 EFTUD2 AGAP1 GNG10 RNF112 RAB42 RAB39B LOC100336669 GNAL MTG1 RAB12 TUBB3 RRAS TUBA4A LOC100295712 ARL1 RHOT2 TUBA1D ARL2 RAB37 RAB3A DIRAS2 GNG5 GNA14 ARHGAP35 NOA1 GNA12 RAB25 RIT1 LRRK2 LOC783604 LOC533307 GPN1 RAB9A DNM1 RAB30 RAN,MF,73,73 of 111,3.2,65.77,2.387E-37,3.203E-35
GO:0045202,synapse,P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MG56(Evidence code:IEA/Database source:UniProtKB:Q6P1F6|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A7MB16(Evidence code:IEA/Database source:UniProtKB:Q8JZQ9|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A6QLG5(Evidence code:IEA/Database source:UniProtKB:Q6ZWN5|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365476)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A6H769(Evidence code:IEA/Database source:UniProtKB:P62082|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)Q5E963(Evidence code:IEA/Database source:UniProtKB:Q9D898|ens)E1BGL9(Evidence code:IEA/Database source:GO:0048791)E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62270|ens)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1BB27(Evidence code:IEA/Database source:InterPro:IPR030524)E1BMQ1(Evidence code:IEA/Database source:GO:0016079)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A2VDQ6(Evidence code:IEA/Database source:UniProtKB:P55288|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)E1BBK9(Evidence code:IEA/Database source:GO:0048791)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)E1BFV9(Evidence code:IEA/Database source:UniProtKB:Q0QWG9|ens)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR008899)F1MDV3(Evidence code:IEA/Database source:UniProtKB:Q99L88|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)A6QP06(Evidence code:IEA/Database source:GO:0048791)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MCW8(Evidence code:IEA/Database source:UniProtKB:Q8BMF5|ens)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770), CYFIP1 SEPT11 PPP2R2A LRP6 CHRNE SYN1 NRXN1 EIF3B DENND1A GABRA5 GRIA3 GRIA2 RPS9 UTRN CAMK2B VAMP1 GRIA1 LIN7C EXOC4 UNC13A VAMP2 RPS7 PTPRZ1 ARPC5L SYT6 DLGAP3 LRRK2 RPS18 SDK2 VAMP3 LIN7A LIN7B WASF2 SYN2 CYFIP2 TRAPPC4 DLG1 DLGAP1 OTOF FBXO45 DNM2 CDH11 RAPGEF2 SNAP25 SYTL1 PTPRN GRID2IP COPS4 RNF112 LAMB2 BSN SNTB1 SPG20 AKR1A1 SYTL2 PPP2CA GRIK4 PCDHB8 ABHD17C,CC,59,59 of 60,2.59,98.33,3.375E-37,4.416E-35
GO:0005694,chromosome,A5PK61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q32L48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A4IFU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A5PK20(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BL49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G8JL00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1B7N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BQ04(Evidence code:IBA/Database source:PANTHER:PTN000344873)G3N2P2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3MYD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1N413(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N3L9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1N453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q5E9F8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N053(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1MUD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)A0A0A0MP90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BH22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BEE6(Evidence code:IBA/Database source:PANTHER:PTN000344873)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3MZR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A0A0A0MP93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N068(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1MMU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3T0W4(Evidence code:IEA/Database source:UniProtKB:Q15435|ens)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A7MAZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BM22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1B8G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BGN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A0A0A0MPA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1MV26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BC18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q2KII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P0C0S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F2Z4E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BGW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q864U1(Evidence code:ISS/Database source:UniProtKB:P48754)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F1N5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3ZBX9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P61283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158), H3F3C HIST1H2BN HIST3H2A DCTN3 PPP2CB HIST1H1E LOC614206 LOC104975684 LOC619094 BLM LOC613345 CDK13 SEPT7 LOC100297725 EHMT2 LOC613363 PAXIP1 HIST2H2BE H3F3B HIST1H2BA HIST2H2BF PPP1CC CDK12 HIST1H2AC HIST2H2AB WRN SEPT2 HIST1H1A LOC523702 LOC614881 LOC614378 H1FX PPP1R7 CSNK1A1 HIST1H1D LOC100300167 HIST3H2BB RAD21L1 HIST2H3D NSFL1C HIST1H2AJ LOC525433 LOC617043 HIST1H2BI H2AFZ HIST1H2BB HIST1H2BJ SEPT6 PPP2CA BRCA1 SIRT2 LOC615183 H2AFJ BANF1,CC,54,54 of 47,2.37,114.89,1.949E-36,2.488E-34
GO:0005783,endoplasmic reticulum,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q56JX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MRU0(Evidence code:IEA/Database source:UniProtKB:P36888|ens)F1MD64(Evidence code:IEA/Database source:UniProtKB:Q92508|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR027670)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)F1N0J3(Evidence code:IEA/Database source:UniProtKB:P98196|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BFD1(Evidence code:IBA/Database source:PANTHER:PTN000469495)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)F1MDD5(Evidence code:IEA/Database source:UniProtKB:Q16787|ens)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR013547)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A7MBJ3(Evidence code:IEA/Database source:UniProtKB:Q9BV94|ens)F1MMG6(Evidence code:IEA/Database source:UniProtKB:Q6AZY7|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MNU6(Evidence code:IBA/Database source:PANTHER:PTN000080880)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)P55156(Evidence code:ISS/Database source:UniProtKB:P55157)A1A4M8(Evidence code:IEA/Database source:UniProtKB:Q9H497|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A4FUH1(Evidence code:IEA/Database source:InterPro:IPR017378)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P61356(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A5PK45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2TBL9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR017378)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P02465(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z3H5)A2VE53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2KJC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q0P568(Evidence code:IEA/Database source:UniProtKB:Q541A5|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)Q32LH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q9BZR6|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)G3MXQ8(Evidence code:IEA/Database source:UniProtKB:Q9UKM7|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MIU7(Evidence code:IEA/Database source:UniProtKB:Q5K4L6|ens)E1BJ75(Evidence code:IEA/Database source:InterPro:IPR033212)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)Q3T0I5(Evidence code:IEA/Database source:GO:0032471)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)A4FUW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BI49(Evidence code:IBA/Database source:PANTHER:PTN000201533)Q32PA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3SZN2(Evidence code:ISS/Database source:UniProtKB:Q15437)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q5EA65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens), DLG1 ARSA CYP7A1 UBXN1 SPCS3 BRINP1 WRB RPS28 FLT3 PIEZO1 CAPN2 EXT1 SEC13 RNF139 MARCH5 ATP11A SPAST ANKLE2 LRRK2 KCNMA1 JSRP1 UBQLN1 AQP5 DNASE1L1 FAM213B LAMA3 P4HA2 HPS6 EDEM2 SCARA3 BRSK2 CIDEC BAIAP3 TRAPPC2L UGGT2 SYVN1 MTTP TOR3A BACE1 ITPR2 DAD1 TOR2A DBH AGPAT1 RPL27 COLGALT1 TRAPPC4 DPM3 PROM1 CUBN TOR1A SAR1B COL1A2 IKBIP FKBP9 UFD1L TMEM30A ZFYVE27 CYB5R4 RTN4R PRNP PDCD6 SEC24A SEC23A TMC6 SCAP ATP8B1 SHISA5 CFTR SEZ6L2 PSEN1 ARCN1 DNAJB11 LARS PIGK MAN1B1 NPC1 CLCC1 SLC27A3 CRTAP SORL1 KEAP1 FIS1 SEC11A ITPR1 FAM20A TOR1B TXNDC11 MAN1A2 FKBP2 SLC35B1 SEC23B AHCYL2 DPAGT1 TRPM4,CC,95,95 of 220,4.17,43.18,2.319E-36,2.89E-34
GO:0042803,protein homodimerization activity,E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36551|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR013867)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)E1BM28(Evidence code:IEA/Database source:UniRule:UR000107503)G3N2I5(Evidence code:IEA/Database source:UniProtKB:D3W0D1|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)P42891(Evidence code:IPI/Database source:UniProtKB:P42891)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)Q3T105(Evidence code:IEA/Database source:UniProtKB:Q14376|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)Q2NL34(Evidence code:ISS/Database source:UniProtKB:O75208)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107684)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)E1BFJ4(Evidence code:IEA/Database source:UniProtKB:Q99MV7|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q0VCK0(Evidence code:ISS/Database source:UniProtKB:P31939)E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)Q1LZA3(Evidence code:IBA/Database source:PANTHER:PTN000206333)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB:Q13554|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR013867)P02510(Evidence code:ISS/Database source:UniProtKB:P02511)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)Q5EAC2(Evidence code:ISS/Database source:UniProtKB:Q08220)E1BMI4(Evidence code:IEA/Database source:UniProtKB:Q8NBZ7|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB:Q9NQW7|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)Q28007(Evidence code:IDA/Database source:)P02638(Evidence code:ISS/Database source:UniProtKB:P04271)Q8SPX7(Evidence code:IEA/Database source:UniProtKB:Q9Y2S2|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)P48034(Evidence code:ISS/Database source:UniProtKB:Q06278)E1BCH6(Evidence code:ISS/Database source:UniProtKB:A4D126)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)E1BM12(Evidence code:IEA/Database source:UniProtKB:P19623|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR017751)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)A6QPK5(Evidence code:IBA/Database source:PANTHER:PTN000927455), CPOX KMT2A TERF2 MAPK4 IKBKG DNPH1 KLRF2 TFRC SFPQ NUDT16 PDCD6IP CHMP4B SYT6 ARID3A ECE1 SP1 GRHPR GALE FCER1G IDE CEBPA DPP4 KIT PFKM ZBTB4 RPS19 IMPA1 EXT1 TPR BANF1 NFKB1 TDG SRF ALDH1A3 COQ9 CHMP1A DGCR8 CTBP1 SNF8 CAMK2A RNF17 PDCD10 ATIC OLFML2A ANO6 VPS25 CUL3 TSC2 VPS4B CUBN GIPC1 PDCD6 SDCBP2 ASNS CAMK2B CRYM SLIT2 WWTR1 ZHX3 TERF1 CRYAB G6PD CHMP4A PTPA KEAP1 GSS UXS1 LRRK2 WRN BLM SLK EPRS XPNPEP1 STAT3 DPYD S100B CRYL1 TENM3 LRP6 TENM2 PTH1R AOX1 ISPD STK26 ADH5 SRM PDGFC DAB2IP GPD1L TSG101 S100A10 TCF7L2,MF,92,92 of 210,4.04,43.81,1.138E-35,1.386E-33
GO:0048471,perinuclear region of cytoplasm,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)O46382(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKL9(Evidence code:IEA/Database source:UniProtKB:Q14517|ens)Q95106(Evidence code:ISS/Database source:UniProtKB:P21237)Q0VCN1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)Q3SZN2(Evidence code:IEA/Database source:UniProtKB:Q9D662|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P00517(Evidence code:ISS/Database source:UniProtKB:P17612)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A6H7F7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q3SZ65(Evidence code:IEA/Database source:UniProtKB:Q14240|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)Q647I9(Evidence code:IDA/Database source:)A4IF89(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)A4FUC9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F6Q0K7(Evidence code:IBA/Database source:PANTHER:PTN002204142)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)A7Z056(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q29RU0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)O18964(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)Q9TU34(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), RAPGEF2 CYFIP2 ABCA1 DCTN3 APC2 LAMP1 TAF10 EIF3G RAB3B S100A14 SNF8 MYO9B OSBP ATP2C2 TWF1 SRC ARFGEF1 FAT1 BDNF NMRAL1 SNAP25 TMEM184A RASEF AXIN1 PSEN1 SEC23B S100B SLK ATP7B FIGNL1 MYO6 MT3 DLG1 PTPRM MRVI1 PRKACA WWC1 TFRC NPC1 NEDD4 TRAPPC2L TRAF6 CLINT1 LRPPRC UBQLN1 EIF4A2 TSC2 NLRP5 EXOC8 STX7 VPS52 RHPN2 SIRT2 STK26 SPATA32 NF2 GALNT2 LMTK2 USP20 CYFIP1 fgfr3 BAG5 NDRG2 RNF128 RAB4A DDX4 CDK5RAP2 COPS8 SYNJ1 RAB3C PINK1 PKHD1 ITPR1 CLIC4 TAF8 VAMP5 PKP4 ABL1 EIF4H VPS35 SYT4 SPAST,CC,82,82 of 170,3.6,48.24,2.507E-34,2.982E-32
GO:0051171,regulation of nitrogen compound metabolic process,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1191,0.04,0.08,3.11E-33,3.618E-31
GO:0016787,hydrolase activity,E1BJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P20456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9XTA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3MHR0(Evidence code:IEA/Database source:InterPro:IPR003140)Q75WB5(Evidence code:IEA/Database source:InterPro:IPR002821)Q58DC0(Evidence code:IEA/Database source:InterPro:IPR004843)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BB73(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08D90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2TBQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P06623(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR005937)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1JPJ2(Evidence code:IEA/Database source:InterPro:IPR000587)F1MQD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P62194(Evidence code:IEA/Database source:InterPro:IPR005937)A7MBJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MS16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MN60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7YWN0(Evidence code:IEA/Database source:InterPro:IPR000407)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MXQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MKI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MS27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BLB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P16386(Evidence code:IEA/Database source:InterPro:IPR002168|I)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5D7T5(Evidence code:IEA/Database source:InterPro:IPR004843|I)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0II50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0Y1(Evidence code:IEA/Database source:InterPro:IPR016615)A8E641(Evidence code:IEA/Database source:InterPro:IPR006680)A6QQN6(Evidence code:IEA/Database source:InterPro:IPR004843)E1BIU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BEZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)H7BWW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QLS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BIX3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0VCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006680)Q17QL8(Evidence code:IEA/Database source:InterPro:IPR003140)P22571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5EA59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MEM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E998(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P61287(Evidence code:IEA/Database source:InterPro:IPR004843|I)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KJI4(Evidence code:IEA/Database source:InterPro:IPR000407)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F6QK60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BNQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJV3(Evidence code:IEA/Database source:InterPro:IPR006680)F1MHB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P11019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MLX9(Evidence code:IEA/Database source:InterPro:IPR006680)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MF35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MNA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P67774(Evidence code:IEA/Database source:InterPro:IPR004843|I)F1MRN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0P594(Evidence code:IEA/Database source:InterPro:IPR004843|I)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0V897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BEQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR005937)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q32PA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BA23(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q8HYW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QQD4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4FUF1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P80227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9TTA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)D3IVZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MMF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033562)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5D980(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BD03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BHX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QK4(Evidence code:IEA/Database source:InterPro:IPR006439)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P0C6R3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0V8H0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BER6(Evidence code:IEA/Database source:InterPro:IPR006680)A6QPF2(Evidence code:IEA/Database source:InterPro:IPR006935)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)G5E631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BN79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P11064(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P48452(Evidence code:IEA/Database source:InterPro:IPR004843|I)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MGC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)G5E5C6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q32KW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A1A4Q9(Evidence code:IEA/Database source:InterPro:IPR000086|I)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR005937)F1MCT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1N0J3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q29460(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR004843|I)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR005937), DHX34 IMPA1 PREP LYPLA1 OPLAH CPPED1 PSMA4 GPN1 PLCG1 INPP5B KLK7 CAPN2 PGLS PRSS23 CNP ATP8B1 DUSP3 PSMC1 DDX4 XPNPEP1 CAPN5 IDE PSMC5 EDEM2 NPEPPS PTPRZ1 USP20 PSMB4 ATP2B3 ATP2B2 ENTPD2 PDXP DPP4 LYZ1 DNM2 TMPRSS9 CAPN11 ATP7B FHIT PDE4D RUVBL1 INPP5J LIPE CHD8 PPP3CC ARSA CASP3 USB1 OTUB1 DPYSL5 SMPDL3B PTPN23 PTPN14 VPS4B HEXB DUSP7 ADAMTS5 CAPN7 ATIC EIF4A2 CAD LYPLA2 PDE6H AHCYL2 ABHD4 DNASE1L2 DHX8 DNPEP CTSV ACE PPP1CC PSMB10 ENTPD6 PSMA7 SIRT2 DHX37 AMDHD1 INPP5A BRCC3 RUVBL2 MAN1A2 FUCA1 ATP6V1E1 HABP2 GDA ABHD2 PTPRA TLL2 HYAL1 TDRD9 DDX1 MBTPS2 PSMA3 PPP2CA ATP13A5 TMPRSS2 DXO PPP2CB DNASE1L1 DHX9 SEC11A HDAC10 HINT3 LOC505658 PSMC3 DICER1 PHPT1 ADAMTS4 PSMB3 KATNAL2 PTPRM AMPD3 atp1A3 PTPN5 LOC100125946 CASP6 APEH PSMB9 ABHD12 SMARCAL1 DDX3Y ATP2C2 USP13 PNPLA2 EIF4A3 PTPN6 PPM1D ERCC2 LIPF RHOT2 ATP6V1B1 PRUNE1 DPEP3 PLCB3 EPHX2 USP5 ATP1A2 BACE1 CES4A ECE1 DHX57 CRMP1 FANCM DNM1 SSH2 PSMB8 PSEN1 DDX3X PIGK MMP19 RHOT1 MAN1B1 TMPRSS6 SPCS3 CES5A HDAC5 ACP1 AGO3 PPP3CA SYNJ1 DNPH1 RNASE2 ACR ATP2B4 IRGC GNPDA2 ABHD17C NUDT16 PSMC2 PCSK6 ATP11A PAFAH1B3 CFTR RPAP2 LTA4H TSN METAP2 SPAST PPP1CB PAN2 PSMC6,MF,181,181 of 836,7.94,21.65,2.715E-32,3.089E-30
GO:0055114,oxidation-reduction process,E1BBS6(Evidence code:IEA/Database source:InterPro:IPR017905|I)A5PJM4(Evidence code:IEA/Database source:InterPro:IPR000103|I)A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000672|I)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424|I)Q3ZBD3(Evidence code:IEA/Database source:GO:0004505)Q32L99(Evidence code:IEA/Database source:InterPro:IPR013149)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139|I)Q58DM4(Evidence code:IEA/Database source:InterPro:IPR005123)F1MMK2(Evidence code:IEA/Database source:InterPro:IPR001282|I)Q3ZCJ2(Evidence code:IEA/Database source:InterPro:IPR018170|I)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR001093|I)F1MF26(Evidence code:IBA/Database source:PANTHER:PTN001038805)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q17QK8(Evidence code:IEA/Database source:InterPro:IPR006393)F1MF74(Evidence code:ISS/Database source:UniProtKB:O94851)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q28007(Evidence code:IEA/Database source:InterPro:IPR005720|I)Q59A28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001236|I)O62768(Evidence code:IEA/Database source:InterPro:IPR004099|I)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)O97764(Evidence code:IEA/Database source:InterPro:IPR013149|I)F1MJY3(Evidence code:IEA/Database source:GO:0070579)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR005123|I)A6QP05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P16116(Evidence code:IEA/Database source:InterPro:IPR018170|I)E1BL62(Evidence code:IEA/Database source:InterPro:IPR002346|I)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139|I)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR000907|I)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q2KHX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)P00376(Evidence code:IEA/Database source:InterPro:IPR001796|I)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006109|I)P48644(Evidence code:IEA/Database source:InterPro:IPR015590|I)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011407|I)Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR002328|I)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR008259|I)F1MQ57(Evidence code:IEA/Database source:GO:0008940)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I)P56560(Evidence code:IEA/Database source:InterPro:IPR001613|I)O46414(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139|I)P23709(Evidence code:IEA/Database source:InterPro:IPR001268|I)Q3T0Z7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q32LH7(Evidence code:IEA/Database source:InterPro:IPR001433|I)Q58D31(Evidence code:IEA/Database source:InterPro:IPR002328|I)A7YY67(Evidence code:IEA/Database source:InterPro:IPR011407|I)Q32L93(Evidence code:IEA/Database source:InterPro:IPR001093|I)Q27995(Evidence code:IEA/Database source:InterPro:IPR001094|I)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR005123|I)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR015590|I)A8E657(Evidence code:IEA/Database source:InterPro:IPR005097)Q3ZBW6(Evidence code:IEA/Database source:GO:0008670)Q2KIT8(Evidence code:IEA/Database source:GO:0016491)Q3T046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q5I598(Evidence code:IEA/Database source:InterPro:IPR003171|I)Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225)P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR016156|I)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)A5D9D7(Evidence code:IEA/Database source:GO:0051213)Q148K4(Evidence code:IEA/Database source:InterPro:IPR006094)E1BKY9(Evidence code:IEA/Database source:InterPro:IPR001260|I)Q58DA7(Evidence code:IEA/Database source:GO:0015035)Q4JIJ2(Evidence code:IEA/Database source:InterPro:IPR001094|I)P48034(Evidence code:IEA/Database source:InterPro:IPR002346|I)P27479(Evidence code:IEA/Database source:InterPro:IPR000907|I)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q8TDZ2)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MHF7(Evidence code:IEA/Database source:GO:0047134), QSOX2 AIFM2 MTHFD1 GAPDHS PCBD1 PTGR2 PHGDH ALKBH2 G6PD AKR1A1 IMPDH2 SH3PXD2A CYP2R1 SPR MICAL2 LOC540627 CYP7A1 DPYD CRYZL1 UEVLD TXNRD1 DHRS3 CRYZ TET3 EGLN3 DHRS12 AKR1B1 AOX4 GRHPR ALOX15B CYP2J2 CRYM LOC100295883 DHFR GPD1L ALDH1A1 CYB561 DHTKD1 ALDH1L2 ADH5 HAO2 GPHN CRYL1 MAOB FTH1 CTBP1 NDUFS3 QDPR CYB5R4 SORD ALDH1L1 GMPR2 NOS2 P4HA2 ALDH1A3 ALDH9A1 AASS DECR2 TSTA3 BDH2 MTHFR HSD3B7 DBH AIFM1 PAH PLOD3 LDHD CPOX GLRX3 MTRR AOX1 ALOX15 MICAL3 STEAP4 FAM213B TXNDC17,BP,76,76 of 162,3.33,46.91,2.358E-31,2.626E-29
GO:0006355,"regulation of transcription, DNA-templated",E1BK57(Evidence code:IEA/Database source:InterPro:IPR001699|I)A6QNT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR000327|I)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR017431|I)Q32S26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR003894|I)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628|I)E1BG94(Evidence code:IEA/Database source:InterPro:IPR003316)Q08DJ3(Evidence code:IEA/Database source:InterPro:IPR015096)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR001699|I)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR017970)F1MPR1(Evidence code:IEA/Database source:InterPro:IPR037644)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217|I)A0JND4(Evidence code:IEA/Database source:InterPro:IPR026741)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BD77(Evidence code:IEA/Database source:InterPro:IPR017970)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR009110|I)Q2KIM2(Evidence code:IEA/Database source:InterPro:IPR027093)G3N2N6(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BP38(Evidence code:IEA/Database source:UniProtKB:Q6GYP7|ens)Q2NL18(Evidence code:IEA/Database source:InterPro:IPR003650)F1MU53(Evidence code:IEA/Database source:InterPro:IPR001909|I)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)G3X812(Evidence code:IEA/Database source:InterPro:IPR022355)E1BDU9(Evidence code:IEA/Database source:InterPro:IPR000679|I)E1BGQ4(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)P17667(Evidence code:IEA/Database source:InterPro:IPR002546)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)A5D7F6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MBH4(Evidence code:IEA/Database source:InterPro:IPR001766|I)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)M5FMX2(Evidence code:IEA/Database source:InterPro:IPR031265)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040|I)E1BL97(Evidence code:IEA/Database source:InterPro:IPR029547)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR003150)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628|I)F1MU40(Evidence code:IEA/Database source:InterPro:IPR017970)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004826|I)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A6QL80(Evidence code:IBA/Database source:PANTHER:PTN000109455)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1B9H3(Evidence code:IEA/Database source:InterPro:IPR025224)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MT17(Evidence code:IEA/Database source:InterPro:IPR017970)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004826|I)Q1MW18(Evidence code:IEA/Database source:InterPro:IPR017970)Q7YRX0(Evidence code:IEA/Database source:InterPro:IPR017970)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MY77(Evidence code:IEA/Database source:InterPro:IPR037967)F1MC99(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BNM4(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR003893|I)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR004827)Q9BE45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A4FUE0(Evidence code:IEA/Database source:InterPro:IPR008422)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR001827|I)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000685235)E1BE02(Evidence code:IEA/Database source:InterPro:IPR003316)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A6QLP0(Evidence code:IEA/Database source:InterPro:IPR001766|I)A6QNK4(Evidence code:IEA/Database source:InterPro:IPR000580)E1BPS0(Evidence code:IEA/Database source:InterPro:IPR004827)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR015431)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR031169)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BHB8(Evidence code:IEA/Database source:InterPro:IPR017970)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR001909|I)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR000679|I)F1MIK5(Evidence code:IEA/Database source:InterPro:IPR022097)E1BCF7(Evidence code:IEA/Database source:InterPro:IPR017970)G3MYE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1B7I2(Evidence code:IEA/Database source:InterPro:IPR000418)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)A6QP40(Evidence code:IEA/Database source:InterPro:IPR019139)E1B8X8(Evidence code:IBA/Database source:PANTHER:PTN000139030)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1N4U8(Evidence code:IEA/Database source:InterPro:IPR007759)Q2HJ84(Evidence code:IEA/Database source:InterPro:IPR008422)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)O02754(Evidence code:IEA/Database source:InterPro:IPR004827)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR003316)P61635(Evidence code:IEA/Database source:InterPro:IPR001217|I)Q1RMU0(Evidence code:IEA/Database source:InterPro:IPR006988|I)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR000327|I)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR001275|I)F1MXR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1B9T7(Evidence code:IBA/Database source:PANTHER:PTN000502888)E1BAI9(Evidence code:IEA/Database source:InterPro:IPR017970)G3N2D1(Evidence code:IEA/Database source:InterPro:IPR007759)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628|I)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569)A6QNN4(Evidence code:IEA/Database source:InterPro:IPR003309)F1ML85(Evidence code:IEA/Database source:InterPro:IPR013767)F1MIL2(Evidence code:IEA/Database source:InterPro:IPR009146)Q3MHL6(Evidence code:IEA/Database source:InterPro:IPR000580)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR003822|I)E1BLB9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BQ37(Evidence code:IBA/Database source:PANTHER:PTN000573360)E1BJP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MZQ1(Evidence code:IEA/Database source:InterPro:IPR024137)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR003894|I)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR000679|I)A5PJW1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR014978)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805), TBX3 FAM120B POU3F1 ZNF750 IRF1 BRD2 CBFA2T2 ESRRG E2F1 FUBP1 MGA EN1 MN1 INSM1 STAT5B SBNO2 RPAP2 ZFHX2 NCOA3 EAF2 ZFP37 RALGAPA1 HEYL ZNF446 RUVBL1 NOTCH4 GATAD2B ZNF316 GCFC2 MYF5 LOC526488 MAML2 FOXF1 NFKB1 IKBKAP SOX4 VPS36 SOX8 ZBTB18 ZBTB8A DDX1 RUNX1 SOX13 STAT5A RFX5 ZFHX3 WWTR1 MCTS1 PRMT5 NR1I2 MNX1 MAF PTPRN PRMT3 SAP18 CCAR2 AHCTF1 HDAC5 CUX2 NFE2L2 LHX4 RAX2 PARP1 MAPK13 HBP1 ZMYND8 FOXI3 ZNF282 SOX17 IRX1 RPS6KA4 CPNE1 ZMYM5 ATF6B NFKBIZ KEAP1 ARID3A USP13 ZNF148 MEIS1 HOXA7 PAK6 E2F7 DYNLL1 FOXO4 TSC22D3 CREBRF TCF7L2 CCNL1 TAF8 KDM3B PKN1 MIER1 PCBD1 RAX UHRF1 ZNF394 PRKCB PAXIP1 RUVBL2 CDC5L GATA6 SOX1 DLX2 MECP2 ETV2 RPS6KA5 Gli3 LRRFIP1 BRCA2 CHD8 UBE2L3 HCFC1 ASXL1 PKNOX1 VPS25 CEBPA TFDP2 STAT3 NAB2 IKBKG BRCA1 SP1 MMS19 SIM2 KMT2B POU4F2 DMRTC2 ONECUT2 EGR4 SUZ12 ANHX ASXL3 NR2F6 DHX9 KMT2A LOC515042 AHR TLE6 TSC22D1 GON4L SHOX2 SFPQ SRF RREB1 SAP130 TAF4B AEBP2 CIDEC gata4 TAF10 SMARCA2 SALL4 ERCC2 FHIT,BP,155,155 of 662,6.8,23.41,2.746E-31,2.995E-29
GO:0043169,cation binding,E1BD03(Evidence code:IEA/Database source:InterPro:IPR000222)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR006048), PPM1D GBE1,MF,2,2 of 1145,0.09,0.17,3.049E-30,3.257E-28
GO:0005096,GTPase activator activity,A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)E1BP38(Evidence code:IEA/Database source:InterPro:IPR000331|I)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR037769)E1BIQ2(Evidence code:IEA/Database source:InterPro:IPR001164)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR000331|I)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MTH3(Evidence code:IEA/Database source:UniProtKB:Q6ZPF3|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR037776)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)F1MBI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)Q0V8A7(Evidence code:IEA/Database source:InterPro:IPR001164)F1MD62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1N746(Evidence code:IEA/Database source:InterPro:IPR033185)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090250)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)G3MXN3(Evidence code:IEA/Database source:InterPro:IPR037745)F1MM72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR030772)Q29RJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037884)F1MHG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)A6QNV8(Evidence code:IEA/Database source:InterPro:IPR030409)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR030061)F1MJI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)A7YY57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR037858)G3X7P3(Evidence code:IBA/Database source:PANTHER:PTN000090250)G3MYM2(Evidence code:IEA/Database source:InterPro:IPR033564)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR028558)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR028557)F1MKZ2(Evidence code:IEA/Database source:InterPro:IPR001164)F1MGL2(Evidence code:IEA/Database source:InterPro:IPR001164)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR000331|I)F1N2I0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)A0JN64(Evidence code:IEA/Database source:InterPro:IPR000331|I)Q58DV1(Evidence code:IEA/Database source:InterPro:IPR039093)F1MM21(Evidence code:IEA/Database source:InterPro:IPR037956)A7MB27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343), TBC1D22B LARS RALGAPA1 TBC1D12 BCR AGAP2 SIPA1L1 ARHGAP35 TIAM2 RACGAP1 RASAL2 ECT2 RANBP2 RASAL1 RGS14 SYNGAP1 MTSS1L ARFGAP1 ARHGAP20 RABGAP1 AXIN1 LRRK2 SGSM2 ARHGAP22 ARHGAP6 TBC1D24 ARHGEF12 ARHGAP21 RGS1 ARHGAP26 SRGAP3 ARHGAP29 ARAP3 AXIN2 TBC1D4 RAPGEF2 DAB2IP MYO9A TBC1D2 MYO9B ASAP2 AGAP1 TSC2 CHML GARNL3 RP2 RGS6 ARHGAP36,MF,48,48 of 54,2.11,88.89,2.814E-29,2.946E-27
GO:0005739,mitochondrion,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36551|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BDG9(Evidence code:IEA/Database source:UniProtKB:Q3SY69|ens)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P61287(Evidence code:ISS/Database source:UniProtKB:P36873)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens)Q3ZBX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P61763(Evidence code:ISS/Database source:UniProtKB:O08599)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR027089)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P0C2B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)O62768(Evidence code:IBA/Database source:PANTHER:PTN002456829)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)A5PKL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A8E657(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2NL34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A4FUD1(Evidence code:IEA/Database source:UniProtKB:Q9HCN4|ens)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2KIN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)A6QLT9(Evidence code:IBA/Database source:PANTHER:PTN000206956)E1BFB5(Evidence code:IEA/Database source:InterPro:IPR033495)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q148K4(Evidence code:IEA/Database source:UniProtKB:Q7TNG8|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)G3N127(Evidence code:IEA/Database source:UniProtKB:P27469|ens)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BEB7(Evidence code:IBA/Database source:PANTHER:PTN000349172)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q58CZ9(Evidence code:ISS/Database source:UniProtKB:Q8QZR1)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A6QLB8(Evidence code:IEA/Database source:GO:1901030)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F1ML89(Evidence code:IEA/Database source:UniProtKB:Q8C196|ens)E1BIP2(Evidence code:IEA/Database source:UniProtKB:A0A024R151)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q17QI3(Evidence code:IBA/Database source:PANTHER:PTN000432235)F1N1T6(Evidence code:IEA/Database source:UniProtKB:A0A024R419)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P11181(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)A4IFC8(Evidence code:IBA/Database source:PANTHER:PTN000048763)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)A4IFE6(Evidence code:IEA/Database source:UniProtKB:P61221|ens)P00376(Evidence code:ISS/Database source:UniProtKB:Q920D2)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)A7YY65(Evidence code:IBA/Database source:PANTHER:PTN001324730)F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)Q32KZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)A5D7A2(Evidence code:IBA/Database source:PANTHER:PTN000078675)Q2TBI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BDI3(Evidence code:IBA/Database source:PANTHER:PTN000030201)A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)A6QR09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A1A4P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3SZK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:F8VVT9|ens)F1MKA6(Evidence code:IBA/Database source:PANTHER:PTN000206956)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)E1BFI2(Evidence code:IEA/Database source:UniProtKB:Q96HY7|ens)Q08E34(Evidence code:IEA/Database source:UniProtKB:O94826|ens)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433398)E1BPX9(Evidence code:IEA/Database source:UniProtKB:E5KNY5|ens)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q3T099(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P02722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)P81127(Evidence code:IEA/Database source:UniProtKB:Q99747|ens)F1MZL5(Evidence code:IBA/Database source:PANTHER:PTN000812494)F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q05B89(Evidence code:IBA/Database source:PANTHER:PTN000351096)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q08DK7(Evidence code:ISS/Database source:UniProtKB:Q8N8R3), LIPE EFHD1 VPS35 MAPK9 CPOX BRAF ALDH1L2 SH3GLB1 PPP1CC LRRK2 POLDIP2 MRPL3 STXBP1 SOX4 MFN2 AIFM2 MRPL52 TXNRD1 HSPA9 OXR1 SIRT2 IMMT AASS COQ9 CAMK2A RHOT1 GPN1 TIMM17B MPV17 KIF1B AARS KIAA0391 SORD LDHD NFKB1 PRKACA TNRC18 G0S2 CPT1B TRUB1 NDUFS3 TAT ADH5 FKBP4 GSK3A NLRP5 CDK1 CPS1 SLC44A1 CRYAB ACAT2 FASTKD2 LRRK1 GOLPH3 PPP3CA GK MARCH5 ARL2 DBT SRC LIG1 MTG1 RAI1 SCO1 FIS1 AIFM1 ABCE1 DHFR PSEN1 BAG5 MTCH1 GK2 MAPK1 MTIF3 CLIC4 GARS TRAP1 POLG GCK SLC25A26 PFDN2 CD3EAP MAOB DYNLL1 TBRG4 BDNF AGTPBP1 AGAP2 AARS2 RHOT2 HIVEP1 DHTKD1 TOMM70A TDRD9 LRPPRC NOA1 PNPT1 SHMT2 PINK1 WARS2 SLC25A4 IDE NAPG SPHKAP GPAT2 RARS2 NIF3L1 CRYM LOC538702 SLC25A29,CC,110,110 of 380,4.82,28.95,3.352E-29,3.44E-27
GO:0046982,protein heterodimerization activity,Q32L48(Evidence code:IEA/Database source:InterPro:IPR009072)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR009072)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)E1BM22(Evidence code:IEA/Database source:InterPro:IPR009072)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)Q5E9F8(Evidence code:IEA/Database source:InterPro:IPR009072)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)P55156(Evidence code:ISS/Database source:UniProtKB:P55157)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)A5PK61(Evidence code:IEA/Database source:InterPro:IPR009072)Q2KII5(Evidence code:IEA/Database source:InterPro:IPR009072)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)G3N3L9(Evidence code:IEA/Database source:InterPro:IPR009072)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)E1BC18(Evidence code:IEA/Database source:InterPro:IPR009072)G3MYD7(Evidence code:IEA/Database source:InterPro:IPR009072)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR009072)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR009072)E1B8G9(Evidence code:IEA/Database source:InterPro:IPR009072)E1BGN3(Evidence code:IEA/Database source:InterPro:IPR009072)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)F2Z4E8(Evidence code:IEA/Database source:InterPro:IPR009072)E1BL49(Evidence code:IEA/Database source:InterPro:IPR009072)G3N2P2(Evidence code:IEA/Database source:InterPro:IPR009072)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR009072)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BGW2(Evidence code:IEA/Database source:InterPro:IPR009072)A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1MUD2(Evidence code:IEA/Database source:InterPro:IPR009072)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)P67774(Evidence code:ISS/Database source:UniProtKB:P67775)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)G3N068(Evidence code:IEA/Database source:InterPro:IPR009072)E1BJF4(Evidence code:IEA/Database source:UniProtKB:P33609|ens)A6QQ14(Evidence code:IEA/Database source:InterPro:IPR009072)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)G3N053(Evidence code:IEA/Database source:InterPro:IPR009072)F1MV26(Evidence code:IEA/Database source:InterPro:IPR009072)F1N453(Evidence code:IEA/Database source:InterPro:IPR009072)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)G8JL00(Evidence code:IEA/Database source:InterPro:IPR009072)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR009072)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR009072)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR009072)F1N5F3(Evidence code:IEA/Database source:InterPro:IPR009072)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)A7MAZ4(Evidence code:IEA/Database source:InterPro:IPR009072)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR009072)E1BH22(Evidence code:IEA/Database source:InterPro:IPR009072)E1BJI4(Evidence code:IEA/Database source:InterPro:IPR009072)G3MZR4(Evidence code:IEA/Database source:InterPro:IPR009072), HIST1H2BN TAF4B IKBKG LOC100300167 SDCBP2 MEIS1 ITGB1 H3F3B MAPK4 MTTP SIM2 H3F3C HIST1H2BI PKNOX1 TCF7L2 LOC613363 TXLNG LOC617043 LOC100297725 H2AFZ LOC619094 HIST3H2BB HIST2H3D CUL3 HIST1H2BB LOC614206 LOC613345 HIST1H2AJ TENM2 HIST1H2BJ EXT1 TENM3 HIST2H2BF NFKB1 PPP2CA SRI LOC614378 POLA1 POLE4 NAE1 HIST1H2BA LOC525433 HIST2H2BE NCOA3 SOX17 LOC104975684 SPTA1 PEF1 ZHX3 FLOT1 LOC614881 HIST3H2A H2AFJ LOC615183 TOP2B TAF8 HIST1H2AC HIST2H2AB BTBD11 LOC523702,MF,60,60 of 103,2.63,58.25,6.021E-29,6.061E-27
GO:0016567,protein ubiquitination,Q0VD59(Evidence code:IEA/Database source:UniPathway:UPA00143)G3MX28(Evidence code:IEA/Database source:GO:0004842)G5E639(Evidence code:IEA/Database source:UniProtKB:P0C2W1|ens)Q3ZC24(Evidence code:IEA/Database source:UniPathway:UPA00143)Q29RU0(Evidence code:IEA/Database source:UniPathway:UPA00143)F1N1X8(Evidence code:IEA/Database source:GO:0061630)E1BK47(Evidence code:IEA/Database source:GO:0004842)F1MUH4(Evidence code:IEA/Database source:InterPro:IPR003613)Q3SX45(Evidence code:IEA/Database source:UniPathway:UPA00143)G8JKY1(Evidence code:IEA/Database source:UniPathway:UPA00143)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens)Q864U1(Evidence code:IEA/Database source:UniPathway:UPA00143)E1BB00(Evidence code:IEA/Database source:UniPathway:UPA00143)F1MDC0(Evidence code:IEA/Database source:InterPro:IPR031127)A2VE03(Evidence code:IEA/Database source:UniPathway:UPA00143)F1N1C5(Evidence code:IEA/Database source:GO:0061630)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)Q1RMX2(Evidence code:IEA/Database source:UniPathway:UPA00143)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6)A8WFQ1(Evidence code:IEA/Database source:InterPro:IPR037299)G3N1V7(Evidence code:IEA/Database source:GO:0004842)Q08DF2(Evidence code:IEA/Database source:UniPathway:UPA00143)F1MNJ8(Evidence code:IEA/Database source:GO:0004842)Q3ZCF3(Evidence code:IEA/Database source:UniPathway:UPA00143)A6QNU0(Evidence code:IEA/Database source:GO:0004842)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)E1BL52(Evidence code:IEA/Database source:GO:0061630)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)E1BE13(Evidence code:IEA/Database source:GO:0004842)Q0V7P2(Evidence code:IEA/Database source:InterPro:IPR031227)E1BAK9(Evidence code:IEA/Database source:InterPro:IPR032832)Q32PF3(Evidence code:IEA/Database source:InterPro:IPR029169)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR027139|I)G3MX12(Evidence code:IEA/Database source:InterPro:IPR010606)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)Q32PG4(Evidence code:IEA/Database source:GO:0004842)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)A7E320(Evidence code:IEA/Database source:UniPathway:UPA00143)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)Q32PG9(Evidence code:IEA/Database source:UniPathway:UPA00143)F2Y8Y4(Evidence code:IEA/Database source:InterPro:IPR039087)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)A7Z061(Evidence code:IEA/Database source:UniPathway:UPA00143)E1BM69(Evidence code:IEA/Database source:GO:0004842)Q08DE9(Evidence code:IEA/Database source:GO:0061630)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR003613|I)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR010606)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)A7MBG4(Evidence code:IEA/Database source:InterPro:IPR030563)P61085(Evidence code:IEA/Database source:UniPathway:UPA00143)E1BG23(Evidence code:IEA/Database source:UniProtKB:Q8C0E3|ens)A5PJZ4(Evidence code:IEA/Database source:GO:0004842)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1B7Q7(Evidence code:IEA/Database source:UniPathway:UPA00143)A7MBJ7(Evidence code:IEA/Database source:GO:0004842)F1MBS7(Evidence code:IEA/Database source:GO:0004842)Q3SZD5(Evidence code:IEA/Database source:InterPro:IPR038914)A5PJF0(Evidence code:IEA/Database source:InterPro:IPR033097)A3KN22(Evidence code:IEA/Database source:GO:0004842)Q17QG5(Evidence code:IEA/Database source:UniPathway:UPA00143)Q08DB6(Evidence code:IEA/Database source:GO:0004842), MARCH8 KLHDC7A FBXO45 MARCH5 RNF128 UBE2Z KLHL35 STUB1 ASB2 ASB14 CUL1 BRCA1 ASB10 ANKIB1 ITCH FBXO40 MYCBP2 UBE2D2 CUL3 CAND1 TRIM37 KLHL34 RNF112 KLHL26 SKP1 RNF31 NFE2L2 UBE2L3 LOC780968 RBX1 ARRDC1 BIRC6 PJA1 SYVN1 PCNP TRAF6 HERC2 TRIM23 NEDD4L CBLC UHRF1 PINK1 WWTR1 FBXL12 VCPIP1 KLHL13 RC3H2 RNF139 CDC27 LOC516599 CUL2 UBE4B MIB2 RNF220 KEAP1 UBE2K TRIM47 HECTD3 NEDD4 TRIP12 KLHL18 MALT1 DCAF15 BARD1 UBE2M UBE2G2 HERC4,BP,67,67 of 137,2.94,48.91,1.087E-28,1.074E-26
GO:0003774,motor activity,F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR001609|I)G3MXV5(Evidence code:IEA/Database source:UniRule:UR000401007)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)A7MBA1(Evidence code:IEA/Database source:UniRule:UR000401007)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)P10568(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MM57(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q3MHM9(Evidence code:IEA/Database source:UniRule:UR000401007)E1BGB0(Evidence code:IEA/Database source:UniRule:UR000401007)E1BC41(Evidence code:IEA/Database source:UniRule:UR000401007)E1BA80(Evidence code:IEA/Database source:InterPro:IPR001609)G5E5S3(Evidence code:IEA/Database source:UniRule:UR000401007)E1BFA7(Evidence code:IEA/Database source:UniRule:UR000401007)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR001609|I)A7E3C1(Evidence code:IEA/Database source:UniRule:UR000401007)Q27966(Evidence code:IEA/Database source:InterPro:IPR001609|I)G5E5V6(Evidence code:IEA/Database source:InterPro:IPR002928)F1MX93(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR001609|I)A5D7N6(Evidence code:IEA/Database source:UniRule:UR000401007)Q0II58(Evidence code:IEA/Database source:UniRule:UR000401007)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q17R14(Evidence code:IEA/Database source:InterPro:IPR001609|I)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)Q32WS5(Evidence code:IEA/Database source:InterPro:IPR002928)F1MG13(Evidence code:IEA/Database source:InterPro:IPR001609)E1BBN7(Evidence code:IEA/Database source:UniRule:UR000401007)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)G3N1E4(Evidence code:IEA/Database source:UniRule:UR000401007)F1MNK8(Evidence code:IEA/Database source:UniRule:UR000401007)F1MMC7(Evidence code:IEA/Database source:InterPro:IPR001609|I)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243), LOC101902172 MYO5A KIF13A DYNLL1 KIFC1 DYNLL2 MYO1A MYH14 MYO5B KIF5B KIF13B KIF15 MYO18B KIF14 KIFC3 MYO7B KIF5A MYO1C CGNL1 MYO5C MYO6 KIF23 KIF5C LOC101905447 MYO9A MYO9B MYO1D DYNLT1 CGN MYO15A KIF1B MYO18A DYNLRB1 DYNC1I2 KIF26A KIF26B MYO1F MYH11 DCTN2,MF,39,39 of 29,1.71,134.48,2.327E-28,2.255E-26
GO:0005813,centrosome,E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)F1MC03(Evidence code:IEA/Database source:InterPro:IPR029560)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A5D7P5(Evidence code:IEA/Database source:UniProtKB:Q9BSJ2|ens)F1MWN4(Evidence code:IEA/Database source:InterPro:IPR030516)A2VDZ4(Evidence code:IEA/Database source:UniProtKB:O00444|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q2KII9(Evidence code:IBA/Database source:PANTHER:PTN000293992)Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q96FJ2|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:A0A024R0F8)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:P18564|ens)F1MM88(Evidence code:IEA/Database source:UniProtKB:Q8TD19|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8TCU4|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8N157)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1BQ19(Evidence code:IEA/Database source:InterPro:IPR029664)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)Q3T140(Evidence code:IEA/Database source:UniProtKB:Q9NP97|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q96GX5)E1BKZ3(Evidence code:IEA/Database source:InterPro:IPR031887)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)G3N2H6(Evidence code:IEA/Database source:UniProtKB:Q0P6D6|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)E1BC48(Evidence code:IEA/Database source:InterPro:IPR028750)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)E1BLZ4(Evidence code:ISS/Database source:UniProtKB:Q68DK2)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)A2VDN5(Evidence code:IEA/Database source:UniRule:UR000107246)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)P61420(Evidence code:ISS/Database source:UniProtKB:P61421)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BFA7(Evidence code:IEA/Database source:UniProtKB:Q9BVG8|ens), RAB23 PRKACB CDK6 VPS4B BICD2 AXIN2 CEP295 SIRT2 TUBGCP2 SFI1 PLK4 PCM1 WRN RGS14 CLIC4 DYNC1LI1 DYNLL2 PKHD1 GPSM2 ITGB6 NEK9 PDE4D CKAP5 ALMS1 AHI1 CDK1 ARL2 NIN BRCA2 E2F1 BRSK2 DYNLRB1 PCNT DCTN2 MASTL SDCCAG8 CDK5RAP2 GNAI1 CDC27 PRKAR2A CCDC15 PLK3 USP20 CEP350 CRMP1 MVB12A ZFYVE26 PPP2R5A RANBP2 DCTN3 RAD18 KIF23 ACTR1A SPAST PSEN1 ATP6V0D1 NUMA1 KIFC3,CC,58,58 of 99,2.54,58.59,3.856E-28,3.669E-26
GO:0016043,cellular component organization,E1B718(Evidence code:IEA/Database source:InterPro:IPR010472)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010472)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010472)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010472)G3N135(Evidence code:IEA/Database source:InterPro:IPR010472), FMNL3 DAAM1 DIAPH3 FMNL1 FMNL2,BP,5,5 of 1191,0.22,0.42,8.347E-28,7.802E-26
GO:0003779,actin binding,G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)E1BKQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MCY2(Evidence code:IEA/Database source:InterPro:IPR029984)O46385(Evidence code:IEA/Database source:InterPro:IPR003128|I)F1MMQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MT60(Evidence code:IEA/Database source:InterPro:IPR013998)E1BL04(Evidence code:IEA/Database source:InterPro:IPR012510|I)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010472|I)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR002108)F1MKE9(Evidence code:IEA/Database source:InterPro:IPR016343)E1BPK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BET5(Evidence code:IEA/Database source:InterPro:IPR026648)E1BLT3(Evidence code:IEA/Database source:InterPro:IPR016343)G3MXH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q17R14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q32LP2(Evidence code:IEA/Database source:InterPro:IPR008954|I)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737)F1MX93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BE25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494)E1BA80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BDP6(Evidence code:IEA/Database source:InterPro:IPR003128|I)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q56JV6(Evidence code:IEA/Database source:InterPro:IPR002108|I)F1MLR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939)F1MG13(Evidence code:IEA/Database source:InterPro:IPR035487)F1N611(Evidence code:IEA/Database source:InterPro:IPR008379)Q0III9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)A5D7L9(Evidence code:IEA/Database source:InterPro:IPR013998)P10568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MGT3(Evidence code:IEA/Database source:InterPro:IPR030059|I)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A5PK55(Evidence code:IEA/Database source:InterPro:IPR028433)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010472|I)B6Z9Q5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)G3MZH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)G3N135(Evidence code:IEA/Database source:InterPro:IPR010472)F6Q0K7(Evidence code:IBA/Database source:PANTHER:PTN002204142)G3MXG3(Evidence code:IEA/Database source:InterPro:IPR027717)A6QLN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q1JP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)A2VDK6(Evidence code:IEA/Database source:InterPro:IPR003124)E1BNV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010472|I)G3N3E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)E1BIG2(Evidence code:IEA/Database source:InterPro:IPR008954|I)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BGT8(Evidence code:IEA/Database source:InterPro:IPR029901|I)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)F1MMC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1B718(Evidence code:IEA/Database source:InterPro:IPR010472|I), MICAL3 MYO18A PHACTR4 SVIL MYO5B NEB XIRP2 DIAPH3 GIPC1 DSTN SPTB MYO6 SSFA2 SPTBN4 MYO9A KCNMA1 MYO1D SYN1 RDX MYO1C UTRN CORO7 MYO5C ARPC5L ACTN2 FLNC SHROOM3 MYO18B VILL TRPM7 MYH14 TWF1 MYO7B MICAL2 MYO15A EPB41L1 ACTN3 NRAP MYO1A MTSS1L LRRK2 PARVA FMNL1 SHROOM2 MYO5A SSH2 FMNL2 SPATA32 CCDC88A MYH11 ARPC1A WASF2 MYO9B DAAM1 SPTBN5 EPS8L1 NF2 CYFIP1 SPIRE1 EPS8 MKL1 MYO1F FMNL3,MF,63,63 of 124,2.76,50.81,8.573E-28,7.873E-26
GO:0006366,transcription by RNA polymerase II,A7MB06(Evidence code:IEA/Database source:GO:0001077)E1BHB8(Evidence code:IEA/Database source:GO:0001077)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)A2VDR9(Evidence code:IEA/Database source:GO:0001077)Q2HJ84(Evidence code:IEA/Database source:GO:0001228)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)P17667(Evidence code:IEA/Database source:GO:0001228)Q32PE0(Evidence code:ISS/Database source:UniProtKB:P61218)E1BDX4(Evidence code:IEA/Database source:GO:0001228)Q2KIM2(Evidence code:IEA/Database source:GO:0001228)F1MCY1(Evidence code:IEA/Database source:GO:0001077)Q7YRX0(Evidence code:IEA/Database source:GO:0001077)F1MXR2(Evidence code:IEA/Database source:GO:0001077)E1B8D8(Evidence code:IEA/Database source:GO:0001077)A4FUE0(Evidence code:IEA/Database source:GO:0001077)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BLU8(Evidence code:IEA/Database source:GO:0001077)F1MIK5(Evidence code:IEA/Database source:GO:0001077)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MBH4(Evidence code:IEA/Database source:GO:0001228)F1MKW9(Evidence code:IEA/Database source:GO:0001205)E1BCF7(Evidence code:IEA/Database source:GO:0001228)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)Q0VCF8(Evidence code:IEA/Database source:GO:0001077)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BC39(Evidence code:IEA/Database source:GO:0001228)E1BAD4(Evidence code:IEA/Database source:GO:0001228)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BGZ3(Evidence code:IEA/Database source:GO:0001228)Q32KX6(Evidence code:IEA/Database source:GO:0001228)Q2KJC1(Evidence code:IEA/Database source:GO:0001228)A2VDU4(Evidence code:IEA/Database source:GO:0001228)A0JNC9(Evidence code:IEA/Database source:GO:0001077)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BD25(Evidence code:IEA/Database source:GO:0001077)E1BGF3(Evidence code:IEA/Database source:GO:0001205)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000684)E1B7I2(Evidence code:IEA/Database source:GO:0001077), SP7 RAX SALL4 ZNF750 PKNOX1 ERCC2 MYF5 POLR2F ZBTB17 EAF2 GLI2 RAX2 ONECUT2 HOXA7 MEIS1 SRF BCL11A POU4F2 SOX1 LEF1 RREB1 FOXF1 NFKB1 DLX2 GATA6 SOX4 HIVEP1 ESRRG RUNX1 HIVEP3 ARID3A TFDP2 CDC5L NR1I2 SP1 ZNF516 BCL11B HCFC1 POLR2A ETV2,BP,40,40 of 34,1.75,117.65,1.109E-27,1E-25
GO:0005768,endosome,Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A5PK00(Evidence code:ISS/Database source:UniProtKB:Q86VN1)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A6QLR4(Evidence code:ISS/Database source:UniProtKB:Q14254)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:F1PRN2)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635134)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)Q1RMR9(Evidence code:IBA/Database source:PANTHER:PTN000860688)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q0VD59(Evidence code:ISS/Database source:UniProtKB:Q5T0T0)P11019(Evidence code:ISS/Database source:UniProtKB:P50518)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)Q08DI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A6QQ47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q1RMW2(Evidence code:ISS/Database source:UniProtKB:Q3UFJ6)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)G5E657(Evidence code:IEA/Database source:UniProtKB:Q9NQE7|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BK71(Evidence code:IBA/Database source:PANTHER:PTN000860688)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635134)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q08DN8(Evidence code:ISS/Database source:UniProtKB:O75955)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56817), UBXN6 TOM1 ABHD17C ITGB1 RNF112 RAPGEF2 CHMP2B MVB12A TLR4 VPS35 BIRC6 STX7 LRRK2 VPS36 TMEM59 FLOT2 SNX3 TSG101 MYO1D SNX8 CPNE6 CHMP1B VPS26A CFTR PTPRN GRB2 CHMP4A ZFYVE27 NPC1 RAB37 ANKFY1 PACSIN2 PTPN23 VPS25 SNX12 RAB4A CHMP3 CD63 MARCH8 ATP6V1E1 PKN1 RAP2C VPS51 TMEM184A SORL1 ARF6 PRSS16 SH3GL1 CHMP4B ITM2B PACSIN3 VPS28 STEAP4 RAB3A RAB26 CUBN VPS4B HPS6 VPS41 FLOT1 LAMP1 TMEM106B TFRC ASTN1 ARL8B SPAST VPS29 SNX27 VTA1 DGKQ BACE1,CC,71,71 of 165,3.11,43.03,1.227E-27,1.088E-25
GO:0032502,developmental process,E1BJB4(Evidence code:IEA/Database source:InterPro:IPR031136)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745), RPGRIP1L PPP2R2A,BP,2,2 of 1033,0.09,0.19,2.591E-27,2.26E-25
GO:0005730,nucleolus,P63097(Evidence code:IEA/Database source:UniProtKB:P63096|ens)Q17QL4(Evidence code:IEA/Database source:UniProtKB:A0A024R9Y7)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)F1MMU4(Evidence code:IEA/Database source:UniProtKB:Q92522|ens)Q9TU47(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MKS6(Evidence code:IEA/Database source:UniProtKB:J3KNS1|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)F6RRD7(Evidence code:IEA/Database source:UniProtKB:Q8IXW5|ens)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BNA1(Evidence code:IEA/Database source:UniProtKB:Q5JTH9|ens)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q9Y4G2|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P30291|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)A5D7J3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q3TPJ7|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)E1BC24(Evidence code:IEA/Database source:UniProtKB:Q9NU22|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)E1B7T1(Evidence code:IEA/Database source:UniProtKB:Q7Z7B0|ens)E1BGE2(Evidence code:IEA/Database source:UniProtKB:O75691|ens)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q647I9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q9D4H8|ens)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q0IIK5(Evidence code:IBA/Database source:PANTHER:PTN000618218)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433607)A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)Q3MI00(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000618218)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:B0LPF3|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:A0A024R8V6)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)Q3T0M9(Evidence code:ISS/Database source:UniProtKB:P40617)F1N397(Evidence code:IEA/Database source:UniProtKB:A0A140VJD0)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T087(Evidence code:ISS/Database source:UniProtKB:P62913)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)Q28141(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BDV5(Evidence code:IEA/Database source:UniProtKB:C9JFV4|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:F8VVT9|ens)Q2NL22(Evidence code:IBA/Database source:PANTHER:PTN000618218)A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), GNAI1 MAGED2 OSBP H1FX EIF6 AGTPBP1 BLM DDX20 RPAP2 PPP1CB BCL9L RPS19 ABL1 RRP12 PLEKHM1 SUZ12 DGCR8 WEE1 PLK3 MALT1 TAOK2 KNOP1 MIDN CKAP5 WRN HSPA9 SIRT2 TSG101 SMG6 ATF6B ACAT2 SDCBP2 MDN1 NUDT16 FILIP1 UTP20 DDX3Y NLRP5 CUL2 MOB1B WDFY3 ATM DDX1 INTS3 GOLGA3 TRIM68 DHX37 PLK4 DCTN3 CHD7 DNAJB1 DDX4 EIF4A2 IKBKAP PARP1 GRB2 USP36 DDX3X MYO1C SAPCD2 XPO1 TRA2A CPS1 ARL4A LRWD1 PPP1CC RPL11 ARL2 DHX9 ADARB1 ARFGEF1 GLI2 PELP1 GCFC2 NF2 AGAP2 EIF4A3 RPS9 PPID PRKDC KANSL3 PTPN6,CC,82,82 of 232,3.6,35.34,6.087E-27,5.223E-25
GO:0003700,DNA-binding transcription factor activity,Q95115(Evidence code:IEA/Database source:InterPro:IPR001217|I)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)A6QLP0(Evidence code:IEA/Database source:InterPro:IPR001766|I)F1MU53(Evidence code:IEA/Database source:InterPro:IPR003309)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR001699|I)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR000327|I)A6QNK4(Evidence code:IEA/Database source:InterPro:IPR000580)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)E1BE02(Evidence code:IEA/Database source:InterPro:IPR003316)F1MBH4(Evidence code:IEA/Database source:InterPro:IPR001766|I)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)G3N2N6(Evidence code:IBA/Database source:PANTHER:PTN001225609)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR001827|I)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628)F1ML85(Evidence code:IEA/Database source:InterPro:IPR033348)E1B7I2(Evidence code:IEA/Database source:InterPro:IPR000418)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q3UH06|ens)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MC99(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR004827|I)E1BPS0(Evidence code:IEA/Database source:InterPro:IPR004827)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR039355)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR003309)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)E1BK57(Evidence code:IEA/Database source:InterPro:IPR001699|I)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR003894|I)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217|I)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR039355)E1B9X1(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR008967|I)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR017431|I)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)O02754(Evidence code:IEA/Database source:InterPro:IPR004827)Q3MHL6(Evidence code:IEA/Database source:InterPro:IPR000580)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR003894|I)F1N281(Evidence code:ISS/Database source:UniProtKB:Q7Z4V0-1)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)E1BGG6(Evidence code:IBA/Database source:PANTHER:PTN000289470)F1ML16(Evidence code:IEA/Database source:InterPro:IPR028424)G3MY92(Evidence code:IBA/Database source:PANTHER:PTN000358347)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN000677913)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)E1BG94(Evidence code:IEA/Database source:InterPro:IPR003316)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR030449)P61635(Evidence code:IEA/Database source:InterPro:IPR001217|I)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR000327)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004827|I)A6QPK5(Evidence code:IBA/Database source:PANTHER:PTN000927455)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004827|I)A6QNN4(Evidence code:IEA/Database source:InterPro:IPR003309)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR026607)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR003316|I), STAT5A LOC526488 FOXO4 ZNF446 TAF10 CTBP1 MGA ARID3A TCF20 ZNF367 POU3F1 TSC22D3 INSM1 E2F7 FOXF1 SOX17 ZFP37 SIM2 HOXA7 ESRRG AHR ETV2 RREB1 ZNF516 FOXI3 PURA ATF6B CREBRF ZBTB17 GATA6 PURB ZNF394 STRN3 TBX3 HIVEP3 SOX4 TAF4B STAT5B gata4 RAI1 RUNX1 ZHX3 IRF1 GLI2 CEBPA TSC22D1 BCL3 CBFA2T2 ZNF438 SALL4 SRF MKL1 LEF1 GCFC2 RFX5 HIC1 ASCL4 MNX1 ONECUT2 AHCTF1 E2F1 NR2F6 NFKB1 NR1I2 SP1 STAT3 Gli3 POU4F2 NFE2L2 TCF7L2 MAF LOC515042 DMRTC2 TFDP2,MF,74,74 of 187,3.25,39.57,6.384E-27,5.389E-25
GO:0044249,cellular biosynthetic process,F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842)Q2NL31(Evidence code:IEA/Database source:InterPro:IPR005251|I), PRPS1L1 PRPS2 MRI1,BP,3,3 of 1045,0.13,0.29,2.862E-26,2.378E-24
GO:0006139,nucleobase-containing compound metabolic process,G3X7J6(Evidence code:IEA/Database source:InterPro:IPR002562)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR006555)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002562)F1MUF5(Evidence code:IEA/Database source:InterPro:IPR000850), EXD3 ERCC2 WRN AK9,BP,4,4 of 1068,0.18,0.37,1.196E-25,9.778E-24
GO:0009058,biosynthetic process,A7YY67(Evidence code:IEA/Database source:InterPro:IPR002376|I)Q59A32(Evidence code:IEA/Database source:InterPro:IPR002376|I)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR004838|I)Q2YDJ9(Evidence code:IEA/Database source:InterPro:IPR005835)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR002376|I), ALDH1L1 GART TAT GMPPB ALDH1L2,BP,5,5 of 1113,0.22,0.45,1.459E-25,1.175E-23
GO:0006508,proteolysis,E1BFV4(Evidence code:IEA/Database source:InterPro:IPR001590)F1MWW8(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A1A4Q9(Evidence code:IEA/Database source:GO:0008235)Q27971(Evidence code:IEA/Database source:InterPro:IPR001300|I)A5D7S6(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BI31(Evidence code:IEA/Database source:InterPro:IPR001375|I)Q1LZE9(Evidence code:IEA/Database source:InterPro:IPR001254|I)G3X743(Evidence code:IEA/Database source:InterPro:IPR001930)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q0III2(Evidence code:IEA/Database source:InterPro:IPR001193|I)F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)Q5E998(Evidence code:IEA/Database source:InterPro:IPR000668)Q2HJH1(Evidence code:IEA/Database source:InterPro:IPR001948)P81425(Evidence code:IEA/Database source:InterPro:IPR001375|I)Q9TT93(Evidence code:IEA/Database source:InterPro:IPR001590)P12820(Evidence code:IEA/Database source:InterPro:IPR001548)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR001590)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)G3MZT7(Evidence code:IEA/Database source:InterPro:IPR001590)F1MRA8(Evidence code:IEA/Database source:InterPro:IPR001590)Q1LZ81(Evidence code:IBA/Database source:PANTHER:PTN000021568)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001254|I)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q29RY7(Evidence code:IEA/Database source:GO:0008233)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q5E9Z2(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR001096)B7TCH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BL29(Evidence code:IEA/Database source:InterPro:IPR004134)Q3ZC89(Evidence code:IEA/Database source:InterPro:IPR002468)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR001309|I)A4FUF1(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q08E55(Evidence code:IEA/Database source:InterPro:IPR000209|I)P12661(Evidence code:IEA/Database source:InterPro:IPR005151)E1BP91(Evidence code:IEA/Database source:InterPro:IPR001930)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR001590)G5E657(Evidence code:IEA/Database source:InterPro:IPR008758)E1B9Z9(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3T0Q2(Evidence code:IEA/Database source:GO:0004175)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)E1BIX3(Evidence code:IEA/Database source:InterPro:IPR001300|I)E1BBU4(Evidence code:IEA/Database source:InterPro:IPR001590)Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR001375|I)P80227(Evidence code:IEA/Database source:InterPro:IPR001375|I)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR000668)Q08DY9(Evidence code:IEA/Database source:InterPro:IPR001309|I)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR001300|I)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MBS7(Evidence code:IEA/Database source:InterPro:IPR001309)P42891(Evidence code:IEA/Database source:InterPro:IPR000718|I)F1MKS6(Evidence code:IEA/Database source:InterPro:IPR000834)Q2HJ40(Evidence code:IEA/Database source:InterPro:IPR001461|I)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR001590)G5E5C6(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08D90(Evidence code:IEA/Database source:InterPro:IPR001254|I)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN001124099)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180|I)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT92(Evidence code:IEA/Database source:InterPro:IPR001590)Q3SZH7(Evidence code:IEA/Database source:InterPro:IPR001930)E1BEQ4(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q24K02(Evidence code:IEA/Database source:InterPro:IPR001431)F1MQD1(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MCT1(Evidence code:IEA/Database source:InterPro:IPR000209|I)F2Y8Y4(Evidence code:IEA/Database source:GO:0004843)Q0IIA3(Evidence code:IBA/Database source:PANTHER:PTN000021568)F1MF35(Evidence code:IEA/Database source:InterPro:IPR001506|I)E1BER3(Evidence code:IEA/Database source:InterPro:IPR000834), ADAMTS14 TMPRSS6 PSMA7 NUDT16 CAPN2 PEF1 PSMB9 PSEN1 DPP9 PRSS23 RNPEP USP5 MBTPS2 NAALAD2 CTSV DNPEP DPP4 ADAMTS4 ACE XPNPEP1 ADAMTS18 USP20 PSMA3 LOC531521 ADAM7 PDCD6 TMPRSS2 BRCC3 PSMA4 FGL2 SPCS3 HABP2 PIGK USP9Y BLMH METAP2 OTUB1 CASP6 LOC100125946 MBTPS1 RBP3 NPEPPS ADAMTS12 PRSS16 TMPRSS9 TMEM59 PSMB3 MMP19 CAPN7 ADAM15 PREP APEH TINAGL1 CASP3 CAPN11 SEC11A MALT1 ECE1 AGTPBP1 BACE1 ADAMTS7 ACR PSMB10 KLK7 USP13 CBLC PSMB8 DPEP3 PSMB4 ADAMTS5 LTA4H LOC505658 IDE CAPN5 PCSK6 VCPIP1 SRI TLL2 CPXM2,BP,79,79 of 230,3.46,34.35,2.194E-25,1.74E-23
GO:0018105,peptidyl-serine phosphorylation,E1BFR5(Evidence code:IBA/Database source:PANTHER:PTN000683254)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P39951)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB:Q16644|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)A5PJL3(Evidence code:IEA/Database source:UniProtKB:P53778|ens)P35509(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)A7E3X2(Evidence code:IEA/Database source:UniProtKB:Q9HCP0|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)A7MB90(Evidence code:IEA/Database source:UniProtKB:P78368|ens)A1A4I4(Evidence code:IBA/Database source:PANTHER:PTN000683254)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)A4IFM7(Evidence code:IBA/Database source:PANTHER:PTN000680267)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)P05126(Evidence code:IBA/Database source:PANTHER:PTN000683254)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63085)P67827(Evidence code:IDA/Database source:), MASTL PRKACA MARK3 WNK1 SMG1 TNKS LMTK2 CDK1 PRKDC HIPK4 MAPKAPK3 RPS6KA2 MAPK12 CSNK1G3 ATM CAMK2A CSNK1G1 MAP3K10 CAMK2B RICTOR DCLK2 SMTNL1 GSK3A UHMK1 PRKCI CSNK1G2 PKN1 LRRK2 CAMK2D DGKQ MYLK2 PAK2 PINK1 MYLK3 MYLK4 PRKCB MAPK9 MAPK1 CSNK1A1,BP,39,39 of 40,1.71,97.5,4.335E-25,3.387E-23
GO:0008152,metabolic process,F1MLW9(Evidence code:IEA/Database source:InterPro:IPR002123)A8E657(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)Q5I598(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q95JH2(Evidence code:IEA/Database source:InterPro:IPR002123)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)A7YWF1(Evidence code:IEA/Database source:InterPro:IPR000873)Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR016039)A5D9G1(Evidence code:IEA/Database source:InterPro:IPR002618)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR005811)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139)A7E3D9(Evidence code:IEA/Database source:InterPro:IPR000873)Q08DD1(Evidence code:IEA/Database source:InterPro:IPR000917|I)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)E1BJM1(Evidence code:IEA/Database source:InterPro:IPR017438)F1MLE1(Evidence code:IEA/Database source:InterPro:IPR000873)P31754(Evidence code:IEA/Database source:InterPro:IPR011060)P11181(Evidence code:IEA/Database source:InterPro:IPR001078|I)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR017438)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q17QI3(Evidence code:IEA/Database source:InterPro:IPR002155|I)F1MFF6(Evidence code:IEA/Database source:InterPro:IPR002213)E1BPZ8(Evidence code:IEA/Database source:InterPro:IPR017849|I)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F1MIU7(Evidence code:IEA/Database source:InterPro:IPR000873)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR015590|I)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q17QK4(Evidence code:IEA/Database source:InterPro:IPR006439)A6QPY4(Evidence code:IEA/Database source:InterPro:IPR000917|I)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR001017)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)A5PKM0(Evidence code:IEA/Database source:InterPro:IPR003081)F1MPW1(Evidence code:IEA/Database source:InterPro:IPR000873)A6QLY4(Evidence code:IEA/Database source:InterPro:IPR000868|I)Q0VCR6(Evidence code:IEA/Database source:InterPro:IPR002123)A7YY67(Evidence code:IEA/Database source:InterPro:IPR015590|I)H7BWW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR016035)Q3ZBF9(Evidence code:IEA/Database source:InterPro:IPR006349)Q0VCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)P48644(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)E1BM45(Evidence code:IEA/Database source:InterPro:IPR017849|I)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139)F1MUX5(Evidence code:IEA/Database source:InterPro:IPR003081)P16386(Evidence code:IEA/Database source:InterPro:IPR002168|I)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)A6QNL8(Evidence code:IEA/Database source:InterPro:IPR016035)A7MBJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)G3N337(Evidence code:IEA/Database source:InterPro:IPR002618)Q3SZD3(Evidence code:IEA/Database source:InterPro:IPR002504|I)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021), GPAT2 AASS MTHFR AGPAT1 DNPH1 PFKM ACSS2 HMGCS1 UAP1 ACLY ALDH9A1 HYAL1 GRHPR ACSL4 ARSA MAN1A2 SPHK2 DIP2B UMPS DBT DGKQ PAH ACAT2 UGT2B10 PIGO MAN1B1 SLC27A3 ALDH1A3 ALDH1L2 EPHX2 SGSH PFKP LYZ1 CTBP1 IDE GART DHTKD1 GALK1 GSTM2 DIP2A ISOC1 TMEM68 ALDH1L1 HEXB PNPLA2 PDXP ATIC ALDH1A1 FUCA1 PIGN PHGDH LOC100295687 LIPE SPAST MCAT EDEM2 UAP1L1 NADK PAK1,BP,59,59 of 2613,2.59,2.26,2.603E-24,2.004E-22
GO:0000786,nucleosome,F1MUD2(Evidence code:IEA/Database source:InterPro:IPR000558|I)G8JL00(Evidence code:IEA/Database source:InterPro:IPR002119|I)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR002119|I)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818|I)F1MV26(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1B8G9(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3MYD7(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BC18(Evidence code:IEA/Database source:InterPro:IPR000558|I)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q5E9F8(Evidence code:IEA/Database source:InterPro:IPR000164|I)A5PK61(Evidence code:IEA/Database source:InterPro:IPR000164|I)G3N053(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3N068(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3N3L9(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818|I)F2Z4E8(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3MZR4(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1N5F3(Evidence code:IEA/Database source:InterPro:IPR000558|I)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR002119|I)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR002119|I)G3N2P2(Evidence code:IEA/Database source:InterPro:IPR000164|I)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR002119|I)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR001951|I)E1BGN3(Evidence code:IEA/Database source:InterPro:IPR000164|I)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BL49(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BGW2(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q32L48(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BH22(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q2KII5(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1N453(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BM22(Evidence code:IEA/Database source:InterPro:IPR000558|I)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818|I), HIST2H2BF LOC104975684 LOC614881 H1FX LOC525433 HIST3H2BB LOC100297725 LOC617043 HIST1H2AJ H2AFJ H3F3B H3F3C HIST1H2BA LOC614378 LOC613363 HIST1H1A HIST1H2BB LOC523702 LOC615183 HIST3H2A H2AFZ LOC613345 HIST1H2AC LOC619094 HIST2H3D HIST1H1D LOC614206 HIST1H2BJ HIST1H2BN HIST2H2AB HIST1H2BI HIST2H2BE LOC100300167 HIST1H1E,CC,34,34 of 28,1.49,121.43,4.772E-24,3.62E-22
GO:0000002,mitochondrial genome maintenance,Q2KIN6(Evidence code:IEA/Database source:UniProtKB:P39210|ens),MPV17,BP,1,1 of 862,0.04,0.12,6.5E-24,4.86E-22
GO:0005887,integral component of plasma membrane,Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR027689)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)P47803(Evidence code:IEA/Database source:UniProtKB:Q9Z2B3|ens)Q2KJ41(Evidence code:IBA/Database source:PANTHER:PTN001060286)Q3ZC83(Evidence code:IEA/Database source:InterPro:IPR030195)Q9GL65(Evidence code:IBA/Database source:PANTHER:PTN000687652)F1MP51(Evidence code:IBA/Database source:PANTHER:PTN000025348)F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN000660491)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)E1BMA2(Evidence code:IBA/Database source:PANTHER:PTN000025348)F1MIU3(Evidence code:IEA/Database source:InterPro:IPR038900)A7YY44(Evidence code:IBA/Database source:PANTHER:PTN000660850)O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230)F1MSN2(Evidence code:IBA/Database source:PANTHER:PTN001799275)A5D7H9(Evidence code:IBA/Database source:PANTHER:PTN000177662)G3N2I5(Evidence code:IEA/Database source:UniProtKB:D3W0D1|ens)Q3ZC26(Evidence code:IBA/Database source:PANTHER:PTN000213391)F1N5R0(Evidence code:IBA/Database source:PANTHER:PTN000177662)G3MW11(Evidence code:IBA/Database source:PANTHER:PTN002384094)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR002438)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)A5D7F4(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MEX4(Evidence code:IEA/Database source:InterPro:IPR027689)F1N4L1(Evidence code:IBA/Database source:PANTHER:PTN000894242)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982)F1MJZ6(Evidence code:IBA/Database source:PANTHER:PTN001060286)O18875(Evidence code:IEA/Database source:InterPro:IPR002984)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)E1BJW2(Evidence code:IBA/Database source:PANTHER:PTN000369696)F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens)F1MUC1(Evidence code:IBA/Database source:PANTHER:PTN002384094)Q1JQB3(Evidence code:IBA/Database source:PANTHER:PTN000660850)Q0VCP0(Evidence code:IBA/Database source:PANTHER:PTN000299690)Q05037(Evidence code:ISS/Database source:UniProtKB:P22459)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN001060286)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR016257)F1MJ94(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)O97711(Evidence code:IEA/Database source:InterPro:IPR028371)E1BAI2(Evidence code:IBA/Database source:PANTHER:PTN000039495)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)Q0VCU9(Evidence code:IEA/Database source:InterPro:IPR038900)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN000642960)E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001173583)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q32PI9(Evidence code:IEA/Database source:InterPro:IPR029870)G3N152(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MEC8(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000642960)E1BAW2(Evidence code:IBA/Database source:PANTHER:PTN000757746)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)F1N5Z0(Evidence code:IBA/Database source:PANTHER:PTN000440615)G3MW09(Evidence code:IBA/Database source:PANTHER:PTN002384094)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)Q58CZ7(Evidence code:IBA/Database source:PANTHER:PTN001060286)E1BDL0(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658000)F1MMU8(Evidence code:IEA/Database source:InterPro:IPR038900)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN000642960)E1B749(Evidence code:IBA/Database source:PANTHER:PTN000213391)O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q6BBL6(Evidence code:IEA/Database source:UniProtKB:O14493|ens), ALCAM TENM3 NPC1 RGR TSPAN14 SLC29A1 TLR4 KCNH5 RXFP3 BACE1 KCNH6 TMC5 F2R TRPC1 TACSTD2 SLC6A14 KLRF2 SLC5A11 SLC6A5 LOC523126 RTN4R SLC6A20 CDON PCDHGC3 TENM2 SLC4A2 PTK7 BOC TSPAN9 SLC6A8 HCN1 NLGN2 STEAP4 TMEM2 LOC515333 GPR4 SLC33A1 KCNA4 CD63 LGR4 VAMP5 EPHB4 PCDHA13 ABCA1 HAS2 KL TFRC CFTR LRRC26 TMC6 ATP2B2 GRM7 FCER1G MPZL1 PCDHB8 PCDH8 ATP13A5 LRRC32 ADORA2A AQP5 LOC509854 PTH1R TSPAN2 LOC786512 ABCC3 TMC3 ATP2B3 SLC5A9 TRPC2 PSEN1 CLDN4,CC,71,71 of 209,3.11,33.97,8.586E-23,6.33E-21
GO:0003723,RNA binding,Q17QN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q5E9A3(Evidence code:IEA/Database source:InterPro:IPR004088|I)E1BQ37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q5JB60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)Q3SYT9(Evidence code:IEA/Database source:InterPro:IPR004088|I)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q2YDI4(Evidence code:IEA/Database source:InterPro:IPR004088|I)A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)G3N065(Evidence code:IBA/Database source:PANTHER:PTN001128910)F1N301(Evidence code:IBA/Database source:PANTHER:PTN000007073)P10881(Evidence code:IEA/Database source:InterPro:IPR002344|I)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MRK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q17QV0(Evidence code:IEA/Database source:InterPro:IPR004088|I)E1BIA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433338)E1BM86(Evidence code:IEA/Database source:InterPro:IPR004088|I)F1MHP1(Evidence code:IEA/Database source:InterPro:IPR000061|I)F1MS84(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q08DJ3(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2KIE4(Evidence code:IEA/Database source:InterPro:IPR002478|I)A6QQP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103)E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)Q0VC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2KJ71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1N6Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BNB4(Evidence code:IEA/Database source:InterPro:IPR002004|I)F1MI56(Evidence code:IEA/Database source:InterPro:IPR004088|I)E1BJV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QR44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A2VE06(Evidence code:IEA/Database source:InterPro:IPR002942)A4IFC3(Evidence code:IEA/Database source:InterPro:IPR002004|I)A6QLE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)O97764(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)P06623(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3SYR7(Evidence code:IBA/Database source:PANTHER:PTN000183645)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BE82(Evidence code:IEA/Database source:InterPro:IPR001313|I)E1B7G5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)G3MZL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A4FV72(Evidence code:IEA/Database source:InterPro:IPR016304|I)E1B719(Evidence code:IEA/Database source:InterPro:IPR004088|I)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BFI4(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q24JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)Q56JX6(Evidence code:IBA/Database source:PANTHER:PTN000080571)Q28165(Evidence code:IEA/Database source:InterPro:IPR034911)A8NJ74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR006536)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MX04(Evidence code:IEA/Database source:InterPro:IPR003890)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I)F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I)A7Z025(Evidence code:IEA/Database source:InterPro:IPR019582)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)P61286(Evidence code:IEA/Database source:InterPro:IPR002004|I)Q2KJ34(Evidence code:IEA/Database source:InterPro:IPR003652|I)G3MZ78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q0P5L0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q0VCY7(Evidence code:IEA/Database source:InterPro:IPR034520)F1N0T4(Evidence code:IEA/Database source:InterPro:IPR002466)Q56JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)O19137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR002942|I)Q08DM8(Evidence code:IEA/Database source:InterPro:IPR033956)Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)A5D7S3(Evidence code:IEA/Database source:InterPro:IPR002905)Q3T087(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QLG1(Evidence code:IEA/Database source:InterPro:IPR002478|I)E1B908(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q08E07(Evidence code:IEA/Database source:InterPro:IPR034648)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR039109)Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245)A6QR01(Evidence code:IEA/Database source:InterPro:IPR005146)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)Q29RQ2(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q32PB9(Evidence code:IBA/Database source:PANTHER:PTN000103359)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q32LC3(Evidence code:IEA/Database source:InterPro:IPR006196)Q2YDE6(Evidence code:IEA/Database source:InterPro:IPR004088|I)F1MVN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q17R11(Evidence code:IEA/Database source:InterPro:IPR033103)A2PYH9(Evidence code:IEA/Database source:InterPro:IPR034126|I)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)A1A4K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694), SNRPN PCBP1 SFPQ NCL GPKOW PCBP2 PURB MEX3C EIF3B DHFR EIF4E1B ZNF385C RPL22 SSB NUDT16 SPEN MARS PCBP3 CLUH TDRD9 MEX3B U2SURP NOVA2 FUBP1 EIF3K AARS MCTS1 MYEF2 PUS10 PNPT1 RPS18 CTU1 TRA2A SETD1B LRPPRC PURA AARS2 PABPC1L ANKRD17 ZNF638 DGCR8 EIF4A2 RPS4Y1 PABPC4 TDRD7 IMPDH2 CRYZ CNP RPL9 DDX1 CDC5L SNRPE DHX34 DXO PUM1 RBM12B RBM28 PPIE ANKHD1 SMG6 DICER1 IGF2BP2 RPL23A TRUB1 RPS28 PABPN1 RBM34 HNRNPL EIF4H EIF4G1 PUS3 EIF5A2 PRPF8 DHX8 AGO3 DHX9 PABPC1 HBP1 CSTF2T UHMK1 RBM42 SRSF1 ADARB1 RPL35A CPSF4 RPS9 TSN SNRNP70 TRMT1L RPL11 SYNJ1 LOC515358 PABPN1L DHX37 CELF3 RPL30 NXF3 LRRC47 SUZ12 LSM4 PRPF40A KHDRBS1 RPL38 AGO4 EIF4A3 EIF3G EIF1AX HDLBP ESRP1 RANBP2 DZIP3 Msi1 RPUSD2 NSUN2,MF,114,114 of 520,5,21.92,9.753E-22,7.09E-20
GO:0004842,ubiquitin-protein transferase activity,E1BK47(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670)G3MX12(Evidence code:IEA/Database source:InterPro:IPR000569|I)A2VE03(Evidence code:IEA/Database source:InterPro:IPR000569|I)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR003613)E1BE13(Evidence code:IEA/Database source:InterPro:IPR022103)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR024162)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)E1BNY9(Evidence code:IEA/Database source:InterPro:IPR000569|I)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)Q0VD59(Evidence code:ISS/Database source:UniProtKB:Q5T0T0)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR027139|I)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)P61085(Evidence code:ISS/Database source:UniProtKB:P61086)F1MUH4(Evidence code:IEA/Database source:InterPro:IPR003613)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)Q1RMX2(Evidence code:ISS/Database source:UniProtKB:P62837)A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081)G3N1V7(Evidence code:IBA/Database source:PANTHER:PTN001973695)F1MJ10(Evidence code:IEA/Database source:InterPro:IPR000569|I)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1B7Q7(Evidence code:IEA/Database source:InterPro:IPR000569|I)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR026254)G3MX28(Evidence code:IBA/Database source:PANTHER:PTN001973695)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)F1MDC0(Evidence code:IEA/Database source:InterPro:IPR031127)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR010606|I)A7MBJ7(Evidence code:IBA/Database source:PANTHER:PTN001973695)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)Q32PG4(Evidence code:IEA/Database source:InterPro:IPR000569|I)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)E1BB00(Evidence code:IBA/Database source:PANTHER:PTN001194385)Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001973695)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN001973695)A5PJZ4(Evidence code:IEA/Database source:InterPro:IPR000569|I)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)Q08DB6(Evidence code:IEA/Database source:InterPro:IPR000569|I)E1BG23(Evidence code:IEA/Database source:UniProtKB:Q8C0E3|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens), KLHL35 RC3H2 HERC2 ITCH UBE4B BIRC6 CBLC RNF139 HUWE1 DZIP3 MARCH8 TRAF6 CUL3 BRCA1 UBE2K STUB1 LOC516599 UBE2D2 UBE2M KLHL34 NEDD4 KLHL13 BCOR MALT1 UBE2L3 UHRF1 TRIP12 RNF31 KLHDC7A TRIM23 ANKIB1 MIB2 KLHL18 RNF220 NEDD4L ASB14 ASB10 UBE2G2 KLHL26 KEAP1 HECTD3 MARCH5 HERC4 TRIM47 TRIM68,MF,45,45 of 81,1.97,55.56,1.539E-21,1.103E-19
GO:0055085,transmembrane transport,F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)Q3ZC26(Evidence code:IEA/Database source:InterPro:IPR001734)Q8MII5(Evidence code:IEA/Database source:InterPro:IPR013657)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)F1MS75(Evidence code:IEA/Database source:InterPro:IPR004841)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)F1MG24(Evidence code:IEA/Database source:InterPro:IPR026082)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR011527|I)E1BI45(Evidence code:IEA/Database source:InterPro:IPR006043)F1N5Z0(Evidence code:IEA/Database source:InterPro:IPR000425)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)G3MW12(Evidence code:IEA/Database source:InterPro:IPR011527)E1B968(Evidence code:IEA/Database source:InterPro:IPR002293)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)O18784(Evidence code:IEA/Database source:InterPro:IPR005821)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR005821)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR026082)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)E1BA07(Evidence code:IEA/Database source:InterPro:IPR011701)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)P02722(Evidence code:IEA/Database source:InterPro:IPR002067|I)P35071(Evidence code:IEA/Database source:InterPro:IPR011527)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)Q1JQC7(Evidence code:IEA/Database source:InterPro:IPR005828)A5D7H9(Evidence code:IEA/Database source:GO:0015293)E1BF03(Evidence code:IEA/Database source:GO:0022829)A1A4L2(Evidence code:IEA/Database source:GO:0015293)E1B749(Evidence code:IEA/Database source:InterPro:IPR001734)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR005821)G3MW09(Evidence code:IEA/Database source:InterPro:IPR011527)F1MS08(Evidence code:IEA/Database source:InterPro:IPR004841)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)O62826(Evidence code:IEA/Database source:InterPro:IPR005821)F1MD64(Evidence code:IEA/Database source:GO:0008381)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)G3N271(Evidence code:IEA/Database source:InterPro:IPR006042|I)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR011527)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)Q08DK7(Evidence code:IEA/Database source:InterPro:IPR002067)G3MW11(Evidence code:IEA/Database source:InterPro:IPR011527)Q1LZD6(Evidence code:IEA/Database source:GO:0042626)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)Q28204(Evidence code:IEA/Database source:InterPro:IPR005821)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)A6QR09(Evidence code:IEA/Database source:InterPro:IPR002067)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006042|I)Q95JC7(Evidence code:IEA/Database source:GO:0015293)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP51(Evidence code:IEA/Database source:InterPro:IPR005821)G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689)E1BM97(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005821)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR005292|I)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821), CACNA1E SLC5A11 SLC35B1 SCN10A SLC12A1 KCNF1 ABCA1 LOC515333 SLC23A1 AQP5 CACNA1B LOC100337053 SLC7A2 CACNA1S TRPC1 ITPR2 ABCA7 CACNA1F SLC17A8 CACNA1C CACNA1H KCNG2 SLC25A4 CFTR KCNC4 SLC22A23 SLC6A14 PANX3 SLC6A20 SLC5A9 KCNA4 KCNH6 LOC509854 SLC12A2 TPCN2 TRPC2 PIEZO1 TRPM7 LOC100337457 LOC100299180 SCN11A SLC25A29 LOC523126 ABCC5 ITPR1 RYR2 SCN5A KCNMA1 KCNC3 SLC25A26 RYR1 SCN8A LOC100298868 SLC1A5 KCNG4 KCNH5 SLC39A6 HCN1 TRPC3 CACNA1D CACNA1A SCN3A ABCC3 TRPM4,BP,64,64 of 183,2.81,34.97,2.887E-21,2.042E-19
GO:0006950,response to stress,Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404),TRAP1,BP,1,1 of 762,0.04,0.13,3.878E-21,2.706E-19
GO:0000287,magnesium ion binding,F1MQE1(Evidence code:IEA/Database source:InterPro:IPR016239)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842|I)Q5EAC2(Evidence code:ISS/Database source:UniProtKB:P48637)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR001697|I)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:P60487)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164)A5PJL6(Evidence code:IEA/Database source:InterPro:IPR012000)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A5PJL3(Evidence code:IEA/Database source:UniProtKB:P53778|ens)E1BN61(Evidence code:IEA/Database source:InterPro:IPR016239)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842|I)Q08DW2(Evidence code:IEA/Database source:InterPro:IPR005946)Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR016239)E1BH93(Evidence code:IEA/Database source:InterPro:IPR015022)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BN72(Evidence code:IEA/Database source:UniProtKB:Q8IY84|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR005946)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MS56(Evidence code:IEA/Database source:InterPro:IPR016066)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR001697|I)A7MBG0(Evidence code:IEA/Database source:UniRule:UR000106960), RPS6KA4 PRPS1L1 GSS TDG PKLR NUDT16 PDCD6 PDXP WEE1 HACL1 ATP8B1 STK26 PINK1 WRN MAPK12 RPS6KA5 PRPS2 PRPSAP1 DXO COMT ABL1 RPS6KA2 MAST4 STK3 NIM1K PRKACA PRPSAP2 RAP2A PRKACB DYRK2 ENO4 ATP11A GNAI1 RAN IMPA1 BRSK2 PGM3 PKM ADSS,MF,39,39 of 58,1.71,67.24,4.819E-21,3.318E-19
GO:0000978,RNA polymerase II proximal promoter sequence-specific DNA binding,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BGG6(Evidence code:IBA/Database source:PANTHER:PTN000289470)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:O00570|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:Q05925|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)A6H7J1(Evidence code:ISS/Database source:UniProtKB:P70661)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q12837|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:Q9Y2V3|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q8K1A6|ens)Q7YRX0(Evidence code:IEA/Database source:UniProtKB:Q96IS3|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens), TBX3 RUNX1 ZFHX3 MYF5 DHX9 RFX5 SP1 GLI2 SOX1 EN1 GLI1 ZNF750 INSM1 SOX4 LEF1 SRF CUX2 POU4F2 GATA6 RAX ETV2 AEBP2 SUZ12 CHD7 CC2D1A RAX2 LITAF TCF7L2 ZBTB17 MEIS1 HOXA7 E2F7 SP7 GCFC2 ONECUT2 BCL11B RREB1,MF,37,37 of 51,1.62,72.55,7.515E-21,5.108E-19
GO:0016070,RNA metabolic process,Q08DM8(Evidence code:IEA/Database source:InterPro:IPR033956),TSN,BP,1,1 of 737,0.04,0.14,1.916E-20,1.286E-18
GO:0006412,translation,A7MB16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q3T0V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)E1BLZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR011035)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)A6QLR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR011035)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592|I)Q3T148(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592|I)Q5E966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR005710)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR001266|I)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2KJG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)Q32LC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q5E938(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)F1MN49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)P0C2B7(Evidence code:IDA/Database source:)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)Q3T057(Evidence code:IEA/Database source:InterPro:IPR000218|I)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)Q3T099(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3T087(Evidence code:IEA/Database source:InterPro:IPR002132|I)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)Q3T076(Evidence code:IEA/Database source:InterPro:IPR001971|I)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)Q32KZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A7MBC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q76I82(Evidence code:IEA/Database source:InterPro:IPR000630|I)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)A7YW98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)F1N030(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q0VCX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648), EIF3B MCTS1 RPS18 RPS28 EIF4A2 EIF4G1 RPS7 EIF3K EIF3F EPRS RPL30 RPL35A LARS AARS2 QARS RPS27 EIF3M RPS27L EIF3I RPS9 AARS RPS19 EIF6 NARS RPL28 RPL9 EIF1AX EIF1 EIF5A2 EIF4H RPS4X MRPL52 RPS17 RPL23 RPL38 WARS2 RPL11 MRPL3 RPS14 LOC511302 RPL27 EIF3G RPS4Y1 RPL23A MTIF3 RARS2 MARS IARS RPS15A RPL22 RARS EIF4E1B ETF1,BP,53,53 of 130,2.32,40.77,2.832E-20,1.855E-18
GO:0031090,organelle membrane,A2VDT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67810(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), HPS6 SEC11A SPCS3,CC,3,3 of 830,0.13,0.36,2.836E-20,1.855E-18
GO:0019901,protein kinase binding,E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q96KP1|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F1MM88(Evidence code:IEA/Database source:UniProtKB:Q8TD19|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A6QQM1(Evidence code:IEA/Database source:InterPro:IPR012399)F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens)Q2TBI4(Evidence code:IEA/Database source:UniProtKB:Q12931|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q0VCF3(Evidence code:IEA/Database source:UniProtKB:Q9BRV8|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1BMW2(Evidence code:IEA/Database source:UniProtKB:P17426|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q6UVK1|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB:Q69ZA1|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BBI6(Evidence code:IEA/Database source:InterPro:IPR012399)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)P04695(Evidence code:IDA/Database source:)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)P81948(Evidence code:IEA/Database source:UniProtKB:P68366|ens)E1B847(Evidence code:IEA/Database source:UniProtKB:Q13233|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), EXOC2 WNK1 DLG1 PTPN23 NEK9 GRB2 CCNY SLC12A2 TRAP1 PPP1CC RPS19 CADPS TRAF6 LCK GATA6 RICTOR DAB2IP DUSP3 KIF13B NBEA ZBTB4 SIKE1 TPCN2 RACGAP1 SASH1 GCN1L1 DNM1 AP2A1 BAG5 FRMD5 PDCD10 CSPG4 CDK13 PAK2 DCTN2 PTPN6 CDK5RAP2 CCNYL1 RFFL JAK2 KIF14 MAPK4 GNAT1 UTRN TUBA4A MAP3K1 TCL1A STAT3,MF,48,48 of 106,2.11,45.28,5.363E-20,3.465E-18
GO:0031625,ubiquitin protein ligase binding,Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629506)E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)Q1KZG4(Evidence code:IEA/Database source:UniProtKB:P49789|ens)P11181(Evidence code:IEA/Database source:UniProtKB:P11182|ens)Q2KJ77(Evidence code:IEA/Database source:UniProtKB:Q9NZL4|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38646|ens)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)A7MBA2(Evidence code:IEA/Database source:UniProtKB:Q99460|ens)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629506)F1N1X8(Evidence code:IBA/Database source:PANTHER:PTN000629506)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BB00(Evidence code:IBA/Database source:PANTHER:PTN001194385)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629506)F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BIN5(Evidence code:IEA/Database source:InterPro:IPR001373|I)P23956(Evidence code:IEA/Database source:UniProtKB:P27449|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)P61085(Evidence code:ISS/Database source:UniProtKB:P61086)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens)Q58DU5(Evidence code:IEA/Database source:UniProtKB:P25788|ens)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)Q08DE9(Evidence code:IEA/Database source:InterPro:IPR001373|I)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)F1MYD0(Evidence code:IEA/Database source:InterPro:IPR001373|I)A3KN22(Evidence code:IBA/Database source:PANTHER:PTN000630367)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens), UBE2V2 USP13 PRKAR2A FHIT DBT HSPBP1 TRAF6 HSPA9 NAE1 AXIN2 PSMD1 ASB14 AXIN1 UBE2V1 UBE2Z TSG101 BTBD11 ASB10 UBE2G2 BTBD3 CUL3 ATP6V0C SPG20 PINK1 RFFL PIAS1 UBXN1 LRPPRC SPOPL RAD18 UBE2K DDX58 OTUB1 PSMA3 BTBD6 BAG5 CUL2 PCBP2 CUL1 UBE2M ARRDC1 PRKACB IKBKG,MF,43,43 of 83,1.89,51.81,8.781E-20,5.605E-18
GO:0061630,ubiquitin protein ligase activity,E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)E1BBN5(Evidence code:IEA/Database source:UniProtKB:Q8R516|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q0V7P2(Evidence code:IEA/Database source:InterPro:IPR031227)P61085(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q08DE9(Evidence code:IBA/Database source:PANTHER:PTN000231993)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BNY9(Evidence code:IBA/Database source:PANTHER:PTN000134256)E1BAK9(Evidence code:IEA/Database source:InterPro:IPR032832)A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens)F1MYD0(Evidence code:IBA/Database source:PANTHER:PTN000231993)E1BIN5(Evidence code:IBA/Database source:PANTHER:PTN000231993)F1N1X8(Evidence code:IBA/Database source:PANTHER:PTN000629506)F1N2S5(Evidence code:IEA/Database source:UniProtKB:Q8TEJ3|ens)A3KN22(Evidence code:IBA/Database source:PANTHER:PTN000630367)Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629506)E1BP63(Evidence code:IBA/Database source:PANTHER:PTN000280277)F1N1C5(Evidence code:IEA/Database source:InterPro:IPR031890)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129805)E1B7Q7(Evidence code:IBA/Database source:PANTHER:PTN000134256)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629506)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q17R11(Evidence code:IEA/Database source:InterPro:IPR033103)E1BCW1(Evidence code:IEA/Database source:InterPro:IPR039164)A2VE03(Evidence code:IEA/Database source:InterPro:IPR024928), MYCBP2 MIB2 TRAF6 RFFL PJA1 UBE2K CUL2 NEDD4 HUWE1 SYVN1 UHRF1 UBE2G2 RAD18 RNF112 CBLC MARCH8 CUL1 CUL3 UBE2Z SH3RF3 UBE2M UBE2V2 RNF139 FBXO40 UBE4B ANKIB1 LOC780968 TRIP12 UBE2V1 RNF165 DZIP3 UBR2 ITCH,MF,33,33 of 41,1.45,80.49,9.779E-20,6.166E-18
GO:0003777,microtubule motor activity,G3N1E4(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1N724(Evidence code:IEA/Database source:InterPro:IPR004273|I)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752|I)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR004273|I)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR004273|I)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR004273|I)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q2KII9(Evidence code:IEA/Database source:InterPro:IPR008467)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q2HJJ0(Evidence code:IEA/Database source:InterPro:IPR002151)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752|I), KIF26A DNAH11 KIF13A KIF14 KIF5A KIF15 DNAH5 KIF5C DNAH7 DYNC1H1 DNAH10 DNHD1 KIF2A KIF1B DYNC1LI1 KIF5B KIF26B KLC4 KIF23 KIFC1 KIFC3 KIF13B,MF,22,22 of 9,0.96,244.44,1.289E-19,8.03E-18
GO:0014069,postsynaptic density,Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q2KHT7(Evidence code:IEA/Database source:UniProtKB:P42677|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)E1BB27(Evidence code:IEA/Database source:UniProtKB:Q9D415|ens)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MJ11(Evidence code:IEA/Database source:UniProtKB:Q68FH0|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)A5PKD9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q8CIN4|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62269|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32LM6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens), RNF112 TSC2 LIN7C RPL30 RPS19 SYNGAP1 RPS27 PAK3 SYN2 RGS14 SCRIB FBXO45 DLGAP1 LIN7B PLEKHA5 BCR PKP4 VPS35 DLG1 ABHD17C PAK2 CAMK2A CAMK2G RPS18 DNM2 LIN7A BSN SHANK1 PALM,CC,29,29 of 28,1.27,103.57,1.567E-19,9.649E-18
GO:0007155,cell adhesion,P80746(Evidence code:IEA/Database source:InterPro:IPR000413)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)F1N416(Evidence code:IEA/Database source:InterPro:IPR020894)V6F7Z2(Evidence code:IEA/Database source:InterPro:IPR033029)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028443)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)P81282(Evidence code:IEA/Database source:InterPro:IPR000538)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR020894)Q2TA30(Evidence code:IEA/Database source:InterPro:IPR007007)Q01107(Evidence code:IEA/Database source:InterPro:IPR020894)Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)A6QLR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)P31836(Evidence code:IEA/Database source:InterPro:IPR009138)F1MUC5(Evidence code:IEA/Database source:InterPro:IPR039070)E1BF53(Evidence code:IEA/Database source:InterPro:IPR020894)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR020894)Q29RN1(Evidence code:IEA/Database source:InterPro:IPR028510)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)Q29423(Evidence code:IEA/Database source:InterPro:IPR000538|I)A6QQ97(Evidence code:IEA/Database source:InterPro:IPR000413)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR020894)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q28084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)P98167(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)F1MKY3(Evidence code:IEA/Database source:InterPro:IPR000538)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)F1N2J5(Evidence code:IEA/Database source:InterPro:IPR000538)O97711(Evidence code:IBA/Database source:PANTHER:PTN000530809)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR020894)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR020894)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR020894|I)P61625(Evidence code:IEA/Database source:InterPro:IPR000413)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR020894)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR020894)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR020894|I)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR020894)Q29442(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)F1MMH2(Evidence code:IEA/Database source:InterPro:IPR000413)E1BLS8(Evidence code:IBA/Database source:PANTHER:PTN000396109)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR000633|I)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN000445299)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR010307)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR020894)G3N152(Evidence code:IEA/Database source:InterPro:IPR020894)P53710(Evidence code:IEA/Database source:InterPro:IPR000413)A5PK55(Evidence code:IEA/Database source:InterPro:IPR028433)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)P13608(Evidence code:IEA/Database source:InterPro:IPR000538)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR020894|I)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR000633|I)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens), ITGAV ITGB1 CDH22 DSCAML1 PKP4 TOR1A MPDZ ALCAM VCAN FAT2 NINJ1 DSC1 F11R FLOT2 NCAM1 COL15A1 CDH7 FAT1 SORBS3 NLGN2 CD44 ITGAD LOC786512 NRXN1 COL4A3 ITGB6 ITGB7 SSPO SUSD5 SRC CD97 HAPLN4 HAS2 PCDH20 DCHS2 PCDH8 ITGAL CDHR1 PCDH1 PCDHGC3 PCDHA13 COL4A4 ITGA9 EMILIN1 HEPACAM CTNNA2 CD63 LAMA3 PSEN1 CDH11 PCDHB8 ITGA2 PARVA TINAGL1 ACAN DPP4 PCDH12 CTNNA1 EPHB4,BP,59,59 of 171,2.59,34.5,1.606E-19,9.776E-18
GO:0016887,ATPase activity,G3MW09(Evidence code:IEA/Database source:InterPro:IPR003439|I)A2VDN5(Evidence code:IBA/Database source:PANTHER:PTN000553509)P35071(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P35998)G3N1E4(Evidence code:IBA/Database source:PANTHER:PTN000649056)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR006544)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR003439|I)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)E1BAN2(Evidence code:IBA/Database source:PANTHER:PTN000553509)Q2NL05(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR011704)A4IFE6(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)E1BFA7(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BC41(Evidence code:IBA/Database source:PANTHER:PTN000648413)A5D7N6(Evidence code:IBA/Database source:PANTHER:PTN000648413)F1MY45(Evidence code:IEA/Database source:InterPro:IPR031046)F1MNE5(Evidence code:IBA/Database source:PANTHER:PTN000553509)E1BGB0(Evidence code:IBA/Database source:PANTHER:PTN000648413)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR011704)Q3SZ65(Evidence code:IEA/Database source:UniProtKB:Q14240|ens)Q0VD48(Evidence code:IBA/Database source:PANTHER:PTN000553509)F1N724(Evidence code:IEA/Database source:InterPro:IPR011704)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)G3MW12(Evidence code:IEA/Database source:InterPro:IPR003439|I)G3MW11(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q28141(Evidence code:IDA/Database source:)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR011704)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR003439|I)A7MBA1(Evidence code:IBA/Database source:PANTHER:PTN000648413)A1A4M8(Evidence code:IEA/Database source:UniProtKB:Q9H497|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)F1MG24(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1MIM5(Evidence code:IEA/Database source:InterPro:IPR011704)E1BC24(Evidence code:IEA/Database source:InterPro:IPR011704|I)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q4ZJV8(Evidence code:IEA/Database source:InterPro:IPR003439|I)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR030088), LOC509854 SPAST CFTR PSMC2 KIF26A LOC100299180 ATP13A5 ABCC3 BLM TOR1A LOC515333 ATP1A2 KATNAL2 KIF2A DYNC1H1 ABCE1 INO80 KIF1B KIFC3 KIF15 KIF23 CARNS1 FIGNL1 KIF13B DDX4 DNAH10 EIF4A2 VPS4B DNAH11 RUVBL1 LOC100337053 LOC523126 MYO9B KIF14 WRN DHX9 TOR1B DNAH5 ABCA7 KIFC1 TOR3A TDRD9 ABCA1 VWA8 MDN1 PTPA ABCG8 SMARCA2,MF,48,48 of 110,2.11,43.64,1.771E-19,1.066E-17
GO:0051252,regulation of RNA metabolic process,F1MS84(Evidence code:IEA/Database source:UniProtKB:A0A1W2P872),NOVA2,BP,1,1 of 703,0.04,0.14,2.116E-19,1.259E-17
GO:0050896,response to stimulus,G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)Q7YRX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)Q8WN91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P22571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716), LOC788626 LOC614090 GNAT1 RRH RAX2 RGR OR5M11 CDHR1 PDE6H OR13C3 LOC531090 OR51Q1 GNAT2,BP,13,13 of 1151,0.57,1.13,2.167E-19,1.274E-17
GO:0030496,midbody,G3X6L5(Evidence code:IEA/Database source:UniProtKB:Q96BM9|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)Q32LM0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A0JNJ3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1MF87(Evidence code:IEA/Database source:UniProtKB:Q96AY4|ens)E1BLZ4(Evidence code:ISS/Database source:UniProtKB:Q68DK2)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O95785|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P27214(Evidence code:ISS/Database source:UniProtKB:P50995)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)G3MWR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q14145|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)A6QQY2(Evidence code:IBA/Database source:PANTHER:PTN000697893), ARL8A PDXP PKN1 SH3GLB1 PKP4 KIF14 SEPT2 SPG20 RACGAP1 TTC28 ZFYVE26 CTNND1 CRMP1 WIZ GNAI1 PPP1CC CHMP4A DNM2 ANXA11 APC2 SVIL CLIC4 SPAST BIRC6 BCL3 SIRT2 SEPT7 CHMP4B MICAL3 KIF23 SEPT6 DCTN3 CDK1 KEAP1 PIN1 KLHL13,CC,36,36 of 55,1.58,65.45,2.842E-19,1.653E-17
GO:1903561,extracellular vesicle,Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens),ARRDC1,CC,1,1 of 696,0.04,0.14,3.12E-19,1.794E-17
GO:0015629,actin cytoskeleton,E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1B8H4(Evidence code:IEA/Database source:UniProtKB:Q9ULE3|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR017904|I)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)E1BP80(Evidence code:IEA/Database source:InterPro:IPR030637)E1BQ32(Evidence code:IEA/Database source:UniProtKB:Q64010|ens)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1B7T1(Evidence code:IEA/Database source:UniProtKB:Q7Z7B0|ens)E1B8E3(Evidence code:IEA/Database source:UniProtKB:Q86SG2|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q69Z38|ens)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR000633)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR000633)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O54834|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), NDC1 ARHGAP35 DHX9 DENND2A PDXP ONECUT2 ARHGAP21 TWF1 DSTN MYLK3 ZNF185 CRK ARPC1A BAIAP2L1 ABL1 FILIP1 ANKRD23 PEAK1 BAIAP2 CTNNA2 CTNNA1 KNTC1 ARHGAP6 TAOK2 ARPC5L TAX1BP3 DDX58,CC,27,27 of 23,1.18,117.39,3.551E-19,2.02E-17
GO:0005576,extracellular region,Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P23206(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q29442(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P81282(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P02668(Evidence code:IEA/Database source:InterPro:IPR000117)P46161(Evidence code:IEA/Database source:InterPro:IPR001855|I)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q95MI6(Evidence code:IEA/Database source:InterPro:IPR000187|I)A5PJL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)G3N183(Evidence code:IEA/Database source:InterPro:IPR000471)P20959(Evidence code:IEA/Database source:InterPro:IPR000867|I)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q70UZ7|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)C6KGD8(Evidence code:IEA/Database source:InterPro:IPR030773)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR001811|I)P98167(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QQN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q0VCP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QR60(Evidence code:IEA/Database source:InterPro:IPR018244)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BF06(Evidence code:IEA/Database source:InterPro:IPR008064)Q9GKN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P02465(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P26917(Evidence code:IEA/Database source:InterPro:IPR004250|I)P56830(Evidence code:IEA/Database source:InterPro:IPR000471)A6YT15(Evidence code:IEA/Database source:InterPro:IPR000827|I)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)P46165(Evidence code:IEA/Database source:InterPro:IPR001855|I)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)Q95LI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q32S24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q1RMH5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q2HJH1(Evidence code:IBA/Database source:PANTHER:PTN002004887)Q29RY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BLS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P58754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P12661(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q7SIB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P56831(Evidence code:IEA/Database source:InterPro:IPR000471)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q27967(Evidence code:IEA/Database source:InterPro:IPR010892)P02459(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MD40(Evidence code:IEA/Database source:UniProtKB:Q8C6K9|ens)Q28038(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P13608(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P07507(Evidence code:IEA/Database source:InterPro:IPR000294|I)P23389(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q2WGK0(Evidence code:IEA/Database source:InterPro:IPR001400|I)Q95106(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P03968(Evidence code:IEA/Database source:InterPro:IPR028210)Q8MJ29(Evidence code:IEA/Database source:InterPro:IPR000471)F1MLJ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)P0C6R3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0767)Q7SIB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BFV4(Evidence code:IEA/Database source:UniProtKB:B2RXX5|ens)Q28083(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F2FB42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MJR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)Q28084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305)A7MB18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A4IFB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P01175(Evidence code:IEA/Database source:InterPro:IPR000981|I)A7E2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964), ITM2B COL10A1 COL4A4 VCAN CSN3 DEFB3 HYAL1 CRH C1QTNF5 LOC104968438 IGFBP3 VWA2 MYDGF HSTN CXCL12 SSPO SMPDL3B OLFML3 CRISPLD1 LIPF CD63 TNFSF15 PRELP COL1A2 SST IFNT2 CCL28 NPC1 DEFB7 HMCN1 VIT ACE COL11A2 TFRC C1QC IDE DNPEP FGL2 HABP2 EMILIN1 LY96 RBP3 COL4A2 ADAMTS4 IFNT3 PRSS23 ADAMTS5 SPP2 COL2A1 COL6A5 MIA ACAN MGP CHGB PROK1 DPP4 PRP8 BDNF FGF1 IFNT SLIT2 NDNF CES4A SFTPD COL4A1 ADAMTS14 COL11A1 MUC5B COL8A2 PDGFC COL4A3 CHGA RNPEP NTN4 TECTB OXT C1QTNF6 COPA,CC,78,78 of 300,3.42,26,4.979E-19,2.802E-17
GO:0046777,protein autophosphorylation,E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:Q13554)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)F1N3K4(Evidence code:IEA/Database source:UniProtKB:P80192|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens), TAOK3 PRKACA CAMK2B SLK MAPKAPK3 EPHB4 TRPM7 CAMK2G CAMK2A STK26 PAK1 AAK1 LMTK2 UHMK1 PEAK1 MYLK2 ZAP70 MAP3K9 KIT ATM ABL1 PAK2 SMG1 HIPK4 SRC LRRK2 PASK,BP,27,27 of 24,1.18,112.5,7.061E-19,3.932E-17
GO:0035556,intracellular signal transduction,G3X7G7(Evidence code:IEA/Database source:InterPro:IPR002219)E1BA57(Evidence code:IEA/Database source:InterPro:IPR000591)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR016251|I)P05126(Evidence code:IEA/Database source:InterPro:IPR002219)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR001562)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR002219)A4IFM7(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR016239)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR001331)E1BB00(Evidence code:IEA/Database source:InterPro:IPR036036)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR028558)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001192|I)E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR016239)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR016251)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q4TVR5(Evidence code:IBA/Database source:PANTHER:PTN000357044)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q6UVK1|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR001331)Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR006019)F1MP30(Evidence code:IEA/Database source:InterPro:IPR002219)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)F1MY16(Evidence code:IEA/Database source:InterPro:IPR002219)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1BP72(Evidence code:IEA/Database source:InterPro:IPR002219)F1MVZ2(Evidence code:IBA/Database source:PANTHER:PTN000678822)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR002219|I)E1BN72(Evidence code:IBA/Database source:PANTHER:PTN000678822)E1BN32(Evidence code:IEA/Database source:InterPro:IPR003533|I)Q29450(Evidence code:IEA/Database source:InterPro:IPR001054|I)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN000680267)P08487(Evidence code:IEA/Database source:InterPro:IPR001192|I)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR000591|I)A7YY57(Evidence code:IEA/Database source:InterPro:IPR002219)F1N657(Evidence code:IEA/Database source:InterPro:IPR001331)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR002219)E1BJP2(Evidence code:IEA/Database source:InterPro:IPR002219)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)A7YVE7(Evidence code:IEA/Database source:InterPro:IPR002219)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A1A4I4(Evidence code:IBA/Database source:PANTHER:PTN000683254)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR002219)F1N6C1(Evidence code:IBA/Database source:PANTHER:PTN000584058)Q3SX45(Evidence code:IEA/Database source:InterPro:IPR036036)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR001331)E1BPX7(Evidence code:IEA/Database source:InterPro:IPR000591)E1BFR5(Evidence code:IBA/Database source:PANTHER:PTN000683254)F1MK99(Evidence code:IEA/Database source:InterPro:IPR002219)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR016251|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR002219)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR028749)E1B9B6(Evidence code:IBA/Database source:PANTHER:PTN000678822)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR001562)A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR001054|I)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR001331)E1BN61(Evidence code:IEA/Database source:InterPro:IPR016239)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR012234)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR002219)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR003533|I)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR001331|I)G8JKY1(Evidence code:IEA/Database source:InterPro:IPR036036)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR002219), PLEKHM1 DEPDC1 JAK1 PRKCB TEC BRAF MYLK2 RPS6KA4 ARHGEF12 ASB10 MYLK4 MYO9A PLCB3 PPP1R1C RPS6KA2 TYK2 MYLK3 CAMK2B DSTYK PSEN1 CSPG4 ECT2 SHC1 UNC13B GNA13 AKAP13 PTPN6 PINK1 CDC42BPB BRSK2 MYO9B NIM1K RP1L1 ADCY7 CAMK2D CAMK2A PLCG1 GNA12 PREX1 ARHGAP29 SPATA13 DGKQ RACGAP1 STK3 WNK1 RGS14 CIT SH2B2 LRRK2 PKN1 UNC13C LRRK1 ASB2 BCR RAPGEF4 MASTL UNC13A JAK2 ROCK2 OXSR1 NUAK1 RASAL1 GUCY1A3 MAP3K4 TIAM2 RPS6KA5 ZAP70 PRKCI DCLK2 KIT VAV2 ASB14 SRC CDC42BPA,BP,74,74 of 275,3.25,26.91,7.612E-19,4.194E-17
GO:0043565,sequence-specific DNA binding,F1MU40(Evidence code:IEA/Database source:InterPro:IPR017970)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BD77(Evidence code:IEA/Database source:InterPro:IPR017970)F1MBH4(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BCF7(Evidence code:IEA/Database source:InterPro:IPR017970)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BLB9(Evidence code:IEA/Database source:InterPro:IPR017970)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q08DM8(Evidence code:IEA/Database source:InterPro:IPR002848|I)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1BL97(Evidence code:IEA/Database source:InterPro:IPR029547)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR017970)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q99592)A6QLP0(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)Q32LB3(Evidence code:ISS/Database source:UniProtKB:Q7LFL8)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR017970)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)E1BGG6(Evidence code:IEA/Database source:UniProtKB:P48382|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)E1BAI9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MC99(Evidence code:IEA/Database source:InterPro:IPR001766|I)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR017970)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR017970)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MT17(Evidence code:IEA/Database source:InterPro:IPR017970)E1B7I2(Evidence code:IEA/Database source:InterPro:IPR000418)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR001275|I)Q7YRX0(Evidence code:IEA/Database source:InterPro:IPR017970)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q1MW18(Evidence code:IEA/Database source:InterPro:IPR017970)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BDU9(Evidence code:IEA/Database source:InterPro:IPR000679)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BHB8(Evidence code:IEA/Database source:InterPro:IPR017970)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR001387|I)F1MME0(Evidence code:IBA/Database source:PANTHER:PTN000388531)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR000679)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR000679)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), MNX1 MEIS1 ZFHX2 FOXF1 DLX2 E2F1 SHOX2 KDM6B ZNF516 HIVEP3 TSN CDC5L SOX13 LEF1 HOXA7 NFKB1 NR2F6 ZBTB18 FOXO4 SUZ12 CXXC5 IRX1 BCL11B SOX1 RFX5 PKNOX1 LOC526488 ANHX ZFHX3 RREB1 TBX3 FOXI3 EN1 MYF5 POU3F1 HIVEP1 CUX2 ETV2 GLI2 SNAPC4 ZBTB4 BCL11A NR1I2 ESRRG DMRTC2 RAX2 SALL4 LHX4 SP1 GATAD2B HIC1 SRF RAX POU4F2 TAF2 gata4 GATA6 SOX17,MF,58,58 of 173,2.54,33.53,9.599E-19,5.234E-17
GO:0003682,chromatin binding,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)E1BBH8(Evidence code:IEA/Database source:UniProtKB:Q96DN6|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)E1BKC4(Evidence code:IEA/Database source:InterPro:IPR033031)F1MM81(Evidence code:IEA/Database source:InterPro:IPR001025)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR001025)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)F1MNH3(Evidence code:IEA/Database source:UniProtKB:A2AVA0|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)A5PJQ1(Evidence code:IBA/Database source:PANTHER:PTN000336336)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)E1BLK1(Evidence code:IEA/Database source:InterPro:IPR001025)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1MME0(Evidence code:IBA/Database source:PANTHER:PTN000388531)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P52632)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)E1B9J3(Evidence code:IBA/Database source:PANTHER:PTN000286904)A5PK20(Evidence code:IDA/Database source:), SIRT6 LEF1 LRWD1 SIRT2 BRD2 MBD6 POU4F2 PYGO2 GLI1 TOP2B NIPBL BAHCC1 DDX1 ASH1L TPR SRF TSHZ1 SUZ12 SFPQ SVEP1 ATRX MB21D1 DEK ANKRD17 CDK1 CHD8 PRDM13 ARID3A PLAC8 MEIS1 HCFC1 POLQ PRKCB TNRC18 KMT2A PKN1 GATA6 TAF2 SHMT2 NFKB1 GLI2 TCF7L2 DLX2 STAT5B ZMYND8 POLG RAD21L1 HIST1H1E,MF,48,48 of 116,2.11,41.38,9.8E-19,5.288E-17
GO:0034645,cellular macromolecule biosynthetic process,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens),EIF4G1,BP,1,1 of 670,0.04,0.15,1.527E-18,8.156E-17
GO:2001141,regulation of RNA biosynthetic process,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens),NCOA3,BP,1,1 of 666,0.04,0.15,2.283E-18,1.207E-16
GO:0044267,cellular protein metabolic process,Q3SZH7(Evidence code:IEA/Database source:UniProtKB:P09960|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), LTA4H PSEN1,BP,2,2 of 715,0.09,0.28,2.405E-18,1.259E-16
GO:0005840,ribosome,E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)Q3T057(Evidence code:IEA/Database source:InterPro:IPR000218|I)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)A6QLG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR001266|I)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)Q3T087(Evidence code:IEA/Database source:InterPro:IPR002132|I)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)P0C2B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592)Q3T076(Evidence code:IEA/Database source:InterPro:IPR001971|I)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)A6QL80(Evidence code:IEA/Database source:UniProtKB:Q922H1|ens)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)Q76I82(Evidence code:IEA/Database source:InterPro:IPR000630|I)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)Q56JX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689), LOC511302 RPL23 RPL22 MRPL3 RPS18 RPL30 RPS4X RPS9 RPS19 RPL9 RPL11 RPS4Y1 MRPL52 RPS27L RPS14 RPL28 RPL35A PRMT3 RPS17 RPS15A RPS7 RPS28 RPS27 RPL38 RPL23A RPL27 RPS25,CC,27,27 of 26,1.18,103.85,2.622E-18,1.359E-16
GO:1903506,regulation of nucleic acid-templated transcription,E1BEZ8(Evidence code:IEA/Database source:GO:0003712),PTPN14,BP,1,1 of 663,0.04,0.15,3.626E-18,1.861E-16
GO:0018108,peptidyl-tyrosine phosphorylation,Q95M13(Evidence code:IEA/Database source:GO:0004713)F1MTD8(Evidence code:IEA/Database source:GO:0004713)E1BIE4(Evidence code:IEA/Database source:GO:0004713)F1N758(Evidence code:IEA/Database source:GO:0004713)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)Q58D16(Evidence code:IEA/Database source:GO:0004713)Q4TVR5(Evidence code:IEA/Database source:GO:0004713)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)E1BG90(Evidence code:IEA/Database source:GO:0004713)F1MQH2(Evidence code:IEA/Database source:GO:0004713)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)F1MRU0(Evidence code:IEA/Database source:GO:0004713)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1B8H0(Evidence code:IEA/Database source:GO:0004715)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)Q56JV6(Evidence code:IEA/Database source:GO:0004713)A3KMY9(Evidence code:IEA/Database source:GO:0004713), fgfr3 HCK EPHB4 ERBB4 TEC MATK DSTYK ABI1 DYRK2 EPHA6 ZAP70 KIT WEE1 FLT3 SRC LCK ABL1 PEAK1 PTPN6 TWF1 JAK1,BP,21,21 of 10,0.92,210,3.999E-18,2.032E-16
GO:0023051,regulation of signaling,A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR024162),CBLC,BP,1,1 of 654,0.04,0.15,5.056E-18,2.545E-16
GO:0006470,protein dephosphorylation,E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000242|I)A5D980(Evidence code:IEA/Database source:InterPro:IPR000242|I)P11064(Evidence code:IEA/Database source:InterPro:IPR002115|I)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens)P67774(Evidence code:IEA/Database source:GO:0004721)Q0P594(Evidence code:IEA/Database source:GO:0004721)Q3ZCM0(Evidence code:IEA/Database source:GO:0004722)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000242)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR020405|I)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR020422)Q58DC0(Evidence code:IEA/Database source:GO:0004721)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000242)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR008343|I)P61287(Evidence code:ISS/Database source:UniProtKB:P63087)E1BD03(Evidence code:IEA/Database source:InterPro:IPR015655)F1MG56(Evidence code:IEA/Database source:UniProtKB:P63151|ens)A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens)G5E526(Evidence code:IEA/Database source:GO:0008138)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q3ZBF9(Evidence code:IDA/Database source:)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000242|I)P48452(Evidence code:ISS/Database source:UniProtKB:Q08209)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000242), PTPN14 PTPN6 ACP1 CTDSP1 PPP2CA PPP2CB LCK PTPN5 PTPN23 PHPT1 DUSP3 SSH2 CPPED1 PTPRM DUSP7 PPP1CC PPM1D PPP2R2A PPP3CC PTP4A1 PPP1CB PPP2R5A PDXP PTPRA PPP3CA PTPRZ1,BP,26,26 of 24,1.14,108.33,5.626E-18,2.805E-16
GO:0008017,microtubule binding,E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776|I)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752)G3N1E4(Evidence code:IEA/Database source:InterPro:IPR001752)E1BC48(Evidence code:IEA/Database source:InterPro:IPR028750)E1BI79(Evidence code:IEA/Database source:InterPro:IPR009234)E1BAN2(Evidence code:IEA/Database source:UniRule:UR000107529)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752)A3KN15(Evidence code:IEA/Database source:UniProtKB:Q5KU39|ens)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752)A8E641(Evidence code:IEA/Database source:InterPro:IPR030626)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752)F1N1R8(Evidence code:IBA/Database source:PANTHER:PTN000347035)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170013)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170013)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170013)F1N3M8(Evidence code:IEA/Database source:InterPro:IPR015656|I)E1BF73(Evidence code:IEA/Database source:UniProtKB:Q3UHI0|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens), KIF15 GLI1 CDK5RAP2 KIF26B RGS14 PRNP KIF1B SPAST KIF5C KIF26A CEP350 APC2 KATNAL2 KIF23 KIF2A NAV3 KIF13B KIF5B NUMA1 EML2 KIFC3 KIF5A VPS41 KIFC1 DPYSL5 KIF13A EML4 DNM2 DNM1 KIF14 MX2 MAP1A CCSER2 RACGAP1,MF,34,34 of 55,1.49,61.82,9.875E-18,4.876E-16
GO:0006351,"transcription, DNA-templated",F1MVD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QNT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BK57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QLP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A2VDU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BJP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MU53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MKK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A8QQK8(Evidence code:IEA/Database source:InterPro:IPR005570)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P61635(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1ML85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)O02754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3N2D1(Evidence code:IEA/Database source:InterPro:IPR007759)E1BKB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3MHL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q7YRX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000722|I)Q95115(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR006110|I)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7Z017(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3MWI7(Evidence code:IEA/Database source:UniRule:UR000400705)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G5E5M1(Evidence code:IEA/Database source:InterPro:IPR003618|I)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A5PJW1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1N3S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0VCF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A5D7F6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3SYX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1N4U8(Evidence code:IEA/Database source:InterPro:IPR007759)F1MT17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BC39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MXR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3MYE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9TUM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3MYR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BLU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q5NUA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A0JND4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P17667(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q32S26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BAD4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BEP4(Evidence code:IBA/Database source:PANTHER:PTN000063846)Q32KX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BG94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9BE45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804), NCOA3 DYNLL1 SAP18 FAM120B TBX3 ZBTB8A GTF3C6 DHX9 FOXO4 CPNE1 DMRTC2 NR1I2 FHIT SRF ZNF446 SIM2 HEYL BRCA1 HBP1 POLR2H VPS25 ZNF148 STAT3 RPAP2 CIDEC AHR PRKCB CEBPA CHD8 HDAC5 ASXL3 MGA PTPRN TSC22D1 VPS36 RAX2 POLR2A STAT5A POLR2F PRMT5 MAPK13 MAF ZFPM1 IRF1 PHF3 MCTS1 MMS19 RUVBL1 KMT2A BCL3 INO80 ZBTB18 TAF10 AEBP2 NR2F6 SOX4 EGR4 PCBD1 MAML2 ZNF394 UHRF1 PARP1 DDX1 ASXL1 CUX2 ESRRG TAF8 ZNF750 ONECUT2 CDC5L PAXIP1 MECP2 STAT5B POU3F1 E2F7 ERCC2 POU4F2 NFE2L2 UBE2L3 SBNO2 IKBKAP PKN1 MYF5 RUVBL2 BRD2 IKBKG ZMYM5 RUNX1 ASH2L TFDP2 E2F1 INSM1 NFKBIZ,BP,93,93 of 435,4.08,21.38,1.574E-17,7.701E-16
GO:0004713,protein tyrosine kinase activity,Q58D16(Evidence code:IEA/Database source:InterPro:IPR020635)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR020635)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR020635|I)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR020635)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR020635)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR020635)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0829)P43481(Evidence code:IEA/Database source:InterPro:IPR020635)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR020635)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR020635)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR020635)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR020635)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR020635)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR020635)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR020635)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR020635)Q95M13(Evidence code:IEA/Database source:InterPro:IPR020635)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0829)F1N758(Evidence code:IEA/Database source:InterPro:IPR016245)A7MB57(Evidence code:IEA/Database source:InterPro:IPR020635)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), MATK LCK ABL1 EPHB4 FLT3 EPHA6 DSTYK KIT SRC ZAP70 JAK2 HCK TYK2 TEC JAK1 FRK fgfr3 WEE1 ERBB4 YES1 DYRK2 TWF1,MF,22,22 of 14,0.96,157.14,1.748E-17,8.47E-16
GO:0097367,carbohydrate derivative binding,Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR001347)F1MZY2(Evidence code:IEA/Database source:InterPro:IPR001347), GFPT2 GFPT1,MF,2,2 of 686,0.09,0.29,1.767E-17,8.487E-16
GO:0070588,calcium ion transmembrane transport,F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408)F1MWI8(Evidence code:IEA/Database source:GO:0005262)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR000699)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR002153|I)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408|I)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002077|I)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005445)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000699)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR002077|I)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000699)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR002077|I)O18784(Evidence code:IEA/Database source:InterPro:IPR002153|I)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR002077|I)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR002077|I)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR000699)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005447)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR030334)F1MRN7(Evidence code:IEA/Database source:GO:0005388)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002077|I)O62826(Evidence code:IEA/Database source:InterPro:IPR002153|I)Q9XT97(Evidence code:IEA/Database source:GO:0005262)F1MPF0(Evidence code:IEA/Database source:GO:0005262)E1BNX9(Evidence code:IEA/Database source:GO:0005262)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR000699), ATP2B3 GRIN3B ANO6 RYR1 TRPC3 ATP2B4 CACNA1E CACNA1H ITPR1 CACNA1D ITPR2 ATP2B2 CACNA1F TRPC1 CACNA1C CACNA1S RYR2 CACNA1A ATP2C2 ATP13A5 CACNA1B TRPC2 PSEN1 TRPM7 TRPM4 RYR3,BP,26,26 of 26,1.14,100,2.011E-17,9.57E-16
GO:0045892,"negative regulation of transcription, DNA-templated",E1BN44(Evidence code:IEA/Database source:UniProtKB:Q3UH06|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q9WUK6)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)F1N281(Evidence code:ISS/Database source:UniProtKB:Q7Z4V0-1)E1BA57(Evidence code:IEA/Database source:UniProtKB:Q5TB30|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q60749|ens)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q1RMU0(Evidence code:IEA/Database source:InterPro:IPR006989)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR013289)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR033277)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)P62194(Evidence code:IEA/Database source:UniProtKB:P62196|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens), RREB1 RPS6KA5 EMILIN1 LANCL2 PURA CUX2 MT3 ZHX3 SFPQ TBX3 CTBP1 DAB2IP ZBTB18 STRN3 TRAF6 SPEN ZNF438 DEPDC1 KHDRBS1 PURB SIRT2 TSG101 TMPRSS6 SMTNL1 NR1I2 CCAR2 NAB2 IRF1 LEF1 ATP8B1 CBFA2T2 BCOR SIRT6 CEBPA ZBTB4 NIPBL MAP3K10 FZD1 GON4L GATA6 HOXA7 E2F1 NACC1 BCL3 ARHGAP35 SMARCA2 PSMC5 TFDP2 PDCD4 CHMP1A FAM129B SIM2 NFKB1 CHD8 COPS2 SBNO2,BP,56,56 of 178,2.46,31.46,3.791E-17,1.788E-15
GO:0008233,peptidase activity,Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR010909)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR010909)F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR010909)Q3T0P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q5E998(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BFV4(Evidence code:IEA/Database source:InterPro:IPR010909)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MQD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9XTA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)B7TCH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P67810(Evidence code:IEA/Database source:InterPro:IPR001733)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q8R016|ens)Q29RY7(Evidence code:IEA/Database source:InterPro:IPR033083)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A4FUF1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MF35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MCT1(Evidence code:IEA/Database source:InterPro:IPR010909)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MXQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08D90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08DI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR001096)E1BEQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)G5E5C6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BIX3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645), SPCS3 ADAMTS7 DNPEP ADAMTS18 NAALAD2 ADAMTS12 CASP6 CASP3 USP20 USP5 CTSV USP13 OTUB1 ADAMTS14 NPEPPS DPEP3 PSMA3 CAPN5 MBTPS2 TMPRSS9 PSMB9 ADAMTS5 PREP TMPRSS2 ADAMTS4 PSMA7 CAPN2 MALT1 USP9Y PSMB3 SEC11A IDE PSMB4 HABP2 BLMH FGL2 BRCC3 PSMB8 LOC100125946 LTA4H TLL2 PCSK6 PSEN1 TMPRSS6 ACE ECE1 BACE1 PSMA4 DPP4 CAPN11 KLK7 PRSS23 MMP19 PIGK LOC505658 PSMB10 ACR METAP2 XPNPEP1 CAPN7,MF,60,60 of 205,2.63,29.27,5.021E-17,2.346E-15
GO:0007399,nervous system development,P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MEC8(Evidence code:IBA/Database source:PANTHER:PTN001932250)A5D7F4(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000686332)Q08DH7(Evidence code:IEA/Database source:InterPro:IPR027703)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MKK8(Evidence code:IBA/Database source:PANTHER:PTN000548801)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000686332)F1MJ94(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)A8E641(Evidence code:IEA/Database source:InterPro:IPR030626)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)Q28053(Evidence code:IEA/Database source:InterPro:IPR028866)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)Q3T0P7(Evidence code:IBA/Database source:PANTHER:PTN000103178)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)E1BER6(Evidence code:IEA/Database source:InterPro:IPR030624)P98167(Evidence code:IEA/Database source:InterPro:IPR030119)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MIK5(Evidence code:IEA/Database source:InterPro:IPR031268)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524), CYFIP1 PHACTR4 PCDH8 PCDHGC3 RNF112 TAOK3 INA DYNLT1 SIM2 KIF2A TAOK2 PCDHA13 NDRG2 DPYSL5 DLG1 RAPGEF2 APP CAMK2A SPAST CAMK2D ITM2B PURA CRMP1 SSPO INSM1 SOX1 SCRIB CAMK2B,BP,28,28 of 36,1.23,77.78,1.032E-16,4.78E-15
GO:0006334,nucleosome assembly,G3N068(Evidence code:IBA/Database source:PANTHER:PTN000603808)A5PK61(Evidence code:IBA/Database source:PANTHER:PTN000152096)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BC18(Evidence code:IBA/Database source:PANTHER:PTN000603808)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR019809)F1MUD2(Evidence code:IBA/Database source:PANTHER:PTN000603808)G3MZR4(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1BL49(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1BGN3(Evidence code:IBA/Database source:PANTHER:PTN000152096)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)E1B8G9(Evidence code:IBA/Database source:PANTHER:PTN000603808)Q2KII5(Evidence code:IBA/Database source:PANTHER:PTN000603808)A6H767(Evidence code:IEA/Database source:InterPro:IPR002164)G3N3L9(Evidence code:IBA/Database source:PANTHER:PTN000603808)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)Q2TA40(Evidence code:IEA/Database source:InterPro:IPR002164)G3MYD7(Evidence code:IBA/Database source:PANTHER:PTN000152096)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818|I)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)E1BGW2(Evidence code:IBA/Database source:PANTHER:PTN000603808)Q32L48(Evidence code:IBA/Database source:PANTHER:PTN000603808)F1MV26(Evidence code:IBA/Database source:PANTHER:PTN000603808)F1N453(Evidence code:IBA/Database source:PANTHER:PTN000603808)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BM22(Evidence code:IBA/Database source:PANTHER:PTN000603808), LOC614378 H3F3C H1FX LOC617043 HIST1H1A LOC619094 HIST2H2BF LOC523702 LOC614206 HIST2H3D HIST1H2BA HIST3H2BB HIST1H2BI NAP1L1 LOC613363 H3F3B BRD2 NAP1L4 LOC100297725 HIST1H1D ATRX HIST1H2BJ HIST1H2BN LOC525433 HIST2H2BE HIST1H1E LOC100300167,BP,27,27 of 33,1.18,81.82,1.491E-16,6.848E-15
GO:0005874,microtubule,Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)A7E3C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR027188)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)A5D7P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)A7MBA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F6RP72(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q0II58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)P81948(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q2HJJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BFA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR000217|I)A5D7N6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3MHM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR000217|I)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1B953(Evidence code:IEA/Database source:InterPro:IPR000217|I)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F1N3M8(Evidence code:IEA/Database source:InterPro:IPR015656|I), TUBB3 NDRG1 DYNLT1 HSPH1 KIF5A DCTN2 DNM2 KIF2A TUBGCP2 LOC101905447 DNM1 KIFC1 LOC100295712 DCLK2 TUBA1A KIF5C DYNLL2 TUBA4A TEKT4 KLC4 KIFC3 KIF14 CDK5RAP2 CCT3 DYNLL1 TUBA1D KIF23 DYNC1I2 FKBP4 KATNAL2 TUBA8 KIF5B LOC101902172 LRPPRC LOC100141266 TUBB1 SIRT2 TUBA3E TUBB4A LOC533307 SPAST DLG1 DYNLRB1 MAP1A,CC,44,44 of 114,1.93,38.6,1.996E-16,9.082E-15
GO:0051015,actin filament binding,E1BET5(Evidence code:IEA/Database source:UniProtKB:P28290|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR008989)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR008989)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)P85091(Evidence code:IDA/Database source:)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR008989)Q5E963(Evidence code:IBA/Database source:PANTHER:PTN000291131)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)E1BE25(Evidence code:IEA/Database source:InterPro:IPR032461)F1MX93(Evidence code:IEA/Database source:InterPro:IPR008989)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)B6Z9Q5(Evidence code:IEA/Database source:InterPro:IPR014800|I)F1MF57(Evidence code:IEA/Database source:UniProtKB:O76041|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR001033|I)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)Q1JP79(Evidence code:IBA/Database source:PANTHER:PTN000076207)F1N643(Evidence code:IEA/Database source:InterPro:IPR014800|I)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR008989)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR008989)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)E1BDP6(Evidence code:IEA/Database source:InterPro:IPR007122)E1BP80(Evidence code:IEA/Database source:InterPro:IPR030637)O46385(Evidence code:IEA/Database source:InterPro:IPR007122|I)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR001033|I)Q5E9D5(Evidence code:ISS/Database source:UniProtKB:P60981)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR031244), SSFA2 IQGAP2 MYO5A MYO7B MYBPC3 CYFIP1 MYO1D MYH11 ARPC5L MYH14 FLNC MYO5C MICALL2 SHROOM2 NEBL CTNNA1 FMNL1 ARPC1A SHROOM3 FERMT2 ABL1 MYO5B MYO6 SYNE3 VILL ZNF185 SVIL MYO1A CTNNA2 DSTN MYO18A,MF,31,31 of 50,1.36,62,2.471E-16,1.115E-14
GO:0005604,basement membrane,F1MDD5(Evidence code:IEA/Database source:UniProtKB:Q61789|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1B7H2(Evidence code:IEA/Database source:UniProtKB:Q63870|ens)F1MUC5(Evidence code:IEA/Database source:InterPro:IPR039070)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)Q7SIB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)Q28084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)F1MF97(Evidence code:IEA/Database source:UniProtKB:O88322|ens)E1BN52(Evidence code:IEA/Database source:InterPro:IPR032825)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:P55268|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)Q29442(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)E1BH09(Evidence code:IEA/Database source:InterPro:IPR030755)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)A7MB18(Evidence code:IEA/Database source:UniProtKB:Q9JI33|ens)E1BJW3(Evidence code:IEA/Database source:UniProtKB:A6H6E2|ens), LAMA3 COL2A1 COL7A1 COL15A1 LAMC3 COL4A2 COL4A3 FREM2 NID2 FREM1 HMCN1 LAMB2 LAMB1 COL4A5 COL4A4 VWA2 FRAS1 COL4A1 COL4A6 NTN4 MMRN2,CC,21,21 of 15,0.92,140,3.619E-16,1.619E-14
GO:0006886,intracellular protein transport,A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR028642|I)Q5BIP4(Evidence code:IEA/Database source:InterPro:IPR002014|I)Q3B7N3(Evidence code:IEA/Database source:InterPro:IPR001494)Q3SYU7(Evidence code:IEA/Database source:InterPro:IPR001494)A5PK10(Evidence code:IEA/Database source:InterPro:IPR002014|I)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)A6QP06(Evidence code:IEA/Database source:InterPro:IPR010911)A0JN39(Evidence code:IEA/Database source:InterPro:IPR002553|I)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q3T0M0(Evidence code:IBA/Database source:PANTHER:PTN000122547)E1BGE5(Evidence code:IEA/Database source:InterPro:IPR001494|I)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)E0AE16(Evidence code:IEA/Database source:InterPro:IPR028644|I)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q0VD53(Evidence code:IBA/Database source:PANTHER:PTN000260563)Q3T0T7(Evidence code:IEA/Database source:InterPro:IPR006687)P63009(Evidence code:IEA/Database source:InterPro:IPR002553|I)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR000804)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)A1A4I8(Evidence code:IEA/Database source:InterPro:IPR001494)P04973(Evidence code:IEA/Database source:InterPro:IPR000996)E1BE98(Evidence code:IEA/Database source:InterPro:IPR001494)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692|I)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR000804)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR002553|I)F1MPE5(Evidence code:IEA/Database source:InterPro:IPR001494)E1B8Q8(Evidence code:IEA/Database source:InterPro:IPR001494)E1BME2(Evidence code:IEA/Database source:InterPro:IPR002553)A2VE21(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR006012)A4IFB8(Evidence code:IEA/Database source:InterPro:IPR001494)Q2HJE9(Evidence code:IEA/Database source:InterPro:IPR005678)Q08DL9(Evidence code:IEA/Database source:InterPro:IPR002014)P35604(Evidence code:IEA/Database source:InterPro:IPR000804)Q2KI57(Evidence code:IEA/Database source:InterPro:IPR001494)Q2HJG5(Evidence code:IBA/Database source:PANTHER:PTN000120819)A3KN15(Evidence code:IEA/Database source:InterPro:IPR000547)E1BFV0(Evidence code:IEA/Database source:InterPro:IPR001494)P63171(Evidence code:TAS/Database source:)Q3ZC13(Evidence code:IEA/Database source:InterPro:IPR001392|I)P81127(Evidence code:IEA/Database source:InterPro:IPR000744)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1N2I0(Evidence code:IEA/Database source:InterPro:IPR001738)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR028667|I)G5E567(Evidence code:IEA/Database source:InterPro:IPR001494)E1BBK9(Evidence code:IEA/Database source:InterPro:IPR010911)Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2)E1B8Q9(Evidence code:IEA/Database source:InterPro:IPR001494|I), TBC1D22B SNX33 TOM1 RANBP6 TNPO1 TOM1L2 SEC24D SEC24C PDCD6 COPB2 RABGAP1 SYTL2 COPB1 TBC1D12 AP2B1 VPS29 IPO7 SEC23A SNX9 SEC24A VPS26A SAR1B AP2B1 TBC1D2 AP1S1 SEC23B XPO7 CLTA XPO1 AP2A1 CTTN COPA AP2S1 AP2A2 IPO5 XPOT AP3B2 COPG2 STX7 IPO4 TIMM17B STAM COPZ1 TNPO2 VPS35 VPS41 KPNB1 DYNLT1 AP2M1 NAPG SGSM2 CHML SNX27 IPO9 SYTL1 SNX8 IPO8,BP,57,57 of 196,2.5,29.08,3.666E-16,1.626E-14
GO:0016324,apical plasma membrane,A7YY70(Evidence code:IEA/Database source:UniProtKB:Q06495|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX1)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5)P11019(Evidence code:ISS/Database source:UniProtKB:P50518)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)F1MS75(Evidence code:IBA/Database source:PANTHER:PTN000930541)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens)P35071(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QL5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F1MS08(Evidence code:IBA/Database source:PANTHER:PTN000930541)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q3ZC83(Evidence code:IEA/Database source:UniProtKB:Q99808|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P81425(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q61146|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)A2VE13(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)E1B9W1(Evidence code:IEA/Database source:UniProtKB:Q9D563|ens)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens), SLC34A1 PRKCI TJP1 DSTYK KCNMA1 MPDZ CUBN PFKM SEPT7 ATP6V1E1 ATP6V1B1 RAB17 SLC12A1 AQP5 CFTR TMEM30A STK26 SLC12A2 RAPGEF2 SLC29A1 C1QTNF5 DPP4 PKHD1 CD44 AMOTL1 OCLN ATP8B1 SLC23A1 FAT1 MAL2 AKR1A1 TMEM114 MYO1A,CC,33,33 of 60,1.45,55,3.868E-16,1.701E-14
GO:0016459,myosin complex,G3MXH1(Evidence code:IEA/Database source:InterPro:IPR001609)A0JNJ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0518)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MM57(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BA80(Evidence code:IEA/Database source:InterPro:IPR001609)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000934383)P85100(Evidence code:IEA/Database source:UniProtKB-KW:KW-0518)Q32WS5(Evidence code:IEA/Database source:InterPro:IPR002928)F1MX93(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q0P571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0518)F1MMC7(Evidence code:IEA/Database source:InterPro:IPR001609|I)P10568(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR001609)G5E5V6(Evidence code:IEA/Database source:InterPro:IPR002928)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q17R14(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q27966(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR001609)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MG13(Evidence code:IEA/Database source:InterPro:IPR001609|I), MYO9A MYL1 MYH11 MYH14 MYO18B MYO6 DYNLL2 MYL3 CGN MYO5C MYLPF MYO1F MYO1A MYO7B CGNL1 MYO5A MYO1D MYO1C MYO9B MYO5B MYO18A MYO15A,CC,22,22 of 18,0.96,122.22,4.015E-16,1.751E-14
GO:0015031,protein transport,P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR014536)P63009(Evidence code:IEA/Database source:InterPro:IPR016342)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A4IFN6(Evidence code:IEA/Database source:InterPro:IPR014536)A6QP64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR017104)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q9TTK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BC70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P81127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR016635)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E0AE16(Evidence code:IEA/Database source:InterPro:IPR014536)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR017104)A4IF89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P61763(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3ZC43(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A3KN51(Evidence code:IEA/Database source:InterPro:IPR008883)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q5BIP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A7YY62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BME2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P83437(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BIU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0V8C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR016342)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q08DR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A5PK10(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)F1MV07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P26882(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR016635)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2HJG5(Evidence code:IEA/Database source:InterPro:IPR005378)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3SYU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A6QQ47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0VD53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR008883)A6QLD1(Evidence code:IEA/Database source:InterPro:IPR007191)Q0P5B1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653), RAB3C SNX33 AP2B1 SAR1B SNX18 VPS37B AP2A1 SNX27 RAB3B CHMP4A LYST VPS37C SNX3 NAPG VPS25 COPE AP1S1 CORO7 SNX9 MVB12A AP2A2 EXOC8 COPB1 STXBP1 ARFGEF1 SEC24A ARCN1 RAB25 VTA1 EXOC7 TSG101 SEC23A CHMP1B VPS4B TOM1 COPZ1 FAM160A2 AP3B2 COG5 MYO1C CHMP2B RAB39B SEC24C RAB3A VPS36 EXOC3 VAMP3 LIN7C AP2B1 AP2M1 TIMM17B SNF8 COPB2 LIN7B SNX8 RAB26 COPG2 TOM1L2 SEC24D PPID AP2S1 VPS41 LIN7A SEC13 RANBP2 PSEN1 VPS29 VPS35 COPA RAN RAB4A TNPO1 SEC23B CD63 ARRDC1 ARL6 VPS51 VPS26A FRAS1 UEVLD EXOC4 PEX13 CHMP3 VPS28,BP,84,84 of 394,3.68,21.32,5.782E-16,2.501E-14
GO:0048856,anatomical structure development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668), GLI2 AMER3,BP,2,2 of 617,0.09,0.32,1.24E-15,5.319E-14
GO:0098793,presynapse,Q9XT97(Evidence code:IEA/Database source:GO:0016080)A5D7F2(Evidence code:IEA/Database source:GO:0048791)Q0P5F3(Evidence code:IEA/Database source:GO:0007269)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q99961|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)Q2KIB6(Evidence code:IEA/Database source:GO:0007269)E1BGA9(Evidence code:IEA/Database source:UniProtKB:Q6P5E8|ens)E1BMQ1(Evidence code:IEA/Database source:GO:0016079)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)E1BBX9(Evidence code:IEA/Database source:UniProtKB:Q8K0T7|ens)F1MS16(Evidence code:IEA/Database source:GO:0099509)A6QP06(Evidence code:IEA/Database source:GO:0048791)O18964(Evidence code:IEA/Database source:GO:0048488)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)F1MKZ3(Evidence code:IEA/Database source:GO:0016079)F1MNU6(Evidence code:IEA/Database source:GO:1905413)E1BBK9(Evidence code:IEA/Database source:GO:0048791)F1MME2(Evidence code:IEA/Database source:GO:0048488)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)Q9TU34(Evidence code:IDA/Database source:)Q32LM6(Evidence code:IEA/Database source:GO:0007269)E1BGL9(Evidence code:IEA/Database source:GO:0048791), PSEN1 SYT4 LIN7C GIPC1 UNC13A SH3GL1 SEPT6 UNC13B LIN7B DGKQ OTOF BSN UNC13C ATP2B3 SYTL2 SYNJ1 BACE1 CADPS BAIAP3 SYTL1 DENND1A FBXO45 DNAJC5 ITPR1 LIN7A SYT6,CC,26,26 of 34,1.14,76.47,1.671E-15,7.109E-14
GO:0005769,early endosome,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8NFT8|ens)P61420(Evidence code:IEA/Database source:UniProtKB:P51863|ens)E1BBN5(Evidence code:IEA/Database source:UniProtKB:Q8R516|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)Q9GL65(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q8K3H0|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN000634601)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens), SNX3 ANKFY1 RIN3 BACE1 VPS29 STX7 TOM1 TFRC SORL1 LMTK2 MAPK1 DNER ATP6V0D1 MIB2 SNX12 CHMP1A CLN3 SNX27 TSG101 CFTR LRP6 NF2 FLOT1 VPS26A WASF2 TLR4 VPS41 APPL1 VPS35 RAB17 PTPN23,CC,31,31 of 55,1.36,56.36,1.774E-15,7.488E-14
GO:0005216,ion channel activity,G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001508)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR005821)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005821)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001508)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001508)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001508)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR005821)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001508)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR005821)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP51(Evidence code:IEA/Database source:InterPro:IPR005821)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR005821)P02715(Evidence code:IEA/Database source:InterPro:IPR002394|I)F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)E1BM97(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)O18784(Evidence code:IEA/Database source:InterPro:IPR004729|I)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)Q08E50(Evidence code:IEA/Database source:InterPro:IPR001390|I)O62826(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)Q28204(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821), CACNA1C GRIN3B CACNA1S RYR1 KCNC4 KCNF1 TRPC3 GRIK4 GRIA2 KCNA4 CACNA1H SCN8A CACNA1D GRIA3 SCN11A ITPR1 GRIA1 TRPM7 ITPR2 SCN10A CACNA1A KCNC3 KCNH5 KCNG4 TRPM4 TPCN2 RYR2 CHRNE CACNA1E HCN1 KCNG2 CACNA1F TRPC1 KCNH6 CACNA1B GABRA5 TRPC2 SCN5A KCNMA1 SCN3A,MF,40,40 of 101,1.75,39.6,2.198E-15,9.202E-14
GO:0016607,nuclear speck,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q28165(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q14004)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q9H3U1|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BB50(Evidence code:ISS/Database source:UniProtKB:Q3MJK5)F1MZQ1(Evidence code:IEA/Database source:UniProtKB:Q9H0E3|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979)A7YY70(Evidence code:IEA/Database source:UniProtKB:A0A024R7R9)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:A0A024R4V5)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q8CHI8|ens)E1BI51(Evidence code:IEA/Database source:UniProtKB:Q4ZHG4|ens)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1B7Q7(Evidence code:IEA/Database source:UniProtKB:Q14669|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:A2ABF8|ens)F1N2Q3(Evidence code:IEA/Database source:UniProtKB:P49842|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9BYH8|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q12837|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:A0A024R8V6)Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422)P67827(Evidence code:ISS/Database source:UniProtKB:P48729)Q32S26(Evidence code:IEA/Database source:UniProtKB:P25440|ens), PUM1 GLI2 PABPN1 RREB1 CDK13 BDNF E2F7 UNC45A PRPF40A PIN1 CDK12 SAP130 SDCBP2 UHMK1 SLC34A1 SRSF1 FOXO4 MAML2 WRN BRD1 PCBP1 SYF2 PACSIN2 EP400 FNDC1 PPP1CC DGKQ EIF4A3 AP5Z1 TRIP12 EHMT2 STK19 CDC5L SNRNP70 NFKBIZ POU4F2 USP36 SAP18 CSNK1A1 BRD2,CC,40,40 of 103,1.75,38.83,3.714E-15,1.543E-13
GO:0001701,in utero embryonic development,E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q6PDM2|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)F1MSK0(Evidence code:IEA/Database source:UniProtKB:A2A690|ens)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)Q5E9I4(Evidence code:IEA/Database source:UniProtKB:P27808|ens)E1BIU0(Evidence code:IEA/Database source:UniProtKB:G3X972|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1MV07(Evidence code:IEA/Database source:UniProtKB:Q6NXL1|ens)P08487(Evidence code:ISS/Database source:UniProtKB:Q62077)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A6H7B5(Evidence code:IEA/Database source:UniProtKB:O88543|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens), ETV2 GLI2 SRSF1 GATA6 CHD8 TANC2 GNA12 MGAT1 SEC24C RPGRIP1L SEC24D PLCG1 CUL3 MYO18B SYF2 FOXF1 PYGO2 SALL4 SRF COPS3 MAPK8IP3 TBX3 GNA13 KEAP1 CHD7 INPP5B,BP,26,26 of 36,1.14,72.22,4.395E-15,1.811E-13
GO:0005089,Rho guanyl-nucleotide exchange factor activity,E1BG38(Evidence code:IEA/Database source:InterPro:IPR000219|I)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR000219|I)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MQ44(Evidence code:IEA/Database source:InterPro:IPR000219)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR000219)F1MHU4(Evidence code:IEA/Database source:InterPro:IPR000219)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR000219)Q58CS5(Evidence code:IEA/Database source:InterPro:IPR000219)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR000219)F1MSU8(Evidence code:IEA/Database source:InterPro:IPR000219)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR000219)F1MY16(Evidence code:IEA/Database source:InterPro:IPR000219)F1MRP8(Evidence code:IEA/Database source:InterPro:IPR000219)F1N657(Evidence code:IEA/Database source:InterPro:IPR000219), ARHGEF1 ARHGEF12 VAV2 MCF2L2 TRIO TIAM2 PLEKHG3 BCR FGD3 PREX1 PLEKHG2 EPS8L1 ECT2 AKAP13 PLEKHG1 SPATA13,MF,16,16 of 6,0.7,266.67,6.803E-15,2.782E-13
GO:0000139,Golgi membrane,P83437(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BB48(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7I4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKQ6(Evidence code:IEA/Database source:GO:0048194)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)F1N7I5(Evidence code:IEA/Database source:InterPro:IPR026650)P67827(Evidence code:IDA/Database source:)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q1RMW9(Evidence code:IEA/Database source:GO:0048194)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)Q3SZN2(Evidence code:IEA/Database source:GO:0090114)P35604(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)G3MXQ8(Evidence code:IBA/Database source:PANTHER:PTN000201534)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1LZ81(Evidence code:IEA/Database source:GO:0048208)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MV07(Evidence code:IEA/Database source:GO:0090110)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35605(Evidence code:ISS/Database source:UniProtKB:O35142)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28104(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32LM0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE21(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7S6(Evidence code:IEA/Database source:GO:0048208)Q9XT97(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53619(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens)A6QNT8(Evidence code:IEA/Database source:GO:0090110)F1MT17(Evidence code:IBA/Database source:PANTHER:PTN000361901)Q27954(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIU0(Evidence code:IEA/Database source:GO:0090110)A3KMX1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC9(Evidence code:IEA/Database source:GO:0090110)E1BIN5(Evidence code:IEA/Database source:GO:0048208)A2VDL8(Evidence code:IEA/Database source:GO:0090110)A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6PW02(Evidence code:IEA/Database source:GO:0048208), COG5 GALNT2 EXT1 TPST2 MYO18A OSBP NUMA1 CSNK1A1 ARFGEF1 GOLPH3 CORO7 SERINC3 LFNG MAPK8IP3 SCAP SEC23B COPZ1 MAN1A2 MAN1B1 ITM2B PDCD6 GALNT7 SEC24D TMEM59 COPB2 POMGNT1 COPE SH3GLB1 COPG2 PEF1 PSEN1 ARCN1 ARFIP1 B3GALT4 TRIM23 RAB26 SEC24A CUX2 COPA SEC24C CHST14 ARL1 SEC13 CUL3 SEC23A COPB1 TFG,CC,47,47 of 147,2.06,31.97,6.915E-15,2.806E-13
GO:0008022,protein C-terminus binding,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:O75970|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)Q08DF4(Evidence code:IPI/Database source:UniProtKB:P20488)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)P63026(Evidence code:IPI/Database source:UniProtKB:F1N348)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), NPAT SP1 MYO1C DLG1 GPSM2 PFKM TOP2B BANF1 SASH1 PPP2CA SNF8 MPDZ TAX1BP3 SDCBP2 BRCA2 TERF2 DNM1 LCK VPS4B ABL1 NIPBL VAMP2 PEX1 ERCC2 SRC NUMA1,MF,26,26 of 37,1.14,70.27,7.005E-15,2.82E-13
GO:0006811,ion transport,F1MS75(Evidence code:IEA/Database source:InterPro:IPR002443|I)O46563(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MS08(Evidence code:IEA/Database source:InterPro:IPR002443|I)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P11019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR005821)O18875(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)P35071(Evidence code:IEA/Database source:InterPro:IPR009147)P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1N4L1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)A6H7B0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q3T0E0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)P61420(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001508)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001508)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR005821)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)O62826(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)P21282(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q28204(Evidence code:IEA/Database source:InterPro:IPR005821)O18784(Evidence code:IEA/Database source:InterPro:IPR004729|I)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)F1MN60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005821)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001508)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BM97(Evidence code:IEA/Database source:InterPro:IPR005821)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR005821)Q08E50(Evidence code:IEA/Database source:InterPro:IPR001390|I)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001508)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)F1MS16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MP51(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR005821)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)P02715(Evidence code:IEA/Database source:InterPro:IPR002394|I)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001508)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821), SLC12A1 ATP6V1H PANX3 SLC5A11 TPCN2 ATP1A2 SLC12A2 KCNC3 CLDN4 ATP6V1E1 ITPR2 SLC6A8 CACNA1C CFTR ATP6V0C CACNA1D CACNA1H ATP2C2 SLC4A2 CACNA1F PLLP ATOX1 ATP6V1B1 WNK1 ATP6V0D1 CACNA1A SCN5A GRIN3B SCN10A GRIK4 RYR2 KCNG4 TRPC2 SCN3A ATP6V1C1 KCNMA1 TRPC1 SCN11A KCNF1 ATP2B2 RYR1 TRPC3 BEST3 KCNA4 GRIA2 CLIC4 SCN8A KCNG2 CACNA1B CLIC6 HCN1 KCNH6 GABRA5 CLCC1 GRIA1 TRPM7 ATP2B3 CACNA1E ATP2B4 KCNH5 ITPR1 KCNC4 CHRNE CACNA1S GRIA3 TRPM4,BP,66,66 of 278,2.89,23.74,8.757E-15,3.499E-13
GO:0032268,regulation of cellular protein metabolic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 539,0.04,0.19,9.232E-15,3.66E-13
GO:0000502,proteasome complex,Q5E964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q1JP95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P35998)Q17QP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)A4FUZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q2NKS3(Evidence code:IBA/Database source:PANTHER:PTN001257301)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T112(Evidence code:IEA/Database source:InterPro:IPR035705)Q2KJ25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)P56701(Evidence code:IEA/Database source:InterPro:IPR016643)A7MBA2(Evidence code:IEA/Database source:InterPro:IPR016642)Q2KIW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q3T0B2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647), PSMD13 PSMC3 PSMB3 PSMC2 PSMD14 PSMA7 PSMC5 PSMC1 PSMG3 RAD23B PSMB8 PSMD12 PSMA4 PSMD2 PSMD1 PSMC6 PSMB10 PSMB9 PSMB4 UBXN1 PSMD6 PSMA3,CC,22,22 of 23,0.96,95.65,1.051E-14,4.134E-13
GO:0031965,nuclear membrane,Q3T0A9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BJE7(Evidence code:IEA/Database source:UniProtKB:O60318|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:A0A140VJR0)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB:B0QZ18|ens)P80227(Evidence code:IEA/Database source:UniProtKB:A0A024R2U9)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BIJ4(Evidence code:IEA/Database source:UniProtKB:A0A024RBB9)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens), SHISA5 SPAST MCM3AP MYO6 INA PDE4D IPO4 ANKRD17 PRNP RANBP2 TNPO1 AHCTF1 TNRC18 KPNB1 XPO1 DNAJB2 GCHFR TNKS TPR TMC6 PCM1 TOR1A CPNE1 APEH RIF1 LEMD3 PSEN1 TXLNG HOXA7 SYNE3 IPO5 TNPO3 NDC1 GATA6,CC,34,34 of 75,1.49,45.33,1.163E-14,4.544E-13
GO:0007275,multicellular organism development,F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q0VCP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q08DH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR007875)G3X812(Evidence code:IEA/Database source:InterPro:IPR011656)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR000747)E1BLB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A7MB15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A7MBJ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)E1BHB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN001364370)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MT17(Evidence code:IBA/Database source:PANTHER:PTN001019067)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1B8D8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P17667(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q0VD00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)O02754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BMA1(Evidence code:IEA/Database source:InterPro:IPR033011)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN001364370)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217), HIVEP3 OLFML3 INA NDRG2 SPRY4 NOTCH4 INSM1 EN1 SHOX2 FZD1 RAPGEF2 SPAST LFNG HYDIN PHACTR4 MGP ARVCF TDRD5 LRP6 MTURN BRAF FGF1 RREB1 TSHZ1 RAX ZMYM4 DDX1 HIVEP1 CDK3 DDX4 CYFIP1 CUX2 TAF8 CDK6 ZNF516 HOXA7 MYF5 LGR4 KIF2A HEYL VAMP5 KCTD15 CEBPA PRTG ZMYM5 ZBTB18,BP,46,46 of 145,2.02,31.72,1.669E-14,6.471E-13
GO:0008013,beta-catenin binding,E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BPF3(Evidence code:IEA/Database source:InterPro:IPR015668)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BI79(Evidence code:IEA/Database source:InterPro:IPR009224|I)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)E1BJ93(Evidence code:IEA/Database source:InterPro:IPR028769)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)E1B8K0(Evidence code:IEA/Database source:InterPro:IPR015668)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)F1MPU1(Evidence code:IEA/Database source:InterPro:IPR021989)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047), AXIN1 BCL9 KDM6B FOXO4 APC2 SOX17 PSEN1 TAX1BP3 CHD8 LEF1 ASH2L BCL9L PIN1 AMER3 MED12L CTNNA1,MF,16,16 of 7,0.7,228.57,2.096E-14,8.066E-13
GO:0004715,non-membrane spanning protein tyrosine kinase activity,Q58D16(Evidence code:IEA/Database source:EC:2.7.10.2)E1BPI3(Evidence code:IEA/Database source:EC:2.7.10.2)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BIM8(Evidence code:IEA/Database source:EC:2.7.10.2)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR016251)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR016251|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR012234|I)Q3ZCM0(Evidence code:IEA/Database source:EC:2.7.10.2)F1MSH3(Evidence code:IEA/Database source:EC:2.7.10.2)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR016251|I)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR015015)F1MTD8(Evidence code:IEA/Database source:EC:2.7.10.2)A7MB57(Evidence code:IEA/Database source:EC:2.7.10.2)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164), MATK FRK PEAK1 GRB2 SRC TYK2 JAK2 ZAP70 LCK TEC JAK1 ABL1 HCK YES1 WEE1,MF,15,15 of 5,0.66,300,2.276E-14,8.695E-13
GO:0007420,brain development,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens)Q2YDD2(Evidence code:ISS/Database source:UniProtKB:Q9DB90)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)Q3ZBA8(Evidence code:IBA/Database source:PANTHER:PTN000112095)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q3MHH4(Evidence code:ISS/Database source:UniProtKB:P47897)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)Q29460(Evidence code:IBA/Database source:PANTHER:PTN000220758)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR016362)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9Z2J0)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens), PYGO2 BRCA2 RAX SMG9 NIPBL NDRG2 NF2 COL4A1 ARL6 PRKDC HYDIN RPGRIP1L SPHK2 PSEN1 QARS STK36 CDK5RAP2 EXT1 PAFAH1B3 POU3F1 SLC23A1 BCR CHD8,BP,23,23 of 28,1.01,82.14,2.397E-14,9.093E-13
GO:0030425,dendrite,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)A8E641(Evidence code:IEA/Database source:UniProtKB:Q9EQF6|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:Q61011|ens)Q27971(Evidence code:ISS/Database source:UniProtKB:Q07009)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens)Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)Q9BH13(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32L41(Evidence code:IEA/Database source:UniProtKB:P30047|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens), PSEN1 SHANK1 GRM7 CACNA1B GABRA5 MARK3 DPYSL5 GNB3 CAPN2 PRNP BRINP1 MAPK8IP3 DENND1A RGS14 DNER TUBB3 PURA HCN1 LRRK2 GPHN CPNE6 SYT4 BSN ZFYVE27 RAB17 ALCAM GCHFR TRAPPC4,CC,28,28 of 50,1.23,56,4.457E-14,1.678E-12
GO:0015630,microtubule cytoskeleton,Q2HJB8(Evidence code:IEA/Database source:UniProtKB:Q9NY65|ens)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:Q5KU39|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q3SZ20(Evidence code:IEA/Database source:UniProtKB:P34897|ens)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)P81948(Evidence code:IEA/Database source:UniProtKB:P68366|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)E1BB08(Evidence code:IBA/Database source:PANTHER:PTN000347035)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1B9B6(Evidence code:IEA/Database source:UniProtKB:A0A024RBL3)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:Q71U36|ens)F1N1R8(Evidence code:IBA/Database source:PANTHER:PTN000347035)E1BF73(Evidence code:IEA/Database source:UniProtKB:Q3UHI0|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680687), TUBA8 TACC1 TUBB3 VPS41 APC2 SHMT2 LYST SPAST TUBA4A PIK3R4 EML2 PRKCI NUAK1 TUBA1A EML4 CCSER2 CLIC4 ACTR1A DCLK2,CC,19,19 of 16,0.83,118.75,5.63E-14,2.105E-12
GO:0051641,cellular localization,Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0),MYO1D,BP,1,1 of 509,0.04,0.2,6.608E-14,2.453E-12
GO:0035335,peptidyl-tyrosine dephosphorylation,E1BFE6(Evidence code:IEA/Database source:GO:0004725)E1BIU7(Evidence code:IEA/Database source:GO:0004725)E1BPN5(Evidence code:IEA/Database source:GO:0004725)E1BPU9(Evidence code:IEA/Database source:GO:0005001)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)P11064(Evidence code:IEA/Database source:GO:0004725)E1BEZ8(Evidence code:IEA/Database source:GO:0004725)A6QQD4(Evidence code:IEA/Database source:GO:0004725)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)P56722(Evidence code:IEA/Database source:GO:0004725)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)A6QLS1(Evidence code:IEA/Database source:GO:0004725)G5E526(Evidence code:IEA/Database source:GO:0004725)E1BPA0(Evidence code:IEA/Database source:GO:0004725), MTMR1 PTPN23 SSH2 PTPRM PTPN6 ACP1 PTPN14 PTPN5 PTPRZ1 PTPRN DUSP3 DUSP7 PTP4A1 PTPRA,BP,14,14 of 4,0.61,350,7.231E-14,2.647E-12
GO:0030900,forebrain development,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q64511|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), SRC SOX1 fgfr3 TOP2B ARID1A E2F1 MKL1 SRF POU3F1 PSEN1 FRS2 ATRX ARHGAP35 MAPK8IP3,BP,14,14 of 4,0.61,350,7.231E-14,2.647E-12
GO:0030424,axon,Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q9TU34(Evidence code:IDA/Database source:)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140)P56722(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE99(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q05037(Evidence code:ISS/Database source:UniProtKB:P15385)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A4FUY1(Evidence code:IEA/Database source:UniProtKB:Q14CZ8|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BHM6(Evidence code:IEA/Database source:UniProtKB:Q9R053|ens), TUBB3 BSN MYH14 DAB2IP TAOK2 PINK1 ZFYVE27 MYO1D BACE1 KIF13B GARS SNAP25 ITPR1 UNC13A SYT4 HCN1 ALCAM CPNE6 PTPRN SEPT11 UHMK1 MAPK8IP3 KCNA4 LRRK2 SETX PSEN1 HEPACAM SPTBN4 SCN11A,CC,29,29 of 56,1.27,51.79,7.287E-14,2.648E-12
GO:0007283,spermatogenesis,F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)E1BJ75(Evidence code:IEA/Database source:UniProtKB:Q9CYD3|ens)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)F1MS56(Evidence code:IEA/Database source:UniProtKB:Q9CYR6|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)E1BDZ4(Evidence code:IEA/Database source:UniProtKB:Q86W24|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)G5E5Q8(Evidence code:IEA/Database source:UniProtKB:Q6ZPE2|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8K1H1)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)F6Q0K7(Evidence code:IEA/Database source:InterPro:IPR029297)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q29460(Evidence code:ISS/Database source:UniProtKB:Q61205)E1B970(Evidence code:IEA/Database source:InterPro:IPR033288)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54728|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744), TDRD1 TDRD9 TDRD5 CRTAP INPP5B SEPT2 GLI1 HIST1H1A RAD21L1 UBR2 PGM3 BRCA2 PIWIL2 NLRP14 DDX4 SBF1 PUM1 KIT TDRD7 ATRX SEPT7 SPATA32 LGR4 SOX17 PAFAH1B3 GOLGA3 RACGAP1 CELF3 NDC1 CCNYL1 RAD23B SEPT6,BP,32,32 of 72,1.4,44.44,1.047E-13,3.779E-12
GO:0009986,cell surface,Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8QZY6|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q3UUY6|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)G3X812(Evidence code:IEA/Database source:UniProtKB:Q99466|ens)F1MPW1(Evidence code:IEA/Database source:UniProtKB:Q14689|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)F1MQD1(Evidence code:IEA/Database source:UniProtKB:O15484|ens)Q29RY7(Evidence code:ISS/Database source:UniProtKB:Q8MIP7)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q95J79(Evidence code:ISS/Database source:UniProtKB:O43914)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:O95183|ens)F1MP51(Evidence code:IEA/Database source:UniProtKB:Q8NCM2|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q68SA9|ens)F1MP76(Evidence code:IBA/Database source:PANTHER:PTN000099415)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens), TSPAN14 PROM2 PRNP PDGFC CLIC4 PSEN1 ADAM15 NOTCH4 DIP2A IQGAP2 IDE CAPN5 FGL2 BSN TFRC ITGB7 ITGB1 LAMP1 HFE2 DPP4 FCER1G CD63 TYROBP PCSK6 VAMP5 KCNH5 HIST1H1A KIT LRP6 BACE1 FZD1 PROM1 ADAMTS7 SDC3 RC3H2 RTN4R,CC,36,36 of 94,1.58,38.3,1.169E-13,4.192E-12
GO:0031410,cytoplasmic vesicle,Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P23389(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E0AE16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q8WN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q29455(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)Q08DS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q9TU34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q9NZM1|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A2VDN5(Evidence code:IEA/Database source:UniProtKB:Q9UBP0|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P62194(Evidence code:IEA/Database source:UniProtKB:P62195|ens)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BHK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968), COPE CHGB SNX9 COPA ITPR2 CLN3 SNX18 MARCH8 MYO1D SH3GLB1 CLINT1 CLTA GIPC1 SEC23B VPS41 COPB1 PIGT FNDC3A RAB39B TAOK2 AP1S1 TFRC DYSF SNX3 PTPRN LRRK2 COPB2 DNAJC5 AMOTL1 CHGA SCAP TMEM184A MYO6 SEC13 COPS4 TBC1D2 AP2B1 SEC24A ITPR1 DNM2 VAMP1 OCLN CPNE6 MPDZ CORO7 RIN3 FLOT1 PRKACA MYOF ATM CHMP4A COPG2 BDNF SEC23A PSEN1 TMEM30A DBH ARRDC1 MYO1C CADPS ARCN1 SPAST HYAL1 COPZ1 CYB561 PSMC5 ATP2C2 BACE1 LRP6 BICD2 ATP7B RNF112 PDCD6 RAB25 VAMP2 SNX33,CC,76,76 of 379,3.33,20.05,2.005E-13,7.139E-12
GO:0043025,neuronal cell body,E1BID8(Evidence code:IEA/Database source:UniProtKB:Q8JZW4|ens)F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)A8E641(Evidence code:IEA/Database source:UniProtKB:Q9EQF6|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)P02638(Evidence code:IEA/Database source:UniProtKB:P50114|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB:Q9Z2M7|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294), CPNE5 GRIN3B SYT4 HCFC1 DPYSL5 PURA PTPRN PSEN1 TUBB3 TUBB4A RAB17 MYO1D S100B FABP7 BRINP1 SEZ6L2 RTN4R PMM2 DENND1A LRRK2 DAB2IP VPS35 RAPGEF2 DNER SPTBN4 LRP6 CACNA1B,CC,27,27 of 50,1.18,54,2.415E-13,8.541E-12
GO:0006996,organelle organization,A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens), HPS6 TOR1A,BP,2,2 of 532,0.09,0.38,2.817E-13,9.895E-12
GO:0003676,nucleic acid binding,E1BK83(Evidence code:IEA/Database source:InterPro:IPR002775|I)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR010979)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR011545|I)A4FV57(Evidence code:IEA/Database source:InterPro:IPR013087)E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR035979)Q2YDI4(Evidence code:IEA/Database source:InterPro:IPR004087)E1BM86(Evidence code:IEA/Database source:InterPro:IPR004087)E1B7E6(Evidence code:IEA/Database source:InterPro:IPR003165|I)Q2KJ71(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BH78(Evidence code:IEA/Database source:InterPro:IPR011545)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006172|I)E1BQ01(Evidence code:IEA/Database source:InterPro:IPR013087)E1BNL0(Evidence code:IEA/Database source:InterPro:IPR013087)Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR011545)E1BAR2(Evidence code:IEA/Database source:InterPro:IPR001878|I)Q08E07(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MU53(Evidence code:IEA/Database source:InterPro:IPR001909|I)G3MY13(Evidence code:IEA/Database source:InterPro:IPR013087)A6H727(Evidence code:IEA/Database source:InterPro:IPR013087)E1BCS0(Evidence code:IEA/Database source:InterPro:IPR013087)E1BCS5(Evidence code:IEA/Database source:InterPro:IPR013087)F1MI56(Evidence code:IEA/Database source:InterPro:IPR004087)F1MXK6(Evidence code:IEA/Database source:InterPro:IPR003165|I)O18964(Evidence code:IEA/Database source:InterPro:IPR000504|I)A5D7T6(Evidence code:IEA/Database source:InterPro:IPR013087)G3MZ78(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q3Y4E1(Evidence code:IEA/Database source:InterPro:IPR013087)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR018165)E1BDH6(Evidence code:IEA/Database source:InterPro:IPR001374|I)G3MY25(Evidence code:IEA/Database source:InterPro:IPR004875)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR002121|I)E1BNB4(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q3ZC12(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1B7G5(Evidence code:IEA/Database source:InterPro:IPR000504|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR003156|I)A0JN76(Evidence code:IEA/Database source:InterPro:IPR013087)F1MEM4(Evidence code:IEA/Database source:InterPro:IPR003029)F1MIB3(Evidence code:IEA/Database source:InterPro:IPR013087)Q28165(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BFI4(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q08DJ3(Evidence code:IEA/Database source:InterPro:IPR004087|I)F1MRW7(Evidence code:IEA/Database source:InterPro:IPR011545)F1MX93(Evidence code:IEA/Database source:InterPro:IPR013087)A4FV72(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MMF1(Evidence code:IEA/Database source:InterPro:IPR013087)Q5E9A3(Evidence code:IEA/Database source:InterPro:IPR004087)Q3SYT9(Evidence code:IEA/Database source:InterPro:IPR004087)E1BJZ5(Evidence code:IEA/Database source:InterPro:IPR013087)E1BN44(Evidence code:IEA/Database source:InterPro:IPR013087)E1BP84(Evidence code:IEA/Database source:InterPro:IPR013087)A4IFC3(Evidence code:IEA/Database source:InterPro:IPR000504|I)G3N2D0(Evidence code:IEA/Database source:InterPro:IPR013087)A6H7J1(Evidence code:IEA/Database source:InterPro:IPR013087)A7MB06(Evidence code:IEA/Database source:InterPro:IPR013087)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q0IIK5(Evidence code:IEA/Database source:InterPro:IPR011545)E1BN14(Evidence code:IEA/Database source:InterPro:IPR000467)E1BQ37(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MFQ4(Evidence code:IEA/Database source:InterPro:IPR013087)Q2NL22(Evidence code:IEA/Database source:InterPro:IPR011545)A7MB16(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MBK6(Evidence code:IEA/Database source:InterPro:IPR013087)E1BNQ2(Evidence code:IEA/Database source:InterPro:IPR011545)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1B908(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q6T5B7(Evidence code:IEA/Database source:InterPro:IPR003165|I)F1MGC2(Evidence code:IEA/Database source:InterPro:IPR001427)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MRK2(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BJE7(Evidence code:IEA/Database source:InterPro:IPR035979)E1BNM4(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q0VCJ6(Evidence code:IEA/Database source:InterPro:IPR013087)F1MKU1(Evidence code:IEA/Database source:InterPro:IPR011545)G3MWI7(Evidence code:IEA/Database source:InterPro:IPR013087)F1N0D7(Evidence code:IEA/Database source:InterPro:IPR013087)E1BML0(Evidence code:IEA/Database source:InterPro:IPR036397)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR011545)Q2YDE6(Evidence code:IEA/Database source:InterPro:IPR004087)E1BD25(Evidence code:IEA/Database source:InterPro:IPR013087)F1MHP1(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q29RQ2(Evidence code:IEA/Database source:InterPro:IPR004087)G3N2N6(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q28141(Evidence code:IEA/Database source:InterPro:IPR011545)E1BD77(Evidence code:IEA/Database source:InterPro:IPR003604|I)F1N281(Evidence code:IEA/Database source:InterPro:IPR013087)Q0P5L0(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q17QR0(Evidence code:IEA/Database source:InterPro:IPR013087)E1BGF9(Evidence code:IEA/Database source:InterPro:IPR013087)E1B719(Evidence code:IEA/Database source:InterPro:IPR004087)F1MLJ0(Evidence code:IEA/Database source:InterPro:IPR013087)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR013087)A2PYH9(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MI25(Evidence code:IEA/Database source:InterPro:IPR003604|I)Q1RMR2(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BCA0(Evidence code:IEA/Database source:InterPro:IPR013087)D3IVZ2(Evidence code:IEA/Database source:InterPro:IPR011545)F1MVN3(Evidence code:IEA/Database source:InterPro:IPR000504|I)A6QL80(Evidence code:IEA/Database source:InterPro:IPR013087)Q5JB60(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1ML16(Evidence code:IEA/Database source:InterPro:IPR013087)F1N312(Evidence code:IEA/Database source:InterPro:IPR013087)A6QNZ1(Evidence code:IEA/Database source:InterPro:IPR013087)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR006555)F1MLP0(Evidence code:IEA/Database source:InterPro:IPR013087)F1MS84(Evidence code:IEA/Database source:InterPro:IPR004087)P61286(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MWZ3(Evidence code:IEA/Database source:InterPro:IPR013087)A8NJ74(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MNG4(Evidence code:IEA/Database source:InterPro:IPR013087)F1MGZ7(Evidence code:IEA/Database source:InterPro:IPR013087)F1MLT5(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q0II93(Evidence code:IEA/Database source:InterPro:IPR035979)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002121|I)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004365)Q0VCY7(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BDX4(Evidence code:IEA/Database source:InterPro:IPR013087)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR003604|I)Q17QV0(Evidence code:IEA/Database source:InterPro:IPR004087)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR013087)E1BGQ4(Evidence code:IEA/Database source:InterPro:IPR001909|I)A7YWM6(Evidence code:IEA/Database source:InterPro:IPR001427)A5D7S3(Evidence code:IEA/Database source:InterPro:IPR013087)E1BC37(Evidence code:IEA/Database source:InterPro:IPR000467|I)G3MZL2(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MCY1(Evidence code:IEA/Database source:InterPro:IPR013087)G3X7J6(Evidence code:IEA/Database source:InterPro:IPR002562|I)O19137(Evidence code:IEA/Database source:InterPro:IPR001878|I)P10881(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR000504|I)A6QQP0(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q5W5U4(Evidence code:IEA/Database source:InterPro:IPR011545)E1B928(Evidence code:IEA/Database source:InterPro:IPR013087)K7N846(Evidence code:IEA/Database source:InterPro:IPR013087)E1BFV5(Evidence code:IEA/Database source:InterPro:IPR013087)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR013087)G3N065(Evidence code:IEA/Database source:InterPro:IPR003604|I)Q9GL32(Evidence code:IEA/Database source:InterPro:IPR013087)F1MNA1(Evidence code:IEA/Database source:InterPro:IPR011545)E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR003029|I)G5E631(Evidence code:IEA/Database source:InterPro:IPR011545)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR013087)E1BHU5(Evidence code:IEA/Database source:InterPro:IPR013087)Q1JPH6(Evidence code:IEA/Database source:InterPro:IPR000504|I), RPP25 RPS18 POLQ AEBP2 LEMD3 MEX3C MEX3B PIWIL2 TRA2A SNRNP200 POLA1 ZNF687 ZNF142 EIF4A2 ZCCHC6 CELF3 ZNF446 TSHZ1 GLI1 ZNF366 ZBTB47 ANKRD17 AGO4 SYNJ1 YY1 CSTF2T ZNF148 AARS2 R3HDM1 TIGD5 BLM PABPC1L EIF3G RBM12B AARS ZBTB18 DHX8 ZNF462 PABPN1 IGF2BP2 FUBP1 DDX20 MYO5C PPIE PRDM13 PCBP1 PCBP2 SALL4 RREB1 ZNF512B PABPC4 ZNF469 INSM1 SP7 ZNF394 DDX1 GPKOW SFPQ ZBTB4 EIF4A3 EIF3B HIVEP3 DHX37 SETD1B PABPN1L AGO3 RNASE2 UHMK1 SPEN MCM3AP ZNF282 ZBTB8A DDX58 ZFPM1 ZIC2 PAN2 HNRNPL DICER1 HDLBP BCL11B U2SURP KHDRBS1 ZFP37 DHX9 ZFHX2 ZNF438 RBM42 BCL11A ZHX3 ANKHD1 WIZ RNF31 Msi1 HIVEP1 SNRNP70 ZNF516 DDX3Y ESRP1 PRMT3 NCL HIC1 ZNF608 FIZ1 ERCC2 ZBTB22 NOVA2 PABPC1 ZNF827 RBM34 ZNF280D ZNF384 TNRC6C NXF3 WRN NARS SRSF1 ZBTB17 ZFHX3 PCBP3 SP1 ZNF316 RNASE13 TRMT1L GPATCH8 RBM28 GLI2 EXD3 CPSF4 SSB ZNF638 MYEF2 DDX4 ZNF598 KLF7 ZNF367 Gli3 ZNF385C EGR4 TDRD9 PNPT1 DDX3X TRIM23 ZBTB32 EIF4H,MF,144,144 of 989,6.32,14.56,2.944E-13,1.027E-11
GO:0008134,transcription factor binding,E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR028314)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)Q05B89(Evidence code:IEA/Database source:UniProtKB:Q9GZT8|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q32LB3(Evidence code:ISS/Database source:UniProtKB:Q7LFL8)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BHY2(Evidence code:IEA/Database source:InterPro:IPR028319)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:Q9NRP7|ens)A7MBG4(Evidence code:IEA/Database source:InterPro:IPR030563), HOXA7 SIRT2 PIAS1 NAB2 ZBTB17 E2F1 TFDP2 GLI2 CDK12 TAF4B CTBP1 BCOR PSMC5 BCL3 FOXO4 PURA LEF1 GATA6 NIF3L1 MAPK9 SALL4 PURB PPID SOX17 CXXC5 HYAL1 SP1 CDK13 SNF8 PPP1R13B PTPRN SRF NFKB1 PRKDC STK36 KEAP1,MF,36,36 of 98,1.58,36.73,3.183E-13,1.103E-11
GO:0005201,extracellular matrix structural constituent,Q28084(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1N2Y2(Evidence code:IEA/Database source:InterPro:IPR000885)F1MJQ6(Evidence code:IEA/Database source:InterPro:IPR000885)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)F1N2J5(Evidence code:IBA/Database source:PANTHER:PTN001105676)Q7SIB2(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1MZD0(Evidence code:IEA/Database source:InterPro:IPR011398)Q29442(Evidence code:IEA/Database source:InterPro:IPR001442|I)P02459(Evidence code:IEA/Database source:InterPro:IPR000885)Q7SIB3(Evidence code:IEA/Database source:InterPro:IPR001442|I)P13608(Evidence code:IBA/Database source:PANTHER:PTN001105676)F1N474(Evidence code:IEA/Database source:InterPro:IPR001442|I)P07507(Evidence code:IBA/Database source:PANTHER:PTN000011588)P02465(Evidence code:IEA/Database source:InterPro:IPR000885)Q148M4(Evidence code:IEA/Database source:InterPro:IPR000885)Q32S24(Evidence code:IEA/Database source:InterPro:IPR000885)P81282(Evidence code:IBA/Database source:PANTHER:PTN001105676)F1MJY9(Evidence code:IEA/Database source:InterPro:IPR001442|I)Q9GKN8(Evidence code:IEA/Database source:InterPro:IPR027216), COL4A3 COL5A2 COL5A3 LAMB1 HAPLN4 COL4A1 FBN3 COL4A4 COL2A1 COL4A2 ACAN COL4A5 MGP COL1A2 COL27A1 COL11A2 VCAN COL4A6 PRELP,MF,19,19 of 19,0.83,100,4.033E-13,1.389E-11
GO:0006816,calcium ion transport,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)O62826(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR013333|I)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR006413)F1MN60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493|I)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493|I)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR013333|I)F1MS16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)E1BIB9(Evidence code:IBA/Database source:PANTHER:PTN001295293)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)O18784(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR013333|I), TRPM4 CAMK2G TRPC2 RYR2 ATP2C2 ATP2B2 CACNA1E ITPR2 TRPM7 CACNA1S PSEN1 PRKCB CACNA1D ITPR1 PPP3CA RYR1 ATP2B3 ATP2B4 CACNA1B CAMK2A TPCN2 CACNA1C TRPC1 SRI CACNA1F RYR3,BP,26,26 of 47,1.14,55.32,4.346E-13,1.487E-11
GO:0005515,protein binding,Q0P594(Evidence code:IPI/Database source:UniProtKB:Q28205)Q2NKZ1(Evidence code:IPI/Database source:UniProtKB:F1MWD3)Q9TRY0(Evidence code:IPI/Database source:UniProtKB:P02639)P08487(Evidence code:IPI/Database source:UniProtKB:P48025)P04973(Evidence code:IPI/Database source:UniProtKB:O00291)P00515(Evidence code:IPI/Database source:UniProtKB:Q6XGM8)P02510(Evidence code:IPI/Database source:UniProtKB:P02470)P63026(Evidence code:IPI/Database source:UniProtKB:F1N348)P61286(Evidence code:IPI/Database source:UniProtKB:P15170)P13608(Evidence code:IPI/Database source:UniProtKB:P49747)Q2TA37(Evidence code:IPI/Database source:UniProtKB:Q28205)P63097(Evidence code:IPI/Database source:UniProtKB:P62871)O46385(Evidence code:IPI/Database source:UniProtKB:P35579)E1BHE1(Evidence code:IPI/Database source:UniProtKB:Q89582)Q1RMR3(Evidence code:IPI/Database source:UniProtKB:F1MUI0)A6QLP2(Evidence code:IPI/Database source:UniProtKB:Q9GL77)P02668(Evidence code:IPI/Database source:UniProtKB:Q9RA63)P63171(Evidence code:IPI/Database source:UniProtKB:P02699)Q17QQ3(Evidence code:IPI/Database source:UniProtKB:Q704P2)P35605(Evidence code:IPI/Database source:UniProtKB:Q27954)Q29455(Evidence code:IPI/Database source:UniProtKB:Q80TN5)O19137(Evidence code:IPI/Database source:UniProtKB:P03120)Q28104(Evidence code:IPI/Database source:UniProtKB:Q27954)P10279(Evidence code:IPI/Database source:UniProtKB:P04156)A2VDL6(Evidence code:IPI/Database source:UniProtKB:Q3SZX0)P04695(Evidence code:IPI/Database source:UniProtKB:Q28181)Q0VCK5(Evidence code:IPI/Database source:UniProtKB:Q61548)P00517(Evidence code:IPI/Database source:UniProtKB:P63251)P81948(Evidence code:IPI/Database source:UniProtKB:P90521)P03968(Evidence code:IPI/Database source:UniProtKB:P21802)Q27954(Evidence code:IPI/Database source:UniProtKB:P35605)P0C7Q4(Evidence code:IPI/Database source:UniProtKB:P02699)P42891(Evidence code:IPI/Database source:UniProtKB:Q95N27)F1MSG6(Evidence code:IPI/Database source:UniProtKB:Q02248)G3MZY8(Evidence code:IPI/Database source:UniProtKB:A5PJW8)P61763(Evidence code:IPI/Database source:UniProtKB:P32850)Q0IIE2(Evidence code:IPI/Database source:UniProtKB:Q9QYY0)P61625(Evidence code:IPI/Database source:UniProtKB:Q7BHI8)F1MQ85(Evidence code:IPI/Database source:UniProtKB:Q89582)P48452(Evidence code:IPI/Database source:UniProtKB:P63099)P53619(Evidence code:IPI/Database source:UniProtKB:P23514)P02638(Evidence code:IPI/Database source:UniProtKB:Q9CXW3)Q08DF4(Evidence code:IPI/Database source:UniProtKB:F1N548)Q3SYU7(Evidence code:IPI/Database source:UniProtKB:P52293)P26882(Evidence code:IPI/Database source:UniProtKB:P02639), PPP2CB CCT7 FKBP4 PLCG1 CLTA PRKAR2A CRYAB VAMP2 PABPC1 ACAN ARL2 GNAI1 SVIL TAOK3 CTTN AHCYL2 CSN3 DYNLT1 SNAP25 COPB2 DNAJC5 CPSF4 COPE PRNP ATP1A2 GNAT1 AP2A2 PRKACA TUBA4A FGF1 COPA GNAT3 ECE1 RAPGEF2 POLR2A STXBP1 SHC1 ITGAL ATRX PPP3CA ARCN1 S100B DNM1 TNPO1 PPID,MF,45,45 of 1669,1.97,2.7,4.389E-13,1.492E-11
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR002126)G3N152(Evidence code:IEA/Database source:InterPro:IPR002126)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR002126)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR000233|I)Q01107(Evidence code:IEA/Database source:InterPro:IPR000233|I)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR002126)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR002126)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR002126)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR002126)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR002126)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR002126)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR002126)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR002126|I)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR002126)F1N416(Evidence code:IEA/Database source:InterPro:IPR000233|I)E1BF53(Evidence code:IEA/Database source:InterPro:IPR000233|I), SDK2 PTPRM DCHS2 PCDHB8 LOC786512 CDH11 DSC1 PCDH1 PCDHA13 PCDHGC3 FAT1 CDHR1 FAT2 PCDH8 PCDH12 PCDH20 CDH22 CDH7,BP,18,18 of 16,0.79,112.5,4.617E-13,1.559E-11
GO:0001784,phosphotyrosine residue binding,F1N6T8(Evidence code:IEA/Database source:UniProtKB:P52735|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR024159)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A6QQD4(Evidence code:IEA/Database source:UniProtKB:P54829|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens), VAV2 CRK IRS1 GRB2 CBLC CRKL PTPN6 ABL1 PTPN5 LCK YES1 ZAP70,MF,12,12 of 2,0.53,600,5.57E-13,1.869E-11
GO:0007049,cell cycle,A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q5E9L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2NKY7(Evidence code:IEA/Database source:InterPro:IPR008113)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR015648)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6QQY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BKC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3MHQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR004582)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3MHY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)F1N746(Evidence code:IEA/Database source:InterPro:IPR033185)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q32PF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A7Z052(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131), SEPT11 ARL2 DCTN3 BRINP1 PPP1CB PPP1CC INSM1 SEPT7 SEPT6 ARL8B CLTA RAN BRCC3 SEPT2 DYNLT1 TFDP2 UHRF1 ZFYVE26 MAPK13 VPS4B KLHL13 PIN1 CDK6 KIF2A CDK1 MCTS1 NIPBL HEPACAM MAPK1 NCAPH RAD17 CHMP1B BRCA1 E2F7 CSNK1A1 TERF1 RABGAP1 ANXA11 PCNP MASTL SPAST CDC5L WDR6 GNAI1,BP,44,44 of 151,1.93,29.14,6.837E-13,2.279E-11
GO:0050793,regulation of developmental process,G3X812(Evidence code:IEA/Database source:InterPro:IPR008297),NOTCH4,BP,1,1 of 473,0.04,0.21,6.969E-13,2.309E-11
GO:0008536,Ran GTPase binding,A1A4I8(Evidence code:IEA/Database source:InterPro:IPR001494)F1MPE5(Evidence code:IEA/Database source:InterPro:IPR001494)Q3B7N3(Evidence code:IEA/Database source:InterPro:IPR001494)E1B8Q9(Evidence code:IEA/Database source:InterPro:IPR001494)A4IFB8(Evidence code:IEA/Database source:InterPro:IPR001494)E1B8Q8(Evidence code:IEA/Database source:InterPro:IPR001494)G5E567(Evidence code:IEA/Database source:InterPro:IPR001494)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566730)Q3SYU7(Evidence code:IEA/Database source:InterPro:IPR001494)Q2KI57(Evidence code:IEA/Database source:InterPro:IPR001494)E1BGE5(Evidence code:IEA/Database source:InterPro:IPR001494)E1BFV0(Evidence code:IEA/Database source:InterPro:IPR001494)E1BE98(Evidence code:IEA/Database source:InterPro:IPR001494)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens), XPO7 IPO5 RANBP6 IPO8 IPO4 XPOT IPO9 RANBP2 TNPO1 TNPO2 IPO7 KPNB1 XPO1 MYCBP2,MF,14,14 of 6,0.61,233.33,8.062E-13,2.654E-11
GO:0009966,regulation of signal transduction,E1BE13(Evidence code:IBA/Database source:PANTHER:PTN000005165)Q17R10(Evidence code:IEA/Database source:InterPro:IPR030115)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR007875), BIRC6 AFAP1L2 CRK SPRY4,BP,4,4 of 593,0.18,0.67,9.023E-13,2.952E-11
GO:0005244,voltage-gated ion channel activity,E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens), KCNC3 CACNA1D SCN8A KCNA4 CACNA1S SCN5A HCN1 KCNMA1 KCNH6 SCN11A KCNC4 CACNA1C KCNH5 CLIC4 SCN3A CACNA1B CACNA1F KCNG2 SCN10A CACNA1E KCNG4 CLIC6 KCNF1 ANO6,MF,24,24 of 41,1.05,58.54,1.365E-12,4.438E-11
GO:0051260,protein homooligomerization,A4FUH1(Evidence code:IEA/Database source:UniProtKB:Q5JU69|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P30273|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)Q05037(Evidence code:IEA/Database source:InterPro:IPR003131)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003131)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003131)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003131)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003131)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q5GFL6|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)P10279(Evidence code:IEA/Database source:InterPro:IPR000817|I)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003131)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)P02668(Evidence code:IDA/Database source:)Q0VD00(Evidence code:IEA/Database source:InterPro:IPR003131)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1B905(Evidence code:IEA/Database source:InterPro:IPR003131), TOR2A IDE KCNMA1 POLQ FCER1G FIS1 CHMP4A PDCD6IP PRTG KCNA4 FLOT1 CHMP2A KCNC3 CHMP4B RASEF SPAST KCNC4 CLDN3 TOR1A KCNG2 NACC1 CRYAB KCNG4 VWA2 PNPT1 TOR1B PRNP KCNF1 TAF10 CSN3 KCTD15 BLM KCTD16,BP,33,33 of 88,1.45,37.5,1.883E-12,6.083E-11
GO:0005923,bicellular tight junction,F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)F1MTP9(Evidence code:IEA/Database source:InterPro:IPR005419)Q3B7N4(Evidence code:IEA/Database source:InterPro:IPR003552|I)Q6BBL6(Evidence code:IEA/Database source:InterPro:IPR003550|I)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)A2VE81(Evidence code:IEA/Database source:InterPro:IPR002958)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)E1BEQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)F1N2D3(Evidence code:IEA/Database source:InterPro:IPR005417|I)A4IFM4(Evidence code:IEA/Database source:InterPro:IPR003926|I)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q765N9(Evidence code:IEA/Database source:InterPro:IPR003549|I)Q29RS2(Evidence code:IEA/Database source:InterPro:IPR005417|I)E1B7V9(Evidence code:IEA/Database source:InterPro:IPR030033)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796), MPDZ RAPGEF2 LIN7C TJP2 CLDN7 CLDN4 MICALL2 RAP2C LIN7A DDX58 OCLN LIN7B AMOTL1 TJP1 CLDN8 C1QTNF5 DLG1 CLDN3 TJP3 MAGI1 F11R,CC,21,21 of 30,0.92,70,2.792E-12,8.966E-11
GO:0001726,ruffle,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)P85091(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:Q15735|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PAK1 CDK6 BAIAP2 MYO6 ARAP3 ARF6 CYFIP1 NF2 MTSS1L CTTN SH2B2 TRPM7 INPP5J WASF2 S100B PLCG1 MYO1C ITGB1,CC,18,18 of 19,0.79,94.74,3.049E-12,9.73E-11
GO:0006974,cellular response to DNA damage stimulus,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q864U1(Evidence code:IEA/Database source:InterPro:IPR031099)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)F1N2G1(Evidence code:IEA/Database source:UniProtKB:Q8NFC6|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)P84798(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)G5E639(Evidence code:IEA/Database source:UniProtKB:P0C2W1|ens)A5PJJ9(Evidence code:IEA/Database source:UniProtKB:Q00526|ens)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens), SETX PLK3 RUVBL2 ZFYVE26 BRCA2 ALKBH2 ASH2L UHRF1 RAD18 BRCA1 INTS3 IKBKG ZBTB4 SFPQ RUVBL1 OTUB1 PSEN1 WRN SMARCAL1 ERCC2 ETAA1 POLQ RIF1 MMS19 MASTL DYRK2 TRAF6 ABL1 LIG1 BRCC3 BCL3 BOD1L1 RAD23B TRIP12 BLM ATM MB21D1 NIPBL POLD3 MCTS1 PARP1 CDC5L E2F7 FBXO45 CDK3 PAXIP1 TAOK3 TAOK2,BP,48,48 of 188,2.11,25.53,3.671E-12,1.165E-10
GO:0031982,vesicle,P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)P63026(Evidence code:ISS/Database source:UniProtKB:P63027)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)Q0III3(Evidence code:ISS/Database source:UniProtKB:Q13409)G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q9HBX8|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q3ZCF0(Evidence code:ISS/Database source:UniProtKB:Q13561)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60880|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)A7YY70(Evidence code:IBA/Database source:PANTHER:PTN001293650)E1BJQ7(Evidence code:IBA/Database source:PANTHER:PTN000956809)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), RAB3C HIST1H1A VAMP2 CHMP4B VPS26A RAB3B DYNC1I2 LGR6 STX7 LAMP1 SYT4 DCTN2 RAB4A MVB12A SNAP25 SRI SLC34A1 GIPC1 NPC1,CC,19,19 of 1000,0.83,1.9,3.744E-12,1.181E-10
GO:0007605,sensory perception of sound,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)P31407(Evidence code:ISS/Database source:UniProtKB:P15313)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)F1MG13(Evidence code:IEA/Database source:InterPro:IPR035487)F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), CACNA1D ATP6V1B1 DNM1 NAV2 CRYM GRM7 SPTBN4 ATP8B1 NIPBL MYO1A POU4F2 TJP1 KCNMA1 COL2A1 MYO15A ATP2B2 ALMS1 GABRA5 CHD7,BP,19,19 of 23,0.83,82.61,3.932E-12,1.229E-10
GO:0031098,stress-activated protein kinase signaling cascade,G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825), PAK4 STK26 MAP2K4 STK25 SLK PAK1 MAP3K4 TAOK3 MAP3K14 PAK2 TAOK2 STK3 PAK3 MAP3K8 MAP3K1 PAK6,BP,16,16 of 13,0.7,123.08,3.944E-12,1.229E-10
GO:0008021,synaptic vesicle,P37359(Evidence code:ISS/Database source:UniProtKB:P28184)F1N159(Evidence code:IEA/Database source:InterPro:IPR001359)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)P17599(Evidence code:IEA/Database source:InterPro:IPR001359)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN001530779)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN001530779)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens)P10949(Evidence code:IEA/Database source:UniProtKB:P62823|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)A0JNA0(Evidence code:IEA/Database source:InterPro:IPR030529)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens), MT3 SYN2 COPS5 SYN1 COPS4 GIPC1 DNAJC5 RAB26 RAB37 LRRK2 SNAP25 SEPT6 RAB3C TOR1A RNF112 RAB3A LAMP1 RAB3B APBA2 PTPRN TRAPPC4,CC,21,21 of 31,0.92,67.74,4.388E-12,1.359E-10
GO:0007165,signal transduction,F1MJI3(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR000159|I)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1B7G7(Evidence code:IEA/Database source:InterPro:IPR000159)F1MS53(Evidence code:IEA/Database source:InterPro:IPR000159)A7Z090(Evidence code:IEA/Database source:InterPro:IPR000488)E1B800(Evidence code:IEA/Database source:InterPro:IPR008936)P04896(Evidence code:IEA/Database source:InterPro:IPR011025)A0JN96(Evidence code:IEA/Database source:InterPro:IPR011524)F1MTR1(Evidence code:IEA/Database source:InterPro:IPR008936)A6QPG6(Evidence code:IBA/Database source:PANTHER:PTN000296773)P04696(Evidence code:IEA/Database source:InterPro:IPR011025)E1BKZ0(Evidence code:IEA/Database source:InterPro:IPR028745)E1BD25(Evidence code:IBA/Database source:PANTHER:PTN000579295)G5E5D0(Evidence code:IEA/Database source:InterPro:IPR000159)E1BF06(Evidence code:IEA/Database source:InterPro:IPR008064)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MD62(Evidence code:IEA/Database source:InterPro:IPR000159|I)A7MB27(Evidence code:IEA/Database source:InterPro:IPR000198|I)Q58DL5(Evidence code:IEA/Database source:InterPro:IPR028849)Q3ZBA8(Evidence code:IBA/Database source:PANTHER:PTN000867215)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR000159|I)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR000159)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BA57(Evidence code:IEA/Database source:InterPro:IPR008936)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR020849)Q3SYX0(Evidence code:IBA/Database source:PANTHER:PTN000867215)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR009471)Q1JQB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR000159|I)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108192)P63217(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR020849)P38408(Evidence code:IEA/Database source:InterPro:IPR011025)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR008936)P04695(Evidence code:IEA/Database source:InterPro:IPR011025)A5PKD6(Evidence code:IEA/Database source:InterPro:IPR016346)G3MWT9(Evidence code:IEA/Database source:InterPro:IPR001573)A4FUC9(Evidence code:IEA/Database source:InterPro:IPR011072)P08487(Evidence code:IEA/Database source:InterPro:IPR001711|I)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR020849)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BB14(Evidence code:IEA/Database source:InterPro:IPR016346)A7YY57(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1B7Q8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)P63097(Evidence code:IEA/Database source:InterPro:IPR011025)Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR000159)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR003116)A7YY44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MZM7(Evidence code:IEA/Database source:InterPro:IPR000198|I)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR020849)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1MRH8(Evidence code:IEA/Database source:InterPro:IPR030520|I)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR011025)E1BPZ4(Evidence code:IEA/Database source:InterPro:IPR008466)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BGE5(Evidence code:IBA/Database source:PANTHER:PTN000108192)F1MS27(Evidence code:IEA/Database source:InterPro:IPR002073|I)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR003116)Q3SZ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000488)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)P30671(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BKU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)A6QLJ4(Evidence code:IBA/Database source:PANTHER:PTN001004344)E1BB73(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR003116)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1B714(Evidence code:IEA/Database source:InterPro:IPR029797)F1MJ20(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001711)A6H7H0(Evidence code:IEA/Database source:InterPro:IPR008936)Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR029586)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR020849)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q29450(Evidence code:IBA/Database source:PANTHER:PTN000228924)E1B801(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BIM3(Evidence code:IEA/Database source:InterPro:IPR000198|I)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR012227)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR011025)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q1LZF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR011025)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR000157)Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN000385798)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR000159)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR020849)A2VDZ0(Evidence code:IEA/Database source:InterPro:IPR002554)A4FV68(Evidence code:IEA/Database source:InterPro:IPR002554)Q1RMI6(Evidence code:IEA/Database source:InterPro:IPR000159)P61635(Evidence code:IEA/Database source:InterPro:IPR001217|I)Q32PI9(Evidence code:IEA/Database source:InterPro:IPR029870)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR011072)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q2YDG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR000159)F1MHG5(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1MM72(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BJP2(Evidence code:IEA/Database source:InterPro:IPR000198|I)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BMN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)P63026(Evidence code:IMP/Database source:)F1MBI8(Evidence code:IEA/Database source:InterPro:IPR008936)E1BB77(Evidence code:IEA/Database source:InterPro:IPR008936)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BLE8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BLK3(Evidence code:IEA/Database source:UniProtKB:Q9JJA9|ens)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR011025), SRGAP3 ARAP3 LOC788626 BCL11A PLEKHH3 RAPGEF6 ANK3 RASAL2 GNAS STK3 IQGAP2 LANCL2 GNAT2 PCNT BCL11B RIN3 TNFSF15 OR13C3 ARHGAP20 ARHGAP36 BCAR3 NDRG2 DGKQ MYO9A HIVEP3 DEPDC1 RAP2C NDRG1 TENM3 GPR4 LOC531090 MYO9B IPO8 GNG5 RIT1 GNA14 RASAL1 GNAT1 GNB4 AKAP12 RHPN2 PLCG1 OR51Q1 HRAS HIVEP1 LOC614090 GNB3 ARHGAP29 PTH2R GNAI1 Grb10 RREB1 PTPRM BRAF F2R SYDE2 RRAS ARHGAP6 SH2B2 GNA13 PPP1R1C ZNF516 IPO7 PDE4D TIAM2 GNG10 BCR NFKB1 STAT5B CDK6 GNG7 ADORA2A CDC42SE2 INPP5B RGS14 IMPA1 ARHGAP26 AXIN1 ARHGAP28 PLCB3 IQGAP3 SHC1 DIRAS2 OR5M11 ADCY7 ARHGAP35 ARHGAP11A CDK3 TRAF6 GNA12 SALL4 PTH1R GNAT3 LGR4 FCER1G TLR4 CRH RRH SNX27 RAP2A PPP2R5A PPP2R5E RASSF4 STAT3 MPZL1 PKN1 CD97 GPRC5C RAPGEF2 ARHGAP21 ARHGAP22 RACGAP1 STAT5A NMBR VAMP2 SYNGAP1 DAB2IP RGR GRM7 GRASP GNAL,BP,121,121 of 809,5.31,14.96,4.517E-12,1.391E-10
GO:0030036,actin cytoskeleton organization,O02811(Evidence code:IBA/Database source:PANTHER:PTN000006021)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR030061)E1BGT8(Evidence code:IEA/Database source:UniProtKB:Q08AE8|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BL04(Evidence code:IEA/Database source:InterPro:IPR012510|I)E1BP72(Evidence code:IEA/Database source:InterPro:IPR033232)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1B718(Evidence code:IEA/Database source:InterPro:IPR010473)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010473)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)Q1RMR9(Evidence code:IEA/Database source:InterPro:IPR028521|I)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010473)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)A2VDK6(Evidence code:IEA/Database source:InterPro:IPR028288)Q28021(Evidence code:IEA/Database source:InterPro:IPR020684)Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR030133)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010473|I), PI4KA ARHGAP26 SPIRE1 SPTA1 SRF PAK2 TAOK2 BCR PAK6 PAK4 XIRP2 CDC42BPB PAK3 FMNL3 SH2B2 PAK1 DAAM1 NF2 CLN3 ABL1 PHACTR4 PACSIN2 FMNL1 MKL1 WASF2 ROCK2 TMOD3 DIAPH3,BP,28,28 of 64,1.23,43.75,4.652E-12,1.424E-10
GO:0005581,collagen trimer,Q1RMH5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q7SIB2(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)F1N0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)F1MJY9(Evidence code:IEA/Database source:InterPro:IPR001442|I)P02459(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)P23206(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)F1N474(Evidence code:IEA/Database source:InterPro:IPR001442|I)P02465(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)F1MJR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q28084(Evidence code:IEA/Database source:InterPro:IPR001442|I)Q28083(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)A5PJL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q7SIB3(Evidence code:IEA/Database source:InterPro:IPR001442|I)Q32S24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)A5D9D7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)A7E2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q29442(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1MUC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)E1BLS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176), C1QC COL4A1 COL5A2 COLEC10 COL4A6 COL2A1 COL10A1 SFTPD COL4A5 COL1A2 COL8A2 COL4A3 COL11A1 C1QTNF5 COL4A2 COL11A2 PLOD3 C1QTNF6 COL4A4 COL15A1 EMILIN1,CC,21,21 of 32,0.92,65.62,6.809E-12,2.072E-10
GO:0005635,nuclear envelope,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000308195)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)Q3T054(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P61283(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BGE5(Evidence code:IBA/Database source:PANTHER:PTN000108134)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)G5E567(Evidence code:IBA/Database source:PANTHER:PTN000108134)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)P27214(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens), WDFY3 SPAG4 RANBP2 IPO8 NPC1 SEC13 PARP1 RAN BANF1 IPO7 TOR1A BICD2 TPR CHMP4B IPO9 KPNB1 CHMP2A ANXA11 SYNE3 TOR1B,CC,20,20 of 28,0.88,71.43,7.035E-12,2.128E-10
GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357), ALOX15 SNAP25 RACGAP1 ABL1 JAK2 TYK2 FERMT2 LCK FRK YES1 ZAP70 SRC SNX18 GRB2 TEC,CC,15,15 of 11,0.66,136.36,7.722E-12,2.323E-10
GO:0008360,regulation of cell shape,F1N3Q4(Evidence code:IEA/Database source:InterPro:IPR004965)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)E1B718(Evidence code:IEA/Database source:InterPro:IPR027655)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q8BKX1)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)P35509(Evidence code:IBA/Database source:PANTHER:PTN000225966)P67827(Evidence code:IBA/Database source:PANTHER:PTN000225966)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0133)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0133)A7E3X2(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR027657)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000225966), PALM KIT SYNE3 FMNL3 BAIAP2 ARAP3 SPTA1 TAOK2 SEMA3E GNA12 CSNK1G3 CSNK1A1 CDC42SE2 GNA13 PRPF40A STRIP2 CYFIP1 CSNK1G1 CRK DLG1 ARHGAP35 FMNL1 CSNK1G2,BP,23,23 of 43,1.01,53.49,1.589E-11,4.724E-10
GO:0005938,cell cortex,Q2NKY7(Evidence code:ISS/Database source:UniProtKB:Q9DE33)Q58DA7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)P63097(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)P03968(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604)Q06002(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q647I9(Evidence code:IDA/Database source:)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)G3MWR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens), SEPT2 GLRX3 NEDD4 GNAI1 FRYL RYR1 NUMA1 TRAF6 MYO9B FGF1 FRY BFSP1 ARF6 NLRP5 GRM7 GPSM2 HMCN1 MICAL3 PSEN1 CTTN GIPC1,CC,21,21 of 34,0.92,61.76,1.582E-11,4.724E-10
GO:0005262,calcium channel activity,F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)O62826(Evidence code:IEA/Database source:InterPro:IPR002153|I)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000699)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR000699)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR000699)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000699)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR002153|I)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR000699)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)O18784(Evidence code:IEA/Database source:InterPro:IPR002153|I)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens), CACNA1E TRPC2 ITPR1 CACNA1D CACNA1S RYR3 RYR2 ITPR2 CACNA1B TRPC3 RYR1 CACNA1C GRIN3B PSEN1 CACNA1F TRPM7 TRPC1 TRPM4,MF,18,18 of 22,0.79,81.82,1.611E-11,4.763E-10
GO:0006796,phosphate-containing compound metabolic process,P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens),IMPA1,BP,1,1 of 417,0.04,0.24,2.338E-11,6.874E-10
GO:0005764,lysosome,Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)G5E657(Evidence code:IEA/Database source:UniProtKB:Q9NQE7|ens)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3T0Q2(Evidence code:ISS/Database source:UniProtKB:Q9BXS4)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q5E998(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q0VD53(Evidence code:IEA/Database source:UniProtKB:O75436|ens)Q3SZJ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q0VD59(Evidence code:ISS/Database source:UniProtKB:Q5T0T0)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q2KJA5(Evidence code:IEA/Database source:InterPro:IPR018397)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8BWC0|ens), CAPN2 fgfr3 HYAL1 PRSS16 TMEM106B UBXN6 LARS TMEM59 FUCA1 SEC13 STX7 LAMP1 RAB9A TSC2 LRRK2 CTSV ARL8B CD63 CHMP2B NPC1 ARSA VPS26A LAMP2 MARCH8 VPS41 SRC NEU4 TINAGL1 CLN3 VPS35 LAPTM5 TPCN2,CC,32,32 of 93,1.4,34.41,2.512E-11,7.346E-10
GO:0035023,regulation of Rho protein signal transduction,F1N6T8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MQ44(Evidence code:IEA/Database source:InterPro:IPR000219)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR000219)E1BG38(Evidence code:IEA/Database source:InterPro:IPR000219)F1MHU4(Evidence code:IEA/Database source:InterPro:IPR000219)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR000219)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)Q58CS5(Evidence code:IEA/Database source:InterPro:IPR000219)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR000219)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR000219)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)F1MRP8(Evidence code:IEA/Database source:InterPro:IPR000219)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MSU8(Evidence code:IEA/Database source:InterPro:IPR000219)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1MY16(Evidence code:IEA/Database source:InterPro:IPR000219|I)F1N657(Evidence code:IEA/Database source:InterPro:IPR000219)A6QLJ4(Evidence code:IEA/Database source:InterPro:IPR039056)A5D793(Evidence code:IEA/Database source:InterPro:IPR000219), VAV2 MCF2L2 PREX1 ARHGEF1 PLEKHG3 TIAM2 EPS8L1 FGD3 ARHGEF12 BCR MYO9B PLEKHG1 TRIO PLEKHG2 FLOT1 AKAP13 SPATA13 CDC42SE2 ECT2,BP,19,19 of 27,0.83,70.37,2.82E-11,8.201E-10
GO:0006464,cellular protein modification process,A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081)A3KN51(Evidence code:IEA/Database source:InterPro:IPR008883)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR008883)P15246(Evidence code:IEA/Database source:InterPro:IPR000682)Q08E58(Evidence code:IEA/Database source:InterPro:IPR004344), UBE2M TSG101 UEVLD PCMT1 TTLL12,BP,5,5 of 565,0.22,0.88,2.84E-11,8.212E-10
GO:0005911,cell-cell junction,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q86SQ7|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1PBJ0)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8N157)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)A4FUY1(Evidence code:IEA/Database source:UniProtKB:Q14CZ8|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR030720)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q9R1N9|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:Q14517|ens)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens), TWF1 WASF2 SDCCAG8 RAPGEF2 DLG1 KIT LIN7B CLIC4 LIN7C PTK7 AHI1 FABP7 PAK1 HEPACAM GRB2 TJP1 PKP4 MICALL2 SCRIB PCDH12 PTPN6 CTNND1 LIN7A FLOT1 COL13A1 PACSIN2 ZAP70 FAT1 PTPRM OCLN FRS2,CC,31,31 of 88,1.36,35.23,3.127E-11,8.994E-10
GO:0032559,adenyl ribonucleotide binding,P58108(Evidence code:IEA/Database source:InterPro:IPR039166),PRKAG1,MF,1,1 of 412,0.04,0.24,3.454E-11,9.88E-10
GO:0005085,guanyl-nucleotide exchange factor activity,F1MS53(Evidence code:IEA/Database source:InterPro:IPR001895)Q5E9S7(Evidence code:IEA/Database source:InterPro:IPR001895|I)G3MXA5(Evidence code:IEA/Database source:InterPro:IPR033360)Q58DL5(Evidence code:IEA/Database source:InterPro:IPR001895|I)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)Q32P83(Evidence code:IEA/Database source:InterPro:IPR007515)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR028570)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR001331)E1BPX7(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1N657(Evidence code:IEA/Database source:InterPro:IPR001331)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR001331|I)E1B7C4(Evidence code:IEA/Database source:InterPro:IPR026791)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR001331)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR001331)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR001895)E1BK77(Evidence code:IEA/Database source:InterPro:IPR026791|I)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0344)F1MQ43(Evidence code:IEA/Database source:InterPro:IPR026791|I)A5D793(Evidence code:IEA/Database source:InterPro:IPR001331|I)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR001331), RAPGEF6 RASGEF1A TIAM1 BCAR3 MYCBP2 RABIF TRIO BCR RAPGEF4 SPATA13 EIF2B5 ARHGEF12 DOCK10 VAV2 PREX1 RAPGEF2 DOCK6 ARFGEF1 DOCK9 ECT2 TIAM2,MF,21,21 of 36,0.92,58.33,3.518E-11,1.001E-09
GO:0007507,heart development,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)Q2YDD2(Evidence code:ISS/Database source:UniProtKB:Q9DB90)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1BL04(Evidence code:IEA/Database source:InterPro:IPR030072|I)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MF74(Evidence code:ISS/Database source:UniProtKB:F1RA39)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), MTHFD1 SALL4 GLI2 RPS6KA2 PSEN1 SOX4 POU4F2 SMG9 DNAH5 XIRP2 SRF MICAL2 FREM2 PRKDC NIPBL FOXF1 DNAH11 BCOR CRKL PTK7,BP,20,20 of 32,0.88,62.5,4.083E-11,1.155E-09
GO:0004721,phosphoprotein phosphatase activity,A6QLS1(Evidence code:IEA/Database source:EC:3.1.3.16)A6QQD4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)P11064(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)E1BPU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)Q32PA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)E1BD03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)A5D980(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)E1BDE3(Evidence code:IBA/Database source:PANTHER:PTN000258719)Q58DC0(Evidence code:IEA/Database source:EC:3.1.3.16)P48452(Evidence code:IEA/Database source:EC:3.1.3.16)Q3SWW9(Evidence code:IEA/Database source:EC:3.1.3.16)Q3ZBF9(Evidence code:IDA/Database source:)A5D7T5(Evidence code:IEA/Database source:EC:3.1.3.16)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)P67774(Evidence code:IEA/Database source:EC:3.1.3.16)Q0P594(Evidence code:IEA/Database source:EC:3.1.3.16)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:Q9D7X3|ens)F6RRD7(Evidence code:IEA/Database source:EC:3.1.3.16)P61287(Evidence code:IEA/Database source:EC:3.1.3.16)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904), DUSP7 PTPN5 ACP1 PTPRM PHPT1 PPM1D PTPN6 CTDSP1 CPPED1 PPP3CA PPP1CB PDXP PPP3CC PTPRZ1 PPP2CA PPP2CB PTPRA DUSP3 RPAP2 PPP1CC PPP2R5A PTPN14,MF,22,22 of 41,0.96,53.66,4.146E-11,1.167E-09
GO:0007186,G-protein coupled receptor signaling pathway,G3N0Y0(Evidence code:IEA/Database source:InterPro:IPR000276|I)P05131(Evidence code:IEA/Database source:InterPro:IPR039083)Q2YDG0(Evidence code:IEA/Database source:InterPro:IPR017978)P04695(Evidence code:IEA/Database source:InterPro:IPR001019|I)F1MR98(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1BMN4(Evidence code:IEA/Database source:InterPro:IPR000276|I)P47803(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469|I)E1BMX7(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR000832|I)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019|I)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR000832|I)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367|I)A7MB15(Evidence code:IEA/Database source:GO:0004930)F1MLX5(Evidence code:IEA/Database source:InterPro:IPR000276|I)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469|I)Q3SZ98(Evidence code:IEA/Database source:InterPro:IPR001770|I)F1MSU3(Evidence code:IEA/Database source:InterPro:IPR000276)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR000832|I)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MM21(Evidence code:IEA/Database source:InterPro:IPR015898|I)E1BMY3(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P63097(Evidence code:IEA/Database source:InterPro:IPR001019|I)P30671(Evidence code:IEA/Database source:InterPro:IPR001770|I)E1BEB2(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR017978)G3X828(Evidence code:IEA/Database source:InterPro:IPR000276|I)P38408(Evidence code:IEA/Database source:InterPro:IPR000654|I)F1MG76(Evidence code:IEA/Database source:InterPro:IPR000276)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)E1BLE8(Evidence code:IEA/Database source:InterPro:IPR000162|I)Q1JQB3(Evidence code:IEA/Database source:InterPro:IPR000276|I)P04896(Evidence code:IEA/Database source:InterPro:IPR000367|I)P04696(Evidence code:IEA/Database source:InterPro:IPR001019|I)E1BKU0(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3X8A9(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037801|I)P63217(Evidence code:IEA/Database source:InterPro:IPR001770|I)G3X6G8(Evidence code:IEA/Database source:InterPro:IPR002131)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7), LOC788626 PRKACB GPRC5C GNAT1 RRH BAIAP3 NMBR RGR DGKQ GNA12 OR51Q1 PTH1R GNAT3 PTH2R GNAL FZD1 LGR4 GNA13 GNG10 RXFP3 CD97 F2R RGS6 LOC614090 ABCA1 GNAI1 GNG7 LOC531090 GPR179 OR13C3 GNA14 GPR75 PREX1 GRM7 GPR4 GNAS GNAT2 ADORA2A OR5M11 ARHGEF12 GNG5 LGR6 RAPGEF2,BP,43,43 of 168,1.89,25.6,4.271E-11,1.195E-09
GO:0017137,Rab GTPase binding,F1N746(Evidence code:IEA/Database source:UniProtKB:Q9Y3P9|ens)E1BKQ2(Evidence code:IEA/Database source:InterPro:IPR037789)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)F1N2I0(Evidence code:IEA/Database source:UniRule:UR000859759)E1BBK9(Evidence code:IEA/Database source:InterPro:IPR010911)E1BDC9(Evidence code:IBA/Database source:PANTHER:PTN000367098)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)A7E3D4(Evidence code:IEA/Database source:InterPro:IPR037789)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)F6REL8(Evidence code:IEA/Database source:InterPro:IPR028563)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)A6QP06(Evidence code:IEA/Database source:InterPro:IPR010911|I), RABGAP1 RAB11FIP1 ANKFY1 RIN3 CHML SYTL1 VPS52 RIMS1 DENND1A RAB11FIP2 SGSM2 MICALL2 BICD2 TBC1D22B TBC1D2 TBC1D12 HPS6 SYTL2,MF,18,18 of 24,0.79,75,4.416E-11,1.229E-09
GO:0030054,cell junction,Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)E1B968(Evidence code:IEA/Database source:UniProtKB:P52569|ens)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A4IFM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BL04(Evidence code:IEA/Database source:InterPro:IPR012510)E1BQ03(Evidence code:IEA/Database source:UniProtKB:A0A024R7E0)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MJ11(Evidence code:IEA/Database source:UniProtKB:Q99569|ens)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q2YDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q9XT97(Evidence code:IEA/Database source:UniProtKB:A0A024R6A3)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)Q01107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q765N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1N2D3(Evidence code:IEA/Database source:UniProtKB:G3V1L9|ens), ITGB6 F11R LIN7B ABHD17C MAGI1 SLC7A2 COPS4 FAT1 GRIA1 LIN7C ABCA7 LIN7A GRIA3 SYN1 DSTYK CLDN8 CHRNE CLDN7 TBC1D2 VAMP1 CYFIP1 PAK1 DNM2 DPP4 CLDN4 XIRP2 NACC1 DLG1 SCRIB PKP4 NRXN1 VAMP2 TES ARHGAP21 GRIA2 ITGB1 OCLN CDK5RAP2 UTRN ITGAV RAPGEF2 CAMK2B OSBP GABRA5 PANX3 PTPRN CTNNA1 PRUNE1 SH3GL1 HMCN1 AMOTL1 PSEN1 RNF112 RAB23 DSC1 S100A14 SNAP25 SEPT11 CLDN3 SVIL VAMP3 TJP1,CC,62,62 of 315,2.72,19.68,5.48E-11,1.518E-09
GO:0006511,ubiquitin-dependent protein catabolic process,E1BMF7(Evidence code:IEA/Database source:InterPro:IPR018200)Q3ZCF3(Evidence code:IEA/Database source:InterPro:IPR001232|I)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)E1BND0(Evidence code:IEA/Database source:InterPro:IPR018200)A7Z056(Evidence code:IEA/Database source:InterPro:IPR018200)F1MF37(Evidence code:IEA/Database source:InterPro:IPR018200)E1BG52(Evidence code:IEA/Database source:InterPro:IPR018200)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR000426)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P35998)G5E630(Evidence code:IEA/Database source:InterPro:IPR018200)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR019474)Q08DE9(Evidence code:IEA/Database source:InterPro:IPR001373|I)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR018200)A1L548(Evidence code:IEA/Database source:InterPro:IPR018200)F1N0A8(Evidence code:IEA/Database source:InterPro:IPR018200)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q3UE37|ens)A6H7B5(Evidence code:IBA/Database source:PANTHER:PTN000079485)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR000426)E1BGW4(Evidence code:IEA/Database source:InterPro:IPR018200)G5E639(Evidence code:IEA/Database source:UniProtKB:P0C2W1|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629793)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)E1BIN5(Evidence code:IEA/Database source:InterPro:IPR001373|I)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)F1MYD0(Evidence code:IEA/Database source:InterPro:IPR001373|I)A2VE03(Evidence code:IEA/Database source:InterPro:IPR024928)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR000426)Q0P568(Evidence code:IEA/Database source:InterPro:IPR004854)B7TCH8(Evidence code:IEA/Database source:InterPro:IPR018200)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens), USP13 SKP1 TRIP12 USP24 USP20 USP31 USP35 PSMA3 PSMC2 USP9X UBE4B CUL2 RANBP2 USP32 USP5 USP34 NEDD4 UBE2Z COPS3 PSMD13 PSMA7 USP36 FBXO45 UBR2 UBE2G2 SYVN1 CUL3 UHRF1 CUL1 ITCH ARRDC1 CBLC PSMA4 UFD1L USP9Y RFFL,BP,36,36 of 122,1.58,29.51,5.709E-11,1.573E-09
GO:0031594,neuromuscular junction,F1MRT9(Evidence code:IEA/Database source:UniProtKB:E9Q6R7|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)P02715(Evidence code:IEA/Database source:UniProtKB:P20782|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)E1B7T7(Evidence code:IEA/Database source:UniProtKB:Q8R1C0|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens), UTRN DNAJC5 CHRNE UNC13A KCNC4 PRKACA PSEN1 UNC13B CRKL DLGAP3 COL4A5 DLG1 F2R LAMB2 TUBA1A,CC,15,15 of 14,0.66,107.14,6.397E-11,1.753E-09
GO:0008284,positive regulation of cell proliferation,E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)Q95M13(Evidence code:IEA/Database source:InterPro:IPR016248)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1MN49(Evidence code:IEA/Database source:UniProtKB:Q9GZV4|ens)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), ASH2L NUDT16 CRKL WWTR1 MARCH7 SPHK2 DOT1L RPS15A PDGFC PTPN6 RAB25 DPP4 TCL1A F2R SUZ12 BIRC6 DLG1 STAT5A RPS9 PKHD1 fgfr3 PLAC8 TRPM4 EIF4G1 PROK1 PURA PAK1 FGF1 EIF5A2 CDK6 LEF1 KIT SOX4 STAT5B CDK3 NACC1 TBX3 GLI1 SAPCD2 GLI2 PDCD10 KIF14,BP,42,42 of 164,1.84,25.61,6.986E-11,1.904E-09
GO:0048365,Rac GTPase binding,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)F1MJI3(Evidence code:IBA/Database source:PANTHER:PTN001021265)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)P85091(Evidence code:IDA/Database source:)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens), MTSS1L SRGAP3 PAK2 PAK4 NCKAP1 PKN1 PAK6 FMNL1 PAK3 CYFIP1 IQGAP2 PAK1,MF,12,12 of 6,0.53,200,8.832E-11,2.395E-09
GO:0005200,structural constituent of cytoskeleton,Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR002452)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR002453)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR002452)F6RP72(Evidence code:IEA/Database source:InterPro:IPR002452)P81948(Evidence code:IEA/Database source:InterPro:IPR002452)F1N611(Evidence code:IBA/Database source:PANTHER:PTN001150527)F1MKE9(Evidence code:IEA/Database source:InterPro:IPR016343)E1B953(Evidence code:IEA/Database source:InterPro:IPR002453)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR002453)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR002453)E1BLT3(Evidence code:IEA/Database source:InterPro:IPR016343)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR002452)F1MGE1(Evidence code:IBA/Database source:PANTHER:PTN001150527)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR002452)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR002452)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR030634), TUBA8 TUBB4A TUBA1A LOC100295712 TUBA4A EPB41L1 SPTB LOC533307 TUBB1 TUBB3 SPTBN4 TUBA3E FRMD5 TUBA1D LOC100141266 TUBGCP2 SYNM,MF,17,17 of 22,0.75,77.27,1.098E-10,2.961E-09
GO:0008285,negative regulation of cell proliferation,Q2YDE9(Evidence code:ISS/Database source:UniProtKB:Q9UGI8)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR031215)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)O46414(Evidence code:ISS/Database source:UniProtKB:Q8TD27)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)Q58DD3(Evidence code:ISS/Database source:UniProtKB:P25686)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)G3X749(Evidence code:IEA/Database source:UniProtKB:Q96F45|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q96AV8)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens), TES SH3BP4 IRF1 COPS8 F2R CEBPA DAB2IP FAM129B INSM1 IGFBP3 ADARB1 FTH1 ALOX15B fgfr3 DNAJB2 FOXO4 STK3 EEF1E1 SIRT6 KMT2A PHF14 RAPGEF2 PTPN14 TSG101 SMARCA2 SOX4 ZBTB17 NF2 RNF139 SIRT2 ZNF503 BCL11B AXIN2 E2F7 TAX1BP3,BP,35,35 of 119,1.54,29.41,1.121E-10,3.008E-09
GO:0060271,cilium assembly,E1BIU7(Evidence code:IEA/Database source:InterPro:IPR028770)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462267)F1MQV5(Evidence code:IEA/Database source:InterPro:IPR033561)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223362)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)P61420(Evidence code:ISS/Database source:UniProtKB:Q6PGV1)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223362)E1BK86(Evidence code:IEA/Database source:UniProtKB:E9PZ36|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223362)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223362)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:Q9H0T7|ens)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:P42208)Q0IIM2(Evidence code:ISS/Database source:UniProtKB:Q9H0F7), PTPN23 TEKT4 FBF1 RPGRIP1L DYNLL1 IQUB PCNT SEPT7 AHI1 ATP6V0D1 RAB23 PCM1 STK36 WWTR1 DYNLL2 PKHD1 ONECUT2 LOC101902172 ALMS1 LOC101905447 C1H21ORF2 RAB17 SEPT2 ARL6,BP,24,24 of 55,1.05,43.64,1.558E-10,4.161E-09
GO:0007409,axonogenesis,Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN000689595)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q64511|ens)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:P53810|ens)P02638(Evidence code:NAS/Database source:)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)A2VDN5(Evidence code:IEA/Database source:UniRule:UR000107246), PRELP SPTBN4 PTPRZ1 FLOT1 RNF165 TAOK2 CNP PAK3 TOP2B PITPNA S100B BCL11B RAB3A POU4F2 RTN4R SPAST,BP,16,16 of 19,0.7,84.21,1.605E-10,4.264E-09
GO:0007018,microtubule-based movement,Q3T140(Evidence code:IEA/Database source:InterPro:IPR016561)F1N724(Evidence code:IEA/Database source:InterPro:IPR004273|I)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752|I)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752|I)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)Q0III3(Evidence code:IEA/Database source:InterPro:IPR025956)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752|I)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR004273|I)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR004273|I)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR004273|I)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q2KII9(Evidence code:IEA/Database source:InterPro:IPR008467)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752|I)G3N1E4(Evidence code:IBA/Database source:PANTHER:PTN000649056)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR004273|I), DYNLRB1 DNAH11 KIF1B KIF14 BICD2 DYNC1I2 KIF13A KIF23 KIF5C DYNC1H1 KIF26B DNHD1 KIF5A DNAH7 KIFC1 DNAH10 DYNC1LI1 KIF2A KIF13B KIF15 KIFC3 KIF5B KIF26A DNAH5,BP,24,24 of 56,1.05,42.86,2.085E-10,5.511E-09
GO:0090263,positive regulation of canonical Wnt signaling pathway,E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q5VTB9)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens), TNKS NFKB1 SRC LRRK1 RUVBL1 PTK7 LGR4 VPS35 RNF220 WNK1 SOX4 TRPM4 CCAR2 LRRK2 PIN1,BP,15,15 of 16,0.66,93.75,2.181E-10,5.709E-09
GO:0007229,integrin-mediated signaling pathway,P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)A6QQ97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1MMH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)A7MB21(Evidence code:IEA/Database source:InterPro:IPR037837|I), ITGAL TEC ITGAV ITGA2 ITGB1 ITGB6 ITGAD SRC ITGA9 CUL3 ABL1 ITGB7 FCER1G ADAM15 FERMT2,BP,15,15 of 16,0.66,93.75,2.181E-10,5.709E-09
GO:0016477,cell migration,E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1BP72(Evidence code:IEA/Database source:InterPro:IPR033232)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MP76(Evidence code:IBA/Database source:PANTHER:PTN000099415)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q5E963(Evidence code:IBA/Database source:PANTHER:PTN000974138)G3MXG3(Evidence code:IEA/Database source:InterPro:IPR027717)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)A4FUD6(Evidence code:IEA/Database source:InterPro:IPR030713)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q5E9S7(Evidence code:IEA/Database source:UniProtKB:Q8N9B8|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN001231165)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)G5E630(Evidence code:IBA/Database source:PANTHER:PTN001163006)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN001231165)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1B718(Evidence code:IEA/Database source:InterPro:IPR027655)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326), PAK6 GOLPH3 FRK CDC42BPB PRPF40A SRC SDC3 CUL3 ARPC5L CCDC88A CD63 ELMO2 WWC1 ADAMTS12 VAV2 PAK3 RASGEF1A GRB2 MYO18A PEAK1 LCK ASTN1 PAK4 STRIP2 PTK7 EMILIN1 GSK3A PAK1 USP9X SCRIB TYK2 ARHGAP35 CLN3 ZAP70 YES1 JAK2 FMNL3 PAK2,BP,38,38 of 143,1.67,26.57,2.205E-10,5.741E-09
GO:0008237,metallopeptidase activity,Q3SZH7(Evidence code:IEA/Database source:InterPro:IPR014782|I)P42891(Evidence code:IEA/Database source:InterPro:IPR024079)G3MZT7(Evidence code:IEA/Database source:InterPro:IPR024079)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)F1MRA8(Evidence code:IEA/Database source:InterPro:IPR024079)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR024079)F1MF35(Evidence code:IEA/Database source:InterPro:IPR006026|I)Q9TT92(Evidence code:IEA/Database source:InterPro:IPR024079)P12820(Evidence code:IEA/Database source:InterPro:IPR001548)Q9TT93(Evidence code:IEA/Database source:InterPro:IPR024079)G3X743(Evidence code:IEA/Database source:InterPro:IPR014782|I)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR024079)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR024079)E1BBU4(Evidence code:IEA/Database source:InterPro:IPR024079)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR006026|I)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)E1BFV4(Evidence code:IEA/Database source:InterPro:IPR024079)E1BP91(Evidence code:IEA/Database source:InterPro:IPR014782), LTA4H ECE1 LOC531521 XPNPEP1 ADAM7 DNPEP IDE ADAMTS12 TLL2 ADAMTS5 ACE ADAMTS4 RNPEP MBTPS2 BRCC3 ADAMTS18 ADAMTS7 ADAM15 COPS5 MMP19 DPEP3 ADAMTS14 NPEPPS,MF,23,23 of 51,1.01,45.1,2.228E-10,5.773E-09
GO:1902531,regulation of intracellular signal transduction,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997),LEMD3,BP,1,1 of 382,0.04,0.26,2.423E-10,6.246E-09
GO:0030286,dynein complex,F1N1K6(Evidence code:IEA/Database source:InterPro:IPR004273)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR004273)F1ME41(Evidence code:IEA/Database source:InterPro:IPR001372|I)E1B7A3(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q3MHR3(Evidence code:IEA/Database source:InterPro:IPR001372|I)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR004273)F1N724(Evidence code:IEA/Database source:InterPro:IPR004273)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR004273)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR004273)P61285(Evidence code:IEA/Database source:InterPro:IPR001372|I), DNHD1 DYNLRB1 DCTN2 DNAH7 LOC101902172 LOC101905447 DYNLL2 DNAH10 DNAH11 DYNC1I2 DYNC1H1 DYNLT1 DNAH5 DYNLL1,CC,14,14 of 13,0.61,107.69,2.671E-10,6.82E-09
GO:0001843,neural tube closure,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)A6H769(Evidence code:IEA/Database source:UniProtKB:P62082|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens), TRAF6 ARHGAP35 ABL1 LRP6 PRKACB SALL4 PTK7 SCRIB RPS7 PHACTR4 SHROOM3 PRKACA MTHFD1 ARID1A,BP,14,14 of 13,0.61,107.69,2.671E-10,6.82E-09
GO:0007266,Rho protein signal transduction,Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037801)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7), PAK1 COL1A2 PAK3 ROCK2 GNA12 EPS8L1 GNA13 TAX1BP3 ARHGEF12 PAK2 PAK6 PAK4 PHACTR4,BP,13,13 of 10,0.57,130,2.792E-10,7.06E-09
GO:0006342,chromatin silencing,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)E1BLK1(Evidence code:IBA/Database source:PANTHER:PTN000968522)A0A0A0MP90(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR021169)Q3ZBX9(Evidence code:IBA/Database source:PANTHER:PTN000604564)A0A0A0MP93(Evidence code:IBA/Database source:PANTHER:PTN000604564)P0C0S4(Evidence code:IBA/Database source:PANTHER:PTN000604564)A4IFU5(Evidence code:IBA/Database source:PANTHER:PTN000604564)A0A0A0MPA2(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BH22(Evidence code:IBA/Database source:PANTHER:PTN000604564)F1MM81(Evidence code:IBA/Database source:PANTHER:PTN000968522)G8JL00(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens), UBR2 TNRC18 HIST1H2AC DOT1L H2AFJ LOC614881 H2AFZ HIST3H2A HIST1H2AJ HIST2H2AB BAHCC1 LOC104975684 PPM1D,BP,13,13 of 10,0.57,130,2.792E-10,7.06E-09
GO:0030117,membrane coat,E1BME2(Evidence code:IEA/Database source:InterPro:IPR002553)P35604(Evidence code:IEA/Database source:InterPro:IPR000804)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR000804)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A2VE21(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692)A0JN39(Evidence code:IEA/Database source:InterPro:IPR002553)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR000804)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q0IIM2(Evidence code:IDA/Database source:)P63009(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens), AP3B2 COPZ1 COPB2 AP2B1 AP2A2 AP2S1 CHMP4B COPG2 COPA COPB1 AP2A1 AP1S1 CHMP4A CHMP2A ARL6 AP2B1 DNM1,CC,17,17 of 24,0.75,70.83,2.867E-10,7.215E-09
GO:0050821,protein stabilization,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q05204(Evidence code:ISS/Database source:UniProtKB:P11438)P02668(Evidence code:IBA/Database source:PANTHER:PTN000895253)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)E1BGW4(Evidence code:IEA/Database source:UniProtKB:B1AQJ2|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O95785|ens)E1BJ75(Evidence code:IEA/Database source:UniProtKB:O75718|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), STK3 CCT3 PIN1 CRYAB SYVN1 HCFC1 AAK1 BAG5 SOX17 FLOT1 LAMP1 CSN3 USP13 USP36 PDCD10 MARCH7 SOX4 USP9X WIZ CRTAP MT3 PINK1,BP,22,22 of 47,0.96,46.81,3.129E-10,7.837E-09
GO:0000413,protein peptidyl-prolyl isomerization,Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)P48820(Evidence code:IEA/Database source:InterPro:IPR002130)Q32PA9(Evidence code:IEA/Database source:GO:0003755)G3X8B1(Evidence code:IEA/Database source:InterPro:IPR002130)P26882(Evidence code:IEA/Database source:InterPro:IPR002130)Q29RZ2(Evidence code:IEA/Database source:InterPro:IPR002130)Q5BIN5(Evidence code:IEA/Database source:GO:0003755)Q2KJC8(Evidence code:IEA/Database source:GO:0003755)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)Q2KJ44(Evidence code:IEA/Database source:GO:0003755)A4FV72(Evidence code:IEA/Database source:InterPro:IPR002130), FKBP4 RANBP2 FKBP2 LOC613401 PPID PPWD1 PIN1 FKBP9 FKBP5 PTPA PPIE,BP,11,11 of 5,0.48,220,3.349E-10,8.23E-09
GO:0045505,dynein intermediate chain binding,P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q3T140(Evidence code:IBA/Database source:PANTHER:PTN002244005)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491), DYNLL1 LOC101905447 DNAH10 DNHD1 LOC101902172 DNAH5 DNAH11 DYNLL2 DYNLRB1 DYNC1H1 DNAH7,MF,11,11 of 5,0.48,220,3.349E-10,8.23E-09
GO:0051959,dynein light intermediate chain binding,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491), BICD2 LOC101905447 DNAH7 LOC101902172 DYNLL2 DYNC1H1 DNAH5 DNAH11 DNAH10 DYNLL1 DNHD1,MF,11,11 of 5,0.48,220,3.349E-10,8.23E-09
GO:0009898,cytoplasmic side of plasma membrane,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)G5E526(Evidence code:IEA/Database source:UniProtKB:Q93096|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), TRAF6 ATP2C2 CHMP4A DLG1 LITAF fgfr3 PTP4A1 PKP4 G6PD CHMP4B PPP3CA,CC,11,11 of 5,0.48,220,3.349E-10,8.23E-09
GO:0003714,transcription corepressor activity,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)Q3MI00(Evidence code:ISS/Database source:UniProtKB:P0DMV8)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q66L42|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR033277)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)E1BGF9(Evidence code:IBA/Database source:PANTHER:PTN001435424)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR013289)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8), TCF7L2 AEBP2 DNAJB1 NPAT CRYM COPS2 MAP3K10 E2F7 ZNF366 CTBP1 POU4F2 GON4L SIRT6 TSG101 ZHX3 BCOR CBFA2T2 WWTR1 PRMT5,MF,19,19 of 33,0.83,57.58,3.514E-10,8.596E-09
GO:0033554,cellular response to stress,Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173),GCN1L1,BP,1,1 of 375,0.04,0.27,3.575E-10,8.702E-09
GO:0032991,protein-containing complex,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:P11274|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q92598|ens)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)E1BJ75(Evidence code:ISS/Database source:UniProtKB:Q90830)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens)Q2YDE9(Evidence code:IEA/Database source:UniProtKB:Q9UGI8|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)Q3SZD5(Evidence code:IEA/Database source:UniProtKB:Q66K64|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1BAD4(Evidence code:IDA/Database source:)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)F1MSL9(Evidence code:IEA/Database source:UniProtKB:Q9NYU1|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BAH0(Evidence code:IEA/Database source:UniProtKB:O75420|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)F1MDV3(Evidence code:IEA/Database source:UniProtKB:Q13884|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens), ACR FIS1 PCM1 STK3 BCR UTRN MIER1 LSM4 H3F3B PAK1 SALL4 TJP1 CRK XPO1 HSPH1 UBE2D2 UBQLN1 PSEN1 IPO4 RNF165 PRKAR2A TCL1A POLG E2F1 MPP5 EPS8L1 CRTAP WASF2 PRKDC TRAF6 ZBTB17 BRCA2 PTPN6 GPSM2 KPNB1 RAPGEF2 RYR1 PLCB3 TES HCFC1 BCL3 NCOA3 PPP1CC DCAF15 NUMA1 SASH1 RUNX1 DOT1L UGGT2 ABL1 KEAP1 GIGYF1 MALT1 SNTB1 CKAP5,CC,55,55 of 1693,2.41,3.25,4.51E-10,1.093E-08
GO:0003713,transcription coactivator activity,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BPF3(Evidence code:IEA/Database source:InterPro:IPR015668)E1B8K0(Evidence code:IEA/Database source:InterPro:IPR015668)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)E1BNH7(Evidence code:IEA/Database source:UniProtKB:Q9BZ95|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR009110|I), TAF10 UBE2L3 WWC1 DHX9 MKL1 ASXL1 POU3F1 SOX17 HCFC1 SMARCA2 TAF4B MAML2 NPAT BCL9 BCL9L FAM129B RUVBL1 RAP2C CEBPA LPIN2 SOX4 BRCA1 WHSC1L1 WWTR1 NCOA3,MF,25,25 of 65,1.1,38.46,5.459E-10,1.317E-08
GO:0003824,catalytic activity,E1BPZ8(Evidence code:IEA/Database source:InterPro:IPR002591|I)Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR001509)E1BI49(Evidence code:IEA/Database source:InterPro:IPR012341)E1BCH6(Evidence code:IEA/Database source:InterPro:IPR018294)F1MIU7(Evidence code:IEA/Database source:InterPro:IPR000873)Q5I598(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011034)F1MLE1(Evidence code:IEA/Database source:InterPro:IPR000873)E1BM45(Evidence code:IEA/Database source:InterPro:IPR002591|I)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR015813)Q08DD1(Evidence code:IEA/Database source:InterPro:IPR017849|I)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)A5PK51(Evidence code:IEA/Database source:InterPro:IPR013785)Q5E985(Evidence code:IEA/Database source:InterPro:IPR013785)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR004838|I)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR005811)A3KN12(Evidence code:IEA/Database source:InterPro:IPR008948|I)Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR015421|I)F1MJ90(Evidence code:IEA/Database source:InterPro:IPR008928)Q3T0S5(Evidence code:IEA/Database source:InterPro:IPR013785)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR006047|I)Q17QI3(Evidence code:IEA/Database source:InterPro:IPR016039)Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR000845|I)Q17QK4(Evidence code:IEA/Database source:InterPro:IPR000639)Q32L93(Evidence code:IEA/Database source:InterPro:IPR001093|I)Q1KZG4(Evidence code:IEA/Database source:InterPro:IPR011146)A6QPY4(Evidence code:IEA/Database source:InterPro:IPR017849|I)A7E3D9(Evidence code:IEA/Database source:InterPro:IPR000873)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR013785)A5PJL6(Evidence code:IEA/Database source:InterPro:IPR011766)F1MPW1(Evidence code:IEA/Database source:InterPro:IPR000873)A7YY67(Evidence code:IEA/Database source:InterPro:IPR011034)E1BP41(Evidence code:IEA/Database source:InterPro:IPR015421)F1MI35(Evidence code:IEA/Database source:InterPro:IPR011041)Q24K02(Evidence code:IEA/Database source:InterPro:IPR011249)A8E657(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)A2VDS1(Evidence code:IEA/Database source:InterPro:IPR015421|I)G3MXQ8(Evidence code:IEA/Database source:InterPro:IPR012341)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR015421)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR015955)E1BM12(Evidence code:IEA/Database source:InterPro:IPR001045)Q148K4(Evidence code:IEA/Database source:InterPro:IPR004113|I)P15101(Evidence code:IEA/Database source:InterPro:IPR008977)A6QLY4(Evidence code:IEA/Database source:InterPro:IPR000868|I)A7MBJ3(Evidence code:IEA/Database source:InterPro:IPR012341)A4FUD0(Evidence code:IEA/Database source:InterPro:IPR020867)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR015813)Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR016039)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q28007(Evidence code:IEA/Database source:InterPro:IPR013785)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR011013|I)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)E1BD03(Evidence code:IEA/Database source:InterPro:IPR001932)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR010997)Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR016193)A6QPG6(Evidence code:IEA/Database source:InterPro:IPR012341)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR001093|I)E1B7K0(Evidence code:IEA/Database source:InterPro:IPR013785)Q75WB5(Evidence code:IEA/Database source:InterPro:IPR003692)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q1RMX7(Evidence code:IEA/Database source:InterPro:IPR013785)P31754(Evidence code:IEA/Database source:InterPro:IPR011060|I)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR010997)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q2YDJ4(Evidence code:IEA/Database source:InterPro:IPR011146)A7YWF1(Evidence code:IEA/Database source:InterPro:IPR000873), PIGO TSTA3 MAN1A2 ISPD SLC27A3 MTHFR ALDH1L2 DIP2B PIGN PKM ARSA PAK1 NAPRT HYAL1 TAT ACLY ADSL SHMT2 PHKB ALDOB GBE1 ACAT2 MTAP EPHX2 GMPR2 FHIT SGSH ACSL4 GART HAO2 HACL1 DIP2A ALDH1L1 CSAD HHIPL1 IDE AASS SCLY MAN1B1 PDXDC1 UEVLD SRM LDHD DBH ISOC1 EDEM2 MTHFD1 PKLR HMGCS1 LYZ1 SPAST DPYD MAN2C1 PFKP PPM1D BLM ATIC LANCL2 IMPDH2 GALC OPLAH PAH NANS UMPS WRN PFKM HINT3 ACSS2,MF,68,68 of 1952,2.98,3.48,5.655E-10,1.355E-08
GO:0045893,"positive regulation of transcription, DNA-templated",Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)F1MBK6(Evidence code:IEA/Database source:UniProtKB:Q5T1R4|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR008013)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BNH7(Evidence code:IEA/Database source:UniProtKB:Q9BZ95|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)Q5NUA6(Evidence code:IBA/Database source:PANTHER:PTN000696756)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BAD4(Evidence code:IEA/Database source:UniRule:UR000461770)Q05B89(Evidence code:IEA/Database source:UniProtKB:Q9GZT8|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:Q9WVH3|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR008013), AFAP1L2 HIVEP3 TBX3 CDK5RAP2 EAF2 BRCA2 CHD8 SOX17 GATA6 ZFHX3 SRF NFKB1 WHSC1L1 ESRRG IRF1 NFE2L2 ARID1A PSEN1 SP1 SOX4 ERCC2 BCL3 FOXF1 RUNX1 NIF3L1 FAM129B KMT2A FOXO4 LEF1 STAT3 BRCA1 GLI1 HCFC1 LRP6 POU3F1 FZD1 TAF8 E2F1 RAI1 MT3 BLM GLI2 F2R SMARCA2 NR1I2 ZNF516 NPAT AXIN1 MKL1 EMILIN1 ZBTB17 gata4,BP,52,52 of 255,2.28,20.39,5.671E-10,1.355E-08
GO:0030097,hemopoiesis,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)F1MS56(Evidence code:IEA/Database source:UniProtKB:Q9CYR6|ens)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR030118)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)E1BDL2(Evidence code:IEA/Database source:UniProtKB:Q8BGB2|ens)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q14004)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), SPTA1 ETV2 ASXL1 PKNOX1 KIT PGM3 FLT3 MEIS1 RUNX1 TTC7A CDK13 CDK6 BRCA2,BP,13,13 of 11,0.57,118.18,5.719E-10,1.36E-08
GO:0010033,response to organic substance,A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979), CDK3 CDK6,BP,2,2 of 408,0.09,0.49,5.884E-10,1.393E-08
GO:0000790,nuclear chromatin,E1BH22(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A0A0A0MP90(Evidence code:IBA/Database source:PANTHER:PTN000604564)P0C0S4(Evidence code:IBA/Database source:PANTHER:PTN000604564)G8JL00(Evidence code:IBA/Database source:PANTHER:PTN000604564)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)A4IFU5(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q8VDF2)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)Q3ZBX9(Evidence code:IBA/Database source:PANTHER:PTN000604564)A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens)A0A0A0MP93(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A5PK20(Evidence code:IDA/Database source:)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:Q02539|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)A0A0A0MPA2(Evidence code:IBA/Database source:PANTHER:PTN000604564), HIST2H2AB E2F1 HIST1H2AC H2AFZ LOC104975684 SMARCA2 HIST3H2A RIF1 SP1 UHRF1 TTC21B H2AFJ IPO4 LOC614881 SRF HIST1H1E CCAR2 ARID1A HIST1H1A NCOA3 HIST1H2AJ,CC,21,21 of 44,0.92,47.73,5.952E-10,1.403E-08
GO:0016579,protein deubiquitination,Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)A1L548(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BGW4(Evidence code:IEA/Database source:InterPro:IPR001394)E1BND0(Evidence code:IEA/Database source:InterPro:IPR001394|I)F1MF37(Evidence code:IEA/Database source:InterPro:IPR001394)Q3T0Y1(Evidence code:IEA/Database source:InterPro:IPR016615|I)B7TCH8(Evidence code:IEA/Database source:InterPro:IPR001394)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:O00303|ens)F1MWQ8(Evidence code:IBA/Database source:PANTHER:PTN000364080)E1BG52(Evidence code:IEA/Database source:InterPro:IPR001394)A7Z056(Evidence code:IEA/Database source:InterPro:IPR001394)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)F1N0A8(Evidence code:IEA/Database source:InterPro:IPR001394)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR001394|I)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR001394)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR001394)G5E630(Evidence code:IEA/Database source:InterPro:IPR001394), STAMBP USP5 USP36 USP24 USP31 OTUB1 USP9Y EIF3F DMWD USP35 USP20 OTUD7B USP34 USP13 USP39 COPS5 USP32 USP9X,BP,18,18 of 30,0.79,60,6.194E-10,1.454E-08
GO:0045087,innate immune response,Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)A4FUZ5(Evidence code:ISS/Database source:UniProtKB:Q13530)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens)E1B719(Evidence code:IBA/Database source:PANTHER:PTN001506277)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)P05059(Evidence code:NAS/Database source:)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BGE5(Evidence code:IEA/Database source:UniProtKB:Q9EPL8|ens)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)P58754(Evidence code:IEA/Database source:InterPro:IPR039217)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357), LCK PIK3CD DHX9 SERINC3 TLR4 FCER1G MALT1 IRF1 TRIM14 ANKHD1 TYK2 YES1 JAK2 ABL1 IFNT3 SERINC5 ANKRD17 LOC516599 SRC ZAP70 FRK TEC IFNT2 CHGA DDX58 IPO7 MB21D1 NFKB1 LOC104968438 LGR4 SFTPD ADAM15 LY96 MX2 GRB2,BP,35,35 of 131,1.54,26.72,9.686E-10,2.263E-08
GO:0045211,postsynaptic membrane,Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)F1MCW8(Evidence code:IEA/Database source:UniProtKB:Q8BMF5|ens)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens)P02715(Evidence code:IEA/Database source:InterPro:IPR002394)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628), LIN7B GRIK4 GRIA2 ABHD17C SCRIB GRIA3 LIN7A GABRA5 RNF112 KCNMA1 F2R LIN7C UTRN SHANK2 DLG1 KCTD16 GRIA1 GPHN SHANK1 PCDHB8 CHRNE DNM2,CC,22,22 of 51,0.96,43.14,1.05E-09,2.443E-08
GO:0016491,oxidoreductase activity,O46414(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)O97764(Evidence code:IEA/Database source:InterPro:IPR002364|I)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q59A28(Evidence code:IEA/Database source:InterPro:IPR020843)Q5EAD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MXW0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P48034(Evidence code:IEA/Database source:InterPro:IPR002346|I)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P48644(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q32L99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A5PJM4(Evidence code:IEA/Database source:InterPro:IPR000103|I)Q32L93(Evidence code:IEA/Database source:InterPro:IPR015875)F1MMK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR016156|I)F1MYP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q2KHX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A6QP05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR015590|I)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR013328)Q3T046(Evidence code:IEA/Database source:InterPro:IPR020904)Q5I598(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR005123)Q4JIJ2(Evidence code:IEA/Database source:InterPro:IPR001433|I)Q3T0Z7(Evidence code:IEA/Database source:InterPro:IPR020904)Q3MHF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZCJ2(Evidence code:IEA/Database source:InterPro:IPR018170|I)P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q32LH7(Evidence code:IEA/Database source:InterPro:IPR001433|I)Q2KJE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q28007(Evidence code:IEA/Database source:InterPro:IPR023753)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001236)P16116(Evidence code:IEA/Database source:InterPro:IPR018170|I)P56560(Evidence code:IEA/Database source:InterPro:IPR001613|I)Q17QK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BBS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR002328|I)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q58DM4(Evidence code:IEA/Database source:InterPro:IPR005123)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR015590|I)E1BL62(Evidence code:IEA/Database source:InterPro:IPR002346|I)F1MB84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR000262|I)Q58D31(Evidence code:IEA/Database source:InterPro:IPR002328|I)F1MF74(Evidence code:ISS/Database source:UniProtKB:O94851)Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR028614)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I)O62768(Evidence code:IEA/Database source:InterPro:IPR001100|I)A7YY67(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q27995(Evidence code:IEA/Database source:InterPro:IPR001433|I)P10897(Evidence code:IBA/Database source:PANTHER:PTN000010357)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR005123)Q148K4(Evidence code:IEA/Database source:InterPro:IPR006094)F1MEU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR015875)A8E657(Evidence code:IEA/Database source:InterPro:IPR005097), FTH1 CRYZ DHRS3 LOC100295883 DBH CRYZL1 PHGDH NDUFS3 ALOX15B AOX1 MICAL3 ALDH1A1 ALDH9A1 PTGR2 AIFM2 GMPR2 G6PD FAM213B AIFM1 CTBP1 CRYM DHRS12 ALDH1A3 GPD1L BDH2 MTHFR P4HA2 MTRR QDPR HSD3B7 CYP2J2 AKR1A1 DHFR CYB5R4 GAPDHS CYP2R1 DPYD UEVLD AKR1B1 MAOB SPR CYP7A1 QSOX2 ADH5 ALOX15 PAH ALKBH2 ALDH1L2 AOX4 GRHPR HAO2 SORD MICAL2 TSTA3 CRYL1 TXNRD1 ALDH1L1 NOS2 CYB561 EGLN3 LDHD LOC540627 IMPDH2 AASS,MF,64,64 of 361,2.81,17.73,1.104E-09,2.558E-08
GO:0004386,helicase activity,D3IVZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)F1MNA1(Evidence code:IEA/Database source:InterPro:IPR007502)E1BJ90(Evidence code:IEA/Database source:InterPro:IPR007502)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q9TTA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q0V8H0(Evidence code:IEA/Database source:InterPro:IPR007502)E1BNQ2(Evidence code:IEA/Database source:InterPro:IPR007502)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)F1MEM4(Evidence code:IEA/Database source:InterPro:IPR007502)G5E631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q28141(Evidence code:IEA/Database source:InterPro:IPR007502), DDX3Y TDRD9 DHX34 DDX1 RUVBL1 RUVBL2 EIF4A3 SMARCAL1 WRN DICER1 DHX57 DHX37 DDX4 DHX8 DDX3X CHD8 ERCC2 BLM EIF4A2 DHX9,MF,20,20 of 41,0.88,48.78,1.127E-09,2.587E-08
GO:0005770,late endosome,F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PK00(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QR68(Evidence code:IEA/Database source:UniProtKB:Q8K211|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)Q3T0Q2(Evidence code:ISS/Database source:UniProtKB:Q9BXS4)Q05204(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8), ATP7B CHMP2B VPS29 PIK3R4 CLN3 EXOC8 VPS41 VPS36 SLC31A1 STX7 VPS35 SRC MAPK1 TSG101 BACE1 VAMP5 RAB9A TMEM59 LAMP1 RAPGEF2,CC,20,20 of 41,0.88,48.78,1.127E-09,2.587E-08
GO:0038083,peptidyl-tyrosine autophosphorylation,Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357), GRB2 TEC FRK YES1 JAK2 ABL1 TYK2 LCK ZAP70 SRC,BP,10,10 of 4,0.44,250,1.237E-09,2.827E-08
GO:0001077,"transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding",A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:Q9Y2V3|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)Q7YRX0(Evidence code:IEA/Database source:UniProtKB:Q96IS3|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), SP7 POU4F2 SP1 RAX ZBTB17 MEIS1 ZNF750 RAX2 GLI2 TCF7L2 ETV2 SRF ONECUT2 SOX1 BCL11B SOX4 HOXA7 LEF1,MF,18,18 of 32,0.79,56.25,1.344E-09,3.06E-08
GO:0034765,regulation of ion transmembrane transport,Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851), CLIC4 KCNMA1 KCNC4 KCNG2 CACNA1D HCN1 NEDD4 CACNA1S SCN10A SCN8A CACNA1B CACNA1E KCNH5 SCN5A CLIC6 KCNA4 CACNA1C KCNC3 KCNF1 KCNH6 SCN3A CACNA1F SCN11A KCNG4,BP,24,24 of 63,1.05,38.1,1.393E-09,3.155E-08
GO:0018107,peptidyl-threonine phosphorylation,Q08E45(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63085)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680267)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN000680267)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens), CAMK2A CAMK2B LMTK2 MAPK1 DCLK2 CDK1 LRRK2 CAMK2D MYLK2 MYLK3 MYLK4 MAP3K10 PRKACA TNKS,BP,14,14 of 16,0.61,87.5,1.6E-09,3.61E-08
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q3T0B2(Evidence code:IBA/Database source:PANTHER:PTN000365348)A6QNS2(Evidence code:IEA/Database source:UniProtKB:O95155|ens)Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)E1B7Y9(Evidence code:IEA/Database source:UniProtKB:Q6IQ16|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596256)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)F1MJP2(Evidence code:IBA/Database source:PANTHER:PTN000280277)P61085(Evidence code:IBA/Database source:PANTHER:PTN000629609)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN000697161)P33672(Evidence code:IEA/Database source:InterPro:IPR033811)E1BP63(Evidence code:IBA/Database source:PANTHER:PTN000280277)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR015360|I)A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), SIRT2 PSMD6 UBE4B PSMD12 PSMC5 SPOPL NFE2L2 PPP2CB BTBD3 NSFL1C CUL3 BTBD6 RNF165 UBE2K PCBP2 KIF14 BTBD11 KEAP1 PSMB3 RNF139 PSMD2 RAD23B PSMD1 RFFL FBXO45 GSK3A,BP,26,26 of 76,1.14,34.21,1.904E-09,4.278E-08
GO:0072686,mitotic spindle,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)A7YY70(Evidence code:IEA/Database source:UniProtKB:A0A024R7R9)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)P46196(Evidence code:ISS/Database source:UniProtKB:P26696)P61285(Evidence code:ISS/Database source:UniProtKB:P63167)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens), NUMA1 SIRT2 TPR KIF23 IKBKG SLC34A1 PKHD1 CDK1 PKP4 MAPK1 DYNLL1 RACGAP1 EML2,CC,13,13 of 13,0.57,100,2.1E-09,4.696E-08
GO:0090630,activation of GTPase activity,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3MXA5(Evidence code:IEA/Database source:InterPro:IPR033360)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)E1BP38(Evidence code:IBA/Database source:PANTHER:PTN000006983)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561), MTSS1L SCRIB TBC1D22B TIAM1 RABGAP1 TAX1BP3 RALGAPA1 TBC1D12 APC2 SGSM2 TBC1D2,BP,11,11 of 7,0.48,157.14,2.154E-09,4.796E-08
GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q8CGN4|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q6S7F2|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)G3MY92(Evidence code:IBA/Database source:PANTHER:PTN000358347)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BL97(Evidence code:IEA/Database source:UniProtKB:Q04891|ens)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens), ARID3A EAF2 BCOR RUNX1 FOXF1 LEF1 NFKB1 RREB1 ZBTB4 ESRRG SP1 NR1I2 CDC5L ARHGAP35 E2F7 EHMT2 PURB TFDP2 ASCL4 GATA6 GLI1 DLX2 SOX13 ZMYND8 CUX2 LMO2,MF,26,26 of 77,1.14,33.77,2.386E-09,5.291E-08
GO:0006897,endocytosis,Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)Q2KJA1(Evidence code:IEA/Database source:InterPro:IPR028501)Q2KHV6(Evidence code:IBA/Database source:PANTHER:PTN000058569)A7E3X2(Evidence code:IBA/Database source:PANTHER:PTN000226268)Q1RMH8(Evidence code:IBA/Database source:PANTHER:PTN000058569)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)P35509(Evidence code:IBA/Database source:PANTHER:PTN000226268)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR027188)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR028642|I)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000226268)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)F1MX23(Evidence code:IEA/Database source:InterPro:IPR028501|I)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)F1N7K7(Evidence code:IEA/Database source:UniProtKB:Q60754|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)E0AE16(Evidence code:IEA/Database source:InterPro:IPR028644|I)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254), DNM1 SH3GL1 SNX8 CSNK1G1 SNX3 MYO6 CSNK1G3 DNM2 AP2A2 SNX33 NPC1 SNX18 CSNK1G2 CLINT1 SH3GL3 AP2M1 AP2S1 AAK1 USP20 MARCO LRRK2 AP2A1 WASF2 CLN3 SNX12 DENND1A AP2B1 SNX9 SYNJ1,BP,29,29 of 96,1.27,30.21,2.486E-09,5.489E-08
GO:0043231,intracellular membrane-bounded organelle,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN000642960)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q9Y4G2|ens)F1MFF6(Evidence code:IBA/Database source:PANTHER:PTN000230403)E1BMN0(Evidence code:IBA/Database source:PANTHER:PTN000066595)O19137(Evidence code:IEA/Database source:UniProtKB:O95639|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MNM7(Evidence code:IEA/Database source:UniProtKB:Q96Q06|ens)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)E1BKQ2(Evidence code:IEA/Database source:UniProtKB:Q6WKZ4|ens)F1N0J3(Evidence code:IEA/Database source:UniProtKB:P98196|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q9H8M5|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:Q9H2B2|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)E1BCG1(Evidence code:IBA/Database source:PANTHER:PTN000442469)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:A0A024QYT6)F1N397(Evidence code:IEA/Database source:UniProtKB:A0A140VJD0)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB:P25789|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)E1BP22(Evidence code:IEA/Database source:UniProtKB:A0A024R899)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)Q2KHV6(Evidence code:IEA/Database source:UniProtKB:Q9Y5X2|ens)A5D7C4(Evidence code:IEA/Database source:UniProtKB:A0A024R794)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q9UJQ4|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:A0A024R1Y6)E1BJM1(Evidence code:IEA/Database source:UniProtKB:A0A024QZH5)Q5EA65(Evidence code:IEA/Database source:UniProtKB:Q9H3H5|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)Q1LZF8(Evidence code:IEA/Database source:UniProtKB:A0A024R0G0)A0JN39(Evidence code:IEA/Database source:UniProtKB:P53618|ens)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)A4IFC8(Evidence code:IEA/Database source:UniProtKB:P18858|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z5H3)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)A7MBC2(Evidence code:IEA/Database source:UniProtKB:Q6P996|ens)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q17QB7(Evidence code:IEA/Database source:UniProtKB:A8K5R1|ens)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN000642960)Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q92968|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q9NZM1|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:J3KNS1|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)F1MN49(Evidence code:IEA/Database source:UniProtKB:Q9GZV4|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)E1BJV5(Evidence code:IEA/Database source:UniProtKB:Q14966|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:A0A024R7E0)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000642960)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens), PACSIN2 ABCA1 ATP2B3 PLEKHM1 UGT2B10 NEU4 CPSF4 RUNX1 PLIN4 FMNL3 DENND1A RAB11FIP1 ATP11A XPO1 KANSL3 CNNM2 LITAF LRRK2 SYT4 TOR1A ABCA7 MYCBP2 TAX1BP3 AP1S1 LRWD1 GOLPH3 DNAJC13 PSMA4 HPS6 RC3H2 DOT1L SNX8 TNPO3 SEC11A CTTN SALL4 PALM SPHK2 DPAGT1 MAP3K14 CLCC1 COPB1 SPCS3 LIG1 CLINT1 SMARCA2 PDXDC1 DBH EPS15 RAB30 ATP2B2 PEX13 ANKFY1 GOLGA4 TRA2A AHCYL2 MYOF PIK3R4 AGTPBP1 ARID3A EIF5A2 NUP214 ZNF638 NACC1 ACSS2 SEC13 ATP13A5 PRNP BCL3,CC,69,69 of 1927,3.03,3.58,2.704E-09,5.947E-08
GO:0071805,potassium ion transmembrane transport,F1N4T0(Evidence code:IEA/Database source:GO:0005249)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q05037(Evidence code:ISS/Database source:UniProtKB:P22459)G3N279(Evidence code:IEA/Database source:GO:0005249)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q17QQ3(Evidence code:IEA/Database source:GO:0005249)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631), KCNT2 KCNG4 KCNA4 KCNQ5 LRRC26 KCNC3 KCNH6 HCN1 KCNH5 KCNF1 SNAP25 KCNMA1 KCNG2 KCNC4,BP,14,14 of 17,0.61,82.35,2.738E-09,5.997E-08
GO:0017124,SH3 domain binding,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)A4IFC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)A4FUD6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)O46631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens), PTPN6 AFAP1L2 SH3BGRL2 ADAM15 ELMO2 DENND1A ABL1 SIRPA GRB2 CRK WASF2 DAB2IP MVB12A ABI1 CBLC,MF,15,15 of 21,0.66,71.43,2.937E-09,6.405E-08
GO:0086010,membrane depolarization during action potential,F1MMU9(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MP22(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1B9S9(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MHP0(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MTK5(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1BIB9(Evidence code:IBA/Database source:PANTHER:PTN000004140)G3MYM1(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1BHM6(Evidence code:IBA/Database source:PANTHER:PTN000004140), SCN8A CACNA1E CACNA1F SCN5A CACNA1D TPCN2 SCN10A SCN11A,BP,8,8 of 1,0.35,800,3.063E-09,6.653E-08
GO:0006887,exocytosis,A4IF89(Evidence code:IEA/Database source:InterPro:IPR033961)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR009976|I)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)A5D7F2(Evidence code:IEA/Database source:InterPro:IPR028683)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)A6QLT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)A6QP06(Evidence code:IEA/Database source:InterPro:IPR027006)Q3ZC43(Evidence code:IEA/Database source:InterPro:IPR004140)P63026(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q0V8C2(Evidence code:IEA/Database source:InterPro:IPR010326)E1BBK9(Evidence code:IEA/Database source:InterPro:IPR028378)A6QQU0(Evidence code:IEA/Database source:InterPro:IPR019160)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473), EXOC8 LIN7B VAMP3 EXOC5 LIN7C RAB3A VAMP5 SYT4 LIN7A VAMP1 PAK1 EXOC6 RIMS1 SYTL2 EXOC7 VAMP2 EXOC3 SYTL1 EXOC1 MICAL3 EXOC4,BP,21,21 of 50,0.92,42,3.632E-09,7.855E-08
GO:0004843,thiol-dependent ubiquitin-specific protease activity,E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)Q3T0Y1(Evidence code:IEA/Database source:InterPro:IPR030298)E1BG52(Evidence code:IEA/Database source:UniProtKB:Q9P2H5|ens)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR006615)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:O00303|ens)F1MF37(Evidence code:IEA/Database source:UniProtKB:Q70CQ4|ens)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR016652)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)A1L548(Evidence code:IEA/Database source:InterPro:IPR016652)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)G3N2I1(Evidence code:IEA/Database source:UniProtKB:Q5VV17|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)A7Z056(Evidence code:IEA/Database source:InterPro:IPR006615)F2Y8Y4(Evidence code:IEA/Database source:InterPro:IPR039087), OTUD4 USP36 OTUB1 USP35 USP32 OTUD7B EIF3F USP31 USP13 STAMBP USP5 BRCC3 OTUD1 COPS5 USP20 VCPIP1,MF,16,16 of 26,0.7,61.54,4.202E-09,9.051E-08
GO:0004725,protein tyrosine phosphatase activity,E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000242|I)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR016130)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000242|I)G5E526(Evidence code:IBA/Database source:PANTHER:PTN000596945)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR016130)A5D980(Evidence code:IEA/Database source:InterPro:IPR000242|I)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000242|I)P11064(Evidence code:IEA/Database source:InterPro:IPR017867)A6QLS1(Evidence code:IEA/Database source:EC:3.1.3.48)P56722(Evidence code:ISS/Database source:UniProtKB:Q60673)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR016130), PTPN14 PTPRZ1 PTPRA SSH2 PTPRM PTP4A1 PTPN23 MTMR1 PTPN6 PTPN5 ACP1 DUSP7 PTPRN DUSP3,MF,14,14 of 18,0.61,77.78,4.569E-09,0.000000098
GO:0010469,regulation of signaling receptor activity,P01175(Evidence code:IEA/Database source:GO:0005179)G3N183(Evidence code:IEA/Database source:GO:0005125)Q28038(Evidence code:IEA/Database source:GO:0008083)Q2WGK0(Evidence code:IEA/Database source:GO:0005179)Q27954(Evidence code:IEA/Database source:GO:0005179)A4FV80(Evidence code:IEA/Database source:GO:0008083)P56831(Evidence code:IEA/Database source:GO:0005125)Q8MJ29(Evidence code:IEA/Database source:GO:0005125)E1BF06(Evidence code:IEA/Database source:GO:0005125)P56830(Evidence code:IEA/Database source:GO:0005125)Q95106(Evidence code:IEA/Database source:GO:0008083)P26917(Evidence code:IEA/Database source:GO:0005179)P03968(Evidence code:IEA/Database source:GO:0008083)A6YT15(Evidence code:IEA/Database source:GO:0005125)E1BJY4(Evidence code:IEA/Database source:GO:0008083), OXT LOC104968438 MIA PRP8 COPA FBRS IFNT3 IFNT TNFSF15 IFNT2 BDNF SST FGF1 CCL28 PDGFC,BP,15,15 of 22,0.66,68.18,4.634E-09,0.000000099
GO:0008286,insulin receptor signaling pathway,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000037430)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)F1MGG8(Evidence code:IEA/Database source:InterPro:IPR039011)F1MXR0(Evidence code:IBA/Database source:PANTHER:PTN001022094)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)Q5EAD0(Evidence code:IBA/Database source:PANTHER:PTN001022094)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18052|ens)F1MYE0(Evidence code:IEA/Database source:InterPro:IPR039011)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens), APPL1 GSK3A SHC1 FOXO4 IRS4 BAIAP2L1 KL BAIAP2 PTPRA IRS1 GRB2 SH2B2,BP,12,12 of 11,0.53,109.09,4.697E-09,9.952E-08
GO:0007224,smoothened signaling pathway,A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:P42208), GLI1 DYRK2 Gli3 MAP3K10 IQUB C1H21ORF2 FOXF1 GLI2 CDON BOC TTC21B SEPT2,BP,12,12 of 11,0.53,109.09,4.697E-09,9.952E-08
GO:0022008,neurogenesis,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)E1BP55(Evidence code:IEA/Database source:InterPro:IPR039041)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579503)E1BD25(Evidence code:IBA/Database source:PANTHER:PTN001905569)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN001905569)F1MHF3(Evidence code:IEA/Database source:InterPro:IPR039041)G3X736(Evidence code:IBA/Database source:PANTHER:PTN000073673)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN001229949)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), CDK5RAP2 NAV3 SALL4 BCL11B PRDM13 BCL11A NAV2 COPS2 BTBD6 FABP7 PSEN1,BP,11,11 of 8,0.48,137.5,4.805E-09,1.014E-07
GO:0043066,negative regulation of apoptotic process,P02510(Evidence code:ISS/Database source:UniProtKB:P02511)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q5E9C2(Evidence code:IEA/Database source:UniProtKB:P61804|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens), CRYAB AGAP2 MT3 MYO18A PRNP GATA6 PLAC8 LEF1 CHD8 PLK3 FAM129B TBX3 KIF14 BRAF ANKLE2 BCL3 BIRC6 ALMS1 PRKDC CDK1 PAK2 PSEN1 AHI1 ASNS SETX DSTYK PDCD10 PKHD1 TCL1A GOLPH3 STAT5A AGO4 MYDGF COPS5 STAT5B DAD1 GLI2 FIGNL1 SRC BCL11B GLO1,BP,41,41 of 186,1.8,22.04,5.056E-09,1.063E-07
GO:0000165,MAPK cascade,Q28165(Evidence code:ISS/Database source:UniProtKB:Q8CCS6)P46196(Evidence code:IEA/Database source:GO:0004707)F1N3T0(Evidence code:IEA/Database source:GO:0004709)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1B7J7(Evidence code:IEA/Database source:GO:0004708)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR038785)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN001553005)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MDL4(Evidence code:IEA/Database source:GO:0004709)F1N5W5(Evidence code:IEA/Database source:GO:0008349)A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR038786)Q3SWY6(Evidence code:IEA/Database source:GO:0008349)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)F1MVV5(Evidence code:IEA/Database source:GO:0004707), PABPN1 MAPK1 MAP3K4 TAOK3 PAK3 MAPK13 SETX LRRK2 MAPKAPK3 fgfr3 BRAF STK26 MAP2K4 MAPK12 STK25 POU4F2 MAPK4,BP,17,17 of 31,0.75,54.84,5.118E-09,1.067E-07
GO:0003743,translation initiation factor activity,A7MB16(Evidence code:ISS/Database source:UniProtKB:P55884)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q5E938(Evidence code:IEA/Database source:InterPro:IPR001950|I)Q32LJ9(Evidence code:IEA/Database source:InterPro:IPR001950|I)Q32LC3(Evidence code:IEA/Database source:InterPro:IPR001253|I)Q3ZC12(Evidence code:ISS/Database source:UniProtKB:O75821)Q5E966(Evidence code:IEA/Database source:InterPro:IPR027525)F1MX04(Evidence code:IEA/Database source:InterPro:IPR037584)E1BLZ8(Evidence code:IBA/Database source:PANTHER:PTN000056988)Q3T148(Evidence code:IEA/Database source:InterPro:IPR027528)Q3T0V3(Evidence code:ISS/Database source:UniProtKB:Q9UBQ5)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR037583)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)Q32KZ1(Evidence code:IEA/Database source:InterPro:IPR001288|I)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396), EIF3B EIF6 EIF4H EIF1 EIF1B EIF1AX EIF3G EIF3I EIF4G1 EIF3F EIF3M EIF3K EIF4E1B EIF4A2 EIF2B5 MTIF3 MCTS1,MF,17,17 of 31,0.75,54.84,5.118E-09,1.067E-07
GO:0006281,DNA repair,Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1B7Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR037706)A4IF83(Evidence code:IEA/Database source:InterPro:IPR003310|I)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR004582|I)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR018982)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)Q05B83(Evidence code:IBA/Database source:PANTHER:PTN000186209)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)E1B8X8(Evidence code:IEA/Database source:InterPro:IPR015525)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364|I)P84798(Evidence code:IEA/Database source:UniProtKB-KW:KW-0228)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR018982)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q32LH8(Evidence code:IEA/Database source:InterPro:IPR006642)E1BGK8(Evidence code:IBA/Database source:PANTHER:PTN000485246)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)F1MBL6(Evidence code:IBA/Database source:PANTHER:PTN000124197)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q08DI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BMC0(Evidence code:IEA/Database source:UniProtKB:Q8CGS6|ens)Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR030101)Q4VE16(Evidence code:IEA/Database source:InterPro:IPR001126|I), RUVBL2 PAXIP1 TRIP12 PRKDC TDG RAD17 CDK1 RUVBL1 BLM MMS19 RFC2 BRCC3 LIG1 ATM BRCA2 BRCA1 POLD3 CDC5L WRN PARP1 UHRF1 RAD18 DOT1L ERCC2 INO80 RAD23B SMG1 INTS3 ALKBH2 ETAA1 ZFYVE26 POLQ SMARCAL1 POLI,BP,34,34 of 136,1.49,25,6.886E-09,0.000000143
GO:0005249,voltage-gated potassium channel activity,Q05037(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1N4T0(Evidence code:IEA/Database source:UniProtKB:Q6UVM3|ens)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1MP51(Evidence code:IEA/Database source:InterPro:IPR003938|I)G3N279(Evidence code:IEA/Database source:InterPro:IPR028325)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR003938|I)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003968|I)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003968|I)Q17QQ3(Evidence code:IEA/Database source:InterPro:IPR039077)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)E1BM97(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q28204(Evidence code:IEA/Database source:InterPro:IPR028325), KCNA4 KCNT2 KCNG2 KCNH5 KCNQ5 KCNC3 KCNH6 KCNG4 KCNC4 KCNF1 SNAP25 LRRC26 HCN1 KCNMA1,MF,14,14 of 19,0.61,73.68,7.447E-09,1.541E-07
GO:0042592,homeostatic process,Q2KIN6(Evidence code:IEA/Database source:UniProtKB:P39210|ens),MPV17,BP,1,1 of 330,0.04,0.3,8.106E-09,0.000000167
GO:0046907,intracellular transport,A3KN15(Evidence code:IEA/Database source:InterPro:IPR016902)P48820(Evidence code:IEA/Database source:InterPro:IPR000156), VPS41 RANBP2,BP,2,2 of 369,0.09,0.54,8.538E-09,1.753E-07
GO:0032508,DNA duplex unwinding,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)Q0P5I4(Evidence code:IEA/Database source:GO:0003678)Q2TBU9(Evidence code:IEA/Database source:GO:0004003)A7MBG8(Evidence code:IEA/Database source:GO:0004003)F1MLB2(Evidence code:IEA/Database source:GO:0003678)A6QLJ0(Evidence code:IEA/Database source:GO:0043139)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)F1MFY4(Evidence code:IEA/Database source:GO:0004003)Q28141(Evidence code:IDA/Database source:), DDX1 MCM4 RUVBL2 RUVBL1 CHD8 ERCC2 BLM WRN HELB DHX9,BP,10,10 of 6,0.44,166.67,8.742E-09,0.000000178
GO:0032266,phosphatidylinositol-3-phosphate binding,A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR028667|I)A5PK00(Evidence code:IEA/Database source:InterPro:IPR021648)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR028730)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493), LANCL2 SNX27 VPS36 SNX19 SH3PXD2A ZFYVE26 PLEKHA5 DENND1A DAB2IP SNX3,MF,10,10 of 6,0.44,166.67,8.742E-09,0.000000178
GO:0017048,Rho GTPase binding,E1B718(Evidence code:IEA/Database source:InterPro:IPR010473)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q28021(Evidence code:IEA/Database source:InterPro:IPR015008)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q0VCF3(Evidence code:IEA/Database source:UniProtKB:Q9BRV8|ens)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010473|I)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010473|I)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)A6QLJ4(Evidence code:IEA/Database source:InterPro:IPR039056)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010473), FMNL3 MYO9B ROCK2 LRRK2 SIKE1 DAAM1 STRN3 PAK3 DIAPH3 IQGAP2 CDC42SE2 FMNL1,MF,12,12 of 12,0.53,100,8.821E-09,0.000000179
GO:0043209,myelin sheath,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)P81127(Evidence code:IEA/Database source:UniProtKB:Q9CWZ7|ens)P02722(Evidence code:IEA/Database source:UniProtKB:P48962|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:P53810|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens)A5PKD6(Evidence code:IEA/Database source:UniProtKB:P29387|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q8BHJ6|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61164|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens), CCT3 MYO1D DNM1 TSPAN2 CRYAB ATP1A2 INA MYH14 NAPG SLC25A4 ARF6 FAM213B PITPNA PDCD6IP GNB4 TUBA1A SIRT2 SERINC5 ACTR1A HSPA9 SYN2 TUBB4A CNP SNAP25,CC,24,24 of 71,1.05,33.8,9.432E-09,1.906E-07
GO:0065003,protein-containing complex assembly,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)F1N7B7(Evidence code:IEA/Database source:UniProtKB:Q86UR5|ens), KMT2A PPID RIMS1,BP,3,3 of 397,0.13,0.76,1.067E-08,2.148E-07
GO:0032270,positive regulation of cellular protein metabolic process,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens),EIF4G1,BP,1,1 of 322,0.04,0.31,1.172E-08,0.000000235
GO:0044212,transcription regulatory region DNA binding,E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1B9X1(Evidence code:IBA/Database source:PANTHER:PTN000383895)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR001346)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P49715)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)E1BD25(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens), RUNX1 GATA6 E2F1 LEF1 SMARCA2 CDK5RAP2 ATF6B CDC5L SNAPC4 RAI1 HIVEP1 HIVEP3 TCF20 ASH2L BCL11A SP1 TAF2 RREB1 GLI2 BCOR CDK13 ZNF516 SOX17 NFKB1 IRF1 FOXF1 GLI1 CEBPA CDK12 KMT2A BCL11B SALL4 SFPQ,MF,33,33 of 133,1.45,24.81,1.323E-08,2.643E-07
GO:0017112,Rab guanyl-nucleotide exchange factor activity,G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)E1BJE1(Evidence code:IEA/Database source:UniProtKB:Q7Z401|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)A5D7B4(Evidence code:IEA/Database source:UniProtKB:P78524|ens)F1MLZ5(Evidence code:IEA/Database source:UniProtKB:A2RT67|ens)G5E5Q8(Evidence code:IEA/Database source:UniProtKB:O95248|ens)E1B8H4(Evidence code:IEA/Database source:UniProtKB:Q9ULE3|ens)Q2TBL9(Evidence code:IBA/Database source:PANTHER:PTN000583159)F1N1V1(Evidence code:IEA/Database source:UniProtKB:Q9H6A0|ens), RIN3 DENND4A DENND1A ST5 DENND3 SBF1 DENND2A TRAPPC4 DENND2D,MF,9,9 of 4,0.39,225,1.338E-08,2.664E-07
GO:0036459,thiol-dependent ubiquitinyl hydrolase activity,B7TCH8(Evidence code:IEA/Database source:InterPro:IPR001394|I)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR001394|I)Q3T0Y1(Evidence code:IEA/Database source:EC:3.4.19.12)F1MF37(Evidence code:IEA/Database source:InterPro:IPR001394|I)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BND0(Evidence code:IEA/Database source:InterPro:IPR001394|I)A7Z056(Evidence code:IEA/Database source:InterPro:IPR001394|I)G5E630(Evidence code:IEA/Database source:InterPro:IPR001394|I)F1N0A8(Evidence code:IEA/Database source:InterPro:IPR001394|I)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR001394)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)E1BGW4(Evidence code:IEA/Database source:InterPro:IPR001394|I)A1L548(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BG52(Evidence code:IEA/Database source:InterPro:IPR001394|I)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736), USP9Y PSMD14 USP13 OTUB1 USP31 USP32 USP24 USP20 USP9X USP34 USP39 OTUD7B USP36 USP5 USP35 BRCC3,MF,16,16 of 29,0.7,55.17,1.347E-08,0.000000267
GO:0051082,unfolded protein binding,Q3T0K2(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404)Q3ZBA6(Evidence code:IEA/Database source:InterPro:IPR008971)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)Q3ZCI9(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3ZCH0(Evidence code:IEA/Database source:InterPro:IPR012725)Q2NKZ1(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR001305|I)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)F1MGK3(Evidence code:IEA/Database source:UniProtKB:Q96DZ1|ens)Q3MI00(Evidence code:IEA/Database source:InterPro:IPR008971)Q32L40(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3T084(Evidence code:IEA/Database source:InterPro:IPR002194|I)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)A1A4P5(Evidence code:IEA/Database source:InterPro:IPR002777)Q2KIT4(Evidence code:IEA/Database source:InterPro:IPR008971)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens), CCT3 TRAP1 DNAJB11 UGGT2 CCT8 HSPA9 CCT7 DZIP3 SYVN1 DNAJA2 CRYAB ERLEC1 DNAJB1 TCP1 CCT6B TOR1A PFDN2 DNAJB4 DNAJB2,MF,19,19 of 44,0.83,43.18,1.386E-08,2.737E-07
GO:0031463,Cul3-RING ubiquitin ligase complex,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)G3MX28(Evidence code:IBA/Database source:PANTHER:PTN001973695)G3N1V7(Evidence code:IBA/Database source:PANTHER:PTN001973695)A7MBG4(Evidence code:IEA/Database source:InterPro:IPR030563)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)A7MBJ7(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BK47(Evidence code:IBA/Database source:PANTHER:PTN001973695)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)E1B7Y9(Evidence code:IEA/Database source:UniProtKB:Q6IQ16|ens), CUL3 PDCD6 KLHDC7A KLHL34 KEAP1 KLHL26 LOC780968 PEF1 KLHL18 KLHL35 KLHL13 SPOPL,CC,12,12 of 13,0.53,92.31,1.593E-08,3.123E-07
GO:0005905,clathrin-coated pit,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)E1BMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168), EPS15 AP2S1 DNM2 AP2B1 TFRC AP2A2 AP2A1 AP2M1 AAK1 CLTA CUBN AP1S1,CC,12,12 of 13,0.53,92.31,1.593E-08,3.123E-07
GO:0004222,metalloendopeptidase activity,F1MF35(Evidence code:IEA/Database source:InterPro:IPR001506|I)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR001590)Q0III2(Evidence code:IEA/Database source:InterPro:IPR001193|I)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR001590)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR001590)Q9TT93(Evidence code:IEA/Database source:InterPro:IPR001590)G3MZT7(Evidence code:IEA/Database source:InterPro:IPR001590)Q9TT92(Evidence code:IEA/Database source:InterPro:IPR001590)Q24K02(Evidence code:IEA/Database source:InterPro:IPR001431)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)E1BBU4(Evidence code:IEA/Database source:InterPro:IPR001590|I)F1MBP8(Evidence code:IEA/Database source:InterPro:IPR037740)F1MRA8(Evidence code:IEA/Database source:InterPro:IPR001590)E1BFV4(Evidence code:IEA/Database source:InterPro:IPR001590)P42891(Evidence code:IEA/Database source:InterPro:IPR000718|I), TLL2 ADAMTS7 MBTPS2 ADAMTS18 ADAMTS12 ADAMTS4 LOC531521 ADAMTS5 IDE MMP19 ADAM15 COPS5 ADAM7 ADAMTS14 ECE1,MF,15,15 of 25,0.66,60,1.644E-08,3.211E-07
GO:0003729,mRNA binding,Q08DM8(Evidence code:IEA/Database source:UniProtKB:Q62348|ens)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q6PHQ9|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359236)G3MZ78(Evidence code:IBA/Database source:PANTHER:PTN000566843)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)E1BFI4(Evidence code:IEA/Database source:InterPro:IPR028743)P00376(Evidence code:ISS/Database source:UniProtKB:P00374)F1MX04(Evidence code:IEA/Database source:InterPro:IPR037584)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)Q0II93(Evidence code:IEA/Database source:InterPro:IPR030216)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BIA7(Evidence code:IEA/Database source:UniProtKB:O75153|ens)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8NHU6)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens), TSN RC3H2 PABPC4 PURB DXO ESRP1 PIWIL2 SNRNP70 CSTF2T PPIE IGF2BP2 DHFR EIF4G1 DHX9 PCBP1 NUDT16 SRSF1 NXF3 TPR CLUH TDRD7 EIF4A3,MF,22,22 of 62,0.96,35.48,1.876E-08,3.587E-07
GO:0016363,nuclear matrix,Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)A0JNA8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)O46382(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)E1B8Q8(Evidence code:IBA/Database source:PANTHER:PTN000409486)A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens), CLIC4 NUMA1 CHMP1A DNMT3A SPTBN4 CAD PAXIP1 BLM PRPF40A SFPQ ARFGEF1 AHCTF1 XPOT UHRF1,CC,14,14 of 21,0.61,66.67,1.859E-08,3.587E-07
GO:0032154,cleavage furrow,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q96GX5)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q32LP2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PKN1 SVIL PDXP MASTL RACGAP1 SEPT6 SEPT7 ARF6 NF2 RDX PPP1CC STAMBP DCTN3 SEPT2,CC,14,14 of 21,0.61,66.67,1.859E-08,3.587E-07
GO:0006813,potassium ion transport,G3N279(Evidence code:IEA/Database source:InterPro:IPR028325)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003968|I)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775)E1BM97(Evidence code:IEA/Database source:InterPro:IPR003938)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1N4T0(Evidence code:IEA/Database source:InterPro:IPR003929)F1MP51(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q28204(Evidence code:IEA/Database source:InterPro:IPR003929|I)Q05037(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003968|I)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003968|I), KCNQ5 KCNG2 KCNG4 ATP1A2 HCN1 KCNC3 KCNT2 KCNH5 KCNMA1 KCNA4 KCNH6 VPS4B KCNC4 KCNF1,BP,14,14 of 21,0.61,66.67,1.859E-08,3.587E-07
GO:0004004,ATP-dependent RNA helicase activity,Q28141(Evidence code:IBA/Database source:PANTHER:PTN000433338)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000618218)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q0IIK5(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433338)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR037583)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433338), DHX9 DDX3Y SNRNP200 DDX20 DDX1 DHX8 DDX3X EIF4A2 EIF4A3 DHX37 DHX34 DDX4 TDRD9,MF,13,13 of 17,0.57,76.47,1.878E-08,3.587E-07
GO:0019905,syntaxin binding,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)G3X6A9(Evidence code:IEA/Database source:InterPro:IPR026183)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000752023)P63026(Evidence code:IPI/Database source:UniProtKB:Q3SWZ3)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q5T7P8|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens), ABCA1 TXLNG SYT4 SYTL1 VPS52 VAMP1 VAMP2 STX7 NAPG ABL1 SYTL2 SYT6 BAIAP3,MF,13,13 of 17,0.57,76.47,1.878E-08,3.587E-07
GO:0055037,recycling endosome,F1N0J3(Evidence code:IEA/Database source:UniProtKB:P98196|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)A6QR68(Evidence code:IEA/Database source:UniProtKB:Q8K211|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q8BU31|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:Q71U36|ens)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000538677)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3), ATP11A MICALL2 SLC31A1 STX7 VPS52 LMTK2 TFRC SORL1 RAP2C SNF8 TUBA1A ITGB1 RAP2A TBC1D12 RAB17 VPS51,CC,16,16 of 30,0.7,53.33,1.937E-08,3.687E-07
GO:0016757,"transferase activity, transferring glycosyl groups",F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)A5PK45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q0P582(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1MCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5EA65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1B8R5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1BMM8(Evidence code:IEA/Database source:UniProtKB:Q6IQX7|ens)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR004263|I)F1MSM4(Evidence code:IEA/Database source:InterPro:IPR002495)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR003378)Q5E9E7(Evidence code:IEA/Database source:InterPro:IPR002495)Q32LF7(Evidence code:IEA/Database source:InterPro:IPR003859)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328), GALNT7 MGAT1 COLGALT1 PARP14 PARP8 DPAGT1 B3GALT4 HAS2 TNKS ST8SIA3 pofut2 MTAP CHPF POMGNT1 PARP1 EXT1 GYG2 LFNG GLT8D1 B4GALT4 UGT2B10 GALNT2 UMPS,MF,23,23 of 69,1.01,33.33,2.347E-08,0.000000445
GO:0016323,basolateral plasma membrane,Q2KIB6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658318)Q3ZC83(Evidence code:IEA/Database source:UniProtKB:Q99808|ens)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX1)A4IFM4(Evidence code:IEA/Database source:UniProtKB:Q9Z260|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6), LIN7B TFRC RAB17 DLG1 MYO1A MYO1D SCRIB LIN7C ABCC3 SLC29A1 DSTYK CLDN8 LIN7A CLDN7 FLOT1 CNNM2 ATP7B ATP6V1B1,CC,18,18 of 41,0.79,43.9,0.000000027,5.102E-07
GO:0007160,cell-matrix adhesion,A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)F1MF97(Evidence code:IEA/Database source:InterPro:IPR003886)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)F1MJQ6(Evidence code:IEA/Database source:UniProtKB:Q9JLI2|ens)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)E1BN52(Evidence code:IEA/Database source:InterPro:IPR032825)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q5TAT6|ens), ITGB7 ADAMTS12 NID2 FERMT2 SRF CD63 ITGB6 EMILIN1 COL5A3 ITGB1 FREM1 COL13A1,BP,12,12 of 14,0.53,85.71,2.779E-08,5.213E-07
GO:0005902,microvillus,F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q3UQ44|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)A6QLD1(Evidence code:IEA/Database source:UniProtKB:O35382|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)Q29423(Evidence code:ISS/Database source:UniProtKB:P15379)F1MLR9(Evidence code:IEA/Database source:UniProtKB:Q6PIF6|ens)Q32LP2(Evidence code:ISS/Database source:UniProtKB:P26043)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6), IQGAP2 LRRK2 CLIC4 MYO1C STARD10 AQP5 EXOC4 MYO1A CD44 MYO7B RDX ATP6V1B1,CC,12,12 of 14,0.53,85.71,2.779E-08,5.213E-07
GO:0016055,Wnt signaling pathway,G3X7P3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:Q9H0F7|ens)E1B714(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000226268)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1BI79(Evidence code:IEA/Database source:InterPro:IPR009223|I)E1BJ93(Evidence code:IEA/Database source:InterPro:IPR024940|I)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR028731)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)A7MB15(Evidence code:IEA/Database source:InterPro:IPR026548)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1BEQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879), AXIN2 ARL6 AXIN1 LGR4 CSNK1G2 CSNK1A1 APC2 LEF1 PTK7 HBP1 LRP6 TNKS FERMT2 FZD1 CSNK1G3 NDRG2 AMOTL1 CUL3 CSNK1G1 ETV2 CHD8,BP,21,21 of 58,0.92,36.21,2.941E-08,5.498E-07
GO:0001228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding",Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens), CDC5L EAF2 RUNX1 FOXF1 SRF POU4F2 MYF5 ESRRG TFDP2 LMO2 SOX17 LEF1 ZBTB17 GATA6 ARID3A DLX2 NR1I2 RREB1 PKNOX1,MF,19,19 of 47,0.83,40.43,3.222E-08,6.001E-07
GO:0032456,endocytic recycling,Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F6REL8(Evidence code:IEA/Database source:InterPro:IPR028563)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), SNF8 DENND1A VPS52 RAB17 VPS51 PTPN23 MICALL2 LMTK2 ARF6,BP,9,9 of 5,0.39,180,3.525E-08,6.542E-07
GO:0007080,mitotic metaphase plate congression,Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)A7MBA1(Evidence code:IEA/Database source:UniProtKB:Q9BW19|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens), CHMP6 KIF14 CHMP1A CHMP4A VPS4B KIFC1 CHMP2A CHMP4B CHMP2B KPNB1 CUL3,BP,11,11 of 11,0.48,100,3.72E-08,0.000000688
GO:0010941,regulation of cell death,Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q8NC60)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens), NOA1 CRYAB,BP,2,2 of 342,0.09,0.58,3.756E-08,6.922E-07
GO:0006888,ER to Golgi vesicle-mediated transport,Q2TBL9(Evidence code:IBA/Database source:PANTHER:PTN000583159)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)P35605(Evidence code:IBA/Database source:PANTHER:PTN000458798)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q27954(Evidence code:IBA/Database source:PANTHER:PTN000458798)F6PW02(Evidence code:IEA/Database source:InterPro:IPR033512)A0JN39(Evidence code:IBA/Database source:PANTHER:PTN000067242)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)A6H7F7(Evidence code:IEA/Database source:InterPro:IPR006722)Q28104(Evidence code:IBA/Database source:PANTHER:PTN000086687)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895|I), TRAPPC4 CUL3 SEC24D PDCD6 COPB2 PEF1 COPA TFG COPB1 SEC23A SEC24C SPAST TRAPPC2L COPE SEC23B SEC24A,BP,16,16 of 32,0.7,50,3.877E-08,0.000000712
GO:0021772,olfactory bulb development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens), RPGRIP1L CHD7 EXT1 LRRK2 AGTPBP1 DLX2 KIF14,BP,7,7 of 1,0.31,700,4.122E-08,7.439E-07
GO:0030663,COPI-coated vesicle membrane,P35605(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE21(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q27954(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53619(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35604(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28104(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), COPB2 COPG2 COPA ARCN1 COPZ1 COPE COPB1,CC,7,7 of 1,0.31,700,4.122E-08,7.439E-07
GO:0060384,innervation,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens), UNC13A UNC13B FBXO45 RNF165 GABRA5 CHD7 ADARB1,BP,7,7 of 1,0.31,700,4.122E-08,7.439E-07
GO:0008569,"ATP-dependent microtubule motor activity, minus-end-directed",E1BFA7(Evidence code:IEA/Database source:InterPro:IPR027325)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491), KIFC3 DNHD1 DNAH11 DNAH10 DNAH5 DNAH7 DYNC1H1,MF,7,7 of 1,0.31,700,4.122E-08,7.439E-07
GO:0046914,transition metal ion binding,F1N226(Evidence code:IEA/Database source:InterPro:IPR011178|I),APLP2,MF,1,1 of 309,0.04,0.32,4.098E-08,7.439E-07
GO:0005871,kinesin complex,Q2HJJ0(Evidence code:IEA/Database source:InterPro:IPR002151)G5E5S3(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BC41(Evidence code:IBA/Database source:PANTHER:PTN000648413)G3N1E4(Evidence code:IBA/Database source:PANTHER:PTN000648413)A7MBA1(Evidence code:IBA/Database source:PANTHER:PTN000648413)Q2NL05(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BGB0(Evidence code:IBA/Database source:PANTHER:PTN000648413)A5D7N6(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BBN7(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens), KLC4 KIF14 KIF15 KIF26A KIFC1 KIF2A KIF13B KIF23 KIF1B KIFC3,CC,10,10 of 8,0.44,125,4.221E-08,7.566E-07
GO:0005245,voltage-gated calcium channel activity,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR002077|I)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR002077|I)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR028798)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005445)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002077|I)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005447)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR002077)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002077|I), RYR1 CACNA1S CACNA1D CACNA1C TPCN2 CACNA1H CACNA1E CACNA1A CACNA1F CACNA1B,MF,10,10 of 8,0.44,125,4.221E-08,7.566E-07
GO:0047485,protein N-terminus binding,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)A6QLD1(Evidence code:IEA/Database source:UniProtKB:Q96A65|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q9D4H1|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), ATM NPAT TRAF6 VPS25 CHMP6 EXOC4 PDCD10 ARF6 BANF1 EXOC2 PPP1CC NCOA3 SNF8 NIPBL,MF,14,14 of 23,0.61,60.87,4.31E-08,7.698E-07
GO:0005819,spindle,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)E1BP36(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P04973(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)P27214(Evidence code:ISS/Database source:UniProtKB:P50995)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)P48734(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MWR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIV2(Evidence code:IEA/Database source:UniProtKB:O43566|ens)E1BAN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P63171(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KI07(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NL05(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)P46196(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), RPS6KA2 MMS19 SEPT7 SEPT2 CLTA SPAST DCTN3 ERCC2 ANXA11 SEPT6 SIRT2 CDK1 MICAL3 RGS14 KATNAL2 DYNLT1 ARL8B KIF2A KIF23 MAPK1,CC,20,20 of 54,0.88,37.04,4.585E-08,8.163E-07
GO:0032147,activation of protein kinase activity,A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BN63(Evidence code:IEA/Database source:GO:0030295)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825), MAP2K4 MAP3K4 AXIN1 WNK1 MAP3K1 MAP3K14 PAK6 KIF14 SLK DLG1 PAK1 PAK2 PAK4 PRNP PAK3 STK3 TRAF6 MAP3K8,BP,18,18 of 43,0.79,41.86,4.812E-08,8.508E-07
GO:0005901,caveola,F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q05204(Evidence code:IDA/Database source:)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63086)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)Q08DN8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P16386(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)P63026(Evidence code:IDA/Database source:)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)A6QLR4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), MYOF KCNMA1 LAMP1 IRS1 SRC MAPK1 F2R FLOT1 LIPE LRP6 VAMP2 PACSIN2 FLOT2,CC,13,13 of 19,0.57,68.42,4.801E-08,8.508E-07
GO:0045503,dynein light chain binding,E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277823)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277823)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491), DYNC1H1 DYNC1I2 DNAH11 DNHD1 DNAH7 DNAH10 WDR78 DNAH5,MF,8,8 of 3,0.35,266.67,4.976E-08,8.769E-07
GO:0030027,lamellipodium,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)P0C1G6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)P08487(Evidence code:ISS/Database source:UniProtKB:P19174), MTSS1L WASF2 IQGAP2 AMOTL1 DPP4 CTTN PHACTR4 PTPRM FLOT1 NF2 ABI1 ARAP3 PDXP ITGB1 CYFIP1 SWAP70 FAT1 PLCG1,CC,18,18 of 44,0.79,40.91,6.358E-08,0.000001117
GO:0042147,"retrograde transport, endosome to Golgi",Q08DW1(Evidence code:IBA/Database source:PANTHER:PTN001178525)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q3T0M0(Evidence code:IEA/Database source:InterPro:IPR028661)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)Q2HJG5(Evidence code:IEA/Database source:InterPro:IPR005378)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:Q15836)E1B8H4(Evidence code:IEA/Database source:UniProtKB:Q9ULE3|ens)Q2KHV6(Evidence code:IEA/Database source:InterPro:IPR028662)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)E1BDC9(Evidence code:IBA/Database source:PANTHER:PTN000367098)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:P61967|ens), RAB9A BAIAP3 VPS29 ANKFY1 VPS35 VAMP3 DENND2A SNX8 ARL1 GCC2 VPS51 VPS26A VPS52 AP1S1,BP,14,14 of 24,0.61,58.33,6.405E-08,0.000001117
GO:0007411,axon guidance,Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506)Q32LG4(Evidence code:IEA/Database source:InterPro:IPR032985)E1BCH6(Evidence code:IEA/Database source:UniProtKB:Q5RJG7|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A8E641(Evidence code:IEA/Database source:InterPro:IPR030626)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BER6(Evidence code:IEA/Database source:InterPro:IPR030624)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)Q2T9S0(Evidence code:ISS/Database source:UniProtKB:Q9ERD7)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), CXCL12 ROBO2 ISPD EXT1 GLI2 DPYSL5 ARHGAP35 CRMP1 LAMB2 TUBB3 POU4F2 BOC MAPK8IP3 SLIT2,BP,14,14 of 24,0.61,58.33,6.405E-08,0.000001117
GO:0042393,histone binding,E1BCP6(Evidence code:IEA/Database source:InterPro:IPR020693)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)F1MLY5(Evidence code:IEA/Database source:UniProtKB:P55198|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens)A5PJQ1(Evidence code:IEA/Database source:UniProtKB:P35659|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BGE5(Evidence code:IEA/Database source:UniProtKB:Q9EPL8|ens)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR029295)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)E1B7N2(Evidence code:IBA/Database source:PANTHER:PTN000826174)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens), JAK2 PRKCB UHRF1 MLLT6 BRD1 DEK LEF1 IPO7 SMARCA2 HIST1H2BA CHD8 PKN1 ATRX ZMYND8 LOC619094 PYGO2 TNKS,MF,17,17 of 39,0.75,43.59,7.072E-08,0.00000123
GO:0019003,GDP binding,Q2TBH7(Evidence code:ISS/Database source:UniProtKB:P20338)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)P04695(Evidence code:IMP/Database source:)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:Q9H0T7|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:Q9D0J4|ens), RAB4A RASEF RRAS TRIM23 GNAI1 GNAT1 RAB9A DYNC1LI1 RAB17 RAP2A RAP2C RAB3B ARL2,MF,13,13 of 20,0.57,65,7.438E-08,0.000001289
GO:0070062,extracellular exosome,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)Q3T0P7(Evidence code:IBA/Database source:PANTHER:PTN000103178)E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN000689792)A5D7A2(Evidence code:IEA/Database source:UniProtKB:Q9CZD3|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q12791), SORD ADAM15 ITM2B TFRC CD63 RAB4A PDCD6IP SRI PROM1 PRELP GARS CUBN SNX18 TSG101 KCNMA1,CC,15,15 of 691,0.66,2.17,7.599E-08,0.000001313
GO:0043621,protein self-association,Q28165(Evidence code:IDA/Database source:)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)F1MRU0(Evidence code:IEA/Database source:UniProtKB:P36888|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens), PABPN1 TDG ZFYVE27 PTH1R FLT3 SMTNL1 GPSM2 RNF112 CRK SGTA MALT1 TCF7L2,MF,12,12 of 16,0.53,75,7.722E-08,0.000001325
GO:0008076,voltage-gated potassium channel complex,G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)G3N279(Evidence code:IEA/Database source:InterPro:IPR028325)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003968|I)Q05037(Evidence code:IEA/Database source:InterPro:IPR003968|I)Q28204(Evidence code:IEA/Database source:InterPro:IPR028325)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1N4T0(Evidence code:IBA/Database source:PANTHER:PTN000002873)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003968|I)P63026(Evidence code:ISS/Database source:UniProtKB:P63045)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003968|I), LRRC26 KCNQ5 KCNC4 KCNG2 KCNA4 KCNMA1 KCNF1 KCNT2 CTTN KCNG4 VAMP2 KCNC3,CC,12,12 of 16,0.53,75,7.722E-08,0.000001325
GO:0042325,regulation of phosphorylation,F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), RICTOR PSEN1,BP,2,2 of 330,0.09,0.61,7.956E-08,0.000001361
GO:0000159,protein phosphatase type 2A complex,Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)F1MG56(Evidence code:IEA/Database source:InterPro:IPR000009)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)A4FV68(Evidence code:IEA/Database source:InterPro:IPR002554)E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)A2VDZ0(Evidence code:IEA/Database source:InterPro:IPR002554), PPP2CB PPP2R2A PPP2CA PPP2R5E STRN4 STRN3 IER5 PTPA PPP2R5A,CC,9,9 of 6,0.39,150,8.289E-08,0.000001409
GO:0034446,substrate adhesion-dependent cell spreading,E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:P63024)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), PEAK1 MICALL2 LAMB1 ITGB7 ABL1 VAMP3 SRC FERMT2 KIF14,BP,9,9 of 6,0.39,150,8.289E-08,0.000001409
GO:0000281,mitotic cytokinesis,E0AE16(Evidence code:IEA/Database source:InterPro:IPR028644|I)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR028642|I)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), SNX9 BRCA2 KIF23 RACGAP1 SNX18 CHMP4B STAMBP SNX33 PDCD6IP SPAST,BP,10,10 of 9,0.44,111.11,8.377E-08,0.000001414
GO:0005868,cytoplasmic dynein complex,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223362)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223362)P63171(Evidence code:ISS/Database source:UniProtKB:Q5XI90)Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q9D0M5|ens)Q0III3(Evidence code:IEA/Database source:InterPro:IPR025956)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000072732)Q2KII9(Evidence code:IEA/Database source:InterPro:IPR008467)Q3T140(Evidence code:IEA/Database source:InterPro:IPR016561)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223362), TPR LOC101905447 DYNLL1 DYNLT1 DYNLL2 DYNC1I2 DYNC1H1 DYNC1LI1 DYNLRB1 LOC101902172,CC,10,10 of 9,0.44,111.11,8.377E-08,0.000001414
GO:0043524,negative regulation of neuron apoptotic process,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)Q17QR2(Evidence code:IEA/Database source:UniProtKB:Q9CQ26|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens), PINK1 KIF14 CLN3 F2R NDNF GABRA5 EN1 MT3 STAMBP AARS BRAF SYNGAP1 BDNF DNAJC5 PRKCI,BP,15,15 of 30,0.66,50,1.025E-07,0.000001725
GO:0022624,proteasome accessory complex,Q2KJ25(Evidence code:ISS/Database source:UniProtKB:Q9D8W5)P62194(Evidence code:ISS/Database source:UniProtKB:P62196)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62192|ens)Q2KIW6(Evidence code:ISS/Database source:UniProtKB:P62334)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O35593|ens)A7MBA2(Evidence code:IEA/Database source:UniRule:UR000777776)P56701(Evidence code:ISS/Database source:UniProtKB:Q8VDM4)Q3T0B2(Evidence code:ISS/Database source:UniProtKB:Q99JI4)Q0P5A6(Evidence code:ISS/Database source:UniProtKB:Q8BJY1)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P46471)Q5E964(Evidence code:ISS/Database source:UniProtKB:Q9WVJ2), PSMD12 PSMC5 PSMC1 PSMC6 PSMD14 PSMD1 PSMD2 PSMD6 PSMD5 PSMC2 PSMD13,CC,11,11 of 13,0.48,84.62,1.162E-07,0.000001949
GO:0001501,skeletal system development,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P13608(Evidence code:IBA/Database source:PANTHER:PTN001105676)P81282(Evidence code:IBA/Database source:PANTHER:PTN001105676)F1N2J5(Evidence code:IBA/Database source:PANTHER:PTN001105676)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens), TBX3 COL1A2 ACAN VCAN HAPLN4 SOX4 COL2A1 GLI2 COL5A2 RAI1 ASH1L CHD7,BP,12,12 of 17,0.53,70.59,1.237E-07,0.000002069
GO:0005802,trans-Golgi network,Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P61212)O46382(Evidence code:ISS/Database source:UniProtKB:D4A631)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)A7Z035(Evidence code:TAS/Database source:)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56818)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), ARL1 ARFGEF1 RAB30 LRRK2 GOLPH3 GCC2 OSBP CLINT1 BIRC6 MYO18A NBEA ATP7B BACE1 CORO7 SNAP25 SORL1,CC,16,16 of 36,0.7,44.44,0.000000138,0.0000023
GO:0000920,cell separation after cytokinesis,Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens), CHMP6 VPS4B CHMP2B CHMP2A PDCD6IP CHMP1A CHMP4B CHMP4A,BP,8,8 of 4,0.35,200,1.405E-07,0.000002335
GO:0045184,establishment of protein localization,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens), ABL1 KPNB1 CHMP2A KIF14 RAP2A,BP,5,5 of 416,0.22,1.2,1.504E-07,0.00000249
GO:0035725,sodium ion transmembrane transport,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)E1BHM6(Evidence code:IEA/Database source:GO:0005248)A7YY70(Evidence code:IEA/Database source:GO:0005436)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)F1MHP0(Evidence code:IEA/Database source:GO:0005248)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)F1MMU9(Evidence code:IEA/Database source:GO:0005248)E1BHR8(Evidence code:IEA/Database source:GO:0005248)E1BI45(Evidence code:IEA/Database source:GO:0015081), SCN10A SCN11A SLC34A1 HCN1 SCN2B SCN5A ANO6 SCN8A SCN3A SLC23A1,BP,10,10 of 10,0.44,100,1.575E-07,0.000002593
GO:1902476,chloride transmembrane transport,F1MS75(Evidence code:IEA/Database source:GO:0015377)Q1LZF8(Evidence code:IEA/Database source:GO:0005254)Q08E50(Evidence code:IEA/Database source:GO:0005254)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)Q6BBL6(Evidence code:IEA/Database source:GO:0005254)E1BF90(Evidence code:IEA/Database source:GO:0005254)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)F1MS08(Evidence code:IEA/Database source:GO:0015377)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295), SLC12A1 CLCC1 GABRA5 CLIC6 CLIC4 CLDN4 BEST3 CFTR SLC12A2 ANO6,BP,10,10 of 10,0.44,100,1.575E-07,0.000002593
GO:0006915,apoptotic process,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)E1BF06(Evidence code:IEA/Database source:InterPro:IPR008064)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3MHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P37359(Evidence code:IEA/Database source:GO:0043027)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR031215)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A4FUD6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P62248(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)E1BE13(Evidence code:IEA/Database source:InterPro:IPR022103)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q9TU34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR037554)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)F1MN90(Evidence code:IEA/Database source:InterPro:IPR003508)P26882(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)E1BHY2(Evidence code:IEA/Database source:InterPro:IPR028319)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens), TAF10 TNFSF15 SHISA5 S100A14 PRKCB DYNLL1 SH3GLB1 MT3 SLC5A11 IRF1 PAK1 ELMO2 MYDGF FHIT CDK1 BIRC6 NOA1 ITPR1 CASP6 FIS1 CIDEC PPID PSEN1 AIFM2 CYFIP2 AIFM1 DAD1 CASP3 MAPK1 CUL1 EGLN3 PPP1R13B PDCD6,BP,33,33 of 151,1.45,21.85,0.000000172,0.000002823
GO:0030879,mammary gland development,G3X812(Evidence code:IEA/Database source:UniProtKB:Q99466|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), NOTCH4 PYGO2 LEF1 TBX3 GLI2 ARHGAP35 STAT5A,BP,7,7 of 2,0.31,350,1.748E-07,0.000002858
GO:0005891,voltage-gated calcium channel complex,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002077|I)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR002077|I)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR002077|I)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005447)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR002077|I)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005445)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002077|I), PDE4D CACNA1B CACNA1F CACNA1S CACNA1D CACNA1A CACNA1C CACNA1H CACNA1E,CC,9,9 of 7,0.39,128.57,1.782E-07,0.000002897
GO:0032467,positive regulation of cytokinesis,A2VDN5(Evidence code:IEA/Database source:UniProtKB:Q9UBP0|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)O46385(Evidence code:IMP/Database source:)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028443)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)F1MSU3(Evidence code:IEA/Database source:UniProtKB:Q9NSD7|ens), SPAST RACGAP1 CUL3 SVIL GIPC1 PKP4 KIF14 KIF23 RXFP3,BP,9,9 of 7,0.39,128.57,1.782E-07,0.000002897
GO:0031902,late endosome membrane,Q3T0N1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)A5PK00(Evidence code:IBA/Database source:PANTHER:PTN000319648)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)Q5E994(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KI07(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDY3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SX42(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58CS7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T178(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens), MVB12A TMEM106B VPS41 VPS36 UBXN6 CD63 CHMP1B ARL8B TMEM59 CHMP4A SNF8 VPS4B CHMP2B CHMP3 VPS28 BAIAP3,CC,16,16 of 37,0.7,43.24,1.855E-07,0.000003005
GO:0008104,protein localization,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)E1BJG8(Evidence code:IEA/Database source:UniProtKB:Q9H2F9|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512256)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512256)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), SCRIB CCDC68 DLG1 MAL2 PLLP NBEA PALM MAPK8IP3,BP,8,8 of 497,0.35,1.61,2.354E-07,0.000003803
GO:0016462,pyrophosphatase activity,Q5E9Y6(Evidence code:IEA/Database source:InterPro:IPR004097),PRUNE1,MF,1,1 of 277,0.04,0.36,2.648E-07,0.000004252
GO:0022414,reproductive process,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,BP,1,1 of 277,0.04,0.36,2.648E-07,0.000004252
GO:0002020,protease binding,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)F1MPR9(Evidence code:IEA/Database source:UniProtKB:Q6P4R8|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), RYR1 FLOT1 NFRKB SH3PXD2A SRI COL1A2 DPP4 PINK1 RFFL RNF139 KIT POLG BRCA2 MALT1 PRNP,MF,15,15 of 33,0.66,45.45,2.686E-07,0.000004299
GO:0006606,protein import into nucleus,E1BGE5(Evidence code:IEA/Database source:UniProtKB:Q9EPL8|ens)A5D7C4(Evidence code:IEA/Database source:UniProtKB:Q9Y5L0|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:Q80U93|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)P61635(Evidence code:ISS/Database source:UniProtKB:P40763)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)G5E567(Evidence code:IBA/Database source:PANTHER:PTN000108134)E1BF47(Evidence code:IEA/Database source:InterPro:IPR012929)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens), IPO7 TNPO3 NUP214 PTTG1IP POM121L2 IPO8 STAT3 PPP3CA MBTPS1 RANBP2 RAN IPO9 TPR KPNB1,BP,14,14 of 28,0.61,50,2.718E-07,0.000004337
GO:0072659,protein localization to plasma membrane,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)E1B9D3(Evidence code:IEA/Database source:UniProtKB:E9PY61|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)E1BDL2(Evidence code:IEA/Database source:UniProtKB:Q9ULT0|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635134)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635134), FCER1G GPR179 CLN3 DLG1 RAP2A LRP6 S100A10 ZFYVE27 FLOT1 TTC7A PALM TSPAN14 ATP2C2 F11R RAPGEF2 RAB26 RAB37,BP,17,17 of 44,0.75,38.64,2.813E-07,0.00000447
GO:0050852,T cell receptor signaling pathway,Q9BE45(Evidence code:ISS/Database source:UniProtKB:Q9EST8)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens), NFKBIZ PDE4D WNK1 MALT1 TRAF6 PSEN1 ZAP70 EIF2B5 RC3H2 BRAF,BP,10,10 of 11,0.44,90.91,2.827E-07,0.00000447
GO:0008180,COP9 signalosome,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q8IY63|ens)A4FV74(Evidence code:IEA/Database source:InterPro:IPR033205)G3X736(Evidence code:IEA/Database source:InterPro:IPR037750)A6QQ21(Evidence code:IEA/Database source:InterPro:IPR033859)Q3SZA0(Evidence code:IEA/Database source:InterPro:IPR037754)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A6H7B5(Evidence code:IEA/Database source:InterPro:IPR037753)F1MBP8(Evidence code:IEA/Database source:InterPro:IPR037740), FLOT1 AMOTL1 COPS8 COPS2 COPS6 COPS4 PLCG1 GRB2 COPS3 COPS5,CC,10,10 of 11,0.44,90.91,2.827E-07,0.00000447
GO:0016311,dephosphorylation,A5D980(Evidence code:IEA/Database source:InterPro:IPR000387|I)G5E526(Evidence code:IEA/Database source:InterPro:IPR000340|I)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR000340|I)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000387|I)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR000387|I)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000387|I)E1BCN1(Evidence code:IEA/Database source:GO:0008195)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000387)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000387|I)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR000340|I)A1A4Q9(Evidence code:IEA/Database source:GO:0098519)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000387|I)Q5E9Y6(Evidence code:IEA/Database source:GO:0016791)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000387|I)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR000340|I), PTPN6 PTP4A1 SSH2 PTPN5 MTMR1 PTPRA LPIN2 PTPN23 PTPRM DUSP7 NUDT16 PTPN14 PRUNE1 PTPRZ1 PPP3CA DUSP3,BP,16,16 of 39,0.7,41.03,3.272E-07,0.000005158
GO:0007608,sensory perception of smell,G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BI89(Evidence code:IEA/Database source:InterPro:IPR034433)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens), OR13C3 LOC531090 LOC614090 OR51Q1 LOC788626 OR5M11 LOC101908058 NAV2,BP,8,8 of 5,0.35,160,3.439E-07,0.000005326
GO:0034260,negative regulation of GTPase activity,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MLJ7(Evidence code:IEA/Database source:GO:0005095)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), WNK1 F11R ARFGEF1 ARL2 SH3BP4 LRRK2 SLIT2 DAB2IP,BP,8,8 of 5,0.35,160,3.439E-07,0.000005326
GO:0030127,COPII vesicle coat,A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895|I)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596), PEF1 SEC24C PDCD6 SEC24D SEC24A SEC23B SEC23A SEC13,CC,8,8 of 5,0.35,160,3.439E-07,0.000005326
GO:0070273,phosphatidylinositol-4-phosphate binding,E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)Q1RMW9(Evidence code:IEA/Database source:InterPro:IPR008628)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492), OSBP ARFIP1 SH3PXD2A PLEKHA5 DAB2IP LANCL2 GOLPH3 SNX3,MF,8,8 of 5,0.35,160,3.439E-07,0.000005326
GO:0016327,apicolateral plasma membrane,Q6BBL6(Evidence code:IEA/Database source:UniProtKB:O35054|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1B9W1(Evidence code:IEA/Database source:UniProtKB:Q9D563|ens)A4IFM4(Evidence code:IEA/Database source:UniProtKB:Q9Z260|ens)Q3B7N4(Evidence code:IEA/Database source:UniProtKB:Q9Z261|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:O75970|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q61146|ens), CLDN4 CLDN3 TJP1 TMEM114 CLDN8 CLDN7 MPDZ OCLN,CC,8,8 of 5,0.35,160,3.439E-07,0.000005326
GO:0000145,exocyst,E1BDW9(Evidence code:IEA/Database source:InterPro:IPR029175)A6QQU0(Evidence code:IEA/Database source:InterPro:IPR019160)Q3ZC43(Evidence code:IEA/Database source:InterPro:IPR004140)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR033960)A6QLD1(Evidence code:IEA/Database source:InterPro:IPR007191)A6QLT7(Evidence code:IEA/Database source:InterPro:IPR007225)A4IF89(Evidence code:IEA/Database source:InterPro:IPR033961)Q0V8C2(Evidence code:IEA/Database source:InterPro:IPR010326), EXOC2 EXOC1 EXOC7 EXOC5 EXOC4 EXOC6 EXOC8 EXOC3,CC,8,8 of 5,0.35,160,3.439E-07,0.000005326
GO:0001764,neuron migration,F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q64511|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q8BL48|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), ASTN1 RAPGEF2 PSEN1 TOP2B SOX1 NDNF MKL1 FBXO45 USP9X PCM1 UNK SDCCAG8 PEX13 SRF,BP,14,14 of 29,0.61,48.28,3.783E-07,0.000005841
GO:0004812,aminoacyl-tRNA ligase activity,A5D7A2(Evidence code:IEA/Database source:InterPro:IPR000738|I)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR012947)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR000738|I)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR012947)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I), GARS EPRS QARS RARS2 WARS2 LARS RARS NARS AARS MARS AARS2 IARS,MF,12,12 of 20,0.53,60,4.461E-07,0.000006828
GO:0051865,protein autoubiquitination,Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)F1N2S5(Evidence code:IEA/Database source:UniProtKB:Q8TEJ3|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens), RNF220 TRIM68 SH3RF3 TRAF6 UHRF1 RNF112 BRCA1 UBE2D2 UBE4B MARCH5 MARCH7 RAD18,BP,12,12 of 20,0.53,60,4.461E-07,0.000006828
GO:0042826,histone deacetylase binding,F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR031169)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens), HIC1 TOP2B DDX20 NIPBL MIER1 TRAF6 BCOR SIRT2 LEF1 PKN1 SP1 SFPQ,MF,12,12 of 20,0.53,60,4.461E-07,0.000006828
GO:0005643,nuclear pore,Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0906)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0906)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens), SEC13 XPO7 BICD2 PIK3R4 MYO1C TPR AHCTF1 RANBP2 NDC1 XPOT,CC,10,10 of 12,0.44,83.33,4.873E-07,0.000007436
GO:0005623,cell,F1MF57(Evidence code:IDA/Database source:)E1BDL2(Evidence code:IEA/Database source:GO:0006879)A5PKI0(Evidence code:IDA/Database source:)E1BHV1(Evidence code:IEA/Database source:GO:0006874)B6Z9Q5(Evidence code:IEA/Database source:GO:0032401)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)Q0II43(Evidence code:IEA/Database source:GO:0045454)F1N3Q4(Evidence code:IDA/Database source:)E1BNF8(Evidence code:IEA/Database source:GO:0070050)G3N0E5(Evidence code:IEA/Database source:GO:0006874)G3MXV5(Evidence code:IEA/Database source:GO:0072383), NEBL TTC7A APPL1 RYR2 SHROOM2 FAM20A TXNL1 PALM FGGY RYR3 KIF13A,CC,11,11 of 16,0.48,68.75,5.037E-07,0.000007664
GO:0012505,endomembrane system,Q29RU0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BF03(Evidence code:IBA/Database source:PANTHER:PTN001039730)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB:Q15437|ens)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN000445299)Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349), RNF128 CHMP1A PANX3 SGSM2 TBC1D2 NBEA SEC23B TBC1D22B RABGAP1 VAMP5 LARS ATF6B CD63 STX7,CC,14,14 of 30,0.61,46.67,5.208E-07,0.000007902
GO:0043065,positive regulation of apoptotic process,E1B7H4(Evidence code:IBA/Database source:PANTHER:PTN000584371)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)A7YY65(Evidence code:IBA/Database source:PANTHER:PTN001324730)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622311)Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1B9H3(Evidence code:IEA/Database source:InterPro:IPR028811)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)A5PJF0(Evidence code:IEA/Database source:InterPro:IPR033097)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens)P20959(Evidence code:ISS/Database source:UniProtKB:P17936), MAP3K10 DDX20 MTCH1 PSEN1 EEF1E1 ATM PRKDC UNC13B STK3 MAPK9 SAP18 SCRIB CCAR2 PPID ABL1 SOX4 KCNMA1 SLIT2 AIFM2 BARD1 fgfr3 UBE2Z ALDH1A3 PTPA DAB2IP E2F1 ANO6 IGFBP3,BP,28,28 of 121,1.23,23.14,5.264E-07,0.000007963
GO:0039702,viral budding via host ESCRT complex,Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), CHMP2B CHMP6 VPS4B CHMP4A CHMP4B PDCD6IP CHMP2A,BP,7,7 of 3,0.31,233.33,5.489E-07,0.000008161
GO:0017101,aminoacyl-tRNA synthetase multienzyme complex,Q3MHH4(Evidence code:ISS/Database source:UniProtKB:P47897)A7MBC5(Evidence code:IEA/Database source:UniProtKB:P41252|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q8BMJ2|ens)A7YW98(Evidence code:ISS/Database source:UniProtKB:P54136)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q2T9L8(Evidence code:ISS/Database source:UniProtKB:P56192)Q3SZ15(Evidence code:IEA/Database source:UniProtKB:Q9D1M4|ens), QARS IARS LARS RARS EPRS MARS EEF1E1,CC,7,7 of 3,0.31,233.33,5.489E-07,0.000008161
GO:0046835,carbohydrate phosphorylation,A6QP44(Evidence code:IEA/Database source:UniProtKB:Q7TMC8|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)A6H768(Evidence code:IEA/Database source:InterPro:IPR000705)Q0IIG5(Evidence code:IEA/Database source:GO:0008443)A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)E1BNF8(Evidence code:IEA/Database source:UniProtKB:Q96C11|ens), FUK HK2 GALK1 PFKM GCK FGGY,BP,6,6 of 1,0.26,600,5.463E-07,0.000008161
GO:0033290,eukaryotic 48S preinitiation complex,A7MB16(Evidence code:IEA/Database source:UniRule:UR000106119)Q3ZC12(Evidence code:IEA/Database source:UniRule:UR000106306)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)Q5E966(Evidence code:IEA/Database source:UniRule:UR000107081)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107)E1BLZ8(Evidence code:IEA/Database source:UniRule:UR000106280), EIF3B EIF3G EIF3M EIF3I EIF3K EIF3F,CC,6,6 of 1,0.26,600,5.463E-07,0.000008161
GO:0035235,ionotropic glutamate receptor signaling pathway,G0T3G6(Evidence code:IEA/Database source:GO:0004970)E1BGZ0(Evidence code:IEA/Database source:GO:0004971)F1MWI8(Evidence code:IEA/Database source:GO:0004970)F1MCW8(Evidence code:IEA/Database source:GO:0004970)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MBY1(Evidence code:IEA/Database source:GO:0004971), GRIA1 GRIA3 GRIN3B GRIK4 CLN3 GRIA2,BP,6,6 of 1,0.26,600,5.463E-07,0.000008161
GO:0001732,formation of cytoplasmic translation initiation complex,Q3ZC12(Evidence code:IEA/Database source:UniRule:UR000106306)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)Q5E966(Evidence code:IEA/Database source:UniRule:UR000107081)E1BLZ8(Evidence code:IEA/Database source:UniRule:UR000106280)A7MB16(Evidence code:IEA/Database source:UniRule:UR000106119), EIF3G EIF3K EIF3M EIF3I EIF3F EIF3B,BP,6,6 of 1,0.26,600,5.463E-07,0.000008161
GO:0005516,calmodulin binding,F1MVF1(Evidence code:IEA/Database source:InterPro:IPR013543)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)A5D7H2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)F1MJ90(Evidence code:IEA/Database source:InterPro:IPR008734)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR013543)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR013543)P10568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q08E45(Evidence code:IEA/Database source:InterPro:IPR013543), CAMK2G CDK5RAP2 PLCB3 NOS2 MYLK2 PPP3CA SMTNL1 MAPKAPK3 STRN3 MYO1C PHKB MYO9B MYO1D IQGAP2 CAMK2D ATP2B4 CAMK2B MYO1A CAMK2A,MF,19,19 of 59,0.83,32.2,0.000000577,0.000008555
GO:0016874,ligase activity,Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q3T099(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A7YW98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q3MHH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)E1BE47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A7MBC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q3ZBF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q6PWM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR014042)Q08E58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A7MBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q2KJG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A6QLR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436), GART LIG1 ITCH AARS AARS2 MARS WARS2 RARS QARS MGRN1 NAPRT IARS NADSYN1 PFAS GSS TTLL12 ADSS ASNS NARS RARS2 LARS,MF,21,21 of 72,0.92,29.17,5.898E-07,0.00000872
GO:0043087,regulation of GTPase activity,F1MZM7(Evidence code:IBA/Database source:PANTHER:PTN000571279)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR001936|I)E1BJP2(Evidence code:IBA/Database source:PANTHER:PTN000571279)F1MBI8(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR030770)E1B800(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1N6T8(Evidence code:IEA/Database source:UniProtKB:P52735|ens)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR030772)F1N746(Evidence code:IEA/Database source:UniProtKB:Q9Y3P9|ens)A6H7H0(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MTR1(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1B801(Evidence code:IBA/Database source:PANTHER:PTN000571279)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens)G5E5Q8(Evidence code:IEA/Database source:InterPro:IPR030574)E1BB77(Evidence code:IEA/Database source:InterPro:IPR001936|I), SYDE2 RASAL1 RACGAP1 SYNGAP1 SIPA1L1 RASAL2 VAV2 ARHGAP6 RABGAP1 IQGAP3 IQGAP2 RICTOR CRK ARHGAP35 PROM2 SBF1 DAB2IP,BP,17,17 of 47,0.75,36.17,5.965E-07,0.000008795
GO:0098794,postsynapse,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:Q6P5E8|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q96FJ2|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)F1MN60(Evidence code:IEA/Database source:GO:0099566)E1BPU0(Evidence code:IEA/Database source:GO:0060079)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB:Q9Z2U0|ens)E1BKU0(Evidence code:IEA/Database source:GO:0060080)Q3ZC13(Evidence code:IEA/Database source:GO:0098884), GIPC1 DGKQ VPS35 DYNLL2 SNAP25 ATP2B2 LRRK2 PURA INA PSMA7 ADORA2A AP2M1,CC,12,12 of 21,0.53,57.14,6.585E-07,0.000009655
GO:0030433,ubiquitin-dependent ERAD pathway,Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)G3MXQ8(Evidence code:IEA/Database source:UniProtKB:Q9UKM7|ens)E1BAK9(Evidence code:IEA/Database source:InterPro:IPR032832)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)F1MGK3(Evidence code:IBA/Database source:PANTHER:PTN000395729)A6QNS2(Evidence code:IBA/Database source:PANTHER:PTN000358161), PSMC2 UBE2G2 UBQLN1 PSMC6 SGTA PSMC1 MAN1B1 SYVN1 DZIP3 PSMC5 ERLEC1 UBE4B,BP,12,12 of 21,0.53,57.14,6.585E-07,0.000009655
GO:0001756,somitogenesis,Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)F1MEC8(Evidence code:IEA/Database source:UniProtKB:Q7TSK3|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens), ABI1 PCDH8 LEF1 FOXF1 PSEN1 MYF5 AXIN2 LFNG PRKDC,BP,9,9 of 9,0.39,100,6.703E-07,0.000009746
GO:0031532,actin cytoskeleton reorganization,P43481(Evidence code:ISS/Database source:UniProtKB:P10721)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR030770)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)A5PK55(Evidence code:IEA/Database source:InterPro:IPR028433)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens), KIT RICTOR RAP2A SIPA1L1 MICALL2 PARVA PAK1 BRSK2 PTK7,BP,9,9 of 9,0.39,100,6.703E-07,0.000009746
GO:0000186,activation of MAPKK activity,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1B7H4(Evidence code:IEA/Database source:GO:0004709)F1MDL4(Evidence code:IEA/Database source:GO:0004709)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)F1N3K4(Evidence code:IEA/Database source:GO:0004709)E1BHE1(Evidence code:IEA/Database source:GO:0004709), LRRK2 TAOK2 PSEN1 F2R MAP3K10 BRAF MAP3K4 MAP3K9 TAOK3,BP,9,9 of 9,0.39,100,6.703E-07,0.000009746
GO:0016604,nuclear body,A2VDU4(Evidence code:IEA/Database source:UniProtKB:F1D8P9|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q29RZ2(Evidence code:IEA/Database source:UniProtKB:Q96BP3|ens)G5E5Q8(Evidence code:IEA/Database source:UniProtKB:O95248|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:A4LAA3|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F1N0D7(Evidence code:IEA/Database source:UniProtKB:A0A024RDY6)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1B8T3(Evidence code:IEA/Database source:UniProtKB:Q9UGU0|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q14190|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q2L6I0|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens)F1MUU2(Evidence code:IEA/Database source:UniProtKB:Q8TDR2|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens), NR1I2 SUZ12 SETX PPWD1 SBF1 MYO1C ATRX HIVEP1 PTPN23 ZIC2 ABL1 RGS14 TNKS RIF1 TCF20 AGO4 WWTR1 DHX8 INO80 RAD18 DHX9 ZFHX3 ZBTB4 ESRP1 TERF2 RNF112 GTF3C6 NACC1 SIM2 PPP1R10 S100A14 CELF3 STK35 LARS,CC,34,34 of 171,1.49,19.88,7.538E-07,0.00001092
GO:0071339,MLL1 complex,A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)E1BGF3(Evidence code:IEA/Database source:InterPro:IPR037854)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR037935)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q91X20|ens)E1BEJ7(Evidence code:IEA/Database source:InterPro:IPR037932)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR037927)Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230), RUVBL1 HCFC1 MGA ASH2L HCFC2 CHD8 KMT2A RUVBL2,CC,8,8 of 6,0.35,133.33,7.555E-07,0.00001092
GO:0090090,negative regulation of canonical Wnt signaling pathway,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)A0JN59(Evidence code:IEA/Database source:UniProtKB:Q9Y283|ens)E1BI79(Evidence code:IEA/Database source:InterPro:IPR026837)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), STK3 GLI1 FZD1 INVS APC2 AXIN1 SOX17 AXIN2 CTNND1 WWTR1 DAB2IP,BP,11,11 of 17,0.48,64.71,7.796E-07,0.00001124
GO:0009791,post-embryonic development,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), ABL1 KMT2A RC3H2 PYGO2 MAPK8IP3 BCL11B ASH1L RAB3A STK36 PSEN1,BP,10,10 of 13,0.44,76.92,8.106E-07,0.00001166
GO:0017111,nucleoside-triphosphatase activity,Q28141(Evidence code:IDA/Database source:),DHX9,MF,1,1 of 257,0.04,0.39,8.141E-07,0.00001167
GO:0005815,microtubule organizing center,Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BFR5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7MBG4(Evidence code:IEA/Database source:UniProtKB:A0A024R7C0)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7Z056(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P46196(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)P63097(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48734(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32L40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)Q2NL05(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67827(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)A4IFE3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6H769(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28141(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)F1MGF7(Evidence code:IEA/Database source:InterPro:IPR012943)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28021(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), UBXN6 MASTL KEAP1 DCTN2 USP20 CHMP1A NSFL1C CAMK2B MAPK1 CCT8 BIRC6 GNAI1 CDK1 ALDOB TCP1 FLOT1 ARL2 TUBGCP2 KIF2A CSNK1A1 PCNT DBH ACTR1B NDRG1 RPS7 DCTN3 DHX9 RPP25 CDK5RAP2 ZFYVE26 SPAST MVB12A ROCK2,CC,33,33 of 164,1.45,20.12,8.613E-07,0.00001232
GO:0030426,growth cone,Q17QQ3(Evidence code:IDA/Database source:)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q99KJ8|ens)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SNAP25 DNM2 LRRK2 USP9X PSEN1 SETX EXOC8 INPP5J RTN4R MYH14 DCTN2 NDRG2,CC,12,12 of 22,0.53,54.55,9.561E-07,0.00001364
GO:0051301,cell division,A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q2NKY7(Evidence code:IEA/Database source:InterPro:IPR008113)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A6QQY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q3MHQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132), SEPT11 ZFYVE26 BRCC3 SPAST GNAI1 KIF14 CHMP1B CDK1 SEPT2 CHMP1A CSNK1A1 ARL8B VPS4B KLHL13 SEPT7 PPP1CC MASTL CLTA SPG20 DYNLT1 RGS14 PPP1CB ANXA11 KIF2A NCAPH RAN DCTN3 SEPT6,BP,28,28 of 126,1.23,22.22,0.000001051,0.00001494
GO:0061077,chaperone-mediated protein folding,Q32L40(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q2KJC8(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q32PA9(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q3ZCI9(Evidence code:IBA/Database source:PANTHER:PTN000143677)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)Q2NKZ1(Evidence code:IBA/Database source:PANTHER:PTN000143677)E1BJ75(Evidence code:ISS/Database source:UniProtKB:Q90830)Q3T0K2(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q9TRY0(Evidence code:ISS/Database source:UniProtKB:Q02790)Q29RL2(Evidence code:ISS/Database source:UniProtKB:Q9D1P4)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q99KD5|ens)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens), TCP1 FKBP9 FKBP2 CCT8 PPID DNAJC5 TOR1A CCT7 CRTAP CCT3 FKBP4 CHORDC1 UNC45A CCT6B DNAJB2,BP,15,15 of 38,0.66,39.47,0.000001118,0.00001586
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR001824)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR001426|I)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR001426)P43481(Evidence code:IEA/Database source:InterPro:IPR001824)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1N758(Evidence code:IEA/Database source:InterPro:IPR006211|I)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357), TEC FRS2 AHI1 GRB2 ABL1 CSPG4 FLT3 LCK BDNF EPHB4 EPHA6 KIT TYK2 YES1 JAK2 ERBB4 ZAP70 FRK,BP,18,18 of 56,0.79,32.14,0.000001157,0.00001636
GO:0007417,central nervous system development,V6F7Z2(Evidence code:IEA/Database source:InterPro:IPR033029)P13608(Evidence code:IBA/Database source:PANTHER:PTN001105676)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)P81282(Evidence code:IBA/Database source:PANTHER:PTN001105676)E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8NFT8|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)F1N2J5(Evidence code:IBA/Database source:PANTHER:PTN001105676), DSCAML1 ACAN CHD7 VCAN ANKLE2 STK3 SRC AHI1 DNER COL2A1 HAPLN4,BP,11,11 of 18,0.48,61.11,0.00000118,0.00001665
GO:0031648,protein destabilization,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens), CUL3 SRC RNF139 SOX17 VPS35 PEX2 PRKDC PRNP SIRT6,BP,9,9 of 10,0.39,90,0.000001198,0.00001681
GO:0031683,G-protein beta/gamma-subunit complex binding,P04896(Evidence code:IEA/Database source:InterPro:IPR000367|I)P04696(Evidence code:IEA/Database source:InterPro:IPR001019|I)P38408(Evidence code:IEA/Database source:InterPro:IPR001019)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR001019)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367|I)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019|I)P04695(Evidence code:IEA/Database source:InterPro:IPR001019|I)P63097(Evidence code:IEA/Database source:InterPro:IPR001019|I)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR001019), GNAS GNAT2 GNA14 GNA13 GNAL GNAT3 GNAT1 GNAI1 GNA12,MF,9,9 of 10,0.39,90,0.000001198,0.00001681
GO:0009890,negative regulation of biosynthetic process,Q32L41(Evidence code:IEA/Database source:InterPro:IPR009112|I),GCHFR,BP,1,1 of 253,0.04,0.4,0.000001227,0.00001717
GO:0043197,dendritic spine,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A5PKD9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BFV9(Evidence code:IEA/Database source:UniProtKB:Q0QWG9|ens)P48452(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), GIPC1 RGS14 SHANK1 PRKACA ABHD17C GRID2IP PPP3CA CAMK2A SHANK2 SEPT11,CC,10,10 of 14,0.44,71.43,0.000001307,0.00001824
GO:0007030,Golgi organization,Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BPC3(Evidence code:IBA/Database source:PANTHER:PTN001184364)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P61212)A6QQ47(Evidence code:IBA/Database source:PANTHER:PTN000409559)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771), BAG5 GOLPH3 MYO18A LRRK2 ATP8B1 KIFC3 ARL1 VPS51 ARHGAP21 NSFL1C ARFGEF1 RAB30,BP,12,12 of 23,0.53,52.17,0.000001367,0.00001903
GO:0000338,protein deneddylation,A4FV74(Evidence code:IEA/Database source:InterPro:IPR033205)G3X736(Evidence code:IEA/Database source:UniProtKB:P61201|ens)A6H7B5(Evidence code:IEA/Database source:UniProtKB:Q9UNS2|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)A6QQ21(Evidence code:IEA/Database source:InterPro:IPR033859)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q3SZA0(Evidence code:ISS/Database source:UniProtKB:Q9BT78), COPS8 COPS2 COPS3 COPS5 COPS6 TOR1A COPS4,BP,7,7 of 4,0.31,175,0.000001422,0.00001954
GO:0004198,calcium-dependent cysteine-type endopeptidase activity,E1BIX3(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q1LZ81(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q27971(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MQD1(Evidence code:IEA/Database source:InterPro:IPR001300|I)A5D7S6(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q0IIA3(Evidence code:IBA/Database source:PANTHER:PTN000021568), CAPN7 CAPN11 PDCD6 CAPN2 CAPN5 PEF1 SRI,MF,7,7 of 4,0.31,175,0.000001422,0.00001954
GO:0016079,synaptic vesicle exocytosis,P11023(Evidence code:ISS/Database source:UniProtKB:P63011)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)E1BBX9(Evidence code:IEA/Database source:UniProtKB:Q8K0T7|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)E1BMQ1(Evidence code:IEA/Database source:InterPro:IPR029996)F1MKZ3(Evidence code:IEA/Database source:InterPro:IPR033227), RAB3A SNAP25 UNC13C UNC13B UNC13A OTOF CADPS,BP,7,7 of 4,0.31,175,0.000001422,0.00001954
GO:0042169,SH2 domain binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens), SRC CRK LCK JAK2 PTPN6 ABL1 AFAP1L2,MF,7,7 of 4,0.31,175,0.000001422,0.00001954
GO:0004707,MAP kinase activity,G3X793(Evidence code:IEA/Database source:InterPro:IPR003527)P46196(Evidence code:IEA/Database source:InterPro:IPR003527|I)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR003527|I)A4FV00(Evidence code:IEA/Database source:InterPro:IPR003527|I)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR008350)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR003527|I)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR003527|I), MAPK11 MAPK1 MAPK12 MAPK10 MAPK4 MAPK9 MAPK13,MF,7,7 of 4,0.31,175,0.000001422,0.00001954
GO:0070830,bicellular tight junction assembly,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q2TA37(Evidence code:IDA/Database source:)E1BIQ8(Evidence code:IEA/Database source:InterPro:IPR031185)A2VE81(Evidence code:IEA/Database source:InterPro:IPR002958)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens), DLG1 ARL2 MPP5 OCLN SRF MICALL2 CLDN3 PDCD6IP,BP,8,8 of 7,0.35,114.29,0.000001524,0.00002072
GO:0007416,synapse assembly,E1BDL0(Evidence code:IBA/Database source:PANTHER:PTN000617834)G3N152(Evidence code:IBA/Database source:PANTHER:PTN000617834)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR030627)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens), LOC786512 PCDHB8 CRKL VPS35 SDK2 SHANK2 BSN BDNF,BP,8,8 of 7,0.35,114.29,0.000001524,0.00002072
GO:0050885,neuromuscular process controlling balance,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens), BCR SHANK1 POU4F2 ABL1 KCNMA1 ALDH1A3 CLN3 AARS,BP,8,8 of 7,0.35,114.29,0.000001524,0.00002072
GO:0043507,positive regulation of JUN kinase activity,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153), DAB2IP MAPK8IP3 TAOK3 MAP3K4 SASH1 TRAF6 MAP3K10 PAK1,BP,8,8 of 7,0.35,114.29,0.000001524,0.00002072
GO:0016818,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532), ERCC2 BLM,MF,2,2 of 281,0.09,0.71,0.00000157,0.00002129
GO:0019904,protein domain specific binding,F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q2KIB6(Evidence code:IEA/Database source:UniProtKB:Q9HAP6|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)Q2YDM1(Evidence code:IEA/Database source:UniProtKB:P40616|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BF83(Evidence code:IEA/Database source:InterPro:IPR010504)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BBJ2(Evidence code:IBA/Database source:PANTHER:PTN000270003)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)E1BB27(Evidence code:IBA/Database source:PANTHER:PTN000270003)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR010504)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens), TJP1 LIN7B CHMP1A CHMP2A PRKDC IKBKG ARL1 ABL1 SRC ICA1L CHMP2B DLGAP3 LIN7C PRKAR2A NEDD4 OSBP DLGAP1 TFDP2 NUMA1 GPSM2 KHDRBS1 ARFIP1 MPP5 OCLN GRB2 CTBP1 PRKACA STAMBP KPNB1 LAMP1,MF,30,30 of 145,1.32,20.69,0.000001602,0.00002166
GO:0005765,lysosomal membrane,Q05204(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR028798)P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)O46563(Evidence code:IBA/Database source:PANTHER:PTN000842131)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)Q2KI07(Evidence code:ISS/Database source:UniProtKB:Q9NVJ2)F1MX24(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10897(Evidence code:IBA/Database source:PANTHER:PTN001297406)Q3ZC25(Evidence code:ISS/Database source:UniProtKB:Q9NUM4)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC9(Evidence code:ISS/Database source:UniProtKB:P55735)P21282(Evidence code:IBA/Database source:PANTHER:PTN000806076)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)A7MBJ6(Evidence code:IEA/Database source:UniProtKB:Q6PJI9|ens)Q2KJA5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD59(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)P63026(Evidence code:IDA/Database source:)Q3SZJ7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1), LAMP1 TPCN2 ATP6V0D1 ATP6V1H TRIM23 ARL8B CLN3 CYB561 TMEM106B PSEN1 TMEM59 SEC13 ATP6V1C1 LITAF WDR59 LAPTM5 MARCH8 VPS41 HPS6 CD63 VAMP2 LAMP2 UBXN6,CC,23,23 of 92,1.01,25,0.000001704,0.00002298
GO:0000922,spindle pole,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)A5PJP6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)E1BAN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67774(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)Q0P594(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), VPS4B IKBKG KNTC1 CDK5RAP2 TUBGCP2 CKAP5 NUMA1 BRCC3 BIRC6 PKP4 KATNAL2 PPP2CA DYNC1LI1 KIF2A PPP2CB,CC,15,15 of 40,0.66,37.5,0.000001875,0.00002523
GO:0030154,cell differentiation,G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)A6QLP0(Evidence code:IBA/Database source:PANTHER:PTN001371846)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1B7I2(Evidence code:IBA/Database source:PANTHER:PTN000218930)F1MXR2(Evidence code:IBA/Database source:PANTHER:PTN001422142)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)A6QLE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P17667(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3MU93(Evidence code:IEA/Database source:InterPro:IPR010660)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)A6H769(Evidence code:IEA/Database source:UniProtKB:P62082|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BLV9(Evidence code:IBA/Database source:PANTHER:PTN001126776)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)P98167(Evidence code:IEA/Database source:InterPro:IPR030119)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A0JND4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MC99(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BAF6(Evidence code:IBA/Database source:PANTHER:PTN000361728)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)G3X812(Evidence code:IEA/Database source:InterPro:IPR008297|I)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR030118)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A6QNT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1MBH4(Evidence code:IBA/Database source:PANTHER:PTN001371846)Q08DH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221), GNA13 ZNF750 GNA12 FOXO4 PTPN6 ETV2 ONECUT2 DDX4 LGR4 CDC5L TDRD7 TAF8 MYF5 PSMB8 ABL1 ZAP70 CAMK2B Notch1 CPNE1 PURB FRK NDRG2 PURA RPS7 RAPGEF2 BRAF CDK1 GLI2 TSG101 VAMP5 MGP KIAA1522 GRB2 YES1 SSPO SPAST SBNO2 TEC FOXI3 TYK2 CAMK2A CAMK2D INSM1 GATA6 DLX2 DMRTC2 PRRC2A CPNE6 NOTCH4 CAND1 FLT3 CYFIP1 FAM120B SEPT7 SNAPC4 SEPT2 SEPT6 TDRD5 FOXF1 INA KIF2A FGF1,BP,62,62 of 434,2.72,14.29,0.000001905,0.00002557
GO:0044325,ion channel binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1ML52(Evidence code:IEA/Database source:UniProtKB:Q8TDN1|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens), SRC GPD1L SCN10A LRRK2 KCNG4 PDE4D DLG1 S100A10 RIMS1 LRRC26 PHPT1 YES1,MF,12,12 of 24,0.53,50,0.000001926,0.00002578
GO:0055038,recycling endosome membrane,E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)P35071(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PKD9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), RAP2A ZFYVE27 RAB4A ARF6 CFTR ABHD17C RAP2C BAIAP3 PACSIN2 RAB17,CC,10,10 of 15,0.44,66.67,0.000002048,0.00002677
GO:0016328,lateral plasma membrane,Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)Q3B7N4(Evidence code:IEA/Database source:UniProtKB:Q9Z261|ens)Q2TA37(Evidence code:IDA/Database source:)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6), CLDN3 TACSTD2 CLDN7 ARL2 AXIN1 MYO1C C1QTNF5 MYO1A DLG1 ATP6V1B1,CC,10,10 of 15,0.44,66.67,0.000002048,0.00002677
GO:0030324,lung development,F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)E1BI45(Evidence code:IEA/Database source:UniProtKB:Q9Z2J0|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens), SIM2 SLC23A1 GLI2 FOXF1 CRH CEBPA GLI1 RAB3A FGF1,BP,9,9 of 11,0.39,81.82,0.00000205,0.00002677
GO:0010824,regulation of centrosome duplication,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BK86(Evidence code:IEA/Database source:InterPro:IPR028839)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q29RL2(Evidence code:ISS/Database source:UniProtKB:Q9D1P4)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens), VPS4B PKHD1 CHMP2A CHORDC1 CHMP4B CHMP2B CHMP1A PDCD6IP XPO1,BP,9,9 of 11,0.39,81.82,0.00000205,0.00002677
GO:0007040,lysosome organization,A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612)Q3ZC25(Evidence code:IEA/Database source:UniProtKB:Q80X71|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q14703|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q9TTK4(Evidence code:IEA/Database source:InterPro:IPR030464)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), FAM160A2 TMEM106B TPCN2 MBTPS1 LRRK2 VPS35 LYST CLN3 ABCA1,BP,9,9 of 11,0.39,81.82,0.00000205,0.00002677
GO:0030276,clathrin binding,A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)P63009(Evidence code:IEA/Database source:InterPro:IPR016342)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q5T7P8|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR016342)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001285)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB:Q14677|ens), SYT4 SYTL1 AP2B1 SYT6 LRRK2 AP2B1 SYTL2 TOM1 CLINT1,MF,9,9 of 11,0.39,81.82,0.00000205,0.00002677
GO:0034399,nuclear periphery,E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MNL8(Evidence code:IBA/Database source:PANTHER:PTN001854329)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens), KPNB1 IPO5 AHCTF1 IPO4 TNPO1 TPR,CC,6,6 of 2,0.26,300,0.000002061,0.00002677
GO:1903861,positive regulation of dendrite extension,Q2KHY1(Evidence code:IEA/Database source:UniProtKB:O95741|ens)E1BPM0(Evidence code:IEA/Database source:UniProtKB:O95294|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q9UPW8|ens)F1N7B7(Evidence code:IEA/Database source:UniProtKB:Q86UR5|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:Q9H2B2|ens)E1BID8(Evidence code:IEA/Database source:UniProtKB:Q9HCH3|ens), CPNE6 RASAL1 UNC13A RIMS1 SYT4 CPNE5,BP,6,6 of 2,0.26,300,0.000002061,0.00002677
GO:0042800,histone methyltransferase activity (H3-K4 specific),E1BEP4(Evidence code:IBA/Database source:PANTHER:PTN000063846)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569|I)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)F1MYZ3(Evidence code:IEA/Database source:InterPro:IPR037877), ASH2L ASH1L KMT2A SETD1B KMT2B KMT2C,MF,6,6 of 2,0.26,300,0.000002061,0.00002677
GO:0007095,mitotic G2 DNA damage checkpoint,E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:Q9WVH3|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens), TAOK3 CDK1 FOXO4 TAOK2 BLM SYF2,BP,6,6 of 2,0.26,300,0.000002061,0.00002677
GO:0000815,ESCRT III complex,Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), CHMP2B CHMP6 CHMP1A CHMP2A CHMP4A CHMP4B,CC,6,6 of 2,0.26,300,0.000002061,0.00002677
GO:0003950,NAD+ ADP-ribosyltransferase activity,Q0P582(Evidence code:IEA/Database source:InterPro:IPR012317)E1B7S1(Evidence code:IEA/Database source:InterPro:IPR012317)F1MCK0(Evidence code:IEA/Database source:InterPro:IPR012317)P18493(Evidence code:IEA/Database source:InterPro:IPR004102|I)E1BCF8(Evidence code:IEA/Database source:InterPro:IPR012317)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR012317|I), PARP14 PARP12 PARP8 PARP1 ZC3HAV1 TNKS,MF,6,6 of 2,0.26,300,0.000002061,0.00002677
GO:0008565,protein transporter activity,A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR027156)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)Q3T0M0(Evidence code:IBA/Database source:PANTHER:PTN000122547)Q2HJG5(Evidence code:IBA/Database source:PANTHER:PTN000120819)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P56371|ens)Q0VD53(Evidence code:IBA/Database source:PANTHER:PTN000260563)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)E1BGE5(Evidence code:IBA/Database source:PANTHER:PTN000108134)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)G5E567(Evidence code:IEA/Database source:UniProtKB:Q96P70|ens)F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens), IPO4 TNPO1 KPNB1 AP2S1 XPO1 VPS29 VPS35 RAB4A VPS26A IPO8 IPO7 TNPO3 IPO9 IPO5,MF,14,14 of 35,0.61,40,0.000002231,0.00002891
GO:0032465,regulation of cytokinesis,Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BLZ4(Evidence code:ISS/Database source:UniProtKB:Q68DK2)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BE13(Evidence code:IEA/Database source:InterPro:IPR022103)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0), PLK3 ZFYVE26 BRCA2 BIRC6 AHCTF1 KLHL13 PIK3R4 PIN1 PRPF40A CCP110 PDXP,BP,11,11 of 20,0.48,55,0.000002552,0.0000329
GO:0005834,heterotrimeric G-protein complex,P04696(Evidence code:IBA/Database source:PANTHER:PTN000026392)P38408(Evidence code:IBA/Database source:PANTHER:PTN000026392)P63097(Evidence code:IBA/Database source:PANTHER:PTN000026392)P63217(Evidence code:IEA/Database source:InterPro:IPR001770)P30671(Evidence code:IEA/Database source:InterPro:IPR001770)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026392)P04695(Evidence code:IBA/Database source:PANTHER:PTN000026392)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026392)G5E6P3(Evidence code:IBA/Database source:PANTHER:PTN000026392)E1BIL1(Evidence code:IBA/Database source:PANTHER:PTN000026392)Q3SZ98(Evidence code:IEA/Database source:InterPro:IPR001770), GNAT2 GNA14 GNAI1 GNG5 GNG7 GNAT3 GNAT1 GNAS GNA13 GNA12 GNG10,CC,11,11 of 20,0.48,55,0.000002552,0.0000329
GO:0016788,"hydrolase activity, acting on ester bonds",Q29458(Evidence code:IEA/Database source:InterPro:IPR025483),LIPF,MF,1,1 of 240,0.04,0.42,0.000002593,0.00003335
GO:0008305,integrin complex,A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)P80746(Evidence code:IEA/Database source:InterPro:IPR000413)A6QQ97(Evidence code:IEA/Database source:InterPro:IPR000413)P61625(Evidence code:IEA/Database source:InterPro:IPR000413)P53710(Evidence code:IEA/Database source:InterPro:IPR000413)F1MMH2(Evidence code:IEA/Database source:InterPro:IPR000413)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436), ITGB7 ITGAV ITGAD ITGAL ITGA2 ITGA9 ITGB1 ITGB6,CC,8,8 of 8,0.35,100,0.00000287,0.00003673
GO:0007269,neurotransmitter secretion,P17599(Evidence code:IEA/Database source:InterPro:IPR001359|I)Q2KIB6(Evidence code:IEA/Database source:UniProtKB:O88951|ens)F1N159(Evidence code:IEA/Database source:InterPro:IPR001359)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:O88952|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB:Q8JZS0|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017), SYN1 LIN7B SYN2 SYT4 SNAP25 LIN7C LIN7A CACNA1B,BP,8,8 of 8,0.35,100,0.00000287,0.00003673
GO:0001669,acrosomal vesicle,E1BDI1(Evidence code:IEA/Database source:UniProtKB:Q9DA79|ens)G5E5C6(Evidence code:IEA/Database source:InterPro:IPR012267)E1BF83(Evidence code:IEA/Database source:UniProtKB:Q3TY65|ens)Q5EA42(Evidence code:IEA/Database source:UniProtKB:Q9QXM0|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)F1MXQ5(Evidence code:IEA/Database source:UniProtKB:Q6J756|ens)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens), DPEP3 ACR ICA1L ABHD2 FNDC3A IQUB PRKACA CAPN11 MROH2B RAB3A,CC,10,10 of 16,0.44,62.5,0.000003129,0.00003995
GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,F1MI25(Evidence code:IEA/Database source:UniProtKB:F8VPM9|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens), HIVEP1 ATF6B SFPQ NFKB1 KMT2A NR2F6 H3F3B,MF,7,7 of 5,0.31,140,0.000003217,0.00004077
GO:1990841,promoter-specific chromatin binding,A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), ZNF750 SUZ12 GLI2 POU4F2 CHD7 EHMT2 DHX9,MF,7,7 of 5,0.31,140,0.000003217,0.00004077
GO:0031941,filamentous actin,P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:A4UGR9|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens), MYO1A IQGAP2 APC2 MYO1C MYO18B XIRP2 MYO6,CC,7,7 of 5,0.31,140,0.000003217,0.00004077
GO:0031901,early endosome membrane,Q2TBH7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PKA5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)P35071(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q1RMW2(Evidence code:ISS/Database source:UniProtKB:Q3UFJ6)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)Q0VD59(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1), RAB4A SNX27 SNX19 CFTR DNAJC13 TMEM184A STX7 SNX8 SH3GL1 SNX3 HPS6 MARCH8 UBXN6,CC,13,13 of 31,0.57,41.94,0.000003373,0.00004264
GO:0016853,isomerase activity,Q2KJC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q17QA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)F1MU48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3SX07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)G3X8B1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)P26882(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3MHF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3SZI0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q32PA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)F1MS56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3T105(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q0P563(Evidence code:IEA/Database source:InterPro:IPR007721|I), FKBP9 FKBP5 TOP2B PPIE PUS3 FKBP4 PTPA LOC613401 PPID PPWD1 HSD3B7 MPI FKBP2 MRI1 PMM2 PGM3 PTGES3 PIN1 GALE FUOM,MF,20,20 of 75,0.88,26.67,0.000003439,0.00004337
GO:0001650,fibrillar center,Q1KZG4(Evidence code:IEA/Database source:UniProtKB:A0A024R366)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q6P1N0|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)E1BBH8(Evidence code:IEA/Database source:UniProtKB:A0A024RBA3)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)E1B9B6(Evidence code:IEA/Database source:UniProtKB:A0A024RBL3)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BGK7(Evidence code:IEA/Database source:UniProtKB:J3KTH2|ens), FHIT CC2D1A TAX1BP3 CD3EAP MRI1 MBD6 MALT1 MAP3K14 NUAK1 RREB1 TAF4B,CC,11,11 of 21,0.48,52.38,0.000003655,0.00004588
GO:0010976,positive regulation of neuron projection development,F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O43439|ens)Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:P08413)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q8VEK0|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), PRKCI CBFA2T2 CAMK2B NDNF RAPGEF2 TMEM30A ARHGAP35 SNX3 PTK7 SETX DAB2IP,BP,11,11 of 21,0.48,52.38,0.000003655,0.00004588
GO:0071222,cellular response to lipopolysaccharide,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q28165(Evidence code:ISS/Database source:UniProtKB:Q8CCS6)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q61823|ens)P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9), TRAF6 PABPN1 ABL1 NFKB1 LITAF DAB2IP ABCA1 BCR PDE4D SBNO2 PDCD4 LY96,BP,12,12 of 26,0.53,46.15,0.000003677,0.00004605
GO:0005975,carbohydrate metabolic process,Q17QE7(Evidence code:IEA/Database source:InterPro:IPR005076)Q5E985(Evidence code:IEA/Database source:InterPro:IPR018155)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q17QL1(Evidence code:IEA/Database source:InterPro:IPR006148)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR000577|I)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR001360)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312|I)Q2KIM0(Evidence code:IEA/Database source:InterPro:IPR000933|I)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR004193|I)E1BNF8(Evidence code:IEA/Database source:InterPro:IPR000577|I)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)F1MJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR011013|I)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006109)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)F1N5H2(Evidence code:IEA/Database source:InterPro:IPR000933|I)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR015955)Q2TBQ8(Evidence code:IEA/Database source:InterPro:IPR005900|I)A3KMX1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)H7BWW2(Evidence code:IEA/Database source:InterPro:IPR015883|I)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR000577|I)F1MMK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q32LF7(Evidence code:IEA/Database source:InterPro:IPR003859)Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR001250)A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR000577|I)F1MS56(Evidence code:IEA/Database source:InterPro:IPR005844|I)Q3T105(Evidence code:IEA/Database source:InterPro:IPR008089), GBGT1 HYAL1 PPP1CB GNPDA2 LOC538702 KL HK2 FUCA1 GBE1 FGGY PPP1CC PHKB MAN2C1 GPD1L pofut2 FUCA2 GALK1 UEVLD PGLS CHST14 HEXB GK2 G6PD B4GALT4 MPI GCK GK PGM3 GALE,BP,29,29 of 144,1.27,20.14,0.000003734,0.00004664
GO:0035091,phosphatidylinositol binding,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)A6QR61(Evidence code:IEA/Database source:InterPro:IPR001683|I)E1BKW9(Evidence code:IEA/Database source:InterPro:IPR001683|I)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)Q1RMH8(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881)E0AE16(Evidence code:IEA/Database source:InterPro:IPR001683|I)M5FK25(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q08DX0(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q2KHV6(Evidence code:IEA/Database source:InterPro:IPR001683|I)A4IFN6(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR001683|I)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR001683|I), PASK SNX12 SNX19 SH3PXD2A SNX3 ITPR1 SNX9 NOXO1 SNX29 SNX8 SNX18 PITPNA SNX27 TNFAIP8L3 NUMA1 SNX33,MF,16,16 of 49,0.7,32.65,0.000003771,0.00004699
GO:0042995,cell projection,A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A4IF89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A2VDK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A2VDU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A8E4N3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens), CDC42SE2 ITGB1 SEPT6 SWAP70 PPP3CA GNAT1 CYFIP1 DNM2 CSNK1A1 SH3GL1 ALCAM ARPC5L KCNA4 MYO1C CSPG4 BAIAP2 PRKACA SVIL CD44 NDRG2 MICAL3 FABP7 DPP4 PTPRN PHACTR4 CPNE6 ARL6 SORD SEPT2 EXOC8 CCT8 WASF2 PLCG1 TEKT4 TUBB4A ATP2B4 ZFYVE27 MAGI1 RDX SEPT11 ABHD17C PDXP PROM2 RAB25 SPRY4 RSPH3 SEPT7 PAK1 C1QTNF5,CC,49,49 of 317,2.15,15.46,0.000003883,0.00004805
GO:0000398,"mRNA splicing, via spliceosome",A4FUI2(Evidence code:IEA/Database source:InterPro:IPR027078)F1MS84(Evidence code:IEA/Database source:InterPro:IPR033087)Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q9UMS4)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)Q3ZBK6(Evidence code:IEA/Database source:InterPro:IPR034101)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)A7Z025(Evidence code:IEA/Database source:InterPro:IPR012591|I)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)F1MRK2(Evidence code:IBA/Database source:PANTHER:PTN000573351), SNRPE NOVA2 CDC5L TRA2A LSM4 SYF2 SNRNP200 DHX8 SNRNP70 PRPF40A PPIE GPKOW PRPF8 SNRPN SPEN,BP,15,15 of 43,0.66,34.88,0.000003877,0.00004805
GO:0000776,kinetochore,Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)P61285(Evidence code:ISS/Database source:UniProtKB:P63167)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995), SEPT6 DYNC1LI1 SEPT2 DCTN2 PPP1CC CKAP5 PSEN1 SEC13 SEPT7 XPO1 LRWD1 DCTN3 TPR DYNLL1 CSNK1A1,CC,15,15 of 43,0.66,34.88,0.000003877,0.00004805
GO:0022627,cytosolic small ribosomal subunit,Q3T0B7(Evidence code:IBA/Database source:PANTHER:PTN000174285)Q2KHT7(Evidence code:IEA/Database source:UniProtKB:P42677|ens)A5PK63(Evidence code:IBA/Database source:PANTHER:PTN000077142)A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)A2VE06(Evidence code:IBA/Database source:PANTHER:PTN000171891)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)Q3T0R1(Evidence code:ISS/Database source:UniProtKB:P62269)E1BCB7(Evidence code:IBA/Database source:PANTHER:PTN000217533)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)Q56JX6(Evidence code:ISS/Database source:UniProtKB:Q6QAT1)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)A6QLG1(Evidence code:IBA/Database source:PANTHER:PTN000513830), RPS27L RPS27 RPS17 RPS9 RPS4Y1 RPS15A RPS18 LOC511302 MCTS1 RPS7 RPS28 RPS19 LOC515358,CC,13,13 of 32,0.57,40.62,0.000004455,0.000055
GO:0043005,neuron projection,Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622286)E1BID8(Evidence code:IEA/Database source:UniProtKB:Q8JZW4|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622286)A6QLP2(Evidence code:IEA/Database source:UniProtKB:Q68FL4|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN002389359)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8), MAPK9 CPNE5 TENM3 LIN7B RAPGEF2 LRRK2 MAPK10 AHCYL2 SHANK1 BCL11B MYO1D TENM2 SNAP25 TAOK2 VAMP2 LIN7C CAMK2D ABI1 BRAF LIN7A SHANK2 VAMP1 NF2 VPS35 CAMK2A SYT4 VAMP3 RTN4R CAMK2B CYFIP1,CC,30,30 of 154,1.32,19.48,0.000004587,0.00005649
GO:0007286,spermatid development,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BF83(Evidence code:IEA/Database source:UniProtKB:Q3TY65|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)E1B7M8(Evidence code:IEA/Database source:UniProtKB:Q5QNQ6|ens)E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)E1BFJ4(Evidence code:IEA/Database source:UniProtKB:Q99MV7|ens), EHMT2 ICA1L KIT PYGO2 ALMS1 FNDC3A OSBP2 TDRD5 KLHL26 RNF17,BP,10,10 of 17,0.44,58.82,0.000004673,0.00005728
GO:0006096,glycolytic process,Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR000023|I)A6QR34(Evidence code:IEA/Database source:InterPro:IPR019807)E1BME6(Evidence code:IEA/Database source:InterPro:IPR019807)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR001697|I)F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941)Q2KJE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0324)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR000023|I)Q32KN6(Evidence code:IEA/Database source:InterPro:IPR001576|I)Q3T0S5(Evidence code:IEA/Database source:InterPro:IPR000741)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR001697|I), PFKM GCK HK2 PKLR ENO4 GAPDHS PFKP PGK2 ALDOB PKM,BP,10,10 of 17,0.44,58.82,0.000004673,0.00005728
GO:0000981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q12837|ens)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)A6QLP0(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)F1MU53(Evidence code:IBA/Database source:PANTHER:PTN000003381)A6QPH9(Evidence code:ISS/Database source:UniProtKB:Q9UJ78)Q32KX6(Evidence code:IBA/Database source:PANTHER:PTN000284480)A0JNC9(Evidence code:IBA/Database source:PANTHER:PTN001145452)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1B7I2(Evidence code:IBA/Database source:PANTHER:PTN000218930)A5PKI6(Evidence code:IBA/Database source:PANTHER:PTN000317389)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A7MB06(Evidence code:IBA/Database source:PANTHER:PTN001145452)F1MC99(Evidence code:IBA/Database source:PANTHER:PTN001371846)A6QQP0(Evidence code:IEA/Database source:InterPro:IPR034632)F1MKK8(Evidence code:IBA/Database source:PANTHER:PTN000548738)M5FMX2(Evidence code:IEA/Database source:InterPro:IPR031265)F1MVT7(Evidence code:IBA/Database source:PANTHER:PTN000192346), NFKB1 POU4F2 ZMYM4 LMO2 FOXO4 SOX17 ZNF446 ZMYM5 TFDP2 SP1 GATA6 RUNX1 CDC5L TCF7L2 SNAPC4 ETV2 CC2D1A E2F1 SP7 FOXI3 MYEF2 SIM2 SOX8 EPM2AIP1,MF,24,24 of 107,1.05,22.43,0.000005155,0.00006292
GO:0030234,enzyme regulator activity,Q3T0B2(Evidence code:IEA/Database source:InterPro:IPR035268)A7MBA2(Evidence code:IEA/Database source:InterPro:IPR016642|I)P56701(Evidence code:IEA/Database source:InterPro:IPR016643), PSMD6 PSMD1 PSMD2,MF,3,3 of 293,0.13,1.02,0.000005158,0.00006292
GO:0045595,regulation of cell differentiation,A4FV32(Evidence code:IBA/Database source:PANTHER:PTN001023612)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028), PLEKHB2 SOX17 RUNX1,BP,3,3 of 296,0.13,1.01,0.000005234,0.0000637
GO:0010501,RNA secondary structure unwinding,Q2NL22(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q0IIK5(Evidence code:IBA/Database source:PANTHER:PTN000618218)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000618218), EIF4A3 DDX1 DDX3Y AGO4 DDX20 DDX3X DDX4 DHX9 EIF4A2,BP,9,9 of 13,0.39,69.23,0.000005374,0.00006526
GO:0005615,extracellular space,P98167(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)E1BF06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000163972)Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287)P62248(Evidence code:ISS/Database source:UniProtKB:Q969H8)P05059(Evidence code:IDA/Database source:)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P35246(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BGU5(Evidence code:IEA/Database source:InterPro:IPR027881)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN001224703)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)A6QQ02(Evidence code:IEA/Database source:InterPro:IPR000215)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)G3X894(Evidence code:IEA/Database source:InterPro:IPR000215)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)G3MYK9(Evidence code:IBA/Database source:PANTHER:PTN000744245)F1N160(Evidence code:IBA/Database source:PANTHER:PTN000587099)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685978)Q5E998(Evidence code:IBA/Database source:PANTHER:PTN000274640)P01175(Evidence code:IDA/Database source:)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)A6QQN6(Evidence code:IEA/Database source:InterPro:IPR017064)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)G3N183(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)G3X743(Evidence code:IEA/Database source:InterPro:IPR015571)E1BJ75(Evidence code:IEA/Database source:UniProtKB:O75718|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)A6YT15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P26917(Evidence code:IBA/Database source:PANTHER:PTN000059370)P58754(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BJW3(Evidence code:IEA/Database source:UniProtKB:Q9H8L6|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens)E1BBS6(Evidence code:IBA/Database source:PANTHER:PTN000528008)P02668(Evidence code:IDA/Database source:)F1MYW3(Evidence code:IBA/Database source:PANTHER:PTN000744245)A4FV80(Evidence code:IEA/Database source:UniProtKB:Q8R089|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)Q08D90(Evidence code:IEA/Database source:UniProtKB:P49862|ens)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274640)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)Q8MJ29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)E1BH09(Evidence code:IEA/Database source:InterPro:IPR030755)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)E1BN05(Evidence code:IEA/Database source:UniProtKB:Q8BMF8|ens), SSPO FUCA2 TNFSF15 CPXM2 ITM2B MYDGF CHGA COL1A2 SFTPD SOGA3 PRELP DNAJB11 LOC617406 IFNT2 CNP C1QTNF5 IFNT3 LOC786263 CRH SEMA3G VPREB1 DBH LYZ1 CTSV OXT IDE SMPDL3B IGFBP3 SORL1 EMILIN1 LOC104968438 TACSTD2 RNPEP CRTAP HYAL1 TMPRSS6 CCL28 SST LY96 COLEC10 FGF1 PDGFC SLIT2 MMRN2 LAMB1 FAM20A QSOX2 CSN3 SEMA3E FBRS HFE2 PCSK6 KLK7 TINAGL1 KIT IFNT COL2A1 VWA2 KL GLDN,CC,60,60 of 426,2.63,14.08,0.000005462,0.00006618
GO:0045121,membrane raft,Q05204(Evidence code:IDA/Database source:)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10279(Evidence code:ISS/Database source:UniProtKB:P35052)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512256)P81425(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)Q08DN8(Evidence code:ISS/Database source:UniProtKB:O75955)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN001124099)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)A2VE13(Evidence code:IEA/Database source:InterPro:IPR033240)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens), LAMP1 BACE1 PRNP PLLP DPP4 DLG1 PSEN1 ABCA1 LRRK2 ZAP70 CAPN2 FLOT1 MYO1C CBLC LCK MAL2 ARID3A NPC1 S100A10,CC,19,19 of 71,0.83,26.76,0.000005713,0.00006905
GO:0031175,neuron projection development,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q17QM6(Evidence code:IEA/Database source:UniProtKB:Q9D4J1|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000958636)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000958636)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), CYFIP2 ZFYVE27 UBE4B PTPRM EFHD1 LAMB2 TOR1A FRY MICALL2 FRYL UHMK1 NEDD4 LAMB1 MKL1 RAPGEF2 SRF,BP,16,16 of 51,0.7,31.37,0.000005759,0.00006925
GO:0019898,extrinsic component of membrane,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023)F1MM21(Evidence code:IEA/Database source:UniProtKB:P49758|ens)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)Q1RMH8(Evidence code:IBA/Database source:PANTHER:PTN000058569)A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q2KHV6(Evidence code:IBA/Database source:PANTHER:PTN000058569), PACSIN2 SNX33 WDFY3 ATG2B RGS6 SNX12 RNF112 UBXN6 SNX3 SEC23A ALOX15B TPR SNX8,CC,13,13 of 33,0.57,39.39,0.000005833,0.00006925
GO:0001518,voltage-gated sodium channel complex,G3MYM1(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1B757(Evidence code:IEA/Database source:InterPro:IPR029873)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR001696|I), SCN10A SCN5A SCN3A SCN2B SCN8A SCN11A,CC,6,6 of 3,0.26,200,0.000005835,0.00006925
GO:0048786,presynaptic active zone,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)E1BPW2(Evidence code:IEA/Database source:InterPro:IPR019323)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR030627)E1BBX9(Evidence code:IBA/Database source:PANTHER:PTN000826129), UNC13A UNC13B ERC1 RIMS1 BSN UNC13C,CC,6,6 of 3,0.26,200,0.000005835,0.00006925
GO:0035855,megakaryocyte development,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), WASF2 ABI1 PTPN6 KIT MEIS1 SRF,BP,6,6 of 3,0.26,200,0.000005835,0.00006925
GO:0004709,MAP kinase kinase kinase activity,F1N3K4(Evidence code:IEA/Database source:InterPro:IPR016231)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN001554601)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR015785|I)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN001554601), MAP3K9 MAP3K4 BRAF TAOK3 MAP3K10 TAOK2,MF,6,6 of 3,0.26,200,0.000005835,0.00006925
GO:0046875,ephrin receptor binding,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MHL2(Evidence code:IEA/Database source:InterPro:IPR033637)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MXV4(Evidence code:IEA/Database source:UniProtKB:Q8C0T5|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens), ABL1 ANKS1A SRC CRK SIPA1L1 GRB2,MF,6,6 of 3,0.26,200,0.000005835,0.00006925
GO:1902902,negative regulation of autophagosome assembly,A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), CHMP4A PINK1 CHMP4B LRRK2 SCFD1 EHMT2,BP,6,6 of 3,0.26,200,0.000005835,0.00006925
GO:0019866,organelle inner membrane,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,CC,1,1 of 231,0.04,0.43,0.00000595,0.00007045
GO:0008139,nuclear localization sequence binding,Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MH31(Evidence code:IBA/Database source:PANTHER:PTN000573960)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427), TNPO1 NUP214 IPO5 KPNB1 TNPO3 POM121L2 IPO4,MF,7,7 of 6,0.31,116.67,0.000006569,0.00007761
GO:0007257,activation of JUN kinase activity,F1N3K4(Evidence code:IBA/Database source:PANTHER:PTN001147668)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1B7H4(Evidence code:IBA/Database source:PANTHER:PTN001147668), MAP3K9 DAB2IP AXIN1 MAPK8IP3 MAP3K10,BP,5,5 of 1,0.22,500,0.000007098,0.00008293
GO:0035255,ionotropic glutamate receptor binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), GNAS SCRIB SHANK2 DLG1 SHANK1,MF,5,5 of 1,0.22,500,0.000007098,0.00008293
GO:0045332,phospholipid translocation,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q8VEK0|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)F1N0J3(Evidence code:IEA/Database source:GO:0004012), ABCA1 TMEM30A ATP8B1 ABCA7 ATP11A,BP,5,5 of 1,0.22,500,0.000007098,0.00008293
GO:0019774,"proteasome core complex, beta-subunit complex",Q3SZC2(Evidence code:ISS/Database source:UniProtKB:P23724)P33672(Evidence code:IEA/Database source:InterPro:IPR033811)Q3T0T1(Evidence code:ISS/Database source:UniProtKB:P23724)Q3T108(Evidence code:ISS/Database source:UniProtKB:P23724)Q3T112(Evidence code:ISS/Database source:UniProtKB:P23724), PSMB9 PSMB3 PSMB10 PSMB4 PSMB8,CC,5,5 of 1,0.22,500,0.000007098,0.00008293
GO:0071007,U2-type catalytic step 2 spliceosome,Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9), CDC5L PRPF8 DHX8 SYF2 PPIE,CC,5,5 of 1,0.22,500,0.000007098,0.00008293
GO:0006357,regulation of transcription by RNA polymerase II,E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)F1MPU1(Evidence code:IEA/Database source:InterPro:IPR019035)Q32KX6(Evidence code:IBA/Database source:PANTHER:PTN000284480)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)G3MY92(Evidence code:IEA/Database source:InterPro:IPR015660)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN000677913)E1B7I2(Evidence code:IBA/Database source:PANTHER:PTN000218930)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)P62194(Evidence code:IEA/Database source:UniProtKB:P62195|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)F1MC99(Evidence code:IEA/Database source:GO:0000981)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q7Z4L5|ens)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR030503)A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR033486)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)A6QPH9(Evidence code:IEA/Database source:GO:0000981)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR030449)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q9CPU0|ens)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR016362)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)E1BDD9(Evidence code:IBA/Database source:PANTHER:PTN001480141)F1MKK8(Evidence code:IBA/Database source:PANTHER:PTN000548738)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q5NUA6(Evidence code:IBA/Database source:PANTHER:PTN000696756)M5FMX2(Evidence code:IEA/Database source:GO:0000981)Q9BE45(Evidence code:IBA/Database source:PANTHER:PTN001538048)E1BJ93(Evidence code:IEA/Database source:InterPro:IPR028769)F1MHR5(Evidence code:IEA/Database source:GO:0000981)F1MU53(Evidence code:IEA/Database source:GO:0000981)A6QQP0(Evidence code:IEA/Database source:GO:0000981)F1MVT7(Evidence code:IEA/Database source:GO:0000981), RUNX1 MED12L TFDP2 STAT3 ATF6B SMARCAL1 ASCL4 PKN1 MNX1 ETV2 NIPBL PKNOX1 BRD2 CDC5L PSMC5 IKBKAP FOXI3 CTDSP1 EHMT2 TTC21B NFKB1 HIST1H1D DLX2 RUVBL1 RFX5 DGKQ ZMYM5 SP1 SNF8 RAI1 GLO1 RUVBL2 POU3F1 SNAPC4 PRKCB BRCA1 TSHZ1 SP7 ZNF367 MKL1 SIM2 CUL3 NFE2L2 SOX8 NFKBIZ LEF1 ZMYM4 ZNF446 MYEF2 EPM2AIP1,BP,50,50 of 336,2.19,14.88,0.000007296,0.00008505
GO:0034622,cellular protein-containing complex assembly,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens), TAF10 AXIN1,BP,2,2 of 262,0.09,0.76,0.000007346,0.00008544
GO:0019752,carboxylic acid metabolic process,A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001557)E1BP41(Evidence code:IEA/Database source:InterPro:IPR002129)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR002129), UEVLD CSAD PDXDC1,BP,3,3 of 290,0.13,1.03,0.000007492,0.00008695
GO:0005929,cilium,F1N307(Evidence code:IEA/Database source:GO:0035721)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)F6PR93(Evidence code:IEA/Database source:GO:0035721)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:Q9H0F7|ens)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)A8E4N3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)F2Z4K0(Evidence code:IEA/Database source:UniProtKB:P05214|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969), TTC21A AHI1 ATP2B4 SEPT6 TTC21B GLI2 ARL6 PRKACA TEKT4 RSPH3 SORD PKHD1 DNAH7 TUBA3E SEPT7 TUBB4A CCT8 GLI1 SEPT2,CC,19,19 of 73,0.83,26.03,0.000008005,0.00009269
GO:0060070,canonical Wnt signaling pathway,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024458)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MDE1(Evidence code:IEA/Database source:InterPro:IPR017049)E1BPF3(Evidence code:IEA/Database source:InterPro:IPR015668)E1B8K0(Evidence code:IEA/Database source:InterPro:IPR015668)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), FZD1 PSEN1 GLI1 LRP6 BCL9 BCL9L LEF1 PYGO2 SOX17,BP,9,9 of 14,0.39,64.29,0.000008308,0.00009557
GO:0000049,tRNA binding,A7MBC5(Evidence code:IEA/Database source:InterPro:IPR033709)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)Q0VC66(Evidence code:IEA/Database source:InterPro:IPR000541)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)Q56JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820), IARS XPOT MARS AARS2 SSB AARS CTU1 TRMT1L RPL35A,MF,9,9 of 14,0.39,64.29,0.000008308,0.00009557
GO:0002039,p53 binding,G3N065(Evidence code:IBA/Database source:PANTHER:PTN000552321)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)F1N413(Evidence code:IEA/Database source:InterPro:IPR038034)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9D3J3|ens), ZNF385C RFFL BLM PTTG1IP PLK3 CHD8 NUAK1 EHMT2 BCL2L12,MF,9,9 of 14,0.39,64.29,0.000008308,0.00009557
GO:0000209,protein polyubiquitination,E1BP63(Evidence code:IBA/Database source:PANTHER:PTN000280277)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q17R11(Evidence code:IEA/Database source:InterPro:IPR033103)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)P61085(Evidence code:IBA/Database source:PANTHER:PTN000629609)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629793)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)E1BAK9(Evidence code:IBA/Database source:PANTHER:PTN000280277), RNF139 UBE2D2 SASH1 UBE4B RNF165 DZIP3 ANKIB1 CUL3 TRAF6 UBE2K UBE2G2 HUWE1 TNKS RC3H2 UBE2L3 SYVN1,BP,16,16 of 53,0.7,30.19,0.000008636,0.00009888
GO:0035264,multicellular organism growth,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), EN1 ADARB1 RC3H2 WWTR1 ATRX CLIC4 TAF10 PDE4D,BP,8,8 of 10,0.35,80,0.000008652,0.00009888
GO:0001772,immunological synapse,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens), ZAP70 DUSP3 PDCD6IP SNX27 ALCAM STX7 DLG1 LCK,CC,8,8 of 10,0.35,80,0.000008652,0.00009888
GO:0009607,response to biotic stimulus,Q0P559(Evidence code:IEA/Database source:InterPro:IPR007593),IFITM1,BP,1,1 of 225,0.04,0.44,0.000008706,0.00009927
GO:0006338,chromatin remodeling,A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)A7Z075(Evidence code:IEA/Database source:InterPro:IPR029523)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR030088)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR021906)A5PJQ1(Evidence code:IBA/Database source:PANTHER:PTN000336336)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)E1B925(Evidence code:IEA/Database source:InterPro:IPR021906|I)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244), RUVBL1 CHD7 INO80B SMARCA2 ARID1B DEK KDM6B INO80 ARID1A ATRX PABPC1L RUVBL2,BP,12,12 of 29,0.53,41.38,0.000008899,0.0001013
GO:0003755,peptidyl-prolyl cis-trans isomerase activity,A4FV72(Evidence code:IEA/Database source:InterPro:IPR002130|I)Q2KJC8(Evidence code:IEA/Database source:EC:5.2.1.8)Q2KJ44(Evidence code:IEA/Database source:EC:5.2.1.8)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)Q32PA9(Evidence code:IEA/Database source:EC:5.2.1.8)Q29RZ2(Evidence code:IEA/Database source:InterPro:IPR002130|I)P26882(Evidence code:IEA/Database source:InterPro:IPR002130|I)P48820(Evidence code:IEA/Database source:InterPro:IPR002130|I)G3X8B1(Evidence code:IEA/Database source:InterPro:IPR002130|I)Q5BIN5(Evidence code:IEA/Database source:InterPro:IPR000297), PPIE FKBP9 PTPA FKBP5 FKBP4 FKBP2 PPWD1 PPID RANBP2 LOC613401 PIN1,MF,11,11 of 24,0.48,45.83,0.000009816,0.0001112
GO:0000278,mitotic cell cycle,E0AE16(Evidence code:IEA/Database source:InterPro:IPR014536)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR028314)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)A4IFN6(Evidence code:IEA/Database source:InterPro:IPR014536)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR014536)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens), SNX9 CUL3 TFDP2 RGS14 SNX18 WEE1 SNX33 MASTL PPP2R2A DCTN2,BP,10,10 of 19,0.44,52.63,0.000009814,0.0001112
GO:0030336,negative regulation of cell migration,Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10833|ens)F1MJI3(Evidence code:IBA/Database source:PANTHER:PTN001021265)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q5EA42(Evidence code:ISS/Database source:UniProtKB:Q9QXM0)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:Q80ZJ1|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens), RRAS SRGAP3 BCR SLIT2 ARAP3 RAP2C CLIC4 ABHD2 DUSP3 ADAM15 ADARB1 NAV3 RAP2A STK26 ZMYND8,BP,15,15 of 48,0.66,31.25,0.0000116,0.0001311
GO:0006898,receptor-mediated endocytosis,Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)F1MDR7(Evidence code:IBA/Database source:PANTHER:PTN001181218)E1B9M8(Evidence code:IEA/Database source:GO:0005044)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)A2VDV7(Evidence code:IEA/Database source:GO:0005044)F1MI35(Evidence code:IEA/Database source:GO:0005044)E1B9H1(Evidence code:IEA/Database source:GO:0005044)B6ULZ4(Evidence code:IEA/Database source:GO:0005044)Q0V7N1(Evidence code:IEA/Database source:GO:0005044)E1B813(Evidence code:IEA/Database source:GO:0005044)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)F1N7K7(Evidence code:IEA/Database source:GO:0005044)E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513), DNM1 DNAJC13 SCARF2 CUBN TMPRSS2 HHIPL1 TINAGL1 WC1 SUSD2 LOC786796 DNM2 MARCO TFRC,BP,13,13 of 36,0.57,36.11,0.00001247,0.0001393
GO:0030165,PDZ domain binding,A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN001184752)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)A7YY57(Evidence code:IEA/Database source:UniProtKB:Q52LW3|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A6QLD1(Evidence code:IEA/Database source:UniProtKB:O35382|ens)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN001184752)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), FZD1 ATP2B2 RAPGEF2 ARHGAP29 PSEN1 EXOC4 ATP2B3 F11R KIF14,MF,9,9 of 15,0.39,60,0.00001251,0.0001393
GO:0030145,manganese ion binding,Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)Q1JPJ2(Evidence code:ISS/Database source:UniProtKB:Q9NQW7)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), POMGNT1 PRKACA NUDT16 XPNPEP1 DYRK2 GALNT2 ABL1 IMPA1 WRN,MF,9,9 of 15,0.39,60,0.00001251,0.0001393
GO:0071230,cellular response to amino acid stimulus,E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02463|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)Q27971(Evidence code:ISS/Database source:UniProtKB:O08529)P02465(Evidence code:IEA/Database source:UniProtKB:Q01149|ens), SH3BP4 COL5A2 COL4A6 IPO5 LARS COL4A1 PDGFC CAPN2 COL1A2,BP,9,9 of 15,0.39,60,0.00001251,0.0001393
GO:0048306,calcium-dependent protein binding,P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)E1BC70(Evidence code:IEA/Database source:UniProtKB:A5D8V6|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), S100B TSG101 PDCD6 MYO1D PDCD6IP PEF1 SYT6 VPS37C CLN3,MF,9,9 of 15,0.39,60,0.00001251,0.0001393
GO:0048538,thymus development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), ASXL1 PSEN1 BCL11B CRKL ABL1 BRAF SRF,BP,7,7 of 7,0.31,100,0.00001238,0.0001393
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens), CRK RREB1 CRKL PREX1 ABL1 S100A10 BRAF,BP,7,7 of 7,0.31,100,0.00001238,0.0001393
GO:0043207,response to external biotic stimulus,P01175(Evidence code:IDA/Database source:),OXT,BP,1,1 of 219,0.04,0.46,0.00001273,0.0001415
GO:0050790,regulation of catalytic activity,E1BIX7(Evidence code:IEA/Database source:GO:0005092)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)P56701(Evidence code:IEA/Database source:GO:0030234)Q5BIS9(Evidence code:IEA/Database source:InterPro:IPR039160)Q3T0B2(Evidence code:IEA/Database source:GO:0030234)F1N2I0(Evidence code:IEA/Database source:GO:0005092)A7MBA2(Evidence code:IEA/Database source:GO:0030234), GPSM2 SH3BP4 PSMD2 PRKAB1 PSMD6 CHML PSMD1,BP,7,7 of 388,0.31,1.8,0.00001329,0.0001474
GO:0005811,lipid droplet,Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0551)Q3MHF2(Evidence code:IEA/Database source:UniProtKB:Q9H2F3|ens)P16386(Evidence code:ISS/Database source:UniProtKB:P54310)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)F1MNM7(Evidence code:IEA/Database source:UniProtKB:Q96Q06|ens)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0551)P02694(Evidence code:ISS/Database source:UniProtKB:P09455)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens), PNPLA2 HSD3B7 LIPE SPG20 ALOX15 TRAF6 PLIN4 CIDEC RBP1 AIFM2,CC,10,10 of 20,0.44,50,0.00001384,0.0001516
GO:0000724,double-strand break repair via homologous recombination,Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1BEE6(Evidence code:IBA/Database source:PANTHER:PTN000344874)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1BQ04(Evidence code:IBA/Database source:PANTHER:PTN000344874)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR028730)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1B8X8(Evidence code:IEA/Database source:InterPro:IPR015187|I), BRCA1 AP5Z1 WRN SFPQ BLM RAD21L1 ZFYVE26 PSMD14 INO80 BRCA2,BP,10,10 of 20,0.44,50,0.00001384,0.0001516
GO:0006418,tRNA aminoacylation for protein translation,Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001412|I)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001412|I)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR000738|I)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR000738|I), NARS IARS RARS2 LARS RARS GARS EPRS WARS2 QARS MARS,BP,10,10 of 20,0.44,50,0.00001384,0.0001516
GO:0032587,ruffle membrane,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)A2VDU1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), SRC PDXP WWC1 DDX58 SPRY4 ITGB1 MTSS1L EPS8L1 PAK1 TWF1,CC,10,10 of 20,0.44,50,0.00001384,0.0001516
GO:1903543,positive regulation of exosomal secretion,Q08DL9(Evidence code:IEA/Database source:UniProtKB:Q92783|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens), STAM TSG101 SNF8 CHMP2A PDCD6IP VPS4B,BP,6,6 of 4,0.26,150,0.00001376,0.0001516
GO:0005248,voltage-gated sodium channel activity,E1BHM6(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR001696|I), SCN11A SCN3A SCN8A SCN5A HCN1 SCN10A,MF,6,6 of 4,0.26,150,0.00001376,0.0001516
GO:0070536,protein K63-linked deubiquitination,Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)G3N2I1(Evidence code:IEA/Database source:UniProtKB:Q5VV17|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens), PSMD14 USP20 SHMT2 OTUD7B BRCC3 OTUD1 USP13 OTUD4,BP,8,8 of 11,0.35,72.73,0.00001407,0.0001535
GO:0045335,phagocytic vesicle,G3X7D3(Evidence code:IEA/Database source:UniProtKB:Q14964|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens), RAB39A LAMP1 RAB9A ABCA1 SNX3 FMNL1 RAB23 MYO1C,CC,8,8 of 11,0.35,72.73,0.00001407,0.0001535
GO:0009968,negative regulation of signal transduction,G3N1E4(Evidence code:IEA/Database source:UniProtKB:Q52KG5|ens)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460), KIF26A BRAF,BP,2,2 of 245,0.09,0.82,0.00001433,0.0001559
GO:0044255,cellular lipid metabolic process,F1MLW9(Evidence code:IEA/Database source:InterPro:IPR022284)Q3SZH7(Evidence code:IBA/Database source:PANTHER:PTN000164255), GPAT2 LTA4H,BP,2,2 of 247,0.09,0.81,0.0000145,0.0001575
GO:0005215,transporter activity,F1MS75(Evidence code:IEA/Database source:InterPro:IPR002443|I)P63009(Evidence code:TAS/Database source:)A5D7H9(Evidence code:IBA/Database source:PANTHER:PTN000177662)A1A4L2(Evidence code:IBA/Database source:PANTHER:PTN000177662)F1MS08(Evidence code:IEA/Database source:InterPro:IPR002443|I)G3N271(Evidence code:IEA/Database source:InterPro:IPR006042)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006042)Q1RMW2(Evidence code:IBA/Database source:PANTHER:PTN000603211), SLC12A1 AP2B1 SLC6A14 SLC6A20 SLC12A2 LOC100337457 LOC100298868 TMEM184A,MF,8,8 of 411,0.35,1.95,0.00001501,0.0001627
GO:0045766,positive regulation of angiogenesis,A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404)E1BME6(Evidence code:IEA/Database source:UniProtKB:P52789|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q969H8)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:O96013|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), EMC10 SP1 RRAS PRKCB HK2 GATA6 MYDGF SASH1 PAK4 FGF1 PDCD6 HYAL1,BP,12,12 of 31,0.53,38.71,0.00001526,0.0001647
GO:0030308,negative regulation of cell growth,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q58DD3(Evidence code:ISS/Database source:UniProtKB:P25686)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)P23709(Evidence code:ISS/Database source:UniProtKB:O75489)A3KN28(Evidence code:IEA/Database source:UniProtKB:Q8K4P7|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), SOX17 CCAR2 SH3BP4 EAF2 HYAL1 DNAJB2 SMARCA2 MT3 ADAM15 NDUFS3 ST7L SLIT2,BP,12,12 of 31,0.53,38.71,0.00001526,0.0001647
GO:0023014,signal transduction by protein phosphorylation,G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MP51(Evidence code:IEA/Database source:GO:0000155)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825), PAK4 MAP3K4 KCNH5 MAP3K1 MAP2K4 PAK2 PAK1 MAP3K14 STK3 PAK6 MAP3K8 PAK3 SLK,BP,13,13 of 37,0.57,35.14,0.00001583,0.0001705
GO:0005741,mitochondrial outer membrane,P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P63087|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)E1BME6(Evidence code:IEA/Database source:UniProtKB:P52789|ens), MAOB RHOT1 PINK1 CPT1B LRRK2 MARCH5 SH3GLB1 FIS1 GK MFN2 SPG20 PPP1CC AIFM2 RHOT2 HK2,CC,15,15 of 50,0.66,30,0.00001736,0.0001866
GO:1901135,carbohydrate derivative metabolic process,Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR001347)F1MZY2(Evidence code:IEA/Database source:InterPro:IPR001347), GFPT2 GFPT1,BP,2,2 of 240,0.09,0.83,0.00002074,0.0002225
GO:0090305,nucleic acid phosphodiester bond hydrolysis,Q6T5B7(Evidence code:IEA/Database source:GO:0004518)E1BEE6(Evidence code:IEA/Database source:GO:0008408)A5PJT8(Evidence code:IEA/Database source:GO:0004518)E1BMC0(Evidence code:IEA/Database source:GO:0008409)Q0II50(Evidence code:IEA/Database source:GO:0004518)Q2QDE9(Evidence code:IEA/Database source:GO:0004518)Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)E1BPX9(Evidence code:IEA/Database source:GO:0004519)E1BDI3(Evidence code:IEA/Database source:GO:0008408)G3X7J6(Evidence code:IEA/Database source:GO:0008408)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens)E1BML0(Evidence code:IEA/Database source:GO:0004518)Q08DM8(Evidence code:IEA/Database source:GO:0004518)F1MGC2(Evidence code:IEA/Database source:GO:0004519)A7YWM6(Evidence code:IEA/Database source:GO:0004519), AGO3 WRN DNASE1L2 POLQ USB1 DNASE1L1 DXO LRPPRC POLG EXD3 DDX1 PAN2 TSN RNASE2 RNASE13,BP,15,15 of 51,0.66,29.41,0.00002109,0.0002258
GO:0001932,regulation of protein phosphorylation,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)P00515(Evidence code:IEA/Database source:InterPro:IPR012198), PIN1 RICTOR CCNYL1 PRKAR2A,BP,4,4 of 304,0.18,1.32,0.00002161,0.0002308
GO:0030126,COPI vesicle coat,Q27954(Evidence code:IEA/Database source:InterPro:IPR010714)P35605(Evidence code:ISS/Database source:UniProtKB:P35606)A2VE21(Evidence code:IEA/Database source:InterPro:IPR013040|I)P35604(Evidence code:IEA/Database source:UniProtKB:P61923|ens)A0JN39(Evidence code:IEA/Database source:InterPro:IPR011710)Q28104(Evidence code:IDA/Database source:)P53619(Evidence code:IEA/Database source:InterPro:IPR027059), COPA COPB2 COPG2 COPZ1 COPB1 COPE ARCN1,CC,7,7 of 8,0.31,87.5,0.00002188,0.0002314
GO:0008540,"proteasome regulatory particle, base subcomplex",A7MBA2(Evidence code:IEA/Database source:UniRule:UR000777776)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q0P5A6(Evidence code:IBA/Database source:PANTHER:PTN000339132)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMD1 PSMC2 PSMC1 PSMD5 PSMC6 PSMD2 PSMC5,CC,7,7 of 8,0.31,87.5,0.00002188,0.0002314
GO:0006904,vesicle docking involved in exocytosis,A6QLT7(Evidence code:IEA/Database source:InterPro:IPR007225)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635132)E1BG76(Evidence code:IEA/Database source:InterPro:IPR001619|I)A3KMZ0(Evidence code:IEA/Database source:InterPro:IPR001619|I)P61763(Evidence code:IEA/Database source:InterPro:IPR001619|I)A6QLD1(Evidence code:IEA/Database source:InterPro:IPR007191)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635132), EXOC6 RAB26 SCFD1 STXBP3 STXBP1 EXOC4 RAB37,BP,7,7 of 8,0.31,87.5,0.00002188,0.0002314
GO:0030326,embryonic limb morphogenesis,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens), EN1 PSEN1 LEF1 SHOX2 SALL4 MEGF8 FRAS1,BP,7,7 of 8,0.31,87.5,0.00002188,0.0002314
GO:0043195,terminal bouton,F1MP30(Evidence code:IBA/Database source:PANTHER:PTN000826129)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:P61967|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MK99(Evidence code:IBA/Database source:PANTHER:PTN000826129)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)E1BBX9(Evidence code:IBA/Database source:PANTHER:PTN000826129), UNC13B AP1S1 RAB3A KCNMA1 UNC13A AAK1 UNC13C,CC,7,7 of 8,0.31,87.5,0.00002188,0.0002314
GO:0006821,chloride transport,E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q08E50(Evidence code:IEA/Database source:InterPro:IPR005435)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869), BEST3 CLIC4 CLDN4 CLCC1 ANO6 GABRA5 CFTR CLIC6,BP,8,8 of 12,0.35,66.67,0.00002209,0.0002326
GO:0005913,cell-cell adherens junction,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8WU20|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)F1MPF3(Evidence code:IEA/Database source:UniProtKB:Q9NYQ8|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827), FLOT1 MPP5 FRS2 TJP1 FAT2 SCRIB TNKS1BP1 PTPRM,CC,8,8 of 12,0.35,66.67,0.00002209,0.0002326
GO:0016192,vesicle-mediated transport,Q0V7N0(Evidence code:IEA/Database source:InterPro:IPR001388)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)P04973(Evidence code:IEA/Database source:InterPro:IPR000996)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BME2(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR000804)A2VE21(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)A0JN39(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q8BHC1)Q09YL9(Evidence code:IEA/Database source:InterPro:IPR001388)E1BGT8(Evidence code:IEA/Database source:InterPro:IPR029901|I)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR010989)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q3ZC13(Evidence code:IEA/Database source:InterPro:IPR001392|I)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)A3KMZ0(Evidence code:IEA/Database source:InterPro:IPR001619|I)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR000804)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q2KJD2(Evidence code:IEA/Database source:InterPro:IPR001388)A7Z035(Evidence code:IEA/Database source:InterPro:IPR030544)O46382(Evidence code:IBA/Database source:PANTHER:PTN000070561)Q2TBL9(Evidence code:IEA/Database source:InterPro:IPR007233)P35604(Evidence code:IEA/Database source:InterPro:IPR000804)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR002553|I)P63026(Evidence code:IEA/Database source:InterPro:IPR001388)E1BG76(Evidence code:IEA/Database source:InterPro:IPR001619|I)P63009(Evidence code:IEA/Database source:InterPro:IPR002553|I)P61763(Evidence code:IEA/Database source:InterPro:IPR001619|I)P81127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692|I)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR002553|I)A3KN15(Evidence code:IEA/Database source:InterPro:IPR000547)Q2KHY2(Evidence code:IEA/Database source:InterPro:IPR001388)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931), VAMP1 MAPK8IP3 SEC23B CLTA AHI1 AP3B2 AP1S1 COPG2 ZFYVE27 COPB2 TRAPPC2L COPB1 RAB39B STXBP5 SPIRE1 CHMP1A COPE STX7 SEC24A AP2M1 ARCN1 STXBP3 AP2S1 SEC23A AP2A1 VAMP3 CLINT1 ARFGEF1 TRAPPC4 COPZ1 AP2A2 VAMP2 SCFD1 AP2B1 STXBP1 NAPG COPA SEC13 AP2B1 VPS41 VAMP5 SAR1B,BP,42,42 of 277,1.84,15.16,0.00002278,0.0002394
GO:0005838,proteasome regulatory particle,A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62192|ens)P56701(Evidence code:IEA/Database source:UniProtKB:Q8VDM4|ens)P62194(Evidence code:IEA/Database source:UniProtKB:P62196|ens)Q3T0B2(Evidence code:IBA/Database source:PANTHER:PTN000365350)Q2KJ25(Evidence code:IEA/Database source:UniProtKB:Q9D8W5|ens), PSMC1 PSMD2 PSMC5 PSMD6 PSMD12,CC,5,5 of 2,0.22,250,0.00002348,0.0002443
GO:0005790,smooth endoplasmic reticulum,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), RYR1 PSEN1 SYVN1 MYO1D MAPK8IP3,CC,5,5 of 2,0.22,250,0.00002348,0.0002443
GO:0000813,ESCRT I complex,A6QP64(Evidence code:IEA/Database source:InterPro:IPR037859)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T178(Evidence code:IEA/Database source:InterPro:IPR007143)Q3T0N1(Evidence code:IEA/Database source:InterPro:IPR018798)E1BC70(Evidence code:IEA/Database source:InterPro:IPR037859), VPS37B TSG101 VPS28 MVB12A VPS37C,CC,5,5 of 2,0.22,250,0.00002348,0.0002443
GO:0032839,dendrite cytoplasm,E1BMW9(Evidence code:IEA/Database source:GO:0098963)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)E1BQ37(Evidence code:IEA/Database source:GO:0098963)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens), PURA LRRK2 ABHD12 SFPQ UHMK1,CC,5,5 of 2,0.22,250,0.00002348,0.0002443
GO:0090110,cargo loading into COPII-coated vesicle,Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)A6QNT8(Evidence code:ISS/Database source:UniProtKB:O95486)F1MV07(Evidence code:IEA/Database source:UniProtKB:O94855|ens)E1BIU0(Evidence code:IEA/Database source:UniProtKB:P53992|ens), SEC13 SEC23A SEC24A SEC24D SEC24C,BP,5,5 of 2,0.22,250,0.00002348,0.0002443
GO:0003697,single-stranded DNA binding,A6QQP0(Evidence code:IEA/Database source:InterPro:IPR034632)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q08DM8(Evidence code:IEA/Database source:InterPro:IPR033956)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)Q5E9A3(Evidence code:ISS/Database source:UniProtKB:Q15365)G8JKZ3(Evidence code:IBA/Database source:PANTHER:PTN000056764)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens), MYEF2 LRPPRC DHX9 PURB TSN BLM PURA PCBP1 PRIM1 BRCA2,MF,10,10 of 22,0.44,45.45,0.0000263,0.0002731
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MBH4(Evidence code:IBA/Database source:PANTHER:PTN000215836)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), GATA6 PKNOX1 MYF5 MEIS1 LEF1 FOXF1 SOX17 GLI1 SRF,MF,9,9 of 17,0.39,52.94,0.00002647,0.0002738
GO:0005930,axoneme,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:P04350|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q8VD65|ens)Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)Q0IIM2(Evidence code:IDA/Database source:)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), GLI1 TUBB4A PIK3R4 SEPT7 DNAH5 DNAH11 ARL6 PRKAR2A GLI2,CC,9,9 of 17,0.39,52.94,0.00002647,0.0002738
GO:0043198,dendritic shaft,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens), PSEN1 GIPC1 SYNGAP1 RTN4R CACNA1B INPP5J,CC,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0031434,mitogen-activated protein kinase kinase binding,F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens), BRAF TAOK2 PIN1 MAPK8IP3 DAB2IP DLG1,MF,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0003007,heart morphogenesis,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), ASXL1 NIPBL CHD7 MYBPC3 COL2A1 TBX3,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:1901673,regulation of mitotic spindle assembly,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens), TPR CHMP4B CHMP2A CHMP2B CHMP1A VPS4B,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0046718,viral entry into host cell,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q5E985(Evidence code:IEA/Database source:GO:0001618)Q8SQB8(Evidence code:IEA/Database source:GO:0001618)P53712(Evidence code:IEA/Database source:GO:0001618)P80746(Evidence code:IEA/Database source:GO:0001618)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens), EPS15 HYAL1 ITGB6 ITGB1 ITGAV NPC1,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0004683,calmodulin-dependent protein kinase activity,F1MVF1(Evidence code:IEA/Database source:InterPro:IPR013543|I)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR013543|I)Q08E45(Evidence code:IEA/Database source:InterPro:IPR013543|I)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR013543|I), CAMK2G MYLK3 MAPKAPK3 CAMK2D CAMK2A CAMK2B,MF,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0007140,male meiotic nuclear division,E1BDI1(Evidence code:IEA/Database source:UniProtKB:Q9DA79|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens), DPEP3 DDX4 AGO4 UBR2 TDRD9 FIGNL1,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0070403,NAD+ binding,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)F6QK60(Evidence code:IEA/Database source:InterPro:IPR003000)E1BMI4(Evidence code:IEA/Database source:UniProtKB:Q8NBZ7|ens)C6K7D2(Evidence code:IEA/Database source:InterPro:IPR003000)A5D7K6(Evidence code:IEA/Database source:InterPro:IPR003000)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR022694), ALDH1A3 SIRT2 UXS1 Sirt1 SIRT6 CRYL1,MF,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0031011,Ino80 complex,A7Z075(Evidence code:IEA/Database source:InterPro:IPR006880|I)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR027238|I)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)F1MPR9(Evidence code:IEA/Database source:InterPro:IPR024867)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR027238|I), INO80B INO80 RUVBL2 ACTR5 NFRKB RUVBL1,CC,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0030514,negative regulation of BMP signaling pathway,E1BIJ4(Evidence code:IEA/Database source:UniProtKB:Q9Y2U8|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens), LEMD3 FZD1 ABL1 HFE2 TMPRSS6 SPG20,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0007528,neuromuscular junction development,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02463|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens), UNC13A LAMB2 LRRK2 COL4A1 UNC13B COL4A5,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0005070,SH3/SH2 adaptor activity,Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR035036)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)Q58DL5(Evidence code:IBA/Database source:PANTHER:PTN001023064)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), Grb10 KHDRBS1 GRB2 SH2B2 BCAR3 CRK,MF,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0000132,establishment of mitotic spindle orientation,Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)P63171(Evidence code:ISS/Database source:UniProtKB:P51807)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q9D818|ens), NSFL1C GPSM2 DYNLT1 NUMA1 CDK5RAP2 SAPCD2,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0035176,social behavior,E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BFN9(Evidence code:IEA/Database source:UniProtKB:Q9P2S2|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), SHANK2 NRXN2 EN1 SHANK1 CHD8 PCM1,BP,6,6 of 5,0.26,120,0.00002857,0.0002876
GO:0016772,"transferase activity, transferring phosphorus-containing groups",A6QP44(Evidence code:IEA/Database source:InterPro:IPR012887)Q3ZBM7(Evidence code:IEA/Database source:InterPro:IPR002745), FUK TRPT1,MF,2,2 of 236,0.09,0.85,0.00003063,0.0003077
GO:0008234,cysteine-type peptidase activity,Q08DY9(Evidence code:IEA/Database source:InterPro:IPR015917)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)F1MQD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)E1BL29(Evidence code:IBA/Database source:PANTHER:PTN001621808)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR015917)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR000668|I)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q5E998(Evidence code:IEA/Database source:InterPro:IPR000668|I)E1BIX3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)F1MXQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788), CASP3 USP20 CAPN5 CAPN2 BLMH CASP6 OTUD7B TINAGL1 USP13 CTSV CAPN7 PIGK OTUB1 USP5 CAPN11,MF,15,15 of 53,0.66,28.3,0.00003074,0.0003082
GO:0008236,serine-type peptidase activity,Q08D90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)E1BEQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P81425(Evidence code:IEA/Database source:InterPro:IPR001375)G5E5C6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)E1BI31(Evidence code:IEA/Database source:InterPro:IPR001375)G5E657(Evidence code:IEA/Database source:InterPro:IPR008758)P80227(Evidence code:IEA/Database source:InterPro:IPR001375)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P12661(Evidence code:IEA/Database source:InterPro:IPR005151)Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR001375)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)F1MCT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P67810(Evidence code:IEA/Database source:InterPro:IPR019756|I)A4FUF1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720), KLK7 TMPRSS9 LOC505658 DPP4 ACR PRSS23 DPP9 PRSS16 APEH TMPRSS2 RBP3 PREP HABP2 TMPRSS6 PCSK6 SEC11A LOC100125946,MF,17,17 of 67,0.75,25.37,0.00003089,0.0003091
GO:0030018,Z disc,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)Q58DA7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48452(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)F1MF57(Evidence code:ISS/Database source:UniProtKB:O76041), CACNA1D XIRP2 GLRX3 ACTN2 PPP3CA SRI PPP2R5A MYBPC3 CRYAB PSEN1 MYO18B NEBL,CC,12,12 of 34,0.53,35.29,0.00003212,0.0003209
GO:0031047,gene silencing by RNA,F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)E1B7E6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)P61286(Evidence code:ISS/Database source:UniProtKB:P29341)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)Q6T5B7(Evidence code:IEA/Database source:InterPro:IPR028603), TDRD1 DICER1 DHX9 PIWIL2 PABPC1 DDX4 AGO4 AGO3,BP,8,8 of 13,0.35,61.54,0.00003361,0.0003344
GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",O19137(Evidence code:IEA/Database source:GO:0004521)E1B7E6(Evidence code:IEA/Database source:GO:0004521)Q6T5B7(Evidence code:IEA/Database source:GO:0004521)E1BFK4(Evidence code:IEA/Database source:GO:0004521)E1BFB5(Evidence code:IEA/Database source:GO:0004526)Q6TUI4(Evidence code:IEA/Database source:GO:0004525)A6QR44(Evidence code:IEA/Database source:GO:0004525)E1BK83(Evidence code:IEA/Database source:GO:0004526), CPSF4 PIWIL2 AGO3 SMG6 KIAA0391 DICER1 DGCR8 RPP25,BP,8,8 of 13,0.35,61.54,0.00003361,0.0003344
GO:0030139,endocytic vesicle,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q61146|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)A6QLR4(Evidence code:ISS/Database source:UniProtKB:Q14254)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN000634696), DAB2IP ABCA1 ARF6 RAPGEF2 STX7 OCLN CUBN DPP4 FLOT2 RAB17,CC,10,10 of 23,0.44,43.48,0.00003549,0.0003525
GO:0042475,odontogenesis of dentin-containing tooth,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), LRP6 NF2 LEF1 DLX2 BCL11B GLI2 TRAF6,BP,7,7 of 9,0.31,77.78,0.00003667,0.0003635
GO:0030136,clathrin-coated vesicle,F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)F1MH24(Evidence code:ISS/Database source:UniProtKB:F1SPM8)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7Z035(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q1RMR3(Evidence code:IDA/Database source:)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), DENND1A SNX3 AAK1 EPS15 CPNE6 CLINT1 SNX18 CTTN VPS41,CC,9,9 of 18,0.39,50,0.00003737,0.0003691
GO:0000187,activation of MAPK activity,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)E1B7J7(Evidence code:IEA/Database source:GO:0004708)P22571(Evidence code:IEA/Database source:UniProtKB:P61249|ens)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000037430)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), FRS2 FGF1 PAK3 PDE6H SHC1 KIT PROK1 CSPG4 LRRK2,BP,9,9 of 18,0.39,50,0.00003737,0.0003691
GO:0048513,animal organ development,Q00KA9(Evidence code:IEA/Database source:InterPro:IPR030799),LRP4,BP,1,1 of 199,0.04,0.5,0.00003787,0.0003733
GO:0007034,vacuolar transport,P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)Q3SX42(Evidence code:IEA/Database source:InterPro:IPR005024)A2VDY3(Evidence code:IEA/Database source:InterPro:IPR005024)Q58CS7(Evidence code:IEA/Database source:InterPro:IPR005024)Q148L0(Evidence code:IEA/Database source:InterPro:IPR005024)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR005024)F1MX24(Evidence code:IBA/Database source:PANTHER:PTN000104831)Q08E32(Evidence code:IEA/Database source:InterPro:IPR005024)Q3T0U5(Evidence code:IEA/Database source:InterPro:IPR005024)Q3SZ37(Evidence code:IEA/Database source:InterPro:IPR005024)Q5E994(Evidence code:IEA/Database source:InterPro:IPR005024), ATP6V0D1 CHMP2B CHMP4A CHMP3 CHMP6 CHMP1A CLN3 CHMP4B CHMP2A CHMP5 CHMP1B,BP,11,11 of 29,0.48,37.93,0.00003994,0.0003922
GO:0031514,motile cilium,D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)Q58D31(Evidence code:ISS/Database source:UniProtKB:Q64442)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282), ATP2B4 SORD IQUB SEPT7 DAAM1 DNAH11 SEPT2 GLI2 TEKT4 PRKACA SEPT6,CC,11,11 of 29,0.48,37.93,0.00003994,0.0003922
GO:0001725,stress fiber,E1BL04(Evidence code:IEA/Database source:UniProtKB:A4UGR9|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB:Q9NVA2|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q8BPM0|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1MF57(Evidence code:ISS/Database source:UniProtKB:O76041)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens), XIRP2 SH2B2 SEPT11 FERMT2 DAAM1 MICALL2 NEBL MYH14,CC,8,8 of 14,0.35,57.14,0.00004974,0.0004875
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)O46405(Evidence code:IEA/Database source:UniProtKB:P33681|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q6UVK1|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), PRNP DGKQ SRC CD80 PAK2 YES1 LRRK1 TEC RICTOR CSPG4 fgfr3 ABL1,BP,12,12 of 36,0.53,33.33,0.0000508,0.000497
GO:0007268,chemical synaptic transmission,E1BDL0(Evidence code:IBA/Database source:PANTHER:PTN000617834)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1MP30(Evidence code:IEA/Database source:InterPro:IPR027080)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)E1BB27(Evidence code:IEA/Database source:InterPro:IPR030524)G3N152(Evidence code:IBA/Database source:PANTHER:PTN000617834)A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365476)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027080)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR027080|I)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)A0JNA0(Evidence code:IEA/Database source:InterPro:IPR030529)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens), LOC786512 DLG1 UNC13B LRP6 DLGAP1 PCDHB8 EXOC4 UNC13A KCNMA1 UNC13C SCRIB APBA2 GIPC1 GRM7,BP,14,14 of 49,0.61,28.57,0.00005122,0.0004992
GO:0020037,heme binding,E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR038158)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)A7MBF5(Evidence code:IEA/Database source:InterPro:IPR000898|I)F1MP20(Evidence code:IEA/Database source:InterPro:IPR012292)Q32LH7(Evidence code:IEA/Database source:InterPro:IPR018506)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BEL8(Evidence code:IEA/Database source:InterPro:IPR000971|I)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I), CYP7A1 LOC100295883 GUCY1A3 DGCR8 LOC540627 IDO1 ADGB CYB5R4 CYP2R1 NOS2 JAK2 SRC HBE1 CYP2J2,MF,14,14 of 49,0.61,28.57,0.00005122,0.0004992
GO:0042645,mitochondrial nucleoid,E1BFB5(Evidence code:IEA/Database source:UniProtKB:Q8JZY4|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38646|ens)P11181(Evidence code:IEA/Database source:UniProtKB:P11182|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q9Y2S7|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897), KIAA0391 LRPPRC POLG FASTKD2 CPS1 HSPA9 DBT POLDIP2 SHMT2,CC,9,9 of 19,0.39,47.37,0.00005184,0.0005043
GO:0021766,hippocampus development,E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens), DCLK2 LEF1 NF2 SRF KIF14 DLX2,BP,6,6 of 6,0.26,100,0.00005393,0.0005186
GO:1901998,toxin transport,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)P35604(Evidence code:IEA/Database source:UniProtKB:P61924|ens)F1MDE1(Evidence code:IEA/Database source:GO:0019534)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8BRF7|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens), CCT3 COPZ1 LRP6 SCFD1 DNM1 ARID1A,BP,6,6 of 6,0.26,100,0.00005393,0.0005186
GO:0005795,Golgi stack,Q3SZC4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)E1BB36(Evidence code:IEA/Database source:InterPro:IPR007754)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens), NSFL1C MBTPS1 GALNT2 MGAT2 PLK3 TRAPPC4,CC,6,6 of 6,0.26,100,0.00005393,0.0005186
GO:0006284,base-excision repair,A4IFC8(Evidence code:IEA/Database source:UniProtKB:P18858|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens), LIG1 TDG POLQ SIRT6 WRN HUWE1,BP,6,6 of 6,0.26,100,0.00005393,0.0005186
GO:0009925,basal plasma membrane,F1MMH2(Evidence code:IEA/Database source:UniProtKB:B8JK39|ens)E1BI45(Evidence code:IEA/Database source:UniProtKB:Q9Z2J0|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens), ITGA9 SLC23A1 MYO1C AQP5 MYO1A TACSTD2,CC,6,6 of 6,0.26,100,0.00005393,0.0005186
GO:0070006,metalloaminopeptidase activity,G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:P09960|ens)E1BP91(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q3ZC89(Evidence code:IEA/Database source:UniRule:UR000111476)Q2HJH1(Evidence code:IBA/Database source:PANTHER:PTN002004858)Q1JPJ2(Evidence code:IEA/Database source:InterPro:IPR033740), RNPEP LTA4H NPEPPS METAP2 DNPEP XPNPEP1,MF,6,6 of 6,0.26,100,0.00005393,0.0005186
GO:0043069,negative regulation of programmed cell death,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 191,0.04,0.52,0.000054,0.0005186
GO:0004930,G-protein coupled receptor activity,E1B9D3(Evidence code:IEA/Database source:InterPro:IPR017978)G3N0Y0(Evidence code:IEA/Database source:InterPro:IPR000276)G3X8A9(Evidence code:IEA/Database source:InterPro:IPR000276)E1BKU0(Evidence code:IEA/Database source:InterPro:IPR000276)E1BMX7(Evidence code:IEA/Database source:InterPro:IPR000276)F1MSU3(Evidence code:IEA/Database source:InterPro:IPR000276)A7MB15(Evidence code:IBA/Database source:PANTHER:PTN000139394)E1BMY3(Evidence code:IEA/Database source:InterPro:IPR000276)Q2YDG0(Evidence code:IEA/Database source:InterPro:IPR017978)Q1JQB3(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)E1BEB2(Evidence code:IEA/Database source:InterPro:IPR000276)E1BLE8(Evidence code:IEA/Database source:InterPro:IPR000337|I)P47803(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MR98(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1BMN4(Evidence code:IEA/Database source:InterPro:IPR000276)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR000832|I)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR000832|I)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3X828(Evidence code:IEA/Database source:InterPro:IPR000276)F1MG76(Evidence code:IEA/Database source:InterPro:IPR000276), GPR179 LOC788626 OR5M11 ADORA2A OR51Q1 RXFP3 FZD1 LOC614090 GPRC5C GPR4 LGR4 LOC531090 GRM7 RGR RRH PTH2R NMBR CD97 PTH1R F2R OR13C3 GPR75,MF,22,22 of 110,0.96,20,0.00005631,0.0005398
GO:0060341,regulation of cellular localization,Q2HJF7(Evidence code:ISS/Database source:UniProtKB:Q13557),CAMK2D,BP,1,1 of 194,0.04,0.52,0.0000565,0.0005407
GO:0071158,positive regulation of cell cycle arrest,A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), FOXO4 BRCA1 PRKACA INSM1 GATA6 ZBTB17 DAB2IP,BP,7,7 of 10,0.31,70,0.00005876,0.0005521
GO:0001540,amyloid-beta binding,A0JNA0(Evidence code:IEA/Database source:InterPro:IPR030529)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens)Q3T0P7(Evidence code:IBA/Database source:PANTHER:PTN000103178)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), APBA2 PRNP DLGAP3 ITM2B CRYAB BACE1 SORL1,MF,7,7 of 10,0.31,70,0.00005876,0.0005521
GO:0030904,retromer complex,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q0VD53(Evidence code:IEA/Database source:UniProtKB:O75436|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2)Q3T0M0(Evidence code:IEA/Database source:InterPro:IPR028661)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens), VPS35 VPS26A SNX27 SNX3 SNX8 VPS29 ANKFY1,CC,7,7 of 10,0.31,70,0.00005876,0.0005521
GO:0043010,camera-type eye development,E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), RAX ARHGAP35 PKNOX1 CRYAB RPGRIP1L CHD7 MYF5,BP,7,7 of 10,0.31,70,0.00005876,0.0005521
GO:0060021,roof of mouth development,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), TBX3 CHD7 FRAS1 PYGO2 LRP6 BCOR COL2A1,BP,7,7 of 10,0.31,70,0.00005876,0.0005521
GO:0007368,determination of left/right symmetry,F1MCT1(Evidence code:IEA/Database source:UniProtKB:F6XJP7|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), PCSK6 DNAH11 AXIN1 DNAH5 MEGF8 RPGRIP1L FOXF1,BP,7,7 of 10,0.31,70,0.00005876,0.0005521
GO:0032039,integrator complex,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)A5PJT2(Evidence code:IEA/Database source:InterPro:IPR026164)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)E1B8S1(Evidence code:IEA/Database source:InterPro:IPR038902)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens), NIPBL INTS10 CPSF3L INTS1 INTS3,CC,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001285)F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001485), SYT6 RIMS1 SYTL1 SYT4 SYTL2,BP,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0060325,face morphogenesis,Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)A6QR60(Evidence code:IEA/Database source:UniProtKB:Q9H336|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), RRAS NIPBL LEF1 CRISPLD1 LRP6,BP,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T178(Evidence code:ISS/Database source:UniProtKB:Q9UK41)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR028770), VPS4B NEDD4 TSG101 VPS28 PTPN23,BP,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0071773,cellular response to BMP stimulus,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens), GATA6 HFE2 COL2A1 ADAMTS12 ADAMTS7,BP,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0019228,neuronal action potential,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)E1BHM6(Evidence code:IBA/Database source:PANTHER:PTN000798901)F1MMU9(Evidence code:IBA/Database source:PANTHER:PTN000798901)G3MYM1(Evidence code:IBA/Database source:PANTHER:PTN000798901)F1MHP0(Evidence code:IBA/Database source:PANTHER:PTN000798901), KCNMA1 SCN11A SCN8A SCN10A SCN5A,BP,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0005388,calcium-transporting ATPase activity,D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408|I)F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408|I)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408|I)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR006413|I)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000643812), ATP2B4 ATP2B3 ATP2B2 ATP2C2 ATP13A5,MF,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0070064,proline-rich region binding,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:Q9R1C7|ens), ABL1 NEDD4 BAIAP2 BAIAP2L1 PRPF40A,MF,5,5 of 3,0.22,166.67,0.00005917,0.0005521
GO:0030182,neuron differentiation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000048336)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680687), PSEN1 RUNX1 POU4F2 EN1 CASP3 RNF112 ATP2B2 PIGT ABL1 NIF3L1 DCLK2,BP,11,11 of 31,0.48,35.48,0.00006538,0.0006078
GO:0005814,centriole,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8TCU4|ens)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR033700)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207)G3N3M6(Evidence code:IEA/Database source:InterPro:IPR026048)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)E1BC48(Evidence code:IEA/Database source:UniProtKB:Q5VT06|ens)E1BJG8(Evidence code:IEA/Database source:UniProtKB:Q9H2F9|ens), ALMS1 PLK4 CCP110 CEP250 PCM1 SDCCAG8 SIRT2 AHI1 PCNT CEP350 CCDC68,CC,11,11 of 31,0.48,35.48,0.00006538,0.0006078
GO:0098609,cell-cell adhesion,A4FUD6(Evidence code:IEA/Database source:InterPro:IPR030713)F1MSN2(Evidence code:IBA/Database source:PANTHER:PTN001799275)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q5TAT6|ens)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028435)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)A4IF71(Evidence code:IEA/Database source:InterPro:IPR028435)E1BQ11(Evidence code:IEA/Database source:InterPro:IPR028435|I)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028435), ELMO2 TACSTD2 COL13A1 PKP4 CYFIP2 FAT1 SRF ASTN1 FNDC3A SCRIB PSEN1 DLG1 FOXF1 PKP2 CTNND1 ARVCF,BP,16,16 of 65,0.7,24.62,0.00007094,0.0006583
GO:0006997,nucleus organization,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), LEMD3 CHMP1A VPS4B CHMP4B CHMP2B CHMP6 CHMP4A CHMP2A,BP,8,8 of 15,0.35,53.33,0.00007183,0.0006643
GO:0000082,G1/S transition of mitotic cell cycle,A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979), CDK3 TAF10 CAMK2A RANBP2 PPP3CA CAMK2G PLK3 CDK6,BP,8,8 of 15,0.35,53.33,0.00007183,0.0006643
GO:0032259,methylation,E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q7YRV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)P10950(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A6QL80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)G3MZP6(Evidence code:IEA/Database source:InterPro:IPR002877)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A1A4K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489), WHSC1L1 DNMT3A ASH1L ASMT KMT2A KMT2C TRMT1L PRMT3 COMT CMTR2 KMT2B PRMT5 DOT1L PCMT1 NSUN2,BP,15,15 of 58,0.66,25.86,0.00007354,0.0006788
GO:0005267,potassium channel activity,E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631), KCNC4 KCNH6 KCNC3 KCNMA1 KCNA4 HCN1 KCNG2 KCNF1 KCNG4 KCNH5,MF,10,10 of 26,0.44,38.46,0.00008113,0.0007476
GO:0003735,structural constituent of ribosome,Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR001266|I)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR005710)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)Q3T057(Evidence code:IEA/Database source:InterPro:IPR000218|I)Q3T076(Evidence code:IEA/Database source:InterPro:IPR001971|I)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)Q3T087(Evidence code:IEA/Database source:InterPro:IPR002132|I)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)P0C2B7(Evidence code:IEA/Database source:InterPro:IPR034596)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)Q76I82(Evidence code:IEA/Database source:InterPro:IPR000630|I)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592), RPL35A RPS17 RPS19 RPS4Y1 RPL27 RPL23A RPS9 RPL22 RPL9 RPL23 RPS14 MRPL3 RPL11 RPL38 RPS18 MRPL52 RPS27 RPS4X RPS15A RPL28 RPS7 RPL30 LOC511302 RPS28 RPS27L,MF,25,25 of 138,1.1,18.12,0.00008931,0.0008018
GO:0043220,Schmidt-Lanterman incisure,F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens), PRKCI MPP5 SIRT2 MPDZ,CC,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:1990907,beta-catenin-TCF complex,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:O00512|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q9BRQ0|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens), LEF1 BCL9 PYGO2 BCL9L,CC,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0044322,endoplasmic reticulum quality control compartment,A7MBJ3(Evidence code:IEA/Database source:GO:0036509)G3MXQ8(Evidence code:IEA/Database source:UniProtKB:Q9UKM7|ens)E1BAK9(Evidence code:IBA/Database source:PANTHER:PTN000967687)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687), EDEM2 MAN1B1 SYVN1 DZIP3,CC,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0002042,cell migration involved in sprouting angiogenesis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BJW3(Evidence code:IEA/Database source:UniProtKB:A6H6E2|ens)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens), SLIT2 MMRN2 EPHB4 SRF,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0060324,face development,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens), SRF ALDH1A3 BRAF CHD7,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0038191,neuropilin binding,G3MYK9(Evidence code:IBA/Database source:PANTHER:PTN000867406)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)F1MYW3(Evidence code:IBA/Database source:PANTHER:PTN000867406)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), SEMA3G TAOK2 SEMA3E ABL1,MF,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0048593,camera-type eye morphogenesis,E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)E1BMG7(Evidence code:IEA/Database source:UniProtKB:Q9P273|ens)F1MJR6(Evidence code:IEA/Database source:UniProtKB:P25318|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens), FAT1 TENM3 COL8A2 AQP5,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0031435,mitogen-activated protein kinase kinase kinase binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), TRAF6 DAB2IP SASH1 MAPK8IP3,MF,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0048172,regulation of short-term neuronal synaptic plasticity,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens), KMT2A UNC13A UNC13B RAB3A,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0044615,nuclear pore nuclear basket,F1MH31(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573963)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), NUP214 POM121L2 RANBP2 TPR,CC,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0005587,collagen type IV trimer,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)Q29442(Evidence code:IDA/Database source:), COL4A1 COL4A5 COL4A6 COL4A4,CC,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0060996,dendritic spine development,G5E5G9(Evidence code:IEA/Database source:UniProtKB:Q8BTW9|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q8CIN4|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens), PAK4 PAK3 PAK2 CAMK2A,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0006491,N-glycan processing,F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)A7MBJ3(Evidence code:IBA/Database source:PANTHER:PTN000201533)G3MXQ8(Evidence code:IBA/Database source:PANTHER:PTN000201533)E1BI49(Evidence code:IBA/Database source:PANTHER:PTN000201533), ST8SIA3 EDEM2 MAN1B1 MAN1A2,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0006610,ribosomal protein import into nucleus,A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)F1MPE5(Evidence code:IEA/Database source:UniProtKB:O00410|ens)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427), IPO4 KPNB1 IPO5 TNPO1,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0051298,centrosome duplication,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207)E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762), BRCA2 TUBGCP2 CCP110 CKAP5,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:2001224,positive regulation of neuron migration,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), NIPBL RAPGEF2 MAPK8IP3 DAB2IP,BP,4,4 of 1,0.18,400,0.00008977,0.0008018
GO:0042327,positive regulation of phosphorylation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BMG1(Evidence code:IEA/Database source:GO:0019209), PSEN1 MOB1B,BP,2,2 of 214,0.09,0.93,0.00008871,0.0008018
GO:1902533,positive regulation of intracellular signal transduction,F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230), LRRK1 FGF1,BP,2,2 of 217,0.09,0.92,0.00009016,0.0008039
GO:0051209,release of sequestered calcium ion into cytosol,E1BHV1(Evidence code:IEA/Database source:GO:0005219)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8BWC0|ens)Q8WN96(Evidence code:IBA/Database source:PANTHER:PTN001416417)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881)G3N0E5(Evidence code:IEA/Database source:GO:0005219), RYR2 F2R TPCN2 ITPR2 RYR1 ITPR1 RYR3,BP,7,7 of 11,0.31,63.64,0.00009065,0.0008056
GO:0005852,eukaryotic translation initiation factor 3 complex,Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR009374|I)A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)Q3ZC12(Evidence code:IEA/Database source:InterPro:IPR017334)Q5E966(Evidence code:IEA/Database source:InterPro:IPR027525)E1BLZ8(Evidence code:IEA/Database source:InterPro:IPR027531)Q3T148(Evidence code:IEA/Database source:InterPro:IPR027528)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727), EIF3K EIF3B EIF3G EIF3I EIF3F EIF3M ABCE1,CC,7,7 of 11,0.31,63.64,0.00009065,0.0008056
GO:0002183,cytoplasmic translational initiation,Q5E966(Evidence code:IEA/Database source:UniRule:UR000107081)E1BLZ8(Evidence code:IEA/Database source:UniRule:UR000106280)A7MB16(Evidence code:IEA/Database source:UniRule:UR000106119)Q3ZC12(Evidence code:IEA/Database source:UniRule:UR000106306)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107), EIF3I EIF3F EIF3B EIF3G EIF3M EIF3K,BP,6,6 of 7,0.26,85.71,0.00009452,0.0008315
GO:0042472,inner ear morphogenesis,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)F1MG13(Evidence code:IEA/Database source:UniProtKB:Q9QZZ4|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)P31407(Evidence code:ISS/Database source:UniProtKB:P15313), BCR CHD7 COL2A1 MYO15A ALDH1A3 ATP6V1B1,BP,6,6 of 7,0.26,85.71,0.00009452,0.0008315
GO:0000228,nuclear chromosome,Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)E1B9J3(Evidence code:IEA/Database source:InterPro:IPR006909)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q6PIW4|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), H3F3B RAD21L1 SETX FIGNL1 ATRX BLM,CC,6,6 of 7,0.26,85.71,0.00009452,0.0008315
GO:0001947,heart looping,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)F1MF74(Evidence code:ISS/Database source:UniProtKB:F1RA39)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), TBX3 MICAL2 SOX17 PSEN1 AHI1 SRF,BP,6,6 of 7,0.26,85.71,0.00009452,0.0008315
GO:0004003,ATP-dependent DNA helicase activity,A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MFY4(Evidence code:IEA/Database source:InterPro:IPR027044)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I), RUVBL1 BLM HELB WRN RUVBL2 ERCC2,MF,6,6 of 7,0.26,85.71,0.00009452,0.0008315
GO:0021987,cerebral cortex development,F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN000357964)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), BTBD3 TACC1 KIF14 CDON PSEN1 LRP6,BP,6,6 of 7,0.26,85.71,0.00009452,0.0008315
GO:0001568,blood vessel development,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P80746(Evidence code:ISS/Database source:UniProtKB:P43406), TBX3 CHD7 PSEN1 FOXF1 SPHK2 CRKL RAPGEF2 COL1A2 ITGAV,BP,9,9 of 21,0.39,42.86,0.00009514,0.0008327
GO:0032092,positive regulation of protein binding,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens), LRRK2 PSEN1 STK3 MARK3 FLOT1 RAPGEF2 LFNG SPTA1 PIN1,BP,9,9 of 21,0.39,42.86,0.00009514,0.0008327
GO:0001078,"transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579358)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)F1N5R9(Evidence code:IEA/Database source:UniProtKB:Q05925|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q8K1A6|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens), TBX3 CUX2 BCL11A TSHZ1 EN1 GCFC2 CC2D1A POU4F2 AEBP2,MF,9,9 of 21,0.39,42.86,0.00009514,0.0008327
GO:0006302,double-strand break repair,G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens), ACTR5 WRN DDX1 BRCC3 PRKDC SETX TNKS1BP1 POLQ RAD21L1 INO80 PARP1 BRCA2,BP,12,12 of 39,0.53,30.77,0.00009613,0.0008385
GO:0007626,locomotory behavior,F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)F1MG13(Evidence code:IEA/Database source:UniProtKB:Q9QZZ4|ens)E1BA03(Evidence code:IEA/Database source:UniProtKB:Q3ULB5|ens), ASTN1 NAV2 CHD7 ALDH1A3 DBH PEX13 CACNA1B SNAP25 MEIS1 ADORA2A MYO15A PAK6,BP,12,12 of 39,0.53,30.77,0.00009613,0.0008385
GO:0005044,scavenger receptor activity,E1B9H1(Evidence code:IEA/Database source:InterPro:IPR001212)E1B813(Evidence code:IEA/Database source:InterPro:IPR001190)E1B9M8(Evidence code:IEA/Database source:UniProtKB:P59222|ens)F1N7K7(Evidence code:IEA/Database source:InterPro:IPR001190)Q0V7N1(Evidence code:IEA/Database source:InterPro:IPR001212|I)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001190)B6ULZ4(Evidence code:IEA/Database source:InterPro:IPR001190)F1MI35(Evidence code:IEA/Database source:InterPro:IPR001190), TINAGL1 LOC786796 SCARF2 MARCO SUSD2 TMPRSS2 WC1 HHIPL1,MF,8,8 of 16,0.35,50,0.0001015,0.0008839
GO:0016791,phosphatase activity,E1BPN5(Evidence code:IEA/Database source:InterPro:IPR000387)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)A5D980(Evidence code:IEA/Database source:InterPro:IPR000387)G5E526(Evidence code:IEA/Database source:InterPro:IPR000387)Q3ZBF9(Evidence code:IEA/Database source:InterPro:IPR006349)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000387)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR000387)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000387)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000387)P61287(Evidence code:ISS/Database source:UniProtKB:P63087)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000387)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR000387)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000387)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000387)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR000387)E1BDE3(Evidence code:IEA/Database source:InterPro:IPR011948), SSH2 PRUNE1 PTPN6 PTP4A1 PDXP PPP1CB PTPRA DUSP3 PTPN23 PTPN5 PPP1CC PTPRZ1 MTMR1 PTPN14 PTPRM DUSP7 CTDSP1,MF,17,17 of 75,0.75,22.67,0.0001026,0.0008922
GO:0051287,NAD binding,F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139|I)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR011128|I)P48034(Evidence code:IEA/Database source:InterPro:IPR014313)E1BL62(Evidence code:IEA/Database source:InterPro:IPR014313)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139|I)Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens)P48644(Evidence code:ISS/Database source:UniProtKB:Q28399)P18493(Evidence code:IEA/Database source:InterPro:IPR008288)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139|I), CTBP1 GAPDHS GPD1L AOX1 AOX4 PHGDH SORD ALDH1A1 PARP1 GRHPR,MF,10,10 of 27,0.44,37.04,0.0001046,0.0009064
GO:0006814,sodium ion transport,E1BHR8(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR001696|I)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0739)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR001696|I)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1B749(Evidence code:IBA/Database source:PANTHER:PTN001371381)O18875(Evidence code:IEA/Database source:UniProtKB-KW:KW-0739), SCN3A SCN8A SLC5A11 SCN10A SLC23A1 SCN5A ATP1A2 SCN11A SLC5A9 SLC6A8,BP,10,10 of 27,0.44,37.04,0.0001046,0.0009064
GO:0040012,regulation of locomotion,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 183,0.04,0.55,0.0001236,0.001069
GO:0036402,proteasome-activating ATPase activity,Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR035245)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR035263)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR035254)P62194(Evidence code:IEA/Database source:InterPro:IPR035261)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR035244), PSMC2 PSMC6 PSMC3 PSMC5 PSMC1,MF,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0075522,IRES-dependent viral translational initiation,A7MB16(Evidence code:IEA/Database source:UniProtKB:P55884|ens)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:O00303|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens), EIF3B EIF3F PCBP2 MCTS1 SSB,BP,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0006072,glycerol-3-phosphate metabolic process,F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006168)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR005999)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR005999)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR005999), GPAT2 GPD1L GK LOC538702 GK2,BP,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0050853,B cell receptor signaling pathway,P05126(Evidence code:ISS/Database source:UniProtKB:P68404)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000701114)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens), PRKCB TEC ABL1 LCK PTPN6,BP,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0008143,poly(A) binding,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens), KHDRBS1 DDX1 PABPC4 PPIE EIF4A3,MF,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0003151,outflow tract morphogenesis,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), FZD1 NIPBL RYR1 TBX3 SOX17,BP,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0007175,negative regulation of epidermal growth factor-activated receptor activity,Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens), VPS25 PSEN1 CBLC CHMP6 TSG101,BP,5,5 of 4,0.22,125,0.0001258,0.001076
GO:0006260,DNA replication,A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)Q05B83(Evidence code:IEA/Database source:InterPro:IPR008921)E1BDI3(Evidence code:IEA/Database source:InterPro:IPR001098|I)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532|I)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR018982)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR018525)P84798(Evidence code:IEA/Database source:InterPro:IPR019038)G8JKZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR015088)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR001098|I), LIG1 RFC2 POLG DHX9 BLM WRN MCM4 POLD3 PRIM1 POLA1 POLQ,BP,11,11 of 34,0.48,32.35,0.0001289,0.001101
GO:0036064,ciliary basal body,P67827(Evidence code:ISS/Database source:UniProtKB:Q8BK63)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F2Z4K0(Evidence code:IEA/Database source:UniProtKB:P05214|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), CSNK1A1 AHI1 RPGRIP1L C1H21ORF2 DAAM1 PKHD1 ARHGAP35 PTPN23 TUBA3E PCM1,CC,10,10 of 28,0.44,35.71,0.0001336,0.001137
GO:0042383,sarcolemma,E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIS6(Evidence code:IEA/Database source:UniProtKB:Q70IV5|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MRT9(Evidence code:IEA/Database source:UniProtKB:E9Q6R7|ens)P48452(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QQP7(Evidence code:ISS/Database source:UniProtKB:Q9ESD7)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), FLNC CAMK2D SYNM FLOT1 ITGB1 UTRN PPP3CA DYSF LAMP1 ATP1A2,CC,10,10 of 28,0.44,35.71,0.0001336,0.001137
GO:0006413,translational initiation,D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q3T0V3(Evidence code:ISS/Database source:UniProtKB:Q9UBQ5)Q32LC3(Evidence code:IEA/Database source:InterPro:IPR001253|I)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q32KZ1(Evidence code:IEA/Database source:InterPro:IPR001288|I)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)F1MX04(Evidence code:IEA/Database source:GO:0003743)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q5E966(Evidence code:ISS/Database source:UniProtKB:Q13347)E1BLZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q5E938(Evidence code:IEA/Database source:InterPro:IPR001950|I)A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)Q3ZC12(Evidence code:ISS/Database source:UniProtKB:O75821)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q3T148(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q32LJ9(Evidence code:IEA/Database source:InterPro:IPR001950|I)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), DDX3Y EIF3K EIF1AX DDX3X MTIF3 EIF6 EIF4E1B EIF4H EIF4G1 MCTS1 EIF3I EIF3F EIF1 EIF3B EIF3G EIF4A2 EIF3M ABCE1 EIF1B EIF2B5,BP,20,20 of 101,0.88,19.8,0.0001341,0.001139
GO:0032947,protein-containing complex scaffold activity,F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens)E1B7V9(Evidence code:IEA/Database source:InterPro:IPR030033)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BKZ0(Evidence code:IEA/Database source:InterPro:IPR028745), WWC1 OTUD4 MAGI1 DLG1 SASH1 AXIN1 PCNT,MF,7,7 of 12,0.31,58.33,0.0001353,0.001139
GO:0007032,endosome organization,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612), SNX33 VPS4B EXOC8 CHMP2B DNM1 DNAJC13 FAM160A2,BP,7,7 of 12,0.31,58.33,0.0001353,0.001139
GO:0045171,intercellular bridge,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:E9Q5G3|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q0II50(Evidence code:IEA/Database source:UniProtKB:A0A024R6V6)F1N1T6(Evidence code:IEA/Database source:UniProtKB:A0A024R419)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens), SETX KIF23 APC2 USB1 FASTKD2 PRKCI PRKACB,CC,7,7 of 12,0.31,58.33,0.0001353,0.001139
GO:0043666,regulation of phosphoprotein phosphatase activity,A2VDZ0(Evidence code:IEA/Database source:GO:0019888)F1MG56(Evidence code:IEA/Database source:GO:0019888)A4FV68(Evidence code:IEA/Database source:GO:0019888)F1MCY2(Evidence code:IEA/Database source:GO:0072542)P20959(Evidence code:IEA/Database source:GO:0008160)Q3SZC4(Evidence code:IEA/Database source:GO:0019888)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens), PPP2R5A PPP2R2A PPP2R5E PHACTR4 IGFBP3 NSFL1C PTPA,BP,7,7 of 12,0.31,58.33,0.0001353,0.001139
GO:0007613,memory,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P50114|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BA03(Evidence code:IEA/Database source:UniProtKB:Q3ULB5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), SYT4 DBH S100B KMT2B SHANK2 PAK6 PSEN1,BP,7,7 of 12,0.31,58.33,0.0001353,0.001139
GO:0017053,transcriptional repressor complex,F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)E1BA57(Evidence code:IEA/Database source:UniProtKB:Q5TB30|ens)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR031169)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens), DDX20 DEPDC1 MIER1 CTBP1 SPEN INSM1 SP1,CC,7,7 of 12,0.31,58.33,0.0001353,0.001139
GO:0051117,ATPase binding,A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), RUVBL1 CHMP4A BRSK2 UBXN1 SYVN1 LCK ABCA1 PDE4D,MF,8,8 of 17,0.35,47.06,0.0001406,0.001174
GO:0006890,"retrograde vesicle-mediated transport, Golgi to ER",P53619(Evidence code:IEA/Database source:InterPro:IPR027059)P35604(Evidence code:TAS/Database source:)Q28104(Evidence code:IEA/Database source:InterPro:IPR006822)A0JN39(Evidence code:IBA/Database source:PANTHER:PTN000067242)Q27954(Evidence code:TAS/Database source:)P35605(Evidence code:TAS/Database source:)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)Q1RMW9(Evidence code:IBA/Database source:PANTHER:PTN000294961), ARCN1 COPZ1 COPE COPB1 COPA COPB2 BICD2 GOLPH3,BP,8,8 of 17,0.35,47.06,0.0001406,0.001174
GO:0006891,intra-Golgi vesicle-mediated transport,A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)P35605(Evidence code:ISS/Database source:UniProtKB:P35606)Q27954(Evidence code:TAS/Database source:)P35604(Evidence code:IEA/Database source:UniProtKB:P61923|ens)P53619(Evidence code:TAS/Database source:)A2VE21(Evidence code:IEA/Database source:UniProtKB:Q9UBF2|ens)Q28104(Evidence code:IDA/Database source:)A0JN39(Evidence code:IBA/Database source:PANTHER:PTN000067242), RAB33B COPB2 COPA COPZ1 ARCN1 COPG2 COPE COPB1,BP,8,8 of 17,0.35,47.06,0.0001406,0.001174
GO:0000775,"chromosome, centromeric region",Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137), SEPT2 PPP1CC SEPT7 PPP2CB SEPT6 PPP2CA CSNK1A1 DCTN3,CC,8,8 of 17,0.35,47.06,0.0001406,0.001174
GO:0004298,threonine-type endopeptidase activity,P33672(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3T112(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T108(Evidence code:IEA/Database source:InterPro:IPR001353|I), PSMB3 PSMA3 PSMB9 PSMB8 PSMA4 PSMB10 PSMA7 PSMB4,MF,8,8 of 17,0.35,47.06,0.0001406,0.001174
GO:0005667,transcription factor complex,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BE02(Evidence code:IEA/Database source:InterPro:IPR003316)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)E1BG94(Evidence code:IEA/Database source:InterPro:IPR003316)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR003316|I)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), GATA6 LMO2 SNF8 TCF7L2 E2F7 POU3F1 ZFHX3 CTBP1 E2F1 TFDP2 WWTR1 PRKDC SOX17 MEIS1 PKNOX1 LEF1,CC,16,16 of 70,0.7,22.86,0.0001489,0.001241
GO:0032515,negative regulation of phosphoprotein phosphatase activity,E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)F1N1P8(Evidence code:IEA/Database source:GO:0004864)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)A7Z026(Evidence code:IEA/Database source:GO:0004864)E1BPZ4(Evidence code:IEA/Database source:GO:0004865)F1MRI6(Evidence code:IEA/Database source:GO:0004864), MASTL PPP1R26 PTPA PPP1R37 PPP1R1C LMTK2,BP,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0051721,protein phosphatase 2A binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)E1BFD1(Evidence code:IEA/Database source:InterPro:IPR035007)E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens), DAB2IP STRN3 MASTL PTPA ANKLE2 STRN4,MF,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0004693,cyclin-dependent protein serine/threonine kinase activity,P48734(Evidence code:IEA/Database source:EC:2.7.11.22)E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623091)E1BB52(Evidence code:IEA/Database source:EC:2.7.11.22)E1BB50(Evidence code:IEA/Database source:EC:2.7.11.22)F1MN42(Evidence code:IBA/Database source:PANTHER:PTN001172753), CDK1 CDK6 CDK3 CDK13 CDK12 CDK17,MF,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0051568,histone H3-K4 methylation,E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR037842)E1BEP4(Evidence code:IEA/Database source:InterPro:IPR037353)F1MYZ3(Evidence code:IEA/Database source:GO:0042800), KMT2B KMT2A ASH1L SETD1B ASH2L KMT2C,BP,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0008146,sulfotransferase activity,P50227(Evidence code:IEA/Database source:InterPro:IPR000863)F1N638(Evidence code:IEA/Database source:InterPro:IPR000863)F1ME12(Evidence code:IEA/Database source:InterPro:IPR000863)A3KMX1(Evidence code:IEA/Database source:InterPro:IPR005331|I)E1B729(Evidence code:IEA/Database source:InterPro:IPR000863|I)F1MX20(Evidence code:IEA/Database source:UniProtKB:Q9H3Q3|ens), SULT1A1 SULT1C4 DSEL CHST14 HS3ST6 GAL3ST2,MF,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0045111,intermediate filament cytoskeleton,A2VDU4(Evidence code:IEA/Database source:UniProtKB:F1D8P9|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)E1BC24(Evidence code:IEA/Database source:UniProtKB:Q9NU22|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens), NR1I2 NSFL1C INO80 MDN1 INA SMARCA2,CC,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0030332,cyclin binding,A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB:Q14004|ens)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens), CDK3 CDK6 CDK13 CDK12 CUL3 CDK1,MF,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0000060,"protein import into nucleus, translocation",E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), KPNB1 IPO5 BCL3 IPO4 TNPO1 MT3,BP,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0007369,gastrulation,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens), ARID1A SRF SYF2 SOX17 CUL3 EXT1,BP,6,6 of 8,0.26,75,0.0001561,0.001283
GO:0051087,chaperone binding,Q2KIT4(Evidence code:IEA/Database source:UniProtKB:Q9UDY4|ens)A2VE51(Evidence code:IEA/Database source:InterPro:IPR003103|I)E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR004640)Q2TA08(Evidence code:IEA/Database source:InterPro:IPR003103|I)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q2HJ94(Evidence code:IEA/Database source:UniProtKB:O60884|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens), DNAJB4 BAG3 USP13 HSCB BAG5 ATP1A2 SYVN1 DNAJA2 DNAJB2,MF,9,9 of 23,0.39,39.13,0.0001653,0.001356
GO:0042470,melanosome,G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:Q9R0M6|ens)Q95JC7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32L41(Evidence code:IEA/Database source:UniProtKB:P30047|ens)Q29455(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)P27214(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6H767(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P06623(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T054(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SGSM2 FLOT1 LAMP1 RAB9A SLC1A5 GCHFR DNAJC5 RAB17 ANXA11 ITGB1 NAP1L1 CNP RAN CD63,CC,14,14 of 56,0.61,25,0.0001708,0.001399
GO:0070201,regulation of establishment of protein localization,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 175,0.04,0.57,0.000172,0.001407
GO:0010008,endosome membrane,E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q05204(Evidence code:ISS/Database source:UniProtKB:P05300)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BAI0(Evidence code:IBA/Database source:PANTHER:PTN000636003)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q810B6|ens)Q32L63(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD53(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens), TPCN2 CHMP6 RFFL VPS35 LAMP1 VPS25 RAB23 VPS41 DNAJC13 SNX3 APPL1 APPL2 VPS4B VPS29 ANKFY1 VTA1 ITM2B VPS26A SNF8 TFRC,CC,20,20 of 104,0.88,19.23,0.0001886,0.00154
GO:0007219,Notch signaling pathway,E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1MKY3(Evidence code:IEA/Database source:UniProtKB:G3UW60|ens)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0914)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)G3X812(Evidence code:IEA/Database source:InterPro:IPR008297|I)Q3ZBY8(Evidence code:ISS/Database source:UniProtKB:Q1LVF8)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0914), ETV2 SUSD5 HEYL MAML2 CDK6 NOTCH4 GMDS PSEN1,BP,8,8 of 18,0.35,44.44,0.0001913,0.001557
GO:0005839,proteasome core complex,Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q3T108(Evidence code:IEA/Database source:InterPro:IPR001353|I)P33672(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T112(Evidence code:IEA/Database source:InterPro:IPR000243|I), PSMB10 PSMB4 PSMB3 PSMA3 PSMB9 PSMA4 PSMA7 PSMB8,CC,8,8 of 18,0.35,44.44,0.0001913,0.001557
GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), AMER3 SH3PXD2A SDCBP2 MTSS1L SNX18 ALOX15 TWF1,MF,7,7 of 13,0.31,53.85,0.0001963,0.001595
GO:0005506,iron ion binding,F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR006620)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR001885)P27479(Evidence code:IEA/Database source:InterPro:IPR001885)E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)P48034(Evidence code:IEA/Database source:InterPro:IPR016208)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR006620)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)O46414(Evidence code:IBA/Database source:PANTHER:PTN000153092)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BL62(Evidence code:IEA/Database source:InterPro:IPR016208), LOC540627 EGLN3 ABCE1 CYP2R1 ALOX15B ALOX15 LOC100295883 AOX1 PAH P4HA2 CYP2J2 FTH1 CYP7A1 AOX4,MF,14,14 of 57,0.61,24.56,0.0001999,0.00162
GO:0004252,serine-type endopeptidase activity,E1B9Z9(Evidence code:IEA/Database source:InterPro:IPR001254|I)A4FUF1(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q08D90(Evidence code:IEA/Database source:InterPro:IPR001254|I)P80227(Evidence code:IEA/Database source:InterPro:IPR002471)F1MCT1(Evidence code:IEA/Database source:InterPro:IPR000209|I)Q1LZE9(Evidence code:IEA/Database source:InterPro:IPR001254|I)P81425(Evidence code:IEA/Database source:InterPro:IPR002471)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001254|I)F1MWW8(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q08E55(Evidence code:IEA/Database source:InterPro:IPR000209|I)Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR002470|I)Q5E9Z2(Evidence code:IEA/Database source:InterPro:IPR001254|I)E1BEQ4(Evidence code:IEA/Database source:InterPro:IPR001254|I)G5E5C6(Evidence code:IEA/Database source:InterPro:IPR001254|I), TMPRSS9 LOC100125946 KLK7 APEH PCSK6 PRSS23 DPP4 TMPRSS2 TMPRSS6 MBTPS1 PREP HABP2 LOC505658 ACR,MF,14,14 of 57,0.61,24.56,0.0001999,0.00162
GO:0000902,cell morphogenesis,Q58DV1(Evidence code:IEA/Database source:InterPro:IPR016098)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)Q3T0T1(Evidence code:IEA/Database source:UniProtKB:O35955|ens), RP2 TENM2 CUL3 TENM3 FRY SHROOM3 ASXL1 ECT2 FRYL PSMB10,BP,10,10 of 30,0.44,33.33,0.000212,0.001715
GO:0006457,protein folding,P48820(Evidence code:IEA/Database source:InterPro:IPR020892)A4FUW8(Evidence code:IBA/Database source:PANTHER:PTN000432607)P26882(Evidence code:IEA/Database source:InterPro:IPR020892)Q2KIT4(Evidence code:IEA/Database source:InterPro:IPR008971)Q3T0K2(Evidence code:IEA/Database source:InterPro:IPR002194|I)A1A4P5(Evidence code:IEA/Database source:InterPro:IPR002777|I)Q3MI00(Evidence code:IEA/Database source:InterPro:IPR008971)Q2KJC8(Evidence code:IEA/Database source:UniProtKB:Q9Z247|ens)Q3ZCI9(Evidence code:IEA/Database source:InterPro:IPR002194|I)A4FV72(Evidence code:IEA/Database source:InterPro:IPR016304|I)Q3ZCH0(Evidence code:IEA/Database source:InterPro:IPR012725)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR008971|I)Q32L40(Evidence code:IEA/Database source:InterPro:IPR002194|I)G3X8B1(Evidence code:IEA/Database source:InterPro:IPR020892)Q2NKZ1(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3T084(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3ZBA6(Evidence code:IEA/Database source:InterPro:IPR008971)Q2TBX2(Evidence code:IEA/Database source:InterPro:IPR016655)Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404), RANBP2 TXNDC11 PPID DNAJB4 CCT3 PFDN2 DNAJB1 FKBP9 CCT8 PPIE HSPA9 DNAJA2 TCP1 LOC613401 CCT7 CCT6B DNAJB11 VBP1 TRAP1,BP,19,19 of 97,0.83,19.59,0.0002194,0.001772
GO:0045022,early endosome to late endosome transport,F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MDR7(Evidence code:IBA/Database source:PANTHER:PTN001181218)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612), LMTK2 SNF8 DNAJC13 PTPN23 FAM160A2,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0031595,nuclear proteasome complex,Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMD12 PSMC2 PSMC1 PSMC6 PSMC5,CC,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0030742,GTP-dependent protein binding,P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)P10949(Evidence code:IEA/Database source:UniProtKB:P62823|ens), RAB3A UNC13B HPS6 RAB3B RAB3C,MF,5,5 of 5,0.22,100,0.0002379,0.00187
GO:2000582,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed",Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277824)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361), DYNLL2 LOC101902172 LOC101905447 DYNC1I2 DYNLL1,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0001569,branching involved in blood vessel morphogenesis,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens), SEMA3E LEF1 SRF COL4A1 GNA13,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0060173,limb development,E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens), RAX CHD7 EN1 RC3H2 RNF165,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0016242,negative regulation of macroautophagy,A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), POLDIP2 USP36 PINK1 LRRK2 NPC1,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0071108,protein K48-linked deubiquitination,Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens)G5E630(Evidence code:IEA/Database source:GO:1990380), OTUB1 OTUD7B USP20 OTUD4 USP9X,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0030010,establishment of cell polarity,A4IFF6(Evidence code:IEA/Database source:UniProtKB:Q9R0A5|ens)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR033624)F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens), NEK3 MARK3 RICTOR SDCCAG8 WEE1,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0005869,dynactin complex,Q3ZCF0(Evidence code:IEA/Database source:InterPro:IPR028133)A5PKJ3(Evidence code:IEA/Database source:InterPro:IPR027663)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)F2Z4F0(Evidence code:IEA/Database source:InterPro:IPR029909)A4IFE3(Evidence code:IEA/Database source:InterPro:IPR029909), DCTN2 DCTN1 DCTN3 ACTR1A ACTR1B,CC,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0012507,ER to Golgi transport vesicle membrane,A6QM06(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QNT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDL8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SCAP SEC13 SEC24A SEC23A SEC23B,CC,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0035198,miRNA binding,F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)Q6T5B7(Evidence code:IEA/Database source:UniRule:UR000107558), AGO4 ZCCHC6 PUM1 PNPT1 AGO3,MF,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0070840,dynein complex binding,A5PKJ3(Evidence code:IEA/Database source:InterPro:IPR027663)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)G3N3P0(Evidence code:IEA/Database source:InterPro:IPR018477)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), DCTN1 NUMA1 GPSM2 BICD2 TPR,MF,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0004714,transmembrane receptor protein tyrosine kinase activity,Q95M13(Evidence code:IEA/Database source:EC:2.7.10.1)F1N758(Evidence code:IEA/Database source:InterPro:IPR006211)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)P43481(Evidence code:IEA/Database source:InterPro:IPR001824|I)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR001824|I), fgfr3 ERBB4 EPHB4 KIT FLT3,MF,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0043531,ADP binding,E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)P58108(Evidence code:ISS/Database source:UniProtKB:P80385)A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens), MYO18A MYO9B PRKAG1 RUVBL1 CHORDC1,MF,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0035115,embryonic forelimb morphogenesis,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens), EN1 NIPBL RPGRIP1L SHOX2 TBX3,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0071300,cellular response to retinoic acid,Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens), BRINP1 YES1 SETX PTK7 ABCA1,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0046856,phosphatidylinositol dephosphorylation,E1BB73(Evidence code:IEA/Database source:InterPro:IPR000300)E1BLB5(Evidence code:IEA/Database source:InterPro:IPR000300)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR030587|I)F1MHB9(Evidence code:IEA/Database source:InterPro:IPR000300)O18964(Evidence code:IEA/Database source:InterPro:IPR000300|I), INPP5B INPP5J MTMR1 INPP5A SYNJ1,BP,5,5 of 5,0.22,100,0.0002379,0.00187
GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789)Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q32KW2(Evidence code:ISS/Database source:UniProtKB:Q04323)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens), FHIT RPL11 GIPC1 UBXN1 CCAR2 BAG5,BP,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0048146,positive regulation of fibroblast proliferation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)A4FV80(Evidence code:IEA/Database source:UniProtKB:Q8R089|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens), CDK6 FBRS SIRT6 DHX9 E2F1 PDGFC,BP,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0042734,presynaptic membrane,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)Q28146(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MCW8(Evidence code:IEA/Database source:UniProtKB:Q8BMF5|ens)E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001527784), SNAP25 KCTD16 NRXN1 SCRIB GRIK4 GRM7,CC,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0006879,cellular iron ion homeostasis,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)E1BDL2(Evidence code:IEA/Database source:UniProtKB:Q8BGB2|ens)E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)O46414(Evidence code:IEA/Database source:InterPro:IPR001519|I)P61420(Evidence code:ISS/Database source:UniProtKB:P61421), HFE2 TTC7A TFRC TMPRSS6 FTH1 ATP6V0D1,BP,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0005844,polysome,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q9C0B0|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575), EIF4G1 EIF4H PIWIL2 UNK DHX9 VBP1,CC,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0032007,negative regulation of TOR signaling,E1BB46(Evidence code:IEA/Database source:InterPro:IPR035455)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001107228)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q8IWV8|ens)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR003913), SH3BP4 GSK3A PDCD6 PREX1 UBR2 TSC2,BP,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0048286,lung alveolus development,E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)P35246(Evidence code:ISS/Database source:UniProtKB:P35247)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens), MAN1A2 FOXF1 MAPK8IP3 RC3H2 SFTPD PHF14,BP,6,6 of 9,0.26,66.67,0.0002456,0.001905
GO:0051223,regulation of protein transport,E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens),SCFD1,BP,1,1 of 167,0.04,0.6,0.0002449,0.001905
GO:0001882,nucleoside binding,E1BJF4(Evidence code:IEA/Database source:InterPro:IPR015088),POLA1,MF,1,1 of 167,0.04,0.6,0.0002449,0.001905
GO:2000145,regulation of cell motility,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512),PKN1,BP,1,1 of 168,0.04,0.6,0.0002471,0.001913
GO:0006486,protein glycosylation,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q3SZI0(Evidence code:IBA/Database source:PANTHER:PTN000034017)Q5E9I4(Evidence code:IEA/Database source:InterPro:IPR004139)E1BB48(Evidence code:IEA/Database source:UniPathway:UPA00378)Q5EAB6(Evidence code:IEA/Database source:InterPro:IPR004139)Q5EA65(Evidence code:IEA/Database source:UniPathway:UPA00378)E1BCH6(Evidence code:IEA/Database source:UniPathway:UPA00378)F1N4Q3(Evidence code:IEA/Database source:UniPathway:UPA00378)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MX31(Evidence code:IEA/Database source:InterPro:IPR001675|I)Q2HJA3(Evidence code:IEA/Database source:InterPro:IPR002659)Q3ZC71(Evidence code:IEA/Database source:InterPro:IPR013174)Q5E9C2(Evidence code:ISS/Database source:UniProtKB:E2R4X3)F1MSL9(Evidence code:IEA/Database source:InterPro:IPR009448)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR004263), NPC1 MPI MGAT1 GALNT2 POMGNT1 DPAGT1 ISPD GALNT7 PSEN1 ST8SIA3 B3GALT4 DPM3 DAD1 UGGT2 EXT1,BP,15,15 of 66,0.66,22.73,0.0002492,0.001918
GO:0010314,phosphatidylinositol-5-phosphate binding,A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492), LANCL2 SH3PXD2A PLEKHA5 SNX3,MF,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0090543,Flemming body,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), ARF6 VPS4B PDCD6IP KIF14,CC,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0016018,cyclosporin A binding,A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)Q29RZ2(Evidence code:ISS/Database source:UniProtKB:Q96BP3)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), PPIE PPID PPWD1 PPP3CA,MF,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0008266,poly(U) RNA binding,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens), SSB KHDRBS1 PABPC4 PNPT1,MF,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0097264,self proteolysis,E1BIX3(Evidence code:IEA/Database source:UniProtKB:Q9Y6W3|ens)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR022385)F1MEX4(Evidence code:IEA/Database source:InterPro:IPR022385)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens), CAPN7 TENM3 TENM2 TMPRSS6,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0031954,positive regulation of protein autophosphorylation,E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000908679)Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens), PDGFC RAP2C RAP2A TNKS1BP1,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0031290,retinal ganglion cell axon guidance,E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), PTPRM POU4F2 ALCAM SLIT2,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0006004,fucose metabolic process,Q2KIM0(Evidence code:IEA/Database source:InterPro:IPR016286)F1N5H2(Evidence code:IEA/Database source:InterPro:IPR016286)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0294)Q0P563(Evidence code:ISS/Database source:UniProtKB:Q8R2K1), FUCA1 FUCA2 pofut2 FUOM,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0010225,response to UV-C,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749), BRCA2 WRN MAP3K4 BCL3,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0045773,positive regulation of axon extension,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), ZFYVE27 GOLGA4 POU4F2 SRF,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0002161,aminoacyl-tRNA editing activity,A6QLT9(Evidence code:IEA/Database source:UniProtKB:P49588|ens)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR009008)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR009008)E1B937(Evidence code:IEA/Database source:InterPro:IPR003732), AARS LARS IARS DTD2,MF,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0003281,ventricular septum development,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), SALL4 FRS2 XIRP2 PTK7,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0009954,proximal/distal pattern formation,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), DLX2 EN1 GLI1 GLI2,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0036120,cellular response to platelet-derived growth factor stimulus,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), HYAL1 MTSS1L YES1 SRC,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0045725,positive regulation of glycogen biosynthetic process,F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens), EPM2AIP1 DYRK2 IRS1 GCK,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0048041,focal adhesion assembly,E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O54834|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens), TAOK2 ARHGAP6 FERMT2 PEAK1,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0035068,micro-ribonucleoprotein complex,Q6T5B7(Evidence code:IEA/Database source:UniRule:UR000107558)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3)F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187), AGO3 DHX9 DICER1 AGO4,CC,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0017056,structural constituent of nuclear pore,E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:Q80U93|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens), POM121L2 TPR NUP214 NDC1,MF,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0048208,COPII vesicle coating,F6PW02(Evidence code:IEA/Database source:InterPro:IPR033512)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens), TFG PDCD6 PEF1 CUL3,BP,4,4 of 2,0.18,200,0.0002551,0.001918
GO:0019882,antigen processing and presentation,Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)Q3T112(Evidence code:IEA/Database source:UniProtKB:P28063|ens)P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)A7YWH4(Evidence code:IEA/Database source:InterPro:IPR010579)A8E4P0(Evidence code:IEA/Database source:InterPro:IPR010579)F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I)F1N3I2(Evidence code:IEA/Database source:InterPro:IPR010579), RAB4A PSMB8 RAB3C RAB3B BoLA LOC100125916 LOC100848815 LOC788634,BP,8,8 of 19,0.35,42.11,0.0002561,0.001923
GO:0040011,locomotion,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), PSEN1 ATP1A2,BP,2,2 of 196,0.09,1.02,0.0002618,0.001963
GO:0008219,cell death,Q5E9L2(Evidence code:ISS/Database source:UniProtKB:O60477),BRINP1,BP,1,1 of 171,0.04,0.58,0.0002627,0.001967
GO:0006906,vesicle fusion,A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001285)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)P63026(Evidence code:IMP/Database source:)A6QQP7(Evidence code:ISS/Database source:UniProtKB:Q9ESD7)Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001285), SYTL2 VAMP5 SYT4 VAMP2 DYSF STX7 VAMP3 SYTL1 VAMP1 SYT6,BP,10,10 of 31,0.44,32.26,0.0002638,0.001972
GO:0019725,cellular homeostasis,Q5E9M9(Evidence code:ISS/Database source:UniProtKB:Q8IXI1)Q2HJF8(Evidence code:ISS/Database source:UniProtKB:Q8IXI2), RHOT2 RHOT1,BP,2,2 of 198,0.09,1.01,0.0002641,0.001972
GO:0016817,"hydrolase activity, acting on acid anhydrides",E1BDZ3(Evidence code:IEA/Database source:InterPro:IPR006576)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR006576)F1N734(Evidence code:IEA/Database source:InterPro:IPR006576)F1MLB2(Evidence code:IEA/Database source:InterPro:IPR006576)E1BPM4(Evidence code:IEA/Database source:InterPro:IPR006576), CHD9 SMARCA2 CHD6 CHD8 CHD7,MF,5,5 of 283,0.22,1.77,0.0002683,0.002
GO:0006397,mRNA processing,Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q28165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q08E07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)O19137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR006536)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR033809)E1BML0(Evidence code:IEA/Database source:InterPro:IPR030843), SAP18 EFTUD2 PPIE CDC5L CDK13 PPWD1 PABPN1 PABPC1 EIF4A3 SRSF1 CDK12 DHX9 SNRPE LSM4 CELF3 STRAP CPSF4 HNRNPL DDX1 SNRNP70 USP39 PAN2,BP,22,22 of 123,0.96,17.89,0.0002773,0.002064
GO:0042552,myelination,E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)F1N5T9(Evidence code:IEA/Database source:InterPro:IPR029555)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512260)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512260), EIF2B5 POU3F1 SERINC5 NAB2 PLLP TSPAN2 MAL2,BP,7,7 of 14,0.31,50,0.0002776,0.002064
GO:0008283,cell proliferation,G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)E1BB54(Evidence code:IEA/Database source:UniProtKB:Q5W0Q7|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925)Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), COPS2 DCTN2 UBE2L3 CUL1 USPL1 APPL1 GOLPH3 PTGES3 SDCBP2 SCRIB USP13 CDK1 AXIN2 TACC1 APPL2 GNAT1 BRCA2 GLI2 PURB CSPG4 PRKDC PTPN6,BP,22,22 of 124,0.96,17.74,0.0002982,0.002214
GO:0007601,visual perception,P12661(Evidence code:IEA/Database source:InterPro:IPR032956)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)P47803(Evidence code:IEA/Database source:InterPro:IPR001793)P22571(Evidence code:IEA/Database source:InterPro:IPR006952|I)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR032964)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)G3MXA9(Evidence code:IEA/Database source:InterPro:IPR032943)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)F1MR98(Evidence code:IEA/Database source:InterPro:IPR002962|I)Q8WN91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)Q7YRX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157), RBP3 COL2A1 GNAT1 RGR PDE6H GPR179 LAMB2 LAMC3 CNGB3 GNAT2 RRH CDHR1 RAX2 CACNA1F,BP,14,14 of 60,0.61,23.33,0.000314,0.002328
GO:0034707,chloride channel complex,Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869), CLDN4 CLIC6 ANO6 CLIC4 CLCC1 BEST3 GABRA5 CFTR,CC,8,8 of 20,0.35,40,0.0003379,0.002501
GO:0048666,neuron development,A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622286)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622286), MAPK10 TENM3 NR2F6 PSEN1 GLI2 EN1 TENM2 GABRA5 MAPK9,BP,9,9 of 26,0.39,34.62,0.0003472,0.002567
GO:0043130,ubiquitin binding,A5PK00(Evidence code:IEA/Database source:InterPro:IPR021648|I)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596256)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326), VPS36 NEDD4 NSFL1C DNAJB2 MARCH7 UBXN1 MVB12A SIRT2 USP13 TSG101 OTUB1,MF,11,11 of 39,0.48,28.21,0.0003491,0.002577
GO:0016071,mRNA metabolic process,Q3SZK4(Evidence code:ISS/Database source:UniProtKB:Q969Z0),TBRG4,BP,1,1 of 160,0.04,0.62,0.0003557,0.002622
GO:0060041,retina development in camera-type eye,E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934), LAMB2 AGTPBP1 LAMC3 CHD7 GNAT1 POU4F2,BP,6,6 of 10,0.26,60,0.000371,0.002712
GO:0001889,liver development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens), RPGRIP1L ARF6 ONECUT2 CEBPA GATA6 TAF10,BP,6,6 of 10,0.26,60,0.000371,0.002712
GO:0036126,sperm flagellum,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens)D3K0R6(Evidence code:ISS/Database source:UniProtKB:Q6Q477)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462268)Q5EA42(Evidence code:IEA/Database source:UniProtKB:P08910|ens), CUL3 MROH2B ATP2B4 PRKACA TEKT4 ABHD2,CC,6,6 of 10,0.26,60,0.000371,0.002712
GO:0031338,regulation of vesicle fusion,A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561), TBC1D2 SYT4 TBC1D22B RABGAP1 SGSM2 TBC1D12,BP,6,6 of 10,0.26,60,0.000371,0.002712
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)E1BIJ4(Evidence code:IEA/Database source:UniProtKB:Q9Y2U8|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens), EMILIN1 ONECUT2 LEMD3 PIN1 STRAP BCL9L,BP,6,6 of 10,0.26,60,0.000371,0.002712
GO:0007628,adult walking behavior,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), KCNMA1 AGTPBP1 ABHD12 CHD7 SPTBN4 NPC1,BP,6,6 of 10,0.26,60,0.000371,0.002712
GO:0006730,one-carbon metabolic process,E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011407)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)Q5I598(Evidence code:IBA/Database source:PANTHER:PTN000472667)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0554)P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0554)A7YY67(Evidence code:IEA/Database source:InterPro:IPR011407)A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens), ALDH1L2 SHMT2 MTHFR AHCYL2 DHFR ALDH1L1 MTHFD1,BP,7,7 of 15,0.31,46.67,0.000384,0.002791
GO:0004177,aminopeptidase activity,G3X743(Evidence code:IEA/Database source:InterPro:IPR015571)Q3ZC89(Evidence code:IEA/Database source:InterPro:IPR002468)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031)Q2HJH1(Evidence code:IEA/Database source:InterPro:IPR001948|I)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031)Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960), RNPEP METAP2 NPEPPS DPP4 DNPEP XPNPEP1 LTA4H,MF,7,7 of 15,0.31,46.67,0.000384,0.002791
GO:0030509,BMP signaling pathway,E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606)Q00KA9(Evidence code:IEA/Database source:InterPro:IPR030799)E1BCY1(Evidence code:IEA/Database source:UniProtKB:A6ND36|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens), HFE2 LRP4 FAM83G PDCD4 LEF1 USP9X MEGF8,BP,7,7 of 15,0.31,46.67,0.000384,0.002791
GO:0032922,circadian regulation of gene expression,A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)F1MZY2(Evidence code:IEA/Database source:UniProtKB:P47856|ens)P61287(Evidence code:ISS/Database source:UniProtKB:P63087)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens), PRMT5 PPP1CB KMT2A LGR4 GFPT1 PPP1CC RAI1,BP,7,7 of 15,0.31,46.67,0.000384,0.002791
GO:0030316,osteoclast differentiation,A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q9CPU0|ens), SBNO2 FCER1G TFRC TRAF6 GLO1,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:2000300,regulation of synaptic vesicle exocytosis,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens), LRRK2 RIMS1 PRKCB GIPC1 BACE1,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:0014002,astrocyte development,E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), LAMB2 TSPAN2 LAMC3 EIF2B5 MT3,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:0061098,positive regulation of protein tyrosine kinase activity,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)Q17R10(Evidence code:IEA/Database source:GO:0030296)G3MZE2(Evidence code:IEA/Database source:GO:0030296)Q0VCW2(Evidence code:IEA/Database source:GO:0030296)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), HSPH1 AFAP1L2 PAK2 ABI1 PRNP,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:0048839,inner ear development,Q32LM6(Evidence code:IEA/Database source:UniProtKB:Q8JZS0|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), LIN7A fgfr3 FREM2 C1QTNF5 COL2A1,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:0043588,skin development,F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:P05997|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens), FRAS1 PTGES3 BCL11B COL5A2 RYR1,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:0030552,cAMP binding,P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0116)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8), PRKAR2A RAPGEF4 HCN1 PDE4D RAPGEF2,MF,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:1902188,positive regulation of viral release from host cell,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens), VPS4B CHMP4B CHMP2A TSG101 CHMP2B,BP,5,5 of 6,0.22,83.33,0.0004124,0.002965
GO:0000785,chromatin,E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)E1BLK1(Evidence code:IBA/Database source:PANTHER:PTN000968522)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)F1MM81(Evidence code:IBA/Database source:PANTHER:PTN000968522)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q80W00|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)E1BC56(Evidence code:IEA/Database source:InterPro:IPR000079)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens), KDM3B UBR2 TNRC18 NEDD4 PINK1 COPS5 AHCTF1 BAHCC1 PPP1R10 SFPQ CHMP2A CAPN2 LOC785479 ANKRD17 NIPBL,CC,15,15 of 70,0.66,21.43,0.0004284,0.003076
GO:0030218,erythrocyte differentiation,E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000048336)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), JAK2 ETV2 CASP3 KIT PKNOX1 HSPA9 RPS19,BP,7,7 of 16,0.31,43.75,0.0005206,0.003707
GO:0015914,phospholipid transport,Q2HJ54(Evidence code:IEA/Database source:InterPro:IPR001666)C3VEX2(Evidence code:IEA/Database source:InterPro:IPR001666)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539|I)P55156(Evidence code:ISS/Database source:UniProtKB:P55157)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)Q17QL5(Evidence code:IEA/Database source:InterPro:IPR030351)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens), PITPNA PITPNM2 ATP8B1 MTTP ATP11A TMEM30A TNFAIP8L3,BP,7,7 of 16,0.31,43.75,0.0005206,0.003707
GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",A1A4J7(Evidence code:IEA/Database source:InterPro:IPR019354|I)Q2YDD2(Evidence code:IEA/Database source:InterPro:IPR019354|I)Q0VCX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0866)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0866)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR031559|I)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0866), SMG8 SMG9 ETF1 EIF4A3 SMG1 SMG6 PABPC1,BP,7,7 of 16,0.31,43.75,0.0005206,0.003707
GO:0071897,DNA biosynthetic process,A6QQ14(Evidence code:IEA/Database source:GO:0003887)E1BMC0(Evidence code:IEA/Database source:GO:0003887)P84798(Evidence code:IEA/Database source:GO:0003887)P06526(Evidence code:IEA/Database source:GO:0003887)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977)E1BJF4(Evidence code:IEA/Database source:GO:0003887)E1BDI3(Evidence code:IEA/Database source:GO:0003887), POLE4 POLQ POLD3 DNTT LIG1 POLA1 POLG,BP,7,7 of 16,0.31,43.75,0.0005206,0.003707
GO:0071456,cellular response to hypoxia,F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)P37359(Evidence code:IEA/Database source:UniProtKB:P25713|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BP91(Evidence code:IEA/Database source:UniProtKB:P55786|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), NDNF UBQLN1 MT3 SIRT2 GATA6 NPEPPS PINK1,BP,7,7 of 16,0.31,43.75,0.0005206,0.003707
GO:0051046,regulation of secretion,E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens),MYO6,BP,1,1 of 154,0.04,0.65,0.0005179,0.003707
GO:0031122,cytoplasmic microtubule organization,G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000072732)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085), SLK AXIN1 DYNC1H1 PLK3 PCM1 TUBGCP2,BP,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0003678,DNA helicase activity,A7MBG8(Evidence code:IEA/Database source:InterPro:IPR010339)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR010339)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR008047)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), RUVBL1 RUVBL2 CHD8 MCM4 BLM WRN,MF,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0071949,FAD binding,G3MWR8(Evidence code:IEA/Database source:InterPro:IPR002938)P48034(Evidence code:IEA/Database source:InterPro:IPR016166)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)F1MF74(Evidence code:IEA/Database source:InterPro:IPR002938)E1BL62(Evidence code:IEA/Database source:InterPro:IPR016166)Q148K4(Evidence code:IEA/Database source:InterPro:IPR016166), MICAL3 AOX1 AIFM1 MICAL2 AOX4 LDHD,MF,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0031297,replication fork processing,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR030101)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)F1N2G1(Evidence code:IEA/Database source:UniProtKB:Q8NFC6|ens), BLM WRN SMARCAL1 ETAA1 ATRX BOD1L1,BP,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0018024,histone-lysine N-methyltransferase activity,F1N413(Evidence code:IEA/Database source:InterPro:IPR007728|I)F1MHA1(Evidence code:IEA/Database source:EC:2.1.1.43)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR037842)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR021169|I)E1BNH7(Evidence code:IEA/Database source:InterPro:IPR006560)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR006560), EHMT2 KMT2A SETD1B DOT1L WHSC1L1 ASH1L,MF,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:Q9WTX5)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens), CUL1 SKP1 RBX1 LOC780968 KIF14 WWTR1,BP,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0031966,mitochondrial membrane,Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170085)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q58D31(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170085)P23709(Evidence code:ISS/Database source:UniProtKB:O75489), DNM1 LRRK2 DNM2 SORD MX2 NDUFS3,CC,6,6 of 289,0.26,2.08,0.0005347,0.003803
GO:0035914,skeletal muscle cell differentiation,E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens)F1MBK6(Evidence code:IEA/Database source:UniProtKB:A2A884|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), BCL9 COPS2 MYLK2 BCL9L HIVEP3 MYF5,BP,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0008306,associative learning,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), SNAP25 GABRA5 SHANK1 DBH SRF CLN3,BP,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0030864,cortical actin cytoskeleton,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)Q5E9D5(Evidence code:ISS/Database source:UniProtKB:Q9R0P5)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5), FLOT1 NF2 LANCL2 DSTN MTSS1L MYO1A,CC,6,6 of 11,0.26,54.55,0.0005413,0.003803
GO:0051019,mitogen-activated protein kinase binding,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN001553005), ABL1 PPM1D TPR MAPKAPK3,MF,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0043113,receptor clustering,F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens), DLG1 ITGB7 SCRIB SYNGAP1,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0006622,protein targeting to lysosome,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), LARS NEDD4 GCC2 SORL1,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0006189,de novo IMP biosynthetic process,Q59A32(Evidence code:IEA/Database source:InterPro:IPR004607|I)Q0VCK0(Evidence code:IEA/Database source:UniPathway:UPA00074)A3KN12(Evidence code:IEA/Database source:UniPathway:UPA00074)Q2HJ26(Evidence code:IEA/Database source:InterPro:IPR000031|I), GART ATIC ADSL PAICS,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0043328,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,Q08DR7(Evidence code:IEA/Database source:UniRule:UR000342799)Q3T178(Evidence code:IBA/Database source:PANTHER:PTN000309785)A5PK00(Evidence code:IBA/Database source:PANTHER:PTN000319648)Q5E9A6(Evidence code:IBA/Database source:PANTHER:PTN000322234), SNF8 VPS28 VPS36 VPS25,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0035987,endodermal cell differentiation,E1B7H2(Evidence code:IEA/Database source:UniProtKB:Q02388|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)F1MDD5(Evidence code:IEA/Database source:UniProtKB:Q16787|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), COL7A1 LAMB1 LAMA3 GATA6,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0032794,GTPase activating protein binding,E1B718(Evidence code:IEA/Database source:UniProtKB:Q6ZPF4|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MGX4(Evidence code:IEA/Database source:UniProtKB:O95466|ens), FMNL3 RGS14 PIN1 FMNL1,MF,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0016082,synaptic vesicle priming,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)Q17QQ3(Evidence code:IBA/Database source:PANTHER:PTN000447754)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027082), UNC13B CADPS SNAP25 UNC13A,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0090161,Golgi ribbon formation,E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens), MYO18A GOLPH3 PRMT5 GCC2,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0004749,ribose phosphate diphosphokinase activity,F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842|I)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842|I)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR005946)Q08DW2(Evidence code:IEA/Database source:InterPro:IPR005946), PRPS1L1 PRPS2 PRPSAP2 PRPSAP1,MF,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0097016,L27 domain binding,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN000362480)Q32LM6(Evidence code:IEA/Database source:UniProtKB:O14910|ens), DLG1 LIN7C LIN7B LIN7A,MF,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0051393,alpha-actinin binding,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens), CACNA1D MAGI1 ALMS1 XIRP2,MF,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0048013,ephrin receptor signaling pathway,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MXV4(Evidence code:IEA/Database source:UniProtKB:Q8C0T5|ens)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)F1MQH2(Evidence code:IEA/Database source:GO:0005003), CRK SIPA1L1 EPHB4 EPHA6,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0071546,pi-body,E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens), TDRD5 DDX4 TDRD1 PIWIL2,CC,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0097320,plasma membrane tubulation,E1BK71(Evidence code:IEA/Database source:InterPro:IPR028523)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q1RMR9(Evidence code:IEA/Database source:InterPro:IPR028521|I)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens), PACSIN3 SNX33 PACSIN2 CHMP4A,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0031468,nuclear envelope reassembly,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), SPAST NSFL1C CHMP4B CHMP2A,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0042267,natural killer cell mediated cytotoxicity,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698)A6QQ36(Evidence code:IBA/Database source:PANTHER:PTN000422481)F1N4S4(Evidence code:IBA/Database source:PANTHER:PTN000422481), PTPN6 LYST LOC100850276 ULBP11,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0007250,activation of NF-kappaB-inducing kinase activity,E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens), TNFSF15 TRAF6 COPS8 MALT1,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0017160,Ral GTPase binding,A6QLD1(Evidence code:IEA/Database source:UniProtKB:Q96A65|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q96KP1|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens), EXOC4 EXOC8 EXOC2 MYO1C,MF,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0042405,nuclear inclusion body,Q28165(Evidence code:ISS/Database source:UniProtKB:Q86U42)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792), PABPN1 RAD18 TPR RANBP2,CC,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0080182,histone H3-K4 trimethylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:O43151|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens), KMT2A HIST1H1D TET3 KMT2B,BP,4,4 of 3,0.18,133.33,0.0005639,0.003853
GO:0000784,"nuclear chromosome, telomeric region",F1MMS4(Evidence code:IEA/Database source:InterPro:IPR017357|I)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR017357)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q96QC0|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens), TERF2 TERF1 ATRX TNKS PPP1R10 PPP1CC BRCA2 H3F3B,CC,8,8 of 22,0.35,36.36,0.0005649,0.003855
GO:0042626,"ATPase activity, coupled to transmembrane movement of substances",P35071(Evidence code:IEA/Database source:InterPro:IPR011527)G3MW12(Evidence code:IEA/Database source:InterPro:IPR011527)F1MG24(Evidence code:IEA/Database source:InterPro:IPR026082)G3MW11(Evidence code:IEA/Database source:InterPro:IPR011527)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR011527)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR011527)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR026082)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR011527|I)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)G3MW09(Evidence code:IEA/Database source:InterPro:IPR011527), CFTR LOC100337053 ABCA1 LOC523126 LOC100299180 ABCC3 ABCA7 LOC515333 ABCC5 LOC509854,MF,10,10 of 35,0.44,28.57,0.0005888,0.004013
GO:0070374,positive regulation of ERK1 and ERK2 cascade,P27479(Evidence code:ISS/Database source:UniProtKB:P16050)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), ALOX15 CRKL BRAF SRC PDGFC ABL1 F2R DSTYK RAPGEF2 TNFAIP8L3 MT3,BP,11,11 of 42,0.48,26.19,0.0005928,0.004035
GO:0071310,cellular response to organic substance,Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622311)P46196(Evidence code:IBA/Database source:PANTHER:PTN000622282)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)F1MVV5(Evidence code:IBA/Database source:PANTHER:PTN000622282), MAPK9 MAPK1 CUX2 MAPK4,BP,4,4 of 238,0.18,1.68,0.000596,0.004051
GO:0043046,DNA methylation involved in gamete generation,E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens), TDRD5 DDX4 PIWIL2 TDRD9 TDRD1,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0051233,spindle midzone,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)G3X6L5(Evidence code:IEA/Database source:UniProtKB:Q96BM9|ens), RIF1 PKP4 KIF14 RACGAP1 ARL8A,CC,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0031116,positive regulation of microtubule polymerization,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens), CDK5RAP2 PAK1 NUMA1 ARL2 NAV3,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0030032,lamellipodium assembly,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens), GOLPH3 KIT VAV2 CYFIP1 WASF2,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0043001,Golgi to plasma membrane protein transport,P63171(Evidence code:IMP/Database source:)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens), DYNLT1 GOLPH3 GOLGA4 RAB26 VAMP5,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0050435,amyloid-beta metabolic process,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56817)P80227(Evidence code:IEA/Database source:UniProtKB:P13798|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735), UNC13A BACE1 APEH PSEN1 IDE,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0031252,cell leading edge,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:O54988|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8), ABL1 SLK SCRIB ABI1 AAK1,CC,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0017025,TBP-class protein binding,Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC2 PSMC1 RUVBL1 PSMC6 PSMC5,MF,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0016529,sarcoplasmic reticulum,Q2YDF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703), JSRP1 RYR1 MRVI1 CAMK2D CAMK2B,CC,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0071260,cellular response to mechanical stimulus,A5PJP8(Evidence code:IEA/Database source:UniProtKB:P45985|ens)E1B847(Evidence code:IEA/Database source:UniProtKB:Q13233|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131), MAP2K4 MAP3K1 MAP3K14 NFKB1 PIEZO1,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0034067,protein localization to Golgi apparatus,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), GCC2 ARL1 RAB33B BICD2 SORL1,BP,5,5 of 7,0.22,71.43,0.0006684,0.004479
GO:0001649,osteoblast differentiation,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4), GLI2 SHOX2 SP7 GLI1 IGFBP3 LEF1 FIGNL1 WWTR1 LGR4,BP,9,9 of 29,0.39,31.03,0.0006693,0.00448
GO:0008094,DNA-dependent ATPase activity,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR020587)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074), INO80 SMARCAL1 MYO18A CHD8 CHD6 BLM ERCC2,MF,7,7 of 17,0.31,41.18,0.0006931,0.004627
GO:0005178,integrin binding,F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)P03968(Evidence code:ISS/Database source:UniProtKB:P05230), UTRN CXCL12 FRMD5 ADAM15 LAMB2 ITGB6 FGF1,MF,7,7 of 17,0.31,41.18,0.0006931,0.004627
GO:0071013,catalytic step 2 spliceosome,F1N543(Evidence code:IBA/Database source:PANTHER:PTN000336449)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)Q29RZ2(Evidence code:IEA/Database source:UniProtKB:Q96BP3|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens), NRDE2 SNRPN SNRNP200 SRSF1 DHX8 CDC5L PRPF8 SYF2 PPWD1 EIF4A3,CC,10,10 of 36,0.44,27.78,0.0007081,0.004721
GO:0032880,regulation of protein localization,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens), PRNP AAK1 RAB9A,BP,3,3 of 211,0.13,1.42,0.0007165,0.004771
GO:0008380,RNA splicing,E1BB50(Evidence code:ISS/Database source:UniProtKB:Q3MJK5)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR033096)Q08E07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)E1B9H3(Evidence code:IEA/Database source:InterPro:IPR028811)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A7E3C9(Evidence code:IEA/Database source:InterPro:IPR034585)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q0II50(Evidence code:ISS/Database source:UniProtKB:Q9BQ65), CDK12 ZNF638 CELF3 PPIE EIF4A3 STRAP CDC5L CCAR2 PABPC1 SAP18 SNRPE PPWD1 RP9 DHX9 SRSF1 LSM4 CDK13 EFTUD2 USB1,BP,19,19 of 106,0.83,17.92,0.0007648,0.005079
GO:0000723,telomere maintenance,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR017357)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR017357|I), RIF1 TERF1 ATM WRN PRKDC TERF2,BP,6,6 of 12,0.26,50,0.0007667,0.005079
GO:0006493,protein O-linked glycosylation,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)F1MS56(Evidence code:IEA/Database source:UniProtKB:O95394|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:O43151|ens)F1N4Q3(Evidence code:IEA/Database source:UniProtKB:Q80VA0|ens)G3MY32(Evidence code:IEA/Database source:InterPro:IPR003342)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1), GALNT2 PGM3 TET3 GALNT7 TMTC2 POMGNT1,BP,6,6 of 12,0.26,50,0.0007667,0.005079
GO:0003887,DNA-directed DNA polymerase activity,P84798(Evidence code:TAS/Database source:)P06526(Evidence code:IEA/Database source:InterPro:IPR002054)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000805918)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006172|I)E1BDI3(Evidence code:IEA/Database source:InterPro:IPR001098|I)A6QQ14(Evidence code:IEA/Database source:EC:2.7.7.7), POLD3 DNTT POLQ POLA1 POLG POLE4,MF,6,6 of 12,0.26,50,0.0007667,0.005079
GO:0061024,membrane organization,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), MTSS1L CLN3,BP,2,2 of 179,0.09,1.12,0.0007683,0.005084
GO:0006518,peptide metabolic process,E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084)Q2HJH1(Evidence code:IBA/Database source:PANTHER:PTN002004858), CPXM2 DNPEP,BP,2,2 of 181,0.09,1.1,0.0007848,0.005186
GO:0009967,positive regulation of signal transduction,Q29RQ2(Evidence code:IEA/Database source:GO:0005070)F1N6C4(Evidence code:IEA/Database source:GO:0035591)E1BQ32(Evidence code:IEA/Database source:GO:0005070)F1MRH8(Evidence code:IEA/Database source:GO:0005070)Q58DL5(Evidence code:IEA/Database source:GO:0005070)Q3T0F9(Evidence code:IEA/Database source:GO:0005070)Q6U8D5(Evidence code:IEA/Database source:GO:0005070), KHDRBS1 EPS8 CRK SH2B2 BCAR3 GRB2 Grb10,BP,7,7 of 308,0.31,2.27,0.0007872,0.005196
GO:0008168,methyltransferase activity,F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A7YW45(Evidence code:IEA/Database source:InterPro:IPR007857|I)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A1A4K2(Evidence code:IEA/Database source:InterPro:IPR001678)Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR001525)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)P10950(Evidence code:IEA/Database source:InterPro:IPR016461)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)G3MZP6(Evidence code:IEA/Database source:InterPro:IPR002877)A6QL80(Evidence code:IEA/Database source:InterPro:IPR025799), KMT2C TRMT1L PCMT1 KMT2A KMT2B DOT1L PRMT5 COMT NSUN2 DNMT3A ASH1L ASMT WHSC1L1 CMTR2 PRMT3,MF,15,15 of 75,0.66,20,0.0007981,0.005261
GO:0001503,ossification,E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000942785)P31407(Evidence code:ISS/Database source:UniProtKB:P15313)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0892)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)A0JND4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0892)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens), RUNX1 ATP6V1B1 MYF5 MGP COL2A1 ALOX15 SBNO2 TRAF6 EXT1,BP,9,9 of 30,0.39,30,0.0008195,0.005395
GO:0008201,heparin binding,G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)Q1RMW2(Evidence code:IDA/Database source:)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1N226(Evidence code:IEA/Database source:InterPro:IPR015849|I)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)F1MJQ6(Evidence code:IEA/Database source:UniProtKB:Q9JLI2|ens)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN000689792)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q5TAT6|ens), HIST1H1A TMEM184A FGF1 APLP2 NAV2 NDNF RTN4R COL5A3 PCSK6 SLIT2 PRELP COL13A1,MF,12,12 of 52,0.53,23.08,0.0008919,0.005865
GO:0005681,spliceosomal complex,Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433761)A4FUI2(Evidence code:IEA/Database source:InterPro:IPR027078)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)A7Z025(Evidence code:IEA/Database source:InterPro:IPR027652)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747), CDC5L SNRNP70 PPWD1 GPKOW SNRNP200 LSM4 PABPC1 EFTUD2 DHX8 SNRPE SRSF1 EIF4A3 PRPF8 CCAR2 PPIE,CC,15,15 of 76,0.66,19.74,0.0008979,0.005896
GO:0016525,negative regulation of angiogenesis,E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)P05059(Evidence code:TAS/Database source:)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens), DAB2IP PTPRM GPR4 FOXO4 SEMA3E CHGA TCF7L2 EMILIN1,BP,8,8 of 24,0.35,33.33,0.0009015,0.005913
GO:0005903,brush border,Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)F1MLR9(Evidence code:IEA/Database source:UniProtKB:Q6PIF6|ens)A7YY70(Evidence code:IBA/Database source:PANTHER:PTN001293650)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens), MYO1D MYO1C MYO7B SLC34A1 MYH14 MYO1A CUBN,CC,7,7 of 18,0.31,38.89,0.000908,0.005918
GO:0003725,double-stranded RNA binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q91VR5|ens), DHX9 DDX58 RC3H2 AGO4 TFRC DGCR8 DDX1,MF,7,7 of 18,0.31,38.89,0.000908,0.005918
GO:0031593,polyubiquitin modification-dependent protein binding,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736), EPS15 UBXN1 DZIP3 RAD18 RAD23B UBQLN1 BRCC3,MF,7,7 of 18,0.31,38.89,0.000908,0.005918
GO:0030317,flagellated sperm motility,E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:Q96DT5|ens)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462268)Q58D31(Evidence code:ISS/Database source:UniProtKB:Q64442)D3K0R6(Evidence code:ISS/Database source:UniProtKB:Q6Q477)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens), INPP5B DNAH11 TEKT4 SORD ATP2B4 CELF3 CCNYL1,BP,7,7 of 18,0.31,38.89,0.000908,0.005918
GO:0070373,negative regulation of ERK1 and ERK2 cascade,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR030790), DAB2IP PIN1 DLG1 DUSP3 ABL1 EMILIN1 SPRY4,BP,7,7 of 18,0.31,38.89,0.000908,0.005918
GO:0007010,cytoskeleton organization,F1MKE9(Evidence code:IEA/Database source:GO:0005200)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)Q2T9S0(Evidence code:IEA/Database source:GO:0005200)E1BLT3(Evidence code:IEA/Database source:GO:0005200)F1MNF8(Evidence code:IEA/Database source:GO:0005200)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)F1MHR5(Evidence code:IEA/Database source:UniProtKB:Q5VZL5|ens)F2Z4C1(Evidence code:IEA/Database source:GO:0005200)F2Z4K0(Evidence code:IEA/Database source:GO:0005200)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR027657)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)O46385(Evidence code:IEA/Database source:InterPro:IPR003128|I)G3N135(Evidence code:IEA/Database source:InterPro:IPR027656)Q2HJB8(Evidence code:IEA/Database source:GO:0005200)E1B953(Evidence code:IEA/Database source:GO:0005200)P81948(Evidence code:IEA/Database source:GO:0005200)A4FUD6(Evidence code:IEA/Database source:InterPro:IPR030713)E1B718(Evidence code:IEA/Database source:InterPro:IPR027655)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN001364370)Q2HJ86(Evidence code:IEA/Database source:GO:0005200)F6RP72(Evidence code:IEA/Database source:GO:0005200)F1MF74(Evidence code:ISS/Database source:UniProtKB:O94851)Q3ZBU7(Evidence code:IEA/Database source:GO:0005200)E1BDP6(Evidence code:IEA/Database source:InterPro:IPR003128|I), SPTB STRIP2 PRPF40A TUBB3 SPTBN4 LOC100141266 MICAL3 ZMYM4 TUBA1A TUBA3E SYNE3 FMNL1 PALM SVIL FMNL2 TUBA8 LOC533307 TUBA4A ELMO2 FMNL3 ZMYM5 TUBA1D LOC100295712 MICAL2 TUBB4A VILL,BP,26,26 of 174,1.14,14.94,0.0009106,0.005928
GO:0004497,monooxygenase activity,Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR002403)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I)E1BM29(Evidence code:IEA/Database source:InterPro:IPR002403)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)F1MF74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)F1MEU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503), CYP2R1 PAH DBH CYP7A1 LOC100295883 MICAL2 LOC540627 CYP2J2 MICAL3,MF,9,9 of 31,0.39,29.03,0.0009958,0.006475
GO:0007346,regulation of mitotic cell cycle,E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MF87(Evidence code:IEA/Database source:UniProtKB:Q96AY4|ens)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000684825), MAP3K1 TAOK3 CDK1 PAK4 MAP3K4 AFAP1L2 PAK6 TTC28 TAOK2 PAK2 SLK STK3 MAP2K4 PAK1 MAP3K8 PAK3 MAP3K14 STK26 STK25,BP,19,19 of 111,0.83,17.12,0.001073,0.006485
GO:0030335,positive regulation of cell migration,Q32PI9(Evidence code:IEA/Database source:UniProtKB:Q3TEW6|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BE66(Evidence code:IEA/Database source:UniProtKB:O00329|ens)E1B9K4(Evidence code:IBA/Database source:PANTHER:PTN000539684)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q9HBX8|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:Q7TT37|ens)G5E526(Evidence code:IEA/Database source:UniProtKB:Q63739|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), MPZL1 FOXF1 PIK3CD HMCN2 FGF1 F2R LAMB1 LGR6 PAK1 IKBKAP PTP4A1 CXCL12 PDCD10 PDGFC LEF1 ONECUT2 MYO1C PPP3CA,BP,18,18 of 100,0.79,18,0.001064,0.006485
GO:0048812,neuron projection morphogenesis,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000685430)A4IFF6(Evidence code:IEA/Database source:UniProtKB:Q9R0A5|ens)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000685430)E1BKJ6(Evidence code:IEA/Database source:InterPro:IPR026722)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN001216704)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens), DAB2IP STK25 NEK3 STK26 NYAP1 MNX1 DNM2 BDNF LRRK2 WEE1,BP,10,10 of 38,0.44,26.32,0.001007,0.006485
GO:0006952,defense response,P56831(Evidence code:IEA/Database source:InterPro:IPR000471)P46161(Evidence code:IEA/Database source:InterPro:IPR001855|I)Q8MJ29(Evidence code:IEA/Database source:InterPro:IPR000471)P46165(Evidence code:IEA/Database source:InterPro:IPR001855|I)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR033899)G3N183(Evidence code:IEA/Database source:InterPro:IPR000471)P56830(Evidence code:IEA/Database source:InterPro:IPR000471), IFNT3 DEFB3 IFNT DEFB7 CXCL12 LOC104968438 IFNT2,BP,7,7 of 300,0.31,2.33,0.001044,0.006485
GO:0035690,cellular response to drug,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens), PRNP BRAF PPP3CA MT3 TFRC RAP2A,BP,6,6 of 13,0.26,46.15,0.001058,0.006485
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116), AIFM1 EGLN3 LCK TNFSF15 PDCD6 F2R,BP,6,6 of 13,0.26,46.15,0.001058,0.006485
GO:0006513,protein monoubiquitination,F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335), CUL1 HUWE1 UBE4B RBX1 CUL3 RAD18,BP,6,6 of 13,0.26,46.15,0.001058,0.006485
GO:0044183,protein binding involved in protein folding,A1A4P5(Evidence code:IBA/Database source:PANTHER:PTN000329566)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q32L40(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q2NKZ1(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T0K2(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3ZCI9(Evidence code:IBA/Database source:PANTHER:PTN000143677), PFDN2 CCT6B TCP1 CCT7 CCT3 CCT8,MF,6,6 of 13,0.26,46.15,0.001058,0.006485
GO:0035064,methylated histone binding,F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88), ZMYND8 ATRX LRWD1 SUZ12 UHRF1,MF,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0005272,sodium channel activity,F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894), SCN5A SCN3A SCN11A SCN8A SCN10A,MF,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0009636,response to toxic substance,A5D7H9(Evidence code:IEA/Database source:UniProtKB:Q9UN76|ens)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q8R016|ens)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens), SLC6A14 SCFD1 BLMH SLC23A1 CNP,BP,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0005540,hyaluronic acid binding,Q29423(Evidence code:IEA/Database source:InterPro:IPR000538)P81282(Evidence code:IEA/Database source:InterPro:IPR000538)F1N2J5(Evidence code:IEA/Database source:InterPro:IPR000538)P13608(Evidence code:IEA/Database source:InterPro:IPR000538)F1MKY3(Evidence code:IEA/Database source:InterPro:IPR000538), CD44 VCAN HAPLN4 ACAN SUSD5,MF,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0001917,photoreceptor inner segment,Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026521)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P11488|ens)P04696(Evidence code:IEA/Database source:UniProtKB:P19087|ens), DNM1 GNAT3 SHANK2 GNAT1 GNAT2,CC,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0051879,Hsp90 protein binding,A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q99KD5|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9UHD1|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752), UNC45A TSC2 KPNB1 CHORDC1 PPID,MF,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0008543,fibroblast growth factor receptor signaling pathway,E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)Q95M13(Evidence code:IEA/Database source:InterPro:IPR016248)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)P03968(Evidence code:IEA/Database source:InterPro:IPR028210), KL fgfr3 FRS2 SETX FGF1,BP,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0005832,chaperonin-containing T-complex,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)Q32L40(Evidence code:IDA/Database source:)Q3ZCI9(Evidence code:IDA/Database source:)Q2NKZ1(Evidence code:IDA/Database source:)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143755), CCT3 TCP1 CCT8 CCT7 CCT6B,CC,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0045747,positive regulation of Notch signaling pathway,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), PDCD10 LFNG AAK1 TSPAN14 STAT3,BP,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0001671,ATPase activator activity,Q2KIT4(Evidence code:ISS/Database source:UniProtKB:Q9UDY4)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR004640)Q2HJ94(Evidence code:ISS/Database source:UniProtKB:O60884)Q3MI00(Evidence code:ISS/Database source:UniProtKB:P25685)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens), DNAJB4 HSCB DNAJA2 DNAJB1 DNAJB2,MF,5,5 of 8,0.22,62.5,0.001027,0.006485
GO:0031235,intrinsic component of the cytoplasmic side of the plasma membrane,E1BB77(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)F1MBI8(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1BPM0(Evidence code:IBA/Database source:PANTHER:PTN000022879), DAB2IP RASAL2 SYNGAP1 RASAL1,CC,4,4 of 4,0.18,100,0.001069,0.006485
GO:0006607,NLS-bearing protein import into nucleus,F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427), IPO5 TNPO1 KPNB1 IPO4,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0030955,potassium ion binding,B3IVN4(Evidence code:IEA/Database source:InterPro:IPR001697|I)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)Q05037(Evidence code:IEA/Database source:InterPro:IPR012897|I)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR001697|I), PKM ATP1A2 KCNA4 PKLR,MF,4,4 of 4,0.18,100,0.001069,0.006485
GO:0035329,hippo signaling,E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens), MOB1B AMOTL1 STK3 WWTR1,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0048488,synaptic vesicle endocytosis,O18964(Evidence code:IEA/Database source:InterPro:IPR034972)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens), SYNJ1 SCRIB DNM1 DENND1A,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0030033,microvillus assembly,P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens), MYO1A STK26 RAP2A RAPGEF2,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0034451,centriolar satellite,E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), SDCCAG8 PCM1 PCNT FLOT1,CC,4,4 of 4,0.18,100,0.001069,0.006485
GO:0045899,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC2 PSMC5 PSMC6 PSMC1,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0097025,MPP7-DLG1-LIN7 complex,Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN000362480)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN000362480), LIN7A LIN7C DLG1 LIN7B,CC,4,4 of 4,0.18,100,0.001069,0.006485
GO:0030331,estrogen receptor binding,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)P26882(Evidence code:IDA/Database source:), LEF1 ZNF366 TAF10 PPID,MF,4,4 of 4,0.18,100,0.001069,0.006485
GO:0045199,maintenance of epithelial cell apical/basal polarity,Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN001019267)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens)Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q0P5F3(Evidence code:IBA/Database source:PANTHER:PTN001019267), LIN7B PDCD6IP LIN7A LIN7C,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0099738,cell cortex region,F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P63096), NUMA1 GPSM2 ACTR1A GNAI1,CC,4,4 of 4,0.18,100,0.001069,0.006485
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR037858)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens), RACGAP1 IQGAP2 ARAP3 FERMT2,MF,4,4 of 4,0.18,100,0.001069,0.006485
GO:0005080,protein kinase C binding,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)P35605(Evidence code:ISS/Database source:UniProtKB:O35142)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens), ABL1 TDG COPB2 TOP2B,MF,4,4 of 4,0.18,100,0.001069,0.006485
GO:0050860,negative regulation of T cell receptor signaling pathway,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens), PTPN6 PRNP DUSP3 PHPT1,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0043015,gamma-tubulin binding,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), BRCA2 RACGAP1 TUBGCP2 CDK5RAP2,MF,4,4 of 4,0.18,100,0.001069,0.006485
GO:0010842,retina layer formation,E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens), PTPRM AHI1 SDK2 ARL6,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0033391,chromatoid body,F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)Q5W5U4(Evidence code:IDA/Database source:), TDRD1 PIWIL2 TDRD5 DDX4,CC,4,4 of 4,0.18,100,0.001069,0.006485
GO:0051497,negative regulation of stress fiber assembly,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1MJ20(Evidence code:IEA/Database source:UniProtKB:Q8BN58|ens)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O43182|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens), WASF2 ARHGAP28 ARHGAP6 TACSTD2,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0071333,cellular response to glucose stimulus,F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)E1BM29(Evidence code:IEA/Database source:InterPro:IPR030681)P00517(Evidence code:IEA/Database source:InterPro:IPR039035), UNC13B SOX4 CYP7A1 PRKACA,BP,4,4 of 4,0.18,100,0.001069,0.006485
GO:0031005,filamin binding,F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)F1MF57(Evidence code:IEA/Database source:UniProtKB:O76041|ens), MICALL2 CRMP1 NEBL,MF,3,3 of 1,0.13,300,0.001092,0.006485
GO:1904354,negative regulation of telomere capping,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens), ATM SMG6 TERF2,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0001682,tRNA 5-leader removal,E1BFB5(Evidence code:IBA/Database source:PANTHER:PTN001005190)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens), KIAA0391 SSB RPP25,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0035924,cellular response to vascular endothelial growth factor stimulus,Q0IIE2(Evidence code:IDA/Database source:)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)P08487(Evidence code:IDA/Database source:), SHC1 DAB2IP PLCG1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:1903551,regulation of extracellular exosome assembly,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q08DL9(Evidence code:IEA/Database source:UniProtKB:Q92783|ens), PDCD6IP TSG101 STAM,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:1990502,dense core granule maturation,F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens), BAIAP3 SNX19 PTPRN,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0060397,JAK-STAT cascade involved in growth hormone signaling pathway,Q95115(Evidence code:IEA/Database source:InterPro:IPR035858)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR035858)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), STAT5A STAT5B STAT3,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0042921,glucocorticoid receptor signaling pathway,E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), ARID1A NEDD4 PTGES3,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0043422,protein kinase B binding,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), APPL1 TRAF6 PINK1,MF,3,3 of 1,0.13,300,0.001092,0.006485
GO:0004385,guanylate kinase activity,P46195(Evidence code:IEA/Database source:InterPro:IPR017665)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163), GUK1 SCRIB DLG1,MF,3,3 of 1,0.13,300,0.001092,0.006485
GO:0060430,lung saccule development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), ASXL1 GATA6 PTGES3,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0014029,neural crest formation,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens), LRP6 PDCD6 PEF1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0060216,definitive hemopoiesis,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), BCR MEIS1 KMT2A,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0045880,positive regulation of smoothened signaling pathway,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), GLI1 STK36 SHOX2,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:2000772,regulation of cellular senescence,E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens), NUAK1 ABL1 PNPT1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0001556,oocyte maturation,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), RPS6KA2 PABPC1L BRCA2,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0005049,nuclear export signal receptor activity,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens), XPO1 XPO7 NUP214,MF,3,3 of 1,0.13,300,0.001092,0.006485
GO:0034454,microtubule anchoring at centrosome,E1BQ19(Evidence code:IEA/Database source:InterPro:IPR029664)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138)E1BJG8(Evidence code:IEA/Database source:UniProtKB:Q9H2F9|ens), NIN PCM1 CCDC68,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0009597,detection of virus,A4FUZ5(Evidence code:ISS/Database source:UniProtKB:Q13530)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), SERINC3 SERINC5 DDX58,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0035385,Roundabout signaling pathway,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q32LG4(Evidence code:IEA/Database source:InterPro:IPR032985)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), MYO9B ROBO2 SLIT2,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0035371,microtubule plus-end,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), NUMA1 CKAP5 CDK5RAP2,CC,3,3 of 1,0.13,300,0.001092,0.006485
GO:0060218,hematopoietic stem cell differentiation,A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens), SP7 SRF CDK6,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0090611,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), PDCD6IP VPS4B CHMP4B,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0001736,establishment of planar polarity,F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)E1BJB4(Evidence code:IEA/Database source:InterPro:IPR031136)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens), PTK7 RPGRIP1L ALMS1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0043584,nose development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), RPGRIP1L ALDH1A3 CHD7,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0006047,UDP-N-acetylglucosamine metabolic process,F1MIL9(Evidence code:IEA/Database source:InterPro:IPR020004)F1MZY2(Evidence code:IBA/Database source:PANTHER:PTN000101302)Q08DQ2(Evidence code:IBA/Database source:PANTHER:PTN000101302), GNE GFPT1 GFPT2,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0005642,annulate lamellae,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens), XPO1 RANBP2 BICD2,CC,3,3 of 1,0.13,300,0.001092,0.006485
GO:0043140,ATP-dependent 3-5 DNA helicase activity,E1BQ04(Evidence code:IEA/Database source:InterPro:IPR018982)Q28141(Evidence code:IDA/Database source:)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR018982), BLM DHX9 WRN,MF,3,3 of 1,0.13,300,0.001092,0.006485
GO:0006048,UDP-N-acetylglucosamine biosynthetic process,F1MS56(Evidence code:IEA/Database source:UniPathway:UPA00113)Q08DQ2(Evidence code:IEA/Database source:UniPathway:UPA00113)G3N337(Evidence code:IBA/Database source:PANTHER:PTN000237224), PGM3 GFPT2 UAP1L1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0030520,intracellular estrogen receptor signaling pathway,E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens), SRC POU4F2 ARID1A,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:1904355,positive regulation of telomere capping,Q0VCK2(Evidence code:IEA/Database source:UniProtKB:Q9C010|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens), PKIB TNKS MAP3K4,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:1903772,regulation of viral budding via host ESCRT complex,Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens), MVB12A TSG101 SNF8,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0003951,NAD+ kinase activity,E1BJM1(Evidence code:IEA/Database source:InterPro:IPR017438)Q3SZD3(Evidence code:IEA/Database source:InterPro:IPR002504|I)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR017438), SPHK2 NADK DGKQ,MF,3,3 of 1,0.13,300,0.001092,0.006485
GO:0021879,forebrain neuron differentiation,F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971), SOX1 DLX2 LEF1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0031914,negative regulation of synaptic plasticity,E1BBX9(Evidence code:IEA/Database source:UniProtKB:Q8K0T7|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens), UNC13C UNC13B RGS14,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0010735,positive regulation of transcription via serum response element binding,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939), SRF MKL1 MICAL2,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0015825,L-serine transport,A4FUZ5(Evidence code:IEA/Database source:GO:0015194)Q58CW5(Evidence code:IEA/Database source:GO:0015194)F1N5T9(Evidence code:IEA/Database source:GO:0015194), SERINC3 SERINC2 SERINC5,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0032367,intracellular cholesterol transport,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), NPC1 OSBP ABCA1,BP,3,3 of 1,0.13,300,0.001092,0.006485
GO:0030838,positive regulation of actin filament polymerization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)Q5EAD0(Evidence code:IBA/Database source:PANTHER:PTN001022094)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens), DLG1 BAIAP2L1 ARF6 GRB2 RICTOR ALOX15 BAIAP2 CTTN,BP,8,8 of 25,0.35,32,0.001122,0.006648
GO:0007059,chromosome segregation,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0159)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0159)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)Q3T0W4(Evidence code:IEA/Database source:UniProtKB:Q3UM45|ens), RGS14 DDX3Y MMS19 DDX3X ARL8B CDK5RAP2 ERCC2 PPP1R7,BP,8,8 of 25,0.35,32,0.001122,0.006648
GO:0031226,intrinsic component of plasma membrane,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)P58754(Evidence code:ISS/Database source:UniProtKB:Q9Y6Y9)Q29RR0(Evidence code:ISS/Database source:UniProtKB:P51156)Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740), CD63 LY96 RAB26 ALCAM,CC,4,4 of 226,0.18,1.77,0.001153,0.006829
GO:0005884,actin filament,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens), SRC YES1 CTTN MYO9B APC2 SH2B2 KEAP1,CC,7,7 of 19,0.31,36.84,0.001172,0.006932
GO:0051607,defense response to virus,E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)A4FUZ5(Evidence code:ISS/Database source:UniProtKB:Q13530)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)Q8MJ29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)E1B7G0(Evidence code:IEA/Database source:UniProtKB:Q8CGK5|ens)G3N183(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051), MAP3K14 MB21D1 IRF1 IFNT2 DDX58 LOC516599 MX2 SERINC3 SERINC5 IFNT3 IFNT IFNLR1 LOC104968438,BP,13,13 of 62,0.57,20.97,0.001195,0.007058
GO:0005789,endoplasmic reticulum membrane,A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9TU34(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q95JH2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7I4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q8WN96(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE53(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)E1BM45(Evidence code:IEA/Database source:InterPro:IPR007070|I)Q5EA65(Evidence code:ISS/Database source:UniProtKB:P24140)Q29RN8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XT97(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q8MII5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QNT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)A2VDL8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32PA9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67810(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)E1BPZ8(Evidence code:IBA/Database source:PANTHER:PTN000552915)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256598)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BM29(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUW8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), ATF6B SEC13 ITPR1 AGPAT1 SAR1B SPCS3 EXT1 DPM3 ITPR2 SEC23B JSRP1 IKBIP SCAP PIGN DPAGT1 SEZ6L2 PSEN1 DAD1 SLC35B1 SHISA5 SEC24A CFTR SEC23A FKBP2 SEC11A SRI PIGO WRB LPIN2 PIGK ZFYVE27 CYP7A1 TXNDC11,CC,33,33 of 244,1.45,13.52,0.001407,0.008303
GO:0007565,female pregnancy,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0635)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q17QL4(Evidence code:IEA/Database source:UniProtKB:Q9UNF1|ens)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0635), STAT5B IFNT2 CRH STAT5A MAGED2 IFNT3,BP,6,6 of 14,0.26,42.86,0.001427,0.008413
GO:0071347,cellular response to interleukin-1,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q32MK0|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens), NFKB1 HYAL1 MAPK11 ADAMTS12 DAB2IP MYLK3 ADAMTS7,BP,7,7 of 20,0.31,35,0.001493,0.008768
GO:0019005,SCF ubiquitin ligase complex,F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:P63208)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens), BTBD3 RBX1 SPOPL BTBD6 BTBD11 SKP1 CUL1,CC,7,7 of 20,0.31,35,0.001493,0.008768
GO:0030175,filopodium,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens), PALM TWF1 NF2 BAIAP2 IQGAP2 FAT1 UTRN,CC,7,7 of 20,0.31,35,0.001493,0.008768
GO:0002088,lens development in camera-type eye,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens), CDON FRS2 DLG1 CRYAB PYGO2,BP,5,5 of 9,0.22,55.56,0.001511,0.008816
GO:0046854,phosphatidylinositol phosphorylation,P20456(Evidence code:IEA/Database source:InterPro:IPR000760|I)O02811(Evidence code:IEA/Database source:InterPro:IPR015433)E1BE66(Evidence code:IEA/Database source:InterPro:IPR008290|I)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)Q0P5F7(Evidence code:IEA/Database source:GO:0016307), IMPA1 PI4KA PIK3CD SMG1 PIP4K2C,BP,5,5 of 9,0.22,55.56,0.001511,0.008816
GO:1903078,positive regulation of protein localization to plasma membrane,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P05556), DLG1 ARF6 PRNP PRKCI ITGB1,BP,5,5 of 9,0.22,55.56,0.001511,0.008816
GO:0042584,chromaffin granule membrane,Q08DF4(Evidence code:IDA/Database source:)P15101(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q29455(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IDA/Database source:)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), DNM1 DBH DNAJC5 ARF6 SRI,CC,5,5 of 9,0.22,55.56,0.001511,0.008816
GO:1990126,"retrograde transport, endosome to plasma membrane",Q3T0M0(Evidence code:ISS/Database source:UniProtKB:Q9UBQ0)E1B7G6(Evidence code:IEA/Database source:UniProtKB:Q9ULJ7|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1), VPS29 ANKRD50 SNX27 VPS26A VPS35,BP,5,5 of 9,0.22,55.56,0.001511,0.008816
GO:0008542,visual learning,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), DBH BRAF SYNGAP1 KMT2A ATP1A2,BP,5,5 of 9,0.22,55.56,0.001511,0.008816
GO:0031490,chromatin DNA binding,E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)A6H7J1(Evidence code:ISS/Database source:UniProtKB:P70661)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)G3N131(Evidence code:IEA/Database source:UniProtKB:Q02539|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BIJ4(Evidence code:IBA/Database source:PANTHER:PTN001412149)P61635(Evidence code:ISS/Database source:UniProtKB:P40763)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens), KDM3B INSM1 DHX9 HIST1H1A SRF LEMD3 STAT3 SUZ12,MF,8,8 of 27,0.35,29.63,0.001689,0.009823
GO:0007050,cell cycle arrest,Q5E9L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0338)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q9ULX5)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0338)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914), BRINP1 UHMK1 TSG101 RNF112 HEPACAM FOXO4 ATM IRF1,BP,8,8 of 27,0.35,29.63,0.001689,0.009823
GO:0031201,SNARE complex,Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349)P63026(Evidence code:ISS/Database source:UniProtKB:P63027)Q17QQ3(Evidence code:ISS/Database source:UniProtKB:P60880-1)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885), STX7 VAMP2 SNAP25 SYN2 NAPG VAMP1 VAMP3 VAMP5,CC,8,8 of 27,0.35,29.63,0.001689,0.009823
GO:0031597,cytosolic proteasome complex,A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC1 PSMC5 PSMC6 PSMC2,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0009982,pseudouridine synthase activity,E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I)F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103), TRUB1 RPUSD2 PUS3 PUS10,MF,4,4 of 5,0.18,80,0.001823,0.01038
GO:0097009,energy homeostasis,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q8CEE6|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens), PASK STAT3 EIF4G1 AMPD3,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0006002,fructose 6-phosphate metabolic process,Q08DQ2(Evidence code:IBA/Database source:PANTHER:PTN000101302)Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR022953)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR022953)F1MZY2(Evidence code:IBA/Database source:PANTHER:PTN000101302), GFPT2 PFKM PFKP GFPT1,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0043186,P granule,F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN001053513)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN001169089)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens), TDRD1 TDRD9 DDX4 PIWIL2,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0001707,mesoderm formation,E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), ETV2 PRKACA NF2 SRF,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0000788,nuclear nucleosome,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)A4IFU5(Evidence code:IEA/Database source:UniProtKB:Q7L7L0|ens)E1B7N2(Evidence code:IBA/Database source:PANTHER:PTN000826174)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens), HIST1H2BA HIST3H2A LOC619094 H3F3B,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0031258,lamellipodium membrane,Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)P81425(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PDXP APC2 CD44 DPP4,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0032212,positive regulation of telomere maintenance via telomerase,E1B8R5(Evidence code:IEA/Database source:InterPro:IPR028731)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)Q0VCK2(Evidence code:IEA/Database source:UniProtKB:Q9C010|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens), TNKS MAP3K4 PKIB CCT3,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0031932,TORC2 complex,Q24JY1(Evidence code:ISS/Database source:UniProtKB:P62751)F1MHN4(Evidence code:IEA/Database source:InterPro:IPR028268)F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), RPL23A RICTOR TTI1 PINK1,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0005662,DNA replication factor A complex,E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q99459)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9), PURA CDC5L PURB SMARCAL1,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)P48734(Evidence code:IEA/Database source:EC:2.7.11.23)E1BB52(Evidence code:IEA/Database source:EC:2.7.11.23)E1BB50(Evidence code:IEA/Database source:EC:2.7.11.23), ERCC2 CDK1 CDK13 CDK12,MF,4,4 of 5,0.18,80,0.001823,0.01038
GO:0034587,piRNA metabolic process,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens), PIWIL2 DDX4 TDRD1 TDRD9,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0008328,ionotropic glutamate receptor complex,E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163), SHANK2 SCRIB SHANK1 DLG1,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0071541,"eukaryotic translation initiation factor 3 complex, eIF3m",Q5E966(Evidence code:IEA/Database source:UniProtKB:Q9QZD9|ens)A7MB16(Evidence code:IEA/Database source:UniProtKB:Q8JZQ9|ens)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:Q9DCH4|ens), EIF3I EIF3B EIF3M EIF3F,CC,4,4 of 5,0.18,80,0.001823,0.01038
GO:0046037,GMP metabolic process,Q32L93(Evidence code:ISS/Database source:UniProtKB:Q9P2T1)F1N0Y1(Evidence code:IEA/Database source:GO:0004385)F1MNQ3(Evidence code:IEA/Database source:GO:0004385)P46195(Evidence code:IEA/Database source:GO:0004385), GMPR2 SCRIB DLG1 GUK1,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0010718,positive regulation of epithelial to mesenchymal transition,G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens), AXIN2 LEF1 WWTR1 BCL9L,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0071360,cellular response to exogenous dsRNA,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), DHX9 MB21D1 FLOT1 DDX58,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0007173,epidermal growth factor receptor signaling pathway,A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN000544009)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000037430), CBLC SRC ABL1 SHC1,BP,4,4 of 5,0.18,80,0.001823,0.01038
GO:0030217,T cell differentiation,Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens), PKNOX1 KIT LCK SOX4 PREX1 LFNG CHD7,BP,7,7 of 21,0.31,33.33,0.001878,0.01065
GO:0008344,adult locomotory behavior,Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), SEZ6L2 EN1 CNP PUM1 ARCN1 DNM1 ATP1A2,BP,7,7 of 21,0.31,33.33,0.001878,0.01065
GO:0009952,anterior/posterior pattern specification,G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)G3MY13(Evidence code:IEA/Database source:UniProtKB:Q5DTH5|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), CRKL TSHZ1 Gli3 HOXA7 KMT2A CDON GLI2,BP,7,7 of 21,0.31,33.33,0.001878,0.01065
GO:0002244,hematopoietic progenitor cell differentiation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)E1BFI2(Evidence code:IEA/Database source:UniProtKB:A2ATU0|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1B9S6(Evidence code:IEA/Database source:UniProtKB:E9PYY5|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)E1BI99(Evidence code:IEA/Database source:UniProtKB:Q5QNV8|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), PTPN6 DHTKD1 CDK6 WDR78 PTPRZ1 HEATR9 PSEN1,BP,7,7 of 21,0.31,33.33,0.001878,0.01065
GO:0003341,cilium movement,E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277911)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000072879)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens), WDR78 DNHD1 DNAH7 DNAH11 DNAH5 HYDIN,BP,6,6 of 15,0.26,40,0.001887,0.01069
GO:0007188,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,E1BIL1(Evidence code:IBA/Database source:PANTHER:PTN000026392)F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN001954983)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001408)P04695(Evidence code:IEA/Database source:InterPro:IPR001408)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)P04696(Evidence code:IEA/Database source:InterPro:IPR001408)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)P63097(Evidence code:IEA/Database source:InterPro:IPR001408)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)P38408(Evidence code:IBA/Database source:PANTHER:PTN000026392), GNA12 RXFP3 GNAT3 GNAT1 CACNA1D GNAT2 PTH1R GNAI1 GNA13 GNA14,BP,10,10 of 42,0.44,23.81,0.001912,0.01082
GO:0051092,positive regulation of NF-kappaB transcription factor activity,F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)F1MBS7(Evidence code:IEA/Database source:InterPro:IPR033540)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens), TRIM14 PRKCB PRKCI TRAF6 MALT1 DHX9 IKBKG CAMK2A RPS6KA5,BP,9,9 of 35,0.39,25.71,0.002032,0.01147
GO:0000149,SNARE binding,E1BIU0(Evidence code:IEA/Database source:UniProtKB:P53992|ens)F1MV07(Evidence code:IEA/Database source:UniProtKB:O94855|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q0V8C2(Evidence code:IBA/Database source:PANTHER:PTN000480155)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q17QQ3(Evidence code:IEA/Database source:InterPro:IPR039077), SEC24C SEC24D BAIAP3 STX7 VAMP3 EXOC3 VAMP5 LRRK2 SNAP25,MF,9,9 of 35,0.39,25.71,0.002032,0.01147
GO:0001227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding",E1BE02(Evidence code:IEA/Database source:UniProtKB:Q6S7F2|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q17QV0(Evidence code:IEA/Database source:UniProtKB:P57722|ens)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens), E2F7 NFKB1 ZBTB4 HIC1 PURB PCBP3 NR2F6 ARHGAP35,MF,8,8 of 28,0.35,28.57,0.002047,0.01155
GO:0002102,podosome,F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), SH3PXD2A SH3GL1 CTTN SVIL SRC,CC,5,5 of 10,0.22,50,0.002144,0.01194
GO:0040018,positive regulation of multicellular organism growth,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), STAT5A CHD7 NIPBL STAT5B SPTBN4,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0046039,GTP metabolic process,E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826), RAB23 AMPD3 LRRK2 GTPBP1 RAN,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0007098,centrosome cycle,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BKZ3(Evidence code:IEA/Database source:InterPro:IPR031887)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404), CDK5RAP2 PCM1 SDCCAG8 CKAP5 ARL2,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0006306,DNA methylation,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR030487)Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q8C1A3)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), EHMT2 DNMT3A MTRR PPM1D KMT2A,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0061631,ubiquitin conjugating enzyme activity,Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)P61085(Evidence code:IDA/Database source:)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q3UE37|ens)Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q9D2M8|ens), UBE2D2 UBE2K BIRC6 UBE2Z UBE2V2,MF,5,5 of 10,0.22,50,0.002144,0.01194
GO:0043967,histone H4 acetylation,Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens), RUVBL2 EP400 LEF1 RUVBL1 BRCA2,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0007274,neuromuscular synaptic transmission,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q8VCR8|ens), KIF1B RAB3A ADARB1 CHRNE MYLK2,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0030968,endoplasmic reticulum unfolded protein response,F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)A7MBJ3(Evidence code:IBA/Database source:PANTHER:PTN000201758)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)E1BAK9(Evidence code:IBA/Database source:PANTHER:PTN000967687), UGGT2 EDEM2 DZIP3 ATF6B SYVN1,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0030131,clathrin adaptor complex,P63009(Evidence code:IEA/Database source:InterPro:IPR008152|I)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR003164|I)Q3ZC13(Evidence code:IEA/Database source:InterPro:IPR001392|I)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR008152|I)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR003164|I), AP2B1 AP2A2 AP2M1 AP2B1 AP2A1,CC,5,5 of 10,0.22,50,0.002144,0.01194
GO:0043401,steroid hormone mediated signaling pathway,Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)F1N3S3(Evidence code:IEA/Database source:GO:0003707)E1BJ93(Evidence code:IEA/Database source:GO:0030284)A2VDU4(Evidence code:IEA/Database source:GO:0003707)E1BC39(Evidence code:IEA/Database source:GO:0003707), ABHD2 NR2F6 LEF1 NR1I2 ESRRG,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0035307,positive regulation of protein dephosphorylation,A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q3T0W4(Evidence code:IEA/Database source:UniProtKB:Q15435|ens)E1BFD1(Evidence code:IEA/Database source:InterPro:IPR035007)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), PPP2R5A PTPA PPP1R7 ANKLE2 PINK1,BP,5,5 of 10,0.22,50,0.002144,0.01194
GO:0051091,positive regulation of DNA-binding transcription factor activity,P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)Q0III2(Evidence code:IEA/Database source:UniProtKB:O43462|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), KIT FZD1 COPS5 SRF MBTPS2 LRP6 PPP3CA STK3 TRAF6 TRIM14 PINK1 DDX58,BP,12,12 of 59,0.53,20.34,0.002264,0.01259
GO:0042752,regulation of circadian rhythm,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8VDP4|ens)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62140)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)Q28021(Evidence code:ISS/Database source:UniProtKB:P70336)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)P61287(Evidence code:ISS/Database source:UniProtKB:P36873), CCAR2 PPP1CB SFPQ PRKDC ROCK2 MAPK9 PPP1CC,BP,7,7 of 22,0.31,31.82,0.002335,0.01297
GO:0000045,autophagosome assembly,E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257)A4FUD7(Evidence code:IEA/Database source:UniProtKB:O35963|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), RAB23 NSFL1C RAB33B PSEN1 ATG2B UBQLN1,BP,6,6 of 16,0.26,37.5,0.002451,0.01355
GO:0032869,cellular response to insulin stimulus,F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q1JPG7(Evidence code:IBA/Database source:PANTHER:PTN000212861)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:Q8CGC7|ens)A6QLN6(Evidence code:IDA/Database source:), PRKCI PRKDC PKLR IRS1 EPRS MYH11,BP,6,6 of 16,0.26,37.5,0.002451,0.01355
GO:0034605,cellular response to heat,F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P17612)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), IER5 PRKACA MYOF FGF1 TPR PDCD6,BP,6,6 of 16,0.26,37.5,0.002451,0.01355
GO:0043407,negative regulation of MAP kinase activity,A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)A2VDU1(Evidence code:IEA/Database source:UniProtKB:Q9WTP2|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens), CBLC SORL1 DAB2IP PTPN6 SPRY4 RGS14,BP,6,6 of 16,0.26,37.5,0.002451,0.01355
GO:0046330,positive regulation of JNK cascade,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1N2S5(Evidence code:IEA/Database source:UniProtKB:Q8TEJ3|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens), STK3 TAOK3 TAOK2 DAB2IP SH3RF3 MAP3K10,BP,6,6 of 16,0.26,37.5,0.002451,0.01355
GO:1990825,sequence-specific mRNA binding,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q0VCX5(Evidence code:IEA/Database source:UniProtKB:P62495|ens), SSB DHX9 ETF1,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0016188,synaptic vesicle maturation,P11023(Evidence code:ISS/Database source:UniProtKB:P63011)P61763(Evidence code:ISS/Database source:UniProtKB:O08599)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027082), RAB3A STXBP1 UNC13A,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070016,armadillo repeat domain binding,E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens), STRN4 LEF1 STRN3,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0002084,protein depalmitoylation,Q3MHR0(Evidence code:IBA/Database source:PANTHER:PTN001639375)A5PKD9(Evidence code:IEA/Database source:UniProtKB:Q8VCV1|ens)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens), LYPLA1 ABHD17C ABHD12,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0007588,excretion,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)P31407(Evidence code:ISS/Database source:UniProtKB:P15313)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens), GRHPR ATP6V1B1 MLLT6,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0046849,bone remodeling,F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)Q27967(Evidence code:IEA/Database source:InterPro:IPR010892)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), LGR4 SPP2 TRAF6,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0071712,ER-associated misfolded protein catabolic process,Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens), UFD1L UGGT2 TOR1A,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0004370,glycerol kinase activity,F1MSV5(Evidence code:IEA/Database source:InterPro:IPR005999)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR005999)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR005999), GK2 GK LOC538702,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0016558,protein import into peroxisome matrix,E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens), PEX1 PEX10 PEX2,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0008376,acetylgalactosaminyltransferase activity,E1BMM8(Evidence code:IEA/Database source:InterPro:IPR008428)E1B9D0(Evidence code:IEA/Database source:InterPro:IPR008428)F1N0M7(Evidence code:IEA/Database source:InterPro:IPR008428), CHPF CHPF2 B4GALNT3,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0000146,microfilament motor activity,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357), MYO9B MYH14 MYO1D,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0000814,ESCRT II complex,Q5E9A6(Evidence code:IEA/Database source:InterPro:IPR008570)A5PK00(Evidence code:IEA/Database source:InterPro:IPR037855)Q08DR7(Evidence code:IEA/Database source:InterPro:IPR016689), VPS25 VPS36 SNF8,CC,3,3 of 2,0.13,150,0.002594,0.01359
GO:0000812,Swr1 complex,A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens)Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230), RUVBL1 EP400 RUVBL2,CC,3,3 of 2,0.13,150,0.002594,0.01359
GO:0007130,synaptonemal complex assembly,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens), RAD21L1 EHMT2 AGO4,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0021549,cerebellum development,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens), AGTPBP1 RPGRIP1L EN1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0030902,hindbrain development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5), GLI2 EN1 AHI1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0032510,endosome to lysosome transport via multivesicular body sorting pathway,Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1), LYST VPS4B UBXN6,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0019894,kinesin binding,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)A6QLI3(Evidence code:IEA/Database source:InterPro:IPR026198), MAPK8IP3 TOR1A GOLSYN,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070493,thrombin-activated receptor signaling pathway,A7YY44(Evidence code:IEA/Database source:InterPro:IPR003912)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens), F2R DGKQ IQGAP2,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0030122,AP-2 adaptor complex,Q17QC5(Evidence code:IEA/Database source:InterPro:IPR027156)Q0VCK5(Evidence code:IDA/Database source:)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens), AP2S1 AP2A2 EPS15,CC,3,3 of 2,0.13,150,0.002594,0.01359
GO:0046167,glycerol-3-phosphate biosynthetic process,F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q0IID9(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394), GK2 GK LOC538702,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0000403,Y-form DNA binding,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), WRN RAD18 BLM,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0002089,lens morphogenesis in camera-type eye,A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8K1H1)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens), TDRD7 MEIS1 SOX1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:1904778,positive regulation of protein localization to cell cortex,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), GPSM2 GNAI1 NUMA1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0060425,lung morphogenesis,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), SRF MAPK8IP3 FOXF1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0004687,myosin light chain kinase activity,E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN002389378)A4IFM7(Evidence code:IEA/Database source:EC:2.7.11.18), MYLK3 MYLK4 MYLK2,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0048008,platelet-derived growth factor receptor signaling pathway,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141), ABL1 PDGFC SRC,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070932,histone H3 deacetylation,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q2T9N9(Evidence code:IEA/Database source:GO:0032041), SFPQ SIRT2 HDAC5,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0030213,hyaluronan biosynthetic process,Q9XS26(Evidence code:IEA/Database source:InterPro:IPR026108)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)O97711(Evidence code:IEA/Database source:InterPro:IPR028371), HAS3 HYAL1 HAS2,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0035613,RNA stem-loop binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens), DHX9 EPRS RC3H2,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0031209,SCAR complex,Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens), ABI1 WASF2 NCKAP1,CC,3,3 of 2,0.13,150,0.002594,0.01359
GO:0004691,cAMP-dependent protein kinase activity,F1MY16(Evidence code:IEA/Database source:InterPro:IPR028852)P05131(Evidence code:IEA/Database source:InterPro:IPR039083)P00517(Evidence code:IEA/Database source:InterPro:IPR039035), AKAP13 PRKACB PRKACA,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0043984,histone H4-K16 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), KMT2A KANSL3 HCFC1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens), PIK3R4 TNFAIP8L3 VAV2,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070198,"protein localization to chromosome, telomeric region",F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), TERF2 TNKS ATRX,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0050501,hyaluronan synthase activity,O97711(Evidence code:IEA/Database source:InterPro:IPR028371)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q9XS26(Evidence code:IEA/Database source:InterPro:IPR026108), HAS2 HYAL1 HAS3,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070306,lens fiber cell differentiation,A7Z017(Evidence code:IBA/Database source:PANTHER:PTN000014690)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8K1H1)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), MAF TDRD7 NF2,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0030506,ankyrin binding,E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens), FLNC CACNA1D SPTBN4,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0031016,pancreas development,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), ONECUT2 GATA6 FOXF1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0007520,myoblast fusion,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)F1N3I4(Evidence code:IEA/Database source:InterPro:IPR029999)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens), CDON MYOF CAPN2,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0090162,establishment of epithelial cell polarity,F1MQV5(Evidence code:IEA/Database source:InterPro:IPR033561)E1BIQ8(Evidence code:IEA/Database source:InterPro:IPR031185)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), FBF1 MPP5 ARF6,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0090114,COPII-coated vesicle budding,Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR037550)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR037550)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596), SEC23B SEC23A SEC13,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0044295,axonal growth cone,Q9TRY0(Evidence code:ISS/Database source:UniProtKB:Q9QVC8)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens), FKBP4 TAOK2 RTN4R,CC,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070577,lysine-acetylated histone binding,F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440), ZMYND8 KMT2A BRD2,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0002011,morphogenesis of an epithelial sheet,Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), LIN7C MPP5 SRF,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0005112,Notch binding,F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens), AAK1 CUL3 DNER,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0005536,glucose binding,E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I), HK2 G6PD GCK,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0043968,histone H2A acetylation,F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens)Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens), EP400 RUVBL2 RUVBL1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0070569,uridylyltransferase activity,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)A5D9G1(Evidence code:IEA/Database source:InterPro:IPR002618)G3N337(Evidence code:IEA/Database source:InterPro:IPR002618), ZCCHC6 UAP1 UAP1L1,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0017075,syntaxin-1 binding,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A6QLI3(Evidence code:IEA/Database source:InterPro:IPR026198)Q17QQ3(Evidence code:IEA/Database source:InterPro:IPR039077), LRRK2 GOLSYN SNAP25,MF,3,3 of 2,0.13,150,0.002594,0.01359
GO:0031430,M band,A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q6PD03|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569), PPP2R5A SMTNL1 MYBPC3,CC,3,3 of 2,0.13,150,0.002594,0.01359
GO:0030953,astral microtubule organization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), DLG1 KPNB1 NUMA1,BP,3,3 of 2,0.13,150,0.002594,0.01359
GO:0010468,regulation of gene expression,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622075)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)A5PJL3(Evidence code:IBA/Database source:PANTHER:PTN000622075)P46196(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000620029)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622075)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)F1MVV5(Evidence code:IBA/Database source:PANTHER:PTN000622075)G3X793(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q3T0N5(Evidence code:IBA/Database source:PANTHER:PTN000622075)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MZQ1(Evidence code:IBA/Database source:PANTHER:PTN001004204)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)E1BKC4(Evidence code:IEA/Database source:InterPro:IPR033031)Q2NL22(Evidence code:IBA/Database source:PANTHER:PTN000619776)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)G3MY13(Evidence code:IEA/Database source:InterPro:IPR027008)Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR030487)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens), COL2A1 TAF10 MAPK9 CDK6 MAPK12 MAPK1 PIN1 EIF4A2 MAPK10 KDM6B BCL11B MEGF8 DDX3Y KMT2A INSM1 MAPK4 MAPK11 MAPK13 CDK3 PPP2CB MAPK8IP3 CHD8 ASH1L SAP130 GNB3 RC3H2 NIPBL EIF4A3 EN1 TSHZ1 DNMT3A CDK1 MAP3K4 GATA6 LRRK2 DDX3X RICTOR NPAT,BP,38,38 of 870,1.67,4.37,0.002695,0.01411
GO:0055007,cardiac muscle cell differentiation,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), ARID1A KDM6B GATA6 TBX3,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0042162,telomeric DNA binding,F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR013867|I)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR013867|I), SMG1 TERF1 SMG6 TERF2,MF,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0006878,cellular copper ion homeostasis,A6QR68(Evidence code:IEA/Database source:UniProtKB:Q8K211|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O08997|ens)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276), SLC31A1 ATP7B ATOX1 SCO1,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0000380,"alternative mRNA splicing, via spliceosome",Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q69ZA1)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens), DHX9 CDK13 SRSF1 SFPQ,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0071404,cellular response to low-density lipoprotein particle stimulus,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q9BDR7(Evidence code:ISS/Database source:UniProtKB:P20491)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P09055), ABCA1 FCER1G NPC1 ITGB1,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0048813,dendrite morphogenesis,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)Q3ZC25(Evidence code:ISS/Database source:UniProtKB:Q9NUM4)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens), CAMK2A TMEM106B ABI1 BTBD3,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0097431,mitotic spindle pole,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens), GPSM2 TNKS NUMA1 CDK5RAP2,CC,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0044319,"wound healing, spreading of cells",E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070), ARHGAP35 PDCD10 TOR1A CD44,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0035278,miRNA mediated inhibition of translation,F1MLT5(Evidence code:IEA/Database source:InterPro:IPR033499)F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)Q6T5B7(Evidence code:ISS/Database source:UniProtKB:Q9H9G7)Q9TU47(Evidence code:ISS/Database source:UniProtKB:P56537), TNRC6C AGO4 AGO3 EIF6,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0048536,spleen development,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens), KMT2A RC3H2 ABL1 BCL3,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:2000179,positive regulation of neural precursor cell proliferation,P63217(Evidence code:IEA/Database source:UniProtKB:Q80SZ7|ens)A6H767(Evidence code:ISS/Database source:UniProtKB:P28656)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens), GNG5 NAP1L1 INSM1 CDON,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0042733,embryonic digit morphogenesis,F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens), FREM2 GNA12 GLI2 TBX3,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0000054,ribosomal subunit export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q9TU47(Evidence code:IEA/Database source:UniRule:UR000107015)Q3T054(Evidence code:IBA/Database source:PANTHER:PTN000632582), XPO1 ABCE1 EIF6 RAN,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0005719,nuclear euchromatin,E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q91X20|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:Q02539|ens)G3MZY8(Evidence code:IEA/Database source:UniProtKB:P08775|ens), ASH2L POU4F2 HIST1H1A POLR2A,CC,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0051973,positive regulation of telomerase activity,E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)Q0VCK2(Evidence code:IEA/Database source:UniProtKB:Q9C010|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), TNKS MAP3K4 PKIB PTGES3,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0098693,regulation of synaptic vesicle cycle,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens), RAPGEF4 RAB3B BSN DNAJC5,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0043029,T cell homeostasis,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157), STAT5B RC3H2 STAT5A CACNA1F,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0016572,histone phosphorylation,E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519), HIPK4 CDK1 RPS6KA5 ATM,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0016236,macroautophagy,A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1), PIK3R4 CLN3 UBQLN1 UBXN6,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0060291,long-term synaptic potentiation,E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens), SHANK2 RGS14 SNAP25 BRAF,BP,4,4 of 6,0.18,66.67,0.00288,0.01478
GO:0022625,cytosolic large ribosomal subunit,F1N301(Evidence code:IBA/Database source:PANTHER:PTN000007073)Q24JY1(Evidence code:IBA/Database source:PANTHER:PTN000178698)Q3T057(Evidence code:IBA/Database source:PANTHER:PTN000205184)Q3T087(Evidence code:IBA/Database source:PANTHER:PTN000242048)Q32PB9(Evidence code:IBA/Database source:PANTHER:PTN000103359)Q56JY1(Evidence code:IBA/Database source:PANTHER:PTN000096770)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)P61356(Evidence code:IBA/Database source:PANTHER:PTN000052145)Q3SYR7(Evidence code:IBA/Database source:PANTHER:PTN000183647)Q3T0L7(Evidence code:IBA/Database source:PANTHER:PTN000057380), RPL22 RPL23A RPL23 RPL11 RPL38 RPL35A RPL30 RPL27 RPL9 RPL28,CC,10,10 of 45,0.44,22.22,0.002951,0.01504
GO:0002062,chondrocyte differentiation,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000942785)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), COL2A1 RUNX1 SHOX2 SNX19 GLI2,BP,5,5 of 11,0.22,45.45,0.002949,0.01504
GO:0045599,negative regulation of fat cell differentiation,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), ASXL1 WWTR1 E2F1 AXIN1 SIRT2,BP,5,5 of 11,0.22,45.45,0.002949,0.01504
GO:0001570,vasculogenesis,O97711(Evidence code:ISS/Database source:UniProtKB:P70312)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)Q3T099(Evidence code:IEA/Database source:UniProtKB:Q9CYK1|ens)E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), HAS2 FOXF1 WARS2 MYO18B SOX17,BP,5,5 of 11,0.22,45.45,0.002949,0.01504
GO:0005791,rough endoplasmic reticulum,Q8WN96(Evidence code:IDA/Database source:)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q56JX6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9TU34(Evidence code:IDA/Database source:)P61356(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), ITPR2 PSEN1 RPS28 ITPR1 RPL27,CC,5,5 of 11,0.22,45.45,0.002949,0.01504
GO:0000086,G2/M transition of mitotic cell cycle,F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens), BRSK2 TAF2 MASTL PPM1D CCNY,BP,5,5 of 11,0.22,45.45,0.002949,0.01504
GO:0042254,ribosome biogenesis,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q56JX6(Evidence code:ISS/Database source:UniProtKB:P62857)Q4PS77(Evidence code:IBA/Database source:PANTHER:PTN000119716)Q32LB9(Evidence code:IBA/Database source:PANTHER:PTN000119716)Q3T0R1(Evidence code:IBA/Database source:PANTHER:PTN000093238), XPO1 RPS28 MTG1 NOA1 RPS18,BP,5,5 of 11,0.22,45.45,0.002949,0.01504
GO:0046332,SMAD binding,E1BGE5(Evidence code:IEA/Database source:UniProtKB:O95373|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)P02465(Evidence code:IEA/Database source:UniProtKB:Q01149|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens), IPO7 COL5A2 PURB AXIN1 COL1A2 PURA,MF,6,6 of 17,0.26,35.29,0.003132,0.01592
GO:0010811,positive regulation of cell-substrate adhesion,P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q2TA37(Evidence code:IDA/Database source:)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), ALOX15 ARL2 JAK2 EMILIN1 FOXF1 NDNF,BP,6,6 of 17,0.26,35.29,0.003132,0.01592
GO:0016605,PML body,E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), SPTBN4 BLM WDFY3 ATRX PIAS1 TDG,CC,6,6 of 17,0.26,35.29,0.003132,0.01592
GO:0043085,positive regulation of catalytic activity,F1MHN4(Evidence code:IEA/Database source:GO:0008047)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)F1MF26(Evidence code:IEA/Database source:GO:0016176)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), RICTOR PSEN1 SH3PXD2A PHACTR4 MT3,BP,5,5 of 229,0.22,2.18,0.003233,0.01641
GO:0010564,regulation of cell cycle process,G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q9NUQ3|ens),TXLNG,BP,1,1 of 124,0.04,0.81,0.003353,0.017
GO:0050804,modulation of chemical synaptic transmission,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18052|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)A2VDQ6(Evidence code:IEA/Database source:UniProtKB:P55288|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens), PRKACA PPP3CA PTPRA BACE1 PACSIN2 BCR NLGN2 CDH11 RGS14 DNM1,BP,10,10 of 46,0.44,21.74,0.003382,0.01714
GO:0001525,angiogenesis,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997)A1A4M2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)P62248(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR029586)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037), WASF2 LEMD3 EMC10 CLIC4 NDNF GNA13 MYDGF HOXA7 SHC1 MEIS1 SOX17 PKNOX1 FGF1,BP,13,13 of 71,0.57,18.31,0.003395,0.01718
GO:0008289,lipid binding,Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)F1MXU5(Evidence code:IEA/Database source:InterPro:IPR002913)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q2NL34(Evidence code:ISS/Database source:UniProtKB:O75208)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q09139(Evidence code:IEA/Database source:InterPro:IPR000463|I)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A6QNK3(Evidence code:IEA/Database source:InterPro:IPR002913)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A6QQK8(Evidence code:IEA/Database source:InterPro:IPR031468)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)P55156(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)F1MIF5(Evidence code:IEA/Database source:InterPro:IPR000463|I)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q2HJ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)P02694(Evidence code:IEA/Database source:InterPro:IPR000463|I), AP2A2 STARD10 SNX8 COQ9 SH3GLB1 FABP7 AP2M1 STARD7 VPS36 TEX2 SH3GL1 PACSIN3 ZFYVE26 SNX3 MTTP RBP7 DYSF PACSIN2 CLINT1 MVB12A CHMP4A NSFL1C SNX27 PITPNA ALOX15 RBP1,MF,26,26 of 190,1.14,13.68,0.003451,0.01744
GO:0070925,organelle assembly,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 127,0.04,0.79,0.003452,0.01744
GO:0004197,cysteine-type endopeptidase activity,E1BL29(Evidence code:IEA/Database source:InterPro:IPR004134)Q08DY9(Evidence code:IEA/Database source:InterPro:IPR001309|I)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)F1MBS7(Evidence code:IEA/Database source:InterPro:IPR001309|I)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR001309|I)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)Q5E998(Evidence code:IBA/Database source:PANTHER:PTN000274640), BLMH CASP3 USP20 MALT1 CASP6 USP13 TINAGL1 CTSV,MF,8,8 of 31,0.35,25.81,0.003488,0.0176
GO:0009897,external side of plasma membrane,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens), LAMP1 CXCL12 FCER1G TFRC ITGB6 KCNMA1 ASTN1 KIT ABCA1,CC,9,9 of 39,0.39,23.08,0.003788,0.0191
GO:1903507,negative regulation of nucleic acid-templated transcription,A7YW45(Evidence code:IEA/Database source:GO:0003714)F1MHZ3(Evidence code:IEA/Database source:GO:0003714)Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80), PRMT5 NPAT NIF3L1,BP,3,3 of 180,0.13,1.67,0.003861,0.01945
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q2KJ77(Evidence code:IEA/Database source:UniProtKB:Q9NZL4|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395), PIAS1 PSEN1 LRRK2 HSPBP1 SIRT2 ANKIB1,BP,6,6 of 18,0.26,33.33,0.003945,0.01978
GO:0050661,NADP binding,Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)F1MMK2(Evidence code:IEA/Database source:InterPro:IPR022674|I)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144)O97764(Evidence code:IDA/Database source:)Q28007(Evidence code:IDA/Database source:), CRYM G6PD GAPDHS NOS2 CRYZ DPYD,MF,6,6 of 18,0.26,33.33,0.003945,0.01978
GO:0043473,pigmentation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q8BLY7|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens), KIT HPS6 EN1 LYST ARCN1,BP,5,5 of 12,0.22,41.67,0.003953,0.01978
GO:0051496,positive regulation of stress fiber assembly,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), NF2 S100A10 PAK1 BRAF ABL1,BP,5,5 of 12,0.22,41.67,0.003953,0.01978
GO:0043966,histone H3 acetylation,G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)A6QQ14(Evidence code:IEA/Database source:UniProtKB:Q9NR33|ens), BRD1 TAF10 LEF1 BRCA2 POLE4,BP,5,5 of 12,0.22,41.67,0.003953,0.01978
GO:2000378,negative regulation of reactive oxygen species metabolic process,E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), HK2 MT3 SIRT2 BCR PINK1,BP,5,5 of 12,0.22,41.67,0.003953,0.01978
GO:0004364,glutathione transferase activity,F1MUX5(Evidence code:IEA/Database source:InterPro:IPR003081)Q3SZ15(Evidence code:IBA/Database source:PANTHER:PTN000136167)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)A5PKM0(Evidence code:IEA/Database source:InterPro:IPR003081)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443), LOC100295687 EEF1E1 CLIC4 GSTM2 CLIC6,MF,5,5 of 12,0.22,41.67,0.003953,0.01978
GO:0050660,flavin adenine dinucleotide binding,E1BJA2(Evidence code:IEA/Database source:InterPro:IPR016156)O62768(Evidence code:IEA/Database source:InterPro:IPR016156)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144)Q148K4(Evidence code:IEA/Database source:InterPro:IPR004113|I)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q9UBK8)P48034(Evidence code:IEA/Database source:InterPro:IPR036318)E1BL62(Evidence code:IEA/Database source:InterPro:IPR036318), AIFM1 TXNRD1 NOS2 LDHD AIFM2 MTRR AOX1 AOX4,MF,8,8 of 32,0.35,25,0.00411,0.02055
GO:0022857,transmembrane transporter activity,E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006043)E1BI45(Evidence code:IEA/Database source:InterPro:IPR006043)Q3ZC26(Evidence code:IEA/Database source:InterPro:IPR001734)E1B968(Evidence code:IEA/Database source:InterPro:IPR002293)P02722(Evidence code:IEA/Database source:InterPro:IPR002113)E1B749(Evidence code:IEA/Database source:InterPro:IPR001734)G3N271(Evidence code:IEA/Database source:InterPro:IPR006043)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR005292)Q1JQC7(Evidence code:IEA/Database source:InterPro:IPR005828), LOC100298868 SLC23A1 SLC5A11 SLC7A2 SLC25A4 SLC5A9 LOC100337457 ABCC3 SLC22A23,MF,9,9 of 311,0.39,2.89,0.004259,0.02102
GO:0009953,dorsal/ventral pattern formation,D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens), Gli3 GLI2 EN1 GLI1,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1B9M8(Evidence code:IEA/Database source:InterPro:IPR033327), ALCAM TENM2 TENM3 SCARF2,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0001618,virus receptor activity,P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-1183)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-1183)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1183)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), ITGAV ITGB1 ITGB6 HYAL1,MF,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0032509,endosome transport via multivesicular body sorting pathway,E1BC70(Evidence code:IEA/Database source:InterPro:IPR037859)A6QP64(Evidence code:IEA/Database source:InterPro:IPR037859)Q3T178(Evidence code:IEA/Database source:InterPro:IPR007143)A5PK00(Evidence code:IEA/Database source:InterPro:IPR037855), VPS37C VPS37B VPS28 VPS36,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0007249,I-kappaB kinase/NF-kappaB signaling,E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q9WUL6|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216), BCL3 MAP3K14 TRAF6 NFKB1,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0001522,pseudouridine synthesis,F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I), RPUSD2 TRUB1 PUS10 PUS3,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q96AV8)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens), BCL3 ATRX E2F7 MYO6,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0090307,mitotic spindle assembly,A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)A7MBA1(Evidence code:IEA/Database source:UniProtKB:Q9BW19|ens), TUBGCP2 KPNB1 KIF2A KIFC1,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0003382,epithelial cell morphogenesis,Q765N9(Evidence code:ISS/Database source:UniProtKB:Q9Z0G9)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q58DW6(Evidence code:ISS/Database source:UniProtKB:Q9WTL2), CLDN3 FAT1 BCL11B RAB25,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0042060,wound healing,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), SCRIB PAK1 ALOX15 PTK7,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0051085,chaperone cofactor-dependent protein refolding,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR017378)A4FUH1(Evidence code:IEA/Database source:InterPro:IPR017378), HSPH1 DNAJC7 TOR1A TOR2A,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0048565,digestive tract development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens), FOXF1 KIT CHD8 PDGFC,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0070888,E-box binding,A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens), PRMT5 LMO2 SFPQ TCF7L2,MF,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0003785,actin monomer binding,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), MTSS1L MYL3 MKL1 TWF1,MF,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0086091,regulation of heart rate by cardiac conduction,E1BMA2(Evidence code:IBA/Database source:PANTHER:PTN000025645)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens), KCNH6 TRPM4 CACNA1D SCN2B,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0005092,GDP-dissociation inhibitor activity,E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)F1N2I0(Evidence code:IEA/Database source:InterPro:IPR018203)E1BIX7(Evidence code:IEA/Database source:UniProtKB:Q8VDU0|ens)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776), SH3BP4 CHML GPSM2 RGS14,MF,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0071004,U2-type prespliceosome,Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359237), SNRPN UHMK1 PRPF40A SNRNP70,CC,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0001890,placenta development,E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens), ETV2 E2F7 BIRC6 MAP3K4,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0051402,neuron apoptotic process,E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens), NAE1 PIGT PSEN1 AIFM1,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0070207,protein homotrimerization,Q95JC7(Evidence code:ISS/Database source:UniProtKB:Q15758)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens), SLC1A5 TCL1A PNPT1 EMILIN1,BP,4,4 of 7,0.18,57.14,0.00429,0.02102
GO:0045444,fat cell differentiation,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)Q3T112(Evidence code:ISS/Database source:UniProtKB:P28062)A6QNT4(Evidence code:IBA/Database source:PANTHER:PTN000410115)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens), NIPBL PSMB8 FAM120B ARL6 CEBPA PIAS1 ALMS1 STEAP4,BP,8,8 of 33,0.35,24.24,0.004816,0.02322
GO:0042593,glucose homeostasis,O02754(Evidence code:ISS/Database source:UniProtKB:P53566)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), CEBPA DBH SIRT6 GCK SOX4 PFKM ALMS1 STAT3,BP,8,8 of 33,0.35,24.24,0.004816,0.02322
GO:0043022,ribosome binding,Q9TU47(Evidence code:IEA/Database source:InterPro:IPR002769)Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR016020)Q32KZ1(Evidence code:IBA/Database source:PANTHER:PTN000101471)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), EIF6 EIF3K MTIF3 GCN1L1 EIF5A2 RICTOR,MF,6,6 of 19,0.26,31.58,0.004905,0.02322
GO:0045177,apical part of cell,F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), PRKCI TJP1 CLIC4 CUBN NF2 PCM1,CC,6,6 of 19,0.26,31.58,0.004905,0.02322
GO:0006909,phagocytosis,P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)A4FUD6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)P67827(Evidence code:IBA/Database source:PANTHER:PTN000225967)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581), ITGAL ELMO2 ABL1 CDC42SE2 CSNK1A1 DNM2,BP,6,6 of 19,0.26,31.58,0.004905,0.02322
GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",F1MHR3(Evidence code:IEA/Database source:InterPro:IPR016163)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR016163)P48644(Evidence code:IEA/Database source:InterPro:IPR016163)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR016163)A7YY67(Evidence code:IEA/Database source:InterPro:IPR016163)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424|I), ALDH1A3 ALDH1L2 ALDH1A1 ALDH9A1 ALDH1L1 GAPDHS,MF,6,6 of 19,0.26,31.58,0.004905,0.02322
GO:0050770,regulation of axonogenesis,E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000685295)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)F1MXV4(Evidence code:IEA/Database source:UniProtKB:Q8C0T5|ens)E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000685295)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens), PAK3 SSH2 SIPA1L1 KIF13B PAK1 ARHGAP35,BP,6,6 of 19,0.26,31.58,0.004905,0.02322
GO:1990869,cellular response to chemokine,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens), WNK1 CXCL12 SLC12A2,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0030137,COPI-coated vesicle,A0JN39(Evidence code:IEA/Database source:UniProtKB:Q9JIF7|ens)Q28104(Evidence code:IEA/Database source:UniProtKB:O89079|ens)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens), COPB1 COPE ARCN1,CC,3,3 of 3,0.13,100,0.004933,0.02322
GO:0043589,skin morphogenesis,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SRF COL1A2 PSEN1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0048407,platelet-derived growth factor binding,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens), COL4A1 COL1A2 COL2A1,MF,3,3 of 3,0.13,100,0.004933,0.02322
GO:0009298,GDP-mannose biosynthetic process,Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR016305)Q2YDJ9(Evidence code:ISS/Database source:UniProtKB:Q9Y5P6)Q3SZJ9(Evidence code:IEA/Database source:InterPro:IPR005002), MPI GMPPB PMM2,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0097094,craniofacial suture morphogenesis,E1BN52(Evidence code:IEA/Database source:UniProtKB:Q5H8C1|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:Q7Z7M0|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens), FREM1 MEGF8 RAB23,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0030296,protein tyrosine kinase activator activity,G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)Q0VCW2(Evidence code:IEA/Database source:InterPro:IPR028456), PAK2 AFAP1L2 ABI1,MF,3,3 of 3,0.13,100,0.004933,0.02322
GO:0030970,"retrograde protein transport, ER to cytosol",Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens)F1MGK3(Evidence code:IBA/Database source:PANTHER:PTN000395729)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), UFD1L ERLEC1 SYVN1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0060561,apoptotic process involved in morphogenesis,P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), CRYAB SCRIB LEF1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0007099,centriole replication,G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR033700), CCP110 CDK5RAP2 PLK4,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0006303,double-strand break repair via nonhomologous end joining,E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)E1BJF4(Evidence code:IBA/Database source:PANTHER:PTN000035348), PRKDC PSMD14 POLA1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0048675,axon extension,P85091(Evidence code:ISS/Database source:UniProtKB:Q7L576)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), CYFIP1 USP9X POU4F2,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0042789,mRNA transcription by RNA polymerase II,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), SOX17 LMO2 SRF,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0006207,de novo pyrimidine nucleobase biosynthetic process,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR002082|I)P31754(Evidence code:IEA/Database source:InterPro:IPR001754|I)F1ML89(Evidence code:IEA/Database source:InterPro:IPR006274), CAD UMPS CPS1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0010801,negative regulation of peptidyl-threonine phosphorylation,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), EIF4G1 DGKQ SIRT2,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0045056,transcytosis,A2VE13(Evidence code:IEA/Database source:InterPro:IPR033240)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), MAL2 VPS35 RAB17,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0006825,copper ion transport,F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)Q3T0E0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0187), ATP7B SCO1 ATOX1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0031641,regulation of myelination,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), SIRT2 KIF14 DLG1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0008474,palmitoyl-(protein) hydrolase activity,A5PKD9(Evidence code:IEA/Database source:EC:3.1.2.22)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)Q3MHR0(Evidence code:ISS/Database source:UniProtKB:O75608), ABHD17C ABHD12 LYPLA1,MF,3,3 of 3,0.13,100,0.004933,0.02322
GO:0034122,negative regulation of toll-like receptor signaling pathway,F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens), LGR4 SMPDL3B OTUD4,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0048709,oligodendrocyte differentiation,F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens), PTPRZ1 TSPAN2 CNP,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0070863,positive regulation of protein exit from endoplasmic reticulum,Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)F1MPT8(Evidence code:IEA/Database source:UniProtKB:Q3MIR4|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), TMEM30A TMEM30B SORL1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0021591,ventricular system development,E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7), HYDIN TTC21B RAPGEF2,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0097194,execution phase of apoptosis,Q3T0P5(Evidence code:IEA/Database source:GO:0097200)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000825206)F1MN90(Evidence code:ISS/Database source:UniProtKB:Q96AQ7), CASP6 CASP3 CIDEC,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0070971,endoplasmic reticulum exit site,A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), SEC23A PDCD6IP PDCD6,CC,3,3 of 3,0.13,100,0.004933,0.02322
GO:0046755,viral budding,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens), CHMP4B PDCD6IP TSG101,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0008331,high voltage-gated calcium channel activity,F1MP22(Evidence code:IBA/Database source:PANTHER:PTN000004694)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157), CACNA1E CACNA1D CACNA1F,MF,3,3 of 3,0.13,100,0.004933,0.02322
GO:0000800,lateral element,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens), RAD21L1 BLM BRCA2,CC,3,3 of 3,0.13,100,0.004933,0.02322
GO:0031584,activation of phospholipase D activity,G5E6P3(Evidence code:IBA/Database source:PANTHER:PTN000026718)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)G3N3N1(Evidence code:IDA/Database source:), GNA13 ARL1 ARF6,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0006855,drug transmembrane transport,E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334), ATP8B1 TMEM30A ABCC3,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0006729,tetrahydrobiopterin biosynthetic process,Q17QK8(Evidence code:IEA/Database source:InterPro:IPR006393)Q3ZBD3(Evidence code:IEA/Database source:InterPro:IPR001533|I)Q3T0Z7(Evidence code:ISS/Database source:UniProtKB:P11348), SPR PCBD1 QDPR,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0048557,embryonic digestive tract morphogenesis,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), SHOX2 NIPBL FOXF1,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0036010,protein localization to endosome,Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), TMEM30A PACSIN2 ARF6,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0035267,NuA4 histone acetyltransferase complex,Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR037942)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR037938)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens), RUVBL2 RUVBL1 EP400,CC,3,3 of 3,0.13,100,0.004933,0.02322
GO:2000009,negative regulation of protein localization to cell surface,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), SNX33 TAX1BP3 ARF6,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0043149,stress fiber assembly,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), SRF CUL3 SRC,BP,3,3 of 3,0.13,100,0.004933,0.02322
GO:0072687,meiotic spindle,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)F1N3C9(Evidence code:IEA/Database source:UniProtKB:Q8BS90|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), RPS6KA2 BORA SIRT2,CC,3,3 of 3,0.13,100,0.004933,0.02322
GO:0043068,positive regulation of programmed cell death,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 121,0.04,0.83,0.005005,0.02354
GO:0031072,heat shock protein binding,Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)P26882(Evidence code:IEA/Database source:UniProtKB:Q08752|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR001305)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens), FKBP4 DNAJC7 FKBP5 PPID TPR DNAJA2 BCOR,MF,7,7 of 26,0.31,26.92,0.005068,0.02379
GO:0031398,positive regulation of protein ubiquitination,Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)Q2KJ77(Evidence code:IEA/Database source:UniProtKB:Q9NZL4|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), MAPK9 LRRK2 PTTG1IP fgfr3 CUL3 HSPBP1 UBQLN1,BP,7,7 of 26,0.31,26.92,0.005068,0.02379
GO:0051493,regulation of cytoskeleton organization,Q27971(Evidence code:IEA/Database source:InterPro:IPR029539),CAPN2,BP,1,1 of 122,0.04,0.82,0.005104,0.02392
GO:0033993,response to lipid,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 122,0.04,0.82,0.005104,0.02392
GO:0071479,cellular response to ionizing radiation,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q6PIW4|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), INO80 FIGNL1 GRB2 TNKS1BP1 BLM,BP,5,5 of 13,0.22,38.46,0.005178,0.02418
GO:0016234,inclusion body,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), LRRK2 BAG5 WDFY3 MT3 PRNP,CC,5,5 of 13,0.22,38.46,0.005178,0.02418
GO:0032781,positive regulation of ATPase activity,Q2HJ94(Evidence code:IEA/Database source:GO:0001671)Q2KIT4(Evidence code:IEA/Database source:GO:0001671)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)A6QLM8(Evidence code:IEA/Database source:GO:0001671)Q3MI00(Evidence code:IEA/Database source:GO:0001671), DNAJA2 DNAJB4 DNAJB2 HSCB DNAJB1,BP,5,5 of 13,0.22,38.46,0.005178,0.02418
GO:0000028,ribosomal small subunit assembly,A5PK63(Evidence code:IBA/Database source:PANTHER:PTN000077142)Q2KHT7(Evidence code:IBA/Database source:PANTHER:PTN000174285)Q56JX6(Evidence code:IBA/Database source:PANTHER:PTN000080571)Q3T0B7(Evidence code:IBA/Database source:PANTHER:PTN000174285)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), RPS17 RPS27 RPS28 RPS27L RPS19,BP,5,5 of 13,0.22,38.46,0.005178,0.02418
GO:0005788,endoplasmic reticulum lumen,F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A1A4M8(Evidence code:IEA/Database source:UniProtKB:Q9ER38|ens)A5PK45(Evidence code:ISS/Database source:UniProtKB:Q8NBJ5)Q0VD36(Evidence code:IEA/Database source:UniProtKB:Q9JHP7|ens)F1MGK3(Evidence code:IEA/Database source:UniProtKB:Q96DZ1|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)A4FUH1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), TOR1B DNAJB11 TOR3A COLGALT1 KDELC1 ERLEC1 TOR1A TOR2A,CC,8,8 of 34,0.35,23.53,0.00561,0.02617
GO:0005543,phospholipid binding,Q0IIM2(Evidence code:IDA/Database source:)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR037302)E1BNB7(Evidence code:IEA/Database source:UniProtKB:Q9UNA1|ens)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens)F1MP30(Evidence code:IEA/Database source:InterPro:IPR037302)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BLT3(Evidence code:IEA/Database source:InterPro:IPR001605)A6QQP7(Evidence code:ISS/Database source:UniProtKB:O75923)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)F1MKE9(Evidence code:IEA/Database source:InterPro:IPR001605)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR028555)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q8TCU6|ens)F1MK99(Evidence code:IEA/Database source:InterPro:IPR037302)G3MZN6(Evidence code:IEA/Database source:InterPro:IPR001605), ARL6 UNC13C ARHGAP26 MYOF UNC13B PRKCI SPTBN4 DYSF BAIAP3 ARHGAP35 SPTB RASAL1 PREX1 UNC13A PSD2,MF,15,15 of 94,0.66,15.96,0.006008,0.0279
GO:0009566,fertilization,Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551), CLIC4 RAD21L1 EHMT2 SPTBN4 FNDC3A TDRD9 KLHL26,BP,7,7 of 27,0.31,25.93,0.006024,0.0279
GO:0050728,negative regulation of inflammatory response,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens), ASH1L FOXF1 SMPDL3B NFKB1 BCR VPS35 ADORA2A,BP,7,7 of 27,0.31,25.93,0.006024,0.0279
GO:0015991,ATP hydrolysis coupled proton transport,P11019(Evidence code:IEA/Database source:InterPro:IPR002842)P21282(Evidence code:IEA/Database source:InterPro:IPR004907|I)P23956(Evidence code:IEA/Database source:InterPro:IPR000245|I)P31407(Evidence code:IEA/Database source:InterPro:IPR005723)O46563(Evidence code:IEA/Database source:InterPro:IPR004908|I)P61420(Evidence code:IEA/Database source:InterPro:IPR016727), ATP6V1E1 ATP6V1C1 ATP6V0C ATP6V1B1 ATP6V1H ATP6V0D1,BP,6,6 of 20,0.26,30,0.006024,0.0279
GO:0002181,cytoplasmic translation,Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q3SYR7(Evidence code:IBA/Database source:PANTHER:PTN000183645)F1N301(Evidence code:IBA/Database source:PANTHER:PTN000007073)Q56JY1(Evidence code:IBA/Database source:PANTHER:PTN000096770)Q56JX6(Evidence code:ISS/Database source:UniProtKB:P62857)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848), RPL30 RPL9 RPL22 RPL35A RPS28 RPS7,BP,6,6 of 20,0.26,30,0.006024,0.0279
GO:0070936,protein K48-linked ubiquitination,A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863)Q1RMX2(Evidence code:ISS/Database source:UniProtKB:P62837)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)P61085(Evidence code:ISS/Database source:UniProtKB:P61086), ITCH UBE2D2 RFFL UBE2G2 SYVN1 UBE2K,BP,6,6 of 20,0.26,30,0.006024,0.0279
GO:0001822,kidney development,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:E9PZ36|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)Q32LG4(Evidence code:IEA/Database source:InterPro:IPR032985)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens), PYGO2 PKHD1 RPGRIP1L ROBO2 GLI2 GREB1L,BP,6,6 of 20,0.26,30,0.006024,0.0279
GO:0009653,anatomical structure morphogenesis,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)A6QLP0(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MC99(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MZD0(Evidence code:IBA/Database source:PANTHER:PTN001170450)F1MBH4(Evidence code:IBA/Database source:PANTHER:PTN001371846), ONECUT2 FOXO4 FOXI3 FBN3 FOXF1,BP,5,5 of 217,0.22,2.3,0.005986,0.0279
GO:0008589,regulation of smoothened signaling pathway,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), GLI2 ARL6 TTC21B RPGRIP1L,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0072583,clathrin-dependent endocytosis,Q08DF4(Evidence code:IEA/Database source:InterPro:IPR027741)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR017104)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR017104)P04973(Evidence code:IBA/Database source:PANTHER:PTN000067451), DNM1 AP2A2 AP2A1 CLTA,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0006541,glutamine metabolic process,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006274)Q08DQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0315)F1ML89(Evidence code:IEA/Database source:InterPro:IPR006274)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0315), CAD GFPT2 CPS1 ASNS,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0043627,response to estrogen,P01175(Evidence code:IDA/Database source:)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens), OXT ASH2L GATA6 ZNF366,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0043014,alpha-tubulin binding,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), INO80 RACGAP1 HSPH1 SPAST,MF,4,4 of 8,0.18,50,0.0061,0.02796
GO:0000792,heterochromatin,A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), UHRF1 SALL4 TOP2B ATRX,CC,4,4 of 8,0.18,50,0.0061,0.02796
GO:0030282,bone mineralization,A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)P27479(Evidence code:ISS/Database source:UniProtKB:P39654), SBNO2 AXIN2 LGR4 ALOX15,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0060348,bone development,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)A2VDS0(Evidence code:IEA/Database source:UniProtKB:Q8R574|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens), COL2A1 PDGFC PRPSAP2 ASXL1,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0043548,phosphatidylinositol 3-kinase binding,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), LCK DAB2IP IRS4 IRS1,MF,4,4 of 8,0.18,50,0.0061,0.02796
GO:0014065,phosphatidylinositol 3-kinase signaling,E1BKJ6(Evidence code:IEA/Database source:InterPro:IPR026722)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BE66(Evidence code:IEA/Database source:UniProtKB:O00329|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), NYAP1 SIRT2 PIK3CD IRS1,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0004864,protein phosphatase inhibitor activity,A7Z026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0650)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BPZ4(Evidence code:IEA/Database source:InterPro:IPR008466)F1N1P8(Evidence code:IEA/Database source:InterPro:IPR026130), PPP1R37 LMTK2 PPP1R1C PPP1R26,MF,4,4 of 8,0.18,50,0.0061,0.02796
GO:0030866,cortical actin cytoskeleton organization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MGX4(Evidence code:IEA/Database source:UniProtKB:O95466|ens)F1N611(Evidence code:IEA/Database source:InterPro:IPR007477)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), DLG1 FMNL1 EPB41L1 ARF6,BP,4,4 of 8,0.18,50,0.0061,0.02796
GO:0008610,lipid biosynthetic process,Q32PF2(Evidence code:ISS/Database source:UniProtKB:P53396)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens), ACLY ACSS2,BP,2,2 of 142,0.09,1.41,0.006321,0.02895
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)Q2KHV3(Evidence code:ISS/Database source:UniProtKB:Q99732)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404), MAP3K14 LITAF F2R TRAF6 PINK1 ANKRD17 ABL1 S100B IKBKG PRKCB,BP,10,10 of 51,0.44,19.61,0.006347,0.02904
GO:0000781,"chromosome, telomeric region",F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)E1BGK8(Evidence code:IEA/Database source:GO:0006348)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q3MHY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0779)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens), TERF2 BLM RIF1 WRN DOT1L ATM TERF1 TNKS,CC,8,8 of 35,0.35,22.86,0.0065,0.02971
GO:0031492,nucleosomal DNA binding,E1BC56(Evidence code:IEA/Database source:InterPro:IPR000079)A5PK61(Evidence code:IBA/Database source:PANTHER:PTN000152096)E1BGN3(Evidence code:IBA/Database source:PANTHER:PTN000152096)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)G3MYD7(Evidence code:IBA/Database source:PANTHER:PTN000152096), LOC785479 H3F3C HIST2H3D H3F3B LOC100297725,MF,5,5 of 14,0.22,35.71,0.00665,0.03032
GO:0070063,RNA polymerase binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q28165(Evidence code:ISS/Database source:UniProtKB:Q8CCS6), DHX9 BRCA1 TAF10 NEDD4 PABPN1,MF,5,5 of 14,0.22,35.71,0.00665,0.03032
GO:0046580,negative regulation of Ras protein signal transduction,F1MBI8(Evidence code:IEA/Database source:InterPro:IPR037779)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR028555|I)E1BB77(Evidence code:IBA/Database source:PANTHER:PTN000022879)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens), SYNGAP1 RASAL2 RASAL1 DAB2IP STAMBP,BP,5,5 of 14,0.22,35.71,0.00665,0.03032
GO:0050778,positive regulation of immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 112,0.04,0.89,0.007033,0.03201
GO:0006875,cellular metal ion homeostasis,P37359(Evidence code:IEA/Database source:UniProtKB:P28184|ens),MT3,BP,1,1 of 111,0.04,0.9,0.00703,0.03201
GO:0005254,chloride channel activity,Q6BBL6(Evidence code:ISS/Database source:UniProtKB:O35054)P35071(Evidence code:IEA/Database source:InterPro:IPR009147)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869), CLDN4 CFTR CLCC1 GABRA5 BEST3 CLIC6 CLIC4,MF,7,7 of 28,0.31,25,0.007107,0.03232
GO:0019722,calcium-mediated signaling,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)F1N6C0(Evidence code:IEA/Database source:InterPro:IPR039030)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens), ALMS1 CALM1 PPP3CA TRPM4 LRRK2 TPCN2,BP,6,6 of 21,0.26,28.57,0.007319,0.0332
GO:1901800,positive regulation of proteasomal protein catabolic process,P62194(Evidence code:IEA/Database source:GO:0036402)Q1JP95(Evidence code:IEA/Database source:GO:0036402)Q2KIW6(Evidence code:IEA/Database source:GO:0036402)A4FUZ3(Evidence code:IEA/Database source:GO:0036402)Q5E9F9(Evidence code:IEA/Database source:GO:0036402)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), PSMC5 PSMC3 PSMC6 PSMC1 PSMC2 DAB2IP,BP,6,6 of 21,0.26,28.57,0.007319,0.0332
GO:0045995,regulation of embryonic development,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9WVM1|ens)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:G5E870)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), RACGAP1 TRIP12 SOX17 NIPBL LAMA3 TDG,BP,6,6 of 21,0.26,28.57,0.007319,0.0332
GO:0030658,transport vesicle membrane,P15101(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QL5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P05059(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9TU34(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P56722(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P23389(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q8WN96(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10897(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), DBH TMEM184A TMEM30A CHGA ITPR1 PTPRN CHGB ITPR2 CYB561,CC,9,9 of 44,0.39,20.45,0.00744,0.03371
GO:0045504,dynein heavy chain binding,Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277823)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277823), DYNC1I2 DYNC1LI1 WDR78,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0050919,negative chemotaxis,F1MYW3(Evidence code:IBA/Database source:PANTHER:PTN000744245)G3MYK9(Evidence code:IBA/Database source:PANTHER:PTN000744245)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), SEMA3E SEMA3G SLIT2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0016235,aggresome,Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens), PSEN1 UBQLN1 EPS15,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0071480,cellular response to gamma radiation,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), ATM CRYAB WRN,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0051569,regulation of histone H3-K4 methylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens), KMT2A KMT2B PYGO2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0071889,14-3-3 protein binding,E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A5PJP0(Evidence code:IEA/Database source:UniProtKB:Q9NU19|ens), KIF13B DAB2IP TBC1D22B,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0032463,negative regulation of protein homooligomerization,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens), SRC CRYAB VPS35,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0050918,positive chemotaxis,F1N0Y5(Evidence code:IEA/Database source:GO:0042056)Q0P5I9(Evidence code:IEA/Database source:GO:0042056)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens), COLEC10 CXCL12 SCRIB,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0030507,spectrin binding,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens), SPTBN4 DCTN2 PTPRN,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0031054,pre-miRNA processing,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3), ZCCHC6 AGO4 DICER1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0021680,cerebellar Purkinje cell layer development,A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens), AARS AGTPBP1 SEZ6L2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0030513,positive regulation of BMP signaling pathway,F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000007601)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens), GATA6 RNF165 NUMA1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0000242,pericentriolar material,Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), LCK CDK5RAP2 PCM1,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0048268,clathrin coat assembly,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q0VCK5(Evidence code:IC/Database source:GO:0030122)P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens), EPS15 AP2A2 CLTA,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0031527,filopodium membrane,F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:O75781|ens), UTRN ARF6 PALM,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0035116,embryonic hindlimb morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), CHD7 TBX3 RPGRIP1L,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0000794,condensed nuclear chromosome,E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens), LRPPRC CHMP1A RAD21L1,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0033077,T cell differentiation in thymus,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), PRKDC CDK6 BCL11B,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:2000010,positive regulation of protein localization to cell surface,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens), GPD1L FCER1G SNX33,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0001921,positive regulation of receptor recycling,Q2KJD2(Evidence code:ISS/Database source:UniProtKB:P63024)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), VAMP3 SCRIB PSEN1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0035999,tetrahydrofolate interconversion,Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR001085)A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens)Q5I598(Evidence code:ISS/Database source:UniProtKB:P42898), SHMT2 MTHFD1 MTHFR,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0001731,formation of translation preinitiation complex,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)A6QLG1(Evidence code:IBA/Database source:PANTHER:PTN000513830)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens), EIF4H LOC515358 MCTS1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:1990111,spermatoproteasome complex,Q3T0T1(Evidence code:ISS/Database source:UniProtKB:O35955)Q3T112(Evidence code:ISS/Database source:UniProtKB:P28063)Q3SZC2(Evidence code:ISS/Database source:UniProtKB:P28076), PSMB10 PSMB8 PSMB9,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0060272,embryonic skeletal joint morphogenesis,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens), SHOX2 AXIN1 COL2A1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0003810,protein-glutamine gamma-glutamyltransferase activity,Q6TNF3(Evidence code:IEA/Database source:InterPro:IPR008958|I)P51176(Evidence code:IEA/Database source:InterPro:IPR008958|I)A6QP57(Evidence code:IEA/Database source:InterPro:IPR008958|I), TGM1 TGM2 TGM3,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0035019,somatic stem cell population maintenance,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens), BRAF BCL9 BCL9L,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0010458,exit from mitosis,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), SPAST CHMP2A CHMP4B,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:1903361,protein localization to basolateral plasma membrane,Q0P5F3(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN001019267), LIN7C LIN7A LIN7B,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0044257,cellular protein catabolic process,A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MLZ5(Evidence code:IEA/Database source:UniProtKB:A2RT67|ens), UBE4B DAB2IP DENND3,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0030517,negative regulation of axon extension,G3MYK9(Evidence code:IEA/Database source:UniProtKB:Q4LFA9|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens), SEMA3G MT3 RTN4R,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0072357,PTW/PP1 phosphatase complex,P61287(Evidence code:ISS/Database source:UniProtKB:P36873)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR037979)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q80W00|ens), PPP1CC PPP1CB PPP1R10,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0050908,detection of light stimulus involved in visual perception,P04696(Evidence code:IEA/Database source:UniProtKB:P19087|ens)E1B9S9(Evidence code:IEA/Database source:UniProtKB:O60840|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P11488|ens), GNAT2 CACNA1F GNAT1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0032012,regulation of ARF protein signal transduction,F1MIM9(Evidence code:IEA/Database source:InterPro:IPR000904|I)O46382(Evidence code:IEA/Database source:InterPro:IPR000904|I)G3MZN6(Evidence code:IEA/Database source:InterPro:IPR000904|I), IQSEC2 ARFGEF1 PSD2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0045116,protein neddylation,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)E1B8X4(Evidence code:IEA/Database source:InterPro:IPR030667)A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081), LOC780968 NAE1 UBE2M,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0004407,histone deacetylase activity,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320|I), SIRT2 MIER1 HDAC5,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:2000778,positive regulation of interleukin-6 secretion,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), DHX9 F2R DDX58,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0008239,dipeptidyl-peptidase activity,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)G5E657(Evidence code:IBA/Database source:PANTHER:PTN000110021)E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180), DPP4 PRSS16 DPEP3,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0070914,UV-damage excision repair,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)A4IFU5(Evidence code:IEA/Database source:UniProtKB:Q7L7L0|ens), INO80 ACTR5 HIST3H2A,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0090503,"RNA phosphodiester bond hydrolysis, exonucleolytic",E1BIQ0(Evidence code:IEA/Database source:GO:0000175)E1BML0(Evidence code:IEA/Database source:GO:0004535)Q0II50(Evidence code:IEA/Database source:GO:0000175), PNPT1 PAN2 USB1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0070578,RISC-loading complex,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), AGO4 DICER1 DHX9,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0034453,microtubule anchoring,E1BC48(Evidence code:IEA/Database source:InterPro:IPR028750)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens), CEP350 PCM1 GCC2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0032588,trans-Golgi network membrane,F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens), ATP7B ARFIP1 BAIAP3,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0001553,luteinization,P56722(Evidence code:ISS/Database source:UniProtKB:Q60673)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), PTPRN STAT5A STAT5B,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0006337,nucleosome disassembly,E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)A4IFU5(Evidence code:IEA/Database source:UniProtKB:Q7L7L0|ens), ARID1A HIST1H2BA HIST3H2A,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0035640,exploration behavior,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens), KMT2A LRRK2 SHANK2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0005154,epidermal growth factor receptor binding,A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens), CBLC VAV2 GRB2,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0031674,I band,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens), SMTNL1 RYR1 MYL3,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0090557,establishment of endothelial intestinal barrier,Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens), F11R RAPGEF2 RAP2C,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0032433,filopodium tip,E1BMW2(Evidence code:IEA/Database source:UniProtKB:P17426|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)P61085(Evidence code:IEA/Database source:UniProtKB:P61087|ens), AP2A1 ABI1 UBE2K,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0007616,long-term memory,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), RGS14 CHD8 SHANK1,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0046329,negative regulation of JNK cascade,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens), DUSP3 ITCH TAOK3,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0005086,ARF guanyl-nucleotide exchange factor activity,G3MZN6(Evidence code:IEA/Database source:InterPro:IPR000904|I)F1MIM9(Evidence code:IEA/Database source:InterPro:IPR000904|I)O46382(Evidence code:IEA/Database source:InterPro:IPR000904|I), PSD2 IQSEC2 ARFGEF1,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0016514,SWI/SNF complex,E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR038040)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR030088), ARID1B ARID1A SMARCA2,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0019869,chloride channel inhibitor activity,P35071(Evidence code:ISS/Database source:UniProtKB:P13569)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens), CFTR WNK1 STX7,MF,3,3 of 4,0.13,75,0.00821,0.03543
GO:0042246,tissue regeneration,F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700439)Q2TA30(Evidence code:IEA/Database source:InterPro:IPR007007)G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q3UVD5|ens), TEC NINJ1 LGR6,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0042612,MHC class I protein complex,A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490), LOC100125916 LOC788634 BoLA,CC,3,3 of 4,0.13,75,0.00821,0.03543
GO:0048477,oogenesis,F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens), DDX20 SRC PIWIL2,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0000185,activation of MAPKKK activity,Q3SWY6(Evidence code:IEA/Database source:GO:0008349)F1N5W5(Evidence code:IEA/Database source:GO:0008349)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), STK25 STK26 DAB2IP,BP,3,3 of 4,0.13,75,0.00821,0.03543
GO:0019902,phosphatase binding,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MWN4(Evidence code:IEA/Database source:UniProtKB:A8K8P3|ens)F1N1P8(Evidence code:IBA/Database source:PANTHER:PTN000404500)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens), DLG1 SFI1 PPP1R26 SPTBN4 TSC2 DZIP3 WNK1,MF,7,7 of 29,0.31,24.14,0.008329,0.03556
GO:0048863,stem cell differentiation,E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens), HOXA7 FOXO4 KIT SOX17 PUM1,BP,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0042476,odontogenesis,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)G3N201(Evidence code:IEA/Database source:UniProtKB:Q8C3L1|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens), AQP5 LAMB1 SSUH2 AXIN2 BCOR,BP,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0045104,intermediate filament cytoskeleton organization,P67827(Evidence code:ISS/Database source:UniProtKB:P48729)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR030634)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)G3MXL3(Evidence code:IEA/Database source:UniProtKB:P12035|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens), CSNK1A1 SYNM TOR1A KRT3 INA,BP,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0010494,cytoplasmic stress granule,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)P61286(Evidence code:ISS/Database source:UniProtKB:P11940)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens), DDX1 PABPC4 PABPC1 PUM1 KPNB1,CC,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0001750,photoreceptor outer segment,F1MR98(Evidence code:IBA/Database source:PANTHER:PTN000662150)P04696(Evidence code:IEA/Database source:UniProtKB:P19087|ens)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026521)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)P04695(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), RRH GNAT2 GNAT3 SHANK2 GNAT1,CC,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0004722,protein serine/threonine phosphatase activity,E1BD03(Evidence code:IEA/Database source:InterPro:IPR015655)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)P61287(Evidence code:IEA/Database source:InterPro:IPR037981)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR037979), PPM1D LCK PPP1CC PPP2R2A PPP1CB,MF,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0097718,disordered domain specific binding,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q3ZC13(Evidence code:IEA/Database source:UniProtKB:P84091|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), KEAP1 NCOA3 NUMA1 AP2M1 SMTNL1,MF,5,5 of 15,0.22,33.33,0.00839,0.03556
GO:0005528,FK506 binding,Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)Q32PA9(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q2KJC8(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212), FKBP5 FKBP2 FKBP9 FKBP4,MF,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0005328,neurotransmitter:sodium symporter activity,A5D7H9(Evidence code:IEA/Database source:InterPro:IPR000175|I)O18875(Evidence code:IEA/Database source:InterPro:IPR000175|I)F1N5R0(Evidence code:IEA/Database source:InterPro:IPR000175|I)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR000175|I), SLC6A14 SLC6A8 SLC6A5 SLC6A20,MF,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0004029,aldehyde dehydrogenase (NAD) activity,E1BDG9(Evidence code:IBA/Database source:PANTHER:PTN000192421)Q2KJH9(Evidence code:IEA/Database source:EC:1.2.1.3)P48644(Evidence code:IEA/Database source:UniProtKB:P00352|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens), ALDH1L2 ALDH9A1 ALDH1A1 ALDH1A3,MF,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:2000352,negative regulation of endothelial cell apoptotic process,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:O96013|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens), ABL1 BRAF PAK4 NDNF,BP,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0031489,myosin V binding,P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P20336|ens)Q58DW6(Evidence code:IEA/Database source:UniProtKB:P57735|ens), RAB3C RAB3B RAB3A RAB25,MF,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0010613,positive regulation of cardiac muscle hypertrophy,P18493(Evidence code:ISS/Database source:UniProtKB:P27008)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q2HJF7(Evidence code:ISS/Database source:UniProtKB:Q13557), PARP1 TWF1 PPP3CA CAMK2D,BP,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0030173,integral component of Golgi membrane,E1BBS6(Evidence code:IBA/Database source:PANTHER:PTN000528008)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR017374)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081292), QSOX2 LFNG POMGNT1 SLC35B1,CC,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0030216,keratinocyte differentiation,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000048336), TSG101 POU3F1 CLIC4 CASP3,BP,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0005779,integral component of peroxisomal membrane,Q0P5B1(Evidence code:ISS/Database source:UniProtKB:Q92968)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654), PEX13 PEX2 FIS1 PEX10,CC,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0035108,limb morphogenesis,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:Q7Z7M0|ens), TBX3 COL2A1 RPGRIP1L MEGF8,BP,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0008138,protein tyrosine/serine/threonine phosphatase activity,Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR000340|I)G5E526(Evidence code:IEA/Database source:InterPro:IPR000340)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR000340|I)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR000340|I), DUSP3 PTP4A1 DUSP7 SSH2,MF,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0001954,positive regulation of cell-matrix adhesion,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)Q2TA30(Evidence code:IEA/Database source:UniProtKB:O70131|ens)A6YT15(Evidence code:IEA/Database source:UniProtKB:Q9NRJ3|ens), CDK6 UTRN NINJ1 CCL28,BP,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0007595,lactation,F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)P02668(Evidence code:IBA/Database source:PANTHER:PTN000895253)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), ATP7B STAT5A CSN3 STAT5B,BP,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0070491,repressing transcription factor binding,A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens), SP1 DDX20 CTBP1 SRI,MF,4,4 of 9,0.18,44.44,0.008355,0.03556
GO:0006487,protein N-linked glycosylation,Q3SZJ9(Evidence code:IBA/Database source:PANTHER:PTN000049281)Q08DQ2(Evidence code:IBA/Database source:PANTHER:PTN000101302)F1MS56(Evidence code:IEA/Database source:UniProtKB:O95394|ens)F1MZY2(Evidence code:IBA/Database source:PANTHER:PTN000101302)Q5E9C2(Evidence code:IBA/Database source:PANTHER:PTN000076010)Q5EA65(Evidence code:IEA/Database source:InterPro:IPR033895), PMM2 GFPT2 PGM3 GFPT1 DAD1 DPAGT1,BP,6,6 of 22,0.26,27.27,0.008803,0.03722
GO:0071356,cellular response to tumor necrosis factor,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens), DHX9 TCL1A ADAMTS12 DAB2IP NFKB1 ADAMTS7,BP,6,6 of 22,0.26,27.27,0.008803,0.03722
GO:0030178,negative regulation of Wnt signaling pathway,Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BI79(Evidence code:IEA/Database source:InterPro:IPR026818)E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens), TAX1BP3 CHD8 SOX17 APC2 TSC2 HIC1,BP,6,6 of 22,0.26,27.27,0.008803,0.03722
GO:0033365,protein localization to organelle,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), VPS35 PCM1,BP,2,2 of 134,0.09,1.49,0.008894,0.03756
GO:0048646,anatomical structure formation involved in morphogenesis,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), GRB2 GLI2,BP,2,2 of 135,0.09,1.48,0.008899,0.03756
GO:0042391,regulation of membrane potential,F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)P02715(Evidence code:IEA/Database source:UniProtKB:P20782|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)E1BMA2(Evidence code:IBA/Database source:PANTHER:PTN000025348)F1MP51(Evidence code:IBA/Database source:PANTHER:PTN000025348)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens), RIMS1 DLG1 CHRNE LRRK2 NEDD4 PIEZO1 TRPM4 HCN1 KCNH6 KCNH5 KCNMA1,BP,11,11 of 63,0.48,17.46,0.009096,0.03833
GO:0007015,actin filament organization,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)G5E5V6(Evidence code:IEA/Database source:UniProtKB:Q0VF96|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q29RN1(Evidence code:IEA/Database source:InterPro:IPR028510)Q0VCF1(Evidence code:IEA/Database source:InterPro:IPR028506)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR030772)F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623), MYBPC3 FAT1 CGNL1 CTNNA1 DLG1 SRF SORBS3 SORBS1 PRKCI ARHGAP6 ACTR3B,BP,11,11 of 63,0.48,17.46,0.009096,0.03833
GO:0048468,cell development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), LEF1 TRAF6,BP,2,2 of 139,0.09,1.44,0.009263,0.039
GO:2000147,positive regulation of cell motility,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9DAK9|ens),PHPT1,BP,1,1 of 105,0.04,0.95,0.01016,0.04275
GO:0032940,secretion by cell,F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens),PCSK6,BP,1,1 of 106,0.04,0.94,0.01017,0.04276
GO:0051345,positive regulation of hydrolase activity,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens),WRN,BP,1,1 of 107,0.04,0.93,0.01023,0.04297
GO:0042578,phosphoric ester hydrolase activity,O18964(Evidence code:IEA/Database source:InterPro:IPR002013),SYNJ1,MF,1,1 of 108,0.04,0.93,0.01034,0.04338
GO:0046961,"proton-transporting ATPase activity, rotational mechanism",P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)O46563(Evidence code:IEA/Database source:InterPro:IPR004908)P11019(Evidence code:IEA/Database source:InterPro:IPR002842)P23956(Evidence code:IBA/Database source:PANTHER:PTN000813763)P21282(Evidence code:IBA/Database source:PANTHER:PTN000015490), ATP6V0D1 ATP6V1H ATP6V1E1 ATP6V0C ATP6V1C1,MF,5,5 of 16,0.22,31.25,0.01042,0.04364
GO:0005544,calcium-dependent phospholipid binding,P27214(Evidence code:IEA/Database source:InterPro:IPR001464|I)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001283)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001283)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001972), ANXA11 SYTL2 SYTL1 SYT6 SYT4,MF,5,5 of 16,0.22,31.25,0.01042,0.04364
GO:0032091,negative regulation of protein binding,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), PIN1 LRRK2 TDG DNAJB2 SORL1,BP,5,5 of 16,0.22,31.25,0.01042,0.04364
GO:0005484,SNAP receptor activity,P63026(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR006012)Q17QQ3(Evidence code:IBA/Database source:PANTHER:PTN000447753)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885), VAMP2 VAMP1 VAMP3 STX7 SNAP25 VAMP5,MF,6,6 of 23,0.26,26.09,0.01049,0.04386
GO:0099132,ATP hydrolysis coupled cation transmembrane transport,F1MN60(Evidence code:IEA/Database source:GO:0005388)F1MRN7(Evidence code:IEA/Database source:GO:0005388)F1MMF3(Evidence code:IEA/Database source:GO:0005388)F1MKI1(Evidence code:IEA/Database source:GO:0019829)F1MS16(Evidence code:IEA/Database source:GO:0005388)D3K0R6(Evidence code:IEA/Database source:GO:0005388), ATP2B2 ATP13A5 ATP2C2 ATP7B ATP2B3 ATP2B4,BP,6,6 of 23,0.26,26.09,0.01049,0.04386
GO:0034599,cellular response to oxidative stress,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR029845)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens), SIRT2 PNPT1 LRRK2 PINK1 MT3 NFE2L2 G6PD SETX,BP,8,8 of 39,0.35,20.51,0.01116,0.04473
GO:0000932,P-body,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817)F1MXK6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BML0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCK9(Evidence code:ISS/Database source:UniProtKB:Q9R1P0)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P46471)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), LSM4 AGO4 PUM1 PAN2 PSMA4 PSMC2 AGO3,CC,7,7 of 31,0.31,22.58,0.01122,0.04473
GO:0019888,protein phosphatase regulator activity,A4FV68(Evidence code:IEA/Database source:InterPro:IPR002554)F1MG56(Evidence code:IEA/Database source:InterPro:IPR000009)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257)A2VDZ0(Evidence code:IEA/Database source:InterPro:IPR002554)F1MCY2(Evidence code:IEA/Database source:InterPro:IPR029984)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens), PPP2R5E PPP2R2A NSFL1C PPP2R5A PHACTR4 PTPA,MF,6,6 of 24,0.26,25,0.01239,0.04473
GO:0008144,drug binding,P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)P00376(Evidence code:ISS/Database source:UniProtKB:P00374)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens), PPP3CA MT3 PDE4D NR1I2 DHFR ATP1A2,MF,6,6 of 24,0.26,25,0.01239,0.04473
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens), ITPR1 DAB2IP BRSK2 AIFM1,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0051893,regulation of focal adhesion assembly,E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens), PEAK1 GPM6B SLK DUSP3,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0016180,snRNA processing,E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)E1B8S1(Evidence code:IEA/Database source:UniProtKB:Q8N201|ens)A5PJT2(Evidence code:IEA/Database source:InterPro:IPR026164)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens), CPSF3L INTS1 INTS10 INTS3,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0005682,U5 snRNP,Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558)A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens), SNRPN PRPF8 SNRPE SNRNP200,CC,4,4 of 10,0.18,40,0.01109,0.04473
GO:0046632,alpha-beta T cell differentiation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), BCL11B BRAF ABL1 LEF1,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0034314,Arp2/3 complex-mediated actin nucleation,Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383), ARPC5L ACTR3B IQGAP2 ARPC1A,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0045663,positive regulation of myoblast differentiation,P20959(Evidence code:ISS/Database source:UniProtKB:P17936)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982), IGFBP3 CDON MYF5 BOC,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0034389,lipid droplet organization,P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)F1MT41(Evidence code:IEA/Database source:UniProtKB:Q9WV91|ens)F1MN90(Evidence code:ISS/Database source:UniProtKB:Q96AQ7), PPID SPG20 PTGFRN CIDEC,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0033017,sarcoplasmic reticulum membrane,Q2HJF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CAMK2D JSRP1 RYR1 CAMK2B,CC,4,4 of 10,0.18,40,0.01109,0.04473
GO:0051216,cartilage development,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0891)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), HYAL1 MGP DLX2 COL2A1,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0008333,endosome to lysosome transport,A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612)F1MLZ5(Evidence code:IEA/Database source:UniProtKB:A2RT67|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB:Q3UHD6|ens), FAM160A2 DENND3 VPS41 SNX27,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0032743,positive regulation of interleukin-2 production,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens), TRAF6 PDE4D RUNX1 MALT1,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0007569,cell aging,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), BRCA2 TBX3 PDCD4 WRN,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0010389,regulation of G2/M transition of mitotic cell cycle,E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MP51(Evidence code:IEA/Database source:UniProtKB:Q8NCM2|ens)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979), CDK6 KIF14 KCNH5 CDK3,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0051898,negative regulation of protein kinase B signaling,E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), TSC2 PDCD6 PKHD1 DLG1,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0000266,mitochondrial fission,Q3T0I5(Evidence code:IEA/Database source:InterPro:IPR016543)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000902162)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000902162)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000902162), FIS1 DNM1 MX2 DNM2,BP,4,4 of 10,0.18,40,0.01109,0.04473
GO:0035591,signaling adaptor activity,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222)F1MRH8(Evidence code:IEA/Database source:InterPro:IPR030520|I)Q17R10(Evidence code:IEA/Database source:InterPro:IPR030115), DAB2IP EPS8 SH2B2 AFAP1L2,MF,4,4 of 10,0.18,40,0.01109,0.04473
GO:0042805,actinin binding,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens), NFKB1 PROM1 MICALL2,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:Q9D7X3|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens), CBLC DUSP3 TSG101,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0032486,Rap protein signal transduction,Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:Q80ZJ1|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8), RAP2C RAP2A RAPGEF2,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0044548,S100 protein binding,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)P27214(Evidence code:ISS/Database source:UniProtKB:P50995)P02638(Evidence code:ISS/Database source:UniProtKB:P04271), FGF1 ANXA11 S100B,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0016925,protein sumoylation,P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens), RANBP2 TRPM4 PIAS1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0001824,blastocyst development,Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)Q5E9C2(Evidence code:IEA/Database source:UniProtKB:P61804|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens), CAPN2 DAD1 ETV2,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0090141,positive regulation of mitochondrial fission,A5PJP5(Evidence code:IBA/Database source:PANTHER:PTN001121970)Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), PINK1 FIS1 VPS35,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0016358,dendrite development,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens), SYNGAP1 TRAPPC4 PAK3,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0043142,single-stranded DNA-dependent ATPase activity,E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250), POLQ RAD18 RFC2,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0045647,negative regulation of erythrocyte differentiation,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B HSPA9 STAT5A,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0051156,glucose 6-phosphate metabolic process,E1BME6(Evidence code:IEA/Database source:GO:0004340)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens), HK2 G6PD GCK,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0004697,protein kinase C activity,F1MQ96(Evidence code:IEA/Database source:InterPro:IPR034661)A1A4I4(Evidence code:IEA/Database source:EC:2.7.11.13)P05126(Evidence code:IEA/Database source:InterPro:IPR014375), PRKCI PKN1 PRKCB,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0008327,methyl-CpG binding,F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744), ZBTB4 LRWD1 PRMT5,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0003374,dynamin family protein polymerization involved in mitochondrial fission,A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170085), DNM2 DNM1 MX2,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0042274,ribosomal small subunit biogenesis,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q56JX6(Evidence code:IEA/Database source:UniProtKB:P62857|ens)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848), RPS19 RPS28 RPS7,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0090136,epithelial cell-cell adhesion,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)E1BFA7(Evidence code:IEA/Database source:UniProtKB:Q9BVG8|ens), SRF CTNNA1 KIFC3,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0051966,"regulation of synaptic transmission, glutamatergic",E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001173581)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), GRM7 LRRK2 PSEN1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0060079,excitatory postsynaptic potential,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)P02715(Evidence code:IEA/Database source:GO:0022848), PPP3CA LRRK2 CHRNE,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0098869,cellular oxidant detoxification,Q58CY6(Evidence code:IEA/Database source:GO:0016209)F1MHF7(Evidence code:IEA/Database source:GO:0004601)O62768(Evidence code:IEA/Database source:GO:0004791), FAM213B TXNDC17 TXNRD1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0016742,"hydroxymethyl-, formyl- and related transferase activity",A7YY67(Evidence code:IEA/Database source:InterPro:IPR002376|I)Q59A32(Evidence code:IEA/Database source:InterPro:IPR002376|I)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR002376|I), ALDH1L1 GART ALDH1L2,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0060292,long term synaptic depression,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BFV9(Evidence code:IEA/Database source:UniProtKB:Q0QWG9|ens), SRF SHANK2 GRID2IP,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0033627,cell adhesion mediated by integrin,P53712(Evidence code:ISS/Database source:UniProtKB:P05556)P80746(Evidence code:ISS/Database source:UniProtKB:P06756)Q8SQB8(Evidence code:ISS/Database source:UniProtKB:P18564), ITGB1 ITGAV ITGB6,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0035136,forelimb morphogenesis,F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), RNF165 TBX3 NIPBL,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens), HYAL1 ANKRD17 EIF4G1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0006658,phosphatidylserine metabolic process,A4FUZ5(Evidence code:IEA/Database source:InterPro:IPR029557)Q58CW5(Evidence code:IEA/Database source:InterPro:IPR029554)F1N5T9(Evidence code:IEA/Database source:InterPro:IPR029555), SERINC3 SERINC2 SERINC5,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0005523,tropomyosin binding,F1MF57(Evidence code:IEA/Database source:UniProtKB:O76041|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR004934|I), NEBL SMTNL1 TMOD3,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0006882,cellular zinc ion homeostasis,F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), ATP7B LCK MT3,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:2000648,positive regulation of stem cell proliferation,E1BGK7(Evidence code:IEA/Database source:UniProtKB:G5E8Z2|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), TAF4B SIRT6 TBX3,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0043425,bHLH transcription factor binding,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)A6QPK5(Evidence code:IBA/Database source:PANTHER:PTN000927455)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens), LMO2 TCF7L2 MAP3K10,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0015194,L-serine transmembrane transporter activity,A4FUZ5(Evidence code:IBA/Database source:PANTHER:PTN000043695)F1N5T9(Evidence code:IBA/Database source:PANTHER:PTN000043695)Q58CW5(Evidence code:IBA/Database source:PANTHER:PTN000043695), SERINC3 SERINC5 SERINC2,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0034237,protein kinase A regulatory subunit binding,P05131(Evidence code:IEA/Database source:InterPro:IPR039083)P00517(Evidence code:IEA/Database source:InterPro:IPR039035)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6), PRKACB PRKACA ARFGEF1,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0043653,mitochondrial fragmentation involved in apoptotic process,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens), FIS1 VPS35 CCAR2,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0006471,protein ADP-ribosylation,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)P18493(Evidence code:IEA/Database source:InterPro:IPR004102|I), SIRT6 TNKS PARP1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0032281,AMPA glutamate receptor complex,F1MBY1(Evidence code:IBA/Database source:PANTHER:PTN000438080)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)E1BGZ0(Evidence code:IEA/Database source:UniProtKB:Q9Z2W9|ens), GRIA2 ABHD12 GRIA3,CC,3,3 of 5,0.13,60,0.01249,0.04473
GO:0046627,negative regulation of insulin receptor signaling pathway,Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR035036)E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943)P05126(Evidence code:ISS/Database source:UniProtKB:P68403), Grb10 TSC2 PRKCB,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0010719,negative regulation of epithelial to mesenchymal transition,P67774(Evidence code:IEA/Database source:UniProtKB:P67775|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens), PPP2CA DAB2IP STRAP,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0007254,JNK cascade,Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN001171982), MAPK9 MAPK8IP3 MAPK10,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:2000251,positive regulation of actin cytoskeleton reorganization,F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)Q5EAD0(Evidence code:IBA/Database source:PANTHER:PTN001022094)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), BAIAP2L1 BAIAP2 ABL1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0042130,negative regulation of T cell proliferation,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens), MARCH7 DLG1 PTPN6,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0005104,fibroblast growth factor receptor binding,E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8WU20|ens)P03968(Evidence code:IEA/Database source:InterPro:IPR028210), KL FRS2 FGF1,MF,3,3 of 5,0.13,60,0.01249,0.04473
GO:0032331,negative regulation of chondrocyte differentiation,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens), ADAMTS12 GLI2 ADAMTS7,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0051145,smooth muscle cell differentiation,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BDD9(Evidence code:IBA/Database source:PANTHER:PTN000513566), FOXF1 GATA6 MKL1,BP,3,3 of 5,0.13,60,0.01249,0.04473
GO:0061357,positive regulation of Wnt protein secretion,E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens), PTPN23 VPS35,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0097440,apical dendrite,Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)E1B7M8(Evidence code:IEA/Database source:UniProtKB:Q5QNQ6|ens), MYO1D OSBP2,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0045162,clustering of voltage-gated sodium channels,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BN05(Evidence code:IEA/Database source:InterPro:IPR031224), SPTBN4 GLDN,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0046833,positive regulation of RNA export from nucleus,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens), DHX9 KHDRBS1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0033129,positive regulation of histone phosphorylation,F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens), RPS6KA4 RPS6KA5,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0070679,"inositol 1,4,5 trisphosphate binding",Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493), ITPR1 ITPR2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0072711,cellular response to hydroxyurea,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), ATRX BLM,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060575,intestinal epithelial cell differentiation,F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens), CBFA2T2 GATA6,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0031065,positive regulation of histone deacetylation,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens), NIPBL CTBP1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0048495,Roundabout binding,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), MYO9B SLIT2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0003310,pancreatic A cell differentiation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), INSM1 GATA6,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0000733,DNA strand renaturation,Q9TTA5(Evidence code:IEA/Database source:GO:0036310)E1BQ04(Evidence code:IEA/Database source:GO:0036310), SMARCAL1 BLM,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0042731,PH domain binding,F1MHB9(Evidence code:IEA/Database source:UniProtKB:Q14642|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens), INPP5A LSM4,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0050473,arachidonate 15-lipoxygenase activity,P27479(Evidence code:IEA/Database source:EC:1.13.11.33)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens), ALOX15 ALOX15B,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060009,Sertoli cell development,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens), ATRX FNDC3A,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0005658,alpha DNA polymerase:primase complex,G8JKZ3(Evidence code:IBA/Database source:PANTHER:PTN000056765)E1BJF4(Evidence code:IEA/Database source:UniProtKB:P33609|ens), PRIM1 POLA1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0051683,establishment of Golgi localization,F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens), ARHGAP21 PDCD10,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0016618,hydroxypyruvate reductase activity,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107947), GRHPR CTBP1,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0061615,glycolytic process through fructose-6-phosphate,E1BCW3(Evidence code:IEA/Database source:GO:0003872)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens), PFKP PFKM,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1902430,negative regulation of amyloid-beta formation,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), SORL1 PRNP,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000321,positive regulation of T-helper 17 cell differentiation,Q9BE45(Evidence code:ISS/Database source:UniProtKB:Q9EST8)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens), NFKBIZ MALT1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0050847,progesterone receptor signaling pathway,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141), NEDD4 SRC,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0097542,ciliary tip,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens), GLI2 GLI1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0005168,neurotrophin TRKA receptor binding,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8WU20|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens), FRS2 GRB2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0048617,embryonic foregut morphogenesis,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), FOXF1 SOX17,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0042471,ear morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), NIPBL CHD7,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0071233,cellular response to leucine,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q8IWV8|ens), LARS UBR2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0051292,nuclear pore complex assembly,E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens), NDC1 AHCTF1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0034515,proteasome storage granule,A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661), PSMD1 PSMD2,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000394,positive regulation of lamellipodium morphogenesis,E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), RREB1 SRC,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0099074,mitochondrion to lysosome transport,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), VPS35 PINK1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0046976,histone methyltransferase activity (H3-K27 specific),E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), SUZ12 EHMT2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004439,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",O18964(Evidence code:IEA/Database source:EC:3.1.3.36)E1BB73(Evidence code:IEA/Database source:UniProtKB:P32019|ens), SYNJ1 INPP5B,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0006419,alanyl-tRNA aminoacylation,F1MKA6(Evidence code:IEA/Database source:InterPro:IPR018162|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR018162|I), AARS2 AARS,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0090286,cytoskeletal anchoring at nuclear membrane,F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000985481)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR030267), SPAG4 SYNE3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0035562,negative regulation of chromatin binding,A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), TDG PPP3CA,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0006415,translational termination,A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q0VCX5(Evidence code:IEA/Database source:InterPro:IPR004403), ABCE1 ETF1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0097200,cysteine-type endopeptidase activity involved in execution phase of apoptosis,Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR037554)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000825206), CASP6 CASP3,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0019784,NEDD8-specific protease activity,Q3SZA0(Evidence code:IBA/Database source:PANTHER:PTN000091645)Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326), COPS4 OTUB1,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0015871,choline transport,E1BIP2(Evidence code:IEA/Database source:UniProtKB:Q6X893|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SLC44A1 PSEN1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0005721,pericentric heterochromatin,F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), LRWD1 ATRX,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0071930,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q96AV8)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens), E2F7 E2F1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0006409,tRNA export from nucleus,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens), SSB XPOT,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0045794,negative regulation of cell volume,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens), KCNMA1 ANO6,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0051151,negative regulation of smooth muscle cell differentiation,A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:Q99NH0|ens), FOXO4 ANKRD17,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0008349,MAP kinase kinase kinase kinase activity,Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000685430)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000685430), STK25 STK26,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0031467,Cul7-RING ubiquitin ligase complex,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:P63208), LOC780968 SKP1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0002315,marginal zone B cell differentiation,Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens), LFNG BCL3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1990745,EARP complex,A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens), VPS51 VPS52,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043996,histone acetyltransferase activity (H4-K8 specific),F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), KANSL3 HCFC1,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:2001271,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens), RFFL PAK2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0033572,transferrin transport,E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513|I)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens), TFRC LMTK2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0016233,telomere capping,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens), TERF2 PRKDC,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0016081,synaptic vesicle docking,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), UNC13A UNC13B,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1905606,regulation of presynapse assembly,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), EIF4G1 FZD1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0015680,intracellular copper ion transport,Q3T0E0(Evidence code:IBA/Database source:PANTHER:PTN001106576)F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens), ATOX1 ATP7B,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043276,anoikis,E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens), TSC2 E2F1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0003923,GPI-anchor transamidase activity,Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR028361)F1N4W0(Evidence code:IBA/Database source:PANTHER:PTN000311103), PIGK PIGT,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0036449,microtubule minus-end,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)O46385(Evidence code:IDA/Database source:), NUMA1 SVIL,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060412,ventricular septum morphogenesis,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), TBX3 FZD1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0007398,ectoderm development,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens), NF2 ZBTB17,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043995,histone acetyltransferase activity (H4-K5 specific),E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0001841,neural tube formation,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens), SOX4 STK3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0048668,collateral sprouting,Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), BDNF ABL1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0045176,apical protein localization,B6Z9Q5(Evidence code:IEA/Database source:InterPro:IPR027686)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens), SHROOM2 HCN1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,A2VDL6(Evidence code:IEA/Database source:GO:0005391)Q8HYW6(Evidence code:IEA/Database source:GO:0005391), ATP1A2 atp1A3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0031436,BRCA1-BARD1 complex,A5PJF0(Evidence code:IEA/Database source:InterPro:IPR033097)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398), BARD1 BRCA1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0019372,lipoxygenase pathway,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O35936|ens)P27479(Evidence code:IEA/Database source:UniProtKB:P16050|ens), ALOX15B ALOX15,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0022038,corpus callosum development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens), RPGRIP1L RTN4R,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043987,histone H3-S10 phosphorylation,E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens), RPS6KA5 RPS6KA4,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0038027,apolipoprotein A-I-mediated signaling pathway,E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)F1MG24(Evidence code:IEA/Database source:GO:0034188), ABCA7 ABCA1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), SGTA UBQLN1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0001939,female pronucleus,F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens), TET3 RIF1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0097487,"multivesicular body, internal vesicle",Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), CD63 LRRK2,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0045334,clathrin-coated endocytic vesicle,E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB:Q9Z140|ens), MYO6 CPNE6,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0014816,skeletal muscle satellite cell differentiation,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q8VCR8|ens), CDON MYLK2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0090160,Golgi to lysosome transport,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens), LAMP1 ANKFY1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0006425,glutaminyl-tRNA aminoacylation,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR004514|I), LARS QARS,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1990712,HFE-transferrin receptor complex,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606), TFRC HFE2,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0042074,cell migration involved in gastrulation,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:Q7Z7M0|ens), SOX17 MEGF8,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0001927,exocyst assembly,A4IF89(Evidence code:IBA/Database source:PANTHER:PTN000484343)E1BDW9(Evidence code:IBA/Database source:PANTHER:PTN000315823), EXOC8 EXOC2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0090103,cochlea morphogenesis,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), GLI2 PTK7,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1990023,mitotic spindle midzone,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), CTTN NUMA1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060074,synapse maturation,Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens), SEZ6L2 PALM,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0009051,"pentose-phosphate shunt, oxidative branch",F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q2TBQ8(Evidence code:IBA/Database source:PANTHER:PTN000114544), G6PD PGLS,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0070197,meiotic attachment of telomere to nuclear envelope,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BIJ4(Evidence code:IBA/Database source:PANTHER:PTN001412149), RAD21L1 LEMD3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0038061,NIK/NF-kappaB signaling,E1BL08(Evidence code:IEA/Database source:GO:0004704)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216), MAP3K14 NFKB1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000463,positive regulation of excitatory postsynaptic potential,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), CUX2 SHANK1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:1990481,mRNA pseudouridine synthesis,E1BEB7(Evidence code:IEA/Database source:UniProtKB:Q8WWH5|ens)Q3SX07(Evidence code:IBA/Database source:PANTHER:PTN000124846), TRUB1 PUS3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0035701,hematopoietic stem cell migration,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q9C0K0|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), BCL11B KIT,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060219,camera-type eye photoreceptor cell differentiation,F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens), SDK2 PROM1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060152,microtubule-based peroxisome localization,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens), PEX13 PEX1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004813,alanine-tRNA ligase activity,F1MKA6(Evidence code:IEA/Database source:InterPro:IPR018162|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR018162|I), AARS2 AARS,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0007252,I-kappaB phosphorylation,E1BPW2(Evidence code:IEA/Database source:UniProtKB:Q8IUD2|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), ERC1 DAB2IP,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0051013,microtubule severing,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BAN2(Evidence code:IEA/Database source:UniRule:UR000107529), SPAST KATNAL2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0008568,microtubule-severing ATPase activity,A2VDN5(Evidence code:IEA/Database source:InterPro:IPR017179|I)E1BAN2(Evidence code:IEA/Database source:EC:3.6.4.3), SPAST KATNAL2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0003910,DNA ligase (ATP) activity,P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I), PARP1 LIG1,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0030991,intraciliary transport particle A,F1N307(Evidence code:IBA/Database source:PANTHER:PTN000380174)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens), TTC21A TTC21B,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0008526,phosphatidylinositol transporter activity,Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens), PITPNA TNFAIP8L3,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0031018,endocrine pancreas development,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN000677917), ONECUT2 MNX1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0019158,mannokinase activity,A6QR34(Evidence code:IBA/Database source:PANTHER:PTN000455410)E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350), GCK HK2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004360,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,F1MZY2(Evidence code:IEA/Database source:InterPro:IPR005855)Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR005855), GFPT1 GFPT2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060026,convergent extension,F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), PTK7 LRP6,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000042,negative regulation of double-strand break repair via homologous recombination,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens), RIF1 POLQ,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0048846,axon extension involved in axon guidance,Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), ALCAM SLIT2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000642,negative regulation of early endosome to late endosome transport,A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens), SNX12 SNX3,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0090527,actin filament reorganization,F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604), FRY FRYL,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0015026,coreceptor activity,E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606)O46405(Evidence code:IEA/Database source:InterPro:IPR037676), HFE2 CD80,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0006273,lagging strand elongation,E1BJF4(Evidence code:IBA/Database source:PANTHER:PTN000035348)P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695), POLA1 PARP1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0000938,GARP complex,E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3), VPS52 VPS51,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0014044,Schwann cell development,G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens), POU3F1 LAMB2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0005522,profilin binding,F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens), FMNL1 CTTN,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0072520,seminiferous tubule development,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), RAD21L1 ATRX,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004560,alpha-L-fucosidase activity,Q2KIM0(Evidence code:IEA/Database source:InterPro:IPR000933|I)F1N5H2(Evidence code:IEA/Database source:InterPro:IPR000933|I), FUCA1 FUCA2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0070087,chromo shadow domain binding,F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), ATRX NIPBL,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0034499,late endosome to Golgi transport,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens), GCC2 SGSM2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0001574,ganglioside biosynthetic process,F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)Q2HJA3(Evidence code:IEA/Database source:UniProtKB:O96024|ens), ST8SIA3 B3GALT4,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0036035,osteoclast development,F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), LRRK1 SRC,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043141,ATP-dependent 5-3 DNA helicase activity,A7MBG8(Evidence code:IEA/Database source:InterPro:IPR027238|I)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR027238|I), RUVBL1 RUVBL2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0008865,fructokinase activity,E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350)A6QR34(Evidence code:IBA/Database source:PANTHER:PTN000455410), HK2 GCK,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:1901315,negative regulation of histone H2A K63-linked ubiquitination,E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens), TRIP12 OTUB1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P61286(Evidence code:ISS/Database source:UniProtKB:P11940)E1BJ90(Evidence code:IEA/Database source:UniProtKB:Q14147|ens), PABPC1 DHX34,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060119,inner ear receptor cell development,E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), ATP8B1 GABRA5,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0022028,tangential migration from the subventricular zone to the olfactory bulb,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), LRRK2 SRF,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0046972,histone acetyltransferase activity (H4-K16 specific),E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0033192,calmodulin-dependent protein phosphatase activity,P48452(Evidence code:ISS/Database source:UniProtKB:Q08209)A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens), PPP3CA PPP3CC,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:1990909,Wnt signalosome,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), LRP6 LRRK2,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043219,lateral loop,E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), MPP5 DLG1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0008093,cytoskeletal adaptor activity,G3N3P0(Evidence code:IEA/Database source:InterPro:IPR018477)Q5EAD0(Evidence code:IEA/Database source:InterPro:IPR030128), BICD2 BAIAP2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0061578,Lys63-specific deubiquitinase activity,E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens)Q17QP9(Evidence code:IEA/Database source:InterPro:IPR035299), OTUD4 PSMD14,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004340,glucokinase activity,A6QR34(Evidence code:IEA/Database source:InterPro:IPR039073)E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350), GCK HK2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0070742,C2H2 zinc finger domain binding,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), EHMT2 LEF1,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0071763,nuclear membrane organization,A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)F1MBM5(Evidence code:IEA/Database source:UniProtKB:Q9ER41|ens), TOR1A TOR1B,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0032183,SUMO binding,E1BB54(Evidence code:IEA/Database source:InterPro:IPR028890)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), USPL1 TDG,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004819,glutamine-tRNA ligase activity,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR004514|I), LARS QARS,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0004396,hexokinase activity,A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312|I), GCK HK2,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0060134,prepulse inhibition,F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens), CHD8 FABP7,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0046855,inositol phosphate dephosphorylation,F1MHB9(Evidence code:IBA/Database source:PANTHER:PTN000313248)P20456(Evidence code:IEA/Database source:InterPro:IPR033942), INPP5A IMPA1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0043988,histone H3-S28 phosphorylation,E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens), RPS6KA5 RPS6KA4,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0030267,glyoxylate reductase (NADP) activity,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107947), GRHPR CTBP1,MF,2,2 of 1,0.09,200,0.01248,0.04473
GO:0016080,synaptic vesicle targeting,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SCRIB PSEN1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0048790,maintenance of presynaptic active zone structure,E1BMN9(Evidence code:IEA/Database source:GO:0098882)P11023(Evidence code:ISS/Database source:UniProtKB:P63011), BSN RAB3A,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0045059,positive thymic T cell selection,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens), SRF ZAP70,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0071257,cellular response to electrical stimulus,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens), PALM GNAT1,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:2000467,positive regulation of glycogen (starch) synthase activity,F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), EPM2AIP1 GSK3A,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0048312,intracellular distribution of mitochondria,E1BIA7(Evidence code:IEA/Database source:InterPro:IPR027523)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), CLUH LRRK2,BP,2,2 of 1,0.09,200,0.01248,0.04473
GO:0097449,astrocyte projection,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), SYT4 PINK1,CC,2,2 of 1,0.09,200,0.01248,0.04473
GO:0001817,regulation of cytokine production,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens), LITAF F11R,BP,2,2 of 131,0.09,1.53,0.01273,0.04553
GO:0070613,regulation of protein processing,P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens), PRKACB RNF139 PRKACA RPS6KA2 INPP5B,BP,5,5 of 17,0.22,29.41,0.01277,0.04561
GO:0006865,amino acid transport,A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens)Q95JC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0029)E1B968(Evidence code:IEA/Database source:InterPro:IPR004755)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0029)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), SLC6A20 SLC1A5 SLC7A2 SLC25A29 CLN3,BP,5,5 of 17,0.22,29.41,0.01277,0.04561
GO:0048037,cofactor binding,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR003781), LMO2 ACLY,MF,2,2 of 132,0.09,1.52,0.01288,0.046
GO:0006259,DNA metabolic process,Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)P06526(Evidence code:ISS/Database source:UniProtKB:P04053)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR020587)F1MU48(Evidence code:IEA/Database source:InterPro:IPR013758)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens), SMARCAL1 DNTT MMS19 MYO18A TOP2B WRN,BP,6,6 of 217,0.26,2.76,0.01417,0.05056
GO:0006954,inflammatory response,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453991)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9EST8|ens)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)P58754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens), HYAL1 NFKB1 AFAP1L2 TSPAN2 JAK2 PIK3CD F2R HIST1H2BA NOS2 NFKBIZ TLR4 KIT DHX9 LY96 CRH STAT3 ITGB6,BP,17,17 of 121,0.75,14.05,0.01434,0.05077
GO:0018279,protein N-linked glycosylation via asparagine,F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)E1BB36(Evidence code:IEA/Database source:UniProtKB:Q921V5|ens)Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), UGGT2 MGAT2 UBE2G2 SYVN1,BP,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0071944,cell periphery,E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens), AXIN1 STK26 FABP7 TUBB3,CC,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0005548,phospholipid transporter activity,C3VEX2(Evidence code:IEA/Database source:InterPro:IPR001666)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q2HJ54(Evidence code:IEA/Database source:InterPro:IPR001666)P55156(Evidence code:ISS/Database source:UniProtKB:P55157), PITPNM2 ABCA1 PITPNA MTTP,MF,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0050873,brown fat cell differentiation,Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)Q3T0M9(Evidence code:IEA/Database source:UniProtKB:P61213|ens), PLAC8 SH2B2 ZNF516 ARL4A,BP,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0043679,axon terminus,E1B7T7(Evidence code:IEA/Database source:UniProtKB:Q8R1C0|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294), KCNC4 PTPRN SEPT6 CACNA1B,CC,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0005669,transcription factor TFIID complex,E1BGK7(Evidence code:IEA/Database source:InterPro:IPR007900)F1MME0(Evidence code:IEA/Database source:InterPro:IPR037813)A7MAZ4(Evidence code:IEA/Database source:InterPro:IPR037818)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens), TAF4B TAF2 TAF8 TAF10,CC,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0005685,U1 snRNP,Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304), SNRNP70 SNRPN PRPF40A SNRPE,CC,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0031307,integral component of mitochondrial outer membrane,Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR021181)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR021181)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), RHOT2 RHOT1 FIS1 PINK1,CC,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0016597,amino acid binding,A6QLT9(Evidence code:IBA/Database source:PANTHER:PTN000206950)Q58CZ9(Evidence code:ISS/Database source:UniProtKB:P04694)F1MKA6(Evidence code:IBA/Database source:PANTHER:PTN000206950)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006130|I), AARS TAT AARS2 CAD,MF,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0006939,smooth muscle contraction,E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8BWC0|ens)E1B9K4(Evidence code:IBA/Database source:PANTHER:PTN000539684)Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), TPCN2 HMCN2 ROCK2 PDE4D,BP,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0051018,protein kinase A binding,G3MWT9(Evidence code:IEA/Database source:InterPro:IPR028540)F1MZL5(Evidence code:IEA/Database source:UniProtKB:Q2M3C7|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens), AKAP12 SPHKAP LRRK2 WASF2,MF,4,4 of 11,0.18,36.36,0.01435,0.05077
GO:0031397,negative regulation of protein ubiquitination,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)A6QL80(Evidence code:IEA/Database source:UniProtKB:O60678|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)E1B7Y9(Evidence code:IEA/Database source:UniProtKB:Q6IQ16|ens)Q32KW2(Evidence code:ISS/Database source:UniProtKB:Q04323)Q3T178(Evidence code:ISS/Database source:UniProtKB:Q9UK41), SOX4 PRMT3 BAG5 SPOPL UBXN1 VPS28,BP,6,6 of 25,0.26,24,0.01453,0.05138
GO:0060627,regulation of vesicle-mediated transport,Q58DW6(Evidence code:IEA/Database source:UniProtKB:P57735|ens),RAB25,BP,1,1 of 100,0.04,1,0.01469,0.05192
GO:0019843,rRNA binding,F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)Q24JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)A2VE06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)Q3T0R1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR001912|I)Q3T087(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699), FASTKD2 RPL9 RPL23A RPS4Y1 RPS18 RPS9 RPL11,MF,7,7 of 33,0.31,21.21,0.01478,0.05221
GO:0007610,behavior,A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0085),TRMT1L,BP,1,1 of 102,0.04,0.98,0.01494,0.05273
GO:0035097,histone methyltransferase complex,F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569)F1MYZ3(Evidence code:IEA/Database source:UniProtKB:Q8NEZ4|ens)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569), KMT2A KMT2C SETD1B ASH2L KMT2B,CC,5,5 of 18,0.22,27.78,0.01544,0.05432
GO:0005776,autophagosome,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000538677)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q8R317|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens), CLN3 TBC1D12 UBQLN1 WDFY3 RAB23,CC,5,5 of 18,0.22,27.78,0.01544,0.05432
GO:0010923,negative regulation of phosphatase activity,A7Z026(Evidence code:ISS/Database source:UniProtKB:O75864)Q17R14(Evidence code:ISS/Database source:UniProtKB:O94832)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)F1MWN4(Evidence code:IEA/Database source:UniProtKB:A8K8P3|ens)F1N1P8(Evidence code:IEA/Database source:InterPro:IPR026130), PPP1R37 MYO1D WNK1 SFI1 PPP1R26,BP,5,5 of 18,0.22,27.78,0.01544,0.05432
GO:0031623,receptor internalization,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q9BDR7(Evidence code:ISS/Database source:UniProtKB:P20491)P53712(Evidence code:ISS/Database source:UniProtKB:P09055), NEDD4 GRB2 TFRC FCER1G ITGB1,BP,5,5 of 18,0.22,27.78,0.01544,0.05432
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558), MYDGF PTPN6 PDGFC NEDD4 F2R,BP,5,5 of 18,0.22,27.78,0.01544,0.05432
GO:0007264,small GTPase mediated signal transduction,E1B7C4(Evidence code:IEA/Database source:InterPro:IPR026791)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)E1BPX7(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1N2I0(Evidence code:IEA/Database source:InterPro:IPR018203)Q5E9S7(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1MQ43(Evidence code:IEA/Database source:InterPro:IPR026791|I)Q32P83(Evidence code:IEA/Database source:InterPro:IPR007515)E1BK77(Evidence code:IEA/Database source:InterPro:IPR026791|I)Q58DL5(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1MS53(Evidence code:IEA/Database source:InterPro:IPR001895)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR001895), DOCK10 VAV2 RAPGEF4 CHML RASGEF1A DOCK9 RABIF DOCK6 BCAR3 RAPGEF6 RAPGEF2,BP,11,11 of 64,0.48,17.19,0.01593,0.056
GO:0000226,microtubule cytoskeleton organization,F1N3M8(Evidence code:IEA/Database source:InterPro:IPR015656|I)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR033624)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)E1BER6(Evidence code:IEA/Database source:InterPro:IPR030624)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)Q2KII9(Evidence code:IBA/Database source:PANTHER:PTN000293992), MAP1A MARK3 APC2 CDK5RAP2 CDK1 WEE1 TUBGCP2 CRMP1 DCLK2 TACC1 PCNT DYNC1LI1,BP,12,12 of 77,0.53,15.58,0.01632,0.05734
GO:0006869,lipid transport,A6QQK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)E1B7M8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)P55156(Evidence code:IEA/Database source:InterPro:IPR001747|I)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)E1BCG1(Evidence code:IBA/Database source:PANTHER:PTN000442469)E1BPW1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)A6QQ47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)F1MG24(Evidence code:IBA/Database source:PANTHER:PTN000442469)G3X8E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445), TEX2 OSBP2 MTTP TMEM30A ABCA7 OSBP VPS51 ABCA1 OSBPL10,BP,9,9 of 51,0.39,17.65,0.01642,0.05766
GO:0000777,condensed chromosome kinetochore,Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67827(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens), SEPT7 SEPT2 PPP1CC CSNK1A1 SEPT6 DCTN3 AHCTF1,CC,7,7 of 34,0.31,20.59,0.01684,0.05906
GO:1903508,positive regulation of nucleic acid-templated transcription,A7MBG8(Evidence code:IEA/Database source:GO:0003713)Q08DI5(Evidence code:IEA/Database source:GO:0003713)A1A4I4(Evidence code:IEA/Database source:GO:0030374)Q3MHP1(Evidence code:IEA/Database source:GO:0003713)O02754(Evidence code:IEA/Database source:GO:0003713)P05126(Evidence code:IEA/Database source:GO:0030374)F1N3I6(Evidence code:IEA/Database source:GO:0003713)A5PJW1(Evidence code:IEA/Database source:GO:0003713), RUVBL1 RAP2C PKN1 UBE2L3 CEBPA PRKCB WWC1 TAF10,BP,8,8 of 255,0.35,3.14,0.01697,0.05948
GO:0005158,insulin receptor binding,F1MGG8(Evidence code:IEA/Database source:InterPro:IPR039011)Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR035036)F1MYE0(Evidence code:IEA/Database source:InterPro:IPR039011), IRS4 Grb10 IRS1,MF,3,3 of 6,0.13,50,0.01783,0.0614
GO:0001958,endochondral ossification,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q9R1N9|ens), COL2A1 NAB2 COL13A1,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0005847,mRNA cleavage and polyadenylation specificity factor complex,P67827(Evidence code:ISS/Database source:UniProtKB:P48729)O19137(Evidence code:ISS/Database source:UniProtKB:O95639)G3MZ78(Evidence code:IBA/Database source:PANTHER:PTN000566843), CSNK1A1 CPSF4 CSTF2T,CC,3,3 of 6,0.13,50,0.01783,0.0614
GO:0048188,Set1C/COMPASS complex,E1BGF3(Evidence code:IEA/Database source:InterPro:IPR037854)E1BEP4(Evidence code:IEA/Database source:InterPro:IPR037353)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR037842), HCFC1 ASH2L SETD1B,CC,3,3 of 6,0.13,50,0.01783,0.0614
GO:0048016,inositol phosphate-mediated signaling,F1MHB9(Evidence code:IBA/Database source:PANTHER:PTN000313248)Q8WN96(Evidence code:IEA/Database source:GO:0005220)Q9TU34(Evidence code:IEA/Database source:GO:0005220), INPP5A ITPR2 ITPR1,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0043024,ribosomal small subunit binding,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)Q32KZ1(Evidence code:ISS/Database source:UniProtKB:Q9H2K0)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727), EIF4H MTIF3 ABCE1,MF,3,3 of 6,0.13,50,0.01783,0.0614
GO:0050681,androgen receptor binding,E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)P05126(Evidence code:ISS/Database source:UniProtKB:P05771), TRIM68 PKN1 PRKCB,MF,3,3 of 6,0.13,50,0.01783,0.0614
GO:0035024,negative regulation of Rho protein signal transduction,E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens), ARAP3 ARHGAP35 CUL3,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0042572,retinol metabolic process,O77769(Evidence code:IEA/Database source:InterPro:IPR032969)P02694(Evidence code:ISS/Database source:UniProtKB:Q00915)P48644(Evidence code:IEA/Database source:UniPathway:UPA00912), DHRS3 RBP1 ALDH1A1,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0035066,positive regulation of histone acetylation,F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens), RPS6KA4 BRCA1 RPS6KA5,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0007340,acrosome reaction,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens)E1BGL9(Evidence code:IEA/Database source:InterPro:IPR028701)Q5EA42(Evidence code:IEA/Database source:UniProtKB:Q9QXM0|ens), ACR SYT6 ABHD2,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0007031,peroxisome organization,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR015342)Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654), PEX2 PEX1 PEX10,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0001965,G-protein alpha-subunit binding,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)E1BIX7(Evidence code:IEA/Database source:UniProtKB:Q8VDU0|ens)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776|I), F2R GPSM2 RGS14,MF,3,3 of 6,0.13,50,0.01783,0.0614
GO:0034142,toll-like receptor 4 signaling pathway,P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens), LY96 TLR4 S100A14,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0048701,embryonic cranial skeleton morphogenesis,Q2NL22(Evidence code:ISS/Database source:UniProtKB:P38919)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens), EIF4A3 DLX2 NIPBL,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0006020,inositol metabolic process,F1MNG6(Evidence code:IBA/Database source:PANTHER:PTN000297581)P20456(Evidence code:IBA/Database source:PANTHER:PTN000465134)A4FV33(Evidence code:IEA/Database source:UniProtKB:Q8R071|ens), PPIP5K2 IMPA1 ITPKA,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0016442,RISC complex,Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN000383724)F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)Q6T5B7(Evidence code:IEA/Database source:UniRule:UR000107558), DICER1 AGO4 AGO3,CC,3,3 of 6,0.13,50,0.01783,0.0614
GO:0001833,inner cell mass cell proliferation,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q9EQH4|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), SALL4 TAF8 BRCA2,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0030048,actin filament-based movement,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens), MYO9B WASF2 MYH14,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0040015,negative regulation of multicellular organism growth,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens), ALMS1 RAI1 PLAC8,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0006183,GTP biosynthetic process,A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564)Q3SWY3(Evidence code:IBA/Database source:PANTHER:PTN000226903)A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564), NME1 IMPDH2 NME3,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0032420,stereocilium,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens)F1MG13(Evidence code:IEA/Database source:UniProtKB:Q9QZZ4|ens), MYO1C ATP8B1 MYO15A,CC,3,3 of 6,0.13,50,0.01783,0.0614
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens), DYRK2 BRCA2 BCL3,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0010738,regulation of protein kinase A signaling,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens)F1MZL5(Evidence code:IBA/Database source:PANTHER:PTN000027542), LRRK2 AKAP12 SPHKAP,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0033137,negative regulation of peptidyl-serine phosphorylation,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), PDE4D INPP5J GPD1L,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0046825,regulation of protein export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens), XPO1 UHMK1 PTPN14,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0002040,sprouting angiogenesis,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens), LEF1 E2F7 SEMA3E,BP,3,3 of 6,0.13,50,0.01783,0.0614
GO:0006506,GPI anchor biosynthetic process,E1BPZ8(Evidence code:IEA/Database source:InterPro:IPR037675)Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0337)E1BM45(Evidence code:IEA/Database source:InterPro:IPR007070|I), PIGO DPM3 PIGK PIGN,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,G3N065(Evidence code:IBA/Database source:PANTHER:PTN000552321)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens), ZNF385C PPP1R13B FHIT E2F1,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens), ASH1L ABL1 DAB2IP OTUD7B,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0032008,positive regulation of TOR signaling,A7MBJ6(Evidence code:IEA/Database source:InterPro:IPR037591)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens), WDR59 GOLPH3 RICTOR SEC13,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0030971,receptor tyrosine kinase binding,Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR029586)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN000544009)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens), SHC1 CBLC DUSP3 PTPN14,MF,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0006611,protein export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens), XPO1 XPO7 NUP214 HSPA9,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0001541,ovarian follicle development,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens), KMT2B KIT EIF2B5 LFNG,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0017158,regulation of calcium ion-dependent exocytosis,E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001972)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001485), SYT6 SYTL1 SYT4 SYTL2,BP,4,4 of 12,0.18,33.33,0.01815,0.06215
GO:0042100,B cell proliferation,P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT3 LOC104968438 ABL1 LEF1 IFNT2,BP,5,5 of 19,0.22,26.32,0.01847,0.06306
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), CRYAB SRC MKL1 LEF1 MT3,BP,5,5 of 19,0.22,26.32,0.01847,0.06306
GO:0042632,cholesterol homeostasis,E1BM29(Evidence code:IEA/Database source:InterPro:IPR030681)A6QNT8(Evidence code:IEA/Database source:UniProtKB:Q3U2P1|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens), CYP7A1 SEC24A NPC1 ABCA1 ALMS1,BP,5,5 of 19,0.22,26.32,0.01847,0.06306
GO:0010595,positive regulation of endothelial cell migration,F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q3TAS6)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), SASH1 FGF1 PDCD6 EMC10 ABL1,BP,5,5 of 19,0.22,26.32,0.01847,0.06306
GO:0019827,stem cell population maintenance,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens), TBX3 NIPBL RIF1 ARID1A SALL4,BP,5,5 of 19,0.22,26.32,0.01847,0.06306
GO:0090501,RNA phosphodiester bond hydrolysis,Q6TUI4(Evidence code:IEA/Database source:GO:0004525)E1BFK4(Evidence code:IEA/Database source:GO:0004540)A6QR44(Evidence code:IEA/Database source:GO:0004525)E1BK83(Evidence code:IEA/Database source:GO:0004526)F1MGC2(Evidence code:IEA/Database source:GO:0004540)A7YWM6(Evidence code:IEA/Database source:GO:0004540)E1BFB5(Evidence code:IEA/Database source:GO:0004526), DICER1 SMG6 DGCR8 RPP25 RNASE2 RNASE13 KIAA0391,BP,7,7 of 35,0.31,20,0.01908,0.06506
GO:0050768,negative regulation of neurogenesis,E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)P37359(Evidence code:IEA/Database source:UniProtKB:P28184|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)P63171(Evidence code:ISS/Database source:UniProtKB:P51807), PRTG MT3 DNAJB11 CTDSP1 SORL1 PCM1 DYNLT1,BP,7,7 of 35,0.31,20,0.01908,0.06506
GO:0007017,microtubule-based process,Q3MHR3(Evidence code:IEA/Database source:InterPro:IPR001372|I)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR000217|I)F6RP72(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575)P81948(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3ZCF0(Evidence code:IEA/Database source:InterPro:IPR028133)E1B953(Evidence code:IEA/Database source:InterPro:IPR000217|I)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:Q9Z0Y1|ens)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR000217|I)F1ME41(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1B7A3(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR000217|I)P61285(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR000217|I)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR000217|I), DYNLL2 TUBB1 LOC100295712 KIFC3 VBP1 TUBA4A DCTN2 LOC533307 LOC100141266 DCTN3 TUBA1A LOC101902172 TUBA1D LOC101905447 TUBA8 TUBB3 DYNLL1 TUBB4A TUBA3E,BP,19,19 of 149,0.83,12.75,0.01925,0.06561
GO:0009117,nucleotide metabolic process,Q32L93(Evidence code:IEA/Database source:InterPro:IPR005993)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0546)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0546), GMPR2 DNPH1 NUDT16,BP,3,3 of 147,0.13,2.04,0.01932,0.06579
GO:0050680,negative regulation of epithelial cell proliferation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851), CDK6 PEX2 DLG1 STRAP DAB2IP fgfr3,BP,6,6 of 27,0.26,22.22,0.01954,0.06639
GO:0031032,actomyosin structure organization,Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)F1N611(Evidence code:IBA/Database source:PANTHER:PTN001150527)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1BP72(Evidence code:IEA/Database source:UniProtKB:Q9Y5S2|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1MGE1(Evidence code:IBA/Database source:PANTHER:PTN001150527), F11R EPB41L1 MYO18A CDC42BPB TRPM7 FRMD5,BP,6,6 of 27,0.26,22.22,0.01954,0.06639
GO:0050776,regulation of immune response,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR031215), SH2B2 FCER1G IRF1,BP,3,3 of 148,0.13,2.03,0.01951,0.06639
GO:0048731,system development,F1MXR2(Evidence code:IBA/Database source:PANTHER:PTN001422142),ONECUT2,BP,1,1 of 94,0.04,1.06,0.02119,0.07198
GO:0045931,positive regulation of mitotic cell cycle,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens), DUSP3 STAT5A ABL1 BRCA2 POLDIP2 STAT5B ASNS,BP,7,7 of 37,0.31,18.92,0.02418,0.07241
GO:0033138,positive regulation of peptidyl-serine phosphorylation,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), PDCD10 TNKS1BP1 PAK1 TCL1A EIF4G1 GSK3A PINK1,BP,7,7 of 36,0.31,19.44,0.02153,0.07241
GO:0042493,response to drug,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q8R016|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), SMTNL1 PTPRM FZD1 LCK BLMH GATA6 NPC1,BP,7,7 of 37,0.31,18.92,0.02418,0.07241
GO:1901215,negative regulation of neuron death,A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62192|ens), CHMP4A CHMP4B SORL1 LRRK2 EN1 VPS35 PSMC1,BP,7,7 of 36,0.31,19.44,0.02153,0.07241
GO:0010634,positive regulation of epithelial cell migration,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BIX3(Evidence code:IEA/Database source:UniProtKB:Q9Y6W3|ens)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)Q58DW6(Evidence code:IEA/Database source:UniProtKB:P57735|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), SRC CAPN7 PLCG1 RREB1 RAB25 HYAL1,BP,6,6 of 28,0.26,21.43,0.02243,0.07241
GO:0010977,negative regulation of neuron projection development,E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q9TRY0(Evidence code:ISS/Database source:UniProtKB:P27124)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens), INPP5J RTN4R FKBP4 CRMP1 BAG5,BP,5,5 of 20,0.22,25,0.02186,0.07241
GO:0006749,glutathione metabolic process,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q3SZ15(Evidence code:IBA/Database source:PANTHER:PTN000136167)Q75WB5(Evidence code:IBA/Database source:PANTHER:PTN000146326)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443), G6PD EEF1E1 OPLAH CLIC6 CLIC4,BP,5,5 of 20,0.22,25,0.02186,0.07241
GO:0050808,synapse organization,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q8BHC1), PSEN1 SEMA3E NLGN2 LAMB2 RAB39B,BP,5,5 of 20,0.22,25,0.02186,0.07241
GO:0046540,U4/U6 x U5 tri-snRNP complex,E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens)A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760), SNRNP200 PRPF8 SNRPE SNRPN,CC,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0008584,male gonad development,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens), GATA6 KIT KLHL26 AGO4,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0030199,collagen fibril organization,E1BFV4(Evidence code:IEA/Database source:UniProtKB:B2RXX5|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:P05997|ens), ADAMTS14 COL1A2 COL2A1 COL5A2,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0048704,embryonic skeletal system morphogenesis,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), MEGF8 DLG1 HOXA7 MYF5,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0001578,microtubule bundle formation,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BF73(Evidence code:IEA/Database source:UniProtKB:Q3UHI0|ens), CDK5RAP2 NUMA1 SPAST CCSER2,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0030168,platelet activation,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), F2R PIK3CD GNA13 SRF,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0010507,negative regulation of autophagy,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens), LARS MT3 EIF4G1 SIRT2,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0007179,transforming growth factor beta receptor signaling pathway,P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens), COL1A2 SRC FERMT2 USP9X,BP,4,4 of 13,0.18,30.77,0.02251,0.07241
GO:0045746,negative regulation of Notch signaling pathway,Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens), ARRDC1 DLX2 CBFA2T2,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0019433,triglyceride catabolic process,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)P16386(Evidence code:IEA/Database source:UniPathway:UPA00256)Q2KI18(Evidence code:IEA/Database source:UniPathway:UPA00256), CPS1 LIPE PNPLA2,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0008541,"proteasome regulatory particle, lid subcomplex",Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911), PSMD14 PSMD12 PSMD13,CC,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490), LOC100125916 LOC788634 BoLA,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0030041,actin filament polymerization,Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)Q1RMR3(Evidence code:IEA/Database source:InterPro:IPR015503), CORO7 MICALL2 CTTN,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0070498,interleukin-1-mediated signaling pathway,F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), RPS6KA4 RPS6KA5 TRAF6,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0071364,cellular response to epidermal growth factor stimulus,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P52632)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens), STAT5B PLCG1 DUSP3,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:1900745,positive regulation of p38MAPK cascade,F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q3TAS6)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens), SASH1 EMC10 MAP3K4,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0006336,DNA replication-independent nucleosome assembly,F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens), ATRX H3F3B IPO4,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0090026,positive regulation of monocyte chemotaxis,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens), CXCL12 S100A14 ANO6,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0006353,"DNA-templated transcription, termination",A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0806), PRMT5 SETX DHX9,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0031418,L-ascorbic acid binding,P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0847)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR006620)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR006620), DBH P4HA2 EGLN3,MF,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0010800,positive regulation of peptidyl-threonine phosphorylation,P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens), UBE2K GSK3A TNKS1BP1,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0048240,sperm capacitation,Q5EA42(Evidence code:IEA/Database source:UniProtKB:P08910|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P26361), ABHD2 PRKACA CFTR,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0045453,bone resorption,F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), LRRK1 SRC TRAF6,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)F1MSU3(Evidence code:IEA/Database source:UniProtKB:Q8BGE9|ens)Q1JQB3(Evidence code:IBA/Database source:PANTHER:PTN000660850), F2R RXFP3 GPR4,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0019773,"proteasome core complex, alpha-subunit complex",Q58DU5(Evidence code:IEA/Database source:InterPro:IPR000426)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR000426)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR000426|I), PSMA3 PSMA7 PSMA4,CC,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0043950,positive regulation of cAMP-mediated signaling,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)P04896(Evidence code:ISS/Database source:UniProtKB:P63092), RAPGEF2 MB21D1 GNAS,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0045576,mast cell activation,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3SYX0(Evidence code:IEA/Database source:InterPro:IPR030693)P05059(Evidence code:ISS/Database source:UniProtKB:P10645), FCER1G NDRG1 CHGA,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163), SCRIB FAT1 DLG1,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0061014,positive regulation of mRNA catabolic process,Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens), GTPBP1 ZC3HAV1 PNPT1,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0071353,cellular response to interleukin-4,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)Q3SWY3(Evidence code:IEA/Database source:UniProtKB:P24547|ens), LEF1 KEAP1 IMPDH2,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0000245,spliceosomal complex assembly,A6QQX8(Evidence code:IEA/Database source:InterPro:IPR033809)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596745), USP39 GCFC2 LSM4,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0070584,mitochondrion morphogenesis,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens), PNPT1 FIS1 POLDIP2,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0045987,positive regulation of smooth muscle contraction,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824), CTTN SRF F2R,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0006998,nuclear envelope organization,A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)E1BIJ4(Evidence code:IBA/Database source:PANTHER:PTN001412149)F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000308195), TOR1A LEMD3 SPAG4,BP,3,3 of 7,0.13,42.86,0.02424,0.07241
GO:0001205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding",F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:Q61191|ens), NFKB1 HCFC1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0071481,cellular response to X-ray,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), ATM NIPBL,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0031915,positive regulation of synaptic plasticity,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens), UNC13A SNAP25,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0033604,negative regulation of catecholamine secretion,P05059(Evidence code:IDA/Database source:)A5D7F2(Evidence code:IEA/Database source:UniProtKB:Q9H2B2|ens), CHGA SYT4,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:2000535,regulation of entry of bacterium into host cell,F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q96KP1|ens), FUCA2 EXOC2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0032009,early phagosome,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493), UNC13B SNX3,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030539,male genitalia development,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens), TBX3 GREB1L,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035330,regulation of hippo signaling,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens), NF2 WWC1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0042101,T cell receptor complex,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740), ZAP70 ALCAM,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0001758,retinal dehydrogenase activity,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)P48644(Evidence code:IEA/Database source:EC:1.2.1.36), ALDH1A3 ALDH1A1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint,Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), DYNC1LI1 TPR,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1990381,ubiquitin-specific protease binding,Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), DZIP3 SYVN1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0050901,leukocyte tethering or rolling,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens), ITGB7 GOLPH3,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0005412,glucose:sodium symporter activity,E1B749(Evidence code:IBA/Database source:PANTHER:PTN001371381)Q3ZC26(Evidence code:IBA/Database source:PANTHER:PTN001371381), SLC5A9 SLC5A11,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0008340,determination of adult lifespan,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens), LRRK2 IDE,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006999,nuclear pore organization,E1BM06(Evidence code:IBA/Database source:PANTHER:PTN000327778)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), NDC1 TPR,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0046543,development of secondary female sexual characteristics,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030950,establishment or maintenance of actin cytoskeleton polarity,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282), ARHGAP35 RICTOR,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0090148,membrane fission,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), SPAST CHMP4B,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0070365,hepatocyte differentiation,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens), E2F7 TAF10,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens), MARCH7 PTTG1IP,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1903077,negative regulation of protein localization to plasma membrane,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens), TMEM59 PPP2R5A,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043546,molybdopterin cofactor binding,P48034(Evidence code:IEA/Database source:InterPro:IPR022407)F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens), AOX1 GPHN,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0033276,transcription factor TFTC complex,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens), TAF10 TAF2,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0021904,dorsal/ventral neural tube patterning,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), GLI2 PSEN1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0007492,endoderm development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens), SOX17 EXT1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0036310,annealing helicase activity,Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR030101)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), SMARCAL1 BLM,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006013,mannose metabolic process,Q3SZJ9(Evidence code:IBA/Database source:PANTHER:PTN000049281)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR000602|I), PMM2 MAN2C1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0032762,mast cell cytokine production,P43481(Evidence code:ISS/Database source:UniProtKB:P10721)P05059(Evidence code:ISS/Database source:UniProtKB:P10645), KIT CHGA,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0003222,ventricular trabecula myocardium morphogenesis,A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), UBE4B CHD7,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0016266,O-glycan processing,Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens), POMGNT1 GALNT2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030619,U1 snRNA binding,A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558)Q1RMR2(Evidence code:IEA/Database source:InterPro:IPR034143), PRPF8 SNRNP70,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030976,thiamine pyrophosphate binding,A5PJL6(Evidence code:IEA/Database source:InterPro:IPR011766|I)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603), HACL1 DHTKD1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035089,establishment of apical/basal cell polarity,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), SCRIB PRKCI,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0090102,cochlea development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), RPGRIP1L GABRA5,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0046931,pore complex assembly,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens), CCT3 ANO6,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035032,"phosphatidylinositol 3-kinase complex, class III",Q08DG0(Evidence code:IEA/Database source:UniProtKB:Q8VCQ3|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q8VD65|ens), NRBF2 PIK3R4,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0042765,GPI-anchor transamidase complex,F1N4W0(Evidence code:IEA/Database source:InterPro:IPR007245)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR028361), PIGT PIGK,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043368,positive T cell selection,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), BRAF BCL11B,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0008626,granzyme-mediated apoptotic signaling pathway,A6QNS2(Evidence code:IEA/Database source:UniProtKB:O95155|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens), UBE4B LAMP1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1903608,protein localization to cytoplasmic stress granule,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens), SSB DDX1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0042289,MHC class II protein binding,Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens), MARCH8 COL2A1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:1902741,positive regulation of interferon-alpha secretion,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), DDX58 DHX9,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0005131,growth hormone receptor binding,E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN001231348)F1MCX4(Evidence code:IEA/Database source:UniProtKB:P29597|ens), JAK2 TYK2,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0019788,NEDD8 transferase activity,A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806), UBE2M LOC780968,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0016303,1-phosphatidylinositol-3-kinase activity,E1BE66(Evidence code:IEA/Database source:InterPro:IPR008290)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens), PIK3CD ATM,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P05126(Evidence code:ISS/Database source:UniProtKB:P68404), MT3 PRKCB,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0022011,myelination in peripheral nervous system,G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), POU3F1 SIRT2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0097422,tubular endosome,Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1), VPS26A VPS35,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0005068,transmembrane receptor protein tyrosine kinase adaptor activity,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens), FRS2 SH2B2,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), FCER1G TRAF6,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0042908,xenobiotic transport,A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334), NR1I2 ABCC3,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0050321,tau-protein kinase activity,F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens), BRSK2 MARK3,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0004415,hyalurononglucosaminidase activity,F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens)Q5E985(Evidence code:IEA/Database source:InterPro:IPR018155), TMEM2 HYAL1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0001657,ureteric bud development,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), DLG1 SLIT2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0031698,beta-2 adrenergic receptor binding,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793), NEDD4 GNAS,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0070885,negative regulation of calcineurin-NFAT signaling cascade,E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), DYRK2 PRNP,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0001754,eye photoreceptor cell differentiation,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), AGTPBP1 STAT3,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043923,positive regulation by host of viral transcription,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens), LEF1 SP1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0002551,mast cell chemotaxis,P05059(Evidence code:ISS/Database source:UniProtKB:P10645)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens), CHGA KIT,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0003872,6-phosphofructokinase activity,Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR000023|I)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR000023|I), PFKM PFKP,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0002318,myeloid progenitor cell differentiation,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), BRAF KIT,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens), EEF1E1 ATM,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0071599,otic vesicle development,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5), COL2A1 AHI1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0044666,MLL3/4 complex,E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)F1MYZ3(Evidence code:IEA/Database source:InterPro:IPR037877), ASH2L KMT2C,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0016255,attachment of GPI anchor to protein,Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR028361)F1N4W0(Evidence code:IEA/Database source:InterPro:IPR007245), PIGK PIGT,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0010592,positive regulation of lamellipodium assembly,F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens), NCKAP1 WASF2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043277,apoptotic cell clearance,P27479(Evidence code:ISS/Database source:UniProtKB:P39654)F1N7K7(Evidence code:IEA/Database source:UniProtKB:Q60754|ens), ALOX15 MARCO,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0045198,establishment of epithelial cell apical/basal polarity,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), FOXF1 PTK7,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0016540,protein autoprocessing,A2VDV7(Evidence code:IEA/Database source:UniProtKB:O15393|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens), TMPRSS2 HFE2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0003309,type B pancreatic cell differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0), GATA6 INSM1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1901509,regulation of endothelial tube morphogenesis,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens), FGF1 ADAMTS12,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006098,pentose-phosphate shunt,F1MMK2(Evidence code:IEA/Database source:UniPathway:UPA00115)Q2TBQ8(Evidence code:IEA/Database source:InterPro:IPR005900), G6PD PGLS,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0044351,macropinocytosis,Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q3UMW7)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens), MAPKAPK3 SNX33,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043497,regulation of protein heterodimerization activity,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), CDON DAB2IP,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0034185,apolipoprotein binding,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), ABCA1 LRP6,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035050,embryonic heart tube development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), SOX17 TBX3,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0031996,thioesterase binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), TRAF6 ARF6,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:2000738,positive regulation of stem cell differentiation,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens), TACSTD2 SP7,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035418,protein localization to synapse,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens), SHANK1 BSN,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0097255,R2TP complex,Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR037942)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR037938), RUVBL2 RUVBL1,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0031462,Cul2-RING ubiquitin ligase complex,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q13617|ens), LOC780968 CUL2,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0071253,connexin binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), SRC TJP1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0071816,tail-anchored membrane protein insertion into ER membrane,Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765)Q3SZ26(Evidence code:IEA/Database source:InterPro:IPR028945|I), SGTA WRB,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0017145,stem cell division,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens), CUL3 WWTR1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060351,cartilage development involved in endochondral bone morphogenesis,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), COL2A1 SHOX2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0032958,inositol phosphate biosynthetic process,F1MNG6(Evidence code:IBA/Database source:PANTHER:PTN000297581)A4FV33(Evidence code:IEA/Database source:InterPro:IPR005522), PPIP5K2 ITPKA,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0021854,hypothalamus development,E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens), LEF1 RAX,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0010586,miRNA metabolic process,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens), ZCCHC6 AGO4,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BJW3(Evidence code:IEA/Database source:UniProtKB:Q9H8L6|ens), PDCD10 MMRN2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1990403,embryonic brain development,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5), EN1 RNF112,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0008157,protein phosphatase 1 binding,F1MCY2(Evidence code:IEA/Database source:InterPro:IPR029984)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), PHACTR4 SMTNL1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0008420,RNA polymerase II CTD heptapeptide repeat phosphatase activity,F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens), RPAP2 CTDSP1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030906,"retromer, cargo-selective complex",Q2HJG5(Evidence code:IEA/Database source:InterPro:IPR005378)Q0VD53(Evidence code:IEA/Database source:UniProtKB:O75436|ens), VPS35 VPS26A,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0010499,proteasomal ubiquitin-independent protein catabolic process,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q14145|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236), KEAP1 NFE2L2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060371,regulation of atrial cardiac muscle cell membrane depolarization,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens), SCN2B SCN10A,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9D3J3|ens), MARCH7 BCL2L12,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035331,negative regulation of hippo signaling,F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens), WWC1 MARK3,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0036477,somatodendritic compartment,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens), SNAP25 SYT4,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0000405,bubble DNA binding,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), WRN BLM,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060997,dendritic spine morphogenesis,E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), PAK3 SHANK1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0097197,tetraspanin-enriched microdomain,F1MJZ6(Evidence code:IEA/Database source:UniProtKB:O75954|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8QZY6|ens), TSPAN9 TSPAN14,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens), DAB2IP STAMBP,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0051256,mitotic spindle midzone assembly,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens), RACGAP1 KIF23,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0070878,primary miRNA binding,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens), SRF DGCR8,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0004814,arginine-tRNA ligase activity,Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001278|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001278|I), RARS2 RARS,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0046541,saliva secretion,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460), AQP5 KCNMA1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8WWN8|ens), SH3PXD2A ARAP3,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0097284,hepatocyte apoptotic process,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), STK3 ARF6,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0021952,central nervous system projection neuron axonogenesis,F1MLJ7(Evidence code:IBA/Database source:PANTHER:PTN000690515)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), SLIT2 SPTBN4,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0003214,cardiac left ventricle morphogenesis,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), GSK3A FOXF1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0017166,vinculin binding,F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)E1BIS6(Evidence code:IEA/Database source:UniProtKB:O15061|ens), UTRN SYNM,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0010459,negative regulation of heart rate,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), SPTBN4 SRI,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0016922,nuclear receptor binding,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens), NCOA3 ARID1A,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:1904263,positive regulation of TORC1 signaling,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596), LARS SEC13,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0032287,peripheral nervous system myelin maintenance,Q3SYX0(Evidence code:IEA/Database source:InterPro:IPR030693)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens), NDRG1 MPP5,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0036302,atrioventricular canal development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)O97711(Evidence code:ISS/Database source:UniProtKB:P70312), CHD7 HAS2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0016812,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides",A5PJV3(Evidence code:IEA/Database source:InterPro:IPR005920)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR002195), AMDHD1 CAD,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0004032,alditol:NADP+ 1-oxidoreductase activity,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)P16116(Evidence code:IEA/Database source:EC:1.1.1.21), AKR1A1 AKR1B1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0051103,DNA ligation involved in DNA repair,P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695)A4IFC8(Evidence code:IBA/Database source:PANTHER:PTN000048794), PARP1 LIG1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0032226,"positive regulation of synaptic transmission, dopaminergic",Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), FLOT1 PINK1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0021510,spinal cord development,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q95LI2(Evidence code:ISS/Database source:UniProtKB:Q8VHI5), SOX4 VIT,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006420,arginyl-tRNA aminoacylation,Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001278|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001278|I), RARS2 RARS,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0061003,positive regulation of dendritic spine morphogenesis,Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:P08413)F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298), CAMK2B CUX2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1903753,negative regulation of p38MAPK cascade,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens), DLG1 HSPH1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0002407,dendritic cell chemotaxis,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295), TRPM4 ANO6,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1903751,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens), PINK1 HSPH1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0035721,intraciliary retrograde transport,F1N307(Evidence code:IBA/Database source:PANTHER:PTN000380174)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens), TTC21A TTC21B,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006382,adenosine to inosine editing,F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0), ADARB1 NUDT16,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0070938,contractile ring,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens), PDXP UTRN,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), CHMP4A CHMP4B,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060161,positive regulation of dopamine receptor signaling pathway,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), VPS35 LRRK2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0048644,muscle organ morphogenesis,P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), MYF5 SMTNL1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0070528,protein kinase C signaling,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), FLOT1 DGKQ,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060013,righting reflex,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), ALDH1A3 SHANK1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0004505,phenylalanine 4-monooxygenase activity,Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61458|ens)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR005961), PCBD1 PAH,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0030540,female genitalia development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens), CHD7 TBX3,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0034116,positive regulation of heterotypic cell-cell adhesion,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens), FLOT1 LCK,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0046007,negative regulation of activated T cell proliferation,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BAW2(Evidence code:IEA/Database source:UniProtKB:G3XA59|ens), PRNP LRRC32,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation,Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens), STRAP EMILIN1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0021522,spinal cord motor neuron differentiation,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), SOX4 GLI2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060322,head development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), RPGRIP1L GLI2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0051010,microtubule plus-end binding,E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), CKAP5 NUMA1,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0007076,mitotic chromosome condensation,Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888)Q3MHQ9(Evidence code:IEA/Database source:InterPro:IPR022816), CHMP1A NCAPH,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:1904288,BAT3 complex binding,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens), USP13 SGTA,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0097178,ruffle assembly,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1MGT3(Evidence code:IEA/Database source:InterPro:IPR030059), ARF6 MTSS1L,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0006654,phosphatidic acid biosynthetic process,Q95JH2(Evidence code:IEA/Database source:UniProtKB:Q99943|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), AGPAT1 DGKQ,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0021846,cell proliferation in forebrain,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens), KIF14 FABP7,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0008160,protein tyrosine phosphatase activator activity,P20959(Evidence code:ISS/Database source:UniProtKB:P17936)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens), IGFBP3 PTPA,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060065,uterus development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), GREB1L SRC,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0046604,positive regulation of mitotic centrosome separation,Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604), NSFL1C RANBP2,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0032489,regulation of Cdc42 protein signal transduction,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), ABCA1 ABL1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0080025,"phosphatidylinositol-3,5-bisphosphate binding",Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens), SNX3 PLEKHA5,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0097428,protein maturation by iron-sulfur cluster transfer,E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR004640), MMS19 HSCB,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0036089,cleavage furrow formation,A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens), SNX18 SNX33,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0048143,astrocyte activation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)P02638(Evidence code:NAS/Database source:), PSEN1 S100B,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0090647,modulation of age-related behavioral decline,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), PRNP PSEN1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)F1N4Q3(Evidence code:IEA/Database source:UniProtKB:Q80VA0|ens), GALNT2 GALNT7,MF,2,2 of 2,0.09,100,0.02386,0.07241
GO:0060174,limb bud formation,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), COL2A1 SOX4,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0048821,erythrocyte development,Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR030133)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), TMOD3 SRF,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0098911,regulation of ventricular cardiac muscle cell action potential,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens), DLG1 TRPM4,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0002188,translation reinitiation,A6QLG1(Evidence code:IBA/Database source:PANTHER:PTN000513830)Q2KIE4(Evidence code:IBA/Database source:PANTHER:PTN000513830), LOC515358 MCTS1,BP,2,2 of 2,0.09,100,0.02386,0.07241
GO:0000221,"vacuolar proton-transporting V-type ATPase, V1 domain",O46563(Evidence code:IEA/Database source:InterPro:IPR004908|I)P21282(Evidence code:IBA/Database source:PANTHER:PTN000015490), ATP6V1H ATP6V1C1,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0071547,piP-body,Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens), DDX4 TDRD9,CC,2,2 of 2,0.09,100,0.02386,0.07241
GO:0071900,regulation of protein serine/threonine kinase activity,P58108(Evidence code:IEA/Database source:InterPro:IPR039166),PRKAG1,BP,1,1 of 95,0.04,1.05,0.02133,0.07241
GO:0098662,inorganic cation transmembrane transport,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens),TRPM4,BP,1,1 of 96,0.04,1.04,0.02157,0.07241
GO:0051640,organelle localization,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 98,0.04,1.02,0.02232,0.07241
GO:0009725,response to hormone,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,BP,1,1 of 96,0.04,1.04,0.02157,0.07241
GO:0009888,tissue development,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens),SALL4,BP,1,1 of 96,0.04,1.04,0.02157,0.07241
GO:0015267,channel activity,E1BF03(Evidence code:IEA/Database source:InterPro:IPR039099)F1N5Z0(Evidence code:IEA/Database source:InterPro:IPR000425), PANX3 AQP5,MF,2,2 of 117,0.09,1.71,0.0248,0.07404
GO:0006091,generation of precursor metabolites and energy,A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283)E1BFI2(Evidence code:IEA/Database source:UniProtKB:Q96HY7|ens), AASS DHTKD1,BP,2,2 of 120,0.09,1.67,0.02554,0.07622
GO:0045666,positive regulation of neuron differentiation,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q5E9L2(Evidence code:IEA/Database source:InterPro:IPR033237)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q6NZJ6|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), TCF7L2 BRINP1 EIF4G1 ECT2 CDON GLI2,BP,6,6 of 29,0.26,20.69,0.0256,0.07627
GO:0045727,positive regulation of translation,E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), BCL3 PIWIL2 SOX4 EIF6 EIF4A3 PINK1,BP,6,6 of 29,0.26,20.69,0.0256,0.07627
GO:0000387,spliceosomal snRNP assembly,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596745)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens), PRMT5 LSM4 SNRPE STRAP DDX20,BP,5,5 of 21,0.22,23.81,0.02563,0.07627
GO:0051897,positive regulation of protein kinase B signaling,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens), STK3 MYDGF RICTOR SRC TNFAIP8L3,BP,5,5 of 21,0.22,23.81,0.02563,0.07627
GO:0007189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P04896(Evidence code:ISS/Database source:UniProtKB:P63092)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens), PTH1R GNA13 ABCA1 GNAS ADORA2A,BP,5,5 of 21,0.22,23.81,0.02563,0.07627
GO:0007154,cell communication,E1BN52(Evidence code:IEA/Database source:InterPro:IPR003644)F1MFH3(Evidence code:IEA/Database source:InterPro:IPR003644)F1N740(Evidence code:IEA/Database source:InterPro:IPR003644), FREM1 FREM2 FRAS1,BP,3,3 of 138,0.13,2.17,0.02621,0.07795
GO:0004857,enzyme inhibitor activity,F1MYQ7(Evidence code:IEA/Database source:UniProtKB:E9Q8I9|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q2KJ77(Evidence code:IBA/Database source:PANTHER:PTN001062464), FRY CCAR2 HSPBP1,MF,3,3 of 139,0.13,2.16,0.02627,0.07809
GO:1990904,ribonucleoprotein complex,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q5U4C9|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A6QLG5(Evidence code:ISS/Database source:UniProtKB:P46781)Q28165(Evidence code:ISS/Database source:UniProtKB:Q86U42)P10881(Evidence code:IEA/Database source:InterPro:IPR002344)P61286(Evidence code:ISS/Database source:UniProtKB:P11940), EPRS DDX1 LRPPRC XPO1 RUVBL1 PABPC4 LRRK2 TDRD1 DYRK2 DHX9 RPS9 PABPN1 SSB PABPC1,CC,14,14 of 360,0.61,3.89,0.02669,0.07929
GO:0030030,cell projection organization,Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0970)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)P61420(Evidence code:IEA/Database source:UniProtKB-KW:KW-0970)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0970), ARL6 MYO1A ATP6V0D1 TEKT4,BP,4,4 of 164,0.18,2.44,0.02704,0.08027
GO:0007519,skeletal muscle tissue development,A0JN76(Evidence code:ISS/Database source:UniProtKB:Q9WUK6)Q0P571(Evidence code:IEA/Database source:UniProtKB:P97457|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens), ZBTB18 MYLPF MYF5 VAMP5,BP,4,4 of 14,0.18,28.57,0.02746,0.08135
GO:0032418,lysosome localization,Q2KI07(Evidence code:ISS/Database source:UniProtKB:Q9NVJ2)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)Q3ZC25(Evidence code:ISS/Database source:UniProtKB:Q9NUM4)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q7TSI1|ens), ARL8B HPS6 TMEM106B PLEKHM1,BP,4,4 of 14,0.18,28.57,0.02746,0.08135
GO:0043204,perikaryon,Q2KHY1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)P56722(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), CPNE6 LRRK2 PTPRN SIRT2,CC,4,4 of 14,0.18,28.57,0.02746,0.08135
GO:0044291,cell-cell contact zone,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569), FLOT1 RAP2C SCRIB PKP4,CC,4,4 of 14,0.18,28.57,0.02746,0.08135
GO:0005507,copper ion binding,Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O00244|ens)P10279(Evidence code:ISS/Database source:UniProtKB:P04156)P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR006122)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), ATOX1 PRNP DBH SCO1 ATP7B MT3,MF,6,6 of 30,0.26,20,0.02906,0.08597
GO:0045454,cell redox homeostasis,Q0II43(Evidence code:IEA/Database source:InterPro:IPR013766|I)E1BBS6(Evidence code:IEA/Database source:InterPro:IPR013766)O62768(Evidence code:IEA/Database source:InterPro:IPR004099)A4FUW8(Evidence code:IEA/Database source:InterPro:IPR013766)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)Q58DA7(Evidence code:IEA/Database source:InterPro:IPR002109|I), TXNL1 QSOX2 TXNRD1 TXNDC11 NFE2L2 GLRX3,BP,6,6 of 30,0.26,20,0.02906,0.08597
GO:0043330,response to exogenous dsRNA,F1MKU1(Evidence code:IEA/Database source:UniProtKB:Q6Q899|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q91VR5|ens)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053), DDX58 DDX1 IFNT3 IFNT2 LOC104968438,BP,5,5 of 22,0.22,22.73,0.02979,0.0881
GO:0016798,"hydrolase activity, acting on glycosyl bonds",E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)A7MBJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)H7BWW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326), DNPH1 MAN1A2 MAN1B1 LYZ1 HYAL1 EDEM2 HEXB FUCA1,MF,8,8 of 48,0.35,16.67,0.02992,0.08843
GO:0030198,extracellular matrix organization,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), EMILIN1 MYF5 COL4A6 FOXF1 BCL3 OLFML2A NDNF,BP,7,7 of 39,0.31,17.95,0.03015,0.08905
GO:0051090,regulation of DNA-binding transcription factor activity,E1B793(Evidence code:IEA/Database source:UniProtKB:Q9NRP7|ens),STK36,BP,1,1 of 87,0.04,1.15,0.03044,0.08987
GO:0022618,ribonucleoprotein complex assembly,Q32PB9(Evidence code:IBA/Database source:PANTHER:PTN000103359),RPL38,BP,1,1 of 90,0.04,1.11,0.03109,0.09172
GO:0032206,positive regulation of telomere maintenance,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q96QC0|ens), ATRX SIRT6 PPP1R10,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0042098,T cell proliferation,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)Q3T0T1(Evidence code:IEA/Database source:UniProtKB:O35955|ens), RC3H2 MALT1 PSMB10,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0006261,DNA-dependent DNA replication,Q05B83(Evidence code:IBA/Database source:PANTHER:PTN000186208)F1MFY4(Evidence code:IEA/Database source:InterPro:IPR027044)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR002298), RFC2 HELB POLQ,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0001953,negative regulation of cell-matrix adhesion,E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens), ADAM15 SEMA3E HOXA7,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0030073,insulin secretion,P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens), PTPRN SNX19 RAPGEF4,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0051965,positive regulation of synapse assembly,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)A4IFI5(Evidence code:IEA/Database source:UniProtKB:Q8BHA1|ens)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens), CUX2 LRRC24 BDNF,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0047497,mitochondrion transport along microtubule,Q5E9M9(Evidence code:ISS/Database source:UniProtKB:Q8IXI1)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)Q2HJF8(Evidence code:ISS/Database source:UniProtKB:Q8IXI2), RHOT2 KIF1B RHOT1,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0016575,histone deacetylation,Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320|I)Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), HDAC5 MIER1 SIRT2,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0000175,3-5-exoribonuclease activity,E1BML0(Evidence code:IEA/Database source:UniProtKB:Q504Q3|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)Q0II50(Evidence code:ISS/Database source:UniProtKB:Q9BQ65), PAN2 PNPT1 USB1,MF,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0010181,FMN binding,Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR012133)Q27995(Evidence code:IEA/Database source:InterPro:IPR001094|I)Q4JIJ2(Evidence code:IEA/Database source:InterPro:IPR001094|I), HAO2 NOS2 MTRR,MF,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0009086,methionine biosynthetic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0486)Q4JIJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0486), MTHFD1 MRI1 MTRR,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0048741,skeletal muscle fiber development,F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), DNER RYR1 PPP3CA,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0035145,exon-exon junction complex,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens), SMG6 EIF4A3 SRSF1,CC,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0030042,actin filament depolymerization,G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR017904)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939), MICAL3 DSTN MICAL2,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0018149,peptide cross-linking,Q6TNF3(Evidence code:IEA/Database source:InterPro:IPR001102|I)A6QP57(Evidence code:IEA/Database source:InterPro:IPR001102|I)P51176(Evidence code:IEA/Database source:InterPro:IPR001102|I), TGM1 TGM3 TGM2,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0043539,protein serine/threonine kinase activator activity,Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens), ETAA1 TCL1A FAM20A,MF,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0010955,negative regulation of protein processing,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens), TMEM59 LRRK2 SNX12,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0061512,protein localization to cilium,F1N307(Evidence code:IBA/Database source:PANTHER:PTN000380174)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:Q9H0F7|ens)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q7Z4L5|ens), TTC21A ARL6 TTC21B,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0007498,mesoderm development,P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens), PPP2CA FOXF1 EXT1,BP,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,Q95KU9(Evidence code:IEA/Database source:InterPro:IPR034735)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens), IKBKG OTUD7B PRPF8,MF,3,3 of 8,0.13,37.5,0.03172,0.09249
GO:0006644,phospholipid metabolic process,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 91,0.04,1.1,0.03156,0.09249
GO:0015934,large ribosomal subunit,P61356(Evidence code:ISS/Database source:UniProtKB:A1XQU5),RPL27,CC,1,1 of 92,0.04,1.09,0.03216,0.09373
GO:0010951,negative regulation of endopeptidase activity,E1BHA8(Evidence code:IEA/Database source:GO:0004866)P20811(Evidence code:IEA/Database source:GO:0004869)F1N226(Evidence code:IEA/Database source:GO:0004867)G3X894(Evidence code:IEA/Database source:GO:0004867)E1BE13(Evidence code:IEA/Database source:GO:0004869)E1B7H2(Evidence code:IEA/Database source:GO:0004867), CPAMD8 CAST APLP2 LOC786263 BIRC6 COL7A1,BP,6,6 of 31,0.26,19.35,0.0328,0.09549
GO:0051289,protein homotetramerization,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61458|ens), TRPM4 HCN1 SHMT2 CRYZ ALDH1A3 PCBD1,BP,6,6 of 31,0.26,19.35,0.0328,0.09549
GO:0000077,DNA damage checkpoint,E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)E1BGK8(Evidence code:IBA/Database source:PANTHER:PTN000485246)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR018324), ATM DOT1L E2F1 RAD17,BP,4,4 of 15,0.18,26.67,0.03302,0.0959
GO:0051291,protein heterooligomerization,Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61458|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB:Q9NVA2|ens), CLDN3 CHMP2A PCBD1 SEPT11,BP,4,4 of 15,0.18,26.67,0.03302,0.0959
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,P62248(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BLD5(Evidence code:IEA/Database source:UniProtKB:Q96AX2|ens), MYDGF PROM1 COPB1 RAB37,CC,4,4 of 15,0.18,26.67,0.03302,0.0959
GO:2000045,regulation of G1/S transition of mitotic cell cycle,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), KIF14 E2F1 INO80 PTPN6,BP,4,4 of 15,0.18,26.67,0.03302,0.0959
GO:0060548,negative regulation of cell death,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), VPS4B CHMP2A VPS35 RAD18 SOX4 CHMP4B,BP,6,6 of 202,0.26,2.97,0.03349,0.09721
GO:0019903,protein phosphatase binding,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)E1BHP3(Evidence code:IEA/Database source:UniProtKB:Q6ZSY5|ens), SNX3 LCK CDC27 GRB2 PPP1R3F,MF,5,5 of 23,0.22,21.74,0.03436,0.09968
GO:1901137,carbohydrate derivative biosynthetic process,Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR005855)F1MZY2(Evidence code:IEA/Database source:InterPro:IPR005855), GFPT2 GFPT1,BP,2,2 of 110,0.09,1.82,0.03459,0.1002
GO:0005774,vacuolar membrane,P23956(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241), ATP6V0C NAPG,CC,2,2 of 109,0.09,1.83,0.03456,0.1002
GO:0045596,negative regulation of cell differentiation,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), SUZ12 POU4F2,BP,2,2 of 113,0.09,1.77,0.03535,0.1023
GO:0008047,enzyme activator activity,F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616), RICTOR ARL1,MF,2,2 of 113,0.09,1.77,0.03535,0.1023
GO:0036464,cytoplasmic ribonucleoprotein granule,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q5E9F9(Evidence code:IEA/Database source:UniProtKB:A0A140VK70)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)F1MW03(Evidence code:IEA/Database source:UniProtKB:Q8NFU3|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9BYH8|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:Q71U36|ens), DHX9 PSMC2 PCBP1 TSTD1 INA DDX3X DDX3Y NFKBIZ TUBA1A,CC,9,9 of 54,0.39,16.67,0.0355,0.1026
GO:0016779,nucleotidyltransferase activity,E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)P06526(Evidence code:IEA/Database source:InterPro:IPR019843)E1BAR2(Evidence code:IEA/Database source:InterPro:IPR002934)Q0VC66(Evidence code:IEA/Database source:UniRule:UR000160875)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)Q2YDJ9(Evidence code:IEA/Database source:InterPro:IPR005835)E1BCH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)G3MZY8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548), POLA1 DNTT ZCCHC6 CTU1 POLE4 GMPPB ISPD MB21D1 POLR2A,MF,9,9 of 54,0.39,16.67,0.0355,0.1026
GO:0009314,response to radiation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), KIT PLK3,BP,2,2 of 114,0.09,1.75,0.03583,0.1036
GO:0019221,cytokine-mediated signaling pathway,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)F1MTF9(Evidence code:IEA/Database source:GO:0004896)G3X7E9(Evidence code:IEA/Database source:GO:0004896)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)E1B7G0(Evidence code:IBA/Database source:PANTHER:PTN000466212), JAK2 LOC104968438 IFNT3 STAT5B KIT RTN4R IL9R IL13RA1 STAT5A SH2B2 IFNT2 IFNLR1,BP,12,12 of 86,0.53,13.95,0.03773,0.1037
GO:0005858,axonemal dynein complex,E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277911)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens), WDR78 DNAH5,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0016139,glycoside catabolic process,F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)Q2KIM0(Evidence code:IEA/Database source:UniProtKB:P04066|ens), FUCA2 FUCA1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0033173,calcineurin-NFAT signaling cascade,A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), PPP3CC PPP3CA,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,Q01107(Evidence code:TAS/Database source:)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444), DSC1 ARVCF,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0044208,de novo AMP biosynthetic process,A7MBG0(Evidence code:IEA/Database source:UniPathway:UPA00075)A3KN12(Evidence code:IEA/Database source:UniPathway:UPA00075), ADSS ADSL,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0005883,neurofilament,Q08DH7(Evidence code:IEA/Database source:InterPro:IPR027703)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens), INA SHANK2,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0007042,lysosomal lumen acidification,P23956(Evidence code:IBA/Database source:PANTHER:PTN000813819)F1MX24(Evidence code:IBA/Database source:PANTHER:PTN000104838), ATP6V0C CLN3,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0071285,cellular response to lithium ion,Q29450(Evidence code:ISS/Database source:UniProtKB:P51829)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), ADCY7 GSK3A,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0007263,nitric oxide mediated signal transduction,F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)Q27995(Evidence code:IBA/Database source:PANTHER:PTN001066032), NDNF NOS2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0035067,negative regulation of histone acetylation,Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens), BRCA1 CTBP1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0016591,"RNA polymerase II, holoenzyme",F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens), RPAP2 MYO6,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030014,CCR4-NOT complex,E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BHL0(Evidence code:IEA/Database source:InterPro:IPR019312), TNKS1BP1 CNOT11,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0042994,cytoplasmic sequestering of transcription factor,A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN000697161)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens), KEAP1 SRI,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0045780,positive regulation of bone resorption,E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q7TSI1|ens), TFRC PLEKHM1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0007004,telomere maintenance via telomerase,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280), PTGES3 SMG6,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0032497,detection of lipopolysaccharide,Q9GL65(Evidence code:ISS/Database source:UniProtKB:O00206)P58754(Evidence code:ISS/Database source:UniProtKB:Q9Y6Y9), TLR4 LY96,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0016331,morphogenesis of embryonic epithelium,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)F1MEC8(Evidence code:IEA/Database source:UniProtKB:Q7TSK3|ens), SCRIB PCDH8,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0016581,NuRD complex,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens), APPL1 APPL2,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0004525,ribonuclease III activity,Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR000999|I)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens), DICER1 DGCR8,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0031748,D1 dopamine receptor binding,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793), VPS35 GNAS,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0005220,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493), ITPR1 ITPR2,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0001956,positive regulation of neurotransmitter secretion,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens), UNC13A BAIAP3,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0046696,lipopolysaccharide receptor complex,P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), LY96 TLR4,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0005720,nuclear heterochromatin,A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens), UHRF1 TNKS1BP1,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:2001222,regulation of neuron migration,Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:Q13554)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens), CAMK2B CAMK2A,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030214,hyaluronan catabolic process,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens), HYAL1 TMEM2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), SASH1 TRAF6,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0006809,nitric oxide biosynthetic process,E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens)Q27995(Evidence code:IEA/Database source:InterPro:IPR004030|I), SLC7A2 NOS2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0060444,branching involved in mammary gland duct morphogenesis,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), TBX3 SRC,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030220,platelet formation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), PTPN6 SRF,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0003689,DNA clamp loader activity,A6QNK6(Evidence code:IEA/Database source:InterPro:IPR018324)Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250), RAD17 RFC2,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0036091,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens), MT3 CHD6,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0036157,outer dynein arm,Q3T140(Evidence code:IBA/Database source:PANTHER:PTN002244005)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000840538), DYNLRB1 DNAH5,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:1903204,negative regulation of oxidative stress-induced neuron death,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)F1MTK2(Evidence code:IEA/Database source:UniProtKB:Q8K0P3|ens), FZD1 TLDC1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0006348,chromatin silencing at telomere,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)E1BGK8(Evidence code:IBA/Database source:PANTHER:PTN000485246), RIF1 DOT1L,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0090166,Golgi disassembly,Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P39951), PLK3 CDK1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0031672,A band,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens), MYBPC3 MYL3,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0048194,Golgi vesicle budding,E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens), MYO18A GOLPH3,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0005391,sodium:potassium-exchanging ATPase activity,A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775)Q8HYW6(Evidence code:IEA/Database source:EC:3.6.3.9), ATP1A2 atp1A3,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:1904357,negative regulation of telomere maintenance via telomere lengthening,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens), TERF2 TNKS,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0032584,growth cone membrane,A6QLD1(Evidence code:IEA/Database source:UniProtKB:O35382|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7), EXOC4 ZFYVE27,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0042813,Wnt-activated receptor activity,F1MDE1(Evidence code:IEA/Database source:InterPro:IPR017049)A7MB15(Evidence code:IEA/Database source:InterPro:IPR026548), LRP6 FZD1,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0035360,positive regulation of peroxisome proliferator activated receptor signaling pathway,F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O35936|ens), STARD10 ALOX15B,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030901,midbrain development,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), EN1 LRP6,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0072001,renal system development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens), FOXF1 SOX17,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030007,cellular potassium ion homeostasis,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens), ATP1A2 KCNMA1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0008469,histone-arginine N-methyltransferase activity,A7YW45(Evidence code:IBA/Database source:PANTHER:PTN000077429)A6QL80(Evidence code:IBA/Database source:PANTHER:PTN000109455), PRMT5 PRMT3,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0001502,cartilage condensation,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), COL2A1 MYF5,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0048012,hepatocyte growth factor receptor signaling pathway,Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens), PAK1 SIRT2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0042982,amyloid precursor protein metabolic process,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768), DLG1 PSEN1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0042088,T-helper 1 type immune response,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), BCL3 TRAF6,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:1901621,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens), PRKACA PRKACB,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0043116,negative regulation of vascular permeability,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens), SLIT2 ARHGAP35,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q9UKS6|ens), SNX33 PACSIN3,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0034098,VCP-NPL4-UFD1 AAA ATPase complex,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q0P568(Evidence code:IEA/Database source:UniProtKB:P70362|ens), UBXN1 UFD1L,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:1904659,glucose transmembrane transport,E1B749(Evidence code:IBA/Database source:PANTHER:PTN001371381)Q3ZC26(Evidence code:IBA/Database source:PANTHER:PTN001371381), SLC5A9 SLC5A11,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0060718,chorionic trophoblast cell differentiation,F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2), MAP3K4 E2F7,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0010815,bradykinin catabolic process,Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)Q1JPJ2(Evidence code:ISS/Database source:UniProtKB:Q9NQW7), IDE XPNPEP1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0097038,perinuclear endoplasmic reticulum,Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens), CAPN2 SYT6,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030423,targeting of mRNA for destruction involved in RNA interference,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3), DHX9 DICER1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0051444,negative regulation of ubiquitin-protein transferase activity,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), PSEN1 ABL1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0017147,Wnt-protein binding,F1MDE1(Evidence code:IEA/Database source:InterPro:IPR017049)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), LRP6 FZD1,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0006166,purine ribonucleoside salvage,Q17R18(Evidence code:IEA/Database source:InterPro:IPR001805)Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0660), ADK MTAP,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0090036,regulation of protein kinase C signaling,G3MWT9(Evidence code:IEA/Database source:InterPro:IPR028540)Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens), AKAP12 SEZ6L2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0044754,autolysosome,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), LAMP1 LRRK2,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0090129,positive regulation of synapse maturation,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:P08413), DAB2IP CAMK2B,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0036435,K48-linked polyubiquitin modification-dependent protein binding,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q0P568(Evidence code:IEA/Database source:UniProtKB:P70362|ens), UBXN1 UFD1L,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0009931,calcium-dependent protein serine/threonine kinase activity,Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), MAPKAPK3 CAMK2A,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), CHD7 PDE4D,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0005787,signal peptidase complex,P67810(Evidence code:IEA/Database source:InterPro:IPR037712)Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653), SEC11A SPCS3,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0070208,protein heterotrimerization,F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O88286|ens)P02465(Evidence code:IEA/Database source:UniProtKB:Q01149|ens), WIZ COL1A2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0060976,coronary vasculature development,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), MEGF8 PTK7,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0002138,retinoic acid biosynthetic process,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)P02694(Evidence code:IEA/Database source:InterPro:IPR031264), ALDH1A3 RBP1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0035641,locomotory exploration behavior,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens), LRRK2 CRH,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0031105,septin complex,Q3SZN0(Evidence code:IEA/Database source:InterPro:IPR030644)Q6Q137(Evidence code:IEA/Database source:InterPro:IPR008115), SEPT6 SEPT7,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0030878,thyroid gland development,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), BRAF SRF,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0033601,positive regulation of mammary gland epithelial cell proliferation,E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens), RREB1 AGAP2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0008484,sulfuric ester hydrolase activity,Q08DD1(Evidence code:IEA/Database source:InterPro:IPR000917)A6QPY4(Evidence code:IEA/Database source:InterPro:IPR000917), ARSA SGSH,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0033622,integrin activation,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens), CXCL12 FERMT2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0000188,inactivation of MAPK activity,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)A6QLS1(Evidence code:IEA/Database source:GO:0017017), DUSP3 DUSP7,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0021983,pituitary gland development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens), GLI2 GLI1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0050774,negative regulation of dendrite morphogenesis,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), RAPGEF2 PPP3CA,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0031080,nuclear pore outer ring,Q3ZCC9(Evidence code:ISS/Database source:UniProtKB:P55735)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens), SEC13 AHCTF1,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0034450,ubiquitin-ubiquitin ligase activity,A6QNS2(Evidence code:IEA/Database source:InterPro:IPR019474)P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens), UBE4B UBE2K,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0045656,negative regulation of monocyte differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens), CDK6 HOXA7,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0043495,protein membrane anchor,F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000308195)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), SPAG4 PDCD6,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0014898,cardiac muscle hypertrophy in response to stress,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), GATA6 PPP3CA,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0001135,RNA polymerase II transcription factor recruiting activity,E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606), SNAPC4 CDC5L,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0070324,thyroid hormone binding,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens), ALDH1A3 CRYM,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0006707,cholesterol catabolic process,P37359(Evidence code:ISS/Database source:UniProtKB:P28184)E1BM29(Evidence code:IEA/Database source:InterPro:IPR030681), MT3 CYP7A1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0006526,arginine biosynthetic process,F1MVC0(Evidence code:IBA/Database source:PANTHER:PTN000150223)F1ML89(Evidence code:IBA/Database source:PANTHER:PTN000150223), CAD CPS1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0021884,forebrain neuron development,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens), RAPGEF2 SOX1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0043030,regulation of macrophage activation,E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens), SLC7A2 MYO18A,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:2000641,regulation of early endosome to late endosome transport,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens), SRC DNAJC13,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0007129,synapsis,E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens), NDC1 RAD21L1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0070734,histone H3-K27 methylation,E1B9T7(Evidence code:IEA/Database source:GO:0046976)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), SUZ12 EHMT2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0001964,startle response,F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens), CHD8 FABP7,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0042421,norepinephrine biosynthetic process,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)P15101(Evidence code:ISS/Database source:UniProtKB:P09172), INSM1 DBH,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0004012,phospholipid-translocating ATPase activity,E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539|I)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539), ATP8B1 ATP11A,MF,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0000164,protein phosphatase type 1 complex,P61287(Evidence code:IEA/Database source:InterPro:IPR037981)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR037979), PPP1CC PPP1CB,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0016281,eukaryotic translation initiation factor 4F complex,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens), EIF4H EIF4G1,CC,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0007220,Notch receptor processing,F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), DNER PSEN1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0036159,inner dynein arm assembly,F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN001321402)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens), DNHD1 DNAH7,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0002053,positive regulation of mesenchymal cell proliferation,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), SHOX2 FOXF1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0019673,GDP-mannose metabolic process,Q2KIT8(Evidence code:IEA/Database source:UniProtKB:Q13630|ens)Q3ZBY8(Evidence code:IEA/Database source:InterPro:IPR006368), TSTA3 GMDS,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0046549,retinal cone cell development,P04696(Evidence code:IEA/Database source:UniProtKB:P50149|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens), GNAT2 HCN1,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0033160,"positive regulation of protein import into nucleus, translocation",Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), PSEN1 LRRK2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0032211,negative regulation of telomere maintenance via telomerase,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens), SRC TERF2,BP,2,2 of 3,0.09,66.67,0.03804,0.1037
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)F1ML16(Evidence code:IEA/Database source:InterPro:IPR028424)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens), PRKDC BRCA2 HIC1 E2F1,BP,4,4 of 16,0.18,25,0.03917,0.1066
GO:0010633,negative regulation of epithelial cell migration,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens), TACSTD2 PTPN23 DAB2IP STRAP,BP,4,4 of 16,0.18,25,0.03917,0.1066
GO:0019897,extrinsic component of plasma membrane,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1MH24(Evidence code:IDA/Database source:)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P08207|ens), NUMA1 AAK1 HIST1H2BA S100A10,CC,4,4 of 16,0.18,25,0.03917,0.1066
GO:0051321,meiotic cell cycle,Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0469)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0469)F1N2F6(Evidence code:IEA/Database source:InterPro:IPR013940)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085), DDX4 PPP2CA TEX11 TUBGCP2,BP,4,4 of 16,0.18,25,0.03917,0.1066
GO:0030659,cytoplasmic vesicle membrane,Q2HJ40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD59(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)E0AE16(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)Q17QU4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BHK6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QQP7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)P04973(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DW1(Evidence code:IEA/Database source:UniProtKB:Q9R0M6|ens)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDY3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IFN6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), BACE1 MARCH8 MYO1C SNX9 VAMP5 RAB39B SNX33 DYSF VAMP1 KIF1B CLTA RAB9A TMEM184A CHMP4A SNX18 AP1S1,CC,16,16 of 126,0.7,12.7,0.03933,0.1069
GO:0008026,ATP-dependent helicase activity,E1BEE6(Evidence code:IEA/Database source:InterPro:IPR004589)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR006555)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR004589)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499), WRN ERCC2 BLM SNRNP200 DDX1,MF,5,5 of 24,0.22,20.83,0.03933,0.1069
GO:0042981,regulation of apoptotic process,Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN001231382)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MPW1(Evidence code:IEA/Database source:UniProtKB:Q14689|ens)F1MN90(Evidence code:IBA/Database source:PANTHER:PTN000959605)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR012227)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)P26882(Evidence code:IBA/Database source:PANTHER:PTN000869969)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F1N6N6(Evidence code:IEA/Database source:InterPro:IPR008477)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK70(Evidence code:IBA/Database source:PANTHER:PTN000142983)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)A6QPJ9(Evidence code:IEA/Database source:InterPro:IPR036834)A5PJP5(Evidence code:IBA/Database source:PANTHER:PTN001121970)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR035065)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR035065)E1B9A2(Evidence code:IEA/Database source:InterPro:IPR001315)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens), LCK TAOK2 TAOK3 DIP2A CIDEC MAP3K14 PAK4 STK25 MAP3K4 TRAF6 JAK2 WRN MAP3K8 NF2 PPID MALT1 PAK6 STK26 TNFAIP8L3 STK3 MAP3K1 NME3 MAP2K4 BCL3 BCL2L12 PINK1 PAK1 PAK2 PAK3 CARD6 FRS2 NAE1 SLK,BP,33,33 of 317,1.45,10.41,0.03952,0.1074
GO:0030141,secretory granule,A5D7A2(Evidence code:IEA/Database source:UniProtKB:Q9CZD3|ens)P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BEQ4(Evidence code:IBA/Database source:PANTHER:PTN001208501)P05059(Evidence code:IEA/Database source:InterPro:IPR001819|I)P23389(Evidence code:IEA/Database source:InterPro:IPR001819|I)Q9TU34(Evidence code:IDA/Database source:)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305), GARS RAB3B PTPRN BRCA2 LOC505658 CHGA CHGB ITPR1 RNPEP,CC,9,9 of 57,0.39,15.79,0.0399,0.108
GO:0006914,autophagy,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q08DG0(Evidence code:IEA/Database source:InterPro:IPR015056)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072)E1BH30(Evidence code:IEA/Database source:InterPro:IPR026849)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917), PSEN1 NPC1 NRBF2 USP13 CHMP4B RAB39B TMEM59 ATG2B LOC516599,BP,9,9 of 57,0.39,15.79,0.0399,0.108
GO:0034613,cellular protein localization,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)A4FUY1(Evidence code:IEA/Database source:UniProtKB:Q640R3|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), LRRK2 AXIN2 RAP2A HEPACAM AHI1 NIPBL SPTBN4,BP,7,7 of 215,0.31,3.26,0.0401,0.108
GO:0006367,transcription initiation from RNA polymerase II promoter,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens), TCF7L2 TAF10 TAF2,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0019933,cAMP-mediated signaling,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), RAPGEF4 RAPGEF2 DGKQ,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0048514,blood vessel morphogenesis,A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens), MEIS1 COL4A1 ETV2,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0043392,negative regulation of DNA binding,F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), ZNF462 E2F1 LEF1,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0045214,sarcomere organization,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569), SRF MYLK3 MYBPC3,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:1901224,positive regulation of NIK/NF-kappaB signaling,A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens), PDCD4 RC3H2 SASH1,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0045907,positive regulation of vasoconstriction,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558), SMTNL1 DBH F2R,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0031624,ubiquitin conjugating enzyme binding,F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens), ANKIB1 MARCH7 TRAF6,MF,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0060236,regulation of mitotic spindle organization,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), GPSM2 GNAI1 NUMA1,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0048487,beta-tubulin binding,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), RACGAP1 LRPPRC SPAST,MF,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0042311,vasodilation,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)P63026(Evidence code:IMP/Database source:), CPS1 KCNMA1 VAMP2,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0070129,regulation of mitochondrial translation,E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17), LRPPRC SHMT2 MTG1,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0001530,lipopolysaccharide binding,Q3T108(Evidence code:IEA/Database source:UniProtKB:P99026|ens)Q9GL65(Evidence code:IBA/Database source:PANTHER:PTN000687407)P58754(Evidence code:IEA/Database source:InterPro:IPR039217), PSMB4 TLR4 LY96,MF,3,3 of 9,0.13,33.33,0.04026,0.108
GO:2000249,regulation of actin cytoskeleton reorganization,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens), PHPT1 F11R SEMA3E,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0006071,glycerol metabolic process,Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0319)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394)F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394), GK LOC538702 GK2,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0043153,entrainment of circadian clock by photoperiod,P61287(Evidence code:ISS/Database source:UniProtKB:P63087)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens), PPP1CC PPP1CB NR2F6,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0005885,Arp2/3 protein complex,Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383), ARPC5L ACTR3B ARPC1A,CC,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0005665,"RNA polymerase II, core complex",G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000684)F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR028363), POLR2A CHD6 POLR2F,CC,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0002026,regulation of the force of heart contraction,Q58DA7(Evidence code:ISS/Database source:UniProtKB:Q9CQM9)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens), GLRX3 ATP1A2 MYL3,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0070301,cellular response to hydrogen peroxide,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens), ABL1 KDM6B SETX,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0033344,cholesterol efflux,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens), ABCA1 NPC1 ABCA7,BP,3,3 of 9,0.13,33.33,0.04026,0.108
GO:0007166,cell surface receptor signaling pathway,E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR017981)Q58CZ7(Evidence code:IBA/Database source:PANTHER:PTN001060286)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN001553005)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR017981)A7MB15(Evidence code:IEA/Database source:InterPro:IPR000539|I)F1MJZ6(Evidence code:IBA/Database source:PANTHER:PTN001060286)Q2KJ41(Evidence code:IBA/Database source:PANTHER:PTN001060286)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR003153|I)P46196(Evidence code:IBA/Database source:PANTHER:PTN001171853)Q9BDR7(Evidence code:IEA/Database source:InterPro:IPR003110)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN001060286)P26917(Evidence code:IBA/Database source:PANTHER:PTN000059370)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR017981), PTH2R TSPAN2 MAPKAPK3 PTH1R FZD1 TSPAN9 TSPAN14 CBLC MAPK1 FCER1G CD63 SST KHDRBS1 CD97,BP,14,14 of 344,0.61,4.07,0.04095,0.1098
GO:0034976,response to endoplasmic reticulum stress,Q5E953(Evidence code:IEA/Database source:UniProtKB:Q9Y3C8|ens)Q08DG0(Evidence code:IEA/Database source:UniProtKB:Q8VCQ3|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)A4FUW8(Evidence code:IBA/Database source:PANTHER:PTN000432607)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61961)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), UFC1 NRBF2 FLOT1 PPP2CB UBQLN1 TXNDC11 UBE4B UFM1 ALOX15 EIF2B5,BP,10,10 of 70,0.44,14.29,0.04177,0.1119
GO:0006812,cation transport,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR027256)E1BF03(Evidence code:IEA/Database source:InterPro:IPR039099)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR006544)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR029601), TRPM4 ATP7B PANX3 ATP13A5 ANO6 TRPM7,BP,6,6 of 191,0.26,3.14,0.04277,0.1146
GO:0050662,coenzyme binding,Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR001509),TSTA3,MF,1,1 of 81,0.04,1.23,0.04376,0.1171
GO:0072594,establishment of protein localization to organelle,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 83,0.04,1.2,0.04424,0.1184
GO:0006458,de novo protein folding,Q32L40(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3ZCI9(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q2NKZ1(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T0K2(Evidence code:IBA/Database source:PANTHER:PTN000143677), TCP1 CCT8 CCT7 CCT6B CCT3,BP,5,5 of 25,0.22,20,0.04471,0.1196
GO:0008033,tRNA processing,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q3SX07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819)Q0VC66(Evidence code:IEA/Database source:InterPro:IPR035107)E1BFB5(Evidence code:IEA/Database source:InterPro:IPR033495)A5D7S3(Evidence code:IEA/Database source:InterPro:IPR002905)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819)Q3ZBM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819), SSB PUS3 CTU1 KIAA0391 TRMT1L DDX1 TRPT1,BP,7,7 of 43,0.31,16.28,0.04487,0.1199
GO:0019787,ubiquitin-like protein transferase activity,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens),RNF139,MF,1,1 of 85,0.04,1.18,0.04543,0.1214
GO:0060828,regulation of canonical Wnt signaling pathway,Q00KA9(Evidence code:IEA/Database source:InterPro:IPR030799)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49769)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens), LRP4 LRRK2 WWTR1 AMER3 PSEN1 CCNY,BP,6,6 of 34,0.26,17.65,0.04586,0.1223
GO:0010970,transport along microtubule,F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223362)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277824)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223362)A5PKJ3(Evidence code:IEA/Database source:InterPro:IPR027663)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223362)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223362), LOC101902172 DYNC1I2 DYNLL2 DCTN1 DYNLL1 LOC101905447,BP,6,6 of 34,0.26,17.65,0.04586,0.1223
GO:0030593,neutrophil chemotaxis,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)F1MMH2(Evidence code:IEA/Database source:UniProtKB:B8JK39|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), FCER1G PREX1 ITGA9 PDE4D,BP,4,4 of 17,0.18,23.53,0.04594,0.1223
GO:0003727,single-stranded RNA binding,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), AGO4 DLX2 DDX58 DHX9,MF,4,4 of 17,0.18,23.53,0.04594,0.1223
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458), CDK6 CDK1 CDK3 CCNL1,CC,4,4 of 17,0.18,23.53,0.04594,0.1223
GO:0042542,response to hydrogen peroxide,P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens), CRYAB PDCD10 STK26 PPP2CB,BP,4,4 of 17,0.18,23.53,0.04594,0.1223
GO:0003707,steroid hormone receptor activity,F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001723)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001723)Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001723|I), NR2F6 NR1I2 ABHD2 ESRRG,MF,4,4 of 17,0.18,23.53,0.04594,0.1223
GO:0001933,negative regulation of protein phosphorylation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens), INSM1 PRKDC WWTR1 PSEN1 CTDSP1 LRRK2 SLIT2 DAB2IP LRP6 IGFBP3 PRNP CRKL,BP,12,12 of 91,0.53,13.19,0.04633,0.1233
GO:0004175,endopeptidase activity,Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR000426|I)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR000243|I)A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661)E1BIX3(Evidence code:IEA/Database source:UniProtKB:Q9Y6W3|ens)Q3T112(Evidence code:IEA/Database source:InterPro:IPR000243|I)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)P42891(Evidence code:IDA/Database source:)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR000426)P33672(Evidence code:IEA/Database source:InterPro:IPR016050)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR000426)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9QY73|ens)Q3T108(Evidence code:IEA/Database source:InterPro:IPR016050), PSMA4 PSMB9 PSMD1 CAPN7 PSMB8 PSMD2 ECE1 PSMA7 PSMB3 PSMA3 MBTPS1 PCSK6 BACE1 PSMB10 PSEN1 TMEM59 PSMB4,MF,17,17 of 139,0.75,12.23,0.04975,0.1313
GO:0045806,negative regulation of endocytosis,E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens), PACSIN3 PACSIN2 SNX33,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0030501,positive regulation of bone mineralization,A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens)E1BAI2(Evidence code:IEA/Database source:UniProtKB:Q9UEF7|ens)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295), GPM6B KL ANO6,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0035861,site of double-strand break,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9), RIF1 RAD18 SMARCAL1,CC,3,3 of 10,0.13,30,0.04983,0.1313
GO:0042622,photoreceptor outer segment membrane,P04696(Evidence code:IDA/Database source:)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)P04695(Evidence code:IDA/Database source:), GNAT2 PROM1 GNAT1,CC,3,3 of 10,0.13,30,0.04983,0.1313
GO:0048643,positive regulation of skeletal muscle tissue development,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), CDON FLOT1 SOX17,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0060048,cardiac muscle contraction,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q6PDM2|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens), SCN2B SRSF1 MYL3,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0010324,membrane invagination,Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens), CHMP2A CHMP4A SNX3,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",F1MXW0(Evidence code:IEA/Database source:InterPro:IPR000907|I)P27479(Evidence code:IEA/Database source:InterPro:IPR000907|I)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR013547), ALOX15B ALOX15 P4HA2,MF,3,3 of 10,0.13,30,0.04983,0.1313
GO:0043491,protein kinase B signaling,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens), MT3 SIRT2 SETX,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0016574,histone ubiquitination,E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens), HUWE1 UHRF1 SUZ12,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0008307,structural constituent of muscle,E1BIS6(Evidence code:IEA/Database source:InterPro:IPR030634)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)Q0P571(Evidence code:IEA/Database source:UniProtKB:P97457|ens), SYNM MYBPC3 MYLPF,MF,3,3 of 10,0.13,30,0.04983,0.1313
GO:0035025,positive regulation of Rho protein signal transduction,Q1JQB3(Evidence code:IBA/Database source:PANTHER:PTN000660850)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q9BZR6|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558), GPR4 RTN4R F2R,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0031985,Golgi cisterna,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), GOLPH3 RAB30 SORL1,CC,3,3 of 10,0.13,30,0.04983,0.1313
GO:0007035,vacuolar acidification,O46563(Evidence code:IBA/Database source:PANTHER:PTN000075631)P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens), ATP6V1H ATP6V0D1 CLIC4,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0003746,translation elongation factor activity,F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I)Q3SZ15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251)Q3SZ32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251), EIF5A2 EEF1E1 TCEB2,MF,3,3 of 10,0.13,30,0.04983,0.1313
GO:0032391,photoreceptor connecting cilium,G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens), PCDHB8 C1H21ORF2 GNAT1,CC,3,3 of 10,0.13,30,0.04983,0.1313
GO:0006368,transcription elongation from RNA polymerase II promoter,E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q3SZ32(Evidence code:IEA/Database source:InterPro:IPR039049)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455), CDK12 TCEB2 CDK13,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0005798,Golgi-associated vesicle,F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)A7Z035(Evidence code:TAS/Database source:)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), STK26 CLINT1 LRRK2,CC,3,3 of 10,0.13,30,0.04983,0.1313
GO:0072091,regulation of stem cell proliferation,Q6T5B7(Evidence code:IEA/Database source:InterPro:IPR028603)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), AGO3 SOX17 NF2,BP,3,3 of 10,0.13,30,0.04983,0.1313
GO:0000151,ubiquitin ligase complex,A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)E1BB00(Evidence code:IBA/Database source:PANTHER:PTN001194385)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR019474)Q3SZ52(Evidence code:ISS/Database source:UniProtKB:Q13404)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)E1BBN5(Evidence code:IEA/Database source:UniProtKB:Q8R516|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens), CAND1 DYRK2 UBE2D2 ASB10 ANKIB1 UBE4B UBE2V1 ASB14 MIB2 IKBKG UBR2,CC,11,11 of 79,0.48,13.92,0.05043,0.1328
GO:0030667,secretory granule membrane,Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q504M8|ens)Q8WN96(Evidence code:IDA/Database source:)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN001179253)Q1RMW2(Evidence code:ISS/Database source:UniProtKB:Q3UFJ6), RAB26 ITPR2 DBH RAB37 TMEM184A,CC,5,5 of 26,0.22,19.23,0.05052,0.1329
GO:0030307,positive regulation of cell growth,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens), EIF4G1 LEF1 HYAL1 H3F3B INO80,BP,5,5 of 26,0.22,19.23,0.05052,0.1329
GO:0005875,microtubule associated complex,Q0P5A1(Evidence code:IEA/Database source:UniProtKB:Q9Z0Y1|ens)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)P61285(Evidence code:IEA/Database source:InterPro:IPR019763)F1ME41(Evidence code:IEA/Database source:InterPro:IPR019763)E1B7A3(Evidence code:IEA/Database source:InterPro:IPR019763)Q3MHR3(Evidence code:IEA/Database source:InterPro:IPR019763), DCTN3 KIF1B DYNLL1 LOC101902172 LOC101905447 DYNLL2,CC,6,6 of 35,0.26,17.14,0.05084,0.1336
GO:0006352,"DNA-templated transcription, initiation",A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A5PJW1(Evidence code:IEA/Database source:InterPro:IPR003923)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR004823)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR007900), TCF7L2 TAF10 LOC619094 TAF4B,BP,4,4 of 18,0.18,22.22,0.05331,0.1365
GO:0007052,mitotic spindle organization,Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)Q3ZCF0(Evidence code:IBA/Database source:PANTHER:PTN000394123)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens), KIF2A PCNT DCTN2 GPSM2,BP,4,4 of 18,0.18,22.22,0.05331,0.1365
GO:0006446,regulation of translational initiation,Q5E938(Evidence code:IEA/Database source:UniProtKB:P41567|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A7MB16(Evidence code:ISS/Database source:UniProtKB:P55884)Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR016020), EIF1 EIF4G1 EIF3B EIF3K,BP,4,4 of 18,0.18,22.22,0.05331,0.1365
GO:0070411,I-SMAD binding,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens), AXIN2 AXIN1,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0030898,actin-dependent ATPase activity,Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens), MYO1D MYH14,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0010744,positive regulation of macrophage derived foam cell differentiation,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens), ALOX15B MAPK9,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0030132,clathrin coat of coated pit,P04973(Evidence code:IEA/Database source:InterPro:IPR000996)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens), CLTA EPS15,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0009881,photoreceptor activity,F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0600)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0600), RRH RGR,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0015278,calcium-release channel activity,Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR033215), ITPR1 RYR1,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0032703,negative regulation of interleukin-2 production,E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), NAV3 PRNP,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,P04696(Evidence code:IBA/Database source:PANTHER:PTN000026521)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026521), GNAT2 GNAT3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0042755,eating behavior,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), ADORA2A STAT3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001766,membrane raft polarization,A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512256)A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512256), PLLP MAL2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0016208,AMP binding,P58108(Evidence code:ISS/Database source:UniProtKB:P80385)A7YWF1(Evidence code:IEA/Database source:InterPro:IPR011904), PRKAG1 ACSS2,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0006167,AMP biosynthetic process,Q17R18(Evidence code:IEA/Database source:GO:0004001)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR027529), ADK ADSS,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0008045,motor neuron axon guidance,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens), SLIT2 RNF165,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0097352,autophagosome maturation,Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), UBQLN1 CLN3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0005227,calcium activated cation channel activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581), ANO6 TRPM4,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0085029,extracellular matrix assembly,O97711(Evidence code:ISS/Database source:UniProtKB:P70312)A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens), HAS2 GPM6B,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0070402,NADPH binding,O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens), CRYZ GRHPR,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0051123,RNA polymerase II transcriptional preinitiation complex assembly,E1BGK7(Evidence code:IEA/Database source:GO:0001075)F1MME0(Evidence code:IEA/Database source:GO:0001075), TAF4B TAF2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0046621,negative regulation of organ growth,F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens), WWC1 STK3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0030728,ovulation,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens), KMT2B ALMS1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048255,mRNA stabilization,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens), E2F1 AXIN2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0006895,Golgi to endosome transport,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737), EPS15 CORO7,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0007205,protein kinase C-activating G-protein coupled receptor signaling pathway,E1BGA9(Evidence code:IEA/Database source:InterPro:IPR000756)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824), DGKQ F2R,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:2001275,positive regulation of glucose import in response to insulin stimulus,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), IRS1 POU4F2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0009301,snRNA transcription,F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)E1BCK9(Evidence code:IEA/Database source:InterPro:IPR031282), RPAP2 SNAPC4,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:2000780,negative regulation of double-strand break repair,E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens), TRIP12 OTUB1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048566,embryonic digestive tract development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), GLI2 FOXF1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0051601,exocyst localization,A4IF89(Evidence code:IBA/Database source:PANTHER:PTN000484343)Q0V8C2(Evidence code:IBA/Database source:PANTHER:PTN000480155), EXOC8 EXOC3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0060563,neuroepithelial cell differentiation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), ABL1 SOX4,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0019432,triglyceride biosynthetic process,E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565)F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens), LPIN2 GPAT2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0015269,calcium-activated potassium channel activity,F1N4T0(Evidence code:IBA/Database source:PANTHER:PTN000002873)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens), KCNT2 KCNMA1,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0047372,acylglycerol lipase activity,Q5EA42(Evidence code:IEA/Database source:EC:3.1.1.23)Q08DW9(Evidence code:IEA/Database source:InterPro:IPR026605), ABHD2 ABHD12,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0070816,phosphorylation of RNA polymerase II C-terminal domain,E1BB52(Evidence code:ISS/Database source:UniProtKB:Q14004)E1BB50(Evidence code:ISS/Database source:UniProtKB:Q9NYV4), CDK13 CDK12,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001759,organ induction,P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens), FGF1 FRS2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0017070,U6 snRNA binding,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817)A7Z025(Evidence code:IEA/Database source:InterPro:IPR019580), LSM4 PRPF8,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0018344,protein geranylgeranylation,F1N2I0(Evidence code:IEA/Database source:InterPro:IPR001738)P29702(Evidence code:ISS/Database source:UniProtKB:P49354), CHML FNTA,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048009,insulin-like growth factor receptor signaling pathway,E1BAH0(Evidence code:IEA/Database source:UniProtKB:Q99MR1|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), GIGYF1 IRS1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0030123,AP-3 adaptor complex,E1BME2(Evidence code:IEA/Database source:InterPro:IPR026740)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens), AP3B2 VPS41,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048168,regulation of neuronal synaptic plasticity,P02638(Evidence code:IEA/Database source:UniProtKB:P50114|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), S100B CAMK2A,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0000492,box C/D snoRNP assembly,Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244)A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244), RUVBL2 RUVBL1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0045843,negative regulation of striated muscle tissue development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens), LEF1 SIRT2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0060045,positive regulation of cardiac muscle cell proliferation,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), GLI1 GATA6,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0008544,epidermis development,G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0), POU3F1 ZNF750,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0000243,commitment complex,Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359236)E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979), SNRNP70 UHMK1,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048147,negative regulation of fibroblast proliferation,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens), DAB2IP PEX2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:1904322,cellular response to forskolin,P35071(Evidence code:ISS/Database source:UniProtKB:P13569)P63097(Evidence code:ISS/Database source:UniProtKB:P10824), CFTR GNAI1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0034113,heterotypic cell-cell adhesion,E1BN05(Evidence code:IEA/Database source:GO:0086080)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens), GLDN ITGB7,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0086004,regulation of cardiac muscle cell contraction,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), PDE4D SRI,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0071354,cellular response to interleukin-6,A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens), SBNO2 NFKB1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0006559,L-phenylalanine catabolic process,Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR005961)Q58CZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0585), PAH TAT,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0015020,glucuronosyltransferase activity,A5D7I4(Evidence code:IEA/Database source:InterPro:IPR027670)F1MFF6(Evidence code:IEA/Database source:EC:2.4.1.17), EXT1 UGT2B10,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0034380,high-density lipoprotein particle assembly,E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), ABCA7 ABCA1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048484,enteric nervous system development,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)G3N1E4(Evidence code:IEA/Database source:UniProtKB:Q52KG5|ens), PHACTR4 KIF26A,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048048,embryonic eye morphogenesis,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens), AXIN1 ALDH1A3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0005109,frizzled binding,A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), FZD1 LRP6,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0005952,cAMP-dependent protein kinase complex,P00515(Evidence code:IEA/Database source:InterPro:IPR012198)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens), PRKAR2A PRKACA,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0031119,tRNA pseudouridine synthesis,Q3SX07(Evidence code:ISS/Database source:UniProtKB:Q9BZE2)F1MRD5(Evidence code:IBA/Database source:PANTHER:PTN000490775), PUS3 PUS10,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",P61286(Evidence code:ISS/Database source:UniProtKB:P29341)F1MLT5(Evidence code:IEA/Database source:UniProtKB:Q9HCJ0|ens), PABPC1 TNRC6C,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0006228,UTP biosynthetic process,A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564)A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564), NME1 NME3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:1904646,cellular response to amyloid-beta,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), PRNP PSEN1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0006911,"phagocytosis, engulfment",Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens), FCER1G ABCA1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0045182,translation regulator activity,A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens), RPS9 AARS,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001975,response to amphetamine,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens), DBH ADORA2A,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0060411,cardiac septum morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens), CHD7 DNAH11,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0004862,cAMP-dependent protein kinase inhibitor activity,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)Q0VCK2(Evidence code:IEA/Database source:InterPro:IPR004171), PRKAR2A PKIB,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:1900016,negative regulation of cytokine production involved in inflammatory response,Q29450(Evidence code:ISS/Database source:UniProtKB:P51829)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q61823|ens), ADCY7 PDCD4,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0035234,ectopic germ cell programmed cell death,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), PRKDC KIT,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001875,lipopolysaccharide receptor activity,P58754(Evidence code:ISS/Database source:UniProtKB:Q9Y6Y9)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), LY96 TLR4,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0071437,invadopodium,O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153), SVIL PAK1,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0021670,lateral ventricle development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens), RPGRIP1L DNAH5,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0070050,neuron cellular homeostasis,Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BNF8(Evidence code:IEA/Database source:UniProtKB:Q96C11|ens), CHMP2B FGGY,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:2000480,negative regulation of cAMP-dependent protein kinase activity,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)Q0VCK2(Evidence code:IBA/Database source:PANTHER:PTN000395870), PRKAR2A PKIB,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0030315,T-tubule,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), RYR1 ATP1A2,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001779,natural killer cell differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0017134,fibroblast growth factor binding,E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), KL RPS19,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0035249,"synaptic transmission, glutamatergic",F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027082), UNC13B UNC13A,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0035458,cellular response to interferon-beta,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens), PNPT1 UBE2K,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0035195,gene silencing by miRNA,Q9TU47(Evidence code:ISS/Database source:UniProtKB:P56537)F1MLT5(Evidence code:IEA/Database source:UniProtKB:Q9HCJ0|ens), EIF6 TNRC6C,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0048743,positive regulation of skeletal muscle fiber development,P17667(Evidence code:IBA/Database source:PANTHER:PTN000898840)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), MYF5 SHOX2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0098789,pre-mRNA cleavage required for polyadenylation,G3MZ78(Evidence code:IBA/Database source:PANTHER:PTN000566843)O19137(Evidence code:IBA/Database source:PANTHER:PTN000559780), CSTF2T CPSF4,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0002385,mucosal immune response,E1B7G0(Evidence code:IEA/Database source:UniProtKB:Q8CGK5|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens), IFNLR1 OTUD7B,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0060087,relaxation of vascular smooth muscle,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q9ERL9|ens), KCNMA1 GUCY1A3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0035246,peptidyl-arginine N-methylation,A6QL80(Evidence code:IEA/Database source:GO:0016274)A7YW45(Evidence code:IEA/Database source:InterPro:IPR007857), PRMT3 PRMT5,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0072673,lamellipodium morphogenesis,Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens), ABI1 WASF2,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0009880,embryonic pattern specification,F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), SIM2 LRP6,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0016274,protein-arginine N-methyltransferase activity,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)A6QL80(Evidence code:IEA/Database source:UniProtKB:Q922H1|ens), PRMT5 PRMT3,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0014003,oligodendrocyte development,E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)A7E331(Evidence code:IBA/Database source:PANTHER:PTN000003938), EIF2B5 PRDM8,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,P61286(Evidence code:ISS/Database source:UniProtKB:P29341)F1MLT5(Evidence code:IEA/Database source:UniProtKB:Q9HCJ0|ens), PABPC1 TNRC6C,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0071439,clathrin complex,P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens), CLTA VPS41,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0008024,cyclin/CDK positive transcription elongation factor complex,E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455), CDK12 CDK13,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0008020,G-protein coupled photoreceptor activity,F1MR98(Evidence code:IBA/Database source:PANTHER:PTN001202194)P47803(Evidence code:IBA/Database source:PANTHER:PTN001202194), RRH RGR,MF,2,2 of 4,0.09,50,0.05459,0.1365
GO:0030660,Golgi-associated vesicle membrane,O02811(Evidence code:ISS/Database source:UniProtKB:O08662)Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287), PI4KA ITM2B,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0018119,peptidyl-cysteine S-nitrosylation,Q27995(Evidence code:ISS/Database source:UniProtKB:P29477)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens), NOS2 ADH5,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0007094,mitotic spindle assembly checkpoint,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), ATM TPR,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0033210,leptin-mediated signaling pathway,P37359(Evidence code:ISS/Database source:UniProtKB:P28184)P61635(Evidence code:ISS/Database source:UniProtKB:P40763), MT3 STAT3,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0061700,GATOR2 complex,A7MBJ6(Evidence code:IEA/Database source:InterPro:IPR037591)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens), WDR59 SEC13,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens), VPS4B CDK1,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001702,gastrulation with mouth forming second,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens), FRS2 ZBTB17,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0071438,invadopodium membrane,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)P53712(Evidence code:ISS/Database source:UniProtKB:P05556), DPP4 ITGB1,CC,2,2 of 4,0.09,50,0.05459,0.1365
GO:0042118,endothelial cell activation,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744), TCF7L2 PRMT5,BP,2,2 of 4,0.09,50,0.05459,0.1365
GO:0001666,response to hypoxia,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), KCNMA1 CRYAB PRKCB EGLN3 CLDN3 SRF RYR1 MT3,BP,8,8 of 50,0.35,16,0.05494,0.1373
GO:0030176,integral component of endoplasmic reticulum membrane,E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens)Q9TU34(Evidence code:IDA/Database source:)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081292)Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens), ANKLE2 ITPR1 ZFYVE27 SLC35B1 DPM3 EXT1,CC,6,6 of 36,0.26,16.67,0.05613,0.1402
GO:0005925,focal adhesion,P80746(Evidence code:ISS/Database source:UniProtKB:P06756)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BL04(Evidence code:IEA/Database source:UniProtKB:A4UGR9|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q69Z38|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)Q08E52(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q8SQB8(Evidence code:ISS/Database source:UniProtKB:P18564)Q2YDE9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens), ITGAV PRUNE1 XIRP2 PEAK1 MAPK1 PAK1 ITGB6 TES ITGB1 NUP214 JAK2 ARL2 FERMT2,CC,13,13 of 103,0.57,12.62,0.05806,0.1449
GO:0006469,negative regulation of protein kinase activity,G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001107228)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)Q0VCK2(Evidence code:IEA/Database source:InterPro:IPR004171), RTN4R LRP6 PREX1 NF2 PPP1R1C PSEN1 WWTR1 PKIB,BP,8,8 of 52,0.35,15.38,0.05936,0.1481
GO:0006325,chromatin organization,Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)Q32S26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)M5FK72(Evidence code:IEA/Database source:InterPro:IPR026936)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156), HDAC5 PKN1 DOT1L UHRF1 RUVBL2 LRWD1 BRD2 ZNF462 PRMT5 PRKCB CHD8 UBN1 ARID1A HIST1H2BA AEBP2 BRCC3 KMT2A,BP,17,17 of 148,0.75,11.49,0.05965,0.1488
GO:0005771,multivesicular body,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens), LAMP1 CD63 BACE1,CC,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0032728,positive regulation of interferon-beta production,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), FLOT1 IRF1 DDX58,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0031640,killing of cells of other organism,P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0295)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), CHGA RPL30 RPS19,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0045740,positive regulation of DNA replication,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), GLI1 GLI2 DHX9,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0007339,binding of sperm to zona pellucida,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)Q08DD1(Evidence code:IEA/Database source:UniProtKB:P50428|ens)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P23578|ens), CCT3 ARSA ACR,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0007585,respiratory gaseous exchange,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0305), MAPK8IP3 MAN1A2 SFTPD,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0014704,intercalated disc,Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), VAMP5 SPTBN4 TJP1,CC,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0051489,regulation of filopodium assembly,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), ARF6 RAB17 CLN3,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,P05059(Evidence code:IDA/Database source:)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens), CHGA RPS19 RPL30,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0071560,cellular response to transforming growth factor beta stimulus,G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), CRKL YES1 SRC,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0034719,SMN-Sm protein complex,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens)Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4), SNRPE DDX20 STRAP,CC,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0071320,cellular response to cAMP,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P26361), RAPGEF2 HCN1 CFTR,BP,3,3 of 11,0.13,27.27,0.06039,0.1497
GO:0071277,cellular response to calcium ion,E1BPM0(Evidence code:IEA/Database source:InterPro:IPR037776)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q2KHY1(Evidence code:IEA/Database source:UniProtKB:Q9Z140|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens), RASAL1 ALOX15 CPNE6 CLIC4,BP,4,4 of 19,0.18,21.05,0.06128,0.1517
GO:0001085,RNA polymerase II transcription factor binding,F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens), GATA6 TBX3 SRF SPEN,MF,4,4 of 19,0.18,21.05,0.06128,0.1517
GO:0005876,spindle microtubule,Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), KIF2A CDC27 CDK1 NUMA1,CC,4,4 of 19,0.18,21.05,0.06128,0.1517
GO:0004519,endonuclease activity,F1MGC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)E1BPX9(Evidence code:IBA/Database source:PANTHER:PTN000755749)A5PJT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)A7YWM6(Evidence code:IBA/Database source:PANTHER:PTN000153528), RNASE2 DICER1 LRPPRC DNASE1L2 TSN AGO3 DNASE1L1 RNASE13,MF,8,8 of 53,0.35,15.09,0.06199,0.1534
GO:0032388,positive regulation of intracellular transport,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,BP,1,1 of 75,0.04,1.33,0.06279,0.1552
GO:0016570,histone modification,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 74,0.04,1.35,0.06276,0.1552
GO:0098797,plasma membrane protein complex,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,CC,1,1 of 76,0.04,1.32,0.06305,0.1557
GO:0004866,endopeptidase inhibitor activity,E1BHA8(Evidence code:IEA/Database source:InterPro:IPR002890),CPAMD8,MF,1,1 of 76,0.04,1.32,0.06305,0.1557
GO:0007611,learning or memory,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)P02638(Evidence code:ISS/Database source:UniProtKB:P50114)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), PRNP S100B PTPRZ1 DNAH11 PSEN1,BP,5,5 of 28,0.22,17.86,0.06339,0.1565
GO:0046486,glycerolipid metabolic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 78,0.04,1.28,0.06429,0.1587
GO:0070124,mitochondrial translational initiation,Q32KZ1(Evidence code:IEA/Database source:UniProtKB:Q9H2K0|ens),MTIF3,BP,1,1 of 79,0.04,1.27,0.06526,0.161
GO:0042742,defense response to bacterium,Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q06285(Evidence code:IEA/Database source:InterPro:IPR030056)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)P46161(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044)P46165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)C6KGD8(Evidence code:IEA/Database source:InterPro:IPR030773)Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453991), S100A14 LYZ1 BCL3 FCER1G PLAC8 DEFB3 DEFB7 CHGA ANKRD17 HSTN NOS2,BP,11,11 of 86,0.48,12.79,0.06539,0.1611
GO:0045859,regulation of protein kinase activity,E1BBQ3(Evidence code:IEA/Database source:GO:0008607)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)A1A4J7(Evidence code:ISS/Database source:UniProtKB:Q8ND04)Q0P5L1(Evidence code:IEA/Database source:GO:0019887), IKBKAP CCNYL1 SMG8 GCN1L1,BP,4,4 of 145,0.18,2.76,0.06539,0.1611
GO:0040008,regulation of growth,Q0IIE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens), SHC1 MCTS1 HEPACAM IGFBP3,BP,4,4 of 145,0.18,2.76,0.06539,0.1611
GO:0050708,regulation of protein secretion,A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793),ARFIP1,BP,1,1 of 80,0.04,1.25,0.06646,0.1636
GO:0046873,metal ion transmembrane transporter activity,A7MBI9(Evidence code:IEA/Database source:InterPro:IPR001046)G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689), SLC11A2 SLC39A6,MF,2,2 of 97,0.09,2.06,0.06698,0.1648
GO:0045732,positive regulation of protein catabolic process,E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), AXIN1 SOX17 SNF8 DAB2IP NEDD4 SORL1,BP,6,6 of 38,0.26,15.79,0.06767,0.1664
GO:0016571,histone methylation,E1BNH7(Evidence code:IEA/Database source:UniProtKB:Q9BZ95|ens)F1MMF1(Evidence code:IEA/Database source:GO:0042054)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens), WHSC1L1 PRDM13 EHMT2 SUZ12,BP,4,4 of 20,0.18,20,0.06984,0.1715
GO:0043039,tRNA aminoacylation,G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR012947)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR012947), EPRS QARS AARS AARS2,BP,4,4 of 20,0.18,20,0.06984,0.1715
GO:0006836,neurotransmitter transport,A5D7H9(Evidence code:IEA/Database source:InterPro:IPR000175)O18875(Evidence code:IEA/Database source:InterPro:IPR000175|I)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR000175|I)F1N5R0(Evidence code:IEA/Database source:InterPro:IPR000175), SLC6A14 SLC6A8 SLC6A20 SLC6A5,BP,4,4 of 20,0.18,20,0.06984,0.1715
GO:0042326,negative regulation of phosphorylation,P02638(Evidence code:IEA/Database source:GO:0019210)E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens), S100B ANKLE2,BP,2,2 of 102,0.09,1.96,0.06983,0.1715
GO:0005657,replication fork,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens), WRN UHRF1 RAD18,CC,3,3 of 12,0.13,25,0.07191,0.1717
GO:0090314,positive regulation of protein targeting to membrane,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), MYO1C FIS1 PRNP,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0051693,actin filament capping,F1MKE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117)E1BLT3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117), SPTB RDX SPTBN4,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116), SRI ABL1 F2R,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0030544,Hsp70 protein binding,P26882(Evidence code:IDA/Database source:)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens), PPID DNAJB2 CDK1,MF,3,3 of 12,0.13,25,0.07191,0.1717
GO:0015485,cholesterol binding,E1B7M8(Evidence code:IEA/Database source:UniProtKB:Q969R2|ens)A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens), OSBP2 SCAP NPC1,MF,3,3 of 12,0.13,25,0.07191,0.1717
GO:0043171,peptide catabolic process,G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960)E1BP91(Evidence code:IBA/Database source:PANTHER:PTN000164249), RNPEP LTA4H NPEPPS,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0005801,cis-Golgi network,Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:O00512|ens), RAB30 SCFD1 BCL9,CC,3,3 of 12,0.13,25,0.07191,0.1717
GO:0043542,endothelial cell migration,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487), GIPC1 ABL1 DPP4,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0032024,positive regulation of insulin secretion,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)A6QR34(Evidence code:IEA/Database source:InterPro:IPR039073), SOX4 PFKM GCK,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0030374,nuclear receptor transcription coactivator activity,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR017426|I)P05126(Evidence code:ISS/Database source:UniProtKB:P05771), PKN1 NCOA3 PRKCB,MF,3,3 of 12,0.13,25,0.07191,0.1717
GO:0010596,negative regulation of endothelial cell migration,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827), DAB2IP SLIT2 PTPRM,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0032204,regulation of telomere maintenance,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens), TERF2 SMG6 SMG1,BP,3,3 of 12,0.13,25,0.07191,0.1717
GO:0016601,Rac protein signal transduction,F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens), NCKAP1 WASF2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0051457,maintenance of protein location in nucleus,A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404), TAF8 ARL2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0043982,histone H4-K8 acetylation,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0031295,T cell costimulation,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)O46405(Evidence code:IEA/Database source:InterPro:IPR037676), DPP4 CD80,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0055003,cardiac myofibril assembly,E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680821)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), MYLK3 SRF,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0030836,positive regulation of actin filament depolymerization,Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR029924)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0), DSTN PDXP,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0048708,astrocyte differentiation,P61635(Evidence code:ISS/Database source:UniProtKB:P42227)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), STAT3 EIF2B5,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0071803,positive regulation of podosome assembly,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens), SRC MAPK9,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0019509,L-methionine salvage from methylthioadenosine,Q2NL31(Evidence code:IEA/Database source:UniPathway:UPA00904)Q3MHF7(Evidence code:IEA/Database source:UniPathway:UPA00904), MRI1 MTAP,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0032790,ribosome disassembly,Q32KZ1(Evidence code:ISS/Database source:UniProtKB:Q9H2K0)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens), MTIF3 MCTS1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0019369,arachidonic acid metabolic process,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)P27479(Evidence code:IEA/Database source:UniProtKB:P16050|ens), ALOX15B ALOX15,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0006085,acetyl-CoA biosynthetic process,A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9QXG4|ens)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR014608), ACSS2 ACLY,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0031402,sodium ion binding,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens), ATP1A2 TDG,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0001963,"synaptic transmission, dopaminergic",Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens), CRH ADORA2A,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0008385,IkappaB kinase complex,Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)E1BPW2(Evidence code:IEA/Database source:UniProtKB:Q8IUD2|ens), IKBKG ERC1,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0006012,galactose metabolic process,Q3T105(Evidence code:IEA/Database source:InterPro:IPR005886)A6H768(Evidence code:IEA/Database source:InterPro:IPR000705), GALE GALK1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0032148,activation of protein kinase B activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P03968(Evidence code:ISS/Database source:UniProtKB:P05230), MT3 FGF1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0051764,actin crosslink formation,F1MXR0(Evidence code:IBA/Database source:PANTHER:PTN001022094)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q8BKX1), BAIAP2L1 BAIAP2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0006388,"tRNA splicing, via endonucleolytic cleavage and ligation",Q3ZBM7(Evidence code:IEA/Database source:InterPro:IPR002745)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499), TRPT1 DDX1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0070531,BRCA1-A complex,A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139), BRCC3 BRCA1,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:1990592,protein K69-linked ufmylation,Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)Q5E953(Evidence code:ISS/Database source:UniProtKB:Q9Y3C8), UFM1 UFC1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:1900746,regulation of vascular endothelial growth factor signaling pathway,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962), TCF7L2 CD63,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0032506,cytokinetic process,P27214(Evidence code:ISS/Database source:UniProtKB:P50995)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), ANXA11 SPAST,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0019911,structural constituent of myelin sheath,A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512260)A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512260), PLLP MAL2,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0019855,calcium channel inhibitor activity,E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens), PACSIN3 PHPT1,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0030247,polysaccharide binding,Q0V7N1(Evidence code:IEA/Database source:InterPro:IPR001212|I)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR001212), SUSD2 TINAGL1,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0080111,DNA demethylation,A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens), TDG TET3,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0014912,negative regulation of smooth muscle cell migration,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), IGFBP3 SLIT2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0042135,neurotransmitter catabolic process,A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128)F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens), COMT NAALAD2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0098519,"nucleotide phosphatase activity, acting on free nucleotides",Q3ZBF9(Evidence code:IBA/Database source:PANTHER:PTN000445841)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0), PDXP NUDT16,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0050772,positive regulation of axonogenesis,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens), SHOX2 BRAF,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0031588,nucleotide-activated protein kinase complex,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)P58108(Evidence code:ISS/Database source:UniProtKB:P80385), PRKAR2A PRKAG1,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0050702,interleukin-1 beta secretion,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q9GL65(Evidence code:ISS/Database source:UniProtKB:Q9QUK6), ABCA1 TLR4,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0048148,behavioral response to cocaine,F1MFI5(Evidence code:IEA/Database source:UniProtKB:Q3UH53|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), SDK1 EHMT2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0035098,ESC/E(Z) complex,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)A4FV57(Evidence code:ISS/Database source:UniProtKB:Q6ZN18), SUZ12 AEBP2,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0000050,urea cycle,F1MVC0(Evidence code:IBA/Database source:PANTHER:PTN000150222)F1ML89(Evidence code:IBA/Database source:PANTHER:PTN000150222), CAD CPS1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765), PSEN1 SGTA,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)Q2YDF7(Evidence code:IBA/Database source:PANTHER:PTN001474972), PDE4D JSRP1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0042629,mast cell granule,P05059(Evidence code:IEA/Database source:GO:0043303)P43481(Evidence code:IEA/Database source:GO:0043303), CHGA KIT,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0043303,mast cell degranulation,P05059(Evidence code:ISS/Database source:UniProtKB:P10645)P43481(Evidence code:ISS/Database source:UniProtKB:P10721), CHGA KIT,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0051014,actin filament severing,Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR029924)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens), DSTN FMNL1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0086002,cardiac muscle cell action potential involved in contraction,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens), CACNA1D SCN2B,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0035162,embryonic hemopoiesis,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), KIT KMT2A,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0010259,multicellular organism aging,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens), WRN RNF165,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0097067,cellular response to thyroid hormone stimulus,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), LMO2 KIT,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0030665,clathrin-coated vesicle membrane,Q08DS7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens), AP2B1 DENND1A,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0030318,melanocyte differentiation,A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)P43481(Evidence code:ISS/Database source:UniProtKB:P05532), HPS6 KIT,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0071565,nBAF complex,E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR038040)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens), ARID1B ARID1A,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0070300,phosphatidic acid binding,F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens), RAPGEF2 PACSIN2,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0043981,histone H4-K5 acetylation,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0071569,protein ufmylation,Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)Q5E953(Evidence code:ISS/Database source:UniProtKB:Q9Y3C8), UFM1 UFC1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)Q0III2(Evidence code:IEA/Database source:UniProtKB:O43462|ens), ATF6B MBTPS2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0022617,extracellular matrix disassembly,A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), EXOC8 FLOT1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0008409,5-3 exonuclease activity,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000805918), DXO POLQ,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0021795,cerebral cortex cell migration,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), PEX13 PSEN1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0016500,protein-hormone receptor activity,F1MLX5(Evidence code:IEA/Database source:InterPro:IPR002131)G3X6G8(Evidence code:IEA/Database source:InterPro:IPR002131), LGR4 LGR6,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0006509,membrane protein ectodomain proteolysis,Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768), BACE1 PSEN1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0021915,neural tube development,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), SALL4 GLI2,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0071203,WASH complex,F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92), DNAJC13 SNX27,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0015279,store-operated calcium channel activity,O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230)O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230), TRPC2 TRPC1,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0032801,receptor catabolic process,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens), NEDD4 PIK3R4,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0008553,"proton-exporting ATPase activity, phosphorylative mechanism",P61420(Evidence code:IEA/Database source:UniProtKB:P51863|ens)P21282(Evidence code:IEA/Database source:UniProtKB:Q9Z1G3|ens), ATP6V0D1 ATP6V1C1,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0010737,protein kinase A signaling,E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens)P00517(Evidence code:IEA/Database source:InterPro:IPR039035), MROH2B PRKACA,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0045579,positive regulation of B cell differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0006465,signal peptide processing,Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)P67810(Evidence code:IEA/Database source:InterPro:IPR001733|I), SPCS3 SEC11A,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0003016,respiratory system process,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011), ADH5 RAB3A,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0070182,DNA polymerase binding,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), SMG6 PTGES3,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0051491,positive regulation of filopodium assembly,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:O75781|ens), SRF PALM,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0097345,mitochondrial outer membrane permeabilization,Q5E9M9(Evidence code:ISS/Database source:UniProtKB:Q8IXI1)Q2HJF8(Evidence code:ISS/Database source:UniProtKB:Q8IXI2), RHOT2 RHOT1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0045086,positive regulation of interleukin-2 biosynthetic process,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0005671,Ada2/Gcn5/Ada3 transcription activator complex,A6QQ14(Evidence code:IEA/Database source:UniProtKB:Q9NR33|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), POLE4 HCFC1,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0031681,G-protein beta-subunit binding,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)G3N3N1(Evidence code:IDA/Database source:), F2R ARF6,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0045830,positive regulation of isotype switching,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens), TFRC RIF1,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0003351,epithelial cilium movement,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens), DNAH11 STK36,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0018298,protein-chromophore linkage,F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0157)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0157), RRH RGR,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0005452,inorganic anion exchanger activity,F1MCB5(Evidence code:IEA/Database source:InterPro:IPR003020|I)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR001717|I), SLC4A7 SLC4A2,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0002230,positive regulation of defense response to virus by host,E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), MB21D1 DDX58,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens)Q6BBL6(Evidence code:ISS/Database source:UniProtKB:Q9Z0G9), CLDN3 CLDN4,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0070552,BRISC complex,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860), SHMT2 BRCC3,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0014032,neural crest cell development,A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), PEF1 PDCD6,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0001662,behavioral fear response,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q6NZJ6|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), EIF4G1 GABRA5,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0019908,nuclear cyclin-dependent protein kinase holoenzyme complex,E1BB50(Evidence code:ISS/Database source:UniProtKB:Q3MJK5)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q69ZA1), CDK12 CDK13,CC,2,2 of 5,0.09,40,0.07314,0.1717
GO:0090398,cellular senescence,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens), SRF TBX3,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:1990380,Lys48-specific deubiquitinase activity,G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens), USP9X OTUD7B,MF,2,2 of 5,0.09,40,0.07314,0.1717
GO:0015701,bicarbonate transport,F1N4L1(Evidence code:IEA/Database source:GO:0008510)P35071(Evidence code:ISS/Database source:UniProtKB:P13569), SLC4A2 CFTR,BP,2,2 of 5,0.09,40,0.07314,0.1717
GO:0030672,synaptic vesicle membrane,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P63026(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SLC17A8 SYN2 VAMP1 VAMP2,CC,4,4 of 21,0.18,19.05,0.07898,0.185
GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",Q08E07(Evidence code:IEA/Database source:UniProtKB:Q5SZQ8|ens)E1BIB4(Evidence code:IEA/Database source:UniProtKB:Q8R081|ens)Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422)Q2NL22(Evidence code:ISS/Database source:UniProtKB:P38919), CELF3 HNRNPL SAP18 EIF4A3,BP,4,4 of 21,0.18,19.05,0.07898,0.185
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BBI6(Evidence code:IEA/Database source:InterPro:IPR012399)A6QQM1(Evidence code:IEA/Database source:InterPro:IPR012399)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR015431), BLM CCNYL1 CCNY CCNL1,BP,4,4 of 21,0.18,19.05,0.07898,0.185
GO:0048754,branching morphogenesis of an epithelial tube,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153), GLI2 SLIT2 CLIC4 PAK1,BP,4,4 of 21,0.18,19.05,0.07898,0.185
GO:0009611,response to wounding,Q5EA42(Evidence code:ISS/Database source:UniProtKB:Q9QXM0)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens), ABHD2 F2R MAP2K4 GLI1,BP,4,4 of 21,0.18,19.05,0.07898,0.185
GO:0015631,tubulin binding,E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), EML2 KIF14 LRRK2 VBP1 PRUNE1 CDK5RAP2 TPR NUMA1 AGTPBP1 PRNP,MF,10,10 of 77,0.44,12.99,0.07928,0.1856
GO:0005882,intermediate filament,F1MFW9(Evidence code:IEA/Database source:InterPro:IPR001664)G3MXL3(Evidence code:IEA/Database source:InterPro:IPR001664)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0403)Q0P5J7(Evidence code:IEA/Database source:InterPro:IPR001664)Q9TU47(Evidence code:IEA/Database source:UniProtKB:O55135|ens)Q08DH7(Evidence code:IEA/Database source:InterPro:IPR001664|I)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR001664|I), KRT24 KRT3 BFSP1 KRT35 EIF6 INA SYNM,CC,7,7 of 45,0.31,15.56,0.0823,0.1926
GO:0001654,eye development,Q2YDD2(Evidence code:ISS/Database source:UniProtKB:Q9DB90)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)E1B8S3(Evidence code:IEA/Database source:UniProtKB:Q8TE60|ens), SMG9 FREM2 ADAMTS18,BP,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0005881,cytoplasmic microtubule,Q05B70(Evidence code:IEA/Database source:UniProtKB:Q96HH9|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens), GRAMD3 APC2 TUBA1A,CC,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0046677,response to antibiotic,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens), HYAL1 PPP2CB JAK2,BP,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0033613,activating transcription factor binding,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), DGKQ ZNF516 HCFC1,MF,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0008375,acetylglucosaminyltransferase activity,Q5E9I4(Evidence code:IEA/Database source:InterPro:IPR004139)A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)Q5EAB6(Evidence code:IEA/Database source:InterPro:IPR004139), MGAT1 EXT1 POMGNT1,MF,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0070534,protein K63-linked ubiquitination,Q3SZ52(Evidence code:ISS/Database source:UniProtKB:Q13404)Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629507)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196), UBE2V1 UBE2V2 TRAF6,BP,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0030016,myofibril,A1A4J8(Evidence code:IEA/Database source:UniProtKB:O75880|ens)A0JNJ5(Evidence code:IEA/Database source:UniProtKB:P05976|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), SCO1 MYL1 TWF1,CC,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0006301,postreplication repair,Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629507)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629507), UBE2V2 RAD18 UBE2V1,BP,3,3 of 13,0.13,23.08,0.08431,0.1966
GO:0004518,nuclease activity,Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)A5PJT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)F1MGC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q0II50(Evidence code:IEA/Database source:InterPro:IPR027521)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540), DXO TSN AGO3 DNASE1L1 DNASE1L2 DDX1 RNASE2 USB1 PAN2 DICER1,MF,10,10 of 79,0.44,12.66,0.08519,0.1985
GO:0007596,blood coagulation,F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)Q2TBQ1(Evidence code:IEA/Database source:UniProtKB:Q07968|ens)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000935|I)A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773), ANO6 PDGFC F13B F2R HPS6,BP,5,5 of 31,0.22,16.13,0.08581,0.1999
GO:0030162,regulation of proteolysis,E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504), SPOPL BTBD3 BTBD6 BTBD11,BP,4,4 of 139,0.18,2.88,0.0873,0.2033
GO:0010506,regulation of autophagy,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BGU5(Evidence code:IEA/Database source:InterPro:IPR027881)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q96DA2)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens), LRRK2 ATM SOGA3 TPCN2 USP13 RAB39B CHMP4B,BP,7,7 of 47,0.31,14.89,0.0885,0.2059
GO:0006310,DNA recombination,A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR004589)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR004589)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I), PAXIP1 BRCA1 BLM WRN RUVBL2 RUVBL1 LIG1,BP,7,7 of 47,0.31,14.89,0.0885,0.2059
GO:0032580,Golgi cisterna membrane,F1N0M7(Evidence code:IEA/Database source:InterPro:IPR008428)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BMM8(Evidence code:IEA/Database source:InterPro:IPR008428)E1B9D0(Evidence code:IEA/Database source:InterPro:IPR008428), B4GALNT3 SAR1B CHPF CHPF2,CC,4,4 of 22,0.18,18.18,0.08868,0.2062
GO:0006399,tRNA metabolic process,E1B937(Evidence code:IBA/Database source:PANTHER:PTN000049487),DTD2,BP,1,1 of 68,0.04,1.47,0.0898,0.2087
GO:0004526,ribonuclease P activity,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)E1BFB5(Evidence code:IBA/Database source:PANTHER:PTN001005190), RPP25 KIAA0391,MF,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0001755,neural crest cell migration,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971), PHACTR4 LEF1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0001656,metanephros development,E1BJK0(Evidence code:IEA/Database source:UniProtKB:P81068|ens)E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens), IRX1 GREB1L,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0005796,Golgi lumen,P02668(Evidence code:IDA/Database source:)A4FUD7(Evidence code:IEA/Database source:UniProtKB:O35963|ens), CSN3 RAB33B,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0050856,regulation of T cell receptor signaling pathway,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157), MALT1 CACNA1F,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0007021,tubulin complex assembly,Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens), VBP1 CRYAB,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0071322,cellular response to carbohydrate stimulus,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens), RPS6KA2 PRKCB,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0030686,90S preribosome,E1BGE2(Evidence code:IBA/Database source:PANTHER:PTN000427367)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848), UTP20 RPS7,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0031115,negative regulation of microtubule polymerization,Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:P04350|ens)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens), TUBB4A EML2,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0009113,purine nucleobase biosynthetic process,Q59A32(Evidence code:IEA/Database source:InterPro:IPR000115|I)A4FUD0(Evidence code:IBA/Database source:PANTHER:PTN001598237), GART MTHFD1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:2000785,regulation of autophagosome assembly,F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000538677)A4FUD7(Evidence code:IBA/Database source:PANTHER:PTN001178308), TBC1D12 RAB33B,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0009435,NAD biosynthetic process,Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003694|I)A5PK51(Evidence code:IEA/Database source:InterPro:IPR036068), NADSYN1 NAPRT,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0048592,eye morphogenesis,F1N2Y2(Evidence code:IEA/Database source:UniProtKB:P05997|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), COL5A2 NIPBL,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0045948,positive regulation of translational initiation,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens), KHDRBS1 UHMK1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0000974,Prp19 complex,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q9UMS4)F1N607(Evidence code:IBA/Database source:PANTHER:PTN000327519), CDC5L SYF2,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0032797,SMN complex,Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens), STRAP DDX20,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:2000679,positive regulation of transcription regulatory region DNA binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens), TRAF6 FAM129B,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0061564,axon development,Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), TSPAN2 MAPK8IP3,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0000729,DNA double-strand break processing,Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q15819|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), UBE2V2 BLM,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0045822,negative regulation of heart contraction,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), PDE4D ATP1A2,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0002098,tRNA wobble uridine modification,Q0VC66(Evidence code:IEA/Database source:InterPro:IPR000541)E1BBQ3(Evidence code:IEA/Database source:InterPro:IPR006849), CTU1 IKBKAP,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), SYVN1 LRRK2,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0016857,"racemase and epimerase activity, acting on carbohydrates and derivatives",Q0P563(Evidence code:ISS/Database source:UniProtKB:Q8R2K1)Q3T105(Evidence code:IEA/Database source:InterPro:IPR008089), FUOM GALE,MF,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0005164,tumor necrosis factor receptor binding,Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR027139|I)E1BF06(Evidence code:IEA/Database source:InterPro:IPR006052|I), TRAF6 TNFSF15,MF,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0051930,regulation of sensory perception of pain,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BHM6(Evidence code:IEA/Database source:UniProtKB:Q9R053|ens), F2R SCN11A,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0007259,JAK-STAT cascade,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0035584,calcium-mediated signaling using intracellular calcium source,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), FIS1 PRNP,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0035035,histone acetyltransferase binding,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens), SIRT2 TRIM68,MF,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:2000637,positive regulation of gene silencing by miRNA,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens), DHX9 PUM1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0051403,stress-activated MAPK cascade,E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens), TAOK2 MAPK11,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens), CXCL12 CCAR2,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0048873,homeostasis of number of cells within a tissue,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558), KMT2A F2R,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:1900006,positive regulation of dendrite development,Q3ZC25(Evidence code:IEA/Database source:UniProtKB:Q80X71|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), TMEM106B DAB2IP,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0010569,regulation of double-strand break repair via homologous recombination,A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q6PIW4|ens), SIRT6 FIGNL1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0032461,positive regulation of protein oligomerization,E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens), TCL1A IDE,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0051016,barbed-end actin filament capping,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222), TWF1 EPS8,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0035269,protein O-linked mannosylation,Q3ZC71(Evidence code:IBA/Database source:PANTHER:PTN000419487)E1BCH6(Evidence code:ISS/Database source:UniProtKB:A4D126), DPM3 ISPD,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0009584,detection of visible light,P47803(Evidence code:IEA/Database source:GO:0008020)F1MR98(Evidence code:IEA/Database source:GO:0008020), RGR RRH,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens), BAIAP3 SRI,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0042573,retinoic acid metabolic process,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)P02694(Evidence code:IEA/Database source:UniProtKB:Q00915|ens), ALDH1A3 RBP1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0060760,positive regulation of response to cytokine stimulus,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), DDX58 DHX9,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0033674,positive regulation of kinase activity,Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3), GCN1L1 DSTYK,BP,2,2 of 92,0.09,2.17,0.09315,0.2119
GO:0006241,CTP biosynthetic process,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0043536,positive regulation of blood vessel endothelial cell migration,A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens), SP1 AMOTL1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0016471,vacuolar proton-transporting V-type ATPase complex,P31407(Evidence code:ISS/Database source:UniProtKB:P15313)P61420(Evidence code:IEA/Database source:UniProtKB:P61421|ens), ATP6V1B1 ATP6V0D1,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0071539,protein localization to centrosome,Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138), DCTN2 PCM1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0005640,nuclear outer membrane,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR030267), PSEN1 SYNE3,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0033209,tumor necrosis factor-mediated signaling pathway,F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens), TXNDC17 JAK2,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0071782,endoplasmic reticulum tubular network,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens), ZFYVE27 KPNB1,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0097546,ciliary base,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens), PRKACA PRKACB,CC,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0004712,protein serine/threonine/tyrosine kinase activity,Q4TVR5(Evidence code:IEA/Database source:EC:2.7.12.1)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens), DSTYK MAPK9,MF,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:1905515,non-motile cilium assembly,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens), RPGRIP1L PCM1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0043011,myeloid dendritic cell differentiation,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), TRAF6 PSEN1,BP,2,2 of 6,0.09,33.33,0.09336,0.2119
GO:0031253,cell projection membrane,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,CC,1,1 of 72,0.04,1.39,0.09218,0.2119
GO:0030031,cell projection assembly,F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens),VAV2,BP,1,1 of 73,0.04,1.37,0.09354,0.2122
GO:0031012,extracellular matrix,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)F1N2E4(Evidence code:IBA/Database source:PANTHER:PTN000396081)E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens)F1MD94(Evidence code:IEA/Database source:UniProtKB:O35701|ens)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)P07507(Evidence code:IEA/Database source:InterPro:IPR027118)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens)F1MD40(Evidence code:IEA/Database source:UniProtKB:A6NMZ7|ens)F1MZD0(Evidence code:IBA/Database source:PANTHER:PTN001170450)F1MF97(Evidence code:IEA/Database source:UniProtKB:O88322|ens)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)E1BJW3(Evidence code:IBA/Database source:PANTHER:PTN000396081)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), EMILIN1 EMILIN3 OLFML2A MATN3 MMP19 MGP NDNF COL6A5 FBN3 NID2 FGF1 NAV2 MMRN2 PTPRZ1 COL2A1,CC,15,15 of 137,0.66,10.95,0.1027,0.213
GO:0006874,cellular calcium ion homeostasis,E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR009460)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR009460)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN000643846)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000643505)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN000643846)D3K0R6(Evidence code:ISS/Database source:UniProtKB:Q6Q477)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR009460), RYR1 PKHD1 RYR3 PRKCB PSEN1 ATP2B2 ATP13A5 ATP2B3 ATP2B4 TPCN2 RYR2,BP,11,11 of 87,0.48,12.64,0.09746,0.213
GO:0001664,G-protein coupled receptor binding,P04696(Evidence code:IBA/Database source:PANTHER:PTN000026392)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469)P04695(Evidence code:IPI/Database source:UniProtKB:P02699)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026392)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)P38408(Evidence code:IEA/Database source:InterPro:IPR000654)F1N7K7(Evidence code:IEA/Database source:UniProtKB:Q9UEW3|ens)A7Z056(Evidence code:IEA/Database source:UniProtKB:Q9Y2K6|ens)F1MN36(Evidence code:IBA/Database source:PANTHER:PTN001050425)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037884), GNAT2 GNA12 GNA13 GNAT1 GNAT3 GNAI1 GNA14 MARCO USP20 PROK1 ARHGEF12,MF,11,11 of 88,0.48,12.5,0.09909,0.213
GO:0006164,purine nucleotide biosynthetic process,Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR002695)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0658)Q2HJ26(Evidence code:IEA/Database source:InterPro:IPR018236)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens)A3KN12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0658)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR005990)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR001114), ATIC GART PAICS MTHFD1 ADSL IMPDH2 ADSS,BP,7,7 of 55,0.31,12.73,0.1275,0.213
GO:0002250,adaptive immune response,P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT3 PRKCB ALCAM MARCH8 PIK3CD LOC104968438 IFNT2,BP,7,7 of 52,0.31,13.46,0.1104,0.213
GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR006620)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR006620), LOC100295883 CYP2J2 LOC540627 CYP2R1 P4HA2 CYP7A1 EGLN3,MF,7,7 of 55,0.31,12.73,0.1275,0.213
GO:0032496,response to lipopolysaccharide,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q3UMW7), BCR LITAF F2R ADH5 S100A14 CPS1 MAPKAPK3,BP,7,7 of 54,0.31,12.96,0.1215,0.213
GO:0051536,iron-sulfur cluster binding,A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0411)P48034(Evidence code:IEA/Database source:InterPro:IPR001041|I)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0411)Q58DA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0411)Q28007(Evidence code:IEA/Database source:InterPro:IPR009051)E1BL62(Evidence code:IEA/Database source:InterPro:IPR001041|I), ERCC2 AOX1 POLA1 GLRX3 DPYD AOX4,MF,6,6 of 40,0.26,15,0.1236,0.213
GO:0051028,mRNA transport,Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509), SRSF1 SEC13 DHX9 MYO1C EIF4A3 RANBP2,BP,6,6 of 40,0.26,15,0.1236,0.213
GO:0015293,symporter activity,O18875(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)F1N5R0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)Q95JC7(Evidence code:IEA/Database source:InterPro:IPR001991|I)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)A1A4L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)A5D7H9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769), SLC6A8 SLC6A5 SLC1A5 SLC5A11 SLC6A20 SLC6A14,MF,6,6 of 39,0.26,15.38,0.1201,0.213
GO:0008203,cholesterol metabolic process,A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0153)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0153)P16386(Evidence code:IEA/Database source:InterPro:IPR010468)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), SCAP MBTPS2 CYP7A1 LIPE ABCA1,BP,5,5 of 33,0.22,15.15,0.1028,0.213
GO:0050890,cognition,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:O14529|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens), NIPBL CUX2 KMT2A CHMP2B CHD7,BP,5,5 of 32,0.22,15.62,0.09409,0.213
GO:0050829,defense response to Gram-negative bacterium,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685984)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)P05059(Evidence code:IDA/Database source:), RPS19 LYZ1 RPL30 TLR4 CHGA,BP,5,5 of 32,0.22,15.62,0.09409,0.213
GO:0030183,B cell differentiation,P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR033277)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT2 LOC104968438 GON4L IFNT3,BP,4,4 of 24,0.18,16.67,0.1097,0.213
GO:0045216,cell-cell junction organization,E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens), XIRP2 PRKCI NF2 OCLN,BP,4,4 of 24,0.18,16.67,0.1097,0.213
GO:0004521,endoribonuclease activity,Q6T5B7(Evidence code:ISS/Database source:UniProtKB:Q9H9G7)O19137(Evidence code:IBA/Database source:PANTHER:PTN000559726)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens), AGO3 CPSF4 SMG6 PIWIL2,MF,4,4 of 24,0.18,16.67,0.1097,0.213
GO:0032868,response to insulin,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135)P20959(Evidence code:IDA/Database source:)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), EIF6 IGFBP3 EPM2AIP1 IRS1,BP,4,4 of 25,0.18,16,0.1209,0.213
GO:0036503,ERAD pathway,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), RNF139 UBXN6 BRSK2 SYVN1,BP,4,4 of 24,0.18,16.67,0.1097,0.213
GO:0008637,apoptotic mitochondrial changes,E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)P02722(Evidence code:IEA/Database source:UniProtKB:P48962|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens), HK2 AIFM2 SLC25A4 PPP2CB,BP,4,4 of 25,0.18,16,0.1209,0.213
GO:0050729,positive regulation of inflammatory response,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q61823|ens)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9BYH8|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B PDCD4 NFKBIZ STAT5A,BP,4,4 of 25,0.18,16,0.1209,0.213
GO:0071901,negative regulation of protein serine/threonine kinase activity,A6QP24(Evidence code:IEA/Database source:GO:0030291)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), FAM212B DAB2IP LRP6 ABL1,BP,4,4 of 25,0.18,16,0.1209,0.213
GO:0002286,T cell activation involved in immune response,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053), PSEN1 IFNT2 LOC104968438 IFNT3,BP,4,4 of 25,0.18,16,0.1209,0.213
GO:0007612,learning,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BA03(Evidence code:IEA/Database source:UniProtKB:Q3ULB5|ens), RGS14 SHANK2 PAK6,BP,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0031113,regulation of microtubule polymerization,Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens), ARL2 ABL1 PRUNE1,BP,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0010508,positive regulation of autophagy,Q3T0Q2(Evidence code:ISS/Database source:UniProtKB:Q9BXS4)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens), TMEM59 LRRK2 SH3BP4,BP,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0007041,lysosomal transport,E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3ZC25(Evidence code:IEA/Database source:UniProtKB:Q80X71|ens), VPS52 NEDD4 TMEM106B,BP,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0046426,negative regulation of JAK-STAT cascade,G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens), RTN4R NF2 BCL3,BP,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0071383,cellular response to steroid hormone stimulus,Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), UBE2L3 ATP1A2 NPC1,BP,3,3 of 15,0.13,20,0.1116,0.213
GO:0002323,natural killer cell activation involved in immune response,P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT3 IFNT2 LOC104968438,BP,3,3 of 15,0.13,20,0.1116,0.213
GO:0006289,nucleotide-excision repair,A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR004806|I), ERCC2 BRCA2 RAD23B,BP,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0003730,mRNA 3-UTR binding,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)Q5E9A3(Evidence code:ISS/Database source:UniProtKB:P11940)O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens), PUM1 PCBP1 CRYZ,MF,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0051225,spindle assembly,E1BJK2(Evidence code:IEA/Database source:UniProtKB:A2AQ07|ens)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR028731)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens), TUBB1 TNKS INO80,BP,3,3 of 15,0.13,20,0.1116,0.213
GO:0015698,inorganic anion transport,F1N4L1(Evidence code:IEA/Database source:GO:0005452)E1BF90(Evidence code:IEA/Database source:UniProtKB:Q6H1V1|ens)F1MCB5(Evidence code:IEA/Database source:GO:0005452), SLC4A2 BEST3 SLC4A7,BP,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0008408,3-5 exonuclease activity,G3X7J6(Evidence code:IEA/Database source:InterPro:IPR002562|I)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002562)E1BDI3(Evidence code:IBA/Database source:PANTHER:PTN000030201), EXD3 WRN POLG,MF,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0033141,positive regulation of peptidyl-serine phosphorylation of STAT protein,G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053), LOC104968438 IFNT2 IFNT3,BP,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0005132,type I interferon receptor binding,P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT2 IFNT3 LOC104968438,MF,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0051017,actin filament bundle assembly,Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q8BKX1)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222)F1MXR0(Evidence code:IBA/Database source:PANTHER:PTN001022094), BAIAP2 EPS8 BAIAP2L1,BP,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0006163,purine nucleotide metabolic process,P46195(Evidence code:IEA/Database source:InterPro:IPR017665)Q32L93(Evidence code:IEA/Database source:UniRule:UR000200031)Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789), GUK1 GMPR2 FHIT,BP,3,3 of 110,0.13,2.73,0.1239,0.213
GO:0042641,actomyosin,E1BP72(Evidence code:IEA/Database source:UniProtKB:Q9Y5S2|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens), CDC42BPB MYO18A PDCD6IP,CC,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0005773,vacuole,A3KN15(Evidence code:IEA/Database source:UniRule:UR000570763)P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0926)F1MWT0(Evidence code:IBA/Database source:PANTHER:PTN000176583), VPS41 ATP6V0C MAN2C1,CC,3,3 of 109,0.13,2.75,0.1229,0.213
GO:0005778,peroxisomal membrane,Q0VC07(Evidence code:IBA/Database source:PANTHER:PTN000598603)Q0P5B1(Evidence code:ISS/Database source:UniProtKB:Q92968)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR025653), PEX10 PEX13 PEX1,CC,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0034968,histone lysine methylation,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)E1BNH7(Evidence code:IEA/Database source:GO:0018024)F1N413(Evidence code:IEA/Database source:InterPro:IPR007728), KMT2B WHSC1L1 EHMT2,BP,3,3 of 15,0.13,20,0.1116,0.213
GO:0017022,myosin binding,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens), MYBPC3 GIPC1 TRPM7,MF,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0043292,contractile fiber,A5PJQ1(Evidence code:IEA/Database source:UniProtKB:Q7TNV0|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens), DEK SMTNL1 CRYAB,CC,3,3 of 14,0.13,21.43,0.09756,0.213
GO:0060415,muscle tissue morphogenesis,P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens), MYF5 SHOX2 ADARB1,BP,3,3 of 15,0.13,20,0.1116,0.213
GO:0005088,Ras guanyl-nucleotide exchange factor activity,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)Q5E9S7(Evidence code:IEA/Database source:UniProtKB:Q8N9B8|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7), RAPGEF4 RASGEF1A RAPGEF2,MF,3,3 of 15,0.13,20,0.1116,0.213
GO:0042054,histone methyltransferase activity,F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q6XZL8|ens)E1B9T7(Evidence code:IBA/Database source:PANTHER:PTN001476056), PRDM13 DOT1L SUZ12,MF,3,3 of 15,0.13,20,0.1116,0.213
GO:0098655,cation transmembrane transport,F1MD64(Evidence code:IEA/Database source:GO:0005261)G3MXA9(Evidence code:IEA/Database source:InterPro:IPR032943)P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363), PIEZO1 CNGB3 CHRNE,BP,3,3 of 109,0.13,2.75,0.1229,0.213
GO:0031023,microtubule organizing center organization,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), GCC2 SDCCAG8 CDK5RAP2,BP,3,3 of 16,0.13,18.75,0.1263,0.213
GO:0044344,cellular response to fibroblast growth factor stimulus,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3), SETX DSTYK,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0004383,guanylate cyclase activity,Q29450(Evidence code:IBA/Database source:PANTHER:PTN000229249)A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR011645), ADCY7 GUCY1A3,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0016272,prefoldin complex,Q2TBX2(Evidence code:IEA/Database source:InterPro:IPR016655)A1A4P5(Evidence code:IEA/Database source:InterPro:IPR002777|I), VBP1 PFDN2,CC,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0001102,RNA polymerase II activating transcription factor binding,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), LMO2 TBX3,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0071498,cellular response to fluid shear stress,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236), SRC NFE2L2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0051984,positive regulation of chromosome segregation,Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), RAD18 NUMA1,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens), E2F7 CTDSP1,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0004806,triglyceride lipase activity,Q29458(Evidence code:IEA/Database source:InterPro:IPR039097)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033903), LIPF PNPLA2,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0031369,translation initiation factor binding,A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:Q9DCH4|ens), EIF3B EIF3F,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0070628,proteasome binding,Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens), PSMD14 USP13,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0032402,melanosome transport,Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q99KJ8|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), DCTN2 RAB17,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0032210,regulation of telomere maintenance via telomerase,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens), ATM TERF2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0010765,positive regulation of sodium ion transport,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens), GPD1L MLLT6,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0008074,"guanylate cyclase complex, soluble",Q29450(Evidence code:IBA/Database source:PANTHER:PTN000229249)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q02108|ens), ADCY7 GUCY1A3,CC,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0003143,embryonic heart tube morphogenesis,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens), SOX17 MEGF8,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0046676,negative regulation of insulin secretion,P05059(Evidence code:IDA/Database source:)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), CHGA IRS1,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0070997,neuron death,E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), MAGI1 LRRK2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0090181,regulation of cholesterol metabolic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens), DGKQ GNB3,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0000791,euchromatin,A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1), UHRF1 DNMT3A,CC,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0060707,trophoblast giant cell differentiation,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2), PLK4 E2F7,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0004435,phosphatidylinositol phospholipase C activity,P08487(Evidence code:IEA/Database source:InterPro:IPR001711|I)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001711|I), PLCG1 PLCB3,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0005159,insulin-like growth factor receptor binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), GNAS IRS1,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0001786,phosphatidylserine binding,E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140), SYT6 CPNE6,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0032401,establishment of melanosome localization,B6Z9Q5(Evidence code:IEA/Database source:InterPro:IPR027686)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), SHROOM2 RAB17,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0031143,pseudopodium,Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735), CAPN2 RAB25,CC,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0006828,manganese ion transport,O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230)O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230), TRPC1 TRPC2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0031210,phosphatidylcholine binding,Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), PITPNA CHMP2A,MF,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0034394,protein localization to cell surface,Q3MHZ7(Evidence code:IBA/Database source:PANTHER:PTN000243120)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), PIGK ARF6,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0071276,cellular response to cadmium ion,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens), MT3 MAPK9,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0006805,xenobiotic metabolic process,A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)F1ML85(Evidence code:IEA/Database source:InterPro:IPR039091), NR1I2 AHR,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0002092,positive regulation of receptor internalization,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962), AHI1 CD63,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0045648,positive regulation of erythrocyte differentiation,P61635(Evidence code:ISS/Database source:UniProtKB:P40763)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P51692), STAT3 STAT5B,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0006623,protein targeting to vacuole,A3KN15(Evidence code:IBA/Database source:PANTHER:PTN000289375)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471), VPS41 PIK3R4,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0023052,signaling,E1BBJ2(Evidence code:IEA/Database source:InterPro:IPR005026)E1BB27(Evidence code:IEA/Database source:InterPro:IPR005026), DLGAP3 DLGAP1,BP,2,2 of 95,0.09,2.11,0.09564,0.213
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,P22571(Evidence code:IEA/Database source:UniProtKB:P61249|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens), PDE6H AFAP1L2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0050771,negative regulation of axonogenesis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens), PSEN1 SYNGAP1,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0046653,tetrahydrofolate metabolic process,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)P00376(Evidence code:ISS/Database source:UniProtKB:P00374), SHMT2 DHFR,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0031526,brush border membrane,G5E6P3(Evidence code:IBA/Database source:PANTHER:PTN000026689)E1BIL1(Evidence code:IBA/Database source:PANTHER:PTN000026689), GNA13 GNA12,CC,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0033180,"proton-transporting V-type ATPase, V1 domain",P21282(Evidence code:IEA/Database source:InterPro:IPR004907|I)P31407(Evidence code:IEA/Database source:InterPro:IPR005723), ATP6V1C1 ATP6V1B1,CC,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0016486,peptide hormone processing,F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)P42891(Evidence code:IEA/Database source:InterPro:IPR029733), PCSK6 ECE1,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0016578,histone deubiquitination,E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens), USP36 TAF10,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0042116,macrophage activation,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens), TLR4 SLC7A2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0010165,response to X-ray,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), BLM BRCA2,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0001765,membrane raft assembly,P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), S100A10 FLOT1,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0050766,positive regulation of phagocytosis,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens), FCER1G BCR,BP,2,2 of 7,0.09,28.57,0.1149,0.213
GO:0005459,UDP-galactose transmembrane transporter activity,Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081293),SLC35B1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070093,negative regulation of glucagon secretion,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN001030516),CRH,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033677,DNA/RNA helicase activity,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499),DDX1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0005247,voltage-gated chloride channel activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1902036,regulation of hematopoietic stem cell differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens),CDK6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1990450,linear polyubiquitin binding,Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens),IKBKG,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0008295,spermidine biosynthetic process,E1BM12(Evidence code:IEA/Database source:UniProtKB:P19623|ens),SRM,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042309,homoiothermy,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004644,phosphoribosylglycinamide formyltransferase activity,Q59A32(Evidence code:IEA/Database source:InterPro:IPR004607),GART,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0032275,luteinizing hormone secretion,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens),TBX3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034993,meiotic nuclear membrane microtubule tethering complex,E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q4FZC9|ens),SYNE3,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0009386,translational attenuation,Q2TBI4(Evidence code:IEA/Database source:UniProtKB:Q12931|ens),TRAP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034983,peptidyl-lysine deacetylation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005940,septin ring,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens),SEPT6,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0097070,ductus arteriosus closure,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006212,uracil catabolic process,Q28007(Evidence code:ISS/Database source:UniProtKB:Q12882),DPYD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005041,low-density lipoprotein particle receptor activity,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens),LRP6,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0008963,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,Q5EA65(Evidence code:IEA/Database source:InterPro:IPR000715),DPAGT1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0051902,negative regulation of mitochondrial depolarization,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005337,nucleoside transmembrane transporter activity,Q3ZC83(Evidence code:IEA/Database source:InterPro:IPR002259|I),SLC29A1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0002674,negative regulation of acute inflammatory response,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000299,negative regulation of Rho-dependent protein serine/threonine kinase activity,Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens),CHORDC1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019145,aminobutyraldehyde dehydrogenase activity,Q2KJH9(Evidence code:ISS/Database source:UniProtKB:P49189),ALDH9A1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0060290,transdifferentiation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101),INSM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904027,negative regulation of collagen fibril organization,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048672,positive regulation of collateral sprouting,Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens),BDNF,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046523,S-methyl-5-thioribose-1-phosphate isomerase activity,Q2NL31(Evidence code:IEA/Database source:EC:5.3.1.23),MRI1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003976,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,Q5EA65(Evidence code:IEA/Database source:UniProtKB:Q9H3H5|ens),DPAGT1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0033878,hormone-sensitive lipase activity,P16386(Evidence code:IEA/Database source:EC:3.1.1.79),LIPE,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0021960,anterior commissure morphogenesis,G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens),FBXO45,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002265,astrocyte activation involved in immune response,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002322,B cell proliferation involved in immune response,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032623,interleukin-2 production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090188,negative regulation of pancreatic juice secretion,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens),WNK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003974,UDP-N-acetylglucosamine 4-epimerase activity,Q3T105(Evidence code:IEA/Database source:EC:5.1.3.7),GALE,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0061590,calcium activated phosphatidylcholine scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0098536,deuterosome,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702),PLK4,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0035272,exocrine system development,Q29RR0(Evidence code:ISS/Database source:UniProtKB:P51156),RAB26,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046847,filopodium assembly,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens),RAB17,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035909,aorta morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0014807,regulation of somitogenesis,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens),LFNG,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097326,melanocyte adhesion,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901187,regulation of ephrin receptor signaling pathway,F1MHL2(Evidence code:IEA/Database source:InterPro:IPR033637),ANKS1A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0017045,corticotropin-releasing hormone activity,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN000385798),CRH,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000320,negative regulation of T-helper 17 cell differentiation,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051660,establishment of centrosome localization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034271,"phosphatidylinositol 3-kinase complex, class III, type I",A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0061589,calcium activated phosphatidylserine scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071361,cellular response to ethanol,Q29450(Evidence code:ISS/Database source:UniProtKB:P51828),ADCY7,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004463,leukotriene-A4 hydrolase activity,Q3SZH7(Evidence code:IEA/Database source:EC:3.3.2.6),LTA4H,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0005638,lamin filament,Q9TU47(Evidence code:IEA/Database source:UniProtKB:O55135|ens),EIF6,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0003985,acetyl-CoA C-acetyltransferase activity,Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens),ACAT2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0033194,response to hydroperoxide,Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5),RNF112,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030889,negative regulation of B cell proliferation,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021773,striatal medium spiny neuron differentiation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0016743,carboxyl- or carbamoyltransferase activity,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006130|I),CAD,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0042840,D-glucuronate catabolic process,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050104,L-gulonate 3-dehydrogenase activity,Q8SPX7(Evidence code:IEA/Database source:EC:1.1.1.45),CRYL1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0038095,Fc-epsilon receptor signaling pathway,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P30273|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens),SRI,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens),ABL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903644,regulation of chaperone-mediated protein folding,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens),DNAJB2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001798,positive regulation of type IIa hypersensitivity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903553,positive regulation of extracellular exosome assembly,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens),PDCD6IP,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033596,TSC1-TSC2 complex,E1BNT2(Evidence code:IEA/Database source:InterPro:IPR003913),TSC2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0045590,negative regulation of regulatory T cell differentiation,Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004146,dihydrofolate reductase activity,P00376(Evidence code:IEA/Database source:InterPro:IPR001796|I),DHFR,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004367,glycerol-3-phosphate dehydrogenase [NAD+] activity,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006109|I),GPD1L,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0042491,inner ear auditory receptor cell differentiation,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1905168,positive regulation of double-strand break repair via homologous recombination,E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76),MMS19,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902938,regulation of intracellular calcium activated chloride channel activity,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1990459,transferrin receptor binding,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006272,leading strand elongation,E1BJF4(Evidence code:IBA/Database source:PANTHER:PTN000035348),POLA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0015670,carbon dioxide transport,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens),AQP5,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1905166,negative regulation of lysosomal protein catabolic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005854,nascent polypeptide-associated complex,F1MGI0(Evidence code:IEA/Database source:InterPro:IPR016641),NACAD,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:1902685,positive regulation of receptor localization to synapse,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0017121,phospholipid scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033634,positive regulation of cell-cell adhesion mediated by integrin,F1MD64(Evidence code:IEA/Database source:UniProtKB:Q92508|ens),PIEZO1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001805,positive regulation of type III hypersensitivity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006589,octopamine biosynthetic process,P15101(Evidence code:IBA/Database source:PANTHER:PTN000806665),DBH,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051160,L-xylitol catabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004301,epoxide hydrolase activity,Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960),LTA4H,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006740,NADPH regeneration,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033690,positive regulation of osteoblast proliferation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904692,positive regulation of type B pancreatic cell proliferation,P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens),PTPRN,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050882,voluntary musculoskeletal movement,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004615,phosphomannomutase activity,Q3SZJ9(Evidence code:IEA/Database source:InterPro:IPR005002),PMM2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0050975,sensory perception of touch,P11023(Evidence code:ISS/Database source:UniProtKB:P63011),RAB3A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904247,positive regulation of polynucleotide adenylyltransferase activity,Q28165(Evidence code:IEA/Database source:InterPro:IPR034911),PABPN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904797,negative regulation of core promoter binding,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000964,mitochondrial RNA 5-end processing,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043622,cortical microtubule organization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048550,negative regulation of pinocytosis,E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens),PROM2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0015866,ADP transport,P02722(Evidence code:ISS/Database source:UniProtKB:P12235),SLC25A4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2001045,negative regulation of integrin-mediated signaling pathway,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7),PHACTR4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060073,micturition,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens),KCNMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031475,myosin V complex,Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q9D0M5|ens),DYNLL2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0086098,angiotensin-activated signaling pathway involved in heart process,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048022,negative regulation of melanin biosynthetic process,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005260,intracellularly ATP-gated chloride channel activity,P35071(Evidence code:IEA/Database source:EC:3.6.3.49),CFTR,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0009994,oocyte differentiation,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens),KMT2B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000455,enzyme-directed rRNA pseudouridine synthesis,F1N088(Evidence code:IBA/Database source:PANTHER:PTN001311753),RPUSD2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031427,response to methotrexate,P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0487),DHFR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903542,negative regulation of exosomal secretion,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001780,neutrophil homeostasis,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005169,neurotrophin TRKB receptor binding,Q95106(Evidence code:IBA/Database source:PANTHER:PTN000173552),BDNF,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0016191,synaptic vesicle uncoating,Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q62419|ens),SH3GL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070671,response to interleukin-12,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051684,maintenance of Golgi location,F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens),ARHGAP21,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005859,muscle myosin complex,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569),MYBPC3,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0060770,negative regulation of epithelial cell proliferation involved in prostate gland development,Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens),EAF2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042769,"DNA damage response, detection of DNA damage",Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945),SOX4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000630,positive regulation of miRNA metabolic process,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens),NFKB1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033235,positive regulation of protein sumoylation,Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens),PIAS1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060083,smooth muscle contraction involved in micturition,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens),KCNMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0016476,regulation of embryonic cell shape,Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5),SEPT7,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061591,calcium activated galactosylceramide scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens),MYO1C,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000984,negative regulation of ATP citrate synthase activity,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens),PHPT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010484,H3 histone acetyltransferase activity,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0042806,fucose binding,Q0P563(Evidence code:ISS/Database source:UniProtKB:Q8R2K1),FUOM,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006930,"substrate-dependent cell migration, cell extension",Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens),CTTN,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004335,galactokinase activity,A6H768(Evidence code:IEA/Database source:InterPro:IPR000705),GALK1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071676,negative regulation of mononuclear cell migration,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902823,negative regulation of late endosome to lysosome transport,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1990426,mitotic recombination-dependent replication fork processing,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050211,procollagen galactosyltransferase activity,A5PK45(Evidence code:IEA/Database source:EC:2.4.1.50),COLGALT1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0060681,branch elongation involved in ureteric bud branching,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019441,tryptophan catabolic process to kynurenine,A7MBF5(Evidence code:IEA/Database source:InterPro:IPR037217),IDO1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0098535,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702),PLK4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090024,negative regulation of neutrophil chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060372,regulation of atrial cardiac muscle cell membrane repolarization,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens),CACNA1D,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051499,D-aminoacyl-tRNA deacylase activity,E1B937(Evidence code:IEA/Database source:InterPro:IPR003732),DTD2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0050910,detection of mechanical stimulus involved in sensory perception of sound,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021870,Cajal-Retzius cell differentiation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021798,forebrain dorsal/ventral pattern formation,F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens),TTC21B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033227,dsRNA transport,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0052651,monoacylglycerol catabolic process,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q8N2K0|ens),ABHD12,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071008,U2-type post-mRNA release spliceosomal complex,E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens),GCFC2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0070981,L-asparagine biosynthetic process,Q1LZA3(Evidence code:IEA/Database source:UniPathway:UPA00134),ASNS,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070262,peptidyl-serine dephosphorylation,F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745),PPP2R2A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0008124,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,Q3ZBD3(Evidence code:IEA/Database source:InterPro:IPR001533|I),PCBD1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0035795,negative regulation of mitochondrial membrane permeability,E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens),HK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0017113,dihydropyrimidine dehydrogenase (NADP+) activity,Q28007(Evidence code:IEA/Database source:EC:1.3.1.2),DPYD,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0090383,phagosome acidification,G3X7D3(Evidence code:IEA/Database source:UniProtKB:Q14964|ens),RAB39A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001887,selenium compound metabolic process,E1BHE5(Evidence code:IEA/Database source:UniProtKB:P97364|ens),SEPHS2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010256,endomembrane system organization,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046831,regulation of RNA export from nucleus,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q60749|ens),KHDRBS1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051891,positive regulation of cardioblast differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001739,sex chromatin,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens),SUZ12,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0060711,labyrinthine layer development,E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens),BIRC6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034353,RNA pyrophosphohydrolase activity,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348),DXO,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0007529,establishment of synaptic specificity at neuromuscular junction,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824),F2R,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035971,peptidyl-histidine dephosphorylation,Q32PA4(Evidence code:IEA/Database source:InterPro:IPR028441),PHPT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000293,ferric-chelate reductase activity,P10897(Evidence code:IEA/Database source:InterPro:IPR028837),CYB561,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070200,establishment of protein localization to telomere,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0009404,toxin metabolic process,Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616),ARL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003358,noradrenergic neuron development,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0),INSM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071045,nuclear histone mRNA catabolic process,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901223,negative regulation of NIK/NF-kappaB signaling,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens),LITAF,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0015879,carnitine transport,Q08DK7(Evidence code:ISS/Database source:UniProtKB:Q8N8R3),SLC25A29,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035963,cellular response to interleukin-13,P27479(Evidence code:ISS/Database source:UniProtKB:P16050),ALOX15,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2001137,positive regulation of endocytic recycling,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003323,type B pancreatic cell development,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens),CDK6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000376,positive regulation of oxygen metabolic process,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032361,pyridoxal phosphate catabolic process,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:P60487),PDXP,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005639,integral component of nuclear inner membrane,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR018996),LEMD3,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0034477,U6 snRNA 3-end processing,Q0II50(Evidence code:IEA/Database source:InterPro:IPR027521),USB1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2001287,negative regulation of caveolin-mediated endocytosis,E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens),PROM2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090326,positive regulation of locomotion involved in locomotory behavior,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002371,dendritic cell cytokine production,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070180,large ribosomal subunit rRNA binding,Q3T057(Evidence code:IBA/Database source:PANTHER:PTN000205184),RPL23,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0032344,regulation of aldosterone metabolic process,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090083,regulation of inclusion body assembly,Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens),BAG5,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0038044,transforming growth factor-beta secretion,Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens),ITGB6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097475,motor neuron migration,E1BFP0(Evidence code:IBA/Database source:PANTHER:PTN000548303),NHSL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0015174,basic amino acid transmembrane transporter activity,Q08DK7(Evidence code:ISS/Database source:UniProtKB:Q8N8R3),SLC25A29,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0044194,cytolytic granule,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens),LAMP1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0022027,interkinetic nuclear migration,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens),PCM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0009048,dosage compensation by inactivation of X chromosome,Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349142),BRCA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034124,regulation of MyD88-dependent toll-like receptor signaling pathway,Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904454,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019373,epoxygenase P450 pathway,F1MEU8(Evidence code:IBA/Database source:PANTHER:PTN000670523),LOC540627,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042582,azurophil granule,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0003937,IMP cyclohydrolase activity,Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR002695),ATIC,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0035912,dorsal aorta morphogenesis,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006404,RNA import into nucleus,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens),TPR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0093001,glycolysis from storage polysaccharide through glucose-1-phosphate,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071896,protein localization to adherens junction,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens),SCRIB,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090235,regulation of metaphase plate congression,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048169,regulation of long-term neuronal synaptic plasticity,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens),SYNGAP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035610,protein side chain deglutamylation,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens),AGTPBP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061104,adrenal chromaffin cell differentiation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0),INSM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031314,extrinsic component of mitochondrial inner membrane,Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q8NC60),NOA1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0050115,myosin-light-chain-phosphatase activity,Q3SWW9(Evidence code:IEA/Database source:EC:3.1.3.53),PPP1CB,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0035878,nail development,Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9R078|ens),PRKAB1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019878,lysine biosynthetic process via aminoadipic acid,A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283),AASS,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005095,GTPase inhibitor activity,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0043538,regulation of actin phosphorylation,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q12792|ens),TWF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043697,cell dedifferentiation,E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788),CDK6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903286,regulation of potassium ion import,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070307,lens fiber cell development,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens),FRS2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019511,peptidyl-proline hydroxylation,Q3SYY3(Evidence code:IEA/Database source:GO:0004656),P4HA2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904888,cranial skeletal system development,F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens),COLEC10,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043366,beta selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097494,regulation of vesicle size,P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens),RAB3B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004838,L-tyrosine:2-oxoglutarate aminotransferase activity,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005957|I),TAT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0050265,RNA uridylyltransferase activity,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens),ZCCHC6,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019863,IgE binding,Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0389),FCER1G,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004098,cerebroside-sulfatase activity,Q08DD1(Evidence code:IEA/Database source:EC:3.1.6.8),ARSA,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0035020,regulation of Rac protein signal transduction,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens),ARF6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050917,sensory perception of umami taste,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens),GNAT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032765,positive regulation of mast cell cytokine production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035005,1-phosphatidylinositol-4-phosphate 3-kinase activity,E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005674),PIK3CD,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0010996,response to auditory stimulus,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens),ABHD12,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070877,microprocessor complex,A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens),DGCR8,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0050480,imidazolonepropionase activity,A5PJV3(Evidence code:IEA/Database source:EC:3.5.2.7),AMDHD1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0098967,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000584,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens),PHF14,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0018401,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1905907,negative regulation of amyloid fibril formation,P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens),CRYAB,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003197,endocardial cushion development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000715,"nucleotide-excision repair, DNA damage recognition",Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens),RAD23B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945),SOX4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004991,parathyroid hormone receptor activity,Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR002170),PTH1R,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0098623,selenite reductase activity,O62768(Evidence code:TAS/Database source:),TXNRD1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003231,cardiac ventricle development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens),GREB1L,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000798,nuclear cohesin complex,E1B9J3(Evidence code:IBA/Database source:PANTHER:PTN000286904),RAD21L1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0021513,spinal cord dorsal/ventral patterning,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0045295,gamma-catenin binding,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0042756,drinking behavior,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens),EN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0009008,DNA-methyltransferase activity,Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR030487),DNMT3A,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0043296,apical junction complex,G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens),SAPCD2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0015234,thiamine transmembrane transporter activity,E1BLU2(Evidence code:IEA/Database source:UniProtKB:O60779|ens),SLC19A2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0061015,snRNA import into nucleus,Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826),RAN,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031871,proteinase activated receptor binding,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens),PDCD6IP,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000615,regulation of histone H3-K9 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005309,creatine:sodium symporter activity,O18875(Evidence code:IEA/Database source:InterPro:IPR002984),SLC6A8,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071397,cellular response to cholesterol,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens),LRP6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0047939,L-glucuronate reductase activity,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004809,tRNA (guanine-N2-)-methyltransferase activity,A5D7S3(Evidence code:IEA/Database source:InterPro:IPR002905),TRMT1L,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0034466,chromaffin granule lumen,P15101(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),DBH,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0043323,positive regulation of natural killer cell degranulation,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032480,negative regulation of type I interferon production,Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens),UFD1L,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0072584,caveolin-mediated endocytosis,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens),PACSIN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060698,endoribonuclease inhibitor activity,A4IFE6(Evidence code:IEA/Database source:UniProtKB:P61221|ens),ABCE1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004820,glycine-tRNA ligase activity,A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002315),GARS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1901874,negative regulation of post-translational protein modification,E1BJ75(Evidence code:IEA/Database source:UniProtKB:O75718|ens),CRTAP,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046544,development of secondary male sexual characteristics,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232),STAT5B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004614,phosphoglucomutase activity,F1MS56(Evidence code:IEA/Database source:UniProtKB:Q9CYR6|ens),PGM3,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0034685,integrin alphav-beta6 complex,Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens),ITGB6,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0009257,10-formyltetrahydrofolate biosynthetic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033829,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR017374),LFNG,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0035359,negative regulation of peroxisome proliferator activated receptor signaling pathway,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050861,positive regulation of B cell receptor signaling pathway,P05126(Evidence code:ISS/Database source:UniProtKB:P68404),PRKCB,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006704,glucocorticoid biosynthetic process,Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens),CRH,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019076,viral release from host cell,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0016077,snoRNA catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061153,trachea gland development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035403,histone kinase activity (H3-T6 specific),P05126(Evidence code:ISS/Database source:UniProtKB:P05771),PRKCB,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071787,endoplasmic reticulum tubular network formation,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4),ZFYVE27,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000791,negative regulation of mesenchymal cell proliferation involved in lung development,F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens),PHF14,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1900426,positive regulation of defense response to bacterium,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens),UNC13B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000628,regulation of miRNA metabolic process,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033857,diphosphoinositol-pentakisphosphate kinase activity,F1MNG6(Evidence code:IEA/Database source:UniProtKB:Q6ZQB6|ens),PPIP5K2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0032447,protein urmylation,Q0VC66(Evidence code:IEA/Database source:UniRule:UR000160875),CTU1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0099639,"neurotransmitter receptor transport, endosome to plasma membrane",Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901640,XTP binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0090482,vitamin transmembrane transporter activity,E1BLU2(Evidence code:IEA/Database source:InterPro:IPR002666),SLC19A2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0046959,habituation,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032835,glomerulus development,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0055073,cadmium ion homeostasis,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005955,calcineurin complex,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004590,orotidine-5-phosphate decarboxylase activity,P31754(Evidence code:IEA/Database source:InterPro:IPR001754|I),UMPS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003338,metanephros morphogenesis,F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens),FRAS1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010385,double-stranded methylated DNA binding,G3MYE7(Evidence code:IEA/Database source:InterPro:IPR017353),MECP2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070150,mitochondrial glycyl-tRNA aminoacylation,A5D7A2(Evidence code:IBA/Database source:PANTHER:PTN000078675),GARS,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0047131,"saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity",A8E657(Evidence code:IEA/Database source:EC:1.5.1.9),AASS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0051932,"synaptic transmission, GABAergic",Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens),DNM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042158,lipoprotein biosynthetic process,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0072757,cellular response to camptothecin,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005161,platelet-derived growth factor receptor binding,E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817),PDGFC,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0051586,positive regulation of dopamine uptake involved in synaptic transmission,P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens),RAB3B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001771,immunological synapse formation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902958,"positive regulation of mitochondrial electron transport, NADH to ubiquinone",A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070602,regulation of centromeric sister chromatid cohesion,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032782,bile acid secretion,F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens),STARD10,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0098719,sodium ion import across plasma membrane,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens),TRPM4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004588,orotate phosphoribosyltransferase activity,P31754(Evidence code:IEA/Database source:InterPro:IPR004467|I),UMPS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0097010,eukaryotic translation initiation factor 4F complex assembly,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859),EIF4H,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901674,regulation of histone H3-K27 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902510,regulation of apoptotic DNA fragmentation,E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens),AIFM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0016322,neuron remodeling,A7MB18(Evidence code:IEA/Database source:UniProtKB:Q9JI33|ens),NTN4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032767,copper-dependent protein binding,Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O00244|ens),ATOX1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0061180,mammary gland epithelium development,F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens),ATP2C2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019767,IgE receptor activity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000156,"regulation of retrograde vesicle-mediated transport, Golgi to ER",A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens),RAB33B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060266,negative regulation of respiratory burst involved in inflammatory response,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens),RPS19,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030853,negative regulation of granulocyte differentiation,Q1RMH5(Evidence code:IEA/Database source:UniProtKB:P02747|ens),C1QC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031697,beta-1 adrenergic receptor binding,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0102084,L-dopa O-methyltransferase activity,A7MBI7(Evidence code:IEA/Database source:EC:2.1.1.6),COMT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0021702,cerebellar Purkinje cell differentiation,F1MKS6(Evidence code:IEA/Database source:InterPro:IPR033852),AGTPBP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035517,PR-DUB complex,F1N4U8(Evidence code:IEA/Database source:UniProtKB:Q8IXJ9|ens),ASXL1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0070937,CRD-mediated mRNA stability complex,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0006776,vitamin A metabolic process,P02694(Evidence code:IEA/Database source:InterPro:IPR031264),RBP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001957,intramembranous ossification,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060478,acrosomal vesicle exocytosis,E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q5T7P8|ens),SYT6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004155,"6,7-dihydropteridine reductase activity",Q3T0Z7(Evidence code:IEA/Database source:EC:1.5.1.34),QDPR,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003960,NADPH:quinone reductase activity,O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens),CRYZ,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004844,uracil DNA N-glycosylase activity,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0017096,acetylserotonin O-methyltransferase activity,P10950(Evidence code:IEA/Database source:EC:2.1.1.4),ASMT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003708,retinoic acid receptor activity,E1BC39(Evidence code:IEA/Database source:InterPro:IPR003078),ESRRG,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1900260,negative regulation of RNA-directed 5-3 RNA polymerase activity,Q3SZ65(Evidence code:IEA/Database source:UniProtKB:Q14240|ens),EIF4A2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051787,misfolded protein binding,A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens),TOR1A,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0045650,negative regulation of macrophage differentiation,Q1RMH5(Evidence code:IEA/Database source:UniProtKB:P02747|ens),C1QC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004637,phosphoribosylamine-glycine ligase activity,Q59A32(Evidence code:IEA/Database source:InterPro:IPR000115|I),GART,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0035735,intraciliary transport involved in cilium assembly,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens),PCM1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0072144,glomerular mesangial cell development,Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens),GPR4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004617,phosphoglycerate dehydrogenase activity,Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006236),PHGDH,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0030586,[methionine synthase] reductase activity,Q4JIJ2(Evidence code:IEA/Database source:EC:1.16.1.8),MTRR,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071500,cellular response to nitrosative stress,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003956,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens),SIRT6,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0048680,positive regulation of axon regeneration,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031076,embryonic camera-type eye development,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens),ALDH1A3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061621,canonical glycolysis,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005534,galactose binding,A6H768(Evidence code:IEA/Database source:InterPro:IPR019539),GALK1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0086016,AV node cell action potential,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens),SCN10A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060080,inhibitory postsynaptic potential,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens),ADORA2A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071504,cellular response to heparin,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000125,PCAF complex,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens),TAF10,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0018243,protein O-linked glycosylation via threonine,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens),GALNT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021517,ventral spinal cord development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904294,positive regulation of ERAD pathway,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004421,hydroxymethylglutaryl-CoA synthase activity,Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR013746),HMGCS1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0008269,JAK pathway signal transduction adaptor activity,F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens),SH2B2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0021554,optic nerve development,F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens),NAV2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000311,regulation of AMPA receptor activity,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003886,DNA (cytosine-5-)-methyltransferase activity,Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1),DNMT3A,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0007614,short-term memory,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298),CUX2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003205,cardiac chamber development,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051903,S-(hydroxymethyl)glutathione dehydrogenase activity,Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR014183),ADH5,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0048703,embryonic viscerocranium morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens),NIPBL,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061588,calcium activated phospholipid scrambling,F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295),ANO6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035408,histone H3-T6 phosphorylation,P05126(Evidence code:ISS/Database source:UniProtKB:P05771),PRKCB,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor,P03968(Evidence code:IEA/Database source:UniProtKB:P05230|ens),FGF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032000,positive regulation of fatty acid beta-oxidation,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens),IRS1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031547,brain-derived neurotrophic factor receptor signaling pathway,F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386),RAPGEF2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046370,fructose biosynthetic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901143,insulin catabolic process,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071598,neuronal ribonucleoprotein granule,E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens),UHMK1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0086012,membrane depolarization during cardiac muscle cell action potential,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens),SCN2B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048935,peripheral nervous system neuron development,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens),ONECUT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031268,pseudopodium organization,Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735),RAB25,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0038036,sphingosine-1-phosphate receptor activity,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9NRA0|ens),SPHK2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0097324,melanocyte migration,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0072307,regulation of metanephric nephron tubule epithelial cell differentiation,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060800,regulation of cell differentiation involved in embryonic placenta development,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071440,regulation of histone H3-K14 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035722,interleukin-12-mediated signaling pathway,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens),CDC27,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903764,regulation of potassium ion export across plasma membrane,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048485,sympathetic nervous system development,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831),SOX4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043314,negative regulation of neutrophil degranulation,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051344,negative regulation of cyclic-nucleotide phosphodiesterase activity,P04695(Evidence code:IDA/Database source:),GNAT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1905205,positive regulation of connective tissue replacement,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004363,glutathione synthase activity,Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR004887|I),GSS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0045446,endothelial cell differentiation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens),KDM6B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003920,GMP reductase activity,Q32L93(Evidence code:IEA/Database source:InterPro:IPR005993),GMPR2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019075,virus maturation,Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens),MVB12A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903298,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003973,(S)-2-hydroxy-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0042780,tRNA 3-end processing,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0052854,medium-chain-(S)-2-hydroxy-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0034750,Scrib-APC-beta-catenin complex,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens),SCRIB,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0042275,error-free postreplication DNA repair,Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q9D2M8|ens),UBE2V2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0008190,eukaryotic initiation factor 4E binding,F1MX04(Evidence code:ISS/Database source:UniProtKB:B2RU06),EIF4G1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004475,mannose-1-phosphate guanylyltransferase activity,Q2YDJ9(Evidence code:IEA/Database source:EC:2.7.7.13),GMPPB,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1902560,GMP reductase complex,Q32L93(Evidence code:IEA/Database source:InterPro:IPR005993),GMPR2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:2000617,positive regulation of histone H3-K9 acetylation,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901639,XDP catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061031,endodermal digestive tract morphogenesis,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0052338,disruption by host of symbiont cell wall,P05059(Evidence code:IDA/Database source:),CHGA,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070820,tertiary granule,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0006344,maintenance of chromatin silencing,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0036122,BMP binding,E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606),HFE2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0017151,DEAD/H-box RNA helicase binding,A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens),SP7,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019919,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine",A6QL80(Evidence code:IEA/Database source:GO:0035242),PRMT3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060033,anatomical structure regression,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903070,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765),SGTA,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0018467,formaldehyde dehydrogenase activity,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P11766|ens),ADH5,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0038089,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens),MYO1C,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0015881,creatine transmembrane transport,O18875(Evidence code:ISS/Database source:UniProtKB:P48029),SLC6A8,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0052853,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0007158,neuron cell-cell adhesion,F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens),ASTN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050897,cobalt ion binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0034057,RNA strand-exchange activity,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859),EIF4H,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004113,"2,3-cyclic-nucleotide 3-phosphodiesterase activity",P06623(Evidence code:IEA/Database source:InterPro:IPR008431),CNP,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070728,leucine binding,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q8IWV8|ens),UBR2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0000032,cell wall mannoprotein biosynthetic process,Q3SZI0(Evidence code:IBA/Database source:PANTHER:PTN000034017),MPI,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035280,miRNA loading onto RISC involved in gene silencing by miRNA,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens),AGO4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031931,TORC1 complex,F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens),TTI1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0006660,phosphatidylserine catabolic process,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens),ABHD12,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0072334,UDP-galactose transmembrane transport,Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081293),SLC35B1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0008206,bile acid metabolic process,E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens),ATP8B1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032274,gonadotropin secretion,F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens),FAM129B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061676,importin-alpha family protein binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0060044,negative regulation of cardiac muscle cell proliferation,G3X793(Evidence code:IEA/Database source:UniProtKB:Q9WUI1|ens),MAPK11,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035021,negative regulation of Rac protein signal transduction,E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens),ARAP3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0044609,DBIRD complex,E1B9H3(Evidence code:IEA/Database source:InterPro:IPR028811),CCAR2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0042796,snRNA transcription by RNA polymerase III,E1BCK9(Evidence code:IEA/Database source:UniProtKB:Q5SXM2|ens),SNAPC4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003149,membranous septum morphogenesis,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens),FZD1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004689,phosphorylase kinase activity,F1MJ90(Evidence code:IBA/Database source:PANTHER:PTN000844181),PHKB,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004013,adenosylhomocysteinase activity,A6QLP2(Evidence code:IBA/Database source:PANTHER:PTN001158976),AHCYL2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070092,regulation of glucagon secretion,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q8CEE6|ens),PASK,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0047006,"17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity",P16116(Evidence code:IEA/Database source:EC:1.1.1.149),AKR1B1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019290,siderophore biosynthetic process,Q3T046(Evidence code:ISS/Database source:UniProtKB:Q8JZV9),BDH2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021797,forebrain anterior/posterior pattern specification,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599),AXIN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046512,sphingosine biosynthetic process,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9NRA0|ens),SPHK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002528,regulation of vascular permeability involved in acute inflammatory response,E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q32MK0|ens),MYLK3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030050,vesicle transport along actin filament,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens),MYO1C,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032264,IMP salvage,E1BA23(Evidence code:IEA/Database source:InterPro:IPR006329|I),AMPD3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004109,coproporphyrinogen oxidase activity,E1BKY9(Evidence code:IEA/Database source:InterPro:IPR001260|I),CPOX,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019483,beta-alanine biosynthetic process,Q28007(Evidence code:IEA/Database source:UniPathway:UPA00131),DPYD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902255,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Q3T087(Evidence code:IEA/Database source:UniProtKB:Q9CXW4|ens),RPL11,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000172,ribonuclease MRP complex,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens),RPP25,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0061670,evoked neurotransmitter secretion,P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens),RAB3A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032809,neuronal cell body membrane,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0071672,negative regulation of smooth muscle cell chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070626,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,A3KN12(Evidence code:IEA/Database source:EC:4.3.2.2),ADSL,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,E1BML0(Evidence code:IEA/Database source:InterPro:IPR030843),PAN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004643,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR002695),ATIC,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0031493,nucleosomal histone binding,A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens),UHRF1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0090191,negative regulation of branching involved in ureteric bud morphogenesis,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens),TACSTD2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0045903,positive regulation of translational fidelity,A6QLG5(Evidence code:IBA/Database source:PANTHER:PTN000216478),RPS9,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061386,closure of optic fissure,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7),PHACTR4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070449,elongin complex,Q3SZ32(Evidence code:IEA/Database source:InterPro:IPR039049),TCEB2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0006062,sorbitol catabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0098560,cytoplasmic side of late endosome membrane,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens),LITAF,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0043203,axon hillock,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004618,phosphoglycerate kinase activity,Q32KN6(Evidence code:IEA/Database source:InterPro:IPR001576|I),PGK2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071955,recycling endosome to Golgi transport,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens),GCC2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005614,interstitial matrix,F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens),NAV2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004016,adenylate cyclase activity,Q29450(Evidence code:ISS/Database source:UniProtKB:P51828),ADCY7,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0009346,citrate lyase complex,Q32PF2(Evidence code:IBA/Database source:PANTHER:PTN000563493),ACLY,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0005964,phosphorylase kinase complex,F1MJ90(Evidence code:IBA/Database source:PANTHER:PTN000844181),PHKB,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0003952,NAD+ synthase (glutamine-hydrolyzing) activity,Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003694|I),NADSYN1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0015805,S-adenosyl-L-methionine transport,A6QR09(Evidence code:ISS/Database source:UniProtKB:Q70HW3),SLC25A26,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032811,negative regulation of epinephrine secretion,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN001030516),CRH,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004332,fructose-bisphosphate aldolase activity,Q3T0S5(Evidence code:IEA/Database source:InterPro:IPR000741),ALDOB,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0005879,axonemal microtubule,Q0IIM2(Evidence code:IDA/Database source:),ARL6,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0003896,DNA primase activity,G8JKZ3(Evidence code:IEA/Database source:InterPro:IPR002755|I),PRIM1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0072177,mesonephric duct development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens),GREB1L,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060352,cell adhesion molecule production,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens),GOLPH3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000564,"regulation of CD8-positive, alpha-beta T cell proliferation",Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090284,positive regulation of protein glycosylation in Golgi,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061501,cyclic-GMP-AMP synthase activity,E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8C6L5),MB21D1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0031802,type 5 metabotropic glutamate receptor binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003419,growth plate cartilage chondrocyte proliferation,F1MP76(Evidence code:IDA/Database source:),SDC3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034272,"phosphatidylinositol 3-kinase complex, class III, type II",A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0071492,cellular response to UV-A,P26882(Evidence code:ISS/Database source:UniProtKB:Q08752),PPID,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005743),PIK3CD,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0060268,negative regulation of respiratory burst,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071987,WD40-repeat domain binding,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q99459),CDC5L,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0015014,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens),EXT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1904378,maintenance of unfolded protein involved in ERAD pathway,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071947,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,E1B9S7(Evidence code:IBA/Database source:PANTHER:PTN001001090),OTUD7B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004143,diacylglycerol kinase activity,E1BGA9(Evidence code:IEA/Database source:InterPro:IPR000756|I),DGKQ,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1902775,mitochondrial large ribosomal subunit assembly,F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens),FASTKD2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071630,nuclear protein quality control by the ubiquitin-proteasome system,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0008559,xenobiotic transmembrane transporting ATPase activity,F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334),ABCC3,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0099590,neurotransmitter receptor internalization,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030242,autophagy of peroxisome,A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042613,MHC class II protein complex,F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I),LOC100848815,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004359,glutaminase activity,Q3ZBF0(Evidence code:IBA/Database source:PANTHER:PTN000557972),NADSYN1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000672,negative regulation of motor neuron apoptotic process,A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens),MAP2K4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003975,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,Q5EA65(Evidence code:IEA/Database source:InterPro:IPR033895),DPAGT1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0007084,mitotic nuclear envelope reassembly,E1BFD1(Evidence code:IEA/Database source:InterPro:IPR035007),ANKLE2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051164,L-xylitol metabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061744,motor behavior,F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens),ADARB1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0036117,hyaluranon cable,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:2001286,regulation of caveolin-mediated endocytosis,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032483,regulation of Rab protein signal transduction,F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens),DENND1A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0052852,very-long-chain-(S)-2-hydroxy-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0017018,myosin phosphatase activity,Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62143),PPP1CB,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1903724,positive regulation of centriole elongation,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1990404,protein ADP-ribosylase activity,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0046870,cadmium ion binding,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0051661,maintenance of centrosome location,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens),GPSM2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046168,glycerol-3-phosphate catabolic process,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR011128),GPD1L,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002924,negative regulation of humoral immune response mediated by circulating immunoglobulin,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035407,histone H3-T11 phosphorylation,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512),PKN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061053,somite development,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003939,L-iditol 2-dehydrogenase activity,Q58D31(Evidence code:IEA/Database source:EC:1.1.1.14),SORD,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0016035,zeta DNA polymerase complex,E1BF32(Evidence code:IBA/Database source:PANTHER:PTN000035411),KIAA2022,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0061474,phagolysosome membrane,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens),LAMP1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004816,asparagine-tRNA ligase activity,Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004522),NARS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0015867,ATP transport,P02722(Evidence code:IEA/Database source:GO:0005471),SLC25A4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097091,synaptic vesicle clustering,F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens),SYN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006214,thymidine catabolic process,Q28007(Evidence code:ISS/Database source:UniProtKB:Q12882),DPYD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002431,Fc receptor mediated stimulatory signaling pathway,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003878,ATP citrate synthase activity,Q32PF2(Evidence code:IEA/Database source:InterPro:IPR014608),ACLY,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1902513,regulation of organelle transport along microtubule,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003334,keratinocyte development,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0045905,positive regulation of translational termination,F1MN49(Evidence code:IEA/Database source:InterPro:IPR019769|I),EIF5A2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035863,dITP catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0),NUDT16,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903416,response to glycoside,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901074,regulation of engulfment of apoptotic cell,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0017061,S-methyl-5-thioadenosine phosphorylase activity,Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR010044),MTAP,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens),PRKDC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000331,regulation of terminal button organization,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002455,humoral immune response mediated by circulating immunoglobulin,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903384,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902992,negative regulation of amyloid precursor protein catabolic process,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030157,pancreatic juice secretion,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens),AQP5,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0007386,compartment pattern specification,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens),LFNG,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902544,regulation of DNA N-glycosylase activity,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0047130,"saccharopine dehydrogenase (NADP+, L-lysine-forming) activity",A8E657(Evidence code:IEA/Database source:EC:1.5.1.8),AASS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006361,transcription initiation from RNA polymerase I promoter,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2),LIPE,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0039536,negative regulation of RIG-I signaling pathway,Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens),UFD1L,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903147,negative regulation of autophagy of mitochondrion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0015227,acyl carnitine transmembrane transporter activity,Q08DK7(Evidence code:IBA/Database source:PANTHER:PTN002377726),SLC25A29,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000465,regulation of glycogen (starch) synthase activity,E1BHP3(Evidence code:IEA/Database source:UniProtKB:Q6ZSY5|ens),PPP1R3F,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043931,ossification involved in bone maturation,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens),RYR1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0061030,epithelial cell differentiation involved in mammary gland alveolus development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031937,positive regulation of chromatin silencing,Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens),MIER1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019408,dolichol biosynthetic process,Q5EA65(Evidence code:ISS/Database source:UniProtKB:P24140),DPAGT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0044547,DNA topoisomerase binding,Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens),SRSF1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1904706,negative regulation of vascular smooth muscle cell proliferation,A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens),PDCD4,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030432,peristalsis,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048769,sarcomerogenesis,E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680821),MYLK3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens),CTNND1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051500,D-tyrosyl-tRNA(Tyr) deacylase activity,E1B937(Evidence code:IBA/Database source:PANTHER:PTN000049487),DTD2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0051563,smooth endoplasmic reticulum calcium ion homeostasis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003912,DNA nucleotidylexotransferase activity,P06526(Evidence code:IEA/Database source:InterPro:IPR027292),DNTT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0010265,SCF complex assembly,A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6),CAND1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010666,positive regulation of cardiac muscle cell apoptotic process,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens),CAMK2A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0016206,catechol O-methyltransferase activity,A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128),COMT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0098821,BMP receptor activity,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1990423,RZZ complex,E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens),KNTC1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0006452,translational frameshifting,F1MN49(Evidence code:IEA/Database source:InterPro:IPR019769|I),EIF5A2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034464,BBSome,Q0IIM2(Evidence code:IDA/Database source:),ARL6,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0032173,septin collar,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens),SEPT6,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0001967,suckling behavior,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens),PEX13,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0032998,Fc-epsilon receptor I complex,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0097726,LEM domain binding,P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens),BANF1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006060,sorbitol metabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q64442|ens),SORD,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030215,semaphorin receptor binding,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens),SEMA3E,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006478,peptidyl-tyrosine sulfation,Q3SYY2(Evidence code:IEA/Database source:InterPro:IPR026634),TPST2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060155,platelet dense granule organization,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004500,dopamine beta-monooxygenase activity,P15101(Evidence code:IEA/Database source:EC:1.14.17.1),DBH,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0048757,pigment granule maturation,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004757,sepiapterin reductase activity,Q17QK8(Evidence code:IEA/Database source:InterPro:IPR006393),SPR,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006264,mitochondrial DNA replication,E1BDI3(Evidence code:IBA/Database source:PANTHER:PTN000030201),POLG,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1900028,negative regulation of ruffle assembly,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens),TACSTD2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0051228,mitotic spindle disassembly,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0),SPAST,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060463,lung lobe morphogenesis,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004641,phosphoribosylformylglycinamidine cyclo-ligase activity,Q59A32(Evidence code:IEA/Database source:InterPro:IPR004733),GART,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003105,negative regulation of glomerular filtration,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824),F2R,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903351,cellular response to dopamine,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010940,positive regulation of necrotic cell death,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000829,inositol heptakisphosphate kinase activity,F1MNG6(Evidence code:IEA/Database source:InterPro:IPR037446),PPIP5K2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1990791,dorsal root ganglion development,E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens),POU4F2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070776,MOZ/MORF histone acetyltransferase complex,G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens),BRD1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0008274,gamma-tubulin ring complex,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens),CDK5RAP2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0031630,regulation of synaptic vesicle fusion to presynaptic active zone membrane,P11023(Evidence code:ISS/Database source:UniProtKB:P63011),RAB3A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034595,phosphatidylinositol phosphate 5-phosphatase activity,O18964(Evidence code:IEA/Database source:InterPro:IPR034972),SYNJ1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0072498,embryonic skeletal joint development,A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens),EXT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004052,arachidonate 12-lipoxygenase activity,P27479(Evidence code:IEA/Database source:EC:1.13.11.31),ALOX15,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0000828,inositol hexakisphosphate kinase activity,F1MNG6(Evidence code:IEA/Database source:UniProtKB:Q6ZQB6|ens),PPIP5K2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071442,positive regulation of histone H3-K14 acetylation,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004516,nicotinate phosphoribosyltransferase activity,A5PK51(Evidence code:IEA/Database source:InterPro:IPR006405),NAPRT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071866,negative regulation of apoptotic process in bone marrow,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071797,LUBAC complex,A6QNU0(Evidence code:IEA/Database source:InterPro:IPR026254),RNF31,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0103053,1-ethyladenine demethylase activity,Q58DM4(Evidence code:IEA/Database source:EC:1.14.11.33),ALKBH2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1904970,brush border assembly,F1MLR9(Evidence code:IEA/Database source:UniProtKB:Q6PIF6|ens),MYO7B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035402,histone kinase activity (H3-T11 specific),A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512),PKN1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0000155,phosphorelay sensor kinase activity,F1MP51(Evidence code:IEA/Database source:InterPro:IPR000700),KCNH5,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0071466,cellular response to xenobiotic stimulus,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens),E2F1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043754,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,P11181(Evidence code:IEA/Database source:EC:2.3.1.168),DBT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070187,shelterin complex,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0006285,"base-excision repair, AP site formation",A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042536,negative regulation of tumor necrosis factor biosynthetic process,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097286,iron ion import,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens),TFRC,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021903,rostrocaudal neural tube patterning,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006489,dolichyl diphosphate biosynthetic process,Q5EA65(Evidence code:IBA/Database source:PANTHER:PTN000060284),DPAGT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010593,negative regulation of lamellipodium assembly,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903244,positive regulation of cardiac muscle hypertrophy in response to stress,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006426,glycyl-tRNA aminoacylation,A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002315),GARS,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2001303,lipoxin A4 biosynthetic process,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0018479,benzaldehyde dehydrogenase (NAD+) activity,P48644(Evidence code:IBA/Database source:PANTHER:PTN000192776),ALDH1A1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0038109,Kit signaling pathway,P43481(Evidence code:IEA/Database source:InterPro:IPR027263),KIT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0017168,5-oxoprolinase (ATP-hydrolyzing) activity,Q75WB5(Evidence code:IEA/Database source:EC:3.5.2.9),OPLAH,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0046884,follicle-stimulating hormone secretion,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens),TBX3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0050798,activated T cell proliferation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043194,axon initial segment,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0099641,anterograde axonal protein transport,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens),MAPK8IP3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005585,collagen type II trimer,P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens),COL2A1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0047757,chondroitin-glucuronate 5-epimerase activity,F1ME12(Evidence code:IEA/Database source:UniProtKB:Q0VBN2|ens),DSEL,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019871,sodium channel inhibitor activity,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0031260,pseudopodium membrane,Q58DW6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),RAB25,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:1902037,negative regulation of hematopoietic stem cell differentiation,Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38647),HSPA9,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902953,positive regulation of ER to Golgi vesicle-mediated transport,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090285,negative regulation of protein glycosylation in Golgi,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0047105,4-trimethylammoniobutyraldehyde dehydrogenase activity,Q2KJH9(Evidence code:IEA/Database source:EC:1.2.1.47),ALDH9A1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1900106,positive regulation of hyaluranon cable assembly,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903818,positive regulation of voltage-gated potassium channel activity,G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens),LRRC26,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0070171,negative regulation of tooth mineralization,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071879,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0009000,selenocysteine lyase activity,A2VDS1(Evidence code:IEA/Database source:EC:4.4.1.16),SCLY,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006685,sphingomyelin catabolic process,A6QQN6(Evidence code:IEA/Database source:InterPro:IPR017064),SMPDL3B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003987,acetate-CoA ligase activity,A7YWF1(Evidence code:IEA/Database source:InterPro:IPR011904),ACSS2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004476,mannose-6-phosphate isomerase activity,Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR001250|I),MPI,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0017057,6-phosphogluconolactonase activity,Q2TBQ8(Evidence code:IEA/Database source:InterPro:IPR005900),PGLS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004329,formate-tetrahydrofolate ligase activity,A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000559),MTHFD1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004559,alpha-mannosidase activity,F1MWT0(Evidence code:IEA/Database source:InterPro:IPR000602|I),MAN2C1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000627,positive regulation of miRNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033189,response to vitamin A,P02694(Evidence code:IEA/Database source:UniProtKB:Q00915|ens),RBP1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1990051,activation of protein kinase C activity,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens),ABL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042500,"aspartic endopeptidase activity, intramembrane cleaving",Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031),PSEN1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004726,non-membrane spanning protein tyrosine phosphatase activity,P11064(Evidence code:IEA/Database source:InterPro:IPR002115),ACP1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004483,mRNA (nucleoside-2-O-)-methyltransferase activity,G3MZP6(Evidence code:IEA/Database source:UniProtKB:Q8IYT2|ens),CMTR2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070695,FHF complex,A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612),FAM160A2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:2000766,negative regulation of cytoplasmic translation,F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q9C0B0|ens),UNK,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0033624,negative regulation of integrin activation,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens),KIF14,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0016428,tRNA (cytosine-5-)-methyltransferase activity,A1A4K2(Evidence code:IEA/Database source:InterPro:IPR023270),NSUN2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:2000670,positive regulation of dendritic cell apoptotic process,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004753,saccharopine dehydrogenase activity,A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283),AASS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0048632,negative regulation of skeletal muscle tissue growth,F1MF35(Evidence code:IEA/Database source:UniProtKB:Q9WVM6|ens),TLL2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019346,transsulfuration,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048539,bone marrow development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071688,striated muscle myosin thick filament assembly,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569),MYBPC3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1901641,ITP binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0015186,L-glutamine transmembrane transporter activity,Q95JC7(Evidence code:ISS/Database source:UniProtKB:Q15758),SLC1A5,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens),SHANK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1900134,negative regulation of renin secretion into blood stream,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558),F2R,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097214,positive regulation of lysosomal membrane permeability,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1903358,regulation of Golgi organization,A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens),RAB33B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000215,tRNA 2-phosphotransferase activity,Q3ZBM7(Evidence code:IEA/Database source:EC:2.7.1.160),TRPT1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0016309,1-phosphatidylinositol-5-phosphate 4-kinase activity,Q0P5F7(Evidence code:IEA/Database source:EC:2.7.1.149),PIP4K2C,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1904851,positive regulation of establishment of protein localization to telomere,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens),CCT3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004591,oxoglutarate dehydrogenase (succinyl-transferring) activity,E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603),DHTKD1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0021521,ventral spinal cord interneuron specification,F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens),SOX1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046098,guanine metabolic process,F1MLX9(Evidence code:IBA/Database source:PANTHER:PTN000138455),GDA,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006670,sphingosine metabolic process,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens),SPHK2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1905183,negative regulation of protein serine/threonine phosphatase activity,P05059(Evidence code:IDA/Database source:),CHGA,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034465,response to carbon monoxide,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens),KCNMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004489,methylenetetrahydrofolate reductase (NAD(P)H) activity,Q5I598(Evidence code:IEA/Database source:InterPro:IPR003171|I),MTHFR,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0042043,neurexin family protein binding,A8KC68(Evidence code:IEA/Database source:InterPro:IPR000460|I),NLGN2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0008392,arachidonic acid epoxygenase activity,F1MEU8(Evidence code:IBA/Database source:PANTHER:PTN000670523),LOC540627,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070676,intralumenal vesicle formation,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens),SNX3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060313,negative regulation of blood vessel remodeling,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002643,regulation of tolerance induction,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens),MARCH7,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1990926,short-term synaptic potentiation,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010992,ubiquitin recycling,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0006370,7-methylguanosine mRNA capping,G3MZP6(Evidence code:IEA/Database source:UniProtKB:Q8IYT2|ens),CMTR2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004756,"selenide, water dikinase activity",E1BHE5(Evidence code:IEA/Database source:InterPro:IPR023061),SEPHS2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0046655,folic acid metabolic process,Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q8C1A3),MTRR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001094,TFIID-class transcription factor binding,A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens),RUVBL1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0044313,protein K6-linked deubiquitination,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0072393,microtubule anchoring at microtubule organizing center,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens),BICD2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0047127,thiomorpholine-carboxylate dehydrogenase activity,Q2KHX6(Evidence code:IEA/Database source:EC:1.5.1.25),CRYM,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1990239,steroid hormone binding,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004031,aldehyde oxidase activity,P48034(Evidence code:IEA/Database source:EC:1.2.3.1),AOX1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1990452,Parkin-FBXW7-Cul1 ubiquitin ligase complex,F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens),CUL1,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0000386,second spliceosomal transesterification activity,A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558),PRPF8,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0036500,ATF6-mediated unfolded protein response,Q0III2(Evidence code:IBA/Database source:PANTHER:PTN000330398),MBTPS2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004487,methylenetetrahydrofolate dehydrogenase (NAD+) activity,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0002945,cyclin K-CDK13 complex,E1BB52(Evidence code:IEA/Database source:UniProtKB:Q14004|ens),CDK13,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0036258,multivesicular body assembly,Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060082,eye blink reflex,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0034186,apolipoprotein A-I binding,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0010310,regulation of hydrogen peroxide metabolic process,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0046709,IDP catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0071316,cellular response to nicotine,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens),NFKB1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1905419,sperm flagellum movement involved in flagellated sperm motility,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0008476,protein-tyrosine sulfotransferase activity,Q3SYY2(Evidence code:IEA/Database source:InterPro:IPR026634),TPST2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006069,ethanol oxidation,Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR014183),ADH5,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0052565,response to defense-related host nitric oxide production,A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q9ERL9|ens),GUCY1A3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019002,GMP binding,Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens),RAB26,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0018125,peptidyl-cysteine methylation,P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens),RAB3B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0002467,germinal center formation,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0004018,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity",A3KN12(Evidence code:IEA/Database source:InterPro:IPR004769),ADSL,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0038094,Fc-gamma receptor signaling pathway,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042633,hair cycle,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304),SNRPE,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0021691,cerebellar Purkinje cell layer maturation,P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens),ARCN1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",E1BML0(Evidence code:IEA/Database source:UniRule:UR000166126),PAN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1900112,regulation of histone H3-K9 trimethylation,F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens),ATRX,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0010918,positive regulation of mitochondrial membrane potential,E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens),TCL1A,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090658,cone matrix sheath,P12661(Evidence code:IBA/Database source:PANTHER:PTN000137261),RBP3,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004081,bis(5-nucleosyl)-tetraphosphatase (asymmetrical) activity,A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens),GARS,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0034751,aryl hydrocarbon receptor complex,F1ML85(Evidence code:IEA/Database source:InterPro:IPR033348),AHR,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0002554,serotonin secretion by platelet,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902262,apoptotic process involved in blood vessel morphogenesis,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0035811,negative regulation of urine volume,F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens),MLLT6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048698,negative regulation of collateral sprouting in absence of injury,A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens),SPG20,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042178,xenobiotic catabolic process,O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens),CRYZ,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:1902367,negative regulation of Notch signaling pathway involved in somitogenesis,Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010),LFNG,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043914,NADPH:sulfur oxidoreductase activity,F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939),MICAL2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0008432,JUN kinase binding,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens),MAPK8IP3,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003978,UDP-glucose 4-epimerase activity,Q3T105(Evidence code:IEA/Database source:InterPro:IPR005886),GALE,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0000983,"transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding",E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0019166,trans-2-enoyl-CoA reductase (NADPH) activity,Q3ZBW6(Evidence code:IEA/Database source:UniProtKB:Q9NUI1|ens),DECR2,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0004594,pantothenate kinase activity,A4FV09(Evidence code:IEA/Database source:InterPro:IPR004567|I),PANK4,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0072378,"blood coagulation, fibrin clot formation",Q2TBQ1(Evidence code:IEA/Database source:UniProtKB:Q07968|ens),F13B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0019358,nicotinate nucleotide salvage,A5PK51(Evidence code:IEA/Database source:InterPro:IPR006405),NAPRT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060072,large conductance calcium-activated potassium channel activity,Q28204(Evidence code:IEA/Database source:InterPro:IPR024939),KCNMA1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1905065,positive regulation of vascular smooth muscle cell differentiation,P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens),KIT,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0000056,ribosomal small subunit export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens),XPO1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003365,establishment of cell polarity involved in ameboidal cell migration,E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens),AMOTL1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0030502,negative regulation of bone mineralization,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0001812,positive regulation of type I hypersensitivity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042276,error-prone translesion synthesis,E1BF32(Evidence code:IBA/Database source:PANTHER:PTN000035411),KIAA2022,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0097109,neuroligin family protein binding,Q28146(Evidence code:IPI/Database source:UniProtKB:Q62765),NRXN1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0003157,endocardium development,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0005020,stem cell factor receptor activity,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0006968,cellular defense response,E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens),RAB23,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0048763,calcium-induced calcium release activity,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens),RYR1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1903894,regulation of IRE1-mediated unfolded protein response,F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens),COPS5,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060535,trachea cartilage morphogenesis,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284),LRP6,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0043651,linoleic acid metabolic process,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O35936|ens),ALOX15B,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0090498,extrinsic component of Golgi membrane,E1B970(Evidence code:IEA/Database source:InterPro:IPR033288),GOLGA3,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0045226,extracellular polysaccharide biosynthetic process,O97711(Evidence code:ISS/Database source:UniProtKB:P70312),HAS2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:2000049,positive regulation of cell-cell adhesion mediated by cadherin,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0003909,DNA ligase activity,A4IFC8(Evidence code:IEA/Database source:InterPro:IPR016059),LIG1,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0070032,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0004767,sphingomyelin phosphodiesterase activity,A6QQN6(Evidence code:IEA/Database source:InterPro:IPR017064),SMPDL3B,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0030870,Mre11 complex,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,CC,1,1 of 1,0.04,100,0.1275,0.213
GO:0043570,maintenance of DNA repeat elements,G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens),AXIN2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0031531,thyrotropin-releasing hormone receptor binding,P62194(Evidence code:ISS/Database source:UniProtKB:P62195),PSMC5,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:1904628,cellular response to phorbol 13-acetate 12-myristate,E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens),ADAM15,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0060903,positive regulation of meiosis I,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 1,0.04,100,0.1275,0.213
GO:0042609,CD4 receptor binding,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens),LCK,MF,1,1 of 1,0.04,100,0.1275,0.213
GO:0060326,cell chemotaxis,A4FUD6(Evidence code:ISS/Database source:UniProtKB:Q96JJ3)A6YT15(Evidence code:IEA/Database source:UniProtKB:Q9NRJ3|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), ELMO2 CCL28 KIT PIK3CD CXCL12 LEF1,BP,6,6 of 41,0.26,14.63,0.1277,0.2131
GO:0045861,negative regulation of proteolysis,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens),CLN3,BP,1,1 of 62,0.04,1.61,0.1282,0.2137
GO:0002237,response to molecule of bacterial origin,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens),MALT1,BP,1,1 of 62,0.04,1.61,0.1282,0.2137
GO:0090068,positive regulation of cell cycle process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 62,0.04,1.61,0.1282,0.2137
GO:0045765,regulation of angiogenesis,F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens),PROK1,BP,1,1 of 62,0.04,1.61,0.1282,0.2137
GO:0010038,response to metal ion,F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens),GPHN,BP,1,1 of 62,0.04,1.61,0.1282,0.2137
GO:0045862,positive regulation of proteolysis,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens),CYFIP2,BP,1,1 of 63,0.04,1.59,0.1285,0.2141
GO:0042623,"ATPase activity, coupled",Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR025653), VPS4B PEX1,MF,2,2 of 86,0.09,2.33,0.1287,0.2143
GO:0006820,anion transport,F1N4L1(Evidence code:IEA/Database source:InterPro:IPR001717|I)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR003020|I), SLC4A2 SLC4A7,BP,2,2 of 86,0.09,2.33,0.1287,0.2143
GO:0005261,cation channel activity,F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131),PIEZO1,MF,1,1 of 64,0.04,1.56,0.1292,0.2151
GO:0001819,positive regulation of cytokine production,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q95JH2(Evidence code:IEA/Database source:UniProtKB:Q99943|ens), FLOT1 AGPAT1,BP,2,2 of 88,0.09,2.27,0.1307,0.2176
GO:0016747,"transferase activity, transferring acyl groups other than amino-acyl groups",Q17QI3(Evidence code:IEA/Database source:InterPro:IPR002155|I),ACAT2,MF,1,1 of 66,0.04,1.52,0.1318,0.2193
GO:0030100,regulation of endocytosis,Q1RMR9(Evidence code:IBA/Database source:PANTHER:PTN000860688)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P56371|ens)E1BK71(Evidence code:IBA/Database source:PANTHER:PTN000860688)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN001179601)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens), PACSIN2 SYT4 RAB4A PACSIN3 RAB17 SNX12,BP,6,6 of 42,0.26,14.29,0.1322,0.2199
GO:0004527,exonuclease activity,E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0269)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0269)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0269), PAN2 DXO WRN DDX1,MF,4,4 of 26,0.18,15.38,0.1327,0.2206
GO:0097190,apoptotic signaling pathway,Q08DY9(Evidence code:IEA/Database source:GO:0097199),CASP3,BP,1,1 of 67,0.04,1.49,0.1337,0.2223
GO:0016829,lyase activity,A4FUZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A3KN12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A2VDS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A7MBC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)E1BP41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456), GLO1 ADSL SCLY PDXDC1 PCBD1 ADCY7 ALDOB GUCY1A3 UMPS CSAD,MF,10,10 of 83,0.44,12.05,0.1367,0.2257
GO:0017157,regulation of exocytosis,P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)Q29RR0(Evidence code:ISS/Database source:UniProtKB:P51156)P10949(Evidence code:IEA/Database source:UniProtKB:P62823|ens)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635132), RAB3B RAB3A RAB26 RAB3C RAPGEF4 RAB37,BP,6,6 of 43,0.26,13.95,0.1372,0.2257
GO:0051262,protein tetramerization,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)E1BC13(Evidence code:IEA/Database source:UniProtKB:Q14003|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR032415|I)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1BMI4(Evidence code:IEA/Database source:UniProtKB:Q8NBZ7|ens), SHMT2 KCNC3 RPS19 TRPM7 DNM1 UXS1,BP,6,6 of 43,0.26,13.95,0.1372,0.2257
GO:0019239,deaminase activity,E1BA23(Evidence code:IEA/Database source:InterPro:IPR001365)F1N088(Evidence code:IBA/Database source:PANTHER:PTN000118214), AMPD3 RPUSD2,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0048026,"positive regulation of mRNA splicing, via spliceosome",Q08E07(Evidence code:ISS/Database source:UniProtKB:Q5SZQ8)Q1RMR2(Evidence code:IEA/Database source:UniProtKB:Q62376|ens), CELF3 SNRNP70,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0004402,histone acetyltransferase activity,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens), TAF10 NCOA3,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0072546,ER membrane protein complex,Q3ZCB8(Evidence code:ISS/Database source:UniProtKB:Q9P0I2)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4), EMC3 EMC10,CC,2,2 of 8,0.09,25,0.1376,0.2257
GO:0051894,positive regulation of focal adhesion assembly,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens), ABL1 S100A10,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0045776,negative regulation of blood pressure,Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453988)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305), NOS2 RNPEP,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0010543,regulation of platelet activation,F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens), TEC FCER1G,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0000400,four-way junction DNA binding,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), WRN BLM,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0046326,positive regulation of glucose import,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), IRS1 PRKCI,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0002726,positive regulation of T cell cytokine production,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens), MALT1 TRAF6,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0061337,cardiac conduction,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), TRPM4 SPTBN4,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0001891,phagocytic cup,A6QLJ4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CDC42SE2 DNM2,CC,2,2 of 8,0.09,25,0.1376,0.2257
GO:0016918,retinal binding,P02694(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845)P12661(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845), RBP1 RBP3,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0045668,negative regulation of osteoblast differentiation,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens), AXIN2 CDK6,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0019841,retinol binding,P02694(Evidence code:IEA/Database source:UniProtKB-KW:KW-0683)P12661(Evidence code:IBA/Database source:PANTHER:PTN000137261), RBP1 RBP3,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0097110,scaffold protein binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens), SRC PDE4D,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0006739,NADP metabolic process,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens), GCK G6PD,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0003756,protein disulfide isomerase activity,E1BBS6(Evidence code:IBA/Database source:PANTHER:PTN000528008)A4FUW8(Evidence code:IBA/Database source:PANTHER:PTN000432607), QSOX2 TXNDC11,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0033179,"proton-transporting V-type ATPase, V0 domain",P23956(Evidence code:IEA/Database source:InterPro:IPR000245|I)P61420(Evidence code:IEA/Database source:InterPro:IPR016727), ATP6V0C ATP6V0D1,CC,2,2 of 8,0.09,25,0.1376,0.2257
GO:0046626,regulation of insulin receptor signaling pathway,E1BH09(Evidence code:IEA/Database source:UniProtKB:Q5GFL6|ens)F1MXR0(Evidence code:IEA/Database source:InterPro:IPR030060), VWA2 BAIAP2L1,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0030488,tRNA methylation,A1A4K2(Evidence code:IEA/Database source:GO:0016428)A5D7S3(Evidence code:IEA/Database source:GO:0004809), NSUN2 TRMT1L,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0046686,response to cadmium ion,A7YY70(Evidence code:IEA/Database source:UniProtKB:Q06495|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens), SLC34A1 MAPK9,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0030687,"preribosome, large subunit precursor",Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061)E1BC24(Evidence code:IBA/Database source:PANTHER:PTN000529705), EIF6 MDN1,CC,2,2 of 8,0.09,25,0.1376,0.2257
GO:1903393,positive regulation of adherens junction organization,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens), ARF6 PTPN23,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0004550,nucleoside diphosphate kinase activity,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0002931,response to ischemia,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), CAMK2A NDNF,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0045672,positive regulation of osteoclast differentiation,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), TRAF6 POU4F2,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0000993,RNA polymerase II complex binding,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens), CCAR2 IKBKAP,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:0055010,ventricular cardiac muscle tissue morphogenesis,P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens), MYL3 MYBPC3,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0071985,multivesicular body sorting pathway,Q08DR7(Evidence code:IEA/Database source:InterPro:IPR016689)Q5E9A6(Evidence code:IEA/Database source:InterPro:IPR008570), SNF8 VPS25,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0060612,adipose tissue development,E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens), ZNF516 SPG20,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0070849,response to epidermal growth factor,P46196(Evidence code:ISS/Database source:UniProtKB:P28482)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), MAPK1 TPR,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0001658,branching involved in ureteric bud morphogenesis,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens), DLG1 GREB1L,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0019825,oxygen binding,F1MP20(Evidence code:IEA/Database source:InterPro:IPR012292)E1BEL8(Evidence code:IEA/Database source:InterPro:IPR012292), ADGB HBE1,MF,2,2 of 8,0.09,25,0.1376,0.2257
GO:2000114,regulation of establishment of cell polarity,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), ARFGEF1 RICTOR,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0005687,U4 snRNP,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760), SNRPE SNRPN,CC,2,2 of 8,0.09,25,0.1376,0.2257
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,P04896(Evidence code:ISS/Database source:UniProtKB:P63092)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8), GNAS RAPGEF2,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0009072,aromatic amino acid family metabolic process,Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005957), PAH TAT,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0001974,blood vessel remodeling,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), DBH CHD7,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0060998,regulation of dendritic spine development,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)F1MFI5(Evidence code:IEA/Database source:UniProtKB:Q3UH53|ens), ARF6 SDK1,BP,2,2 of 8,0.09,25,0.1376,0.2257
GO:0034220,ion transmembrane transport,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)F1MHP0(Evidence code:IEA/Database source:GO:0005216)G0T3G6(Evidence code:IEA/Database source:GO:0005216)E1BHM6(Evidence code:IEA/Database source:GO:0005216)F1MCW8(Evidence code:IEA/Database source:GO:0005216)F1N5Z0(Evidence code:IBA/Database source:PANTHER:PTN000440615)F1MPF0(Evidence code:IEA/Database source:GO:0005216)F1MBY1(Evidence code:IEA/Database source:GO:0005216)P02715(Evidence code:IEA/Database source:InterPro:IPR006201)F1MWI8(Evidence code:IEA/Database source:GO:0005216)F1MMU9(Evidence code:IEA/Database source:GO:0005216)E1BHR8(Evidence code:IEA/Database source:GO:0005216)E1BGZ0(Evidence code:IEA/Database source:GO:0005216)Q08E50(Evidence code:IEA/Database source:InterPro:IPR006028|I)F1MD64(Evidence code:IEA/Database source:GO:0005261), TRPM4 SCN5A GRIA1 SCN11A GRIK4 AQP5 TRPM7 GRIA2 CHRNE GRIN3B SCN8A SCN3A GRIA3 GABRA5 PIEZO1,BP,15,15 of 139,0.66,10.79,0.1395,0.2287
GO:0030522,intracellular receptor signaling pathway,A2VDU4(Evidence code:IEA/Database source:GO:0004879)F1MVD0(Evidence code:IBA/Database source:PANTHER:PTN000074430)F1N3S3(Evidence code:IEA/Database source:GO:0004879), NR1I2 NCOA3 NR2F6,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0009100,glycoprotein metabolic process,F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens), ST8SIA3 MAN1A2 PCSK6,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0050905,neuromuscular process,A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens), AARS SPG20 AGTPBP1,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0046427,positive regulation of JAK-STAT cascade,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens), F2R KIT AGAP2,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0006406,mRNA export from nucleus,Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245|I)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280), NXF3 NUP214 SMG6,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0002027,regulation of heart rate,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), PDE4D SCN10A GPD1L,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0006693,prostaglandin metabolic process,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0644)Q32L99(Evidence code:IEA/Database source:InterPro:IPR037399)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0644), PTGES3 PTGR2 FAM213B,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0007602,phototransduction,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)P47803(Evidence code:IEA/Database source:InterPro:IPR001793)P04696(Evidence code:IEA/Database source:UniProtKB:P50149|ens), GNAT1 RGR GNAT2,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0001938,positive regulation of endothelial cell proliferation,Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q969H8)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4), PDCD6 MYDGF EMC10,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0030837,negative regulation of actin filament polymerization,Q56JV6(Evidence code:IEA/Database source:InterPro:IPR028458)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), TWF1 ARFGEF1 SLIT2,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0048705,skeletal system morphogenesis,A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), RAB33B PSEN1 COL2A1,BP,3,3 of 17,0.13,17.65,0.1417,0.2314
GO:0006633,fatty acid biosynthetic process,Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q5BIS9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q32PF2(Evidence code:IBA/Database source:PANTHER:PTN000563493), BRCA1 PRKAB1 FAM213B PRKAG1 PTGES3 ACLY,BP,6,6 of 44,0.26,13.64,0.1427,0.2329
GO:0008277,regulation of G-protein coupled receptor protein signaling pathway,A6QNV8(Evidence code:IEA/Database source:InterPro:IPR030409)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR037881)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)P63171(Evidence code:ISS/Database source:UniProtKB:P51807), RGS1 DGKQ USP20 RGS14 KCTD16 DYNLT1,BP,6,6 of 44,0.26,13.64,0.1427,0.2329
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,P23709(Evidence code:ISS/Database source:UniProtKB:O75489)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens), NDUFS3 PINK1 SRC FIGNL1,BP,4,4 of 27,0.18,14.81,0.1448,0.2364
GO:0005759,mitochondrial matrix,Q32KZ1(Evidence code:TAS/Database source:)P11181(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2TBI4(Evidence code:ISS/Database source:UniProtKB:Q12931)Q3T099(Evidence code:ISS/Database source:UniProtKB:Q9UGM6)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZK4(Evidence code:ISS/Database source:UniProtKB:Q969Z0)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897), MTIF3 DBT TRAP1 WARS2 CCAR2 LRRK2 RARS2 TBRG4 CDK1 MTG1 HSPA9 SHMT2,CC,12,12 of 111,0.53,10.81,0.1474,0.2405
GO:0009116,nucleoside metabolic process,G3MY14(Evidence code:IEA/Database source:InterPro:IPR000836)E1BM28(Evidence code:IEA/Database source:UniRule:UR000107503)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000836)P31754(Evidence code:IEA/Database source:InterPro:IPR000836)Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR000845|I)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR000836), PRPS2 DNPH1 PRPS1L1 UMPS MTAP PRPSAP2,BP,6,6 of 45,0.26,13.33,0.1486,0.2424
GO:0016197,endosomal transport,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1B958(Evidence code:IEA/Database source:InterPro:IPR028781)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR028667), ABCA1 SNX18 VPS4B AP5Z1 ALMS1 SNX33 ANKFY1 SNX27,BP,8,8 of 66,0.35,12.12,0.1537,0.2507
GO:0051592,response to calcium ion,A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)P48452(Evidence code:ISS/Database source:UniProtKB:Q08209)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens), PEF1 PPP3CA KCNMA1 PDCD6,BP,4,4 of 28,0.18,14.29,0.1574,0.2565
GO:0006635,fatty acid beta-oxidation,Q17QI3(Evidence code:IBA/Database source:PANTHER:PTN000432120)Q58DK1(Evidence code:IEA/Database source:UniPathway:UPA00659)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens), ACAT2 CPT1B PEX2,BP,3,3 of 18,0.13,16.67,0.1576,0.2565
GO:0006641,triglyceride metabolic process,Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q0IID9(Evidence code:IBA/Database source:PANTHER:PTN000023394)F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394), LOC538702 GK GK2,BP,3,3 of 18,0.13,16.67,0.1576,0.2565
GO:0032088,negative regulation of NF-kappaB transcription factor activity,E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863), PKHD1 DAB2IP ITCH,BP,3,3 of 18,0.13,16.67,0.1576,0.2565
GO:0007517,muscle organ development,Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0517)P17667(Evidence code:IEA/Database source:InterPro:IPR002546)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens), VAMP5 MYF5 CRYAB,BP,3,3 of 18,0.13,16.67,0.1576,0.2565
GO:0004896,cytokine receptor activity,F1MTF9(Evidence code:IEA/Database source:InterPro:IPR003531)G3X7E9(Evidence code:IEA/Database source:InterPro:IPR003532)E1B7G0(Evidence code:IBA/Database source:PANTHER:PTN000466212), IL9R IL13RA1 IFNLR1,MF,3,3 of 18,0.13,16.67,0.1576,0.2565
GO:1904115,axon cytoplasm,A2VDN5(Evidence code:IEA/Database source:GO:0019896)E1BN82(Evidence code:IEA/Database source:GO:0099641)E1BBN7(Evidence code:IEA/Database source:GO:0008089), SPAST MAPK8IP3 KIF1B,CC,3,3 of 18,0.13,16.67,0.1576,0.2565
GO:0042026,protein refolding,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q2HJ94(Evidence code:IEA/Database source:UniProtKB:O60884|ens), DNAJB2 DNAJA2,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0043457,regulation of cellular respiration,Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q8NC60)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens), NOA1 PNPT1,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0004190,aspartic-type endopeptidase activity,Q9XT97(Evidence code:IEA/Database source:InterPro:IPR001108|I)Q2HJ40(Evidence code:IEA/Database source:InterPro:IPR001461|I), PSEN1 BACE1,MF,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0050699,WW domain binding,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)Q2KHV3(Evidence code:ISS/Database source:UniProtKB:Q99732), RAPGEF2 LITAF,MF,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0042462,eye photoreceptor cell development,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), GNAT1 PRKCI,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0002082,regulation of oxidative phosphorylation,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), SHMT2 PINK1,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0016239,positive regulation of macroautophagy,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens), PINK1 TSC2,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0006970,response to osmotic stress,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), KCNMA1 PLK3,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0016226,iron-sulfur cluster assembly,Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76), HSPA9 MMS19,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0033700,phospholipid efflux,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens), ABCA1 ABCA7,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",F1MF74(Evidence code:ISS/Database source:UniProtKB:Q8BML1)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q8TDZ2), MICAL2 MICAL3,MF,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0006900,vesicle budding from membrane,P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens), S100A10 CHMP4A,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0005686,U2 snRNP,Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555), SNRPN SNRPE,CC,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0046716,muscle cell cellular homeostasis,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), PFKM SRF,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0034709,methylosome,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744), SNRPE PRMT5,CC,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0050710,negative regulation of cytokine secretion,F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)E1BAW2(Evidence code:IEA/Database source:UniProtKB:G3XA59|ens), LGR4 LRRC32,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0005537,mannose binding,F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q8CF98|ens)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens), COLEC10 ACR,MF,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0001708,cell fate specification,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens), PSEN1 CDON,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0030516,regulation of axon extension,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052), ABL1 DNM2,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,Q3SZD5(Evidence code:IEA/Database source:UniProtKB:Q66K64|ens)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806), DCAF15 LOC780968,CC,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0007193,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens), AKAP12 PALM,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0016849,phosphorus-oxygen lyase activity,Q29450(Evidence code:IEA/Database source:InterPro:IPR001054|I)A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR001054|I), ADCY7 GUCY1A3,MF,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0005978,glycogen biosynthetic process,F1MZP0(Evidence code:IEA/Database source:InterPro:IPR037439)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), GBE1 PTGES3,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0006308,DNA catabolic process,Q2QDE9(Evidence code:IEA/Database source:InterPro:IPR016202)A5PJT8(Evidence code:IEA/Database source:InterPro:IPR016202), DNASE1L1 DNASE1L2,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0004181,metallocarboxypeptidase activity,E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084)F1MKS6(Evidence code:IEA/Database source:InterPro:IPR000834|I), CPXM2 AGTPBP1,MF,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0032570,response to progesterone,Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)P02668(Evidence code:IDA/Database source:), ABHD2 CSN3,BP,2,2 of 9,0.09,22.22,0.1611,0.2601
GO:0044877,protein-containing complex binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A5PKD6(Evidence code:IEA/Database source:UniProtKB:Q9HAV0|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BP72(Evidence code:IEA/Database source:UniProtKB:Q9Y5S2|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)E1BCW3(Evidence code:IEA/Database source:UniProtKB:Q01813|ens)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)E1BJ75(Evidence code:ISS/Database source:UniProtKB:Q90830)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), DAB2IP GNB4 TERF2 CDC42BPB WRN CRYAB PFKP NCKAP1 TSG101 ATM STRN4 ABI1 TNKS1BP1 PEX1 CRTAP NUMA1 PRNP RAD18 STRN3 CHMP6 RRAS WASF2 TWF1,MF,23,23 of 243,1.01,9.47,0.173,0.2607
GO:0043086,negative regulation of catalytic activity,Q2KJ77(Evidence code:IEA/Database source:GO:0004857)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MYQ7(Evidence code:IEA/Database source:GO:0004857)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens), HSPBP1 CLN3 FRY CAND1 CCAR2,BP,5,5 of 137,0.22,3.65,0.1732,0.2607
GO:0030534,adult behavior,E1BD77(Evidence code:IEA/Database source:UniProtKB:Q2MHN3|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:Q9Y566|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BFN9(Evidence code:IEA/Database source:UniProtKB:Q9P2S2|ens), ZFHX2 SHANK1 SHANK2 SPTBN4 NRXN2,BP,5,5 of 34,0.22,14.71,0.1815,0.2607
GO:0016573,histone acetylation,A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244)F1MVD0(Evidence code:IEA/Database source:GO:0004402), RUVBL1 RUVBL2 NCOA3,BP,3,3 of 19,0.13,15.79,0.1741,0.2607
GO:0016831,carboxy-lyase activity,E1BP41(Evidence code:IEA/Database source:InterPro:IPR002129|I)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0210)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR002129), CSAD UMPS PDXDC1,MF,3,3 of 19,0.13,15.79,0.1741,0.2607
GO:0010608,posttranscriptional regulation of gene expression,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8NHU6)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670), PUM1 TDRD7 RC3H2,BP,3,3 of 100,0.13,3,0.1625,0.2607
GO:0000422,autophagy of mitochondrion,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023), FIS1 PINK1 ATG2B,BP,3,3 of 19,0.13,15.79,0.1741,0.2607
GO:0000123,histone acetyltransferase complex,F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)G3MY36(Evidence code:IEA/Database source:InterPro:IPR026180)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), KANSL3 KANSL1L HCFC1,CC,3,3 of 19,0.13,15.79,0.1741,0.2607
GO:0005680,anaphase-promoting complex,E1BAB6(Evidence code:IEA/Database source:InterPro:IPR024990)A7Z061(Evidence code:ISS/Database source:UniProtKB:P30260), ANAPC1 CDC27,CC,2,2 of 10,0.09,20,0.1853,0.2607
GO:0008171,O-methyltransferase activity,P10950(Evidence code:IEA/Database source:InterPro:IPR001077)A7MBI7(Evidence code:IEA/Database source:InterPro:IPR002935), ASMT COMT,MF,2,2 of 10,0.09,20,0.1853,0.2607
GO:0030057,desmosome,F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)Q01107(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PKP4 DSC1,CC,2,2 of 10,0.09,20,0.1853,0.2607
GO:1901016,regulation of potassium ion transmembrane transporter activity,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens), NEDD4 CACNA1D,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0009416,response to light stimulus,P04695(Evidence code:IDA/Database source:)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), GNAT1 KMT2A,BP,2,2 of 81,0.09,2.47,0.1782,0.2607
GO:0045047,protein targeting to ER,Q3SZJ9(Evidence code:IBA/Database source:PANTHER:PTN000049281)Q3SZU5(Evidence code:IBA/Database source:PANTHER:PTN000301433), PMM2 SPCS3,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0042562,hormone binding,Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens), ABHD2 CRYM,MF,2,2 of 10,0.09,20,0.1853,0.2607
GO:0010332,response to gamma radiation,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens), BRCA2 PRKDC,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0001678,cellular glucose homeostasis,A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312), GCK HK2,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0006893,Golgi to plasma membrane transport,A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473)E1BDW9(Evidence code:IEA/Database source:InterPro:IPR029175), EXOC4 EXOC2,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0017080,sodium channel regulator activity,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)E1B757(Evidence code:IEA/Database source:InterPro:IPR029873), GPD1L SCN2B,MF,2,2 of 10,0.09,20,0.1853,0.2607
GO:0045860,positive regulation of protein kinase activity,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386), PSEN1 RAPGEF2,BP,2,2 of 83,0.09,2.41,0.1818,0.2607
GO:0042133,neurotransmitter metabolic process,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), AGTPBP1 CLN3,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0008053,mitochondrial fusion,D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884|I)Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6), MFN2 FIS1,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0030414,peptidase inhibitor activity,P98167(Evidence code:IEA/Database source:InterPro:IPR036201)P20811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646), SSPO CAST,MF,2,2 of 80,0.09,2.5,0.1769,0.2607
GO:1901741,positive regulation of myoblast fusion,P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens), MYF5 FLOT1,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0042056,chemoattractant activity,F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506), COLEC10 CXCL12,MF,2,2 of 10,0.09,20,0.1853,0.2607
GO:0006414,translational elongation,Q3SZ15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251)Q3SZ32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251), EEF1E1 TCEB2,BP,2,2 of 83,0.09,2.41,0.1818,0.2607
GO:0033146,regulation of intracellular estrogen receptor signaling pathway,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960), SRC UFM1,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0004114,"3,5-cyclic-nucleotide phosphodiesterase activity",P22571(Evidence code:IEA/Database source:InterPro:IPR006952|I)F1MS27(Evidence code:IEA/Database source:InterPro:IPR002073|I), PDE6H PDE4D,MF,2,2 of 10,0.09,20,0.1853,0.2607
GO:0008361,regulation of cell size,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:P52735|ens), LARS VAV2,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458), CCNY CCNL1,BP,2,2 of 10,0.09,20,0.1853,0.2607
GO:0034452,dynactin binding,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens),BICD2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031293,membrane protein intracellular domain proteolysis,Q0III2(Evidence code:IEA/Database source:UniProtKB:O43462|ens),MBTPS2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000767,positive regulation of cytoplasmic translation,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0055062,phosphate ion homeostasis,A7YY70(Evidence code:ISS/Database source:UniProtKB:Q06495),SLC34A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004530,deoxyribonuclease I activity,Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN001029377),DICER1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000481,positive regulation of cAMP-dependent protein kinase activity,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0002377,immunoglobulin production,F1N160(Evidence code:IBA/Database source:PANTHER:PTN000587099),VPREB1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019556,histidine catabolic process to glutamate and formamide,A5PJV3(Evidence code:IEA/Database source:InterPro:IPR005920),AMDHD1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035928,rRNA import into mitochondrion,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045617,negative regulation of keratinocyte differentiation,E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens),HOXA7,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032036,myosin heavy chain binding,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens),MYBPC3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004342,glucosamine-6-phosphate deaminase activity,Q17QL1(Evidence code:IEA/Database source:InterPro:IPR004547|I),GNPDA2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016593,Cdc73/Paf1 complex,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens),PEX2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:1905820,positive regulation of chromosome separation,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0036376,sodium ion export across plasma membrane,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005953,CAAX-protein geranylgeranyltransferase complex,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097227,sperm annulus,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q14141|ens),SEPT6,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:1903181,positive regulation of dopamine biosynthetic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051584,regulation of dopamine uptake involved in synaptic transmission,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens),TOR1A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008272,sulfate transport,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens),RACGAP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1904293,negative regulation of ERAD pathway,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens),UBXN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006177,GMP biosynthetic process,Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0332),IMPDH2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010467,gene expression,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens),GOLPH3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0038162,erythropoietin-mediated signaling pathway,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035749,myelin sheath adaxonal region,E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens),MPP5,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097165,nuclear stress granule,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004095,carnitine O-palmitoyltransferase activity,Q58DK1(Evidence code:IEA/Database source:EC:2.3.1.21),CPT1B,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005185,neurohypophyseal hormone activity,P01175(Evidence code:IEA/Database source:InterPro:IPR000981|I),OXT,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005945,6-phosphofructokinase complex,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens),PFKM,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033592,RNA strand annealing activity,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859),EIF4H,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000660,negative regulation of interleukin-1-mediated signaling pathway,E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens),OTUD4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032310,prostaglandin secretion,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens),DDX58,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042420,dopamine catabolic process,P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens),DBH,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050509,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,A5D7I4(Evidence code:IEA/Database source:EC:2.4.1.225),EXT1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043553,negative regulation of phosphatidylinositol 3-kinase activity,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035507,regulation of myosin-light-chain-phosphatase activity,E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens),NUAK1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071374,cellular response to parathyroid hormone stimulus,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens),PRKACA,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035377,transepithelial water transport,P35071(Evidence code:ISS/Database source:UniProtKB:P13569),CFTR,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035279,mRNA cleavage involved in gene silencing by miRNA,Q6T5B7(Evidence code:IEA/Database source:GO:0090624),AGO3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033883,pyridoxal phosphatase activity,Q3ZBF9(Evidence code:IEA/Database source:EC:3.1.3.74),PDXP,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0047710,bis(5-adenosyl)-triphosphatase activity,Q1KZG4(Evidence code:IEA/Database source:EC:3.6.1.29),FHIT,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000601,positive regulation of Arp2/3 complex-mediated actin nucleation,F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens),NCKAP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902732,positive regulation of chondrocyte proliferation,A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens),SIRT6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043278,response to morphine,F1MG56(Evidence code:IEA/Database source:UniProtKB:Q6P1F6|ens),PPP2R2A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0021902,commitment of neuronal cell to specific neuron type in forebrain,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030852,regulation of granulocyte differentiation,P02694(Evidence code:IEA/Database source:UniProtKB:Q00915|ens),RBP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051561,positive regulation of mitochondrial calcium ion concentration,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060244,negative regulation of cell proliferation involved in contact inhibition,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153),PAK1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042574,retinal metabolic process,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens),ALDH1A3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016342,catenin complex,E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens),APC2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0052832,inositol monophosphate 3-phosphatase activity,P20456(Evidence code:IEA/Database source:EC:3.1.3.25),IMPA1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046601,positive regulation of centriole replication,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:O00444),PLK4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060486,Clara cell differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030719,P granule organization,E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6),TDRD5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048251,elastic fiber assembly,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008510,sodium:bicarbonate symporter activity,F1N4L1(Evidence code:IBA/Database source:PANTHER:PTN000155503),SLC4A2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0018343,protein farnesylation,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004066,asparagine synthase (glutamine-hydrolyzing) activity,Q1LZA3(Evidence code:IEA/Database source:InterPro:IPR001962|I),ASNS,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004825,methionine-tRNA ligase activity,Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR014758|I),MARS,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016480,negative regulation of transcription by RNA polymerase III,Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q15742|ens),NAB2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060396,growth hormone receptor signaling pathway,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045060,negative thymic T cell selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070345,negative regulation of fat cell proliferation,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens),E2F1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042985,negative regulation of amyloid precursor protein biosynthetic process,Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287),ITM2B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033605,positive regulation of catecholamine secretion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0034351,negative regulation of glial cell apoptotic process,F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens),PRKCI,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902177,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens),SFPQ,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016531,copper chaperone activity,Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O00244|ens),ATOX1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071371,cellular response to gonadotropin stimulus,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0044729,hemi-methylated DNA-binding,A7E320(Evidence code:ISS/Database source:UniProtKB:Q8VDF2),UHRF1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004488,methylenetetrahydrofolate dehydrogenase (NADP+) activity,A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000672|I),MTHFD1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006564,L-serine biosynthetic process,Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006236),PHGDH,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060373,regulation of ventricular cardiac muscle cell membrane depolarization,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens),GPD1L,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0021861,forebrain radial glial cell differentiation,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens),ADAMTS12,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035242,protein-arginine omega-N asymmetric methyltransferase activity,A6QL80(Evidence code:IBA/Database source:PANTHER:PTN000109455),PRMT3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048011,neurotrophin TRK receptor signaling pathway,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7),ZFYVE27,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153),PAK1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060484,lung-associated mesenchyme development,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens),PTK7,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071014,post-mRNA release spliceosomal complex,F1N607(Evidence code:IBA/Database source:PANTHER:PTN000327519),SYF2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0002327,immature B cell differentiation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0001886,endothelial cell morphogenesis,Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens),CLIC4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030893,meiotic cohesin complex,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens),RAD21L1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0072006,nephron development,F1MQP6(Evidence code:IEA/Database source:UniProtKB:A0A0A6YW72),DCHS2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045724,positive regulation of cilium assembly,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0014731,spectrin-associated cytoskeleton,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens),SPTA1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043985,histone H4-R3 methylation,A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8),PRMT5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004517,nitric-oxide synthase activity,Q27995(Evidence code:IEA/Database source:InterPro:IPR004030|I),NOS2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0007413,axonal fasciculation,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004854,xanthine dehydrogenase activity,P48034(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005545,1-phosphatidylinositol binding,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens),WDFY3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902916,positive regulation of protein polyubiquitination,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens),MARCH7,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031045,dense core granule,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens),SYT4,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0052833,inositol monophosphate 4-phosphatase activity,P20456(Evidence code:IEA/Database source:EC:3.1.3.25),IMPA1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050811,GABA receptor binding,P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens),PPP2CA,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048679,regulation of axon regeneration,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097648,G-protein coupled receptor complex,P04695(Evidence code:IDA/Database source:),GNAT1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006363,termination of RNA polymerase I transcription,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2),LIPE,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1903094,negative regulation of protein K48-linked deubiquitination,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens),UBXN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010716,negative regulation of extracellular matrix disassembly,P81425(Evidence code:ISS/Database source:UniProtKB:P27487),DPP4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004865,protein serine/threonine phosphatase inhibitor activity,E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915),PPP1R1C,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens),NF2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010891,negative regulation of sequestering of triglyceride,Q2KI18(Evidence code:ISS/Database source:UniProtKB:Q8BJ56),PNPLA2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006817,phosphate ion transport,A7YY70(Evidence code:ISS/Database source:UniProtKB:Q06495),SLC34A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0002369,T cell cytokine production,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006349,regulation of gene expression by genetic imprinting,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004477,methenyltetrahydrofolate cyclohydrolase activity,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens),MTHFD1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097062,dendritic spine maintenance,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens),CTTN,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004582,dolichyl-phosphate beta-D-mannosyltransferase activity,Q3ZC71(Evidence code:IBA/Database source:PANTHER:PTN000419487),DPM3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000182,regulation of progesterone biosynthetic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031094,platelet dense tubular network,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033269,internode region of axon,Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens),TUBB4A,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061502,early endosome to recycling endosome transport,Q17R14(Evidence code:ISS/Database source:UniProtKB:F1PRN2),MYO1D,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070537,histone H2A K63-linked deubiquitination,A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736),BRCC3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0009331,glycerol-3-phosphate dehydrogenase complex,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006168),GPD1L,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004174,electron-transferring-flavoprotein dehydrogenase activity,A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens),AIFM2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061470,T follicular helper cell differentiation,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090399,replicative senescence,E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519),ATM,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046548,retinal rod cell development,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens),ALMS1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035662,Toll-like receptor 4 binding,P58754(Evidence code:IEA/Database source:InterPro:IPR039217),LY96,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035497,cAMP response element binding,A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809),ATF6B,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003211,cardiac ventricle formation,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831),SOX4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032324,molybdopterin cofactor biosynthetic process,F1MQ57(Evidence code:IEA/Database source:InterPro:IPR005110|I),GPHN,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048066,developmental pigmentation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000301,negative regulation of synaptic vesicle exocytosis,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033026,negative regulation of mast cell apoptotic process,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031372,UBC13-MMS2 complex,Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q15819|ens),UBE2V2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens),PTTG1IP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070634,transepithelial ammonium transport,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048149,behavioral response to ethanol,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033687,osteoblast proliferation,F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens),FIGNL1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051567,histone H3-K9 methylation,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030903,notochord development,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens),COL2A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043129,surfactant homeostasis,P35246(Evidence code:ISS/Database source:UniProtKB:P35247),SFTPD,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097452,GAIT complex,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens),EPRS,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051974,negative regulation of telomerase activity,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005827,polar microtubule,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035511,oxidative DNA demethylation,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0052629,"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity",E1BFE6(Evidence code:IEA/Database source:InterPro:IPR030587),MTMR1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046689,response to mercury ion,A7YY70(Evidence code:IEA/Database source:UniProtKB:Q06495|ens),SLC34A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097125,cyclin B1-CDK1 complex,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051388,positive regulation of neurotrophin TRK receptor signaling pathway,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens),CYFIP2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0000035,acyl binding,P04695(Evidence code:IDA/Database source:),GNAT1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0018242,protein O-linked glycosylation via serine,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens),GALNT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019226,transmission of nerve impulse,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070857,regulation of bile acid biosynthetic process,E1BM29(Evidence code:IEA/Database source:UniProtKB:P22680|ens),CYP7A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045542,positive regulation of cholesterol biosynthetic process,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0017128,phospholipid scramblase activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016176,superoxide-generating NADPH oxidase activator activity,F1MF26(Evidence code:IBA/Database source:PANTHER:PTN001038805),SH3PXD2A,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071942,XPC complex,Q29RK4(Evidence code:ISS/Database source:UniProtKB:P54727),RAD23B,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0015824,proline transport,A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens),SLC6A20,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071711,basement membrane organization,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens),COL4A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010710,regulation of collagen catabolic process,P53712(Evidence code:ISS/Database source:UniProtKB:P05556),ITGB1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0034274,Atg12-Atg5-Atg16 complex,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens),WDFY3,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0009115,xanthine catabolic process,P48034(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005915,zonula adherens,E1BFA7(Evidence code:IEA/Database source:UniProtKB:Q9BVG8|ens),KIFC3,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042754,negative regulation of circadian rhythm,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens),SFPQ,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0001223,transcription coactivator binding,E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens),ZBTB17,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000310,regulation of NMDA receptor activity,Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens),CRH,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061458,reproductive system development,F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens),PLEKHA5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033152,immunoglobulin V(D)J recombination,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061647,histone H3-K9 modification,A5D7K6(Evidence code:IEA/Database source:GO:0046969),SIRT6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1990253,cellular response to leucine starvation,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens),LARS,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071042,nuclear polyadenylation-dependent mRNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097049,motor neuron apoptotic process,F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens),ADARB1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0044300,cerebellar mossy fiber,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045347,negative regulation of MHC class II biosynthetic process,Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens),MARCH8,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060113,inner ear receptor cell differentiation,Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851),fgfr3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0001302,replicative cell aging,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens),WRN,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060215,primitive hemopoiesis,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003418,growth plate cartilage chondrocyte differentiation,F1MP76(Evidence code:IDA/Database source:),SDC3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005797,Golgi medial cisterna,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004579,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,Q5E9C2(Evidence code:IEA/Database source:InterPro:IPR003038),DAD1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090331,negative regulation of platelet aggregation,E1B8S3(Evidence code:IEA/Database source:UniProtKB:Q4VC17|ens),ADAMTS18,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090500,endocardial cushion to mesenchymal transition,O97711(Evidence code:ISS/Database source:UniProtKB:P70312),HAS2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006436,tryptophanyl-tRNA aminoacylation,Q3T099(Evidence code:IEA/Database source:InterPro:IPR002306),WARS2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000707,positive regulation of dense core granule biogenesis,P05059(Evidence code:ISS/Database source:UniProtKB:P26339),CHGA,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019046,release from viral latency,E1BGF3(Evidence code:IEA/Database source:UniProtKB:Q61191|ens),HCFC1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0014033,neural crest cell differentiation,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens),LRP6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0044320,cellular response to leptin stimulus,P61635(Evidence code:ISS/Database source:UniProtKB:P40763),STAT3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042795,snRNA transcription by RNA polymerase II,E1BCK9(Evidence code:IEA/Database source:UniProtKB:Q5SXM2|ens),SNAPC4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032635,interleukin-6 production,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051694,pointed-end actin filament capping,Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR004934|I),TMOD3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030187,melatonin biosynthetic process,P10950(Evidence code:ISS/Database source:UniProtKB:P46597),ASMT,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004576,oligosaccharyl transferase activity,Q5E9C2(Evidence code:ISS/Database source:UniProtKB:E2R4X3),DAD1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0001778,plasma membrane repair,F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens),MYOF,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045901,positive regulation of translational elongation,F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I),EIF5A2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010216,maintenance of DNA methylation,A7E320(Evidence code:ISS/Database source:UniProtKB:Q8VDF2),UHRF1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045917,positive regulation of complement activation,P02638(Evidence code:NAS/Database source:),S100B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003938,IMP dehydrogenase activity,Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR005990),IMPDH2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050815,phosphoserine residue binding,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens),PIN1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0072321,chaperone-mediated protein transport,A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549),TOR1A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048733,sebaceous gland development,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006896,Golgi to vacuole transport,E1BDC9(Evidence code:IBA/Database source:PANTHER:PTN000367098),VPS52,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042382,paraspeckles,E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens),SFPQ,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0001825,blastocyst formation,F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens),TJP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006517,protein deglycosylation,F1MWT0(Evidence code:IBA/Database source:PANTHER:PTN000176395),MAN2C1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071568,UFM1 transferase activity,Q5E953(Evidence code:ISS/Database source:UniProtKB:Q9Y3C8),UFC1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0000966,RNA 5-end processing,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006268,DNA unwinding involved in DNA replication,E1BMW9(Evidence code:IEA/Database source:UniProtKB:Q00577|ens),PURA,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0034205,amyloid-beta formation,Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768),PSEN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0007412,axon target recognition,P61763(Evidence code:ISS/Database source:UniProtKB:O08599),STXBP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004467,long-chain fatty acid-CoA ligase activity,F1MIU7(Evidence code:IEA/Database source:InterPro:IPR030307),SLC27A3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0009838,abscission,A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens),SPG20,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060252,positive regulation of glial cell proliferation,F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens),PRKCI,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016600,flotillin complex,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060712,spongiotrophoblast layer development,E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens),BIRC6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061299,retina vasculature morphogenesis in camera-type eye,Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens),CLIC4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004514,nicotinate-nucleotide diphosphorylase (carboxylating) activity,A5PK51(Evidence code:IEA/Database source:InterPro:IPR036068),NAPRT,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000345,regulation of hepatocyte proliferation,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens),GLI1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060012,"synaptic transmission, glycinergic",F1N5R0(Evidence code:IEA/Database source:UniProtKB:Q9Y345|ens),SLC6A5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010968,regulation of microtubule nucleation,E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens),EML2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0099073,mitochondrion-derived vesicle,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045329,carnitine biosynthetic process,Q2KJH9(Evidence code:IEA/Database source:UniPathway:UPA00118),ALDH9A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032041,NAD-dependent histone deacetylase activity (H3-K14 specific),Q2T9N9(Evidence code:IEA/Database source:EC:3.5.1.98),HDAC5,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046785,microtubule polymerization,E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762),CKAP5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000643,positive regulation of early endosome to late endosome transport,E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens),PTPN23,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006421,asparaginyl-tRNA aminoacylation,Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004522),NARS,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050733,RS domain binding,Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q6PDM2|ens),SRSF1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0007221,positive regulation of transcription of Notch receptor target,A5D7F6(Evidence code:IBA/Database source:PANTHER:PTN001437735),MAML2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035457,cellular response to interferon-alpha,E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens),TPR,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097499,protein localization to non-motile cilium,Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens),ARL6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0000712,resolution of meiotic recombination intermediates,F1MU48(Evidence code:IBA/Database source:PANTHER:PTN000018888),TOP2B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003841,1-acylglycerol-3-phosphate O-acyltransferase activity,Q95JH2(Evidence code:IEA/Database source:InterPro:IPR004552),AGPAT1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1900195,positive regulation of oocyte maturation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0018312,peptidyl-serine ADP-ribosylation,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004660,protein farnesyltransferase activity,P29702(Evidence code:IBA/Database source:PANTHER:PTN000122903),FNTA,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005663,DNA replication factor C complex,Q05B83(Evidence code:IEA/Database source:UniProtKB:P35250|ens),RFC2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019417,sulfur oxidation,F1MF74(Evidence code:ISS/Database source:UniProtKB:Q8BML1),MICAL2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060171,stereocilium membrane,Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),MYO1C,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0007341,penetration of zona pellucida,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P23578|ens),ACR,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000001,regulation of DNA damage checkpoint,Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74),ETAA1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060075,regulation of resting membrane potential,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0047179,platelet-activating factor acetyltransferase activity,Q29460(Evidence code:IBA/Database source:PANTHER:PTN000220758),PAFAH1B3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902966,positive regulation of protein localization to early endosome,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035870,dITP diphosphatase activity,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0),NUDT16,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050816,phosphothreonine residue binding,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens),PIN1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046974,histone methyltransferase activity (H3-K9 specific),F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035612,AP-2 adaptor complex binding,F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8),AAK1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005584,collagen type I trimer,P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens),COL1A2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070034,telomerase RNA binding,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens),SMG6,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000369,regulation of clathrin-dependent endocytosis,F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8),AAK1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048854,brain morphogenesis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0017034,Rap guanyl-nucleotide exchange factor activity,F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739),RAPGEF2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004634,phosphopyruvate hydratase activity,F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941),ENO4,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035542,regulation of SNARE complex assembly,A3KN15(Evidence code:IEA/Database source:UniRule:UR000570763),VPS41,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048096,chromatin-mediated maintenance of transcription,E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens),PABPC1L,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0072492,host cell mitochondrial intermembrane space,A1A4J8(Evidence code:IEA/Database source:UniProtKB:O75880|ens),SCO1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090197,positive regulation of chemokine secretion,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens),ALOX15B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016493,C-C chemokine receptor activity,F1MG76(Evidence code:IEA/Database source:UniProtKB:Q6X632|ens),GPR75,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0072604,interleukin-6 secretion,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043559,insulin binding,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003084,positive regulation of systemic arterial blood pressure,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens),WNK1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1903093,regulation of protein K48-linked deubiquitination,E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens),OTUD4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1903135,cupric ion binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071796,K6-linked polyubiquitin modification-dependent protein binding,Q32KW2(Evidence code:ISS/Database source:UniProtKB:Q04323),UBXN1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031403,lithium ion binding,P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens),IMPA1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033353,S-adenosylmethionine cycle,A6QLP2(Evidence code:IBA/Database source:PANTHER:PTN000602759),AHCYL2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030643,cellular phosphate ion homeostasis,A7YY70(Evidence code:IBA/Database source:PANTHER:PTN000000493),SLC34A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045084,positive regulation of interleukin-12 biosynthetic process,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004366,glycerol-3-phosphate O-acyltransferase activity,F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens),GPAT2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0021695,cerebellar cortex development,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens),KIF14,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032717,negative regulation of interleukin-8 production,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens),OTUD7B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060693,regulation of branching involved in salivary gland morphogenesis,G3X8E7(Evidence code:IEA/Database source:UniProtKB:Q8CFE5|ens),BTBD7,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0098700,neurotransmitter loading into synaptic vesicle,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8NDX2|ens),SLC17A8,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051645,Golgi localization,F1MHG5(Evidence code:IBA/Database source:PANTHER:PTN001141618),ARHGAP21,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0021860,pyramidal neuron development,E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens),DCLK2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0034197,triglyceride transport,P55156(Evidence code:ISS/Database source:UniProtKB:P55157),MTTP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048156,tau protein binding,P02638(Evidence code:IPI/Database source:UniProtKB:P29172),S100B,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042406,extrinsic component of endoplasmic reticulum membrane,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens),TOR1A,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070327,thyroid hormone transport,Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens),CRYM,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003858,3-hydroxybutyrate dehydrogenase activity,Q3T046(Evidence code:IEA/Database source:EC:1.1.1.30),BDH2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046654,tetrahydrofolate biosynthetic process,P00376(Evidence code:IEA/Database source:InterPro:IPR001796),DHFR,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004372,glycine hydroxymethyltransferase activity,Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR001085),SHMT2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0055131,C3HC4-type RING finger domain binding,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0044292,dendrite terminus,E1B9D3(Evidence code:IEA/Database source:UniProtKB:E9PY61|ens),GPR179,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005979,regulation of glycogen biosynthetic process,E1BHP3(Evidence code:IEA/Database source:UniProtKB:Q6ZSY5|ens),PPP1R3F,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008525,phosphatidylcholine transporter activity,Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens),PITPNA,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000650,negative regulation of sodium ion transmembrane transporter activity,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030284,estrogen receptor activity,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008585,female gonad development,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090219,negative regulation of lipid kinase activity,A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens),PPP2R5A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0098532,histone H3-K27 trimethylation,A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens),HIST1H1D,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005251,delayed rectifier potassium channel activity,F1ML52(Evidence code:IEA/Database source:UniProtKB:Q8TDN1|ens),KCNG4,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060993,kidney morphogenesis,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016715,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen",P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I),DBH,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070102,interleukin-6-mediated signaling pathway,P61635(Evidence code:ISS/Database source:UniProtKB:P40763),STAT3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0015321,sodium-dependent phosphate transmembrane transporter activity,A7YY70(Evidence code:IEA/Database source:InterPro:IPR003841|I),SLC34A1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1990001,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9HB09|ens),BCL2L12,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0015816,glycine transport,A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens),SLC6A20,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019557,histidine catabolic process to glutamate and formate,A5PJV3(Evidence code:IEA/Database source:UniPathway:UPA00379),AMDHD1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006431,methionyl-tRNA aminoacylation,Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR014758|I),MARS,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090385,phagosome-lysosome fusion,G3X7D3(Evidence code:IEA/Database source:UniProtKB:Q14964|ens),RAB39A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0098574,cytoplasmic side of lysosomal membrane,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens),LITAF,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004438,phosphatidylinositol-3-phosphatase activity,E1BFE6(Evidence code:IEA/Database source:InterPro:IPR030587),MTMR1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004563,beta-N-acetylhexosaminidase activity,H7BWW2(Evidence code:IEA/Database source:InterPro:IPR025705),HEXB,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1900126,negative regulation of hyaluronan biosynthetic process,E1BMW2(Evidence code:IEA/Database source:UniProtKB:O95782|ens),AP2A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006903,vesicle targeting,A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473),EXOC4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033185,dolichol-phosphate-mannose synthase complex,Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens),DPM3,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0001561,fatty acid alpha-oxidation,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens),PEX13,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043184,vascular endothelial growth factor receptor 2 binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010875,positive regulation of cholesterol efflux,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1901856,negative regulation of cellular respiration,Q2TBI4(Evidence code:ISS/Database source:UniProtKB:Q12931),TRAP1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060670,branching involved in labyrinthine layer morphogenesis,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens),GRB2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033198,response to ATP,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004365,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,Q2KJE5(Evidence code:IEA/Database source:EC:1.2.1.12),GAPDHS,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0017144,drug metabolic process,P48034(Evidence code:ISS/Database source:UniProtKB:Q06278),AOX1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060287,epithelial cilium movement involved in determination of left/right asymmetry,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070922,small RNA loading onto RISC,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1905664,regulation of calcium ion import across plasma membrane,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071920,cleavage body,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499),DDX1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050667,homocysteine metabolic process,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens),CPS1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042105,alpha-beta T cell receptor complex,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046975,histone methyltransferase activity (H3-K36 specific),E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q9NR48|ens),ASH1L,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035522,monoubiquitinated histone H2A deubiquitination,F1N4U8(Evidence code:IEA/Database source:UniProtKB:Q8IXJ9|ens),ASXL1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004019,adenylosuccinate synthase activity,A7MBG0(Evidence code:IEA/Database source:InterPro:IPR001114|I),ADSS,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0097524,sperm plasma membrane,Q5EA42(Evidence code:IEA/Database source:UniProtKB:P08910|ens),ABHD2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031852,mu-type opioid receptor binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793),GNAS,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061549,sympathetic ganglion development,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0),INSM1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043734,DNA-N1-methyladenine dioxygenase activity,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019065,receptor-mediated endocytosis of virus by host cell,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens),EPS15,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030576,Cajal body organization,E1BB54(Evidence code:IEA/Database source:InterPro:IPR033505),USPL1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0002283,neutrophil activation involved in immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0044205,de novo UMP biosynthetic process,P31754(Evidence code:IEA/Database source:InterPro:IPR014732),UMPS,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000116,regulation of cysteine-type endopeptidase activity,Q3SZC2(Evidence code:IEA/Database source:UniProtKB:P28065|ens),PSMB9,BP,1,1 of 56,0.04,1.79,0.1826,0.2607
GO:0000783,nuclear telomere cap complex,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050916,sensory perception of sweet taste,P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026546),GNAT3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2001032,regulation of double-strand break repair via nonhomologous end joining,A5PJQ1(Evidence code:IEA/Database source:UniProtKB:Q7TNV0|ens),DEK,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0002248,connective tissue replacement involved in inflammatory response wound healing,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0086005,ventricular cardiac muscle cell action potential,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens),GPD1L,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051464,positive regulation of cortisol secretion,Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens),CRH,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0050508,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,A5D7I4(Evidence code:IEA/Database source:EC:2.4.1.224),EXT1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000157,negative regulation of ubiquitin-specific protease activity,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens),UBXN1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042134,rRNA primary transcript binding,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2),LIPE,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1905668,positive regulation of protein localization to endosome,A5PKD9(Evidence code:IEA/Database source:UniProtKB:Q8VCV1|ens),ABHD17C,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902951,negative regulation of dendritic spine maintenance,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1990752,microtubule end,E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens),NAV3,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071318,cellular response to ATP,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens),TRPM4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090043,regulation of tubulin deacetylation,A4IFF6(Evidence code:IEA/Database source:UniProtKB:Q9R0A5|ens),NEK3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006266,DNA ligation,A4IFC8(Evidence code:IEA/Database source:GO:0003910),LIG1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005996,monosaccharide metabolic process,Q0P563(Evidence code:IEA/Database source:InterPro:IPR007721|I),FUOM,BP,1,1 of 56,0.04,1.79,0.1826,0.2607
GO:0034214,protein hexamerization,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0),SPAST,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004062,aryl sulfotransferase activity,P50227(Evidence code:IEA/Database source:EC:2.8.2.1),SULT1A1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003356,regulation of cilium beat frequency,F1N724(Evidence code:IEA/Database source:UniProtKB:Q96DT5|ens),DNAH11,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071800,podosome assembly,F1MF26(Evidence code:IBA/Database source:PANTHER:PTN001038814),SH3PXD2A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0015095,magnesium ion transmembrane transporter activity,E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens),CNNM2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0031957,very long-chain fatty acid-CoA ligase activity,F1MIU7(Evidence code:IEA/Database source:InterPro:IPR030307),SLC27A3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005549,odorant binding,G3X8A9(Evidence code:IBA/Database source:PANTHER:PTN001241937),OR5M11,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004030,aldehyde dehydrogenase [NAD(P)+] activity,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens),ALDH1A3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0014041,regulation of neuron maturation,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0055091,phospholipid homeostasis,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048715,negative regulation of oligodendrocyte differentiation,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens),DLX2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016010,dystrophin-associated glycoprotein complex,F1MRT9(Evidence code:IEA/Database source:UniProtKB:E9Q6R7|ens),UTRN,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051454,intracellular pH elevation,P35071(Evidence code:ISS/Database source:UniProtKB:P26361),CFTR,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035370,UBC13-UEV1A complex,Q3SZ52(Evidence code:ISS/Database source:UniProtKB:Q13404),UBE2V1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019800,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens),NDNF,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0055118,negative regulation of cardiac muscle contraction,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens),SRI,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0010159,specification of animal organ position,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens),TBX3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1903044,protein localization to membrane raft,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048478,replication fork protection,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061574,ASAP complex,Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422),SAP18,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0052834,inositol monophosphate phosphatase activity,P20456(Evidence code:IEA/Database source:EC:3.1.3.25),IMPA1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1905323,telomerase holoenzyme complex assembly,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens),PTGES3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071864,positive regulation of cell proliferation in bone marrow,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048549,positive regulation of pinocytosis,F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens),ANKFY1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060374,mast cell differentiation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033300,dehydroascorbic acid transmembrane transporter activity,E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7),SLC23A1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0034774,secretory granule lumen,P15101(Evidence code:ISS/Database source:UniProtKB:P09172),DBH,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033600,negative regulation of mammary gland epithelial cell proliferation,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0009410,response to xenobiotic stimulus,F1ML85(Evidence code:IEA/Database source:InterPro:IPR033348|I),AHR,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032754,positive regulation of interleukin-5 production,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens),PDE4D,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070166,enamel mineralization,F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens),FAM20A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008934,inositol monophosphate 1-phosphatase activity,P20456(Evidence code:IEA/Database source:InterPro:IPR033942),IMPA1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004308,exo-alpha-sialidase activity,E1BMN0(Evidence code:IEA/Database source:InterPro:IPR026856|I),NEU4,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0009313,oligosaccharide catabolic process,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051430,corticotropin-releasing hormone receptor 1 binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793),GNAS,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070682,proteasome regulatory particle assembly,Q0P5A6(Evidence code:IBA/Database source:PANTHER:PTN000339132),PSMD5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033588,Elongator holoenzyme complex,E1BBQ3(Evidence code:IEA/Database source:InterPro:IPR006849),IKBKAP,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0042567,insulin-like growth factor ternary complex,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens),IGFBP3,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:1900044,regulation of protein K63-linked ubiquitination,F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens),SASH1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032877,positive regulation of DNA endoreduplication,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2),E2F7,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030167,proteoglycan catabolic process,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens),ADAMTS12,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0021794,thalamus development,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284),LRP6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006287,"base-excision repair, gap-filling",E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens),POLG,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061333,renal tubule morphogenesis,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens),COL4A1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0000138,Golgi trans cisterna,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035729,cellular response to hepatocyte growth factor stimulus,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006369,termination of RNA polymerase II transcription,E1BAS6(Evidence code:IEA/Database source:UniProtKB:A2AKX3|ens),SETX,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060077,inhibitory synapse,A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023),NLGN2,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004966,galanin receptor activity,F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN001954983),RXFP3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0007603,"phototransduction, visible light",P04695(Evidence code:IEA/Database source:UniProtKB:P11488|ens),GNAT1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003831,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity",E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q6VNB8|ens),WDFY3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0033028,myeloid cell apoptotic process,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens),ARF6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060510,type II pneumocyte differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048665,neuron fate specification,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008187,poly-pyrimidine tract binding,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979),UHMK1,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051747,cytosine C-5 DNA demethylase activity,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0038166,angiotensin-activated signaling pathway,Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens),CAMK2A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004662,CAAX-protein geranylgeranyltransferase activity,P29702(Evidence code:IBA/Database source:PANTHER:PTN000122903),FNTA,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0019887,protein kinase regulator activity,Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173),GCN1L1,MF,1,1 of 58,0.04,1.72,0.1843,0.2607
GO:0070294,renal sodium ion absorption,Q17QL4(Evidence code:IEA/Database source:UniProtKB:Q9UNF1|ens),MAGED2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000233,negative regulation of rRNA processing,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0043951,negative regulation of cAMP-mediated signaling,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens),PDE4D,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0060426,lung vasculature development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0048739,cardiac muscle fiber development,E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens),MYO18B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0021955,central nervous system neuron axonogenesis,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016560,"protein import into peroxisome matrix, docking",Q0P5B1(Evidence code:IEA/Database source:InterPro:IPR007223|I),PEX13,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:2000270,negative regulation of fibroblast apoptotic process,F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens),CHD8,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1903748,negative regulation of establishment of protein localization to mitochondrion,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens),HSPH1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0061738,late endosomal microautophagy,Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens),VPS4B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003148,outflow tract septum morphogenesis,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens),GATA6,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046294,formaldehyde catabolic process,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens),ADH5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032971,regulation of muscle filament sliding,A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens),MYLK2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006883,cellular sodium ion homeostasis,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046790,virion binding,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens),TSG101,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004830,tryptophan-tRNA ligase activity,Q3T099(Evidence code:IEA/Database source:InterPro:IPR002306|I),WARS2,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032471,negative regulation of endoplasmic reticulum calcium ion concentration,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0089701,U2AF,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979),UHMK1,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0045842,positive regulation of mitotic metaphase/anaphase transition,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0006529,asparagine biosynthetic process,Q1LZA3(Evidence code:IEA/Database source:InterPro:IPR001962|I),ASNS,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0070933,histone H4 deacetylation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030983,mismatched DNA binding,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0016639,"oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor",Q2KHX6(Evidence code:IBA/Database source:PANTHER:PTN000352164),CRYM,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,A4FUZ5(Evidence code:IEA/Database source:UniProtKB:Q9QZI9|ens),SERINC3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0002087,regulation of respiratory gaseous exchange by neurological system process,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0030285,integral component of synaptic vesicle membrane,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens),SLC17A8,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0071321,cellular response to cGMP,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035631,CD40 receptor complex,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005968,Rab-protein geranylgeranyltransferase complex,F1N2I0(Evidence code:IEA/Database source:InterPro:IPR001738),CHML,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0051775,response to redox state,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P11766|ens),ADH5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0003828,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens),ST8SIA3,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0032926,negative regulation of activin receptor signaling pathway,E1BIJ4(Evidence code:IEA/Database source:UniProtKB:Q9Y2U8|ens),LEMD3,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0035871,protein K11-linked deubiquitination,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens),OTUD7B,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0090344,negative regulation of cell aging,Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47),MARCH5,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:0052405,negative regulation by host of symbiont molecular function,Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens),RAB9A,BP,1,1 of 2,0.04,50,0.1851,0.2607
GO:1990454,L-type voltage-gated calcium channel complex,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens),CACNA1D,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0008607,phosphorylase kinase regulator activity,E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens),IKBKAP,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0005965,protein farnesyltransferase complex,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,CC,1,1 of 2,0.04,50,0.1851,0.2607
GO:0004430,1-phosphatidylinositol 4-kinase activity,O02811(Evidence code:IEA/Database source:EC:2.7.1.67),PI4KA,MF,1,1 of 2,0.04,50,0.1851,0.2607
GO:0046390,ribose phosphate biosynthetic process,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 59,0.04,1.69,0.1859,0.2614
GO:0048638,regulation of developmental growth,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens),NIPBL,BP,1,1 of 61,0.04,1.64,0.1905,0.2678
GO:0048729,tissue morphogenesis,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 61,0.04,1.64,0.1905,0.2678
GO:0007338,single fertilization,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)O62826(Evidence code:IBA/Database source:PANTHER:PTN001298123)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P23578|ens), ASH1L TRPC2 ACR,BP,3,3 of 20,0.13,15,0.191,0.2681
GO:0005212,structural constituent of eye lens,Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0273)P02510(Evidence code:IEA/Database source:InterPro:IPR003090)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36552|ens), BFSP1 CRYAB CPOX,MF,3,3 of 20,0.13,15,0.191,0.2681
GO:0000910,cytokinesis,A5D7N6(Evidence code:IEA/Database source:InterPro:IPR032924)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR028730)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817), KIF23 ZFYVE26 ECT2,BP,3,3 of 20,0.13,15,0.191,0.2681
GO:0006612,protein targeting to membrane,A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473)Q0IIM2(Evidence code:IDA/Database source:)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens), EXOC4 ARL6 MYO1C,BP,3,3 of 20,0.13,15,0.191,0.2681
GO:0048167,regulation of synaptic plasticity,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A4FV33(Evidence code:IEA/Database source:UniProtKB:Q8R071|ens), GIPC1 PSEN1 ITPKA,BP,3,3 of 20,0.13,15,0.191,0.2681
GO:0005777,peroxisome,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q3ZBW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0576)Q0P5B1(Evidence code:IEA/Database source:InterPro:IPR007223|I)Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR015342), IDE HAO2 PEX13 FIS1 PEX1,CC,5,5 of 36,0.22,13.89,0.1918,0.2691
GO:0043254,regulation of protein complex assembly,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), INSM1 DAB2IP HCFC1 PINK1,BP,4,4 of 113,0.18,3.54,0.1935,0.2714
GO:0009615,response to virus,Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q91VR5|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q9BDI7(Evidence code:IDA/Database source:)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)F1MKU1(Evidence code:IEA/Database source:UniProtKB:Q6Q899|ens)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:P61966|ens), RPS15A DDX1 CDK6 MX2 BCL3 DDX58 ZC3HAV1 HYAL1 AP1S1,BP,9,9 of 80,0.39,11.25,0.1939,0.2719
GO:0030001,metal ion transport,F1MKI1(Evidence code:IEA/Database source:InterPro:IPR006121|I)Q3T0E0(Evidence code:IEA/Database source:InterPro:IPR006121|I)G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689)A7MBI9(Evidence code:IEA/Database source:InterPro:IPR001046), ATP7B ATOX1 SLC39A6 SLC11A2,BP,4,4 of 117,0.18,3.42,0.1952,0.2736
GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",F1MLX9(Evidence code:IEA/Database source:InterPro:IPR011059)A5PJV3(Evidence code:IEA/Database source:InterPro:IPR011059)A8E641(Evidence code:IEA/Database source:InterPro:IPR011059)E1BER6(Evidence code:IEA/Database source:InterPro:IPR011059)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR011059), GDA AMDHD1 DPYSL5 CRMP1 CAD,MF,5,5 of 37,0.22,13.51,0.1979,0.2774
GO:0010628,positive regulation of gene expression,E1BE66(Evidence code:IEA/Database source:UniProtKB:O00329|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BAW2(Evidence code:IEA/Database source:UniProtKB:G3XA59|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9Y478|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O54915|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), PIK3CD SOX17 LRRC32 LEF1 RPS6KA2 MAPK11 MT3 TERF2 GSK3A SP1 MYLK2 E2F1 NCOA3 PRKAB1 ETV2 PDCD10 MAPK9 CUX2 POU3F1 SNF8 EMILIN1 CDK6 NR1I2 DGKQ BRAF KIT PPP3CA DDX58 HCFC1 VPS35,BP,30,30 of 331,1.32,9.06,0.2,0.2802
GO:0032956,regulation of actin cytoskeleton organization,Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)Q5EAD0(Evidence code:IEA/Database source:InterPro:IPR030128)G3MXG3(Evidence code:IEA/Database source:InterPro:IPR027717)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens), ROCK2 RICTOR BAIAP2 CCDC88A ARHGAP35 GPM6B CRK ABL1 TAOK2,BP,9,9 of 82,0.39,10.98,0.2016,0.2824
GO:0006402,mRNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR012162)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0)Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)Q6T5B7(Evidence code:ISS/Database source:UniProtKB:Q9H9G7), PNPT1 AGO4 NUDT16 DXO AGO3,BP,5,5 of 38,0.22,13.16,0.2046,0.2866
GO:0071902,positive regulation of protein serine/threonine kinase activity,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P67775|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MJW4(Evidence code:IEA/Database source:GO:0043539)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens), SRC PPP2CA DAB2IP FAM20A ETAA1 TCL1A PDCD10,BP,7,7 of 59,0.31,11.86,0.2061,0.2886
GO:0034614,cellular response to reactive oxygen species,Q2KIN6(Evidence code:IBA/Database source:PANTHER:PTN002259008)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens), MPV17 SRC MAPK9,BP,3,3 of 21,0.13,14.29,0.2083,0.2914
GO:0008235,metalloexopeptidase activity,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)Q3ZC89(Evidence code:IEA/Database source:InterPro:IPR002468)E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180), NUDT16 METAP2 DPEP3,MF,3,3 of 21,0.13,14.29,0.2083,0.2914
GO:0032874,positive regulation of stress-activated MAPK cascade,E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens), TAOK2 PDCD10 TAOK3,BP,3,3 of 21,0.13,14.29,0.2083,0.2914
GO:0055072,iron ion homeostasis,Q3T046(Evidence code:ISS/Database source:UniProtKB:Q8JZV9)E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens), BDH2 HFE2 TMPRSS6,BP,3,3 of 21,0.13,14.29,0.2083,0.2914
GO:0006378,mRNA polyadenylation,O19137(Evidence code:IBA/Database source:PANTHER:PTN000559726)E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens), CPSF4 PABPC1L,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)G3N127(Evidence code:IEA/Database source:UniProtKB:P27469|ens), PAK2 G0S2,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0042273,ribosomal large subunit biogenesis,Q9TU47(Evidence code:IEA/Database source:UniRule:UR000107015)Q56JY1(Evidence code:IBA/Database source:PANTHER:PTN000096770), EIF6 RPL35A,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458), CCNY CCNL1,MF,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0046324,regulation of glucose import,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens), APPL1 HK2,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0019915,lipid storage,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0042104,positive regulation of activated T cell proliferation,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0031663,lipopolysaccharide-mediated signaling pathway,P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), LY96 TLR4,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0042149,cellular response to glucose starvation,Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q8VD65|ens), ASNS PIK3R4,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0048814,regulation of dendrite morphogenesis,E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR030770), RAP2A SIPA1L1,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0046464,acylglycerol catabolic process,Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)Q08DW9(Evidence code:ISS/Database source:UniProtKB:Q99LR1), ABHD2 ABHD12,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:2000649,regulation of sodium ion transmembrane transporter activity,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), SCN2B GPD1L,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0043248,proteasome assembly,Q0P5A6(Evidence code:IEA/Database source:InterPro:IPR019538)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911), PSMD5 PSMD13,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0071346,cellular response to interferon-gamma,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens), EPRS MYO1C,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0045071,negative regulation of viral genome replication,P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens), BANF1 ZC3HAV1,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), LEF1 MT3,MF,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0051443,positive regulation of ubiquitin-protein transferase activity,E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens), AXIN1 PIN1,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0046928,regulation of neurotransmitter secretion,E1B7T7(Evidence code:IEA/Database source:UniProtKB:Q8R1C0|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), KCNC4 CAMK2A,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens), PTPN6 LRRK1,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0006182,cGMP biosynthetic process,A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR011645)Q29450(Evidence code:IBA/Database source:PANTHER:PTN000229249), GUCY1A3 ADCY7,BP,2,2 of 11,0.09,18.18,0.21,0.2921
GO:0009887,animal organ morphogenesis,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens), TRAF6 ASXL1 CRKL PDGFC CUL1 FOXF1 TBX3,BP,7,7 of 60,0.31,11.67,0.2109,0.2934
GO:0043406,positive regulation of MAP kinase activity,P03968(Evidence code:IEA/Database source:UniProtKB:P05230|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), FGF1 PSEN1 PDCD10 PDGFC KIT,BP,5,5 of 39,0.22,12.82,0.2119,0.2946
GO:0043235,receptor complex,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056261)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18433|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:P18564|ens), ITGB7 LRP6 KCTD16 PTPRA TAOK2 GRM7 ITGB6,CC,7,7 of 61,0.31,11.48,0.2162,0.3005
GO:0045597,positive regulation of cell differentiation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), INSM1 DLX2 SOX17 POU4F2 SRF fgfr3 NF2,BP,7,7 of 167,0.31,4.19,0.2182,0.3032
GO:0009451,RNA modification,F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I)E1BPX9(Evidence code:IBA/Database source:PANTHER:PTN000755749)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I), PUS10 TRUB1 PUS3 LRPPRC RPUSD2,BP,5,5 of 40,0.22,12.5,0.2197,0.3052
GO:0005743,mitochondrial inner membrane,Q2KIN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q2NL34(Evidence code:IBA/Database source:PANTHER:PTN000484410)Q2TBI4(Evidence code:ISS/Database source:UniProtKB:Q12931)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17)A6QR09(Evidence code:ISS/Database source:UniProtKB:Q70HW3)Q3ZBX6(Evidence code:TAS/Database source:)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)P0C2B7(Evidence code:TAS/Database source:)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P02722(Evidence code:IEA/Database source:InterPro:IPR002113)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999), MPV17 COQ9 TRAP1 SLC25A29 TIMM17B SHMT2 SCO1 MTG1 SLC25A26 MRPL3 EFHD1 PINK1 MRPL52 NDUFS3 LRRK2 IMMT PSEN1 SRC SLC25A4 NOA1,CC,20,20 of 215,0.88,9.3,0.2345,0.3072
GO:0010629,negative regulation of gene expression,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)G3X749(Evidence code:IEA/Database source:UniProtKB:Q96F45|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)F1MPW1(Evidence code:IEA/Database source:UniProtKB:Q14689|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens), NFKB1 PPP3CA PDCD10 PINK1 CRYAB SNX12 CRKL ZNF503 TCF7L2 VPS35 TERF2 DIP2A DGKQ EMILIN1,BP,14,14 of 281,0.61,4.98,0.2376,0.3072
GO:0045296,cadherin binding,F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)E1BQ11(Evidence code:IEA/Database source:InterPro:IPR028439)A6QP29(Evidence code:IEA/Database source:UniProtKB:Q9BYX2|ens)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR001033)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR001033|I)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827), PROM1 CTNND1 TBC1D2 CTNNA2 CTNNA1 PSEN1 PTPRM,MF,7,7 of 64,0.31,10.94,0.234,0.3072
GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001557|I)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR011128)Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139), UEVLD PHGDH GRHPR FAM213B GPD1L HSD3B7 CTBP1,MF,7,7 of 62,0.31,11.29,0.2218,0.3072
GO:0032993,protein-DNA complex,A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), ATF6B PRKDC SUZ12 ZBTB17 LEF1,CC,5,5 of 41,0.22,12.2,0.2279,0.3072
GO:0010942,positive regulation of cell death,G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), AXIN2 PRNP EIF4G1 AIFM1 MT3,BP,5,5 of 128,0.22,3.91,0.2217,0.3072
GO:0012506,vesicle membrane,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens), DGKQ FNDC3A GRB2 APPL1 GIPC1,CC,5,5 of 128,0.22,3.91,0.2217,0.3072
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens), SRC CTTN BIRC6,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0005977,glycogen metabolic process,F1MJ90(Evidence code:IEA/Database source:InterPro:IPR008734)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0321)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0321), PHKB PPP1CB PPP1CC,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0031491,nucleosome binding,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:P55198|ens)Q2TA40(Evidence code:ISS/Database source:UniProtKB:Q99733), ARID1A MLLT6 NAP1L4,MF,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0046328,regulation of JNK cascade,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens), MAPK8IP3 RAP2A COPS5,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0003899,DNA-directed 5-3 RNA polymerase activity,G8JKZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0240)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000722|I)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR006110|I), PRIM1 POLR2A POLR2F,MF,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0048568,embryonic organ development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens), SOX17 Gli3 SYF2,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0032006,regulation of TOR signaling,E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens), GNA12 PKHD1 TTI1,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0002218,activation of innate immune response,E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884), SFPQ PRKDC MB21D1,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0002064,epithelial cell development,E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494), HYDIN ONECUT2 SHROOM3,BP,3,3 of 22,0.13,13.64,0.226,0.3072
GO:0015459,potassium channel regulator activity,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens), DLG1 LRRC26,MF,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0004879,nuclear receptor activity,F1N3S3(Evidence code:IEA/Database source:InterPro:IPR003068)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens), NR2F6 NR1I2,MF,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0008299,isoprenoid biosynthetic process,Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR013746)E1BCH6(Evidence code:IEA/Database source:InterPro:IPR018294), HMGCS1 ISPD,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0032757,positive regulation of interleukin-8 production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens), DDX58 AFAP1L2,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0050832,defense response to fungus,E1BEQ4(Evidence code:IBA/Database source:PANTHER:PTN000668306)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0295), LOC505658 CHGA,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0042770,signal transduction in response to DNA damage,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), GRB2 ABL1,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0043525,positive regulation of neuron apoptotic process,Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), BACE1 PRNP,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0006779,porphyrin-containing compound biosynthetic process,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)E1BKY9(Evidence code:IEA/Database source:InterPro:IPR001260|I), SPTA1 CPOX,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0043488,regulation of mRNA stability,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q6PHQ9|ens), PUM1 PABPC4,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0034198,cellular response to amino acid starvation,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)A7MBJ6(Evidence code:IEA/Database source:UniProtKB:Q6PJI9|ens), LARS WDR59,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0032040,small-subunit processome,A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)E1BGE2(Evidence code:IBA/Database source:PANTHER:PTN000427367), RPS7 UTP20,CC,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0006555,methionine metabolic process,Q5I598(Evidence code:IEA/Database source:InterPro:IPR003171|I)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens), MTHFR MTHFD1,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0034704,calcium channel complex,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), PTPA PDE4D,CC,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0035326,enhancer binding,E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), RAI1 LEF1,MF,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0006584,catecholamine metabolic process,P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0128)A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128), SULT1A1 COMT,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0097381,photoreceptor disc membrane,P04695(Evidence code:TAS/Database source:)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens), GNAT1 PCDHB8,CC,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0019674,NAD metabolic process,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)Q3SZD3(Evidence code:IEA/Database source:InterPro:IPR017437), GPD1L NADK,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0045646,regulation of erythrocyte differentiation,Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens), HSPA9 CDK6,BP,2,2 of 12,0.09,16.67,0.2349,0.3072
GO:0036132,13-prostaglandin reductase activity,Q32L99(Evidence code:IEA/Database source:EC:1.3.1.48),PTGR2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045445,myoblast differentiation,A5PJL3(Evidence code:IEA/Database source:UniProtKB:P53778|ens),MAPK12,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046966,thyroid hormone receptor binding,E1B7Q7(Evidence code:IEA/Database source:UniProtKB:Q14669|ens),TRIP12,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030325,adrenal gland development,Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens),CRH,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035243,protein-arginine omega-N symmetric methyltransferase activity,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744),PRMT5,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0019215,intermediate filament binding,E1BIS6(Evidence code:IEA/Database source:UniProtKB:Q70IV5|ens),SYNM,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0052745,inositol phosphate phosphatase activity,E1BB73(Evidence code:IEA/Database source:InterPro:IPR037793),INPP5B,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0044020,histone methyltransferase activity (H4-R3 specific),A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744),PRMT5,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043023,ribosomal large subunit binding,Q9TU47(Evidence code:IEA/Database source:UniRule:UR000107015),EIF6,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0007289,spermatid nucleus differentiation,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens),PYGO2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002689,negative regulation of leukocyte chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900034,regulation of cellular response to heat,Q29RL2(Evidence code:ISS/Database source:UniProtKB:Q9D1P4),CHORDC1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0098505,G-rich strand telomeric DNA binding,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0001733,galactosylceramide sulfotransferase activity,F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729),GAL3ST2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900121,negative regulation of receptor binding,E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens),ADAM15,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030169,low-density lipoprotein particle binding,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0001931,uropod,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070765,gamma-secretase complex,Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768),PSEN1,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0005697,telomerase holoenzyme complex,E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280),SMG6,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043560,insulin receptor substrate binding,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens),GRB2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0032060,bleb assembly,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010614,negative regulation of cardiac muscle hypertrophy,Q58DA7(Evidence code:ISS/Database source:UniProtKB:Q9CQM9),GLRX3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0097421,liver regeneration,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens),GLI1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0019732,antifungal humoral response,P05059(Evidence code:IMP/Database source:),CHGA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016584,nucleosome positioning,A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens),HIST1H1D,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0085020,protein K6-linked ubiquitination,Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398),BRCA1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0005921,gap junction,E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0303),PANX3,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0072358,cardiovascular system development,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045252,oxoglutarate dehydrogenase complex,E1BFI2(Evidence code:IBA/Database source:PANTHER:PTN000568211),DHTKD1,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0000305,response to oxygen radical,O62768(Evidence code:IBA/Database source:PANTHER:PTN000530450),TXNRD1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051895,negative regulation of focal adhesion assembly,F1N6V1(Evidence code:IEA/Database source:UniProtKB:O43182|ens),ARHGAP6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000781,positive regulation of double-strand break repair,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0015693,magnesium ion transport,E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens),CNNM2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens),TACSTD2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043034,costamere,E1BIS6(Evidence code:IEA/Database source:UniProtKB:O15061|ens),SYNM,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0071817,MMXD complex,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0009214,cyclic nucleotide catabolic process,P06623(Evidence code:IEA/Database source:InterPro:IPR008431),CNP,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070371,ERK1 and ERK2 cascade,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0003376,sphingosine-1-phosphate receptor signaling pathway,E1BJM1(Evidence code:IEA/Database source:GO:0038036),SPHK2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0000780,"condensed nuclear chromosome, centromeric region",F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens),ATRX,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035904,aorta development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0008603,cAMP-dependent protein kinase regulator activity,P00515(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR2A,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051150,regulation of smooth muscle cell differentiation,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0019853,L-ascorbic acid biosynthetic process,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0047522,15-oxoprostaglandin 13-oxidase activity,Q32L99(Evidence code:IEA/Database source:InterPro:IPR037399),PTGR2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0001782,B cell homeostasis,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004185,serine-type carboxypeptidase activity,E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084),CPXM2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006884,cell volume homeostasis,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0003139,secondary heart field specification,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006307,DNA dealkylation involved in DNA repair,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1903445,protein transport from ciliary membrane to plasma membrane,Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens),ARL6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046597,negative regulation of viral entry into host cell,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens),SNX3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030223,neutrophil differentiation,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004719,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,P15246(Evidence code:IEA/Database source:InterPro:IPR000682),PCMT1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035970,peptidyl-threonine dephosphorylation,E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens),PPM1D,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0001881,receptor recycling,F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens),LMTK2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0007548,sex differentiation,Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0726),DMRTC2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070410,co-SMAD binding,G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens),USP9X,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045820,negative regulation of glycolytic process,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens),SIRT6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046636,negative regulation of alpha-beta T cell activation,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens),ADORA2A,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002281,macrophage activation involved in immune response,A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens),SBNO2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0031821,G-protein coupled serotonin receptor binding,P63097(Evidence code:IBA/Database source:PANTHER:PTN000026625),GNAI1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0048806,genitalia development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051409,response to nitrosative stress,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens),ADH5,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010994,free ubiquitin chain polymerization,P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens),UBE2K,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060441,epithelial tube branching involved in lung morphogenesis,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0036295,cellular response to increased oxygen levels,P61420(Evidence code:ISS/Database source:UniProtKB:P61421),ATP6V0D1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0019864,IgG binding,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0061133,endopeptidase activator activity,Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens),PSMD14,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0036312,phosphatidylinositol 3-kinase regulatory subunit binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1905448,positive regulation of mitochondrial ATP synthesis coupled electron transport,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030206,chondroitin sulfate biosynthetic process,E1BMM8(Evidence code:IEA/Database source:UniProtKB:Q6IQX7|ens),CHPF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0032516,positive regulation of phosphoprotein phosphatase activity,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens),PTPA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0033630,positive regulation of cell adhesion mediated by integrin,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060088,auditory receptor cell stereocilium organization,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens),SCRIB,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030038,contractile actin filament bundle assembly,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1902626,assembly of large subunit precursor of preribosome,Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061),EIF6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1902991,regulation of amyloid precursor protein catabolic process,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens),UNC13A,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,P56722(Evidence code:ISS/Database source:UniProtKB:Q60673),PTPRN,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030323,respiratory tube development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens),IGFBP3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030681,multimeric ribonuclease P complex,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens),RPP25,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000765,regulation of cytoplasmic translation,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004128,"cytochrome-b5 reductase activity, acting on NAD(P)H",Q32LH7(Evidence code:IEA/Database source:EC:1.6.2.2),CYB5R4,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004022,alcohol dehydrogenase (NAD) activity,Q3ZC42(Evidence code:IEA/Database source:EC:1.1.1.1),ADH5,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010820,positive regulation of T cell chemotaxis,E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens),WNK1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0007194,negative regulation of adenylate cyclase activity,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:O75781|ens),PALM,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004322,ferroxidase activity,O46414(Evidence code:IEA/Database source:EC:1.16.3.1),FTH1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0047429,nucleoside-triphosphate diphosphatase activity,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045410,positive regulation of interleukin-6 biosynthetic process,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046527,glucosyltransferase activity,Q0VD36(Evidence code:IBA/Database source:PANTHER:PTN000258330),KDELC1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0003180,aortic valve morphogenesis,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1904262,negative regulation of TORC1 signaling,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016714,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen",Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR019773|I),PAH,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0031545,peptidyl-proline 4-dioxygenase activity,A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016446,somatic hypermutation of immunoglobulin genes,E1BMC0(Evidence code:IEA/Database source:UniProtKB:Q8CGS6|ens),POLQ,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900227,positive regulation of NLRP3 inflammasome complex assembly,Q9GL65(Evidence code:ISS/Database source:UniProtKB:Q9QUK6),TLR4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070940,dephosphorylation of RNA polymerase II C-terminal domain,F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5),RPAP2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0003854,3-beta-hydroxy-delta5-steroid dehydrogenase activity,Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225),HSD3B7,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0047017,prostaglandin-F synthase activity,Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60),FAM213B,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0042987,amyloid precursor protein catabolic process,Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031),PSEN1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0007512,adult heart development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070061,fructose binding,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens),PFKM,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043249,erythrocyte maturation,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0031053,primary miRNA processing,A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens),DGCR8,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070861,regulation of protein exit from endoplasmic reticulum,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens),GCC2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000484,positive regulation of interleukin-8 secretion,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0061029,eyelid development in camera-type eye,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060052,neurofilament cytoskeleton organization,Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens),INA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0005471,ATP:ADP antiporter activity,P02722(Evidence code:IBA/Database source:PANTHER:PTN000640049),SLC25A4,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1902950,regulation of dendritic spine maintenance,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046209,nitric oxide metabolic process,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens),CPS1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0003857,3-hydroxyacyl-CoA dehydrogenase activity,Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I),CRYL1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0015937,coenzyme A biosynthetic process,A4FV09(Evidence code:IEA/Database source:InterPro:IPR004567|I),PANK4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1902692,regulation of neuroblast proliferation,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0042989,sequestering of actin monomers,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens),TWF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0034141,positive regulation of toll-like receptor 3 signaling pathway,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens),RNF139,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006646,phosphatidylethanolamine biosynthetic process,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0000395,mRNA 5-splice site recognition,Q0VCY7(Evidence code:ISS/Database source:UniProtKB:Q07955),SRSF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0014883,transition between fast and slow fiber,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0008622,epsilon DNA polymerase complex,A6QQ14(Evidence code:ISS/Database source:UniProtKB:Q9NR33),POLE4,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0001609,G-protein coupled adenosine receptor activity,E1BKU0(Evidence code:IEA/Database source:InterPro:IPR001634),ADORA2A,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030628,pre-mRNA 3-splice site binding,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979),UHMK1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1903136,cuprous ion binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000035,regulation of stem cell division,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006171,cAMP biosynthetic process,Q29450(Evidence code:IEA/Database source:InterPro:IPR009398|I),ADCY7,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051580,regulation of neurotransmitter uptake,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006572,tyrosine catabolic process,Q58CZ9(Evidence code:ISS/Database source:UniProtKB:P17735),TAT,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0008347,glial cell migration,F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens),CSPG4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0048333,mesodermal cell differentiation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens),KDM6B,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006021,inositol biosynthetic process,P20456(Evidence code:IEA/Database source:UniPathway:UPA00823),IMPA1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1990763,arrestin family protein binding,Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens),ARRDC1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0071526,semaphorin-plexin signaling pathway,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens),SEMA3E,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens),NPAT,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0018026,peptidyl-lysine monomethylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010764,negative regulation of fibroblast migration,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3),DSTYK,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016723,"oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor",Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q9UBK8),MTRR,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0034101,erythrocyte homeostasis,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035374,chondroitin sulfate binding,G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens),RTN4R,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0005123,death receptor binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0050775,positive regulation of dendrite morphogenesis,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298),CUX2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030130,clathrin coat of trans-Golgi network vesicle,P04973(Evidence code:IEA/Database source:InterPro:IPR000996),CLTA,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002862,negative regulation of inflammatory response to antigenic stimulus,Q3T108(Evidence code:IEA/Database source:UniProtKB:P99026|ens),PSMB4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0097150,neuronal stem cell population maintenance,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens),PCM1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900122,positive regulation of receptor binding,Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens),BDNF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0097202,activation of cysteine-type endopeptidase activity,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens),CYFIP2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006265,DNA topological change,F1MU48(Evidence code:IEA/Database source:InterPro:IPR001154|I),TOP2B,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006880,intracellular sequestering of iron ion,O46414(Evidence code:IBA/Database source:PANTHER:PTN000153092),FTH1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1990966,ATP generation from poly-ADP-D-ribose,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0048384,retinoic acid receptor signaling pathway,E1BC39(Evidence code:IEA/Database source:InterPro:IPR003078),ESRRG,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0072606,interleukin-8 secretion,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004427,inorganic diphosphatase activity,Q5E9Y6(Evidence code:IEA/Database source:EC:3.6.1.1),PRUNE1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0005483,soluble NSF attachment protein activity,P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241),NAPG,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0017136,NAD-dependent histone deacetylase activity,F6QK60(Evidence code:IEA/Database source:InterPro:IPR017328),SIRT2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070836,caveola assembly,Q1RMR9(Evidence code:IEA/Database source:InterPro:IPR028521|I),PACSIN2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006278,RNA-dependent DNA biosynthetic process,F1MMS4(Evidence code:IEA/Database source:GO:0003720),TERF2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0000930,gamma-tubulin complex,E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens),CKAP5,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004656,procollagen-proline 4-dioxygenase activity,Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR013547),P4HA2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0005229,intracellular calcium activated chloride channel activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051000,positive regulation of nitric-oxide synthase activity,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0008241,peptidyl-dipeptidase activity,P12820(Evidence code:IEA/Database source:InterPro:IPR001548),ACE,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060972,left/right pattern formation,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens),MEGF8,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002820,negative regulation of adaptive immune response,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060628,regulation of ER to Golgi vesicle-mediated transport,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens),RNF139,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004622,lysophospholipase activity,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q8N2K0|ens),ABHD12,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060333,interferon-gamma-mediated signaling pathway,Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060017,parathyroid gland development,G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens),CRKL,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1901409,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458),CCNL1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016307,phosphatidylinositol phosphate kinase activity,Q0P5F7(Evidence code:IEA/Database source:InterPro:IPR002498),PIP4K2C,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0052650,NADP-retinol dehydrogenase activity,O77769(Evidence code:IEA/Database source:EC:1.1.1.300),DHRS3,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060020,Bergmann glial cell differentiation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0007026,negative regulation of microtubule depolymerization,E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens),NAV3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0044065,regulation of respiratory system process,Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17),MTG1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0021545,cranial nerve development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0071837,HMG box domain binding,A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens),SP1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035253,ciliary rootlet,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004000,adenosine deaminase activity,F1N0T4(Evidence code:IEA/Database source:InterPro:IPR002466),ADARB1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006689,ganglioside catabolic process,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0071850,mitotic cell cycle arrest,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000232,regulation of rRNA processing,E1BGW4(Evidence code:IEA/Database source:UniProtKB:B1AQJ2|ens),USP36,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030043,actin filament fragmentation,Q5E9D5(Evidence code:IEA/Database source:UniProtKB:Q9R0P5|ens),DSTN,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043139,5-3 DNA helicase activity,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0019918,"peptidyl-arginine methylation, to symmetrical-dimethyl arginine",A7YW45(Evidence code:IBA/Database source:PANTHER:PTN000077429),PRMT5,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0043138,3-5 DNA helicase activity,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens),WRN,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0090308,regulation of methylation-dependent chromatin silencing,A7E320(Evidence code:IBA/Database source:PANTHER:PTN000365142),UHRF1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002199,zona pellucida receptor complex,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens),CCT3,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0071638,negative regulation of monocyte chemotactic protein-1 production,P02638(Evidence code:IGI/Database source:UniProtKB:Q62151),S100B,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004647,phosphoserine phosphatase activity,Q3ZBF9(Evidence code:IEA/Database source:EC:3.1.3.3),PDXP,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens),MYOF,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030914,STAGA complex,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens),TAF10,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046325,negative regulation of glucose import,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens),SIRT6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046598,positive regulation of viral entry into host cell,A2VDV7(Evidence code:IEA/Database source:UniProtKB:O15393|ens),TMPRSS2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0047134,protein-disulfide reductase activity,F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens),TXNDC17,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0097157,pre-mRNA intronic binding,A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558),PRPF8,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens),MARCH8,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016577,histone demethylation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens),KDM6B,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016461,unconventional myosin complex,E1BA80(Evidence code:IEA/Database source:UniProtKB:Q8IUG5|ens),MYO18B,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0048738,cardiac muscle tissue development,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2001046,positive regulation of integrin-mediated signaling pathway,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0006547,histidine metabolic process,A5PJV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0369),AMDHD1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060081,membrane hyperpolarization,P35071(Evidence code:ISS/Database source:UniProtKB:P26361),CFTR,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035518,histone H2A monoubiquitination,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030877,beta-catenin destruction complex,E1B714(Evidence code:IEA/Database source:InterPro:IPR029797),AXIN1,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0033268,node of Ranvier,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010766,negative regulation of sodium ion transport,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0075525,viral translational termination-reinitiation,A7MB16(Evidence code:IEA/Database source:UniProtKB:P55884|ens),EIF3B,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0015057,thrombin-activated receptor activity,A7YY44(Evidence code:IEA/Database source:InterPro:IPR003912),F2R,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051571,positive regulation of histone H3-K4 methylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046827,positive regulation of protein export from nucleus,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens),PRKACA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035845,photoreceptor cell outer segment organization,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5),AHI1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0097484,dendrite extension,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens),CYFIP2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051481,negative regulation of cytosolic calcium ion concentration,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0019388,galactose catabolic process,Q3T105(Evidence code:IEA/Database source:UniProtKB:Q14376|ens),GALE,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900449,regulation of glutamate receptor signaling pathway,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0044342,type B pancreatic cell proliferation,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens),IGFBP3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060546,negative regulation of necroptotic process,P02722(Evidence code:IEA/Database source:UniProtKB:P12235|ens),SLC25A4,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000811,negative regulation of anoikis,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0072422,signal transduction involved in DNA damage checkpoint,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q99459),CDC5L,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0032593,insulin-responsive compartment,Q2TBH7(Evidence code:IBA/Database source:PANTHER:PTN001179259),RAB4A,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0002692,negative regulation of cellular extravasation,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0072201,negative regulation of mesenchymal cell proliferation,F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens),PHF14,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0038180,nerve growth factor signaling pathway,F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386),RAPGEF2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045836,positive regulation of meiotic nuclear division,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens),RFFL,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens),RYR1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0044387,negative regulation of protein kinase activity by regulation of protein phosphorylation,F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens),ADARB1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0042711,maternal behavior,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035523,protein K29-linked deubiquitination,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060019,radial glial cell differentiation,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0038093,Fc receptor signaling pathway,P43481(Evidence code:IEA/Database source:InterPro:IPR027263),KIT,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0016064,immunoglobulin mediated immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0001955,blood vessel maturation,F1MI56(Evidence code:IEA/Database source:UniProtKB:Q99NH0|ens),ANKRD17,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0086006,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens),SCN2B,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035927,RNA import into mitochondrion,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0032933,SREBP signaling pathway,A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225),SCAP,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0004045,aminoacyl-tRNA hydrolase activity,E1BK88(Evidence code:IEA/Database source:InterPro:IPR001328|I),PTRH1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1900264,positive regulation of DNA-directed DNA polymerase activity,Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250),RFC2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035315,hair cell differentiation,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060159,regulation of dopamine receptor signaling pathway,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens),LRRK2,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0008195,phosphatidate phosphatase activity,E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256564),LPIN2,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0044539,long-chain fatty acid import,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens),EPRS,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0000055,ribosomal large subunit export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens),XPO1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035357,peroxisome proliferator activated receptor signaling pathway,A6QNT4(Evidence code:IBA/Database source:PANTHER:PTN000410115),FAM120B,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0046912,"transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer",Q32PF2(Evidence code:IEA/Database source:InterPro:IPR002020|I),ACLY,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0010857,calcium-dependent protein kinase activity,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0050220,prostaglandin-E synthase activity,Q3ZBF7(Evidence code:IEA/Database source:EC:5.3.99.3),PTGES3,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1903053,regulation of extracellular matrix organization,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051988,regulation of attachment of spindle microtubules to kinetochore,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens),RACGAP1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0033512,L-lysine catabolic process to acetyl-CoA via saccharopine,A8E657(Evidence code:IEA/Database source:UniPathway:UPA00868),AASS,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0072540,T-helper 17 cell lineage commitment,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045322,unmethylated CpG binding,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens),KMT2A,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0097361,CIA complex,E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76),MMS19,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060340,positive regulation of type I interferon-mediated signaling pathway,P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens),UBE2K,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0008179,adenylate cyclase binding,G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens),AKAP12,MF,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0070876,SOSS complex,E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens),INTS3,CC,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0035093,"spermatogenesis, exchange of chromosomal proteins",G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens),HIST1H2BA,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:1901142,insulin metabolic process,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0030422,production of siRNA involved in RNA interference,Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3),DICER1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0060355,positive regulation of cell adhesion molecule production,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045064,T-helper 2 cell differentiation,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0045714,regulation of low-density lipoprotein particle receptor biosynthetic process,A6QNT8(Evidence code:IEA/Database source:UniProtKB:Q3U2P1|ens),SEC24A,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:2000392,regulation of lamellipodium morphogenesis,Q29423(Evidence code:ISS/Database source:UniProtKB:P16070),CD44,BP,1,1 of 3,0.04,33.33,0.2388,0.3072
GO:0051928,positive regulation of calcium ion transport,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens), CAMK2A F2R CACNA1D,BP,3,3 of 23,0.13,13.04,0.2439,0.3137
GO:0030674,"protein binding, bridging",F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens), DDX20 HCFC1 COL1A2,MF,3,3 of 23,0.13,13.04,0.2439,0.3137
GO:0022407,regulation of cell-cell adhesion,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), SRC LEF1,BP,2,2 of 76,0.09,2.63,0.2458,0.3161
GO:0031647,regulation of protein stability,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P26696)Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens), GIPC1 USP36 VPS35 NF2 MAPK1 DPM3 SOX4 CCAR2,BP,8,8 of 71,0.35,11.27,0.2489,0.32
GO:0051726,regulation of cell cycle,F1MBP8(Evidence code:IEA/Database source:UniProtKB:O35864|ens)E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P40763)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)E1BB50(Evidence code:IEA/Database source:GO:0004693)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)F1MN42(Evidence code:IEA/Database source:GO:0004693)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR030445)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:Q80U93|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)E1BB52(Evidence code:IEA/Database source:GO:0004693), COPS5 TSC2 E2F1 STAT3 ABL1 PHACTR4 CDK12 SRC CDK17 DOT1L SIRT2 NF2 CTBP1 NUP214 FIGNL1 ADARB1 BCR PUM1 TXLNG SFPQ CDK13,BP,21,21 of 232,0.92,9.05,0.2539,0.3263
GO:0030246,carbohydrate binding,F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)P81282(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)G3N2I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR011013)F1MF76(Evidence code:IEA/Database source:InterPro:IPR013784)P13608(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430), GALNT7 VCAN SFTPD KLRF2 GALNT2 MAN2C1 LOC515570 ACAN,MF,8,8 of 73,0.35,10.96,0.2554,0.3279
GO:0006364,rRNA processing,E1BC24(Evidence code:IBA/Database source:PANTHER:PTN000529705)P61356(Evidence code:ISS/Database source:UniProtKB:P61353)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q56JX6(Evidence code:IEA/Database source:UniProtKB:P62857|ens)Q2KHT7(Evidence code:ISS/Database source:UniProtKB:P42677)E1BGE2(Evidence code:IEA/Database source:UniProtKB:O75691|ens)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0698), MDN1 RPL27 RPS19 RPS28 RPS27 UTP20 RPS7 EIF4A3,BP,8,8 of 73,0.35,10.96,0.2554,0.3279
GO:0016485,protein processing,Q9XT97(Evidence code:IEA/Database source:InterPro:IPR001108)F1MCT1(Evidence code:IEA/Database source:UniProtKB:F6XJP7|ens)E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)P42891(Evidence code:ISS/Database source:UniProtKB:P42893), PSEN1 PCSK6 CPXM2 CLN3 ECE1,BP,5,5 of 44,0.22,11.36,0.2554,0.3279
GO:0051056,regulation of small GTPase mediated signal transduction,E1BNT2(Evidence code:IEA/Database source:InterPro:IPR000331|I)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR030061)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR000331|I)A0JN64(Evidence code:IEA/Database source:InterPro:IPR000331|I)E1BP38(Evidence code:IEA/Database source:InterPro:IPR000331|I), TSC2 ARHGAP26 SIPA1L1 GARNL3 RALGAPA1,BP,5,5 of 44,0.22,11.36,0.2554,0.3279
GO:0051302,regulation of cell division,Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens),PLK3,BP,1,1 of 49,0.04,2.04,0.2589,0.3321
GO:0017038,protein import,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens),SNX33,BP,1,1 of 49,0.04,2.04,0.2589,0.3321
GO:1901657,glycosyl compound metabolic process,E1BAI2(Evidence code:IBA/Database source:PANTHER:PTN000039458),KL,BP,1,1 of 49,0.04,2.04,0.2589,0.3321
GO:0055008,cardiac muscle tissue morphogenesis,E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens), XIRP2 MYLK2,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0009409,response to cold,E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens), ZNF516 PLAC8,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0009190,cyclic nucleotide biosynthetic process,A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR001054|I)Q29450(Evidence code:IEA/Database source:InterPro:IPR001054|I), GUCY1A3 ADCY7,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0005501,retinoid binding,F1MIF5(Evidence code:IEA/Database source:UniProtKB:Q9EPC5|ens)P12661(Evidence code:IEA/Database source:InterPro:IPR032956), RBP7 RBP3,MF,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0031579,membrane raft organization,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), NPC1 DLG1,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:1990782,protein tyrosine kinase binding,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens), CRK DUSP3,MF,2,2 of 13,0.09,15.38,0.26,0.3324
GO:1901799,negative regulation of proteasomal protein catabolic process,A1A4J8(Evidence code:IEA/Database source:UniProtKB:Q5SUC9|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens), SCO1 MARCH7,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0048662,negative regulation of smooth muscle cell proliferation,D7GLD1(Evidence code:IEA/Database source:InterPro:IPR027089)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens), MFN2 IGFBP3,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0001516,prostaglandin biosynthetic process,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0643)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60), PTGES3 FAM213B,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0097755,positive regulation of blood vessel diameter,E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28828|ens)Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453988), PTPRM NOS2,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",E1BGE2(Evidence code:IBA/Database source:PANTHER:PTN000427367)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), UTP20 RPS19,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0008089,anterograde axonal transport,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9QYY8), KIF1B SPAST,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0003073,regulation of systemic arterial blood pressure,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens), GSK3A PLCB3,BP,2,2 of 13,0.09,15.38,0.26,0.3324
GO:0042110,T cell activation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 51,0.04,1.96,0.2603,0.3327
GO:0045927,positive regulation of growth,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 52,0.04,1.92,0.2619,0.3347
GO:0002790,peptide secretion,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 53,0.04,1.89,0.2641,0.3375
GO:0009152,purine ribonucleotide biosynthetic process,A3KN12(Evidence code:IEA/Database source:InterPro:IPR004769),ADSL,BP,1,1 of 54,0.04,1.85,0.2669,0.341
GO:0072593,reactive oxygen species metabolic process,F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)P23709(Evidence code:ISS/Database source:UniProtKB:O75489)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), PREX1 NDUFS3 SH3PXD2A LRRK2,BP,4,4 of 29,0.18,13.79,0.2755,0.3518
GO:0005102,signaling receptor binding,G3MYK9(Evidence code:IEA/Database source:UniProtKB:Q4LFA9|ens)E1BET5(Evidence code:IEA/Database source:InterPro:IPR029325)Q95106(Evidence code:IEA/Database source:InterPro:IPR002072)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN001231474)Q3ZBW2(Evidence code:IEA/Database source:UniProtKB:Q9NYQ3|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)Q3ZBW6(Evidence code:IEA/Database source:UniProtKB:Q9NUI1|ens)A7YWH4(Evidence code:IBA/Database source:PANTHER:PTN000422452)P62194(Evidence code:IEA/Database source:UniProtKB:P62196|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)F1N3I2(Evidence code:IBA/Database source:PANTHER:PTN000422452)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Z1Z2|ens), SEMA3G SSFA2 BDNF LCK GSK3A TEC HAO2 GRB2 SRC DNAJB11 DECR2 BoLA PSMC5 DPP4 LAMA3 CTNND1 LOC788634 PTPA IDE TYK2 FRK JAK2 YES1 GIPC1 ABCA1 FZD1 HFE2 FIS1 MYO1C ZAP70 LRP6 ABL1 STRAP,MF,33,33 of 385,1.45,8.57,0.2758,0.3522
GO:0001934,positive regulation of protein phosphorylation,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens), PAK1 PSEN1 FLOT1 LRRK2 FAM20A ABL1 CLN3 CDON FZD1 AXIN2 RAP2A AXIN1 CRKL MYDGF PIN1 MT3 FGF1 PINK1 PROM2,BP,19,19 of 205,0.83,9.27,0.2777,0.3532
GO:0007623,circadian rhythm,E1BAS6(Evidence code:IEA/Database source:UniProtKB:A2AKX3|ens)F1MN36(Evidence code:IBA/Database source:PANTHER:PTN001050425)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268), SETX PROK1 KCNMA1 IMPDH2,BP,4,4 of 31,0.18,12.9,0.289,0.3532
GO:0006405,RNA export from nucleus,P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)F1MH31(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), RANBP2 POM121L2 NUP214 TPR,BP,4,4 of 30,0.18,13.33,0.2819,0.3532
GO:0042177,negative regulation of protein catabolic process,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens), PIN1 SIRT2 SNX12 SNX3,BP,4,4 of 31,0.18,12.9,0.289,0.3532
GO:0016032,viral process,P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945), ITGB1 ITGAV ITGB6 DYNLL1,BP,4,4 of 30,0.18,13.33,0.2819,0.3532
GO:0051213,dioxygenase activity,P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223)A5D9D7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223)F1MXW0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223), ALOX15 PLOD3 ALOX15B ALKBH2,MF,4,4 of 30,0.18,13.33,0.2819,0.3532
GO:0072657,protein localization to membrane,A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), HPS6 FERMT2 CLN3,BP,3,3 of 85,0.13,3.53,0.2856,0.3532
GO:0034097,response to cytokine,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q16644), SRF NFKB1 MAPKAPK3,BP,3,3 of 85,0.13,3.53,0.2856,0.3532
GO:0055074,calcium ion homeostasis,P31407(Evidence code:ISS/Database source:UniProtKB:P15313)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens)E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens), ATP6V1B1 FAM20A KL,BP,3,3 of 88,0.13,3.41,0.2871,0.3532
GO:0044389,ubiquitin-like protein ligase binding,P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)Q08DL9(Evidence code:IEA/Database source:UniProtKB:Q92783|ens)E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens), PTPRN STAM USP13,MF,3,3 of 85,0.13,3.53,0.2856,0.3532
GO:0008509,anion transmembrane transporter activity,F1N4L1(Evidence code:IEA/Database source:InterPro:IPR013769)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR013769)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens), SLC4A2 SLC4A7 ABCA1,MF,3,3 of 87,0.13,3.45,0.2862,0.3532
GO:0070979,protein K11-linked ubiquitination,A7Z061(Evidence code:ISS/Database source:UniProtKB:P30260)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036), CDC27 UBE2L3,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0030301,cholesterol transport,Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens), VPS4B NPC1,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0048015,phosphatidylinositol-mediated signaling,E1BE66(Evidence code:IEA/Database source:InterPro:IPR008290|I)O02811(Evidence code:IEA/Database source:InterPro:IPR015433), PIK3CD PI4KA,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0071011,precatalytic spliceosome,Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359236)A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555), SNRNP70 SNRPE,CC,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0031305,integral component of mitochondrial inner membrane,A1A4J8(Evidence code:ISS/Database source:UniProtKB:O75880)Q2HJE9(Evidence code:IBA/Database source:PANTHER:PTN000050380), SCO1 TIMM17B,CC,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0051057,positive regulation of small GTPase mediated signal transduction,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), CDON SRC,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0006383,transcription by RNA polymerase III,Q32PE0(Evidence code:IEA/Database source:GO:0001056)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens), POLR2F GTF3C6,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0051058,negative regulation of small GTPase mediated signal transduction,G5E5V6(Evidence code:IEA/Database source:UniProtKB:Q0VF96|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), CGNL1 SLIT2,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0005246,calcium channel regulator activity,P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001173589), PRKCB GRM7,MF,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0008483,transaminase activity,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005958)Q08DQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0032), TAT GFPT2,MF,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0001523,retinoid metabolic process,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)P48644(Evidence code:IDA/Database source:), ADH5 ALDH1A1,BP,2,2 of 14,0.09,14.29,0.2851,0.3532
GO:0001103,RNA polymerase II repressing transcription factor binding,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0017017,MAP kinase tyrosine/serine/threonine phosphatase activity,A6QLS1(Evidence code:IEA/Database source:InterPro:IPR008343),DUSP7,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0019211,phosphatase activator activity,Q2KJ44(Evidence code:IEA/Database source:InterPro:IPR004327|I),PTPA,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0046641,positive regulation of alpha-beta T cell proliferation,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0001741,XY body,A2VDZ4(Evidence code:IEA/Database source:UniProtKB:Q64702|ens),PLK4,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0045721,negative regulation of gluconeogenesis,A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens),GCK,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0042474,middle ear morphogenesis,G3MY13(Evidence code:IEA/Database source:UniProtKB:Q5DTH5|ens),TSHZ1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0019321,pentose metabolic process,E1BNF8(Evidence code:IEA/Database source:UniProtKB:Q96C11|ens),FGGY,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0032232,negative regulation of actin filament bundle assembly,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0019953,sexual reproduction,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0005744,mitochondrial inner membrane presequence translocase complex,Q2HJE9(Evidence code:IEA/Database source:InterPro:IPR005678),TIMM17B,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0005890,sodium:potassium-exchanging ATPase complex,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway,E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens),ZNF366,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0045910,negative regulation of DNA recombination,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0043295,glutathione binding,Q5EAC2(Evidence code:ISS/Database source:UniProtKB:P48637),GSS,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0033683,"nucleotide-excision repair, DNA incision",A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0030897,HOPS complex,A3KN15(Evidence code:IEA/Database source:UniRule:UR000570763),VPS41,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:1901797,negative regulation of signal transduction by p53 class mediator,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens),RFFL,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:1901612,cardiolipin binding,E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens),ATP8B1,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0071028,nuclear mRNA surveillance,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348),DXO,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0016441,posttranscriptional gene silencing,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens),PUM1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0003747,translation release factor activity,Q0VCX5(Evidence code:IEA/Database source:InterPro:IPR004403),ETF1,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0000774,adenyl-nucleotide exchange factor activity,Q0IIM3(Evidence code:ISS/Database source:UniProtKB:Q92598),HSPH1,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0031639,plasminogen activation,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens),HIST1H2BA,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0070008,serine-type exopeptidase activity,Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR023302),PREP,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0045988,negative regulation of striated muscle contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0003958,NADPH-hemoprotein reductase activity,Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453822),NOS2,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0007260,tyrosine phosphorylation of STAT protein,E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624),JAK2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0048745,smooth muscle tissue development,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0043268,positive regulation of potassium ion transport,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0010829,negative regulation of glucose transmembrane transport,P05126(Evidence code:ISS/Database source:UniProtKB:P68404),PRKCB,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0019370,leukotriene biosynthetic process,Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960),LTA4H,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0045494,photoreceptor cell maintenance,F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens),PROM1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0033549,MAP kinase phosphatase activity,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens),DUSP3,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0097512,cardiac myofibril,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens),MYBPC3,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0002320,lymphoid progenitor cell differentiation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0042448,progesterone metabolic process,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232),STAT5B,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0031616,spindle pole centrosome,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0071044,histone mRNA catabolic process,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,F6Q9J4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0491),LOC100848815,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0022615,protein to membrane docking,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493),SNX3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0000819,sister chromatid segregation,F1MU48(Evidence code:IBA/Database source:PANTHER:PTN000018888),TOP2B,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034227,tRNA thio-modification,Q0VC66(Evidence code:IEA/Database source:InterPro:IPR000541),CTU1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0097228,sperm principal piece,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0021819,layer formation in cerebral cortex,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0042974,retinoic acid receptor binding,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0030851,granulocyte differentiation,O02754(Evidence code:ISS/Database source:UniProtKB:P53566),CEBPA,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0005641,nuclear envelope lumen,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens),SORL1,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0002063,chondrocyte development,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens),SHOX2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0045475,locomotor rhythm,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0031424,keratinization,A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0417),TGM3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0048265,response to pain,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0019563,glycerol catabolic process,Q0IID9(Evidence code:IEA/Database source:UniPathway:UPA00618),GK,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0010739,positive regulation of protein kinase A signaling,G3MWT9(Evidence code:IEA/Database source:InterPro:IPR028540),AKAP12,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0001504,neurotransmitter uptake,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0006188,IMP biosynthetic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0072163,mesonephric epithelium development,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0051602,response to electrical stimulus,P11023(Evidence code:ISS/Database source:UniProtKB:P63011),RAB3A,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0003279,cardiac septum development,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0030277,maintenance of gastrointestinal epithelium,Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens),STRAP,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034115,negative regulation of heterotypic cell-cell adhesion,E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens),WNK1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0006298,mismatch repair,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0003401,axis elongation,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens),PTK7,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0018126,protein hydroxylation,A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0071564,npBAF complex,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0042953,lipoprotein transport,F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens),CUBN,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0002076,osteoblast development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0005436,sodium:phosphate symporter activity,A7YY70(Evidence code:IBA/Database source:PANTHER:PTN000000493),SLC34A1,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0060999,positive regulation of dendritic spine development,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0008641,ubiquitin-like modifier activating enzyme activity,E1B8X4(Evidence code:IEA/Database source:InterPro:IPR000594|I),NAE1,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0034393,positive regulation of smooth muscle cell apoptotic process,A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens),MAP2K4,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0032528,microvillus organization,E1BN05(Evidence code:IEA/Database source:UniProtKB:Q8BMF8|ens),GLDN,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0050072,m7G(5)pppN diphosphatase activity,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0034979,NAD-dependent protein deacetylase activity,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0032585,multivesicular body membrane,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0003847,1-alkyl-2-acetylglycerophosphocholine esterase activity,Q29460(Evidence code:IEA/Database source:EC:3.1.1.47),PAFAH1B3,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0035265,organ growth,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0001968,fibronectin binding,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens),IGFBP3,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0007131,reciprocal meiotic recombination,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens),UBR2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0060547,negative regulation of necrotic cell death,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0072669,tRNA-splicing ligase complex,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499),DDX1,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0031362,anchored component of external side of plasma membrane,G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q9BZR6|ens),RTN4R,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0072542,protein phosphatase activator activity,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7),PHACTR4,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0071493,cellular response to UV-B,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0015450,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,Q2HJE9(Evidence code:IEA/Database source:InterPro:IPR005678),TIMM17B,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0048645,animal organ formation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0051642,centrosome localization,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens),BICD2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0030060,L-malate dehydrogenase activity,Q5EAD2(Evidence code:IEA/Database source:EC:1.1.1.37),PHGDH,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0045061,thymic T cell selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0004661,protein geranylgeranyltransferase activity,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0006777,Mo-molybdopterin cofactor biosynthetic process,F1MQ57(Evidence code:IEA/Database source:InterPro:IPR008284),GPHN,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0035810,positive regulation of urine volume,O97711(Evidence code:ISS/Database source:UniProtKB:O35776),HAS2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034715,pICln-Sm protein complex,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304),SNRPE,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0000722,telomere maintenance via recombination,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0006596,polyamine biosynthetic process,E1BM12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0620),SRM,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0072488,ammonium transmembrane transport,F1MS08(Evidence code:IEA/Database source:GO:0008519),SLC12A2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034498,early endosome to Golgi transport,Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2),SNX8,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034501,protein localization to kinetochore,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:2001214,positive regulation of vasculogenesis,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0060122,inner ear receptor cell stereocilium organization,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens),ALMS1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0060347,heart trabecula formation,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0097433,dense body,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0034616,response to laminar fluid shear stress,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0000137,Golgi cis cisterna,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0032700,negative regulation of interleukin-17 production,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0042166,acetylcholine binding,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,Q3MI00(Evidence code:ISS/Database source:UniProtKB:P25685),DNAJB1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0060055,angiogenesis involved in wound healing,Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens),GPR4,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0032466,negative regulation of cytokinesis,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2),E2F7,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:2000737,negative regulation of stem cell differentiation,E1BB52(Evidence code:IEA/Database source:UniProtKB:Q69ZA1|ens),CDK13,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0032350,regulation of hormone metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0035751,regulation of lysosomal lumen pH,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034244,negative regulation of transcription elongation from RNA polymerase II promoter,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599),AXIN1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0007020,microtubule nucleation,A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259),TUBGCP2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0005683,U7 snRNP,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304),SNRPE,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0070266,necroptotic process,F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q96QT4|ens),TRPM7,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0019430,removal of superoxide radicals,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0060076,excitatory synapse,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0031529,ruffle organization,P85091(Evidence code:IDA/Database source:),CYFIP1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0045876,positive regulation of sister chromatid cohesion,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens),SFPQ,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0032924,activin receptor signaling pathway,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens),BAG5,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0015250,water channel activity,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens),AQP5,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0050884,neuromuscular process controlling posture,F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens),ADARB1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0048667,cell morphogenesis involved in neuron differentiation,F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q8BL48|ens),UNK,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0032727,positive regulation of interferon-alpha production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens),DDX58,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0000220,"vacuolar proton-transporting V-type ATPase, V0 domain",P23956(Evidence code:IBA/Database source:PANTHER:PTN000029540),ATP6V0C,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0048706,embryonic skeletal system development,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens),DLX2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0030521,androgen receptor signaling pathway,E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens),ARID1A,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0008015,blood circulation,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0070295,renal water absorption,O97711(Evidence code:ISS/Database source:UniProtKB:O35776),HAS2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0051350,negative regulation of lyase activity,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens),PHPT1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0042585,germinal vesicle,Q647I9(Evidence code:IDA/Database source:),NLRP5,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0090131,mesenchyme migration,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0001221,transcription cofactor binding,F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens),CHD6,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0032050,clathrin heavy chain binding,P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens),CLTA,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0005221,intracellular cyclic nucleotide activated cation channel activity,G3MXA9(Evidence code:IEA/Database source:InterPro:IPR032943),CNGB3,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0031432,titin binding,E1B8E3(Evidence code:IEA/Database source:InterPro:IPR028780),ANKRD23,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0033151,V(D)J recombination,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0031145,anaphase-promoting complex-dependent catabolic process,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0030575,nuclear body organization,Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens),CELF3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0043576,regulation of respiratory gaseous exchange,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q8CEE6|ens),PASK,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0043274,phospholipase binding,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0044321,response to leptin,P61635(Evidence code:ISS/Database source:UniProtKB:P40763),STAT3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0046487,glyoxylate metabolic process,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens),GRHPR,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0034969,histone arginine methylation,A6QL80(Evidence code:IEA/Database source:GO:0008469),PRMT3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens),SRI,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0045835,negative regulation of meiotic nuclear division,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens),RPS6KA2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0031284,positive regulation of guanylate cyclase activity,Q27995(Evidence code:IBA/Database source:PANTHER:PTN001066032),NOS2,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0001829,trophectodermal cell differentiation,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0090085,regulation of protein deubiquitination,A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863),ITCH,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0031390,Ctf18 RFC-like complex,Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250),RFC2,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0050765,negative regulation of phagocytosis,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493),SNX3,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0046475,glycerophospholipid catabolic process,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q8N2K0|ens),ABHD12,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0070822,Sin3-type complex,F1MZQ1(Evidence code:IBA/Database source:PANTHER:PTN001004204),SAP130,CC,1,1 of 4,0.04,25,0.289,0.3532
GO:0042256,mature ribosome assembly,Q9TU47(Evidence code:IEA/Database source:InterPro:IPR002769),EIF6,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0044854,plasma membrane raft assembly,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0035567,non-canonical Wnt signaling pathway,A7MB15(Evidence code:IBA/Database source:PANTHER:PTN000139394),FZD1,BP,1,1 of 4,0.04,25,0.289,0.3532
GO:0004535,poly(A)-specific ribonuclease activity,E1BML0(Evidence code:IBA/Database source:PANTHER:PTN000404664),PAN2,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0071933,Arp2/3 complex binding,F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens),IQGAP2,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0000095,S-adenosyl-L-methionine transmembrane transporter activity,A6QR09(Evidence code:ISS/Database source:UniProtKB:Q70HW3),SLC25A26,MF,1,1 of 4,0.04,25,0.289,0.3532
GO:0050767,regulation of neurogenesis,Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), PRUNE1 CHD7 NF2,BP,3,3 of 91,0.13,3.3,0.2918,0.3565
GO:0006631,fatty acid metabolic process,Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q5BIS9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q3MHR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276), BRCA1 PRKAB1 LYPLA1 ALOX15 PTGES3 FAM213B CRYL1 CPT1B PRKAG1,BP,9,9 of 86,0.39,10.47,0.2946,0.3598
GO:0006979,response to oxidative stress,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)P37359(Evidence code:IEA/Database source:UniProtKB:P28184|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q3T0E0(Evidence code:IBA/Database source:PANTHER:PTN001106576), PRNP WRN LRRK2 ERCC2 PINK1 MT3 PSEN1 ABL1 ATOX1,BP,9,9 of 86,0.39,10.47,0.2946,0.3598
GO:0008081,phosphoric diester hydrolase activity,A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR017946)P08487(Evidence code:IEA/Database source:InterPro:IPR017946)F1MS27(Evidence code:IEA/Database source:InterPro:IPR023088|I), SMPDL3B PLCB3 PLCG1 PDE4D,MF,4,4 of 32,0.18,12.5,0.2969,0.3624
GO:0017148,negative regulation of translation,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1BMW9(Evidence code:IEA/Database source:GO:0000900)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens), EPRS PURA RNF139 EIF4A3,BP,4,4 of 32,0.18,12.5,0.2969,0.3624
GO:0045598,regulation of fat cell differentiation,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens), GNB3 SIRT2 TAF8 ALMS1,BP,4,4 of 33,0.18,12.12,0.3055,0.3727
GO:0006479,protein methylation,P15246(Evidence code:IEA/Database source:GO:0004719)A6QL80(Evidence code:IEA/Database source:InterPro:IPR025799)Q0VCX5(Evidence code:IEA/Database source:UniProtKB:P62495|ens)A7YW45(Evidence code:IEA/Database source:InterPro:IPR007857|I), PCMT1 PRMT3 ETF1 PRMT5,BP,4,4 of 33,0.18,12.12,0.3055,0.3727
GO:0032760,positive regulation of tumor necrosis factor production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9), FCER1G LY96,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:1901379,regulation of potassium ion transmembrane transport,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), CACNA1D PRNP,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:0032481,positive regulation of type I interferon production,E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8C6L5)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314), MB21D1 IRF1,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:0006892,post-Golgi vesicle-mediated transport,Q32P83(Evidence code:IBA/Database source:PANTHER:PTN000328285)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), RABIF SORL1,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:0043044,ATP-dependent chromatin remodeling,F1MLB2(Evidence code:IEA/Database source:InterPro:IPR034724)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens), CHD8 ARID1A,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:1903076,regulation of protein localization to plasma membrane,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens), APPL1 STX7,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:0010631,epithelial cell migration,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)F1MPF3(Evidence code:IEA/Database source:UniProtKB:Q9NYQ8|ens), PKN1 FAT2,BP,2,2 of 15,0.09,13.33,0.3101,0.3777
GO:0008652,cellular amino acid biosynthetic process,Q5EAD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028)Q4JIJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028), PHGDH MRI1 MTRR ASNS,BP,4,4 of 34,0.18,11.76,0.3147,0.3832
GO:0009617,response to bacterium,Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens), BAIAP2 PPM1D BAIAP2L1 FUCA2 SNX3 CHD7 HMCN1 FAM20A CUBN,BP,9,9 of 92,0.39,9.78,0.3153,0.3839
GO:0005758,mitochondrial intermembrane space,Q2TA37(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens), ARL2 PINK1 PNPT1 AIFM1,CC,4,4 of 35,0.18,11.43,0.3244,0.3943
GO:0043409,negative regulation of MAPK cascade,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), DUSP3 PTPN6 ASH1L NF2,BP,4,4 of 35,0.18,11.43,0.3244,0.3943
GO:0030170,pyridoxal phosphate binding,Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR001085|I)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR002129)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR004838|I)E1BP41(Evidence code:IEA/Database source:InterPro:IPR002129), SHMT2 PDXDC1 TAT CSAD,MF,4,4 of 35,0.18,11.43,0.3244,0.3943
GO:0010212,response to ionizing radiation,E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens), ATM BRCC3 PRKDC INTS3,BP,4,4 of 35,0.18,11.43,0.3244,0.3943
GO:0005539,glycosaminoglycan binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), PRNP NDNF,MF,2,2 of 64,0.09,3.12,0.3243,0.3943
GO:0050678,regulation of epithelial cell proliferation,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens), TACSTD2 FRS2,BP,2,2 of 64,0.09,3.12,0.3243,0.3943
GO:0051276,chromosome organization,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens), BRCA2 SFPQ,BP,2,2 of 64,0.09,3.12,0.3243,0.3943
GO:0006935,chemotaxis,Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR033899)A6YT15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0145), CXCL12 CCL28,BP,2,2 of 66,0.09,3.03,0.3255,0.3955
GO:0052548,regulation of endopeptidase activity,Q3T112(Evidence code:IEA/Database source:UniProtKB:P28062|ens)Q58DU5(Evidence code:IEA/Database source:UniProtKB:P25788|ens), PSMB8 PSMA3,BP,2,2 of 66,0.09,3.03,0.3255,0.3955
GO:0030163,protein catabolic process,P62194(Evidence code:IEA/Database source:InterPro:IPR005937)E1BCW1(Evidence code:IEA/Database source:InterPro:IPR003769)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR005937)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)Q2HJ40(Evidence code:IBA/Database source:PANTHER:PTN000342793)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR005937)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR005937)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q9D4H8|ens)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR005937), PSMC5 UBR2 PSMC6 RBX1 BACE1 PSMC3 PSMC2 RNF165 CUL2 PSMC1,BP,10,10 of 100,0.44,10,0.3311,0.3956
GO:0043408,regulation of MAPK cascade,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326), SYNGAP1 PAK1 GRB2 PAK2 PAK4 PAK6 PAK3,BP,7,7 of 152,0.31,4.61,0.3355,0.3956
GO:0004180,carboxypeptidase activity,F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0121), NAALAD2 ACE,MF,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0008023,transcription elongation factor complex,Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens), EAF2 IKBKAP,CC,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0035869,ciliary transition zone,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), PCM1 RPGRIP1L,CC,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0015030,Cajal body,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BB54(Evidence code:IEA/Database source:UniProtKB:Q5W0Q7|ens), NPAT USPL1,CC,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0007163,establishment or maintenance of cell polarity,E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), FAT1 RPGRIP1L,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0032729,positive regulation of interferon-gamma production,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens), BCL3 PDE4D,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0051537,"2 iron, 2 sulfur cluster binding",P48034(Evidence code:IEA/Database source:InterPro:IPR006058)E1BL62(Evidence code:IEA/Database source:InterPro:IPR006058), AOX1 AOX4,MF,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0030500,regulation of bone mineralization,P07507(Evidence code:IEA/Database source:InterPro:IPR002384)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens), MGP TXLNG,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:1901216,positive regulation of neuron death,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), ABL1 PRNP,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0048747,muscle fiber development,E1BE25(Evidence code:IEA/Database source:UniProtKB:Q8VHX6|ens)E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971), FLNC LEF1,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0000070,mitotic sister chromatid segregation,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826), INO80 RAN,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0007568,aging,E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), KL PDE4D,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0030295,protein kinase activator activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens), MT3 WNK1,MF,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0045070,positive regulation of viral genome replication,P26882(Evidence code:IEA/Database source:UniProtKB:Q08752|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens), PPID ADARB1,BP,2,2 of 16,0.09,12.5,0.3349,0.3956
GO:0003015,heart process,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0006734,NADH metabolic process,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q3ULJ0|ens),GPD1L,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:1903494,response to dehydroepiandrosterone,P02668(Evidence code:IDA/Database source:),CSN3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0043236,laminin binding,E1B9H1(Evidence code:IEA/Database source:UniProtKB:Q99JR5|ens),TINAGL1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0071801,regulation of podosome assembly,E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141),SRC,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0016868,"intramolecular transferase activity, phosphotransferases",F1MS56(Evidence code:IEA/Database source:InterPro:IPR005843|I),PGM3,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:1904645,response to amyloid-beta,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0014059,regulation of dopamine secretion,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens),SYT4,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0071392,cellular response to estradiol stimulus,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens),NCOA3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0009226,nucleotide-sugar biosynthetic process,Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR028614),TSTA3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0097322,7SK snRNA binding,Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens),CELF3,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0001704,formation of primary germ layer,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0051205,protein insertion into membrane,F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens),GRIN3B,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0000244,spliceosomal tri-snRNP complex assembly,A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens),PRPF8,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0045120,pronucleus,E1BIB4(Evidence code:IEA/Database source:UniProtKB:Q8R081|ens),HNRNPL,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0006625,protein targeting to peroxisome,E1BPU3(Evidence code:IEA/Database source:InterPro:IPR025653),PEX1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0006044,N-acetylglucosamine metabolic process,Q17QL1(Evidence code:IEA/Database source:InterPro:IPR004547|I),GNPDA2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0035646,endosome to melanosome transport,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0003993,acid phosphatase activity,P11064(Evidence code:IEA/Database source:InterPro:IPR002115),ACP1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0048844,artery morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0006107,oxaloacetate metabolic process,Q32PF2(Evidence code:IEA/Database source:UniProtKB:P53396|ens),ACLY,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0055069,zinc ion homeostasis,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0009074,aromatic amino acid family catabolic process,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR011715),TAT,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:1990391,DNA repair complex,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0034340,response to type I interferon,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897),SHMT2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0006750,glutathione biosynthetic process,Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR004887|I),GSS,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0048070,regulation of developmental pigmentation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0021542,dentate gyrus development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:1903432,regulation of TORC1 signaling,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0050872,white fat cell differentiation,F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens),CTBP1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010669,epithelial structure maintenance,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010907,positive regulation of glucose metabolic process,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens),IRS1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0005688,U6 snRNP,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817),LSM4,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010837,regulation of keratinocyte proliferation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0008106,alcohol dehydrogenase (NADP+) activity,Q3ZCJ2(Evidence code:IEA/Database source:EC:1.1.1.2),AKR1A1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0097153,cysteine-type endopeptidase activity involved in apoptotic process,Q3T0P5(Evidence code:IBA/Database source:PANTHER:PTN000047947),CASP6,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0097504,Gemini of coiled bodies,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens),NPAT,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0060047,heart contraction,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens),RPS6KA2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0098586,cellular response to virus,G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens),MAPK11,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0032460,negative regulation of protein oligomerization,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0005675,holo TFIIH complex,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0097730,non-motile cilium,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5),AHI1,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:1903672,positive regulation of sprouting angiogenesis,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0015813,L-glutamate transmembrane transport,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens),SLC17A8,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0048535,lymph node development,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0033962,cytoplasmic mRNA processing body assembly,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817),LSM4,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0060123,regulation of growth hormone secretion,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens),CHD7,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0016559,peroxisome fission,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010485,H4 histone acetyltransferase activity,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0052866,phosphatidylinositol phosphate phosphatase activity,E1BFE6(Evidence code:IEA/Database source:InterPro:IPR037857),MTMR1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0000407,phagophore assembly site,E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023),ATG2B,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0034975,protein folding in endoplasmic reticulum,Q3ZCB8(Evidence code:IBA/Database source:PANTHER:PTN000319097),EMC3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0000212,meiotic spindle organization,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens),ATRX,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0051290,protein heterotetramerization,P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens),S100A10,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0060765,regulation of androgen receptor signaling pathway,E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens),TRIM68,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:2000678,negative regulation of transcription regulatory region DNA binding,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens),SRI,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0008301,"DNA binding, bending",E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0016411,acylglycerol O-acyltransferase activity,Q95JH2(Evidence code:IBA/Database source:PANTHER:PTN000046632),AGPAT1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0070527,platelet aggregation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0042403,thyroid hormone metabolic process,Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens),CRYM,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0070567,cytidylyltransferase activity,E1BCH6(Evidence code:IEA/Database source:InterPro:IPR034683),ISPD,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0005851,eukaryotic translation initiation factor 2B complex,E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens),EIF2B5,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0045309,protein phosphorylated amino acid binding,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens),CRK,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:1902259,regulation of delayed rectifier potassium channel activity,P63026(Evidence code:ISS/Database source:UniProtKB:P63045),VAMP2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0018342,protein prenylation,P29702(Evidence code:IEA/Database source:InterPro:IPR002088),FNTA,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens),CDK5RAP2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0032733,positive regulation of interleukin-10 production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0043691,reverse cholesterol transport,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0016624,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor",E1BFI2(Evidence code:IEA/Database source:InterPro:IPR001017),DHTKD1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0034236,protein kinase A catalytic subunit binding,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens),PRKAR2A,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0005664,nuclear origin of replication recognition complex,F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens),LRWD1,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0097225,sperm midpiece,E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens),MROH2B,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0061351,neural precursor cell proliferation,G3X749(Evidence code:IEA/Database source:UniProtKB:Q7TMA2|ens),ZNF503,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0004791,thioredoxin-disulfide reductase activity,O62768(Evidence code:IEA/Database source:InterPro:IPR006338),TXNRD1,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0045879,negative regulation of smoothened signaling pathway,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens),MEGF8,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0016805,dipeptidase activity,E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180|I),DPEP3,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:1904358,positive regulation of telomere maintenance via telomere lengthening,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0015012,heparan sulfate proteoglycan biosynthetic process,A5D7I4(Evidence code:IEA/Database source:InterPro:IPR027670),EXT1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0006516,glycoprotein catabolic process,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0060390,regulation of SMAD protein signal transduction,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens),WWTR1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0045603,positive regulation of endothelial cell differentiation,E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens),ETV2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0017046,peptide hormone binding,Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431),PTH1R,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0030008,TRAPP complex,Q2TBL9(Evidence code:IEA/Database source:InterPro:IPR007233),TRAPPC4,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010898,positive regulation of triglyceride catabolic process,Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033903),PNPLA2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0046339,diacylglycerol metabolic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0019104,DNA N-glycosylase activity,A4IF83(Evidence code:IEA/Database source:InterPro:IPR003310|I),TDG,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0008318,protein prenyltransferase activity,P29702(Evidence code:IEA/Database source:InterPro:IPR002088),FNTA,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0061157,mRNA destabilization,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens),PUM1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0030125,clathrin vesicle coat,P04973(Evidence code:IBA/Database source:PANTHER:PTN000067451),CLTA,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0071732,cellular response to nitric oxide,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0036158,outer dynein arm assembly,E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000840538),DNAH5,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0005845,mRNA cap binding complex,P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8),CYFIP1,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0035375,zymogen binding,P02668(Evidence code:IPI/Database source:UniProtKB:P00750),CSN3,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0017119,Golgi transport complex,E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens),GOLGA3,CC,1,1 of 5,0.04,20,0.3359,0.3956
GO:0060749,mammary gland alveolus development,E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens),AGAP2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0016556,mRNA modification,Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens),DNAJB11,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0032205,negative regulation of telomere maintenance,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0097602,cullin family protein binding,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129805),LOC780968,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:1903496,response to 11-deoxycorticosterone,P02668(Evidence code:IDA/Database source:),CSN3,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0031580,membrane raft distribution,P63026(Evidence code:IMP/Database source:),VAMP2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010825,positive regulation of centrosome duplication,Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I),ROCK2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0033558,protein deacetylase activity,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0042136,neurotransmitter biosynthetic process,Q2KJH9(Evidence code:ISS/Database source:UniProtKB:P49189),ALDH9A1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0001942,hair follicle development,A5PJT8(Evidence code:IEA/Database source:UniProtKB:Q9D1G0|ens),DNASE1L2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0046697,decidualization,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0023019,signal transduction involved in regulation of gene expression,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0035254,glutamate receptor binding,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens),CAMK2A,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0071280,cellular response to copper ion,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010390,histone monoubiquitination,A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens),UHRF1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0035994,response to muscle stretch,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens),NFKB1,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0043394,proteoglycan binding,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0033522,histone H2A ubiquitination,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens),UBR2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0005313,L-glutamate transmembrane transporter activity,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens),SLC17A8,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0018216,peptidyl-arginine methylation,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744),PRMT5,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0010591,regulation of lamellipodium assembly,E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922),SSH2,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0008443,phosphofructokinase activity,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,MF,1,1 of 5,0.04,20,0.3359,0.3956
GO:0019896,axonal transport of mitochondrion,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9QYY8),SPAST,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0060261,positive regulation of transcription initiation from RNA polymerase II promoter,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,BP,1,1 of 5,0.04,20,0.3359,0.3956
GO:0044297,cell body,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), PINK1 FABP7 RNF112 GABRA5 BRAF CCT3 NF2,CC,7,7 of 68,0.31,10.29,0.345,0.4062
GO:2001235,positive regulation of apoptotic signaling pathway,Q3SZ15(Evidence code:IEA/Database source:UniProtKB:Q9D1M4|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), EEF1E1 ADORA2A MAPK9 DAB2IP,BP,4,4 of 37,0.18,10.81,0.3453,0.4065
GO:0051603,proteolysis involved in cellular protein catabolic process,P33672(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T108(Evidence code:IEA/Database source:InterPro:IPR001353|I)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q5E998(Evidence code:IBA/Database source:PANTHER:PTN000274640)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR001353)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR000243|I)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q3T112(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens), PSMB3 PSMA3 PSMB4 TINAGL1 ADAMTS7 CAPN2 PSMA4 CTSV PSMA7 PSMB9 ADAMTS12 PSMB10 PSMB8 IDE,BP,14,14 of 157,0.61,8.92,0.3563,0.4191
GO:0045930,negative regulation of mitotic cell cycle,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q5E9L2(Evidence code:IEA/Database source:InterPro:IPR033237)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens), DLG1 BRINP1 ABL1 SCRIB,BP,4,4 of 38,0.18,10.53,0.3563,0.4191
GO:0006006,glucose metabolic process,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424)F1MMK2(Evidence code:IEA/Database source:InterPro:IPR001282|I), GCK HK2 GAPDHS G6PD,BP,4,4 of 38,0.18,10.53,0.3563,0.4191
GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",E1BAI2(Evidence code:IEA/Database source:InterPro:IPR001360)F1MIL9(Evidence code:IEA/Database source:InterPro:IPR020004)H7BWW2(Evidence code:IEA/Database source:InterPro:IPR015883)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR004193), KL GNE HEXB GBE1,MF,4,4 of 38,0.18,10.53,0.3563,0.4191
GO:0045095,keratin filament,G3MXL3(Evidence code:IEA/Database source:InterPro:IPR003054)P67827(Evidence code:ISS/Database source:UniProtKB:P48729), KRT3 CSNK1A1,CC,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0019209,kinase activator activity,E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens), MOB1B MALT1,MF,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0001952,regulation of cell-matrix adhesion,P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens), MYF5 ONECUT2,BP,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0003684,damaged DNA binding,Q4VE16(Evidence code:IEA/Database source:InterPro:IPR017961|I)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR015360|I), POLI RAD23B,MF,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0048278,vesicle docking,Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR009976)Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349), EXOC5 STX7,BP,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0045739,positive regulation of DNA repair,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736), DHX9 BRCC3,BP,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0002224,toll-like receptor signaling pathway,Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q3UMW7)Q9GL65(Evidence code:IBA/Database source:PANTHER:PTN000687652), MAPKAPK3 TLR4,BP,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0030863,cortical cytoskeleton,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens), CTTN SPTA1,CC,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0006941,striated muscle contraction,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens), MYBPC3 MYLK2,BP,2,2 of 17,0.09,11.76,0.3594,0.4219
GO:0006520,cellular amino acid metabolic process,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006130|I)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A5D7H9(Evidence code:IBA/Database source:PANTHER:PTN000907055)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005958)Q5EAC2(Evidence code:IBA/Database source:PANTHER:PTN000122964), CAD CLN3 SLC6A14 TAT GSS,BP,5,5 of 118,0.22,4.24,0.3596,0.422
GO:0005198,structural molecule activity,F1MDV3(Evidence code:IEA/Database source:InterPro:IPR015482)Q765N9(Evidence code:IEA/Database source:InterPro:IPR003549|I)F1MFW9(Evidence code:IEA/Database source:InterPro:IPR001664|I)Q3B7N4(Evidence code:IEA/Database source:InterPro:IPR003552|I)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR000633)Q08DH7(Evidence code:IEA/Database source:InterPro:IPR001664)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)A2VE21(Evidence code:IEA/Database source:InterPro:IPR013040|I)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR001664)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)Q6BBL6(Evidence code:IEA/Database source:InterPro:IPR003550|I)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692|I)A0JN39(Evidence code:IEA/Database source:InterPro:IPR011710)Q0P5J7(Evidence code:IEA/Database source:InterPro:IPR001664|I)Q5E9A6(Evidence code:IBA/Database source:PANTHER:PTN000322234)A6QLJ4(Evidence code:IBA/Database source:PANTHER:PTN001004344)F1MUC5(Evidence code:IEA/Database source:InterPro:IPR039070)G3MXL3(Evidence code:IEA/Database source:InterPro:IPR001664)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)A4IFM4(Evidence code:IEA/Database source:InterPro:IPR003926|I)P04973(Evidence code:IEA/Database source:InterPro:IPR000996)Q28104(Evidence code:IEA/Database source:InterPro:IPR006822)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037363|I)F1N611(Evidence code:IEA/Database source:InterPro:IPR008379)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR000633), SNTB1 CLDN3 KRT24 CLDN7 CTNNA2 INA COL4A6 COPG2 SYNM PSMD13 CLDN4 COPA COPB1 KRT35 VPS25 CDC42SE2 COL15A1 KRT3 COPB2 CLDN8 CLTA COPE SEC13 EPB41L1 CTNNA1,MF,25,25 of 294,1.1,8.5,0.364,0.4271
GO:0061136,regulation of proteasomal protein catabolic process,Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens),PSMD14,BP,1,1 of 43,0.04,2.33,0.366,0.429
GO:0016247,channel regulator activity,Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens),SNF8,MF,1,1 of 43,0.04,2.33,0.366,0.429
GO:0031668,cellular response to extracellular stimulus,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 43,0.04,2.33,0.366,0.429
GO:0048858,cell projection morphogenesis,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens),PACSIN2,BP,1,1 of 42,0.04,2.38,0.366,0.429
GO:0050684,regulation of mRNA processing,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 42,0.04,2.38,0.366,0.429
GO:0009790,embryo development,E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817),PDGFC,BP,1,1 of 44,0.04,2.27,0.3669,0.4298
GO:1901990,regulation of mitotic cell cycle phase transition,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,BP,1,1 of 44,0.04,2.27,0.3669,0.4298
GO:0070507,regulation of microtubule cytoskeleton organization,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens),BICD2,BP,1,1 of 45,0.04,2.22,0.3684,0.4313
GO:0030098,lymphocyte differentiation,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 45,0.04,2.22,0.3684,0.4313
GO:0010632,regulation of epithelial cell migration,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 45,0.04,2.22,0.3684,0.4313
GO:0005747,mitochondrial respiratory chain complex I,P23709(Evidence code:ISS/Database source:UniProtKB:O75489),NDUFS3,CC,1,1 of 46,0.04,2.17,0.3707,0.4334
GO:0090287,regulation of cellular response to growth factor stimulus,F1MZD0(Evidence code:IBA/Database source:PANTHER:PTN001170450),FBN3,BP,1,1 of 46,0.04,2.17,0.3707,0.4334
GO:0048608,reproductive structure development,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 46,0.04,2.17,0.3707,0.4334
GO:1903039,positive regulation of leukocyte cell-cell adhesion,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens),LCK,BP,1,1 of 46,0.04,2.17,0.3707,0.4334
GO:0006401,RNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 46,0.04,2.17,0.3707,0.4334
GO:0006396,RNA processing,E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR015848|I)Q28141(Evidence code:IBA/Database source:PANTHER:PTN000433338)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433338)F1N543(Evidence code:IEA/Database source:InterPro:IPR003107)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR002501)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)P10881(Evidence code:IEA/Database source:InterPro:IPR002344)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR000999|I)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR015431)Q3ZBK6(Evidence code:IEA/Database source:InterPro:IPR027141)F1N0T4(Evidence code:IEA/Database source:InterPro:IPR002466)F1MHP1(Evidence code:IEA/Database source:InterPro:IPR000061|I), PNPT1 DHX9 TDRD9 NRDE2 DHX34 TRUB1 DHX37 SSB DICER1 CCNL1 LSM4 ADARB1 U2SURP,BP,13,13 of 246,0.57,5.28,0.3777,0.4354
GO:0061436,establishment of skin barrier,Q6BBL6(Evidence code:IEA/Database source:UniProtKB:O14493|ens),CLDN4,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0006360,transcription by RNA polymerase I,Q32PE0(Evidence code:IEA/Database source:GO:0001054),POLR2F,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0097502,mannosylation,G3MY32(Evidence code:IEA/Database source:GO:0000030),TMTC2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0032689,negative regulation of interferon-gamma production,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0008199,ferric iron binding,O46414(Evidence code:IEA/Database source:InterPro:IPR001519|I),FTH1,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0016024,CDP-diacylglycerol biosynthetic process,Q95JH2(Evidence code:IEA/Database source:UniPathway:UPA00557),AGPAT1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0033561,regulation of water loss via skin,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0008654,phospholipid biosynthetic process,Q95JH2(Evidence code:IEA/Database source:InterPro:IPR004552),AGPAT1,BP,1,1 of 48,0.04,2.08,0.3772,0.4354
GO:0007064,mitotic sister chromatid cohesion,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens),NIPBL,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0016973,poly(A)+ mRNA export from nucleus,Q28165(Evidence code:IEA/Database source:UniProtKB:Q86U42|ens),PABPN1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0070131,positive regulation of mitochondrial translation,F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens),FASTKD2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0034377,plasma lipoprotein particle assembly,P55156(Evidence code:ISS/Database source:UniProtKB:P55157),MTTP,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0061001,regulation of dendritic spine morphogenesis,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens),LRRK2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0034333,adherens junction assembly,Q2TA37(Evidence code:IDA/Database source:),ARL2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0016668,"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",O62768(Evidence code:IEA/Database source:InterPro:IPR012999),TXNRD1,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0043306,positive regulation of mast cell degranulation,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0051354,negative regulation of oxidoreductase activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0031994,insulin-like growth factor I binding,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens),IGFBP3,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens),GIPC1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0050716,positive regulation of interleukin-1 secretion,E1BF03(Evidence code:IEA/Database source:InterPro:IPR039099),PANX3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0017049,GTP-Rho binding,A1A4I4(Evidence code:IEA/Database source:InterPro:IPR037313|I),PKN1,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0019377,glycolipid catabolic process,Q2KIM0(Evidence code:IDA/Database source:),FUCA1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0045324,late endosome to vacuole transport,A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:1901798,positive regulation of signal transduction by p53 class mediator,Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4),RPL11,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0000030,mannosyltransferase activity,G3MY32(Evidence code:IEA/Database source:InterPro:IPR003342),TMTC2,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:1903205,regulation of hydrogen peroxide-induced cell death,F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens),STK26,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0031083,BLOC-1 complex,Q17QQ3(Evidence code:IDA/Database source:),SNAP25,CC,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0017183,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,Q08DM2(Evidence code:IEA/Database source:InterPro:IPR010014),DPH2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0060259,regulation of feeding behavior,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,P20959(Evidence code:IBA/Database source:PANTHER:PTN000167605),IGFBP3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0031952,regulation of protein autophosphorylation,E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens),MOB1B,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0065004,protein-DNA complex assembly,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens),TCF7L2,BP,1,1 of 47,0.04,2.13,0.3736,0.4354
GO:1900078,positive regulation of cellular response to insulin stimulus,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens),MYO1C,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0006563,L-serine metabolic process,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897),SHMT2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0009312,oligosaccharide biosynthetic process,E1BB36(Evidence code:IEA/Database source:InterPro:IPR007754),MGAT2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0010818,T cell chemotaxis,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0010447,response to acidic pH,Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens),GPR4,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0010107,potassium ion import,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0051446,positive regulation of meiotic cell cycle,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens),LFNG,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0010762,regulation of fibroblast migration,E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens),GNA12,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0045947,negative regulation of translational initiation,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens),TPR,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0017127,cholesterol transporter activity,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0005833,hemoglobin complex,E1BEL8(Evidence code:IEA/Database source:InterPro:IPR002337),HBE1,CC,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0008242,omega peptidase activity,P80227(Evidence code:IEA/Database source:UniProtKB:P13798|ens),APEH,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0050779,RNA destabilization,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348),DXO,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0005942,phosphatidylinositol 3-kinase complex,E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005674),PIK3CD,CC,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0040001,establishment of mitotic spindle localization,E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens),KPNB1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0043596,nuclear replication fork,Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74),ETAA1,CC,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0003333,amino acid transmembrane transport,A1A4L2(Evidence code:IEA/Database source:GO:0015171),SLC6A20,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:2000144,"positive regulation of DNA-templated transcription, initiation",E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens),SETX,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0042596,fear response,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0030261,chromosome condensation,Q3MHQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0226),NCAPH,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0090311,regulation of protein deacetylation,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens),CCAR2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0051647,nucleus localization,E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens),PABPC1L,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0051798,positive regulation of hair follicle development,F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens),NUMA1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0060158,phospholipase C-activating dopamine receptor signaling pathway,P38408(Evidence code:IBA/Database source:PANTHER:PTN000026396),GNA14,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens),UBQLN1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0008373,sialyltransferase activity,F1MX31(Evidence code:IEA/Database source:InterPro:IPR001675|I),ST8SIA3,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0034706,sodium channel complex,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens),TRPM4,CC,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0031929,TOR signaling,F1MHN4(Evidence code:IEA/Database source:InterPro:IPR028268),RICTOR,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0046033,AMP metabolic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0007176,regulation of epidermal growth factor-activated receptor activity,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:1902803,regulation of synaptic vesicle transport,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens),LRRK2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0042832,defense response to protozoan,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0014823,response to activity,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens),SMTNL1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0006309,apoptotic DNA fragmentation,Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN001029377),DICER1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:1900119,positive regulation of execution phase of apoptosis,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0060078,regulation of postsynaptic membrane potential,P02715(Evidence code:IEA/Database source:GO:0022848),CHRNE,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0019363,pyridine nucleotide biosynthetic process,A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0662),NAPRT,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0030118,clathrin coat,P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens),CLTA,CC,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0015106,bicarbonate transmembrane transporter activity,P35071(Evidence code:ISS/Database source:UniProtKB:P13569),CFTR,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0030204,chondroitin sulfate metabolic process,F1ME12(Evidence code:IEA/Database source:UniProtKB:Q0VBN2|ens),DSEL,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0005980,glycogen catabolic process,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0010954,positive regulation of protein processing,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026754),GNAS,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0050922,negative regulation of chemotaxis,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens),DUSP3,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:2000810,regulation of bicellular tight junction assembly,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens),MYO1C,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0032967,positive regulation of collagen biosynthetic process,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0031995,insulin-like growth factor II binding,P20959(Evidence code:IBA/Database source:PANTHER:PTN000167605),IGFBP3,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0003688,DNA replication origin binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0071359,cellular response to dsRNA,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens),NFKB1,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0061462,protein localization to lysosome,E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens),SH3BP4,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0070848,response to growth factor,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens),GATA6,BP,1,1 of 47,0.04,2.13,0.3736,0.4354
GO:1903206,negative regulation of hydrogen peroxide-induced cell death,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0016712,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR008071),CYP2J2,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0015295,solute:proton symporter activity,Q0VCP0(Evidence code:IBA/Database source:PANTHER:PTN000299690),SLC33A1,MF,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0001916,positive regulation of T cell mediated cytotoxicity,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 6,0.04,16.67,0.3797,0.4354
GO:0048489,synaptic vesicle transport,A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)Q32LM6(Evidence code:IEA/Database source:UniProtKB:Q8JZS0|ens), TOR1A LIN7A,BP,2,2 of 18,0.09,11.11,0.3836,0.4395
GO:0090559,regulation of membrane permeability,Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens), F11R PDCD6IP,BP,2,2 of 18,0.09,11.11,0.3836,0.4395
GO:0070603,SWI/SNF superfamily-type complex,E1B925(Evidence code:IEA/Database source:InterPro:IPR021906|I)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR021906), ARID1A ARID1B,CC,2,2 of 18,0.09,11.11,0.3836,0.4395
GO:0045055,regulated exocytosis,E1BKQ2(Evidence code:IBA/Database source:PANTHER:PTN000405433)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens), RAB11FIP1 RAB26,BP,2,2 of 18,0.09,11.11,0.3836,0.4395
GO:0050714,positive regulation of protein secretion,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)P26882(Evidence code:IEA/Database source:UniProtKB:Q08752|ens)A6QNT8(Evidence code:IEA/Database source:UniProtKB:Q3U2P1|ens), GOLPH3 UNC13B MYO18A PPID SEC24A,BP,5,5 of 46,0.22,10.87,0.3865,0.4427
GO:0007267,cell-cell signaling,E1BF03(Evidence code:IBA/Database source:PANTHER:PTN001039730)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)P26917(Evidence code:IBA/Database source:PANTHER:PTN000059370)A5D7F4(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q9JHX9)F1MJ94(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MEC8(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283), PANX3 FZD1 SST PCDHGC3 fgfr3 PCDHA13 PCDH8 BDNF,BP,8,8 of 83,0.35,9.64,0.393,0.4501
GO:0016042,lipid catabolic process,Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033562)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)P16386(Evidence code:IEA/Database source:InterPro:IPR010468)Q5EA59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR014815)Q29460(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442), PNPLA2 ABHD2 LIPF LIPE ABHD4 PLCB3 PAFAH1B3 PLCG1,BP,8,8 of 84,0.35,9.52,0.3968,0.4543
GO:0007389,pattern specification process,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR017374)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens), SYNGAP1 CRKL LFNG GLI2 RAX,BP,5,5 of 48,0.22,10.42,0.3976,0.4551
GO:0016746,"transferase activity, transferring acyl groups",Q58DK1(Evidence code:IEA/Database source:InterPro:IPR000542)A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012)Q0VCR6(Evidence code:IEA/Database source:InterPro:IPR002123)P51176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012)Q95JH2(Evidence code:IEA/Database source:InterPro:IPR002123)F1MLW9(Evidence code:IEA/Database source:InterPro:IPR002123)Q17QI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012)P11181(Evidence code:IEA/Database source:InterPro:IPR001078|I), CPT1B TGM3 TMEM68 TGM2 AGPAT1 GPAT2 ACAT2 DBT,MF,8,8 of 85,0.35,9.41,0.4008,0.4587
GO:0030833,regulation of actin filament polymerization,E1B7J7(Evidence code:IEA/Database source:UniProtKB:O75914|ens)Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)F1MXR0(Evidence code:IEA/Database source:InterPro:IPR030060)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383)F1MSU8(Evidence code:IEA/Database source:UniProtKB:Q9H7P9|ens), PAK3 ARPC5L BAIAP2L1 ARPC1A PLEKHG2,BP,5,5 of 50,0.22,10,0.4106,0.4698
GO:0005126,cytokine receptor binding,G3N183(Evidence code:IEA/Database source:InterPro:IPR000471)Q8MJ29(Evidence code:IEA/Database source:InterPro:IPR000471)P56831(Evidence code:IEA/Database source:InterPro:IPR000471)P56830(Evidence code:IEA/Database source:InterPro:IPR000471), LOC104968438 IFNT IFNT3 IFNT2,MF,4,4 of 97,0.18,4.12,0.418,0.4755
GO:0050673,epithelial cell proliferation,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MJR6(Evidence code:IEA/Database source:UniProtKB:P25318|ens), ALMS1 PSEN1 COL8A2,BP,3,3 of 24,0.13,12.5,0.4204,0.4755
GO:0051539,"4 iron, 4 sulfur cluster binding",E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0004)Q28007(Evidence code:IEA/Database source:UniProtKB-KW:KW-0004)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0004), POLA1 DPYD ERCC2,MF,3,3 of 24,0.13,12.5,0.4204,0.4755
GO:0098656,anion transmembrane transport,F1MCB5(Evidence code:IEA/Database source:GO:0008509)F1N4L1(Evidence code:IEA/Database source:GO:0008509)F1MG24(Evidence code:IEA/Database source:GO:0008509), SLC4A7 SLC4A2 ABCA1,BP,3,3 of 24,0.13,12.5,0.4204,0.4755
GO:0044853,plasma membrane raft,P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens), MYO1A PRKAR2A FLOT1,CC,3,3 of 24,0.13,12.5,0.4204,0.4755
GO:0051258,protein polymerization,Q0IIM2(Evidence code:IDA/Database source:)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens), ARL6 CHMP2A CHMP4A,BP,3,3 of 24,0.13,12.5,0.4204,0.4755
GO:0030194,positive regulation of blood coagulation,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0007566,embryo implantation,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens),RFFL,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0051180,vitamin transport,E1BLU2(Evidence code:IEA/Database source:InterPro:IPR002666),SLC19A2,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0050786,RAGE receptor binding,P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens),S100B,MF,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0006110,regulation of glycolytic process,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135),EIF6,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0090140,regulation of mitochondrial fission,Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47),MARCH5,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0050930,induction of positive chemotaxis,Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506),CXCL12,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0042107,cytokine metabolic process,E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens),TNFSF15,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0070461,SAGA-type complex,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens),HCFC1,CC,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0070293,renal absorption,Q6BBL6(Evidence code:ISS/Database source:UniProtKB:O35054),CLDN4,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0009070,serine family amino acid biosynthetic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens),MTHFD1,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0045717,negative regulation of fatty acid biosynthetic process,Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398),BRCA1,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0033599,regulation of mammary gland epithelial cell proliferation,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens),PYGO2,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0051023,regulation of immunoglobulin secretion,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0009101,glycoprotein biosynthetic process,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens),GOLPH3,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0002360,T cell lineage commitment,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0045604,regulation of epidermal cell differentiation,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens),KEAP1,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0006335,DNA replication-dependent nucleosome assembly,A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens),IPO4,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0050750,low-density lipoprotein particle receptor binding,E1BMW2(Evidence code:IEA/Database source:UniProtKB:O95782|ens),AP2A1,MF,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0060043,regulation of cardiac muscle cell proliferation,G3X793(Evidence code:IEA/Database source:UniProtKB:Q9WUI1|ens),MAPK11,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0061515,myeloid cell development,A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q6PHQ9|ens),PABPC4,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0050687,negative regulation of defense response to virus,Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens),PCBP2,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0050982,detection of mechanical stimulus,F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131),PIEZO1,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0005736,RNA polymerase I complex,Q32PE0(Evidence code:IBA/Database source:PANTHER:PTN000080812),POLR2F,CC,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0050892,intestinal absorption,Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens),F11R,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0043114,regulation of vascular permeability,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0044774,mitotic DNA integrity checkpoint,F1MU48(Evidence code:IBA/Database source:PANTHER:PTN000018888),TOP2B,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0042157,lipoprotein metabolic process,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:1990090,cellular response to nerve growth factor stimulus,F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386),RAPGEF2,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0034472,snRNA 3-end processing,A5PJS8(Evidence code:IEA/Database source:InterPro:IPR038751),INTS8,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0006376,mRNA splice site selection,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens),SETX,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0000177,cytoplasmic exosome (RNase complex),Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59),GTPBP1,CC,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0046688,response to copper ion,F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens),ATP7B,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0002755,MyD88-dependent toll-like receptor signaling pathway,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168),TLR4,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0032469,endoplasmic reticulum calcium ion homeostasis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0046466,membrane lipid catabolic process,A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens),SMPDL3B,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0046040,IMP metabolic process,A7MBG0(Evidence code:IBA/Database source:PANTHER:PTN000217844),ADSS,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0005742,mitochondrial outer membrane translocase complex,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,CC,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0051900,regulation of mitochondrial depolarization,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0060294,cilium movement involved in cell motility,Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462267),TEKT4,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0000793,condensed chromosome,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens),RIF1,CC,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0008395,steroid hydroxylase activity,F1MEU8(Evidence code:IBA/Database source:PANTHER:PTN000670521),LOC540627,MF,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0051782,negative regulation of cell division,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0007214,gamma-aminobutyric acid signaling pathway,Q08E50(Evidence code:IEA/Database source:InterPro:IPR005435),GABRA5,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,Q17QQ3(Evidence code:IBA/Database source:PANTHER:PTN000447754),SNAP25,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0007190,activation of adenylate cyclase activity,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens),ACR,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0045577,regulation of B cell differentiation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0044804,autophagy of nucleus,E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023),ATG2B,BP,1,1 of 7,0.04,14.29,0.4206,0.4755
GO:0048524,positive regulation of viral process,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens), VPS4B TSG101 MVB12A,BP,3,3 of 25,0.13,12,0.4282,0.4838
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116), FIS1 PDCD6 F2R,BP,3,3 of 25,0.13,12,0.4282,0.4838
GO:0045807,positive regulation of endocytosis,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN000445299)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), FLOT1 CD63 PPP3CA,BP,3,3 of 25,0.13,12,0.4282,0.4838
GO:0006400,tRNA modification,F1MKA6(Evidence code:IBA/Database source:PANTHER:PTN000206950)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens)E1BEB7(Evidence code:IBA/Database source:PANTHER:PTN000349172), AARS2 AARS TRUB1,BP,3,3 of 25,0.13,12,0.4282,0.4838
GO:0030695,GTPase regulator activity,E1BIX7(Evidence code:IEA/Database source:InterPro:IPR003109)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR003109), GPSM2 RGS14,MF,2,2 of 57,0.09,3.51,0.4364,0.4928
GO:0010975,regulation of neuron projection development,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens), ARF6 SNAP25,BP,2,2 of 57,0.09,3.51,0.4364,0.4928
GO:0090150,establishment of protein localization to membrane,E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens), SYNE3 NPC1,BP,2,2 of 58,0.09,3.45,0.4366,0.493
GO:0002521,leukocyte differentiation,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens), SRF RRAS,BP,2,2 of 59,0.09,3.39,0.4374,0.4935
GO:0043405,regulation of MAP kinase activity,E1BB50(Evidence code:ISS/Database source:UniProtKB:Q9NYV4)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens), CDK12 TSG101,BP,2,2 of 59,0.09,3.39,0.4374,0.4935
GO:0032870,cellular response to hormone stimulus,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)F1MVD0(Evidence code:IBA/Database source:PANTHER:PTN000074430), SLIT2 NCOA3,BP,2,2 of 59,0.09,3.39,0.4374,0.4935
GO:0015935,small ribosomal subunit,Q3T0R1(Evidence code:ISS/Database source:UniProtKB:P62269)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR005710), RPS18 RPS9,CC,2,2 of 60,0.09,3.33,0.4387,0.4949
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR037309), DAB2IP TRAF6,BP,2,2 of 62,0.09,3.23,0.4428,0.4994
GO:0030133,transport vesicle,A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P05059(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), C1QTNF5 CHGA,CC,2,2 of 63,0.09,3.17,0.4456,0.5024
GO:0005319,lipid transporter activity,B0JYK2(Evidence code:IEA/Database source:InterPro:IPR004765)P55156(Evidence code:IEA/Database source:InterPro:IPR001747|I)E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens), NPC1 MTTP ATP8B1,MF,3,3 of 27,0.13,11.11,0.4462,0.503
GO:0019001,guanyl nucleotide binding,E1BIL1(Evidence code:IEA/Database source:InterPro:IPR001019)P63097(Evidence code:IEA/Database source:InterPro:IPR001019)P04696(Evidence code:IEA/Database source:InterPro:IPR001019)P04695(Evidence code:IEA/Database source:InterPro:IPR001019)P38408(Evidence code:IEA/Database source:InterPro:IPR001019)P04896(Evidence code:IEA/Database source:InterPro:IPR001019)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR001019)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR001019), GNA12 GNAI1 GNAT2 GNAT1 GNA14 GNAS GNAL GNAT3 GNA13,MF,9,9 of 175,0.39,5.14,0.4547,0.5107
GO:0004888,transmembrane signaling receptor activity,P02715(Evidence code:IEA/Database source:InterPro:IPR006201)A7MB15(Evidence code:IEA/Database source:InterPro:IPR017981)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)Q08E50(Evidence code:IEA/Database source:InterPro:IPR006028|I)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR017981)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR017981)Q9BDR7(Evidence code:IEA/Database source:InterPro:IPR003110)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR017981), CHRNE FZD1 LGR4 GABRA5 TLR4 PTH1R PTH2R FCER1G CD97,MF,9,9 of 178,0.39,5.06,0.4572,0.5107
GO:0007281,germ cell development,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BPH3(Evidence code:IEA/Database source:InterPro:IPR037982)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens), EHMT2 TDRD5 TDRD1,BP,3,3 of 28,0.13,10.71,0.4562,0.5107
GO:0015248,sterol transporter activity,E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens),OSBP,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0033619,membrane protein proteolysis,F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens),TMPRSS6,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0032753,positive regulation of interleukin-4 production,Q9BDR7(Evidence code:ISS/Database source:UniProtKB:P20491),FCER1G,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0030515,snoRNA binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0032897,negative regulation of viral transcription,F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens),TRIM14,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0050909,sensory perception of taste,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0016504,peptidase activator activity,Q29RY7(Evidence code:ISS/Database source:UniProtKB:Q8MIP7),FGL2,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0030553,cGMP binding,P22571(Evidence code:IEA/Database source:InterPro:IPR006952|I),PDE6H,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0030857,negative regulation of epithelial cell differentiation,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens),TBX3,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0005344,oxygen carrier activity,E1BEL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0561),HBE1,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0071467,cellular response to pH,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0042634,regulation of hair cycle,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens),NIPBL,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0097472,cyclin-dependent protein kinase activity,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",E1BM28(Evidence code:IEA/Database source:UniRule:UR000107503),DNPH1,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0045662,negative regulation of myoblast differentiation,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens),TBX3,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0060674,placenta blood vessel development,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0030212,hyaluronan metabolic process,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:1902808,positive regulation of cell cycle G1/S phase transition,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens),GLI1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0008250,oligosaccharyltransferase complex,Q5E9C2(Evidence code:IEA/Database source:InterPro:IPR003038),DAD1,CC,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0014910,regulation of smooth muscle cell migration,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0001935,endothelial cell proliferation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:1900015,regulation of cytokine production involved in inflammatory response,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0070192,chromosome organization involved in meiotic cell cycle,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens),ATRX,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0045823,positive regulation of heart contraction,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0008378,galactosyltransferase activity,Q2HJA3(Evidence code:IEA/Database source:InterPro:IPR002659),B3GALT4,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0000118,histone deacetylase complex,Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320),HDAC5,CC,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006626,protein targeting to mitochondrion,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0002724,regulation of T cell cytokine production,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581),TRPM4,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0017156,calcium ion regulated exocytosis,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens),RAPGEF4,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0002260,lymphocyte homeostasis,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens),SPTA1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0030017,sarcomere,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens),MYBPC3,CC,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0045777,positive regulation of blood pressure,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens),ADH5,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0001676,long-chain fatty acid metabolic process,F1MIU7(Evidence code:IEA/Database source:GO:0004467),SLC27A3,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0018345,protein palmitoylation,A5PKD9(Evidence code:IEA/Database source:UniProtKB:Q6PCB6|ens),ABHD17C,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0045652,regulation of megakaryocyte differentiation,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135),EIF6,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006544,glycine metabolic process,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897),SHMT2,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0001836,release of cytochrome c from mitochondria,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006595,polyamine metabolic process,E1BM12(Evidence code:IEA/Database source:InterPro:IPR030668),SRM,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0022829,wide pore channel activity,E1BF03(Evidence code:IBA/Database source:PANTHER:PTN001039730),PANX3,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:2000279,negative regulation of DNA biosynthetic process,F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens),FAM129B,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0001944,vasculature development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0035173,histone kinase activity,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0098636,protein complex involved in cell adhesion,O46405(Evidence code:IEA/Database source:UniProtKB:P33681|ens),CD80,CC,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006833,water transport,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens),AQP5,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006826,iron ion transport,O46414(Evidence code:IEA/Database source:InterPro:IPR001519),FTH1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0045920,negative regulation of exocytosis,Q08DF4(Evidence code:IDA/Database source:),DNM1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0050820,positive regulation of coagulation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006029,proteoglycan metabolic process,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens),COL2A1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0006783,heme biosynthetic process,E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36552|ens),CPOX,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0033617,mitochondrial respiratory chain complex IV assembly,A1A4J8(Evidence code:ISS/Database source:UniProtKB:O75880),SCO1,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens),CAMK2A,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0050850,positive regulation of calcium-mediated signaling,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0098781,ncRNA transcription,Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens),CELF3,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0047555,"3,5-cyclic-GMP phosphodiesterase activity",P22571(Evidence code:IEA/Database source:EC:3.1.4.35),PDE6H,MF,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0051146,striated muscle cell differentiation,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens),CDON,BP,1,1 of 8,0.04,12.5,0.4588,0.5107
GO:0030855,epithelial cell differentiation,F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)E1BM28(Evidence code:IEA/Database source:UniProtKB:O43598|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), CBFA2T2 F11R DNPH1 GATA6 CDK1 FZD1,BP,6,6 of 63,0.26,9.52,0.4612,0.5133
GO:0042102,positive regulation of T cell proliferation,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens), TRAF6 TFRC SPTA1,BP,3,3 of 29,0.13,10.34,0.4666,0.5191
GO:0045665,negative regulation of neuron differentiation,E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens), CTDSP1 MEIS1 CDK5RAP2,BP,3,3 of 29,0.13,10.34,0.4666,0.5191
GO:0048511,rhythmic process,A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090), PRMT5 PPP1CB LGR4 DHX9 PPP1CC ROCK2,BP,6,6 of 67,0.26,8.96,0.4823,0.5364
GO:0015711,organic anion transport,F1N3Y6(Evidence code:IEA/Database source:GO:0008514)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)Q1JQC7(Evidence code:IEA/Database source:GO:0008514), ABCC3 ABCC5 SLC22A23,BP,3,3 of 74,0.13,4.05,0.4886,0.543
GO:0001558,regulation of cell growth,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)P20959(Evidence code:IEA/Database source:InterPro:IPR000867)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens), KIF14 IGFBP3 TSG101,BP,3,3 of 74,0.13,4.05,0.4886,0.543
GO:0045664,regulation of neuron differentiation,E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), CDON BDNF BCL11B,BP,3,3 of 74,0.13,4.05,0.4886,0.543
GO:0038023,signaling receptor activity,E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001508)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001508)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)G3X812(Evidence code:IEA/Database source:InterPro:IPR022355)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001508)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001508)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001508), GRIA3 PRTG ITGB6 ITGB7 GRIK4 PRNP NOTCH4 ITGB1 GRIA1 GRIA2 GRIN3B,MF,11,11 of 204,0.48,5.39,0.489,0.5431
GO:0000027,ribosomal large subunit assembly,Q24JY1(Evidence code:IBA/Database source:PANTHER:PTN000178698)E1BC24(Evidence code:IEA/Database source:InterPro:IPR012099)Q3T087(Evidence code:IBA/Database source:PANTHER:PTN000242048), RPL23A MDN1 RPL11,BP,3,3 of 31,0.13,9.68,0.4889,0.5431
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)P61085(Evidence code:IEA/Database source:UniProtKB:P61087|ens), RAD23B GNA12 UBE2K,BP,3,3 of 31,0.13,9.68,0.4889,0.5431
GO:0060170,ciliary membrane,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:P42208)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), EPS15 SEPT2 ARL6,CC,3,3 of 31,0.13,9.68,0.4889,0.5431
GO:1903202,negative regulation of oxidative stress-induced cell death,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0045236,CXCR chemokine receptor binding,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens),CXCL12,MF,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0035065,regulation of histone acetylation,A7E348(Evidence code:IEA/Database source:GO:0035034),PYGO2,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0004745,retinol dehydrogenase activity,O77769(Evidence code:IEA/Database source:InterPro:IPR032969),DHRS3,MF,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0004659,prenyltransferase activity,P29702(Evidence code:IEA/Database source:UniProtKB-KW:KW-0637),FNTA,MF,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0022848,acetylcholine-gated cation-selective channel activity,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,MF,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0005892,acetylcholine-gated channel complex,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,CC,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0060049,regulation of protein glycosylation,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0002292,T cell differentiation involved in immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0030890,positive regulation of B cell proliferation,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens),TFRC,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0051963,regulation of synapse assembly,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens),RAB17,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0002548,monocyte chemotaxis,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens),RPS19,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0000038,very long-chain fatty acid metabolic process,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens),PEX2,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0006687,glycosphingolipid metabolic process,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0071674,mononuclear cell migration,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens),HIST1H2BA,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0050691,regulation of defense response to virus by host,E1B7G0(Evidence code:IEA/Database source:UniProtKB:Q8IU57|ens),IFNLR1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0042555,MCM complex,Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR008047),MCM4,CC,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0035282,segmentation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:1990138,neuron projection extension,Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292),ALCAM,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0072678,T cell migration,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26011|ens),ITGB7,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0046185,aldehyde catabolic process,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0000460,maturation of 5.8S rRNA,Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061),EIF6,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0014013,regulation of gliogenesis,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens),NF2,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0003009,skeletal muscle contraction,Q2YDF7(Evidence code:ISS/Database source:UniProtKB:Q96MG2),JSRP1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens),COL2A1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0021953,central nervous system neuron differentiation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0015035,protein disulfide oxidoreductase activity,Q58DA7(Evidence code:IEA/Database source:InterPro:IPR002109),GLRX3,MF,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0042423,catecholamine biosynthetic process,P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0127),DBH,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0006829,zinc ion transport,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:1903146,regulation of autophagy of mitochondrion,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens),CTTN,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0002090,regulation of receptor internalization,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:2000406,positive regulation of T cell migration,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens),CXCL12,BP,1,1 of 9,0.04,11.11,0.4944,0.5453
GO:0042127,regulation of cell proliferation,E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)E1B8X8(Evidence code:IBA/Database source:PANTHER:PTN000139037)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q2YDE9(Evidence code:IEA/Database source:InterPro:IPR027683)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)Q3SYX0(Evidence code:IEA/Database source:InterPro:IPR030693)Q5BIN5(Evidence code:ISS/Database source:UniProtKB:Q9QUR7)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357), CDK6 TBX3 IER5 BRCA2 TYK2 TES NF2 EGLN3 BIRC6 FRK PURA NDRG1 PIN1 DBH TEC PIAS1 BRAF RAPGEF2 ZAP70 ABL1 YES1 SRC LCK GRB2 JAK2,BP,25,25 of 309,1.1,8.09,0.5055,0.5574
GO:0055088,lipid homeostasis,P02694(Evidence code:ISS/Database source:UniProtKB:P09455)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)Q2KI18(Evidence code:IBA/Database source:PANTHER:PTN000274414), RBP1 CEBPA PNPLA2,BP,3,3 of 33,0.13,9.09,0.5124,0.5649
GO:0016298,lipase activity,P16386(Evidence code:IEA/Database source:InterPro:IPR010468),LIPE,MF,1,1 of 36,0.04,2.78,0.5147,0.5669
GO:0006694,steroid biosynthetic process,Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225),HSD3B7,BP,1,1 of 36,0.04,2.78,0.5147,0.5669
GO:0044770,cell cycle phase transition,Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036),UBE2L3,BP,1,1 of 36,0.04,2.78,0.5147,0.5669
GO:1903828,negative regulation of cellular protein localization,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 36,0.04,2.78,0.5147,0.5669
GO:0016209,antioxidant activity,Q58CY6(Evidence code:IBA/Database source:PANTHER:PTN002008122),FAM213B,MF,1,1 of 37,0.04,2.7,0.5153,0.5674
GO:0009792,embryo development ending in birth or egg hatching,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens),RICTOR,BP,1,1 of 38,0.04,2.63,0.5167,0.5685
GO:0007088,regulation of mitotic nuclear division,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0),PDXP,BP,1,1 of 38,0.04,2.63,0.5167,0.5685
GO:0031669,cellular response to nutrient levels,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens),EIF4G1,BP,1,1 of 38,0.04,2.63,0.5167,0.5685
GO:0006937,regulation of muscle contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 38,0.04,2.63,0.5167,0.5685
GO:0051168,nuclear export,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens),MALT1,BP,1,1 of 39,0.04,2.56,0.5188,0.5704
GO:0001076,"transcription factor activity, RNA polymerase II transcription factor binding",E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,MF,1,1 of 39,0.04,2.56,0.5188,0.5704
GO:0001818,negative regulation of cytokine production,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens),NFKB1,BP,1,1 of 39,0.04,2.56,0.5188,0.5704
GO:0005179,hormone activity,P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)P01175(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)P26917(Evidence code:IEA/Database source:InterPro:IPR004250|I)Q2WGK0(Evidence code:IEA/Database source:InterPro:IPR001400|I)Q95MI6(Evidence code:IEA/Database source:InterPro:IPR000187|I), IFNT2 COPA OXT IFNT3 SST PRP8 CRH,MF,7,7 of 82,0.31,8.54,0.5256,0.5747
GO:0045787,positive regulation of cell cycle,Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens), RPS15A TBX3 LRP6 ANKRD17,BP,4,4 of 89,0.18,4.49,0.5279,0.5747
GO:0050839,cell adhesion molecule binding,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens), ITGB7 TENM2 TENM3 PTPN6,MF,4,4 of 89,0.18,4.49,0.5279,0.5747
GO:0005761,mitochondrial ribosome,Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17),MTG1,CC,1,1 of 10,0.04,10,0.5278,0.5747
GO:0060706,cell differentiation involved in embryonic placenta development,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0045745,positive regulation of G-protein coupled receptor protein signaling pathway,P22571(Evidence code:IEA/Database source:UniProtKB:P61249|ens),PDE6H,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0006270,DNA replication initiation,Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR001208|I),MCM4,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0001937,negative regulation of endothelial cell proliferation,E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827),PTPRM,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0000731,DNA synthesis involved in DNA repair,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens),WRN,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0097581,lamellipodium organization,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens),MTSS1L,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0002686,negative regulation of leukocyte migration,E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens),HOXA7,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0046638,positive regulation of alpha-beta T cell differentiation,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:2000008,regulation of protein localization to cell surface,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens),TOR1A,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0008519,ammonium transmembrane transporter activity,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,MF,1,1 of 10,0.04,10,0.5278,0.5747
GO:0061028,establishment of endothelial barrier,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0070469,respiratory chain,P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679),NDUFS3,CC,1,1 of 10,0.04,10,0.5278,0.5747
GO:0006024,glycosaminoglycan biosynthetic process,A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens),EXT1,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0042730,fibrinolysis,F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens),TMPRSS6,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0008016,regulation of heart contraction,Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017),CACNA1B,BP,1,1 of 41,0.04,2.44,0.525,0.5747
GO:0006476,protein deacetylation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0048025,"negative regulation of mRNA splicing, via spliceosome",Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422),SAP18,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0019233,sensory perception of pain,G3MYM1(Evidence code:IEA/Database source:InterPro:IPR028809),SCN10A,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0004890,GABA-A receptor activity,Q08E50(Evidence code:IBA/Database source:PANTHER:PTN001055383),GABRA5,MF,1,1 of 10,0.04,10,0.5278,0.5747
GO:0046834,lipid phosphorylation,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0044798,nuclear transcription factor complex,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,CC,1,1 of 41,0.04,2.44,0.525,0.5747
GO:0030291,protein serine/threonine kinase inhibitor activity,A6QP24(Evidence code:IEA/Database source:InterPro:IPR039201),FAM212B,MF,1,1 of 10,0.04,10,0.5278,0.5747
GO:0090200,positive regulation of release of cytochrome c from mitochondria,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0032330,regulation of chondrocyte differentiation,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens),SHOX2,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0045669,positive regulation of osteoblast differentiation,E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens),ZHX3,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0007271,"synaptic transmission, cholinergic",P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0007270,neuron-neuron synaptic transmission,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens),KIF1B,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0090734,site of DNA damage,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,CC,1,1 of 10,0.04,10,0.5278,0.5747
GO:0042310,vasoconstriction,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581),TRPM4,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0031111,negative regulation of microtubule polymerization or depolymerization,Q9TRY0(Evidence code:ISS/Database source:UniProtKB:P27124),FKBP4,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0097729,9+2 motile cilium,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,CC,1,1 of 10,0.04,10,0.5278,0.5747
GO:0006801,superoxide metabolic process,F1MF26(Evidence code:IEA/Database source:UniProtKB:Q5TCZ1|ens),SH3PXD2A,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens),BRSK2,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0043550,regulation of lipid kinase activity,Q08DG0(Evidence code:IEA/Database source:UniProtKB:Q8VCQ3|ens),NRBF2,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0043949,regulation of cAMP-mediated signaling,P63097(Evidence code:ISS/Database source:UniProtKB:P10824),GNAI1,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:1902711,GABA-A receptor complex,Q08E50(Evidence code:IBA/Database source:PANTHER:PTN001055383),GABRA5,CC,1,1 of 10,0.04,10,0.5278,0.5747
GO:0051353,positive regulation of oxidoreductase activity,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens),ABL1,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0032095,regulation of response to food,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0006744,ubiquinone biosynthetic process,Q2NL34(Evidence code:IEA/Database source:InterPro:IPR012762),COQ9,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0070206,protein trimerization,A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens),C1QTNF5,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:1900744,regulation of p38MAPK cascade,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0035094,response to nicotine,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0060317,cardiac epithelial to mesenchymal transition,E1BBU4(Evidence code:IEA/Database source:UniProtKB:O88839|ens),ADAM15,BP,1,1 of 10,0.04,10,0.5278,0.5747
GO:0090575,RNA polymerase II transcription factor complex,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)G3MY92(Evidence code:IBA/Database source:PANTHER:PTN000358347), SFPQ TFDP2 ATF6B ASCL4,CC,4,4 of 39,0.18,10.26,0.5292,0.576
GO:0048589,developmental growth,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), PYGO2 NIPBL SRF GLI2,BP,4,4 of 41,0.18,9.76,0.5389,0.5864
GO:0000976,transcription regulatory region sequence-specific DNA binding,E1BLK1(Evidence code:IBA/Database source:PANTHER:PTN000968522)F1MM81(Evidence code:IBA/Database source:PANTHER:PTN000968522)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)Q5NUA6(Evidence code:IBA/Database source:PANTHER:PTN000696756)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), TNRC18 BAHCC1 KDM3B NFKB1 SFPQ MKL1 NFE2L2 SOX4,MF,8,8 of 93,0.35,8.6,0.5454,0.5933
GO:0043523,regulation of neuron apoptotic process,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens), PINK1 NAE1 GABRA5 KIF14,BP,4,4 of 44,0.18,9.09,0.5568,0.6054
GO:0090329,regulation of DNA-dependent DNA replication,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0008198,ferrous iron binding,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,MF,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:2000779,regulation of double-strand break repair,A5PJQ1(Evidence code:IEA/Database source:UniProtKB:P35659|ens),DEK,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0030150,protein import into mitochondrial matrix,Q2HJE9(Evidence code:IBA/Database source:PANTHER:PTN000050380),TIMM17B,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0051926,negative regulation of calcium ion transport,E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens),PACSIN3,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0033555,multicellular organismal response to stress,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0034629,cellular protein-containing complex localization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0031519,PcG protein complex,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,CC,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0033692,cellular polysaccharide biosynthetic process,A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens),EXT1,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0061640,cytoskeleton-dependent cytokinesis,Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens),DCTN3,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:1901890,positive regulation of cell junction assembly,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:2000177,regulation of neural precursor cell proliferation,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens),NF2,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0097756,negative regulation of blood vessel diameter,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens),SMTNL1,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0009395,phospholipid catabolic process,P08487(Evidence code:IEA/Database source:InterPro:IPR016279),PLCG1,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0032094,response to food,P01175(Evidence code:IDA/Database source:),OXT,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0006111,regulation of gluconeogenesis,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0045814,"negative regulation of gene expression, epigenetic",E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens),PPM1D,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0071624,positive regulation of granulocyte chemotaxis,Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens),S100A14,BP,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0051219,phosphoprotein binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,MF,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0042583,chromaffin granule,P05059(Evidence code:IDA/Database source:),CHGA,CC,1,1 of 11,0.04,9.09,0.5589,0.6054
GO:0008217,regulation of blood pressure,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q9ERL9|ens), ATP1A2 CACNA1B COL1A2 GUCY1A3,BP,4,4 of 45,0.18,8.89,0.5635,0.61
GO:0052689,carboxylic ester hydrolase activity,E1BN79(Evidence code:IBA/Database source:PANTHER:PTN000168392)Q3MHR0(Evidence code:IBA/Database source:PANTHER:PTN001639375)P0C6R3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0719)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0719), CES5A LYPLA1 CES4A ABHD2,MF,4,4 of 45,0.18,8.89,0.5635,0.61
GO:0002009,morphogenesis of an epithelium,F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851), FRAS1 GLI2 FREM2 fgfr3,BP,4,4 of 45,0.18,8.89,0.5635,0.61
GO:0009055,electron transfer activity,E1BL62(Evidence code:IEA/Database source:InterPro:IPR001041|I)P48034(Evidence code:IEA/Database source:InterPro:IPR001041|I)O62768(Evidence code:IEA/Database source:InterPro:IPR001100)Q58DA7(Evidence code:IEA/Database source:InterPro:IPR002109), AOX4 AOX1 TXNRD1 GLRX3,MF,4,4 of 46,0.18,8.7,0.5706,0.6175
GO:0009306,protein secretion,E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635132)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635132)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens), RAB37 RAB26 GOLPH3 C1QTNF5,BP,4,4 of 47,0.18,8.51,0.5779,0.6253
GO:0051224,negative regulation of protein transport,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens), SNX3 SNX12,BP,2,2 of 51,0.09,3.92,0.5822,0.6295
GO:0046822,regulation of nucleocytoplasmic transport,P61287(Evidence code:IEA/Database source:UniProtKB:P63087|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens), PPP1CC NUP214,BP,2,2 of 50,0.09,4,0.5821,0.6295
GO:0016651,"oxidoreductase activity, acting on NAD(P)H",E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)P23709(Evidence code:IEA/Database source:InterPro:IPR010218|I), AIFM1 NDUFS3,MF,2,2 of 51,0.09,3.92,0.5822,0.6295
GO:0000982,"transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR033897), SP1 SRF,MF,2,2 of 50,0.09,4,0.5821,0.6295
GO:0031301,integral component of organelle membrane,Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287), VAMP5 ITM2B,CC,2,2 of 52,0.09,3.85,0.5829,0.6299
GO:1900180,regulation of protein localization to nucleus,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens), NF2 PIN1,BP,2,2 of 52,0.09,3.85,0.5829,0.6299
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), PDGFC PRNP,BP,2,2 of 52,0.09,3.85,0.5829,0.6299
GO:0048598,embryonic morphogenesis,E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), CDON SHOX2,BP,2,2 of 55,0.09,3.64,0.5878,0.6304
GO:0045926,negative regulation of growth,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens), ALOX15B PNPT1,BP,2,2 of 54,0.09,3.7,0.5857,0.6304
GO:0008064,regulation of actin polymerization or depolymerization,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922), ARHGAP35 SSH2,BP,2,2 of 55,0.09,3.64,0.5878,0.6304
GO:1901214,regulation of neuron death,F1MG76(Evidence code:IEA/Database source:UniProtKB:Q6X632|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), GPR75 LRRK2,BP,2,2 of 55,0.09,3.64,0.5878,0.6304
GO:0005520,insulin-like growth factor binding,P20959(Evidence code:IEA/Database source:InterPro:IPR000867|I),IGFBP3,MF,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0009913,epidermal cell differentiation,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens),GLI1,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0030670,phagocytic vesicle membrane,A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),DNM2,CC,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0033120,positive regulation of RNA splicing,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens),SETX,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0032651,regulation of interleukin-1 beta production,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558),F2R,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0006144,purine nucleobase metabolic process,Q32L93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0659),GMPR2,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0050840,extracellular matrix binding,E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens),OLFML2A,MF,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0043631,RNA polyadenylation,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0001190,"transcriptional activator activity, RNA polymerase II transcription factor binding",Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens),LMO2,MF,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0031124,mRNA 3-end processing,G3MZ78(Evidence code:IEA/Database source:InterPro:IPR026896),CSTF2T,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0032411,positive regulation of transporter activity,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens),KMT2A,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0007029,endoplasmic reticulum organization,F1MBM5(Evidence code:IEA/Database source:InterPro:IPR030550),TOR1B,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0016763,"transferase activity, transferring pentosyl groups",Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR018099),MTAP,MF,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",Q2NL34(Evidence code:IEA/Database source:UniProtKB:Q8K1Z0|ens),COQ9,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0009620,response to fungus,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens),MALT1,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0016628,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",Q3T046(Evidence code:ISS/Database source:UniProtKB:Q8JZV9),BDH2,MF,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0071385,cellular response to glucocorticoid stimulus,Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036),UBE2L3,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:2000677,regulation of transcription regulatory region DNA binding,E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens),DOT1L,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0050891,multicellular organismal water homeostasis,P35071(Evidence code:ISS/Database source:UniProtKB:P13569),CFTR,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0071559,response to transforming growth factor beta,E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens),ZFHX3,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:1901222,regulation of NIK/NF-kappaB signaling,E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749),BCL3,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0050810,regulation of steroid biosynthetic process,F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens),DDX20,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0009311,oligosaccharide metabolic process,F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens),ST8SIA3,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0006221,pyrimidine nucleotide biosynthetic process,P31754(Evidence code:IEA/Database source:InterPro:IPR023031),UMPS,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0050795,regulation of behavior,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5),AHI1,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0001508,action potential,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens),CLN3,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0006536,glutamate metabolic process,Q58CZ9(Evidence code:ISS/Database source:UniProtKB:P17735),TAT,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0042168,heme metabolic process,Q3T046(Evidence code:ISS/Database source:UniProtKB:Q561X9),BDH2,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0046888,negative regulation of hormone secretion,P05059(Evidence code:IDA/Database source:),CHGA,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0008535,respiratory chain complex IV assembly,A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276),SCO1,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:1903429,regulation of cell maturation,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens),KIF14,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:1900407,regulation of cellular response to oxidative stress,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0043388,positive regulation of DNA binding,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0045744,negative regulation of G-protein coupled receptor protein signaling pathway,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens),RGS14,BP,1,1 of 12,0.04,8.33,0.588,0.6304
GO:0022904,respiratory electron transport chain,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)A5PJM4(Evidence code:IEA/Database source:GO:0004174), PINK1 AIFM2,BP,2,2 of 56,0.09,3.57,0.5903,0.6327
GO:0019900,kinase binding,E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MF87(Evidence code:IEA/Database source:UniProtKB:Q96AY4|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), MOB1B SRC DAB2IP TTC28 UBQLN1 PFKM PPP2R5A DLG1 WWC1 DGKQ,MF,10,10 of 120,0.44,8.33,0.5933,0.6358
GO:0007009,plasma membrane organization,F1MXR0(Evidence code:IEA/Database source:InterPro:IPR013606)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)Q5EAD0(Evidence code:IEA/Database source:InterPro:IPR013606)F1MGT3(Evidence code:IEA/Database source:InterPro:IPR013606)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens), BAIAP2L1 SPTA1 BAIAP2 MTSS1L MPP5,BP,5,5 of 55,0.22,9.09,0.5966,0.6393
GO:0051480,regulation of cytosolic calcium ion concentration,O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230)F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230)F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens), TRPC2 ATP2B3 CLN3 TRPC1 ATP2B2,BP,5,5 of 57,0.22,8.77,0.6042,0.6471
GO:0051020,GTPase binding,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)A7MBC5(Evidence code:IEA/Database source:UniProtKB:P41252|ens)A3KN15(Evidence code:IBA/Database source:PANTHER:PTN000289375)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens), EPRS IARS VPS41 GNB3 GOLGA4,MF,5,5 of 57,0.22,8.77,0.6042,0.6471
GO:0022900,electron transport chain,O62768(Evidence code:IEA/Database source:GO:0009055)P48034(Evidence code:IEA/Database source:GO:0009055)P10897(Evidence code:IEA/Database source:InterPro:IPR028837)E1BL62(Evidence code:IEA/Database source:GO:0009055)Q58DA7(Evidence code:IEA/Database source:GO:0009055), TXNRD1 AOX1 CYB561 AOX4 GLRX3,BP,5,5 of 59,0.22,8.47,0.613,0.6557
GO:0061025,membrane fusion,Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170085)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170085)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257), DNM1 NAPG MX2 DNM2 NSFL1C,BP,5,5 of 59,0.22,8.47,0.613,0.6557
GO:0019730,antimicrobial humoral response,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0006661,phosphatidylinositol biosynthetic process,P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens),IMPA1,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0048260,positive regulation of receptor-mediated endocytosis,G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens),HIST1H1A,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0035308,negative regulation of protein dephosphorylation,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens),PTPA,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0000271,polysaccharide biosynthetic process,Q5E9E7(Evidence code:IBA/Database source:PANTHER:PTN000349745),GLT8D1,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0034061,DNA polymerase activity,P06526(Evidence code:IEA/Database source:InterPro:IPR001726|I),DNTT,MF,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens),H3F3B,MF,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0032784,"regulation of DNA-templated transcription, elongation",E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens),CCAR2,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0050807,regulation of synapse organization,F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens),TUBA1A,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0015696,ammonium transport,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0045010,actin nucleation,E1BGT8(Evidence code:IEA/Database source:InterPro:IPR029901|I),SPIRE1,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0000015,phosphopyruvate hydratase complex,F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941),ENO4,CC,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0051445,regulation of meiotic cell cycle,P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019),CDK1,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0055117,regulation of cardiac muscle contraction,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens),SCN10A,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0050868,negative regulation of T cell activation,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens),DUSP3,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0000421,autophagosome membrane,Q32LM0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),SH3GLB1,CC,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0021782,glial cell development,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831),SOX4,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0016891,"endoribonuclease activity, producing 5-phosphomonoesters",Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR005034),DICER1,MF,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0044306,neuron projection terminus,E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens),BSN,CC,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:1901796,regulation of signal transduction by p53 class mediator,E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens),HIPK4,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0032355,response to estradiol,P02668(Evidence code:IDA/Database source:),CSN3,BP,1,1 of 13,0.04,7.69,0.6151,0.6557
GO:0008083,growth factor activity,A4FV80(Evidence code:IEA/Database source:UniProtKB:Q8R089|ens)Q95106(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)P03968(Evidence code:IEA/Database source:InterPro:IPR002209)Q28038(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR000072), FBRS BDNF FGF1 MIA PDGFC,MF,5,5 of 60,0.22,8.33,0.6178,0.6585
GO:0016773,"phosphotransferase activity, alcohol group as acceptor",E1BNF8(Evidence code:IEA/Database source:InterPro:IPR000577|I)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR000577|I)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR000577|I)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR000577|I)E1BME6(Evidence code:IEA/Database source:InterPro:IPR022672|I)Q17R18(Evidence code:IEA/Database source:InterPro:IPR002173)A6QR34(Evidence code:IEA/Database source:InterPro:IPR022672|I), FGGY GK GALK1 LOC538702 GK2 HK2 ADK GCK,MF,8,8 of 146,0.35,5.48,0.6243,0.6652
GO:0019899,enzyme binding,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q05B83(Evidence code:IEA/Database source:UniProtKB:Q9WUK4|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:O35864|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)P81948(Evidence code:IEA/Database source:UniProtKB:P68368|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens), CCAR2 RFC2 FOXO4 SRC AXIN1 BACE1 TOP2B TERF2 AXIN2 MARCH7 TAF10 YES1 ZFHX3 TNKS1BP1 ADORA2A GOLPH3 PPP3CA COPS5 UBE4B KPNB1 BANF1 RYR1 SNX12 CAD TUBA4A HSPA9 PRKDC PCBP2 PIAS1 LAMP1 TSPAN14,MF,31,31 of 405,1.36,7.65,0.6276,0.6686
GO:0048193,Golgi vesicle transport,P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)A6QQ47(Evidence code:IBA/Database source:PANTHER:PTN000409559)F1MT17(Evidence code:IBA/Database source:PANTHER:PTN000361901), ARCN1 VPS51 CUX2,BP,3,3 of 69,0.13,4.35,0.6308,0.6719
GO:0071407,cellular response to organic cyclic compound,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q8CIN4|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:Q8BTW9|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), FOXF1 GLI2 PAK3 PAK2 PAK4 GSK3A,BP,6,6 of 68,0.26,8.82,0.6347,0.6759
GO:0030334,regulation of cell migration,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:O54988|ens)P26917(Evidence code:ISS/Database source:UniProtKB:P60041)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR028770)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens), KIF14 SLK SST DOCK10 GNA13 PTPN23 DDX58 LAMA3 FRMD5,BP,9,9 of 160,0.39,5.62,0.6403,0.6817
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens), LCK FIS1,BP,2,2 of 19,0.09,10.53,0.646,0.6871
GO:0008009,chemokine activity,A6YT15(Evidence code:IEA/Database source:InterPro:IPR000827|I)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR001811|I), CCL28 CXCL12,MF,2,2 of 19,0.09,10.53,0.646,0.6871
GO:0070098,chemokine-mediated signaling pathway,F1MG76(Evidence code:IEA/Database source:UniProtKB:Q6X632|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens), GPR75 CXCL12,BP,2,2 of 19,0.09,10.53,0.646,0.6871
GO:0006942,regulation of striated muscle contraction,P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), MYL3 ATP1A2,BP,2,2 of 19,0.09,10.53,0.646,0.6871
GO:1903363,negative regulation of cellular protein catabolic process,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q2TBQ1(Evidence code:IEA/Database source:UniProtKB:Q07968|ens), DAB2IP F13B,BP,2,2 of 19,0.09,10.53,0.646,0.6871
GO:0007093,mitotic cell cycle checkpoint,E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens), KNTC1 INTS3,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0010906,regulation of glucose metabolic process,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens), IGFBP3 GNB3,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0002573,myeloid leukocyte differentiation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), PSEN1 KIT,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0032755,positive regulation of interleukin-6 production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), FCER1G DDX58,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0030490,maturation of SSU-rRNA,Q56JX6(Evidence code:IBA/Database source:PANTHER:PTN000080571)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), RPS28 RPS19,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0070509,calcium ion import,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens), CACNA1D GCK,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0030177,positive regulation of Wnt signaling pathway,G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q9HBX8|ens)P23956(Evidence code:IEA/Database source:UniProtKB:P27449|ens), LGR6 ATP6V0C,BP,2,2 of 20,0.09,10,0.6536,0.6942
GO:0046983,protein dimerization activity,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q2NL18(Evidence code:IEA/Database source:InterPro:IPR011598|I)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR029324)E5CY52(Evidence code:IEA/Database source:InterPro:IPR011598|I)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR011598|I)P17667(Evidence code:IEA/Database source:InterPro:IPR011598|I)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR032394)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR011598|I)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)F1ML85(Evidence code:IEA/Database source:InterPro:IPR011598|I)A6QPK5(Evidence code:IEA/Database source:InterPro:IPR011598|I)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)G3MY92(Evidence code:IEA/Database source:InterPro:IPR011598|I)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A6QPY5(Evidence code:IEA/Database source:InterPro:IPR011598|I)F1MXB9(Evidence code:IEA/Database source:InterPro:IPR011598|I)E1BG94(Evidence code:IEA/Database source:InterPro:IPR032198)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR002100|I)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)A4FV19(Evidence code:IEA/Database source:InterPro:IPR021977), ATM HEYL AIFM1 SREBF1 NCOA3 MYF5 PEF1 DNM1 PPP3CA ANO6 PDCD6IP MGA STAT3 AHR TCF7L2 STAT5B ASCL4 PDCD6 USF2 TCF4 E2F1 SRF GARS BTRC,MF,24,24 of 310,1.05,7.74,0.657,0.6977
GO:0042176,regulation of protein catabolic process,A7MBA2(Evidence code:IEA/Database source:InterPro:IPR016642)P56701(Evidence code:IEA/Database source:InterPro:IPR016643)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens), PSMD1 PSMD2 SNF8 XPO1,BP,4,4 of 81,0.18,4.94,0.661,0.7011
GO:0019216,regulation of lipid metabolic process,F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)F1MYE0(Evidence code:IBA/Database source:PANTHER:PTN000064809), IRS4 BCL11B TNFAIP8L3 IRS1,BP,4,4 of 80,0.18,5,0.6605,0.7011
GO:0006165,nucleoside diphosphate phosphorylation,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0003014,renal system process,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens), BCR MLLT6,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0015171,amino acid transmembrane transporter activity,Q08DK7(Evidence code:IBA/Database source:PANTHER:PTN001942979)A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens), SLC25A29 SLC6A20,MF,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0040029,"regulation of gene expression, epigenetic",Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR030703)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), HDAC5 TDG,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0048872,homeostasis of number of cells,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens), ASXL1 BCR,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:1900181,negative regulation of protein localization to nucleus,E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens), DCLK2 OTUD7B,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0051881,regulation of mitochondrial membrane potential,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens), PINK1 SPG20,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0000904,cell morphogenesis involved in differentiation,F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens), LAMC3 LAMB2,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0035148,tube formation,E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), SDCCAG8 DAB2IP,BP,2,2 of 21,0.09,9.52,0.6618,0.7011
GO:0030427,site of polarized growth,E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604), FRYL FRY,CC,2,2 of 22,0.09,9.09,0.6703,0.7095
GO:0034644,cellular response to UV,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens), NEDD4 INO80,BP,2,2 of 22,0.09,9.09,0.6703,0.7095
GO:0006275,regulation of DNA replication,F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), ANKRD17 EHMT2,BP,2,2 of 22,0.09,9.09,0.6703,0.7095
GO:0042307,positive regulation of protein import into nucleus,F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), IPO5 TPR,BP,2,2 of 22,0.09,9.09,0.6703,0.7095
GO:0022408,negative regulation of cell-cell adhesion,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens), ABL1 NF2,BP,2,2 of 22,0.09,9.09,0.6703,0.7095
GO:0051101,regulation of DNA binding,E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens), BCL3 TAF10,BP,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0042379,chemokine receptor binding,Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens), S100A14 CXCL12,MF,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0045638,negative regulation of myeloid cell differentiation,A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens), MEIS1 CDK6,BP,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0009612,response to mechanical stimulus,Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622311)P01175(Evidence code:IDA/Database source:), MAPK9 OXT,BP,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0008643,carbohydrate transport,Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0762)Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0762), SLC5A11 SLC35B1,BP,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0019218,regulation of steroid metabolic process,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0005230,extracellular ligand-gated ion channel activity,P02715(Evidence code:IEA/Database source:InterPro:IPR006202|I)Q08E50(Evidence code:IEA/Database source:InterPro:IPR006202|I), CHRNE GABRA5,MF,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0045580,regulation of T cell differentiation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens), ABL1 BRAF,BP,2,2 of 23,0.09,8.7,0.6792,0.7178
GO:0006417,regulation of translation,Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)P02638(Evidence code:NAS/Database source:)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810), DHX9 GCN1L1 MTG1 AGO3 S100B AGO4 EIF4A3,BP,7,7 of 89,0.31,7.87,0.6818,0.7204
GO:0016458,gene silencing,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens), KMT2B CHMP1A,BP,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0070555,response to interleukin-1,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), TRAF6 SRC,BP,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0006112,energy reserve metabolic process,E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), KL MT3,BP,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0097191,extrinsic apoptotic signaling pathway,G3N127(Evidence code:IEA/Database source:UniProtKB:P27469|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), G0S2 GSK3A,BP,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0004536,deoxyribonuclease activity,A5PJT8(Evidence code:IEA/Database source:InterPro:IPR016202)Q2QDE9(Evidence code:IEA/Database source:InterPro:IPR016202), DNASE1L2 DNASE1L1,MF,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0045165,cell fate commitment,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens), ONECUT2 KDM6B,BP,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0030856,regulation of epithelial cell differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 24,0.09,8.33,0.6884,0.7263
GO:0001763,morphogenesis of a branching structure,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q9R1N9|ens), FOXF1 COL13A1,BP,2,2 of 25,0.09,8,0.6977,0.736
GO:0007005,mitochondrion organization,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR021181)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BIA7(Evidence code:IEA/Database source:UniRule:UR000107144)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR021181)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), PINK1 RHOT1 AGTPBP1 CLUH RAB3A EIF4G1 RHOT2 LRRK2,BP,8,8 of 104,0.35,7.69,0.705,0.7435
GO:0004869,cysteine-type endopeptidase inhibitor activity,P20811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0789)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens), CAST BIRC6,MF,2,2 of 26,0.09,7.69,0.7072,0.7454
GO:0009408,response to heat,E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR012724), EIF2B5 DNAJA2,BP,2,2 of 26,0.09,7.69,0.7072,0.7454
GO:1903364,positive regulation of cellular protein catabolic process,Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), PTTG1IP VPS35,BP,2,2 of 26,0.09,7.69,0.7072,0.7454
GO:0051781,positive regulation of cell division,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), FGF1 SIRT2,BP,2,2 of 27,0.09,7.41,0.7167,0.7546
GO:0060090,molecular adaptor activity,A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), PEF1 PDCD6,MF,2,2 of 27,0.09,7.41,0.7167,0.7546
GO:0007265,Ras protein signal transduction,Q3T0F9(Evidence code:IEA/Database source:InterPro:IPR030219)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens), GRB2 SYNGAP1,BP,2,2 of 27,0.09,7.41,0.7167,0.7546
GO:0045333,cellular respiration,Q3SZK4(Evidence code:ISS/Database source:UniProtKB:Q14CZ7)P23709(Evidence code:IBA/Database source:PANTHER:PTN000094347), TBRG4 NDUFS3,BP,2,2 of 27,0.09,7.41,0.7167,0.7546
GO:0001894,tissue homeostasis,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens), COL2A1 WWTR1,BP,2,2 of 27,0.09,7.41,0.7167,0.7546
GO:0010950,positive regulation of endopeptidase activity,Q17QP9(Evidence code:IEA/Database source:GO:0061133),PSMD14,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0051648,vesicle localization,P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5),MYO1A,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0019829,cation-transporting ATPase activity,F1MKI1(Evidence code:IEA/Database source:InterPro:IPR027256),ATP7B,MF,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:1903707,negative regulation of hemopoiesis,Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38647),HSPA9,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0051427,hormone receptor binding,E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141),SRC,MF,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0006664,glycolipid metabolic process,Q0VD36(Evidence code:IBA/Database source:PANTHER:PTN000258330),KDELC1,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0002819,regulation of adaptive immune response,Q29450(Evidence code:ISS/Database source:UniProtKB:P51829),ADCY7,BP,1,1 of 30,0.04,3.33,0.7202,0.7565
GO:0071219,cellular response to molecule of bacterial origin,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0019838,growth factor binding,P20959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340),IGFBP3,MF,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0006497,protein lipidation,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0006885,regulation of pH,P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6),ATP6V1B1,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0003954,NADH dehydrogenase activity,P23709(Evidence code:IEA/Database source:EC:1.6.99.3),NDUFS3,MF,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0046474,glycerophospholipid biosynthetic process,Q95JH2(Evidence code:IBA/Database source:PANTHER:PTN000046638),AGPAT1,BP,1,1 of 30,0.04,3.33,0.7202,0.7565
GO:0046488,phosphatidylinositol metabolic process,Q0P5F7(Evidence code:IEA/Database source:InterPro:IPR002498),PIP4K2C,BP,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",Q28007(Evidence code:IEA/Database source:InterPro:IPR005720),DPYD,MF,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0048024,"regulation of mRNA splicing, via spliceosome",Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q60749|ens),KHDRBS1,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0030532,small nuclear ribonucleoprotein complex,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,CC,1,1 of 29,0.04,3.45,0.7198,0.7565
GO:0070160,occluding junction,F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens),TJP1,CC,1,1 of 30,0.04,3.33,0.7202,0.7565
GO:0060491,regulation of cell projection assembly,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 31,0.04,3.23,0.7212,0.7565
GO:0050707,regulation of cytokine secretion,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168),TLR4,BP,1,1 of 32,0.04,3.12,0.7228,0.7575
GO:0007599,hemostasis,A7YY44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356),F2R,BP,1,1 of 32,0.04,3.12,0.7228,0.7575
GO:0070851,growth factor receptor binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,MF,1,1 of 32,0.04,3.12,0.7228,0.7575
GO:0010952,positive regulation of peptidase activity,Q29RY7(Evidence code:IEA/Database source:GO:0016504),FGL2,BP,1,1 of 32,0.04,3.12,0.7228,0.7575
GO:0015081,sodium ion transmembrane transporter activity,E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7),SLC23A1,MF,1,1 of 34,0.04,2.94,0.7274,0.7619
GO:0035239,tube morphogenesis,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 34,0.04,2.94,0.7274,0.7619
GO:0044772,mitotic cell cycle phase transition,P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens),CDK1,BP,1,1 of 34,0.04,2.94,0.7274,0.7619
GO:0032387,negative regulation of intracellular transport,P02510(Evidence code:ISS/Database source:UniProtKB:P02511),CRYAB,BP,1,1 of 35,0.04,2.86,0.7304,0.7646
GO:0031346,positive regulation of cell projection organization,E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens),PROM2,BP,1,1 of 35,0.04,2.86,0.7304,0.7646
GO:2001236,regulation of extrinsic apoptotic signaling pathway,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 35,0.04,2.86,0.7304,0.7646
GO:0032543,mitochondrial translation,Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q9JJG9)P0C2B7(Evidence code:IEA/Database source:InterPro:IPR034596)Q0P5H7(Evidence code:IBA/Database source:PANTHER:PTN000238101), NOA1 MRPL52 RARS2,BP,3,3 of 34,0.13,8.82,0.7339,0.7678
GO:0043433,negative regulation of DNA-binding transcription factor activity,E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN000697161), MAP3K10 PRNP KEAP1,BP,3,3 of 34,0.13,8.82,0.7339,0.7678
GO:0031225,anchored component of membrane,A0JNB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336), LY6H PRNP DPEP3,CC,3,3 of 34,0.13,8.82,0.7339,0.7678
GO:0009267,cellular response to starvation,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens), WRN LRRK2 STK26,BP,3,3 of 35,0.13,8.57,0.7376,0.7714
GO:0007051,spindle organization,E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776), CKAP5 RANBP2 RGS14,BP,3,3 of 35,0.13,8.57,0.7376,0.7714
GO:0006665,sphingolipid metabolic process,Q58CW5(Evidence code:IEA/Database source:InterPro:IPR029554)A4FUZ5(Evidence code:IEA/Database source:InterPro:IPR029557)F1N5T9(Evidence code:IEA/Database source:InterPro:IPR029555), SERINC2 SERINC3 SERINC5,BP,3,3 of 36,0.13,8.33,0.7417,0.7753
GO:0000302,response to reactive oxygen species,P56722(Evidence code:ISS/Database source:UniProtKB:Q16849)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), PTPRN HYAL1 PLK3,BP,3,3 of 36,0.13,8.33,0.7417,0.7753
GO:0034504,protein localization to nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4), XPO1 TOR1A RPL11,BP,3,3 of 37,0.13,8.11,0.746,0.7797
GO:0002376,immune system process,A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR034384)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR034383)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)P58754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)F6Q9J4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391), BoLA FCER1G IRF1 MX2 PRKCB PSMB8 PSMB10 TLR4 LOC788634 PSMB9 LGR4 SFTPD MARCH8 TRAF6 MB21D1 LY96 LOC100848815 DHX9 ALCAM LOC100125916 SERINC3,BP,21,21 of 334,0.92,6.29,0.7463,0.7799
GO:0043393,regulation of protein binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), SRC PSEN1 CRK,BP,3,3 of 38,0.13,7.89,0.7506,0.784
GO:0004540,ribonuclease activity,A7YWM6(Evidence code:IBA/Database source:PANTHER:PTN000153528)E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280)F1MGC2(Evidence code:IBA/Database source:PANTHER:PTN001350296), RNASE13 SMG6 RNASE2,MF,3,3 of 38,0.13,7.89,0.7506,0.784
GO:0005762,mitochondrial large ribosomal subunit,P0C2B7(Evidence code:IEA/Database source:InterPro:IPR034596)Q3ZBX6(Evidence code:ISS/Database source:UniProtKB:P09001), MRPL52 MRPL3,CC,2,2 of 45,0.09,4.44,0.7687,0.8019
GO:0051924,regulation of calcium ion transport,F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), GRIN3B SRI,BP,2,2 of 44,0.09,4.55,0.7682,0.8019
GO:0008528,G-protein coupled peptide receptor activity,E1BMN4(Evidence code:IEA/Database source:InterPro:IPR001556)F1MSU3(Evidence code:IEA/Database source:UniProtKB:Q8BGE9|ens), NMBR RXFP3,MF,2,2 of 45,0.09,4.44,0.7687,0.8019
GO:0071363,cellular response to growth factor stimulus,Q0IIE2(Evidence code:ISS/Database source:UniProtKB:P29353)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), SHC1 STAT5B,BP,2,2 of 44,0.09,4.55,0.7682,0.8019
GO:0050870,positive regulation of T cell activation,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239), MALT1 LCK,BP,2,2 of 45,0.09,4.44,0.7687,0.8019
GO:0007218,neuropeptide signaling pathway,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)F1MSU3(Evidence code:IEA/Database source:GO:0004966), RAPGEF2 RXFP3,BP,2,2 of 43,0.09,4.65,0.768,0.8019
GO:0008135,"translation factor activity, RNA binding",Q32KZ1(Evidence code:ISS/Database source:UniProtKB:Q9H2K0)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens), MTIF3 EIF4G1,MF,2,2 of 46,0.09,4.35,0.7695,0.8025
GO:2001020,regulation of response to DNA damage stimulus,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens), ABL1 SMG1,BP,2,2 of 46,0.09,4.35,0.7695,0.8025
GO:0046425,regulation of JAK-STAT cascade,F1MRH8(Evidence code:IEA/Database source:GO:0008269)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens), SH2B2 DOT1L,BP,2,2 of 47,0.09,4.26,0.7707,0.8035
GO:0017016,Ras GTPase binding,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)E1BB46(Evidence code:IEA/Database source:InterPro:IPR035455), RAPGEF4 SH3BP4,MF,2,2 of 48,0.09,4.17,0.7721,0.8049
GO:0044242,cellular lipid catabolic process,P37359(Evidence code:ISS/Database source:UniProtKB:P28184)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), MT3 SIRT2,BP,2,2 of 49,0.09,4.08,0.7738,0.8063
GO:0016758,"transferase activity, transferring hexosyl groups",F1MFF6(Evidence code:IEA/Database source:InterPro:IPR002213)Q17QE7(Evidence code:IEA/Database source:InterPro:IPR005076), UGT2B10 GBGT1,MF,2,2 of 49,0.09,4.08,0.7738,0.8063
GO:0006605,protein targeting,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)G3MWT9(Evidence code:IEA/Database source:InterPro:IPR001573), SORL1 MYO1C GIPC1 AKAP12,BP,4,4 of 48,0.18,8.33,0.7759,0.8083
GO:2000146,negative regulation of cell motility,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), TACSTD2 FRMD5 PIN1 CRK,BP,4,4 of 50,0.18,8,0.7805,0.813
GO:0010821,regulation of mitochondrion organization,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), FIS1 PINK1 GOLPH3 VPS35,BP,4,4 of 51,0.18,7.84,0.7832,0.8154
GO:0031461,cullin-RING ubiquitin ligase complex,F1MYD0(Evidence code:IEA/Database source:InterPro:IPR016157)E1BIN5(Evidence code:IEA/Database source:InterPro:IPR016157)Q08DE9(Evidence code:IEA/Database source:InterPro:IPR016157)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6), CUL1 CUL3 CUL2 CAND1,CC,4,4 of 51,0.18,7.84,0.7832,0.8154
GO:0000987,proximal promoter sequence-specific DNA binding,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR033897)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens), E2F1 E2F7 SRF ZNF516,MF,4,4 of 53,0.18,7.55,0.789,0.8213
GO:0031396,regulation of protein ubiquitination,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), DNAJB2 UBQLN1 RNF139 PINK1,BP,4,4 of 54,0.18,7.41,0.7922,0.8244
GO:0071345,cellular response to cytokine stimulus,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), FOXF1 POU4F2 LEF1,BP,3,3 of 57,0.13,5.26,0.7977,0.8298
GO:0006959,humoral immune response,P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT3 LOC104968438 IFNT2,BP,3,3 of 57,0.13,5.26,0.7977,0.8298
GO:0035770,ribonucleoprotein granule,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566987)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8NHU6)F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens), UHMK1 TDRD7 FASTKD2,CC,3,3 of 58,0.13,5.17,0.7977,0.8298
GO:2001234,negative regulation of apoptotic signaling pathway,E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens), MKL1 PSEN1 HSPH1,BP,3,3 of 59,0.13,5.08,0.798,0.8299
GO:0006839,mitochondrial transport,Q08DK7(Evidence code:IBA/Database source:PANTHER:PTN000211803)A6QR09(Evidence code:IBA/Database source:PANTHER:PTN000211803)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SLC25A29 SLC25A26 PSEN1,BP,3,3 of 60,0.13,5,0.7986,0.8303
GO:0046034,ATP metabolic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens)P31407(Evidence code:IEA/Database source:InterPro:IPR004100)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens), AMPD3 ATP6V1B1 ATP1A2,BP,3,3 of 62,0.13,4.84,0.8002,0.8318
GO:0090316,positive regulation of intracellular protein transport,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), PDCD10 PCNT PCM1 TPR PLK3,BP,5,5 of 62,0.22,8.06,0.8027,0.8343
GO:0006913,nucleocytoplasmic transport,Q3T054(Evidence code:IEA/Database source:InterPro:IPR002041)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)E1BF47(Evidence code:IBA/Database source:PANTHER:PTN001052033)E1BM06(Evidence code:IEA/Database source:GO:0017056), RAN RGS14 XPO1 TPR NDC1,BP,5,5 of 65,0.22,7.69,0.8077,0.8393
GO:0050727,regulation of inflammatory response,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens)A0JND4(Evidence code:IEA/Database source:InterPro:IPR030410)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), JAK2 ADAMTS12 SLC7A2 SBNO2 RICTOR,BP,5,5 of 66,0.22,7.58,0.8096,0.8411
GO:0009165,nucleotide biosynthetic process,G3MY14(Evidence code:IEA/Database source:InterPro:IPR005946)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR005946)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR005946)Q08DW2(Evidence code:IEA/Database source:InterPro:IPR005946), PRPS2 PRPSAP2 PRPS1L1 PRPSAP1,BP,4,4 of 73,0.18,5.48,0.8185,0.8501
GO:0016050,vesicle organization,F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)Q1RMH8(Evidence code:IBA/Database source:PANTHER:PTN000058569)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q2KHV6(Evidence code:IBA/Database source:PANTHER:PTN000058569), CADPS SNX3 SNX12 SNX8,BP,4,4 of 75,0.18,5.33,0.8193,0.8508
GO:0045786,negative regulation of cell cycle,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BHY2(Evidence code:IEA/Database source:InterPro:IPR028319)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q5E9L2(Evidence code:ISS/Database source:UniProtKB:O60477), ALOX15B CDK6 PPP1R13B CHMP1A BRINP1,BP,5,5 of 90,0.22,5.56,0.8348,0.8666
GO:0022604,regulation of cell morphogenesis,F1MHR5(Evidence code:IEA/Database source:UniProtKB:Q5VZL5|ens)G3N135(Evidence code:IEA/Database source:InterPro:IPR027656)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN001364370)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens), ZMYM4 FMNL2 ZMYM5 AGO4 BCL9L,BP,5,5 of 90,0.22,5.56,0.8348,0.8666
GO:0051259,protein complex oligomerization,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR009073|I)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)Q5EA65(Evidence code:ISS/Database source:UniProtKB:P24140), GRHPR MALT1 HSCB BLM KHDRBS1 PFKM DPAGT1,BP,7,7 of 120,0.31,5.83,0.8568,0.8893
GO:0030155,regulation of cell adhesion,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)P05059(Evidence code:TAS/Database source:)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN001231348)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62140), SRF LAMA3 CHGA STAT5B KIF14 JAK2 NUAK1 STAT5A PPP1CB,BP,9,9 of 121,0.39,7.44,0.8586,0.891
GO:0003690,double-stranded DNA binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:Q6Q899|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)Q17QV0(Evidence code:IEA/Database source:UniProtKB:P57722|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens), DHX9 PURA SP1 PURB TDG DDX58 MB21D1 PCBP3 PRKDC,MF,9,9 of 123,0.39,7.32,0.8602,0.8924
GO:0006629,lipid metabolic process,Q3MHR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q5BIS9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q5EA59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR002641)P08487(Evidence code:IEA/Database source:InterPro:IPR001711|I)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q29460(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001711|I)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443), LYPLA1 ALOX15 BRCA1 CPT1B PRKAB1 SULT1A1 ABHD4 PTGES3 MBTPS1 FAM213B ABHD2 PNPLA2 PLCG1 LIPE PAFAH1B3 SCAP LIPF ACLY ALMS1 PLCB3 AGPAT1 PRKAG1 MBTPS2,BP,23,23 of 325,1.01,7.08,1,1
GO:0008092,cytoskeletal protein binding,E1BIG2(Evidence code:IEA/Database source:InterPro:IPR000798)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)F1MF57(Evidence code:ISS/Database source:UniProtKB:O76041)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q32LP2(Evidence code:IEA/Database source:InterPro:IPR000798)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR030267)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)F1N611(Evidence code:IEA/Database source:InterPro:IPR000798|I)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)A7YY37(Evidence code:IEA/Database source:InterPro:IPR000798)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens), NF2 PACSIN2 NEBL LOC101905447 RDX LOC101902172 DYNLL1 SYNE3 LIN7C TOR1A EPB41L1 FLNC EPB41L4A DUSP3 DYNLL2 PACSIN3,MF,16,16 of 238,0.7,6.72,1,1
GO:0006955,immune response,A7YWH4(Evidence code:IEA/Database source:InterPro:IPR010579)Q0V7N1(Evidence code:IEA/Database source:InterPro:IPR001212|I)F1N3I2(Evidence code:IEA/Database source:InterPro:IPR010579)E1B9S7(Evidence code:IBA/Database source:PANTHER:PTN000332227)A8E4P0(Evidence code:IEA/Database source:InterPro:IPR010579)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)O46414(Evidence code:ISS/Database source:UniProtKB:Q8TD27)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q9WUL6|ens)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR001811|I)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)A6YT15(Evidence code:IEA/Database source:InterPro:IPR000827|I)F1N160(Evidence code:IBA/Database source:PANTHER:PTN000587099)F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR001212)E1BF06(Evidence code:IEA/Database source:InterPro:IPR006052|I), BoLA SUSD2 LOC788634 OTUD7B LOC100125916 TRAF6 FTH1 MAP3K14 CXCL12 ZAP70 CCL28 VPREB1 LOC100848815 TINAGL1 TNFSF15,BP,15,15 of 214,0.66,7.01,1,1
GO:0005912,adherens junction,Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)E1BIS6(Evidence code:IEA/Database source:UniProtKB:O15061|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8N157)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), CTNNA1 FAM129B SYNM FRMD5 AHI1 NF2 MAGI1 TJP1,CC,8,8 of 120,0.35,6.67,1,1
GO:0003712,transcription coregulator activity,E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)F1MPU1(Evidence code:IEA/Database source:InterPro:IPR019035)Q9BE45(Evidence code:IBA/Database source:PANTHER:PTN001538048)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR028314)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499), PTPN14 MED12L NFKBIZ TDG TFDP2 ZMYND8 DDX1,MF,7,7 of 112,0.31,6.25,1,1
GO:0043410,positive regulation of MAPK cascade,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116), DAB2IP WWC1 CDON IGFBP3 KIT MYDGF F2R,BP,7,7 of 102,0.31,6.86,1,1
GO:0005125,cytokine activity,Q8MJ29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)G3N183(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)A6YT15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)E1BF06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202), IFNT LOC104968438 IFNT3 CCL28 TNFSF15 IFNT2,MF,6,6 of 84,0.26,7.14,1,1
GO:0045785,positive regulation of cell adhesion,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), CXCL12 HYAL1 FRMD5 PREX1 PPP3CA,BP,5,5 of 77,0.22,6.49,1,1
GO:0015078,proton transmembrane transporter activity,P23956(Evidence code:IEA/Database source:InterPro:IPR000245|I)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6)P61420(Evidence code:IEA/Database source:InterPro:IPR016727)P21282(Evidence code:IEA/Database source:InterPro:IPR004907|I), ATP6V0C ATP6V1B1 ATP6V0D1 ATP6V1C1,MF,4,4 of 61,0.18,6.56,1,1
GO:0070372,regulation of ERK1 and ERK2 cascade,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), FRS2 RRAS PKHD1 PTPN6,BP,4,4 of 60,0.18,6.67,1,1
GO:0042277,peptide binding,Q3SZH7(Evidence code:IBA/Database source:PANTHER:PTN000164249)E1BP91(Evidence code:IBA/Database source:PANTHER:PTN000164249)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens), LTA4H NPEPPS RNPEP IDE,MF,4,4 of 56,0.18,7.14,1,1
GO:0008202,steroid metabolic process,P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753), LIPE SCAP SULT1A1 MBTPS2,BP,4,4 of 59,0.18,6.78,1,1
GO:0031267,small GTPase binding,E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), TSC2 PAK2 ABCA1,MF,3,3 of 50,0.13,6,1,1
GO:0007204,positive regulation of cytosolic calcium ion concentration,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), F2R FIS1 ABL1,BP,3,3 of 44,0.13,6.82,1,1
GO:0030111,regulation of Wnt signaling pathway,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens), SNX3 LEF1 AXIN2,BP,3,3 of 47,0.13,6.38,1,1
GO:0009411,response to UV,A6QNS2(Evidence code:IEA/Database source:UniProtKB:O95155|ens)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens), UBE4B RAD18 CCAR2,BP,3,3 of 42,0.13,7.14,1,1
GO:0050900,leukocyte migration,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26011|ens), DBH PDE4D ITGB7,BP,3,3 of 44,0.13,6.82,1,1
GO:0004867,serine-type endopeptidase inhibitor activity,G3X894(Evidence code:IBA/Database source:PANTHER:PTN000156122)E1B7H2(Evidence code:IEA/Database source:InterPro:IPR002223|I)F1N226(Evidence code:IEA/Database source:InterPro:IPR002223|I), LOC786263 COL7A1 APLP2,MF,3,3 of 43,0.13,6.98,1,1
GO:0008514,organic anion transmembrane transporter activity,Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)Q1JQC7(Evidence code:IBA/Database source:PANTHER:PTN001936837)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334), ABCC5 SLC22A23 ABCC3,MF,3,3 of 53,0.13,5.66,1,1
GO:0050792,regulation of viral process,Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens), CHMP2A CHMP4B VPS4B,BP,3,3 of 46,0.13,6.52,1,1
GO:0051604,protein maturation,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SORL1 TSPAN14 PSEN1,BP,3,3 of 55,0.13,5.45,1,1
GO:0051099,positive regulation of binding,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P08207|ens), HIST1H2BA S100A10,BP,2,2 of 40,0.09,5,1,1
GO:0019210,kinase inhibitor activity,P02638(Evidence code:NAS/Database source:)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), S100B LRP6,MF,2,2 of 34,0.09,5.88,1,1
GO:0043484,regulation of RNA splicing,Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens), SNRNP70 ESRP1,BP,2,2 of 40,0.09,5,1,1
GO:0009156,ribonucleoside monophosphate biosynthetic process,F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842), PRPS1L1 PRPS2,BP,2,2 of 40,0.09,5,1,1
GO:1902600,proton transmembrane transport,P31407(Evidence code:IEA/Database source:InterPro:IPR004100)Q0VCP0(Evidence code:IEA/Database source:GO:0015295), ATP6V1B1 SLC33A1,BP,2,2 of 42,0.09,4.76,1,1
GO:0050830,defense response to Gram-positive bacterium,P05059(Evidence code:IDA/Database source:)Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685984), CHGA LYZ1,BP,2,2 of 31,0.09,6.45,1,1
GO:0001047,core promoter binding,G3MZY8(Evidence code:IEA/Database source:UniProtKB:P08775|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens), POLR2A ZBTB17,MF,2,2 of 33,0.09,6.06,1,1
GO:0043021,ribonucleoprotein complex binding,E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens), UHMK1 SMG6,MF,2,2 of 31,0.09,6.45,1,1
GO:0050679,positive regulation of epithelial cell proliferation,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens), HYAL1 FGF1,BP,2,2 of 33,0.09,6.06,1,1
GO:2000377,regulation of reactive oxygen species metabolic process,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), EIF6 PINK1,BP,2,2 of 36,0.09,5.56,1,1
GO:0072655,establishment of protein localization to mitochondrion,E1BME6(Evidence code:IEA/Database source:UniProtKB:P52789|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), HK2 PINK1,BP,2,2 of 28,0.09,7.14,1,1
GO:0006936,muscle contraction,A0JNJ5(Evidence code:IEA/Database source:UniProtKB:P05976|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens), MYL1 RYR1,BP,2,2 of 39,0.09,5.13,1,1
GO:0000956,nuclear-transcribed mRNA catabolic process,Q3ZBK6(Evidence code:IEA/Database source:InterPro:IPR034101)E1BJ90(Evidence code:IEA/Database source:UniProtKB:Q14147|ens), LSM4 DHX34,BP,2,2 of 36,0.09,5.56,1,1
GO:0016051,carbohydrate biosynthetic process,A3KMX1(Evidence code:IEA/Database source:InterPro:IPR018011)Q1RMX7(Evidence code:IEA/Database source:InterPro:IPR013132), CHST14 NANS,BP,2,2 of 42,0.09,4.76,1,1
GO:0033135,regulation of peptidyl-serine phosphorylation,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), SPTBN4 RICTOR,BP,2,2 of 41,0.09,4.88,1,1
GO:0050769,positive regulation of neurogenesis,A6H767(Evidence code:ISS/Database source:UniProtKB:P28656)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens), NAP1L1 SPEN,BP,2,2 of 42,0.09,4.76,1,1
GO:0004860,protein kinase inhibitor activity,Q0VCK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0649)G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893), PKIB RTN4R,MF,2,2 of 32,0.09,6.25,1,1
GO:0043009,chordate embryonic development,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349142), BRCA2 BRCA1,BP,2,2 of 37,0.09,5.41,1,1
GO:0051896,regulation of protein kinase B signaling,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens), RICTOR RRAS,BP,2,2 of 32,0.09,6.25,1,1
GO:1900182,positive regulation of protein localization to nucleus,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), CDK1 SRC,BP,2,2 of 30,0.09,6.67,1,1
GO:0070382,exocytic vesicle,E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000797746)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000797746), SYTL1 SYTL2,CC,2,2 of 34,0.09,5.88,1,1
GO:1901981,phosphatidylinositol phosphate binding,F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens), DENND1A ANKFY1,MF,2,2 of 29,0.09,6.9,1,1
GO:0030705,cytoskeleton-dependent intracellular transport,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)E1BGB0(Evidence code:IBA/Database source:PANTHER:PTN000648522), KIF1B KIF13B,BP,2,2 of 36,0.09,5.56,1,1
GO:0010466,negative regulation of peptidase activity,P98167(Evidence code:IEA/Database source:GO:0030414)P20811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646), SSPO CAST,BP,2,2 of 32,0.09,6.25,1,1
GO:0042113,B cell activation,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404), MALT1 PRKCB,BP,2,2 of 39,0.09,5.13,1,1
GO:0006940,regulation of smooth muscle contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 17,0.04,5.88,1,1
GO:0044309,neuron spine,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens),PALM,CC,1,1 of 14,0.04,7.14,1,1
GO:0061097,regulation of protein tyrosine kinase activity,Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31),RAP2C,BP,1,1 of 14,0.04,7.14,1,1
GO:0050851,antigen receptor-mediated signaling pathway,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens),SH2B2,BP,1,1 of 16,0.04,6.25,1,1
GO:0060429,epithelium development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 18,0.04,5.56,1,1
GO:0005504,fatty acid binding,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P11766|ens),ADH5,MF,1,1 of 16,0.04,6.25,1,1
GO:0006695,cholesterol biosynthetic process,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 17,0.04,5.88,1,1
GO:0019835,cytolysis,Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081),LYZ1,BP,1,1 of 17,0.04,5.88,1,1
GO:0072384,organelle transport along microtubule,F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens),ARHGAP21,BP,1,1 of 21,0.04,4.76,1,1
GO:0051492,regulation of stress fiber assembly,E1B958(Evidence code:IEA/Database source:InterPro:IPR028781),ALMS1,BP,1,1 of 19,0.04,5.26,1,1
GO:0032675,regulation of interleukin-6 production,Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens),AFAP1L2,BP,1,1 of 25,0.04,4,1,1
GO:0002028,regulation of sodium ion transport,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,BP,1,1 of 19,0.04,5.26,1,1
GO:0045667,regulation of osteoblast differentiation,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens),GLI1,BP,1,1 of 21,0.04,4.76,1,1
GO:0032432,actin filament bundle,F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens),MICALL2,CC,1,1 of 17,0.04,5.88,1,1
GO:0015918,sterol transport,E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens),OSBP,BP,1,1 of 15,0.04,6.67,1,1
GO:0099003,vesicle-mediated transport in synapse,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 21,0.04,4.76,1,1
GO:0090280,positive regulation of calcium ion import,F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens),ATP2C2,BP,1,1 of 15,0.04,6.67,1,1
GO:0099572,postsynaptic specialization,E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens),DLGAP3,CC,1,1 of 28,0.04,3.57,1,1
GO:0001816,cytokine production,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 21,0.04,4.76,1,1
GO:0061061,muscle structure development,F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens),RNF165,BP,1,1 of 19,0.04,5.26,1,1
GO:0016998,cell wall macromolecule catabolic process,Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685978),LYZ1,BP,1,1 of 16,0.04,6.25,1,1
GO:0032526,response to retinoic acid,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 14,0.04,7.14,1,1
GO:0060395,SMAD protein signal transduction,E1BJI4(Evidence code:IEA/Database source:UniProtKB:Q6GQW0|ens),BTBD11,BP,1,1 of 20,0.04,5,1,1
GO:0060562,epithelial tube morphogenesis,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens),GREB1L,BP,1,1 of 15,0.04,6.67,1,1
GO:0035257,nuclear hormone receptor binding,F1MVD0(Evidence code:IEA/Database source:InterPro:IPR014920|I),NCOA3,MF,1,1 of 21,0.04,4.76,1,1
GO:0046579,positive regulation of Ras protein signal transduction,Q5E9S7(Evidence code:IEA/Database source:UniProtKB:Q8N9B8|ens),RASGEF1A,BP,1,1 of 14,0.04,7.14,1,1
GO:0002443,leukocyte mediated immunity,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 18,0.04,5.56,1,1
GO:0034767,positive regulation of ion transmembrane transport,F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295),ANO6,BP,1,1 of 23,0.04,4.35,1,1
GO:0050709,negative regulation of protein secretion,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens),SYT4,BP,1,1 of 26,0.04,3.85,1,1
GO:0007200,phospholipase C-activating G-protein coupled receptor signaling pathway,F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN000660491),RXFP3,BP,1,1 of 22,0.04,4.55,1,1
GO:0048771,tissue remodeling,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 19,0.04,5.26,1,1
GO:0031279,regulation of cyclase activity,E1BLE8(Evidence code:IEA/Database source:GO:0010855),GRM7,BP,1,1 of 17,0.04,5.88,1,1
GO:0033178,"proton-transporting two-sector ATPase complex, catalytic domain",P11019(Evidence code:IEA/Database source:InterPro:IPR002842),ATP6V1E1,CC,1,1 of 14,0.04,7.14,1,1
GO:1903902,positive regulation of viral life cycle,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 22,0.04,4.55,1,1
GO:0048469,cell maturation,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 24,0.04,4.17,1,1
GO:0097526,spliceosomal tri-snRNP complex,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817),LSM4,CC,1,1 of 16,0.04,6.25,1,1
GO:0001837,epithelial to mesenchymal transition,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 16,0.04,6.25,1,1
GO:0033177,"proton-transporting two-sector ATPase complex, proton-transporting domain",P23956(Evidence code:IEA/Database source:InterPro:IPR002379),ATP6V0C,CC,1,1 of 19,0.04,5.26,1,1
GO:0015108,chloride transmembrane transporter activity,P35071(Evidence code:ISS/Database source:UniProtKB:P26361),CFTR,MF,1,1 of 28,0.04,3.57,1,1
GO:0019205,nucleobase-containing compound kinase activity,F1MUF5(Evidence code:IEA/Database source:InterPro:IPR000850),AK9,MF,1,1 of 18,0.04,5.56,1,1
GO:1903725,regulation of phospholipid metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 15,0.04,6.67,1,1
GO:0019395,fatty acid oxidation,Q3ZBW2(Evidence code:IEA/Database source:UniProtKB:Q9NYQ3|ens),HAO2,BP,1,1 of 21,0.04,4.76,1,1
GO:0051453,regulation of intracellular pH,F1N4L1(Evidence code:IBA/Database source:PANTHER:PTN000894242),SLC4A2,BP,1,1 of 26,0.04,3.85,1,1
GO:0051261,protein depolymerization,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 16,0.04,6.25,1,1
GO:0007062,sister chromatid cohesion,E1B9J3(Evidence code:IBA/Database source:PANTHER:PTN000286904),RAD21L1,BP,1,1 of 14,0.04,7.14,1,1
GO:0016592,mediator complex,F1MPU1(Evidence code:IEA/Database source:InterPro:IPR019035|I),MED12L,CC,1,1 of 18,0.04,5.56,1,1
GO:0048660,regulation of smooth muscle cell proliferation,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens),PRKDC,BP,1,1 of 22,0.04,4.55,1,1
GO:0017004,cytochrome complex assembly,P63026(Evidence code:IMP/Database source:),VAMP2,BP,1,1 of 20,0.04,5,1,1
GO:0015085,calcium ion transmembrane transporter activity,F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens),ATP2B3,MF,1,1 of 26,0.04,3.85,1,1
GO:0097485,neuron projection guidance,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 24,0.04,4.17,1,1
GO:0032592,integral component of mitochondrial membrane,P02722(Evidence code:IDA/Database source:),SLC25A4,CC,1,1 of 28,0.04,3.57,1,1
GO:0001659,temperature homeostasis,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 14,0.04,7.14,1,1
GO:0090207,regulation of triglyceride metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 16,0.04,6.25,1,1
GO:0048029,monosaccharide binding,Q0P563(Evidence code:IEA/Database source:InterPro:IPR007721|I),FUOM,MF,1,1 of 24,0.04,4.17,1,1
GO:0019955,cytokine binding,P43481(Evidence code:IEA/Database source:InterPro:IPR027263),KIT,MF,1,1 of 23,0.04,4.35,1,1
GO:1901888,regulation of cell junction assembly,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,BP,1,1 of 22,0.04,4.55,1,1
GO:0003796,lysozyme activity,Q06285(Evidence code:IEA/Database source:InterPro:IPR000974|I),LYZ1,MF,1,1 of 16,0.04,6.25,1,1
GO:0004601,peroxidase activity,F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens),TXNDC17,MF,1,1 of 19,0.04,5.26,1,1
GO:0045682,regulation of epidermis development,Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens),NAB2,BP,1,1 of 15,0.04,6.67,1,1
GO:0043487,regulation of RNA stability,E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280),SMG6,BP,1,1 of 14,0.04,7.14,1,1
GO:0050866,negative regulation of cell activation,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 21,0.04,4.76,1,1
GO:0050796,regulation of insulin secretion,A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens),GCK,BP,1,1 of 26,0.04,3.85,1,1
GO:0046824,positive regulation of nucleocytoplasmic transport,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,BP,1,1 of 26,0.04,3.85,1,1
GO:0051084,de novo posttranslational protein folding,F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051),UGGT2,BP,1,1 of 17,0.04,5.88,1,1
GO:0046902,regulation of mitochondrial membrane permeability,P02722(Evidence code:IBA/Database source:PANTHER:PTN000640049),SLC25A4,BP,1,1 of 16,0.04,6.25,1,1
GO:0001667,ameboidal-type cell migration,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens),WASF2,BP,1,1 of 23,0.04,4.35,1,1
GO:0031123,RNA 3-end processing,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens),ZCCHC6,BP,1,1 of 22,0.04,4.55,1,1
GO:0038024,cargo receptor activity,Q3ZC13(Evidence code:IEA/Database source:UniProtKB:P84091|ens),AP2M1,MF,1,1 of 17,0.04,5.88,1,1
GO:0031589,cell-substrate adhesion,F1MPF3(Evidence code:IEA/Database source:UniProtKB:Q9NYQ8|ens),FAT2,BP,1,1 of 21,0.04,4.76,1,1
GO:1903307,positive regulation of regulated secretory pathway,P11023(Evidence code:IEA/Database source:UniProtKB:P20336|ens),RAB3A,BP,1,1 of 14,0.04,7.14,1,1
GO:0019208,phosphatase regulator activity,G5E5Q8(Evidence code:IEA/Database source:InterPro:IPR030574),SBF1,MF,1,1 of 24,0.04,4.17,1,1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens),MVB12A,BP,1,1 of 14,0.04,7.14,1,1
GO:0042308,negative regulation of protein import into nucleus,E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens),RAB23,BP,1,1 of 19,0.04,5.26,1,1
GO:0005184,neuropeptide hormone activity,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN000385798),CRH,MF,1,1 of 23,0.04,4.35,1,1
GO:0010001,glial cell differentiation,F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens),DNER,BP,1,1 of 14,0.04,7.14,1,1
GO:0007586,digestion,Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0222),LYZ1,BP,1,1 of 19,0.04,5.26,1,1
GO:0045921,positive regulation of exocytosis,Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens),RAB9A,BP,1,1 of 21,0.04,4.76,1,1
GO:0005496,steroid binding,E1BC39(Evidence code:IEA/Database source:InterPro:IPR024178|I),ESRRG,MF,1,1 of 27,0.04,3.7,1,1
GO:0042692,muscle cell differentiation,F1N1C5(Evidence code:IEA/Database source:UniProtKB:P62932|ens),FBXO40,BP,1,1 of 14,0.04,7.14,1,1
GO:0016202,regulation of striated muscle tissue development,E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971),LEF1,BP,1,1 of 22,0.04,4.55,1,1
GO:0006101,citrate metabolic process,Q32PF2(Evidence code:IEA/Database source:InterPro:IPR014608),ACLY,BP,1,1 of 25,0.04,4,1,1
GO:0007606,sensory perception of chemical stimulus,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026754),GNAS,BP,1,1 of 14,0.04,7.14,1,1
GO:0045600,positive regulation of fat cell differentiation,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 17,0.04,5.88,1,1
GO:0008374,O-acyltransferase activity,F1MLW9(Evidence code:IEA/Database source:InterPro:IPR022284),GPAT2,MF,1,1 of 14,0.04,7.14,1,1
GO:0019229,regulation of vasoconstriction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 17,0.04,5.88,1,1
GO:0006304,DNA modification,P06526(Evidence code:IEA/Database source:UniProtKB-KW:KW-0780),DNTT,BP,1,1 of 19,0.04,5.26,1,1
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens),KIT,BP,1,1 of 15,0.04,6.67,1,1
GO:0035295,tube development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 25,0.04,4,1,1
GO:0000470,maturation of LSU-rRNA,Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061),EIF6,BP,1,1 of 14,0.04,7.14,1,1
GO:0048017,inositol lipid-mediated signaling,F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens),TNFAIP8L3,BP,1,1 of 14,0.04,7.14,1,1
GO:0051279,regulation of release of sequestered calcium ion into cytosol,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 18,0.04,5.56,1,1
GO:2000117,negative regulation of cysteine-type endopeptidase activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 26,0.04,3.85,1,1
GO:0051983,regulation of chromosome segregation,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens),PUM1,BP,1,1 of 27,0.04,3.7,1,1
GO:0009247,glycolipid biosynthetic process,F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729),GAL3ST2,BP,1,1 of 19,0.04,5.26,1,1
GO:2000379,positive regulation of reactive oxygen species metabolic process,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens),GRB2,BP,1,1 of 20,0.04,5,1,1
GO:0006636,unsaturated fatty acid biosynthetic process,Q3ZBW6(Evidence code:IEA/Database source:UniProtKB:Q9NUI1|ens),DECR2,BP,1,1 of 18,0.04,5.56,1,1
GO:0051650,establishment of vesicle localization,Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens),IKBKG,BP,1,1 of 27,0.04,3.7,1,1
GO:0045778,positive regulation of ossification,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens),NIPBL,BP,1,1 of 17,0.04,5.88,1,1
GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",P48034(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX1,MF,1,1 of 23,0.04,4.35,1,1
GO:0045582,positive regulation of T cell differentiation,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens),ZAP70,BP,1,1 of 18,0.04,5.56,1,1
GO:0072341,modified amino acid binding,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens),CPS1,MF,1,1 of 16,0.04,6.25,1,1
GO:0005666,RNA polymerase III complex,Q32PE0(Evidence code:IBA/Database source:PANTHER:PTN000080812),POLR2F,CC,1,1 of 14,0.04,7.14,1,1
GO:0043620,regulation of DNA-templated transcription in response to stress,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens),RGS14,BP,1,1 of 16,0.04,6.25,1,1
GO:0046031,ADP metabolic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 18,0.04,5.56,1,1
GO:0034612,response to tumor necrosis factor,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 26,0.04,3.85,1,1
GO:0090288,negative regulation of cellular response to growth factor stimulus,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 19,0.04,5.26,1,1
GO:0006099,tricarboxylic acid cycle,E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603),DHTKD1,BP,1,1 of 24,0.04,4.17,1,1
GO:0042304,regulation of fatty acid biosynthetic process,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135),EIF6,BP,1,1 of 14,0.04,7.14,1,1
GO:0022843,voltage-gated cation channel activity,E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens),HCN1,MF,1,1 of 26,0.04,3.85,1,1
GO:0007043,cell-cell junction assembly,F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q68FH0),PKP4,BP,1,1 of 15,0.04,6.67,1,1
GO:0008593,regulation of Notch signaling pathway,Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010),LFNG,BP,1,1 of 15,0.04,6.67,1,1
GO:0071375,cellular response to peptide hormone stimulus,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 22,0.04,4.55,1,1
GO:0097722,sperm motility,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 18,0.04,5.56,1,1
GO:0051591,response to cAMP,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 16,0.04,6.25,1,1
GO:0031214,biomineral tissue development,F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens),FAM20A,BP,1,1 of 25,0.04,4,1,1
GO:1903214,regulation of protein targeting to mitochondrion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 20,0.04,5,1,1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens),WNK1,BP,1,1 of 15,0.04,6.67,1,1
GO:0050773,regulation of dendrite development,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens),RAB17,BP,1,1 of 15,0.04,6.67,1,1
GO:0005518,collagen binding,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153),PAK1,MF,1,1 of 15,0.04,6.67,1,1
GO:0043266,regulation of potassium ion transport,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens),GCK,BP,1,1 of 16,0.04,6.25,1,1
GO:0045851,pH reduction,P31407(Evidence code:ISS/Database source:UniProtKB:P15313),ATP6V1B1,BP,1,1 of 16,0.04,6.25,1,1
GO:0061045,negative regulation of wound healing,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens),CRK,BP,1,1 of 20,0.04,5,1,1
GO:0008137,NADH dehydrogenase (ubiquinone) activity,P23709(Evidence code:IEA/Database source:InterPro:IPR001268),NDUFS3,MF,1,1 of 26,0.04,3.85,1,1
GO:0051646,mitochondrion localization,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 14,0.04,7.14,1,1
GO:0010827,regulation of glucose transmembrane transport,A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens),YES1,BP,1,1 of 14,0.04,7.14,1,1
GO:0048534,hematopoietic or lymphoid organ development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 26,0.04,3.85,1,1
GO:0008154,actin polymerization or depolymerization,Q0VCW2(Evidence code:IEA/Database source:InterPro:IPR028456),ABI1,BP,1,1 of 17,0.04,5.88,1,1
GO:0009062,fatty acid catabolic process,E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565),LPIN2,BP,1,1 of 21,0.04,4.76,1,1
GO:0055001,muscle cell development,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599),AXIN1,BP,1,1 of 24,0.04,4.17,1,1
GO:0043271,negative regulation of ion transport,E1BF90(Evidence code:IEA/Database source:UniProtKB:Q6H1V1|ens),BEST3,BP,1,1 of 20,0.04,5,1,1
GO:0065002,intracellular protein transmembrane transport,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 23,0.04,4.35,1,1
GO:0006081,cellular aldehyde metabolic process,Q2KJH9(Evidence code:ISS/Database source:UniProtKB:P49189),ALDH9A1,BP,1,1 of 21,0.04,4.76,1,1
GO:0090303,positive regulation of wound healing,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,BP,1,1 of 15,0.04,6.67,1,1
GO:0048762,mesenchymal cell differentiation,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 21,0.04,4.76,1,1
GO:0009069,serine family amino acid metabolic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 16,0.04,6.25,1,1
GO:0046651,lymphocyte proliferation,Q3SWY3(Evidence code:IEA/Database source:UniProtKB:P24547|ens),IMPDH2,BP,1,1 of 28,0.04,3.57,1,1
GO:0001191,"transcriptional repressor activity, RNA polymerase II transcription factor binding",F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens),SPEN,MF,1,1 of 22,0.04,4.55,1,1
GO:0033108,mitochondrial respiratory chain complex assembly,F1MKA6(Evidence code:IEA/Database source:UniProtKB:Q5JTZ9|ens),AARS2,BP,1,1 of 27,0.04,3.7,1,1
GO:0006986,response to unfolded protein,E1BPS0(Evidence code:IEA/Database source:InterPro:IPR039165),CREBRF,BP,1,1 of 17,0.04,5.88,1,1
GO:0010965,regulation of mitotic sister chromatid separation,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens),TPR,BP,1,1 of 19,0.04,5.26,1,1
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens),PIN1,BP,1,1 of 18,0.04,5.56,1,1
GO:0016706,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors",A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,MF,1,1 of 17,0.04,5.88,1,1
GO:0005637,nuclear inner membrane,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997),LEMD3,CC,1,1 of 17,0.04,5.88,1,1
